Citrus Sinensis ID: 044673
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | 2.2.26 [Sep-21-2011] | |||||||
| Q94A51 | 805 | U-box domain-containing p | yes | no | 0.973 | 0.942 | 0.471 | 0.0 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.953 | 0.892 | 0.426 | 0.0 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.953 | 0.891 | 0.314 | 4e-88 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.515 | 0.490 | 0.421 | 8e-87 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.487 | 0.733 | 0.415 | 3e-85 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.596 | 0.584 | 0.367 | 4e-85 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.483 | 0.446 | 0.410 | 3e-82 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.548 | 0.534 | 0.382 | 1e-80 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.558 | 0.569 | 0.322 | 3e-60 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.396 | 0.324 | 0.365 | 2e-43 |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/811 (47%), Positives = 536/811 (66%), Gaps = 52/811 (6%)
Query: 10 QRVVSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVN 69
+ +V DV+ETIFVAV ++VE++KTTV WA +NF+GKKI LL+VH+ + ++ K
Sbjct: 7 EELVLDVDETIFVAVAEDVERSKTTVLWAARNFSGKKICLLYVHRTARAASWTHKKLVGG 66
Query: 70 GLKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIR 119
K+H K+ ++ + YL LLS+ +Q D + I N+E+ IVE+I + I+
Sbjct: 67 SFKKHDVKVIERVEKPKVDELMNSYLQLLSETEIQTDKLCIAGQNIEECIVELIARHKIK 126
Query: 120 WLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI 179
WLVMGAA+DKHYS K+ +LKSKKAIFVC++AP SCHIWF CKG LI+TR+ +++ + +
Sbjct: 127 WLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSNNRQT 186
Query: 180 SPTFLLMNSNEEMKQSGHLKLESLGYRLGF------PDVEEDADD------ELEETSCCS 227
P + ++S+ E ++S L+ + RL + D E+D E S
Sbjct: 187 MPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAPPLFS 246
Query: 228 VQSSWSSNSLLGTSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKM---------------- 271
SS S +G +P L D + + S +E+ + E ++K+
Sbjct: 247 SGSSSSFGEPVGPEPVSPELVDSDTLNTSNVEEKEREGDVARKVHRYDKAMHDIGQSDRT 306
Query: 272 VYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKT 331
VY E K+W+E+ + EA CK KA++ LC+KE SQRK LEELL KEK EV+ Q++
Sbjct: 307 VYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKLEVKMVIEQNNGF 366
Query: 332 VKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRV 391
+KELQ VQ +N LE Q+ + + KE EK +A+ELL SF+QKRD++RI+ NA + V
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 392 RDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAI 451
+++ +K E +L++SF E+NEATN F+PSWK+GEG+YG+VY+G L+HL VA+
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAV 486
Query: 452 KMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN 511
KM PSYG +H +F+ VE+LSRVRHPNLVTL+G CPESRSL+++Y+ NGSLEDC + +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 512 KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571
L W++R++IAS++CSAL++LHSN PCIIHGNLKPSK+L+D+N +K++D+G LI
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIPCIIHGNLKPSKILLDSNLVTKINDYGISQLI 606
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
P D + ++DP Y + ++T ESD+Y+FGIILL+LLT RPV I
Sbjct: 607 PI------------DGLDKSDPHVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL--VSEIWSVLE 689
+DVKCALE N ++VLD+SAGDWPVA ++LA++A+RCC+ N +NRPDL V ++
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLAVVLRFIDRMK 714
Query: 690 ALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHN 749
A V S + RR PSH++CPI QEVMKDP IAADGFTYE EAIR WL +GH+
Sbjct: 715 APEVPSSETSSYANQNVPRRPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHD 774
Query: 750 TSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780
TSPMTNLK+E CNL+PN+ALH AI +WQ +W
Sbjct: 775 TSPMTNLKMEDCNLIPNHALHLAIQDWQNQW 805
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6EC: .EC: 3EC: .EC: 2EC: .EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 649 bits (1673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/808 (42%), Positives = 497/808 (61%), Gaps = 64/808 (7%)
Query: 16 VEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQHA 75
++E IFVAV K+V K+K+T+ WALQN GKKI L+HVH+PS + +K V +K+
Sbjct: 43 IDEKIFVAVDKHVAKSKSTLIWALQNTGGKKICLIHVHQPSQMIPLMGAKFPVGAVKEEE 102
Query: 76 DKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGA 125
++ + D YL + Q GV+ + ++IE +++E+GIV++I++ IR LVMGA
Sbjct: 103 VRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVMGA 162
Query: 126 AADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEISPTFLL 185
AAD+HYS+++ +LKS+KAIFV ++AP C IWF CKG LI+TR + + +E E +
Sbjct: 163 AADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREATMDDTESEYASPRPS 222
Query: 186 MNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEET-SCCSVQSSWSSNSLLGTSKST 244
+++++ ++ P+ E ++ T S + S+ SS G
Sbjct: 223 ISASDLLQT------------FSTPESEHQHISRVQSTDSVQQLVSNGSSTEQSGRVSDG 270
Query: 245 PLLTDEEEKSQS-------------------------------RLEQAKIEAKNSKKMVY 273
L TDEEE+ ++ +A EA +SK+ +
Sbjct: 271 SLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIRKATSEAHSSKQEAF 330
Query: 274 EEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVK 333
E ++R K E NA++A + K +S +E+ +RK+ E +AKEK+ KN+ + ++
Sbjct: 331 AETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQEVIME 390
Query: 334 ELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRD 393
ELQ+ Q + LE Q+A+S +++L +K+ AV+LL + +R++L+ E A R +
Sbjct: 391 ELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRALREAEE 450
Query: 394 IKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKM 453
++ + L Q +FSFSE+ EATN+F+ + KIGEG YG++Y GLLRH VAIKM
Sbjct: 451 LRSHAETSTLQLPQ-YFTDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKM 509
Query: 454 FPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKK 513
Q +++Q EV+VLS++RHPN++TLIG CPE SLV+EYL GSLED L CK+
Sbjct: 510 LNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNS 569
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHLI- 571
PL WQ R++IA+++C+AL++LHSN+ ++HG+LKP+ +L+D+N SKLSDFG L+
Sbjct: 570 PPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLH 629
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
P G + + + Y+DPE +G+LTP+SDVYSFGIILLRLLTGRP LRI
Sbjct: 630 PNGSKSVRTDVTG------TVAYLDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRIS 683
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+VK AL+ N +LD AGDWP +AEQLA LALRCCE NRPDL +E+W VLE +
Sbjct: 684 NEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENRPDLGTEVWRVLEPM 743
Query: 692 RVSCVFPVSCS-GSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNT 750
R S S G EHR P +F+CPI QEVM+DP +AADGFTYE EAIR WL S H+T
Sbjct: 744 RASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYEAEAIRAWLDSEHDT 803
Query: 751 SPMTNLKLEHCNLLPNYALHQAIIEWQQ 778
SPMTN+KL H +L+ N+AL AI EW Q
Sbjct: 804 SPMTNVKLSHTSLIANHALRSAIQEWLQ 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 260/827 (31%), Positives = 409/827 (49%), Gaps = 83/827 (10%)
Query: 19 TIFVAVGKNVEKNKTTVFWALQNFAGKK---ISLLHVHK-----PSHVF-AFKESKCAVN 69
T+ VA+ + K+K V WA++ FA + LLH+H P+ + A S+ +
Sbjct: 21 TVVVALSGS-SKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDD 79
Query: 70 GLKQHADKI-----QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMG 124
+ + +I ++ Y L + V + + IE DNV I E +T+ +I +V+G
Sbjct: 80 VVTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIG 139
Query: 125 AAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTR------------SGSE 172
++ +S+K + + P C ++ KG L R GSE
Sbjct: 140 GSSRSFFSRK-----ADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSE 194
Query: 173 NRSELEISPTF------LLMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELE----- 221
+ S ++ ++++ + L + + + FP + A +E
Sbjct: 195 RTNSSSGSSGPTSDSSDVMSSAHDSQSRPLSLPVRRMQH---FPAIAGQASVPMETSSVG 251
Query: 222 --ETSCCSVQ-------SSWSSNSLLGTSKSTPLLTDEEEK------SQSRLEQAKIEAK 266
ET C S+ SS + +S TS+ TP D EE+ S S E +
Sbjct: 252 SDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAMSSSSSNREYGNFGTR 311
Query: 267 NS-KKMVYEEVVKRWKEE-DNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRT 324
S M + R ++ N +A + QS +++ E+E+L A+ + +
Sbjct: 312 FSWSGMGVDTTHSRASQQASNMSDALSE----QSYTDNQVNLNFEVEKLRAELRHVQEMY 367
Query: 325 KNQHDKTVKELQTVQDQNSA-LEGQLAESHSVVKELEEKIISAVELLISFKQKRD----Q 379
+T + + + N LE + +KE E + ++ E K +RD +
Sbjct: 368 AVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMR 427
Query: 380 LRIECGNAQRR------VRDIKKSIKREA-LSFFQPGLLEFSFSELNEATNNFEPSWKIG 432
R E AQRR RD K+ K E L Q F++ E+ AT++F KIG
Sbjct: 428 ERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIG 487
Query: 433 EGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRS 492
G YG VY+ L H +K+ S Q +FQ E+E+LS++RHP+LV L+G CPE +
Sbjct: 488 MGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGA 547
Query: 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSK 551
LV+EY+ NGSLED L N PL W R +IA +V +AL++LH ++P IIH +LKP+
Sbjct: 548 LVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPAN 607
Query: 552 VLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDV 611
+L+D NF SK+ D G ++ + + +++ YIDPEY TG+++ +SD+
Sbjct: 608 ILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDI 667
Query: 612 YSFGIILLRLLTGRPVLRIKKDVKCALEKRN-FNSVLDSSAGDWPVAEAEQLAHLALRCC 670
YSFG+ILL+LLT +P + + V+ A++ + F +LD AG+WP+ E +LA LAL C
Sbjct: 668 YSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCT 727
Query: 671 ENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAA 730
E +RPDL +I LE L+ S S + P+HF+CP+L++VM +P +AA
Sbjct: 728 ELRGKDRPDLKDQILPALENLK-KVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAA 786
Query: 731 DGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777
DG+TY+ AI WLK HNTSPMT+ L NLLPNY L+ AI+EW+
Sbjct: 787 DGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEWR 832
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 8e-87, Method: Compositional matrix adjust.
Identities = 177/420 (42%), Positives = 259/420 (61%), Gaps = 18/420 (4%)
Query: 373 FKQKRDQLRIECGNAQRRVRDIKKS------IKREALSFFQPGLL--EFSFSELNEATNN 424
F+QKR R E AQRR ++K + K E S P L EF++ E+ AT++
Sbjct: 403 FEQKR---REEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSS 459
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
F KIG G YG+VY+ L H A+K+ S +F E+E+LS++RHP+LV L+
Sbjct: 460 FSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLL 519
Query: 485 GTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC-II 543
G CP+ +LV+EY+ NGSLED L N P+ W R++IA +V SAL++LH ++P II
Sbjct: 520 GACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPII 579
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLET 602
H +LKP+ +L++ NF SK+ D G +I + + + ++ YIDPEY T
Sbjct: 580 HRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRT 639
Query: 603 GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN---SVLDSSAGDWPVAEA 659
G+++P+SDVY+FG+I+L+LLTG+ + + V+ A+E N + +LD AG+WP+ E
Sbjct: 640 GRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEET 699
Query: 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPIL 719
QLA LAL+C E +RPDL +I VLE+L+ S S + PSHF CP+L
Sbjct: 700 RQLAALALQCTELRSKDRPDLEDQILPVLESLK-KVADKARNSLSAAPSQPPSHFFCPLL 758
Query: 720 QEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
++VMK+P IAADG+TY+ AI W++ H TSP+TN L++ NLLPN+ L+ AI+EW+ R
Sbjct: 759 KDVMKEPCIAADGYTYDRRAIEEWME-NHRTSPVTNSPLQNVNLLPNHTLYAAIVEWRNR 817
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 169/407 (41%), Positives = 250/407 (61%), Gaps = 27/407 (6%)
Query: 378 DQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYG 437
DQL+ E NA ++V +++ +L+FS ++ +AT +F+ + ++G+ YG
Sbjct: 120 DQLKHERDNAVQQVNELRDQSTHI--------ILDFSRKDMEQATEHFKNAREVGDTEYG 171
Query: 438 NVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEY 497
+ Y+G++ ++ V IK+ S FQ EV +L + RHPN++T IG C E +LV+E+
Sbjct: 172 HTYKGMIHNMKVLIKL-----SSSQKLFQQEVSILRQWRHPNIITFIGVCSEVSALVYEW 226
Query: 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-PCIIHGNLKPSKVLIDA 556
L NG+LED + C N +PL W R QI ++C AL++LHSN+ ++HG+L+P +LIDA
Sbjct: 227 LPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDA 286
Query: 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFG 615
N+ SK+ +FG +L Q L N +A + Y+DPE+ TG+LT SDVYS G
Sbjct: 287 NYRSKICNFGMSNLFLQ--------LGTFPPNLTARLPYMDPEFNTTGELTTLSDVYSLG 338
Query: 616 IILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRL 675
+I+LRLLTG P L + + V AL + + ++D SAGDWP EA+QLA + L C R
Sbjct: 339 VIILRLLTGMPPLTLSEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRK 398
Query: 676 NRPDLVSEIWSVLEALR---VSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADG 732
RPDL++E+W V+E L + +P S S + +P+ F+CPI E+MKDPQ+A+DG
Sbjct: 399 KRPDLLNEVWIVIEPLTRKPPAATWPYLQSASGD-SSVPAAFICPISMEIMKDPQVASDG 457
Query: 733 FTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
FTYE EAIR W G + SPMTNL L + NL+PN L I + Q+
Sbjct: 458 FTYEAEAIRCWFDRGISRSPMTNLALPNLNLVPNRVLRSFIHGYLQQ 504
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 185/503 (36%), Positives = 288/503 (57%), Gaps = 38/503 (7%)
Query: 293 VKAMQSLCVKE-MSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAE 351
+K M ++ E + K++++L + +E R KN T++E ++ + +E +
Sbjct: 309 IKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNL---TIRE----EEADEVVEME--- 358
Query: 352 SHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR-----EALSFF 406
+E +E + EL+ ++ + R+E A+ R +++K +R E
Sbjct: 359 -----RERQEDAENEAELVRECIERETEERLE---AEARAEEVRKEKQRLEDALEGGPLQ 410
Query: 407 QPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQ 466
+ ++F + E+ EAT++F KIG G YG+VYR L H VA+K+ S +F
Sbjct: 411 RQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFH 470
Query: 467 NEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN------KKSPLRWQT 520
E+E+LS++RHP+L+ L+G CPE SLV+EY+ NGSLE+ L + + PLRW
Sbjct: 471 QELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFE 530
Query: 521 RMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579
R +IA ++ SAL +LH+NEP I+H +LKP+ +L+D N SK+ D G ++ S
Sbjct: 531 RFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHA- 589
Query: 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE 639
S + NE+ YIDPEY TG +TPESD+Y+FGIILL+L+T R + + ++ AL
Sbjct: 590 STVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALR 649
Query: 640 KRN--FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697
+ F +LD +AGDWPV EA+++ + LRC E + +RPDL EI VLE L+
Sbjct: 650 DQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASI 709
Query: 698 PVSCSGSK---EHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMT 754
+ H P+HF CPI ++VM++P +A+DG+TYE AI+ WL+ H SPMT
Sbjct: 710 ARNMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMT 768
Query: 755 NLKLEHCNLLPNYALHQAIIEWQ 777
+L +LLPN++L AI EW+
Sbjct: 769 DLPFPSDSLLPNHSLLSAIKEWR 791
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 162/395 (41%), Positives = 245/395 (62%), Gaps = 18/395 (4%)
Query: 392 RDIKKSIKREALSFFQPGLL--EFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHV 449
RD ++ K +A S PG+ +++ E+ AT++F + KIG G YG+VY+ L H
Sbjct: 456 RDAREKDKLQA-SLVSPGVQYQHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTG 514
Query: 450 AIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLAC 509
A+K+ + Q +F E+E+LS++RHP+LV L+G CPE LV+EY+ NGSL+D L
Sbjct: 515 AVKVLHAGETQLSKQFDQELEILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLML 574
Query: 510 KNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFF 568
N P+ W R +IA +V SAL++LH ++P IIH +LKP +L+D NF SKL D G
Sbjct: 575 VNDTPPIPWFERFRIALEVASALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLS 634
Query: 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL 628
++ Q + + + + +++ YIDPEY TG ++P+SDVYS G+++L+L+T +P +
Sbjct: 635 TMVNQDDVSSRT-IFKQTSPVGTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAI 693
Query: 629 RIKKDVKCAL-EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687
I V+ A+ + F ++LD AG WP+++ +LA L L C E R +RPDL +I
Sbjct: 694 AITHMVEEAIGDDAEFMAILDKKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPA 753
Query: 688 LEALR-----VSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRG 742
LE LR + + SG PSHF+CP+L+ VM +P +AADG+TY+ EAI
Sbjct: 754 LERLRKVADKAQNLLSRTPSGP------PSHFICPLLKGVMNEPCVAADGYTYDREAIEE 807
Query: 743 WLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777
WL+ +TSP+TNL L + NL+ NY L+ AI+EW+
Sbjct: 808 WLRQ-KDTSPVTNLPLPNKNLIANYTLYSAIMEWK 841
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 180/471 (38%), Positives = 265/471 (56%), Gaps = 43/471 (9%)
Query: 315 AKEKQEVQRT-----KNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVEL 369
A EK+E+QR K ++ K VKE++T + AL + +E ++ I+ V
Sbjct: 360 AVEKEELQRNTAALEKERYMKAVKEVETAK----AL---------LAREFCQRQIAEVNA 406
Query: 370 LISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSW 429
L ++ +K+ + G R +++ E+ AT F P
Sbjct: 407 LRTYLEKKKVIDQLLGTDHR--------------------YRKYTIEEIVTATEGFSPEK 446
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489
IGEG YG VY+ L A+K+ P+ +F EVEVLS++RHP++V L+G CPE
Sbjct: 447 VIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPE 506
Query: 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLK 548
+ LV+EYL NGSLE+ + + K PL W R ++ +V L +LHS++P I+H +LK
Sbjct: 507 NGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLK 566
Query: 549 PSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPE 608
P +L++ N+ SK++D G L+ + N + S YIDPEY TG + P+
Sbjct: 567 PGNILLNRNYVSKIADVGLAKLV-TDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPK 625
Query: 609 SDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALR 668
SD+Y+FGII+L+LLT R I V+ A++K +LD S DWP+AE E+LA + L+
Sbjct: 626 SDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLK 685
Query: 669 CCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQI 728
C E +RPDL SE+ VL+ L + V GS + R PSH+ CPIL+E+M++P+I
Sbjct: 686 CAEFRCRDRPDLKSEVIPVLKRLVETANSKVKKEGS--NLRAPSHYFCPILREIMEEPEI 743
Query: 729 AADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
AADGFTYE +AI WL+ HN SP+T KL+H L PN+ L AI +W+ R
Sbjct: 744 AADGFTYERKAILAWLEK-HNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 164/508 (32%), Positives = 262/508 (51%), Gaps = 72/508 (14%)
Query: 301 VKEMSQRKE-LEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQL-----AESHS 354
+KE S+R+E L+ L +K+ ++ KN +K +L ++ + L ++ A+S +
Sbjct: 294 IKEESERREKLQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQA 353
Query: 355 VVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRV-----RDIKKSIKREALSFFQPG 409
V ELE ++ E++ ++ R Q + RR+ R++ S+ +E + + G
Sbjct: 354 EV-ELERVVLQRGEMITEIEKLRSQRDV----FNRRIEFCKEREVIGSVSKEEV---KCG 405
Query: 410 LLEFSFSELNEATNNFEPSWKIGEG-RYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNE 468
E+ ++ AT + ++ G + NVYRG ++H VA+K+ S F +
Sbjct: 406 YREYVAEDIRLATETYSDRLRLKSGGNWTNVYRGRIKHTTVAVKVIGD--SLSDEAFGAK 463
Query: 469 VEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNGSLEDCLACKNKKSP----LRWQTRMQ 523
V++L+ +RHPNLV + G C + + L+FEY+ NG+L D L +KS L+W R++
Sbjct: 464 VKLLNEIRHPNLVAIAGFCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIR 523
Query: 524 IASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582
IA VCS L +LHS +P I+HG L PSK+L+D N K++ FG Q ++
Sbjct: 524 IAHQVCSGLGFLHSVKPKPIVHGRLTPSKILLDRNLVPKITGFGLIMHSDQSDT------ 577
Query: 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN 642
+ DV +FG++LL LLTGR + K + ++ + +
Sbjct: 578 -------------------------KPDVMAFGVLLLHLLTGRNWHGLLKAM--SMNQTS 610
Query: 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVS-EIWSVLEALRVSCVFPVSC 701
LD +AG WP+ A++ LA++C NR D + EI L +R +
Sbjct: 611 ILRDLDQTAGKWPLELAKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTK 670
Query: 702 SGSKEHRR----------IPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTS 751
G +E IPS F+CPILQEVMK+P +AADGF+YE EAI+ WL GH+TS
Sbjct: 671 GGYEEATNSNMDEGDPNDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTS 730
Query: 752 PMTNLKLEHCNLLPNYALHQAIIEWQQR 779
PMTNL+L++ L PN+ L I +W +
Sbjct: 731 PMTNLRLDYQMLTPNHTLRSLIQDWHSK 758
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 120/328 (36%), Positives = 179/328 (54%), Gaps = 19/328 (5%)
Query: 363 IISAVEL--LISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNE 420
+ +AV L +I+ R ++R A+R+ R K S+K E G+ F+++EL
Sbjct: 569 VAAAVTLTAIIALIIMRKRMRGYSAVARRK-RSSKASLKIE-------GVKSFTYAELAL 620
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLL-RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN 479
AT+NF S +IG+G YG VY+G L VAIK Q +F E+E+LSR+ H N
Sbjct: 621 ATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRN 680
Query: 480 LVTLIGTCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
LV+L+G C E + LV+EY+ NG+L D ++ K K PL + R++IA ++YLH+
Sbjct: 681 LVSLLGFCDEEGEQMLVYEYMENGTLRDNISVK-LKEPLDFAMRLRIALGSAKGILYLHT 739
Query: 538 N-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
P I H ++K S +L+D+ F +K++DFG L P + G S + Y+D
Sbjct: 740 EANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLD 799
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTG-RPVLR---IKKDVKCALEKRNFNSVLDSSAG 652
PEY T +LT +SDVYS G++LL L TG +P+ I +++ A E + S +D
Sbjct: 800 PEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMS 859
Query: 653 DWPVAEAEQLAHLALRCCENNRLNRPDL 680
P E+ A LALRCC RP +
Sbjct: 860 SVPDECLEKFATLALRCCREETDARPSM 887
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | ||||||
| 225464503 | 823 | PREDICTED: U-box domain-containing prote | 0.971 | 0.921 | 0.579 | 0.0 | |
| 302143837 | 840 | unnamed protein product [Vitis vinifera] | 0.971 | 0.902 | 0.571 | 0.0 | |
| 255545246 | 793 | receptor protein kinase, putative [Ricin | 0.973 | 0.957 | 0.614 | 0.0 | |
| 224122334 | 770 | predicted protein [Populus trichocarpa] | 0.960 | 0.972 | 0.612 | 0.0 | |
| 356574505 | 717 | PREDICTED: U-box domain-containing prote | 0.898 | 0.977 | 0.519 | 0.0 | |
| 356534121 | 697 | PREDICTED: U-box domain-containing prote | 0.870 | 0.974 | 0.509 | 0.0 | |
| 51971048 | 805 | unknown protein [Arabidopsis thaliana] | 0.973 | 0.942 | 0.472 | 0.0 | |
| 18408768 | 805 | U-box domain-containing protein 32 [Arab | 0.973 | 0.942 | 0.471 | 0.0 | |
| 359489801 | 881 | PREDICTED: U-box domain-containing prote | 0.976 | 0.864 | 0.446 | 0.0 | |
| 297819520 | 804 | kinase family protein [Arabidopsis lyrat | 0.971 | 0.942 | 0.473 | 0.0 |
| >gi|225464503|ref|XP_002272091.1| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2462), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/820 (57%), Positives = 588/820 (71%), Gaps = 62/820 (7%)
Query: 13 VSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLK 72
V DVE TIFVAVGK VEK+KT +FWA++NF+GK++ +LHVH+P + +A K + N LK
Sbjct: 12 VGDVENTIFVAVGKRVEKSKTALFWAVKNFSGKRVCVLHVHQPENTYASVNKKVSANKLK 71
Query: 73 QHADK----------IQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLV 122
Q A K +++ +QYLL+L+Q GV+ +WIE +N+E GIVE+I Q+NI+WLV
Sbjct: 72 QQAVKASYERERQNMMKLLNQYLLILAQKGVRAYKLWIEMENIEKGIVEIIAQKNIKWLV 131
Query: 123 MGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEISPT 182
MGAAADK+YSKK+ ELKSKKAIFVCQQAP+SCHIWF CKG LIYTR + +E+E+SP
Sbjct: 132 MGAAADKYYSKKMAELKSKKAIFVCQQAPLSCHIWFACKGYLIYTRGSRQVETEIEVSPP 191
Query: 183 FLLMNSNEEMKQSGHLKLESLGYRLGFPDV------------------EEDAD------- 217
LL+N N E KQS +L ES+ Y+ D+ EE+AD
Sbjct: 192 LLLLNKNVESKQSANLISESITYKQKSFDLSSLKSTGRMMLLQYHANTEENADEWDGMSR 251
Query: 218 ------------------DELEETSCCSVQSSWSSNSLLGTSKSTPLLTDEEEKSQSRLE 259
D L T C ++ + L K+ L TD S RLE
Sbjct: 252 RSSSPRLSSSNWSNKGEVDSLHSTLCPKDEAQEEDSILPSDEKNQGLATD---GSYDRLE 308
Query: 260 QAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQ 319
A + KNSK+ +EE VKRW+ ED+A+EA K K ++L K MS+RKELEE LA+ K+
Sbjct: 309 PAIMFTKNSKQDAFEESVKRWQAEDDAMEAIRKAKETETLHTKHMSKRKELEEELARGKE 368
Query: 320 EVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQ 379
EV+R KNQ D+ +KELQ VQDQ S LE ++AESHS KELEEKIISAV+LLIS +QKRD+
Sbjct: 369 EVERMKNQQDELMKELQMVQDQRSILESRIAESHSSEKELEEKIISAVKLLISIRQKRDE 428
Query: 380 LRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNV 439
L +E +A R V +++ S++ EA SF P L FSF E+NEATNNF+PSWKIGEG YG+V
Sbjct: 429 LLVEHKDAIREVNELRGSVQEEAASFCTPQFLSFSFMEINEATNNFDPSWKIGEGSYGSV 488
Query: 440 YRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLR 499
Y+G+LRH+HVAIKM P YG Q HL+FQ+EVEV RVRHPNL+TLIGTCPESRSL++EYL+
Sbjct: 489 YKGVLRHMHVAIKMLPFYGSQDHLEFQHEVEVSCRVRHPNLMTLIGTCPESRSLIYEYLQ 548
Query: 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559
NGSLED L C+N+ PL WQTR++IA+++CSALI+LHSN+P IIHGNLKP+KVL+D N+
Sbjct: 549 NGSLEDRLTCRNRTPPLPWQTRIRIATEICSALIFLHSNKPSIIHGNLKPTKVLLDGNYV 608
Query: 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILL 619
KL D +IP GE+ +++ S S Y+DPE+LETG+L PE DVYSFGII++
Sbjct: 609 CKLGDLDILRIIPPGENM------TKTSPKSTSAYMDPEFLETGELAPELDVYSFGIIMM 662
Query: 620 RLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679
RLLTGRP L I DVKCALE FN+VLD SAGDWP+ +A QLAHLALRCCE N NRPD
Sbjct: 663 RLLTGRPALGIVNDVKCALENEVFNAVLDFSAGDWPLEQANQLAHLALRCCEKNHFNRPD 722
Query: 680 LVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEA 739
L SE+WSVLEA+ VSC +C GS+ HRRIPSHF+CPI QEVMKDP IAADGFTYE +A
Sbjct: 723 LASEVWSVLEAMMVSCTASATCLGSRPHRRIPSHFICPIFQEVMKDPHIAADGFTYEADA 782
Query: 740 IRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
I+GWL+SGHNTSPMTNLKL CNLLPNYAL AI EWQQR
Sbjct: 783 IKGWLQSGHNTSPMTNLKLSDCNLLPNYALLYAIQEWQQR 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143837|emb|CBI22698.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2448), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/837 (57%), Positives = 592/837 (70%), Gaps = 79/837 (9%)
Query: 13 VSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLK 72
V DVE TIFVAVGK VEK+KT +FWA++NF+GK++ +LHVH+P + +A K + N LK
Sbjct: 12 VGDVENTIFVAVGKRVEKSKTALFWAVKNFSGKRVCVLHVHQPENTYASVNKKVSANKLK 71
Query: 73 QHADK----------IQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLV 122
Q A K +++ +QYLL+L+Q GV+ +WIE +N+E GIVE+I Q+NI+WLV
Sbjct: 72 QQAVKASYERERQNMMKLLNQYLLILAQKGVRAYKLWIEMENIEKGIVEIIAQKNIKWLV 131
Query: 123 MGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEISPT 182
MGAAADK+YSKK+ ELKSKKAIFVCQQAP+SCHIWF CKG LIYTR + +E+E+SP
Sbjct: 132 MGAAADKYYSKKMAELKSKKAIFVCQQAPLSCHIWFACKGYLIYTRGSRQVETEIEVSPP 191
Query: 183 FLLMNSNEEMKQSGHLKLESLGYRLGFPDV------------------EEDAD------- 217
LL+N N E KQS +L ES+ Y+ D+ EE+AD
Sbjct: 192 LLLLNKNVESKQSANLISESITYKQKSFDLSSLKSTGRMMLLQYHANTEENADEWDGMSR 251
Query: 218 ------------------DELEETSC------------CSVQSS-----WSSNSLLGTSK 242
D L T C SVQ + +S + + K
Sbjct: 252 RSSSPRLSSSNWSNKGEVDSLHSTLCPKDEAQEEDSILPSVQKAHDGHHYSPSIIFLDEK 311
Query: 243 STPLLTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVK 302
+ L TD S RLE A + KNSK+ +EE VKRW+ ED+A+EA K K ++L K
Sbjct: 312 NQGLATD---GSYDRLEPAIMFTKNSKQDAFEESVKRWQAEDDAMEAIRKAKETETLHTK 368
Query: 303 EMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEK 362
MS+RKELEE LA+ K+EV+R KNQ D+ +KELQ VQDQ S LE ++AESHS KELEEK
Sbjct: 369 HMSKRKELEEELARGKEEVERMKNQQDELMKELQMVQDQRSILESRIAESHSSEKELEEK 428
Query: 363 IISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEAT 422
IISAV+LLIS +QKRD+L +E +A R V +++ S++ EA SF P L FSF E+NEAT
Sbjct: 429 IISAVKLLISIRQKRDELLVEHKDAIREVNELRGSVQEEAASFCTPQFLSFSFMEINEAT 488
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
NNF+PSWKIGEG YG+VY+G+LRH+HVAIKM P YG Q HL+FQ+EVEV RVRHPNL+T
Sbjct: 489 NNFDPSWKIGEGSYGSVYKGVLRHMHVAIKMLPFYGSQDHLEFQHEVEVSCRVRHPNLMT 548
Query: 483 LIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
LIGTCPESRSL++EYL+NGSLED L C+N+ PL WQTR++IA+++CSALI+LHSN+P I
Sbjct: 549 LIGTCPESRSLIYEYLQNGSLEDRLTCRNRTPPLPWQTRIRIATEICSALIFLHSNKPSI 608
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
IHGNLKP+KVL+D N+ KL D +IP GE+ +++ S S Y+DPE+LET
Sbjct: 609 IHGNLKPTKVLLDGNYVCKLGDLDILRIIPPGENM------TKTSPKSTSAYMDPEFLET 662
Query: 603 GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
G+L PE DVYSFGII++RLLTGRP L I DVKCALE FN+VLD SAGDWP+ +A QL
Sbjct: 663 GELAPELDVYSFGIIMMRLLTGRPALGIVNDVKCALENEVFNAVLDFSAGDWPLEQANQL 722
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEV 722
AHLALRCCE N NRPDL SE+WSVLEA+ VSC +C GS+ HRRIPSHF+CPI QEV
Sbjct: 723 AHLALRCCEKNHFNRPDLASEVWSVLEAMMVSCTASATCLGSRPHRRIPSHFICPIFQEV 782
Query: 723 MKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
MKDP IAADGFTYE +AI+GWL+SGHNTSPMTNLKL CNLLPNYAL AI EWQQR
Sbjct: 783 MKDPHIAADGFTYEADAIKGWLQSGHNTSPMTNLKLSDCNLLPNYALLYAIQEWQQR 839
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545246|ref|XP_002513684.1| receptor protein kinase, putative [Ricinus communis] gi|223547592|gb|EEF49087.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 940 bits (2430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/786 (61%), Positives = 583/786 (74%), Gaps = 27/786 (3%)
Query: 15 DVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQH 74
DVE TIFVAVGKNV K T + W +Q+FAG KI LLHVH+P + E + L
Sbjct: 15 DVENTIFVAVGKNVAKGTTALLWTVQSFAGLKICLLHVHRPPDSVSLSE---LLFILFYT 71
Query: 75 ADK-----------IQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVM 123
AD+ + V +Y L+L Q GV D VWIE +N+E GIVE+I Q NIRWLVM
Sbjct: 72 ADRRLFLERERKKMLDVLSRYCLILDQKGVHVDKVWIEMENIEKGIVEIIAQYNIRWLVM 131
Query: 124 GAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEISPTF 183
GAAADK+YSKKL LKSKKA FVCQ APISCHIWF CKGCLIYTR G +RSE E S
Sbjct: 132 GAAADKYYSKKLAGLKSKKARFVCQHAPISCHIWFACKGCLIYTREGRNDRSEAEFSLPL 191
Query: 184 LLMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQSSWSSNSLLGTSKS 243
LL+NS+ M+Q LKL S ++ P + + V S+ + + S
Sbjct: 192 LLLNSDLGMEQPALLKLGSFT-QIHKPLGSMEYFKPFQFRYQYGVLQSFQFKTFHEGTWS 250
Query: 244 TPLLTDEEEKSQSR--------LEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKA 295
L +EEK+Q + L+Q ++AK S++ +EE KRWK+ED+A+EAKCKVKA
Sbjct: 251 MAL---QEEKNQGQTTEKTCLQLQQVILDAKGSQQKAFEEAAKRWKKEDDAMEAKCKVKA 307
Query: 296 MQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSV 355
+++LC+KE+S RKE+EE L ++KQEV++TKNQ D+ VKELQ VQ+ LEGQL ES+ +
Sbjct: 308 LENLCIKEISLRKEMEEELIRKKQEVEKTKNQRDEFVKELQKVQEHKFVLEGQLTESNCM 367
Query: 356 VKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSF 415
V +LEEKIISAVELLISFK +RD R E NA+R +K K EA+SF + +LEFSF
Sbjct: 368 VNDLEEKIISAVELLISFKAQRDAARREYENARREANRQRKLAKVEAVSFCRSDILEFSF 427
Query: 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV 475
E+NEAT +F+PSWKIGEG+YG+VY+G+LRH +VAIKM PSYG QS L F+N VEVL RV
Sbjct: 428 VEINEATQDFDPSWKIGEGKYGSVYKGILRHAYVAIKMLPSYGSQSQLDFRNGVEVLGRV 487
Query: 476 RHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
RHP+LVTLIGTCPESRSLV+EY+RN SLEDCLACKNK+ PL WQTR++IA+++CSALI+L
Sbjct: 488 RHPHLVTLIGTCPESRSLVYEYVRNESLEDCLACKNKRLPLPWQTRIRIATEICSALIFL 547
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA-LCNESNNDSASVY 594
HSN+PCIIHGNLK SKVL+D+N SKLSDFG LIP+GE G++ + +SN + SVY
Sbjct: 548 HSNKPCIIHGNLKLSKVLLDSNSVSKLSDFGISLLIPKGEKMGDTVPMSEKSNPNFTSVY 607
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654
DPEYLE G L P SDVYSFGIILL+LLT RPV + KDVKCALEK N ++LD S+GDW
Sbjct: 608 TDPEYLERGTLIPGSDVYSFGIILLQLLTARPVSGLVKDVKCALEKENLKALLDFSSGDW 667
Query: 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHF 714
P+ + + LA LAL CCENNRLNRPDLVSEIWSVLE +R SC +SC GSKE +RIPSHF
Sbjct: 668 PIEQTKLLAKLALDCCENNRLNRPDLVSEIWSVLEPMRASCGDSLSCLGSKELQRIPSHF 727
Query: 715 VCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAII 774
VCPI QEVMKDPQIAADGFTY+ +AIRGWLKSGHNTSPMTNLKLEHCNLLPN+ALHQAI
Sbjct: 728 VCPIFQEVMKDPQIAADGFTYDADAIRGWLKSGHNTSPMTNLKLEHCNLLPNHALHQAIQ 787
Query: 775 EWQQRW 780
EWQQRW
Sbjct: 788 EWQQRW 793
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122334|ref|XP_002318809.1| predicted protein [Populus trichocarpa] gi|222859482|gb|EEE97029.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2364), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/797 (61%), Positives = 593/797 (74%), Gaps = 48/797 (6%)
Query: 1 MENFEENRQQRVVSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFA 60
ME + +RV +EETIFVAVGKNV+K+K +FW LQ+FAGKKI LL+VH+P++V +
Sbjct: 1 MEGVDGLEAERVFH-LEETIFVAVGKNVDKSKRLLFWVLQSFAGKKICLLYVHRPANVVS 59
Query: 61 FKESKCAVNGLKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIV 110
F K AVN LK+ A K V DQY L+L+Q GV+ D VWI+ D++ GIV
Sbjct: 60 FTHRKLAVNKLKEDAVKAFQELETKKMHDVLDQYRLILAQEGVEADKVWIKMDDIAKGIV 119
Query: 111 EVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSG 170
EVI Q NIRWLVMGAAADK+YSKKL E+KSKKAI VCQQAP SCHIWF C+G LIYTR G
Sbjct: 120 EVIAQYNIRWLVMGAAADKYYSKKLGEIKSKKAIIVCQQAPTSCHIWFVCRGSLIYTREG 179
Query: 171 SENRSELEISPTFLLMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQS 230
+ SE EIS LL++S+ + +Q L+ ESL D EE A D LE
Sbjct: 180 RDYGSETEISLPLLLLSSDSDTEQLRLLRSESLTQLDRSLDAEEVAGD-LE--------- 229
Query: 231 SWSSNSLLGTSKSTPLLTDEEEKSQ--------SRLEQAKIEAKNSKKMVYEEVVKRWKE 282
+LG P+ + EEEK+Q SRLEQA ++ K+SK+ E VKRWKE
Sbjct: 230 -----GILGRFDYYPVHSYEEEKTQTQTTEETCSRLEQAIMDTKDSKQKALVEAVKRWKE 284
Query: 283 EDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQN 342
EDNA+ A+++LC+KE+S RKE+EE L + KQEV++ KNQ D+ +KELQ VQ+
Sbjct: 285 EDNAI-------ALENLCIKEISLRKEMEEALNRRKQEVEKKKNQRDEFLKELQMVQEHK 337
Query: 343 SALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREA 402
ALE Q+AES + V+ELE+KIISAV+LLISFK++RD +E NA++ VR +K+S A
Sbjct: 338 FALESQIAESQNTVEELEQKIISAVQLLISFKERRDAAMVEYENARQEVRRLKRS-AIAA 396
Query: 403 LSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSH 462
+ + +LEFSF E+NEAT+ F+PSWKI EG+YG+VY+GLLRHL VAIKMFPSY QS
Sbjct: 397 AAGSKSEILEFSFMEINEATHYFDPSWKISEGKYGSVYKGLLRHLLVAIKMFPSYSSQSL 456
Query: 463 LKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM 522
L FQN VE+ SRVRHPNLV L+GTCPESRSLV+EY+RNGSLED L CK+K PL WQTR+
Sbjct: 457 LDFQNGVEIFSRVRHPNLVMLVGTCPESRSLVYEYVRNGSLEDNLFCKDKMPPLPWQTRI 516
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-SA 581
+IA +CS+L++LHSN+PCIIHGNLKPSKVL+DANF SKL+DFG F+LIPQ ES N +
Sbjct: 517 RIAVQICSSLVFLHSNKPCIIHGNLKPSKVLLDANFVSKLTDFGVFYLIPQSESGSNLTG 576
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641
+CN+SN + S+YIDPEYLETG LTPESDVYSFGIILL+LLTGR L I K+VKCA+EK
Sbjct: 577 ICNKSNPNFTSLYIDPEYLETGMLTPESDVYSFGIILLQLLTGRAGLDILKEVKCAIEKD 636
Query: 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSC 701
NF ++LD S G+WP EAEQLA+LALRCCE NRL+RPDLV I VLE ++ S +
Sbjct: 637 NFKALLDCSGGNWPFEEAEQLANLALRCCEKNRLDRPDLVL-ILRVLEPMKTSGI----D 691
Query: 702 SGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHC 761
SG KE RIPSHFVCPILQEVM DPQIAADGFTYE EAIRGWLKSGHNTSPMTNLKLEHC
Sbjct: 692 SGPKEPSRIPSHFVCPILQEVMDDPQIAADGFTYEAEAIRGWLKSGHNTSPMTNLKLEHC 751
Query: 762 NLLPNYALHQAIIEWQQ 778
NLLPN+ALHQAI+EW+Q
Sbjct: 752 NLLPNHALHQAILEWRQ 768
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574505|ref|XP_003555387.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/781 (51%), Positives = 533/781 (68%), Gaps = 80/781 (10%)
Query: 12 VVSDVE-ETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNG 70
+V D + +T++VAVGKN EK + + W ++NF+GK+I LLH+H+P + +F + +
Sbjct: 4 IVEDADTDTVYVAVGKNAEKTQQLLHWTVKNFSGKEICLLHIHQPHSLNSFSDRNLSGYE 63
Query: 71 LKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRW 120
K HA K ++ DQY+L L AGV+ + IE D++E GI + I Q NIRW
Sbjct: 64 PKDHAIKAFQEHGNQKVHELLDQYILTLVPAGVRAYKLLIEMDDIEKGITKAIAQHNIRW 123
Query: 121 LVMGAAADKHYS-KKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI 179
LVMGAAA Y+ KL + +S+KAIFV +QA +SC+ WF CKG +I R S++ S++E
Sbjct: 124 LVMGAAAADGYNLGKLAKQESEKAIFVREQALLSCNTWFICKGNVICNREYSKHTSDIET 183
Query: 180 SPTFLLMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQSSWSSNSLLG 239
P L EE +Q+ + C ++ S++
Sbjct: 184 GPALL---EKEEREQARKIN--------------------------CRLE-----RSIID 209
Query: 240 TSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSL 299
+ P + + L++ K+E N ED E++C
Sbjct: 210 AKSAKP------KGYEVALKRWKVENSNM--------------EDEEFESQC-------- 241
Query: 300 CVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKEL 359
KE+ +RKE+EE LA+EKQEVQ+ KNQ D+ ++ELQ VQDQNSAL Q++ES EL
Sbjct: 242 -AKEIQRRKEVEEQLAREKQEVQKMKNQRDEILEELQMVQDQNSALMNQISESQCTETEL 300
Query: 360 EEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELN 419
EEKIISAV+LLISF+++RD+LRIE NA R V+ +++ S ++ FSF E+N
Sbjct: 301 EEKIISAVDLLISFREQRDRLRIEHANALREVKVLRR-FGEAGTSSYRVEFPAFSFVEIN 359
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN 479
EATN+F+PSWKIGEGRYG+VY+GLLR++HVAIKM PSYG QS L+FQ++VEVLSRVRHPN
Sbjct: 360 EATNDFDPSWKIGEGRYGSVYKGLLRNMHVAIKMLPSYGHQSVLEFQHQVEVLSRVRHPN 419
Query: 480 LVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L+TL+G+C ESRSLV+EY+ NGSLE LA K +K+PL WQ R+ IA+D+CSALI+LHS+
Sbjct: 420 LLTLMGSCAESRSLVYEYINNGSLESHLAHK-EKNPLPWQIRISIATDICSALIFLHSSG 478
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG-ESTGNSALCNESNNDSASVYIDPE 598
PCIIHGNLKPSKVL+DANF +KLSD G L+ Q +S S +CN N A Y+DPE
Sbjct: 479 PCIIHGNLKPSKVLLDANFVAKLSDLGIPSLVQQSLDSADTSTICNNPNESLA--YVDPE 536
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658
Y TGKLTPESDVYSFG+ILL+LLTGRP+L + +D+KCALEK NF ++LD S+G+WP+ +
Sbjct: 537 YFVTGKLTPESDVYSFGVILLQLLTGRPLLGLVRDMKCALEKENFKAILDFSSGEWPLFQ 596
Query: 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPI 718
EQLA+LALRCCE LNRPDLVSEIWSVLE + +C+ S SK+ RR+PSHFVCPI
Sbjct: 597 TEQLAYLALRCCEKTWLNRPDLVSEIWSVLEPFKATCIDTSSHLISKKLRRVPSHFVCPI 656
Query: 719 LQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778
+QEVM+DP IAADGFTYE EAIRGWL SGH+TSPMTNLKL+H +L+PNYALH AI+EWQQ
Sbjct: 657 VQEVMEDPYIAADGFTYEEEAIRGWLNSGHDTSPMTNLKLDHTDLVPNYALHNAILEWQQ 716
Query: 779 R 779
+
Sbjct: 717 Q 717
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534121|ref|XP_003535606.1| PREDICTED: U-box domain-containing protein 32-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/777 (50%), Positives = 517/777 (66%), Gaps = 98/777 (12%)
Query: 14 SDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQ 73
+D + ++VAVGKN K + + W ++NF+GK+I LLH+H+P + +F + + K
Sbjct: 8 ADTDTVVYVAVGKNAYKTQQLLHWTVKNFSGKEICLLHIHQPHSLNSFSDRNLSGYEPKD 67
Query: 74 HADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVM 123
HA K ++ DQY+L L AGV+ + IE D++E GI + I Q NIRWLVM
Sbjct: 68 HATKAFQEHGNQTVHKLLDQYVLTLVPAGVRAYKLLIEMDDIEKGITKAIAQHNIRWLVM 127
Query: 124 GAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEISPTF 183
GAAAD++ + S++ S++E P
Sbjct: 128 GAAADRYNLGEY-----------------------------------SKHTSDIETGPAL 152
Query: 184 LLMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQSSWSSNSLLGTSKS 243
L++N N + KQ ++K ES+ +G K
Sbjct: 153 LVLNPNTDAKQFENIKSESIP---------------------------------VGALKY 179
Query: 244 TPLLTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKE 303
LE++ I+AK++K YE +K+WK E++ E K +S C KE
Sbjct: 180 F------------GLEKSIIDAKSAKTKGYEVALKKWKVENSNTEDK----TFESQCAKE 223
Query: 304 MSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKI 363
+ +RKE+EE LA+EKQEVQ+ KNQ D+ ++ELQ VQDQNSAL Q++ES ELEEKI
Sbjct: 224 IRRRKEVEEQLAREKQEVQKMKNQRDEILEELQMVQDQNSALMNQISESQCTETELEEKI 283
Query: 364 ISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATN 423
ISAV+LLISF+++RD+LRIE NA R V+ ++K + + ++ FSF E+NEATN
Sbjct: 284 ISAVDLLISFREQRDRLRIEHANAVREVKVLRKIGEADTSFSYRVEFPAFSFVEINEATN 343
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+F+PSWKIGEGRYG+VY+G LR++HVAIKM PSYG QS L+FQ++VEVLSRVRHPNL+TL
Sbjct: 344 DFDPSWKIGEGRYGSVYKGQLRNMHVAIKMLPSYGCQSLLEFQHQVEVLSRVRHPNLLTL 403
Query: 484 IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+G+C ESRSLV+EY+ NGSLE LA K +K+PL WQ R+ IA+D+CSALI+LHS+EPCII
Sbjct: 404 MGSCAESRSLVYEYINNGSLESHLAHK-EKNPLPWQIRISIATDICSALIFLHSSEPCII 462
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQG-ESTGNSALCNESNNDSASVYIDPEYLET 602
HGNLKPSKVL+DANF +KLSD G L+ + +S S +CN N A Y+DPEY T
Sbjct: 463 HGNLKPSKVLLDANFVAKLSDLGIPSLVQRSLDSADTSTICNNPNERLA--YVDPEYFVT 520
Query: 603 GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
GKLTPESDVYSFG+ILL+LLTGRP+L + +D+KCALEK N +VLDSSAG+WP + EQL
Sbjct: 521 GKLTPESDVYSFGVILLQLLTGRPLLGLVRDMKCALEKENLKAVLDSSAGEWPFFQTEQL 580
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEV 722
A+LALRCCE LNRPDLVSEIWSVLE + +C+ SK+ RRIPSHFVCPI+QEV
Sbjct: 581 AYLALRCCEKTWLNRPDLVSEIWSVLEPFKATCIDTPPHLISKKLRRIPSHFVCPIVQEV 640
Query: 723 MKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
M+DP IAADGFTYE EAIRGWL SGH+TSPMTNLKL+H +L+PNYALH AI+EWQQ+
Sbjct: 641 MEDPYIAADGFTYEEEAIRGWLNSGHDTSPMTNLKLDHTDLVPNYALHNAILEWQQQ 697
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|51971048|dbj|BAD44216.1| unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/811 (47%), Positives = 536/811 (66%), Gaps = 52/811 (6%)
Query: 10 QRVVSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVN 69
+ +V DV+ETIFVAV ++VE++KTTV WA +NF+GKKI LL+VH+ + ++ K
Sbjct: 7 EELVLDVDETIFVAVAEDVERSKTTVLWAARNFSGKKICLLYVHRTARAASWTHKKLVGG 66
Query: 70 GLKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIR 119
K+H K+ ++ + YL LLS+ +Q D + I N+E+ IVE+I + I+
Sbjct: 67 SFKKHDVKVIERVEKPKVDELMNSYLQLLSETEIQTDKLCIAGQNIEECIVELIARHKIK 126
Query: 120 WLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI 179
WLVMGAA+DKHYS K+ +LKSKKAIFVC++AP SCHIWF CKG LI+TR+ +++ + +
Sbjct: 127 WLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSNNRQT 186
Query: 180 SPTFLLMNSNEEMKQSGHLKLESLGYRLGF------PDVEEDADD------ELEETSCCS 227
P + ++S+ E ++S L+ + RL + D E+D E S
Sbjct: 187 MPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAPPLFS 246
Query: 228 VQSSWSSNSLLGTSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKM---------------- 271
SS S +G +P L D + + S +E+ + E ++K+
Sbjct: 247 SGSSSSFGEPVGPEPVSPELVDSDTLNTSNVEEKEREGDVARKVHRYDKAMHDIGQSDRT 306
Query: 272 VYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKT 331
VY E K+W+E+ + EA CK KA++ LC+KE SQRK LEELL KEK EV+ Q++
Sbjct: 307 VYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKLEVKMVIEQNNGF 366
Query: 332 VKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRV 391
+KELQ VQ +N LE Q+ + + KE EK +A+ELL SF+QKRD++RI+ NA + V
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 392 RDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAI 451
+++ +K E +L++SF E+NEATN F+PSWK+GEG+YG+VYRG L+HL VA+
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYRGNLQHLQVAV 486
Query: 452 KMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN 511
KM PSYG +H +F+ VE+LSRVRHPNLVTL+G CPESRSL+++Y+ NGSLEDC + +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 512 KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571
L W++R++IAS++CSAL++LHSN PCIIHGNLKPSK+L+D+N +K++D+G LI
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIPCIIHGNLKPSKILLDSNLVTKINDYGISQLI 606
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
P D + ++DP Y + ++T ESD+Y+FGIILL+LLT RPV I
Sbjct: 607 PI------------DGLDKSDPHVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL--VSEIWSVLE 689
+DVKCALE N ++VLD+SAGDWPVA ++LA++A+RCC+ N +NRPDL V ++
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLAVVLRFIDRMK 714
Query: 690 ALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHN 749
A V S + RR PSH++CPI QEVMKDP IAADGFTYE EAIR WL +GH+
Sbjct: 715 APEVPSSETSSYANQNVPRRPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHD 774
Query: 750 TSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780
TSPMTNLK+E CNL+PN+ALH AI +WQ +W
Sbjct: 775 TSPMTNLKMEDCNLIPNHALHLAIQDWQNQW 805
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18408768|ref|NP_566915.1| U-box domain-containing protein 32 [Arabidopsis thaliana] gi|75332032|sp|Q94A51.1|PUB32_ARATH RecName: Full=U-box domain-containing protein 32; AltName: Full=Plant U-box protein 32 gi|15215682|gb|AAK91387.1| AT3g49060/T2J13_100 [Arabidopsis thaliana] gi|28416483|gb|AAO42772.1| At3g49060/T2J13_100 [Arabidopsis thaliana] gi|51970634|dbj|BAD44009.1| unknown protein [Arabidopsis thaliana] gi|51970796|dbj|BAD44090.1| unknown protein [Arabidopsis thaliana] gi|332644973|gb|AEE78494.1| U-box domain-containing protein 32 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/811 (47%), Positives = 536/811 (66%), Gaps = 52/811 (6%)
Query: 10 QRVVSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVN 69
+ +V DV+ETIFVAV ++VE++KTTV WA +NF+GKKI LL+VH+ + ++ K
Sbjct: 7 EELVLDVDETIFVAVAEDVERSKTTVLWAARNFSGKKICLLYVHRTARAASWTHKKLVGG 66
Query: 70 GLKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIR 119
K+H K+ ++ + YL LLS+ +Q D + I N+E+ IVE+I + I+
Sbjct: 67 SFKKHDVKVIERVEKPKVDELMNSYLQLLSETEIQTDKLCIAGQNIEECIVELIARHKIK 126
Query: 120 WLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI 179
WLVMGAA+DKHYS K+ +LKSKKAIFVC++AP SCHIWF CKG LI+TR+ +++ + +
Sbjct: 127 WLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSNNRQT 186
Query: 180 SPTFLLMNSNEEMKQSGHLKLESLGYRLGF------PDVEEDADD------ELEETSCCS 227
P + ++S+ E ++S L+ + RL + D E+D E S
Sbjct: 187 MPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAPPLFS 246
Query: 228 VQSSWSSNSLLGTSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKM---------------- 271
SS S +G +P L D + + S +E+ + E ++K+
Sbjct: 247 SGSSSSFGEPVGPEPVSPELVDSDTLNTSNVEEKEREGDVARKVHRYDKAMHDIGQSDRT 306
Query: 272 VYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKT 331
VY E K+W+E+ + EA CK KA++ LC+KE SQRK LEELL KEK EV+ Q++
Sbjct: 307 VYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKLEVKMVIEQNNGF 366
Query: 332 VKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRV 391
+KELQ VQ +N LE Q+ + + KE EK +A+ELL SF+QKRD++RI+ NA + V
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 392 RDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAI 451
+++ +K E +L++SF E+NEATN F+PSWK+GEG+YG+VY+G L+HL VA+
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAV 486
Query: 452 KMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN 511
KM PSYG +H +F+ VE+LSRVRHPNLVTL+G CPESRSL+++Y+ NGSLEDC + +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 512 KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571
L W++R++IAS++CSAL++LHSN PCIIHGNLKPSK+L+D+N +K++D+G LI
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIPCIIHGNLKPSKILLDSNLVTKINDYGISQLI 606
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
P D + ++DP Y + ++T ESD+Y+FGIILL+LLT RPV I
Sbjct: 607 PI------------DGLDKSDPHVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL--VSEIWSVLE 689
+DVKCALE N ++VLD+SAGDWPVA ++LA++A+RCC+ N +NRPDL V ++
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLAVVLRFIDRMK 714
Query: 690 ALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHN 749
A V S + RR PSH++CPI QEVMKDP IAADGFTYE EAIR WL +GH+
Sbjct: 715 APEVPSSETSSYANQNVPRRPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHD 774
Query: 750 TSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780
TSPMTNLK+E CNL+PN+ALH AI +WQ +W
Sbjct: 775 TSPMTNLKMEDCNLIPNHALHLAIQDWQNQW 805
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489801|ref|XP_002274993.2| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] gi|297745303|emb|CBI40383.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/839 (44%), Positives = 536/839 (63%), Gaps = 77/839 (9%)
Query: 16 VEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQH- 74
VE+ IFVAVGK V+++K+ + WALQN GK+IS++HVH+P+ + K + LK+
Sbjct: 44 VEDKIFVAVGKEVKESKSILVWALQNSGGKRISIVHVHQPAQMIPIMGGKFPASKLKEQE 103
Query: 75 ---------ADKIQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGA 125
D ++ + YLL+ +AGV+ + ++IE +NVE GI+E+I++ I+ LV+GA
Sbjct: 104 VKAYRDLERQDMHKILNDYLLICRKAGVRAEKLYIESENVEKGILELISEHGIKKLVVGA 163
Query: 126 AADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI-SPTFL 184
AADKHYS+++LE KSKKA +V +AP+ CHIWF C+G LIYTR GS N +++E+ +P
Sbjct: 164 AADKHYSRRMLEPKSKKAAYVRDKAPLFCHIWFVCRGHLIYTREGSLNGADIELRTPPSQ 223
Query: 185 LMNSNEEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQ--------------- 229
+ N E QS + S+ P + +L T V+
Sbjct: 224 QASPNNETGQSNTFRSMSVSLGQNHPSKLVNPGQDLPRTMSVPVRITVLSSPDGTGGVSA 283
Query: 230 ----------------------------SSWSSNSLLGT-------SKSTPLLTDE---- 250
S+ SS + G S+++P+
Sbjct: 284 PWSRMGREGSSDYWDGISKRSPSQASGFSTCSSGDMAGEVNEDGLESRASPVAKQALHHS 343
Query: 251 ------EEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEM 304
EE +LEQA +EA+NS++ ++E ++R K E +A+EA + K + +E+
Sbjct: 344 SPPSVLEENIYDQLEQAMVEAENSRREAFQESLRRSKAEKDAIEAIRRAKEAERSFSEEL 403
Query: 305 SQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKII 364
R+++EE L + +E++ +N+ + ++EL+ + S LE Q+A+S VVKELEEKII
Sbjct: 404 KLRRDIEEALQAQGKELESLRNKQQEIMEELKISLNHKSLLENQIADSEQVVKELEEKII 463
Query: 365 SAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNN 424
+AVELL ++K++RD+L+IE NA + ++KK K + S EFSF+E+ +AT N
Sbjct: 464 AAVELLQNYKKERDELQIERDNAIKTAEELKK--KGASTSHTPQYFAEFSFAEIEKATQN 521
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
F+PS KIGEG YG++Y+G LRH VAIKM S Q +FQ EV++LS++RHPNLVTLI
Sbjct: 522 FDPSVKIGEGGYGSIYKGCLRHTQVAIKMLHSDSFQGPTEFQQEVDILSKLRHPNLVTLI 581
Query: 485 GTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CII 543
G CPE+ +L++EYL NGSLED L C++ PL WQ R++IA+++CS LI+LHSN P I+
Sbjct: 582 GACPEAWALIYEYLPNGSLEDRLNCRDNTPPLSWQARIRIAAELCSVLIFLHSNNPDSIV 641
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQ-GESTGNSALCNESNNDSASVYIDPEYLET 602
HG+LKPS +L+DANFGSKLSDFG +I G S+ ++ +C + Y+DPE+L +
Sbjct: 642 HGDLKPSNILLDANFGSKLSDFGICRVISHDGNSSNSATMCCRTGPKGTFAYMDPEFLSS 701
Query: 603 GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
G+LT +SDVYSFGIILLRLLTG+P + I K+V+ AL++ N N++LD AGDWP +A+QL
Sbjct: 702 GELTVKSDVYSFGIILLRLLTGKPAIGITKEVQHALDQGNLNTLLDPLAGDWPFVQAKQL 761
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSC--SGSKEHRRIPSHFVCPILQ 720
A +ALRCCE NR +RPDLVSE+W VLE ++VSC S GS+E +IP +F+CPI Q
Sbjct: 762 ALMALRCCEMNRKSRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEERGQIPPYFICPIFQ 821
Query: 721 EVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
E+M+DP +AADGFTYE EA+RGWL GH+TSPMTNLKL H NL+PN AL AI EW Q+
Sbjct: 822 EIMQDPCVAADGFTYEAEALRGWLDGGHSTSPMTNLKLGHLNLVPNRALRSAIQEWLQQ 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297819520|ref|XP_002877643.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297323481|gb|EFH53902.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/811 (47%), Positives = 534/811 (65%), Gaps = 53/811 (6%)
Query: 10 QRVVSDVEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVN 69
+ +V DV+ETIFVAV ++VE++KTTV WA +NF+GKKI LL+VH+ + ++ K
Sbjct: 7 EELVLDVDETIFVAVAEDVERSKTTVLWAARNFSGKKICLLYVHRTARAASWTHKKLVGG 66
Query: 70 GLKQHADKI----------QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIR 119
K+H K+ ++ + YL LLS+ VQ D + I N+E+GI+E+I + I+
Sbjct: 67 SFKKHDVKVIERAEKPKVDELMNSYLHLLSETEVQTDKLCIAGQNIEEGILELIARHKIK 126
Query: 120 WLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLIYTRSGSENRSELEI 179
WLVMGAA+DKHYS K+ +LKSKKAIFVC++AP CHIWF CKG LI+TR+ +E + +
Sbjct: 127 WLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDYCHIWFLCKGYLIFTRASNEGSNNRQT 186
Query: 180 SPTFLLMNSNEEMKQSGHLKLESLGYRLGF------PDVEEDADD------ELEETSCCS 227
P + ++S+ E ++S L+ + RL + D E+D E T S
Sbjct: 187 MPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRATPHFS 246
Query: 228 VQSSWSSNSLLGTSKSTPLLTDEEEKSQS----------------RLEQAKIEAKNSKKM 271
SS S +G +P L D + + S R ++A + S++
Sbjct: 247 SGSSSSFGEPVGPEPISPELVDSDTLTTSNVKEKEREGDVARKVHRYDKAMHDIGQSERT 306
Query: 272 VYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKT 331
VY E K WKE+ + EA CK +A++ LC+KE SQRK LEELL KEK EV+ Q+
Sbjct: 307 VYGEAGKNWKEDASTTEALCKARALEGLCIKESSQRKRLEELLEKEKHEVKMVIEQNSGF 366
Query: 332 VKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRV 391
+KELQ VQ QN LE Q+ + + KE EK +A+ELL SF+QKRD++RI+ NA + V
Sbjct: 367 MKELQMVQGQNLKLESQIRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 392 RDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAI 451
+++ IK E F +LE+SF E+NEATN F+PSWK+GEG+YG++Y+G L+HL VA+
Sbjct: 427 NALRRLIKGETGEFSGSEMLEYSFMEINEATNEFDPSWKLGEGKYGSIYKGNLQHLQVAV 486
Query: 452 KMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN 511
KM PSYG +H +F+ VE+LSRVRHPNLVTL+G CPESRSL+++Y+ NGSLEDC + +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 512 KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571
L W++R++IAS++CSAL++LH+N PCIIHGNLKPSK+L+D+N +K++D+G LI
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHTNIPCIIHGNLKPSKILLDSNLVTKVNDYGISQLI 606
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
P D + ++DP Y + ++T ESD+Y+FGIILL LLT RPV I
Sbjct: 607 PI------------DGFDKSDPHVDPHYFVSREMTLESDIYAFGIILLLLLTRRPVSGIL 654
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+DVKCALE N ++VLD+SAG WP+A ++LA++A+RCC+ N +NRPDL + ++ +
Sbjct: 655 RDVKCALENDNISAVLDNSAGAWPIARGKKLANVAIRCCKKNPMNRPDLAV-VLRFIDRM 713
Query: 692 RVSCV--FPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHN 749
+ V S S K RR PSH++CPI QEVMKDP IAADGFTYE EAIR WL +GH+
Sbjct: 714 KAPEVPSSETSYSDQKVPRRPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHD 773
Query: 750 TSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780
TSPMTNLK+E CNL+PN+ALH AI +WQ +W
Sbjct: 774 TSPMTNLKMEDCNLIPNHALHLAIQDWQNQW 804
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | ||||||
| TAIR|locus:2101353 | 805 | AT3G49060 [Arabidopsis thalian | 0.656 | 0.636 | 0.505 | 2.9e-187 | |
| TAIR|locus:2050669 | 834 | AT2G45910 [Arabidopsis thalian | 0.661 | 0.618 | 0.471 | 3.6e-161 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.55 | 0.538 | 0.392 | 6.8e-91 | |
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.538 | 0.502 | 0.411 | 8.1e-87 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.573 | 0.545 | 0.400 | 1e-86 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.553 | 0.539 | 0.398 | 2e-79 | |
| UNIPROTKB|Q0DR28 | 518 | PUB57 "U-box domain-containing | 0.457 | 0.689 | 0.430 | 1.8e-78 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.583 | 0.576 | 0.358 | 8.4e-74 | |
| TAIR|locus:2182613 | 731 | AT5G35380 [Arabidopsis thalian | 0.511 | 0.545 | 0.355 | 1.8e-70 | |
| TAIR|locus:2007908 | 728 | AT1G17540 [Arabidopsis thalian | 0.392 | 0.420 | 0.402 | 5.4e-67 |
| TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1390 (494.4 bits), Expect = 2.9e-187, Sum P(3) = 2.9e-187
Identities = 266/526 (50%), Positives = 367/526 (69%)
Query: 257 RLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRXXXXXXXXX 316
R ++A + S + VY E K+W+E+ + EA CK KA++ LC+KE SQR
Sbjct: 292 RYDKAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEK 351
Query: 317 XXXXVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQK 376
V+ Q++ +KELQ VQ +N LE Q+ + + KE EK +A+ELL SF+QK
Sbjct: 352 EKLEVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQK 411
Query: 377 RDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRY 436
RD++RI+ NA + V +++ +K E +L++SF E+NEATN F+PSWK+GEG+Y
Sbjct: 412 RDEIRIDHENAVKEVNALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKY 471
Query: 437 GNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFE 496
G+VY+G L+HL VA+KM PSYG +H +F+ VE+LSRVRHPNLVTL+G CPESRSL+++
Sbjct: 472 GSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQ 531
Query: 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556
Y+ NGSLEDC + +N L W++R++IAS++CSAL++LHSN PCIIHGNLKPSK+L+D+
Sbjct: 532 YIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIPCIIHGNLKPSKILLDS 591
Query: 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGI 616
N +K++D+G LIP D + ++DP Y + ++T ESD+Y+FGI
Sbjct: 592 NLVTKINDYGISQLIPI------------DGLDKSDPHVDPHYFVSREMTLESDIYAFGI 639
Query: 617 ILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLN 676
ILL+LLT RPV I +DVKCALE N ++VLD+SAGDWPVA ++LA++A+RCC+ N +N
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 677 RPDLVSEIWSV--LEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFT 734
RPDL + + ++A V S + RR PSH++CPI QEVMKDP IAADGFT
Sbjct: 700 RPDLAVVLRFIDRMKAPEVPSSETSSYANQNVPRRPPSHYLCPIFQEVMKDPLIAADGFT 759
Query: 735 YEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780
YE EAIR WL +GH+TSPMTNLK+E CNL+PN+ALH AI +WQ +W
Sbjct: 760 YEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQW 805
|
|
| TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 3.6e-161, Sum P(2) = 3.6e-161
Identities = 247/524 (47%), Positives = 343/524 (65%)
Query: 257 RLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRXXXXXXXXX 316
++ +A EA +SK+ + E ++R K E NA++A + K +S +E+ +R
Sbjct: 314 KIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAK 373
Query: 317 XXXXVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQK 376
KN+ + ++ELQ+ Q + LE Q+A+S +++L +K+ AV+LL + +
Sbjct: 374 EKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDE 433
Query: 377 RDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRY 436
R++L+ E A R +++ + L Q +FSFSE+ EATN+F+ + KIGEG Y
Sbjct: 434 REELQTERDRALREAEELRSHAETSTLQLPQY-FTDFSFSEIEEATNHFDSTLKIGEGGY 492
Query: 437 GNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFE 496
G++Y GLLRH VAIKM Q +++Q EV+VLS++RHPN++TLIG CPE SLV+E
Sbjct: 493 GSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYE 552
Query: 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLID 555
YL GSLED L CK+ PL WQ R++IA+++C+AL++LHSN+ ++HG+LKP+ +L+D
Sbjct: 553 YLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLD 612
Query: 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFG 615
+N SKLSDFG L+ G+ ++ + A Y+DPE +G+LTP+SDVYSFG
Sbjct: 613 SNLVSKLSDFGTCSLL---HPNGSKSVRTDVTGTVA--YLDPEASSSGELTPKSDVYSFG 667
Query: 616 IILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRL 675
IILLRLLTGRP LRI +VK AL+ N +LD AGDWP +AEQLA LALRCCE
Sbjct: 668 IILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSE 727
Query: 676 NRPDLVSEIWSVLEALRVSCVFPVSCS-GSKEHRRIPSHFVCPILQEVMKDPQIAADGFT 734
NRPDL +E+W VLE +R S S G EHR P +F+CPI QEVM+DP +AADGFT
Sbjct: 728 NRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFT 787
Query: 735 YEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778
YE EAIR WL S H+TSPMTN+KL H +L+ N+AL AI EW Q
Sbjct: 788 YEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWLQ 831
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 6.8e-91, Sum P(3) = 6.8e-91
Identities = 177/451 (39%), Positives = 270/451 (59%)
Query: 346 EGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR--EAL 403
E + E + +E +E + EL+ ++ + R+E A+ R +++K +R +AL
Sbjct: 348 EEEADEVVEMERERQEDAENEAELVRECIERETEERLE---AEARAEEVRKEKQRLEDAL 404
Query: 404 S---FFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQ 460
+ ++F + E+ EAT++F KIG G YG+VYR L H VA+K+ S
Sbjct: 405 EGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSS 464
Query: 461 SHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKN------KKS 514
+F E+E+LS++RHP+L+ L+G CPE SLV+EY+ NGSLE+ L + +
Sbjct: 465 LTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPP 524
Query: 515 PLRWQTRMQIASDVCSALIYLHSNEPC-IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
PLRW R +IA ++ SAL +LH+NEP I+H +LKP+ +L+D N SK+ D G ++
Sbjct: 525 PLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNL 584
Query: 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633
S S + NE+ YIDPEY TG +TPESD+Y+FGIILL+L+T R + +
Sbjct: 585 DPSHA-STVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHS 643
Query: 634 VKCALEKRN--FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
++ AL + F +LD +AGDWPV EA+++ + LRC E + +RPDL EI VLE L
Sbjct: 644 IEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERL 703
Query: 692 R-VSCVFPVSCSGS--KEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGH 748
+ V+ + + + H P+HF CPI ++VM++P +A+DG+TYE AI+ WL+ H
Sbjct: 704 KEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNH 763
Query: 749 NTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
SPMT+L +LLPN++L AI EW+ +
Sbjct: 764 K-SPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
|
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
Identities = 179/435 (41%), Positives = 258/435 (59%)
Query: 356 VKELEEKIISAVELLISFKQKRD----QLRIECGNAQRR------VRDIKKSIKREA-LS 404
+KE E + ++ E K +RD + R E AQRR RD K+ K E L
Sbjct: 400 LKEYEARELAEKEKQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLG 459
Query: 405 FFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLK 464
Q F++ E+ AT++F KIG G YG VY+ L H +K+ S Q +
Sbjct: 460 SPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQ 519
Query: 465 FQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
FQ E+E+LS++RHP+LV L+G CPE +LV+EY+ NGSLED L N PL W R +I
Sbjct: 520 FQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRI 579
Query: 525 ASDVCSALIYLHSNEPC-IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
A +V +AL++LH ++P IIH +LKP+ +L+D NF SK+ D G ++ + +
Sbjct: 580 AWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIY 639
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN- 642
+++ YIDPEY TG+++ +SD+YSFG+ILL+LLT +P + + V+ A++ +
Sbjct: 640 KQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDE 699
Query: 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCS 702
F +LD AG+WP+ E +LA LAL C E +RPDL +I LE L+ S
Sbjct: 700 FLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILPALENLK-KVAEKARNS 758
Query: 703 GSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCN 762
S + P+HF+CP+L++VM +P +AADG+TY+ AI WLK HNTSPMT+ L N
Sbjct: 759 FSGVSTQPPTHFICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKN 817
Query: 763 LLPNYALHQAIIEWQ 777
LLPNY L+ AI+EW+
Sbjct: 818 LLPNYTLYTAIMEWR 832
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 827 (296.2 bits), Expect = 1.0e-86, Sum P(2) = 1.0e-86
Identities = 188/469 (40%), Positives = 282/469 (60%)
Query: 325 KNQHDK-TVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIE 383
++ H+ V +++T+ D + L +L + E E K I+ E F+QKR + R E
Sbjct: 357 RHAHEMYAVAQVETL-DASRKLN-ELKFEELTLLEHETKGIAKKETE-KFEQKRREER-E 412
Query: 384 CGNAQRR------VRDIKKSIKREALSFFQPGLL--EFSFSELNEATNNFEPSWKIGEGR 435
AQRR + K+ K E S P L EF++ E+ AT++F KIG G
Sbjct: 413 A--AQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIGMGA 470
Query: 436 YGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVF 495
YG+VY+ L H A+K+ S +F E+E+LS++RHP+LV L+G CP+ +LV+
Sbjct: 471 YGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGALVY 530
Query: 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC-IIHGNLKPSKVLI 554
EY+ NGSLED L N P+ W R++IA +V SAL++LH ++P IIH +LKP+ +L+
Sbjct: 531 EYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPANILL 590
Query: 555 DANFGSKLSDFGFFHLIPQGESTGNS-ALCNESNNDSASVYIDPEYLETGKLTPESDVYS 613
+ NF SK+ D G +I + + +++ YIDPEY TG+++P+SDVY+
Sbjct: 591 NHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSDVYA 650
Query: 614 FGIILLRLLTGRPVLRIKKDVKCALEKRNFNS---VLDSSAGDWPVAEAEQLAHLALRCC 670
FG+I+L+LLTG+ + + V+ A+E N + +LD AG+WP+ E QLA LAL+C
Sbjct: 651 FGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALALQCT 710
Query: 671 ENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAA 730
E +RPDL +I VLE+L+ S S + PSHF CP+L++VMK+P IAA
Sbjct: 711 ELRSKDRPDLEDQILPVLESLK-KVADKARNSLSAAPSQPPSHFFCPLLKDVMKEPCIAA 769
Query: 731 DGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
DG+TY+ AI W+++ H TSP+TN L++ NLLPN+ L+ AI+EW+ R
Sbjct: 770 DGYTYDRRAIEEWMEN-HRTSPVTNSPLQNVNLLPNHTLYAAIVEWRNR 817
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 2.0e-79, Sum P(2) = 2.0e-79
Identities = 176/442 (39%), Positives = 256/442 (57%)
Query: 342 NSALEGQLAESHSVVKELEE--KIISAVELLISFKQKRD-QLRIECGNAQRRVRDIKKSI 398
N+A+E + + ++ E E K + VE + + Q +I NA R + KK I
Sbjct: 358 NNAVEKEELQRNTAALEKERYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVI 417
Query: 399 KREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG 458
+ L +++ E+ AT F P IGEG YG VY+ L A+K+
Sbjct: 418 --DQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDT 475
Query: 459 PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRW 518
P+ +F EVEVLS++RHP++V L+G CPE+ LV+EYL NGSLE+ + + K PL W
Sbjct: 476 PEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPW 535
Query: 519 QTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577
R ++ +V L +LHS++P I+H +LKP +L++ N+ SK++D G L+ +
Sbjct: 536 FIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTD-VAP 594
Query: 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA 637
N + S YIDPEY TG + P+SD+Y+FGII+L+LLT R I V+ A
Sbjct: 595 DNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENA 654
Query: 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697
++K +LD S DWP+AE E+LA + L+C E +RPDL SE+ VL+ L +
Sbjct: 655 VKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANS 714
Query: 698 PVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLK 757
V GS + R PSH+ CPIL+E+M++P+IAADGFTYE +AI WL+ HN SP+T K
Sbjct: 715 KVKKEGS--NLRAPSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQK 771
Query: 758 LEHCNLLPNYALHQAIIEWQQR 779
L+H L PN+ L AI +W+ R
Sbjct: 772 LDHFKLTPNHTLRSAIRDWKSR 793
|
|
| UNIPROTKB|Q0DR28 PUB57 "U-box domain-containing protein 57" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
Identities = 161/374 (43%), Positives = 235/374 (62%)
Query: 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEV 469
+L+FS ++ +AT +F+ + ++G+ YG+ Y+G++ ++ V IK+ S FQ EV
Sbjct: 144 ILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKL-----SSSQKLFQQEV 198
Query: 470 EVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
+L + RHPN++T IG C E +LV+E+L NG+LED + C N +PL W R QI ++C
Sbjct: 199 SILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEIC 258
Query: 530 SALIYLHSNEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
AL++LHSN+ ++HG+L+P +LIDAN+ SK+ +FG +L Q G N
Sbjct: 259 CALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQ---LGTFP----PNL 311
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648
+ Y+DPE+ TG+LT SDVYS G+I+LRLLTG P L + + V AL + + ++D
Sbjct: 312 TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLLID 371
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR---VSCVFPVSCSGSK 705
SAGDWP EA+QLA + L C R RPDL++E+W V+E L + +P S S
Sbjct: 372 KSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASG 431
Query: 706 EHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLP 765
+ +P+ F+CPI E+MKDPQ+A+DGFTYE EAIR W G + SPMTNL L + NL+P
Sbjct: 432 DSS-VPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLALPNLNLVP 490
Query: 766 NYALHQAIIEWQQR 779
N L I + Q+
Sbjct: 491 NRVLRSFIHGYLQQ 504
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
Identities = 171/477 (35%), Positives = 276/477 (57%)
Query: 321 VQRTKNQHDKTVKELQTVQDQNSALEGQ-LAESHSVVKELEEKII---SAVE-------L 369
VQ T + + + +EL Q Q +L + + E+ V+ LE++ + +A E
Sbjct: 305 VQTTLSMYKQACEELVHKQTQVQSLSSECIKETERVITALEKEEMRRKAAAEEKEKHLKA 364
Query: 370 LISFKQKRDQLRIE-CGNAQRRVRDIKKSIKREALS---FFQPGLL-EFSFSELNEATNN 424
+ ++ + L E C + +K+SI+++ + F + G +++ E+ AT+N
Sbjct: 365 VKEVEEAKSMLAKEFCERQLAELDALKQSIEKQKVIEQLFLRDGRYRKYTKEEIAAATDN 424
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
F IGEG YG VY+ L H VA+K+ + +F E+ VLS++RHP++V L+
Sbjct: 425 FSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKKEEFLKEISVLSQLRHPHVVLLL 484
Query: 485 GTCPESRSLVFEYLRNGSLEDC-LACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CI 542
G CPE+ LV+EY+ NGSL DC ++ K K L W R +I + L +LH+++P I
Sbjct: 485 GACPENGCLVYEYMENGSL-DCHISPKKGKPSLSWFIRFRIIYETACGLAFLHNSKPEPI 543
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +LKP +L+D NF SK+ D G L+ E+ + + S Y+DPEY T
Sbjct: 544 VHRDLKPGNILLDRNFVSKIGDVGLAKLMSD-EAPDSVTVYRNSIIAGTLYYMDPEYQRT 602
Query: 603 GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
G + P+SD+Y+FGII+L+LLT R + V+ A+++ F +LD S DWP+AEA++L
Sbjct: 603 GTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGCFEDMLDGSVKDWPIAEAKEL 662
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEV 722
A +A+RC + +RPDL +++ L+ + S + + + R P+H+ CPIL+E+
Sbjct: 663 ARIAIRCSQLKCRDRPDLSTQVLPALKRILESANSRLKTE--QANARAPTHYYCPILKEI 720
Query: 723 MKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
M+DPQIAADGFTYE +AI+ W++ + SP+T +L+H +L PN+ L AI EW+ R
Sbjct: 721 MEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLTPNHTLRSAIREWRSR 777
|
|
| TAIR|locus:2182613 AT5G35380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 1.8e-70, Sum P(2) = 1.8e-70
Identities = 150/422 (35%), Positives = 240/422 (56%)
Query: 321 VQRTKNQHDKTVKE-LQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQ 379
++ T ++ KE + + N L+ + + H +LEE +S + ++++++
Sbjct: 304 LKHTMEMYNSACKEAISAKKAANELLKWKAEKEH----KLEEVRLSKEAAMAMAEREKEK 359
Query: 380 LR--IECGNAQRRVRDI----KKSI-----KREALSFFQPGLLEFSFSELNEATNNFEPS 428
R +E A +++ D+ +K I K+ A+S + +++ E+ EAT +F PS
Sbjct: 360 SRAAMEAAVAAQKLSDLEAEKRKHIETVDEKKRAVSSLR--YRKYTIEEIEEATEDFSPS 417
Query: 429 WKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+GEG YG VY+G L + VAIK+ Q +FQ EVEVL+ +RHPN+V L+G CP
Sbjct: 418 RKVGEGGYGPVYKGTLDYTKVAIKVLRPDAAQGRSQFQREVEVLTCMRHPNMVLLLGACP 477
Query: 489 ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNL 547
E LV+EY+ NGSL+DCL + L WQ R +IAS++ + L +LH +P ++H +L
Sbjct: 478 EYGCLVYEYMANGSLDDCLFRRGNSPILSWQLRFRIASEIATGLHFLHQMKPEPLVHRDL 537
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGKLT 606
KP +L+D +F SK+SD G L+P S ++A + + + YIDPEY +TG L
Sbjct: 538 KPGNILLDQHFVSKISDVGLARLVPP--SVADTATQYRMTSTAGTFFYIDPEYQQTGMLG 595
Query: 607 PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLA 666
+SD+YSFGI+LL++LT +P + + V+ A+EK F +LD + DWP EA A LA
Sbjct: 596 TKSDIYSFGIMLLQILTAKPPMGLTHHVEKAIEKGTFAEMLDPAVPDWPFEEALAAAKLA 655
Query: 667 LRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDP 726
L+C + R +RPDL + + L+ LR + G ++ I S +QE++ DP
Sbjct: 656 LQCAKLRRKDRPDLGNIVLPELKKLRDLAEESIKF-GVRQPSPIRSSGSATSIQEIISDP 714
Query: 727 QI 728
Q+
Sbjct: 715 QL 716
|
|
| TAIR|locus:2007908 AT1G17540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 5.4e-67, Sum P(2) = 5.4e-67
Identities = 126/313 (40%), Positives = 188/313 (60%)
Query: 383 ECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRG 442
E +RR+ +++ K + ++ +S ++ AT+ F + KIGEG YG VY+
Sbjct: 368 EIETQKRRLVEMQARFKEQNMAD-SISYRRYSIRDVEGATDGFSDALKIGEGGYGPVYKA 426
Query: 443 LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGS 502
+L + VAIK+ S Q +F E+EVLS +RHPN+V L+G CPE LV+EY+ NG+
Sbjct: 427 VLENTSVAIKLLKSDVSQGLKQFNQEIEVLSCMRHPNMVILLGACPEYGCLVYEYMENGT 486
Query: 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDANFGSK 561
LED L CK+ PL W+ R +IA+++ + L++LH +P ++H +LKP+ +LID +F SK
Sbjct: 487 LEDRLFCKDNTPPLSWRARFRIAAEIATGLLFLHQAKPEPLVHRDLKPANILIDRHFTSK 546
Query: 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASV--YIDPEYLETGKLTPESDVYSFGIILL 619
+SD G L+P + S N +A YIDPEY +TG L +SD+YSFG++LL
Sbjct: 547 ISDVGLARLVPAAVADSFS---NYHMTAAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLL 603
Query: 620 RLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679
+++T P + + V+ A+EK+ VLD DWP E LA LAL+CCE + +RPD
Sbjct: 604 QIITAMPAMGLSHRVEKAIEKKKLREVLDPKISDWPEEETMVLAQLALQCCELRKKDRPD 663
Query: 680 LVSEIWSVLEALR 692
L S + L LR
Sbjct: 664 LASVLLPALSKLR 676
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q94A51 | PUB32_ARATH | 6, ., 3, ., 2, ., - | 0.4710 | 0.9730 | 0.9428 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 6.3.2 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XII001117 | hypothetical protein (770 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 780 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-42 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 1e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-24 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-17 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| PRK12704 | 520 | PRK12704, PRK12704, phosphodiesterase; Provisional | 6e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 1e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 7e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-05 | |
| TIGR03319 | 514 | TIGR03319, RNase_Y, ribonuclease Y | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| TIGR04211 | 198 | TIGR04211, SH3_and_anchor, SH3 domain protein | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.002 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| COG2433 | 652 | COG2433, COG2433, Uncharacterized conserved protei | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.003 | |
| COG1579 | 239 | COG1579, COG1579, Zn-ribbon protein, possibly nucl | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.004 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 431 IGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHL-KFQNEVEVLSRVRHPNLVTLIGTC 487
+GEG +G VY + VAIK+ S L + E+E+L ++ HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
LV EY GSL+D L K + L ++I + L YLHSN IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSNG--IIHR 116
Query: 546 NLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-TG 603
+LKP +L+D++ G KL+DFG L+ +S + + + Y+ PE L G
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA-------YMAPEVLLGKG 169
Query: 604 KLTPESDVYSFGIILLRL 621
+ +SD++S G+IL L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 52/149 (34%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 19 TIFVAVGKNVEKNKTTVFWALQNFA--GKKISLLHVH-KPSHVFAFKESKCAVNGLKQHA 75
++ VAV K +K+K + WAL N A G+ I L+HVH + + + + KQ
Sbjct: 1 SVAVAVDK-DKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEE 59
Query: 76 DKI--QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSK 133
DK ++ Y S+ GVQ + V +E D+V IVE + I LVMGA++D H+S
Sbjct: 60 DKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSM 119
Query: 134 KLLELKSKKAIFVCQQAPISCHIWFCCKG 162
K KS A V ++AP C ++ KG
Sbjct: 120 KF--KKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 38/208 (18%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
K+GEG +G VY+G L+ VA+K + +F E ++ ++ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L+G C + L V EY+ G L D L + L + +Q+A + + YL S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV------- 593
+H +L L+ N K+SDFG L + D
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFG---------------LSRDIYEDDYYRKRGGGKL 166
Query: 594 ---YIDPEYLETGKLTPESDVYSFGIIL 618
++ PE L+ GK T +SDV+SFG++L
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 66/259 (25%), Positives = 101/259 (38%), Gaps = 31/259 (11%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
K+GEG +G VY + VAIK+ + + E+++L +++HPN+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 487 C--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
+ LV EY G L D L K+ L + SAL YLHS I+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSK--GIVH 120
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YIDPEYL 600
+LKP +L+D + KL+DFG + + + V Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGL------------ARQLDPGEKLTTFVGTPEYMAPEVL 168
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK-RNFNSVLDSSAGDWPVAEA 659
D++S G+IL LLTG+P + +K D
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS---- 224
Query: 660 EQLAHLALRCCENNRLNRP 678
+ L + + R
Sbjct: 225 PEAKDLIRKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 75/261 (28%), Positives = 111/261 (42%), Gaps = 29/261 (11%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
K+G G +G VY+ + VA+K+ S + + E+ +L R+ HPN+V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 486 TC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+ LV EY G L D L+ S + + IA + L YLHSN II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSE--DEAKK-IALQILRGLEYLHSNG--II 120
Query: 544 HGNLKPSKVLIDANFGSKLSDFGF--FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
H +LKP +L+D N K++DFG L T Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FV------GTPWYMAPEVLL 171
Query: 602 TGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD---SSAGDWPVA 657
G P+ DV+S G+IL LLTG+P + + L+ +L +
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-DQLQL--IRRILGPPLEFDEPKWSS 228
Query: 658 EAEQLAHLALRCCENNRLNRP 678
+E+ L +C + RP
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTL 483
K+GEG +G VY+G L+ VA+K + K F E V+ ++ HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 484 IGTCPESRS--LVFEYLRNGSLED------CLACKNKKSPLRWQTRMQIASDVCSALIYL 535
+G C E LV EY+ G L D + +KS L + + A + + YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
S +H +L L+ + K+SDFG + + + I
Sbjct: 122 ASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD--------YYRKKTGGKLPI 171
Query: 596 D---PEYLETGKLTPESDVYSFGIIL 618
PE L+ G T +SDV+SFG++L
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 50/234 (21%)
Query: 430 KIGEGRYGNVYRGLLRHLH------VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVT 482
K+GEG +G VY+G L+ VA+K + ++ F E ++ ++ HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 483 LIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L+G C E +V EY+ G L L + + L + A + + YL S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---- 596
IH +L L+ N K+SDFG L + +D Y
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFG---------------LSRDLYDDD---YYRKRGG 163
Query: 597 --------PEYLETGKLTPESDVYSFGIILLRLLT-------GRPVLRIKKDVK 635
PE L+ GK T +SDV+SFG++L + T G + + +K
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 42/210 (20%)
Query: 430 KIGEGRYGNVYRGLLRHLH------VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVT 482
K+GEG +G VY+G L+ VA+K + ++ F E ++ ++ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 483 LIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L+G C E +V EY+ G L D L KN+ L + A + + YL S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---- 596
IH +L L+ N K+SDFG L + +D Y
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFG---------------LSRDLYDDD---YYKVKGG 164
Query: 597 --------PEYLETGKLTPESDVYSFGIIL 618
PE L+ GK T +SDV+SFG++L
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 2e-27
Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 20/294 (6%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFP---SYGPQSHLKFQNEVEVLSRVRHP-N 479
++ K+GEG +G VY R L VA+K+ + +F E+++L+ + HP N
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL-VALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 480 LVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V L + S LV EY+ GSLED L +K PL + I + + SAL YLHS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 538 NEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
IIH ++KP +L+D + KL DFG L+P ST + ++ + Y+
Sbjct: 120 K--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG-YMA 176
Query: 597 PEYLE---TGKLTPESDVYSFGIILLRLLTGRP------VLRIKKDVKCALEKRNFNSVL 647
PE L + SD++S GI L LLTG P + + S+
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSC 701
+ P ++ + L + + NR S++ L A +S
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
FE KIG+G +G VY+ + VAIK+ + K NE+++L + +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 483 LIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
G+ + +V E+ GSL+D L K+ L + ++ L YLHSN
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YID 596
IIH ++K + +L+ ++ KL DFG SA +++ + V ++
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGL------------SAQLSDTKARNTMVGTPYWMA 165
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + ++D++S GI + L G+P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 431 IGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES 490
IG+G +G+V G R VA+K + F E V++ +RHPNLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 491 RSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLK 548
L V EY+ GSL D L + ++ + ++ A DVC + YL +H +L
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLA 129
Query: 549 PSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETGKL 605
VL+ + +K+SDFG A DS + + PE L K
Sbjct: 130 ARNVLVSEDLVAKVSDFGL-------------AKEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 606 TPESDVYSFGIILLRLLT-GR-PVLRIK-KDVKCALEK 640
+ +SDV+SFGI+L + + GR P RI KDV +EK
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFP-SYGPQSHLK-FQNEVEVLSRVRHPNLVTLIG 485
+G G +G+VY L + +A+K S + L+ + E+ +LS ++HPN+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 486 TC----PESRSLVFEYLRNGSLEDCLACKNKKSP---LRWQTRMQIASDVCSALIYLHSN 538
+ + ++ EY+ GSL L K K P +R TR + L YLHSN
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQ-----ILEGLAYLHSN 120
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
I+H ++K + +L+D++ KL+DFG + E+ S + ++ PE
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE----GTGSVRGTP-YWMAPE 173
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640
+ + +D++S G ++ + TG+P + AL K
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-23
Identities = 35/64 (54%), Positives = 39/64 (60%), Gaps = 1/64 (1%)
Query: 713 HFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQA 772
F+CPI EVMKDP I G TYE AI WL S H T P+T L H +L+PN AL A
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSA 59
Query: 773 IIEW 776
I EW
Sbjct: 60 IQEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 431 IGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489
+G G++G V+ G R + VAIKM G S F E +V+ ++ HPNLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 490 SRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
R + V EY+ NG L + L + +K L + + + SDVC A+ YL SN IH +L
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESN--GFIHRDL 126
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGKLT 606
L+ + K+SDFG + + T S V + PE + + +
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTS-------SQGTKFPVKWAPPEVFDYSRFS 179
Query: 607 PESDVYSFGIILLRLLTG 624
+SDV+SFG+++ + +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 76/289 (26%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 430 KIGEGRYGNVYRGLLRH--------LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNL 480
++GEG +G V L R+ VA+K S Q F+ E+E+L + H N+
Sbjct: 11 QLGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 481 VTLIGTC--PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
V G C P RS L+ EYL +GSL D L + + + + + +S +C + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES--TGNSALCNESNNDSASVY 594
S IH +L +L+++ K+SDFG ++P+ + +S +
Sbjct: 127 SQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE------PGESPIFW 178
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653
PE L T K + SDV+SFG+ L L T G P + + +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDP---------------SQSPPAEFLRMI 223
Query: 654 WPVAEAEQLAHLALRCCENNRLNRP--------DLVSEIWSVLEALRVS 694
+ L E RL RP DL+ W R S
Sbjct: 224 GIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 68/199 (34%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTC 487
KIG+G +G+VY+G+L+ + VA+K S P KF E E+L + HPN+V LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 488 PESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ + + V E + GSL L + KK+ L + +Q++ D + + YL S IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHR 117
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL 605
+L L+ N K+SDFG G T + L +A PE L G+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA-----PEALNYGRY 172
Query: 606 TPESDVYSFGIILLRLLTG 624
T ESDV+S+GI+L +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 36/230 (15%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQN-------EVEVLS 473
++F+ IGEG + V + AIK+ + L + E EVL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD----KRQLIKEKKVKYVKIEKEVLT 56
Query: 474 RV-RHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
R+ HP ++ L T + +L V EY NG L + K L + A+++
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILL 113
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLIPQGESTGNSALCNESN 587
AL YLHS IIH +LKP +L+D + K++DFG + N +
Sbjct: 114 ALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLD-PNSSPESNKGDATNIDS 170
Query: 588 NDSASV-----------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y+ PE L SD+++ G I+ ++LTG+P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 36/214 (16%)
Query: 431 IGEGRYGNVYRGLLRHLH-------VAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG +G VY+G L + VAIK P+ +F+ E E++S ++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 483 LIGTCPESR--SLVFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQIASD 527
L+G C + + ++FEYL +G L + L + KS L + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCN 584
+ + + YL S+ +H +L L+ K+SDFG I + S L
Sbjct: 133 IAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-- 188
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIIL 618
++ PE + GK T ESD++SFG++L
Sbjct: 189 ------PVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 46/225 (20%)
Query: 429 WKIGEGRYGNVYRGLLRHLH-------VAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNL 480
++GEG +G V+ G HL VA+K + + F+ E E+L+ +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCL-----------ACKNKKSPLRWQTRMQIASD 527
V G C E VFEY+ +G L L + + L +QIA
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN 587
+ S ++YL S +H +L L+ + K+ DFG +
Sbjct: 131 IASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDV--------------YT 174
Query: 588 NDSASV---------YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
D V ++ PE + K T ESDV+SFG++L + T
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 431 IGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
IG G +G V RG L+ + VAIK + L F E ++ + HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G +SR + + EY+ NGSL+ L + + + + S + YL +E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL--SEMNY 127
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +L +L+++N K+SDFG + E+T + + PE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT-----KGGKIPIRWTAPEAIAY 182
Query: 603 GKLTPESDVYSFGIILLRLLT 623
K T SDV+SFGI++ +++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 425 FEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
F K+G G +G V+ GL + + VAIK+ S FQ EV+ L R+RH +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 484 IGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
C ++ E + GSL L + L + + +A V + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
IH +L +L+ + K++DFG LI + S+ + PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-------SSDKKIPYKWTAPEAAS 177
Query: 602 TGKLTPESDVYSFGIILLRLLT 623
G + +SDV+SFGI+L + T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIK-MFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIG 485
IG G +G VY+GL VAIK + + LK E+++L ++HPN+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 486 TCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA---SDVCSALIYLHSNEP 540
+ S SL + EY NGSL + K P +A V L YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII---KKFGPF---PESLVAVYVYQVLQGLAYLHEQG- 119
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-IDPEY 599
+IH ++K + +L + KL+DFG +T + + + + + Y + PE
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGV--------ATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
+E + SD++S G ++ LLTG P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 423 NNFEPSWKIGEGRYGNVYR----GLLRH---LHVAIKMFPSYGP-QSHLKFQNEVEVLSR 474
NN E IG+G +G V++ GLL + VA+KM FQ E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 475 VRHPNLVTLIGTCPESRS--LVFEYLRNGSLED-------------------CLACKNKK 513
HPN+V L+G C + L+FEY+ G L + C
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
PL ++ IA V + + YL + +H +L L+ N K++DFG I
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 574 GESTGNSALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ S ND+ + ++ PE + + T ESDV+++G++L + +
Sbjct: 183 AD------YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 14/192 (7%)
Query: 430 KIGEGRYGNVYRGL-LRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
+IG G++G V+ G L VAIK G S F E +V+ ++ HP LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 489 ESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
E LVFE++ +G L D L + ++ +T + + DVC + YL S+ +IH +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESS--NVIHRD 125
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLT 606
L L+ N K+SDFG + + T ++ + PE K +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG------TKFPVKWSSPEVFSFSKYS 179
Query: 607 PESDVYSFGIIL 618
+SDV+SFG+++
Sbjct: 180 SKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGT 486
+G+G G VY+ + A+K G + K E++ L P +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 487 CPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
+ S+V EY+ GSL D L K IA + L YLH+ IIH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKRH-IIH 123
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK 604
++KPS +LI++ K++DFG + N+ + + Y+ PE ++
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGI------SKVLENTLDQCNTFVGTV-TYMSPERIQGES 176
Query: 605 LTPESDVYSFGIILLRLLTGR 625
+ +D++S G+ LL G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G G++G V+ G VA+K G S F E +++ ++RH LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 489 ESRS--LVFEYLRNGSLEDCLACKNKKSP----LRWQTRMQIASDVCSALIYLHSNEPCI 542
E +V EY+ GSL D L KS LR + +A+ + + YL S
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--Y 124
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEY 599
IH +L +L+ N K++DFG LI E T A I PE
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE---------GAKFPIKWTAPEA 175
Query: 600 LETGKLTPESDVYSFGIILLRLLT-GR 625
G+ T +SDV+SFGI+L ++T GR
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 65/228 (28%), Positives = 85/228 (37%), Gaps = 52/228 (22%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP-SYG-PQSHLKFQNEVEVLSRVRHP 478
N +E +GEG YG V + + VAIK F S EV+VL ++RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 479 NLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSP-----LRWQTRMQIASDVCSA 531
N+V L LVFEY+ LE A P WQ A
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQA 112
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
+ Y HS+ IIH ++KP +L+ + KL DFGF + A
Sbjct: 113 IAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRAR---------------PA 155
Query: 592 SVYID---------PEYL----ETGKLTPESDVYSFGIILLRLLTGRP 626
S D PE L G DV++ G I+ LL G P
Sbjct: 156 SPLTDYVATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-18
Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 21/162 (12%)
Query: 467 NEVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
+E+ + +++HPN+V LIG C + L+ EY+ +L + L L W+ R +I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785
Query: 525 ASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
A + AL +LH P ++ GNL P K++ID L L G LC
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR------LSLPG------LLC 833
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
++ +S Y+ PE ET +T +SD+Y FG+IL+ LLTG+
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 73/219 (33%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 431 IGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES 490
IG+G +G+V G R VA+K + + F E V++++RH NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 491 RS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
+ +V EY+ GSL D L + + S L ++ + DVC A+ YL +N +H +L
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDL 128
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV---YIDPEYLETGK 604
VL+ + +K+SDFG L + ST D+ + + PE L K
Sbjct: 129 AARNVLVSEDNVAKVSDFG---LTKEASST----------QDTGKLPVKWTAPEALREKK 175
Query: 605 LTPESDVYSFGIILLRLLT-GR-PVLRIK-KDVKCALEK 640
+ +SDV+SFGI+L + + GR P RI KDV +EK
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH----LHVAIKMFPSYGPQSHLKFQN----EVEVLSR 474
++ E ++G G G V + H +A+K + + Q E+++L +
Sbjct: 1 DDLEYLGELGAGNSGVVS--KVLHRPTGKIMAVKTIRL---EINEAIQKQILRELDILHK 55
Query: 475 VRHPNLVTLIGTC-PESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
P +V G S+ EY+ GSL+ L + P R ++ +A V L
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGL 113
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA- 591
YLH IIH ++KPS +L+++ KL DFG G+ L N
Sbjct: 114 TYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGV-----SGQ------LVNSLAKTFVG 161
Query: 592 -SVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
S Y+ PE ++ + +SD++S G+ L+ L TGR
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 37/212 (17%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G+G +G V L+R A+K+ H E +LSR+ HP +V
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL--TERNILSRINHPFIV 56
Query: 482 TLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ-IASDVCSALIYLHSN 538
L E LV EY G L L K + + R + A+++ AL YLHS
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFS---EERARFYAAEIVLALEYLHSL 112
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----Y 594
II+ +LKP +L+DA+ KL+DFG L +E + + Y
Sbjct: 113 G--IIYRDLKPENILLDADGHIKLTDFGL-----------AKELSSEGSRTNTFCGTPEY 159
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE L D +S G++L +LTG+P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 430 KIGEGRYGNVYRGLLRHL----HVAIK--MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+IG+G +G VY L+R +K + + NEV++L ++ HPN++
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
+ E L V EY G L + K + P + + +C AL YLHS +
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK- 123
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----YI 595
I+H ++KP + + +N KL DFG ++ ST + A +V Y+
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAK---------TVVGTPYYL 170
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + +SD++S G +L L T +
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-17
Identities = 30/73 (41%), Positives = 36/73 (49%), Gaps = 2/73 (2%)
Query: 710 IPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYAL 769
IP F+ PI E+MKDP I G TY+ I L S T P T L H L+PN L
Sbjct: 1 IPDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLEL 60
Query: 770 HQAIIEW--QQRW 780
+ I W + RW
Sbjct: 61 KEKIDAWLEENRW 73
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 431 IGEGRYGNVYRGLLRH----LHVAIKMFPSYGPQS-HLKFQNEVEVLSRV-RHPNLVTLI 484
IGEG +G V R +++ ++ AIKM + ++ H F E+EVL ++ HPN++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 485 GTCPESRSLVF---EYLRNGSLEDCLACK-------------NKKSPLRWQTRMQIASDV 528
G C E+R ++ EY G+L D L S L Q +Q ASDV
Sbjct: 70 GAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
+ + YL + IH +L VL+ N SK++DFG S G ++
Sbjct: 129 ATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGL--------SRGEEVYVKKTMG 178
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRL--LTGRP 626
++ E L T +SDV+SFG++L + L G P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 50/217 (23%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLV 481
+G G +G V L+RH A+K+ H+ NE +L +RHP LV
Sbjct: 9 LGTGSFGRVM--LVRHKGSGKYYALKILSKAKIVKLKQVEHVL--NEKRILQSIRHPFLV 64
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L G+ + +L V EY+ G L L K+ + P A+ V AL YLHS +
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPE--PVARFYAAQVVLALEYLHSLD 121
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
I++ +LKP +L+D++ K++DFGF + T LC PEY
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LCGT-----------PEY 164
Query: 600 LETGKLTPE----------SDVYSFGIILLRLLTGRP 626
L PE D ++ GI++ +L G P
Sbjct: 165 -----LAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 417 ELNEATNNFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMF-PSYGPQSHLKFQNEVE 470
EL+ + E +G GR+G + RG L R L VAI + F E
Sbjct: 1 ELDNKSIKIERI--LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 471 VLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV 528
L + H N+V L G ++ V EY+ NG+L+ L + + L M + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGL 116
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
S + YL +E +H L KVL++++ K+S F + + + A+ +
Sbjct: 117 ASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSG 168
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRIK-KDVKCALEKRNFNS 645
S ++ PE ++ + SDV+SFGI++ +++ RP + +DV A+E
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE------ 222
Query: 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688
D P L L L C + R RP S+I S+L
Sbjct: 223 --DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRF-SQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 449 VAIKMFPSYGPQ-SHL--KFQNEVEVLSRVRHPNLVTLI--GTCPESRSL-VFEYLRNGS 502
VAIK+ + P+ H +F+ E + +R+ HPN+V L+ G P VFEY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--- 559
L + LA L ++ V AL H+ I+H +LKP +++
Sbjct: 66 LREVLA---ADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPH 120
Query: 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILL 619
+K+ DFG L+P + L + Y PE L +TP SD+Y++G+I L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 620 RLLTGRPVL 628
LTG+ V+
Sbjct: 181 ECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 431 IGEGRYGNVYRGLLRH----LHVAIKMFPSYGPQS-HLKFQNEVEVLSRV-RHPNLVTLI 484
IGEG +G V + ++ + AIK Y + H F E+EVL ++ HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 485 GTCPESRSLVF---EYLRNGSLEDCLACK-------------NKKSPLRWQTRMQIASDV 528
G C E R ++ EY +G+L D L + S L Q + A+DV
Sbjct: 63 GAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
+ YL ++ IH +L +L+ N+ +K++DFG S G ++
Sbjct: 122 ARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYVKKTMG 171
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ E L T SDV+S+G++L +++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 429 WKIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
W++GEG +G V+ +L VA+K + FQ E E+L+ ++H ++V
Sbjct: 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKS------------PLRWQTRMQIASD 527
G C E R L VFEY+R+G L L + L + IAS
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCN 584
+ S ++YL S +H +L L+ K+ DFG I + G + L
Sbjct: 131 IASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-- 186
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ PE + K T ESD++SFG++L + T
Sbjct: 187 ------PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 431 IGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G VY+G+ + VAIK+ P+++ + +E V++ V HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 484 IGTCPESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+G C S+ L+ + + G L D + +N K + Q + + + YL E +
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYL--EEKRL 130
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEY 599
+H +L VL+ K++DFG L+ E E + + V I E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--------KEYHAEGGKVPIKWMALES 182
Query: 600 LETGKLTPESDVYSFGIILLRLLT--GRPVLRIK-KDVKCALEK 640
+ T +SDV+S+G+ + L+T +P I ++ LEK
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
N E KIGEG G VY+ R VAIK Q+ NE+ ++ +HPN+
Sbjct: 22 KNLE---KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77
Query: 481 VTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYL 535
V + + +V EY+ GSL D + + QIA +V L YL
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-----MNEPQIAYVCREVLQGLEYL 132
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASV- 593
HS +IH ++K +L+ + GS KL+DFGF +A + + SV
Sbjct: 133 HSQN--VIHRDIKSDNILLSKD-GSVKLADFGF------------AAQLTKEKSKRNSVV 177
Query: 594 ----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRP 626
++ PE + K P+ D++S GI+ + + G P
Sbjct: 178 GTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 56/232 (24%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYG-----PQSHLKFQNEVEVLSRV 475
+E +IGEG YG VY+ R+ VA+K P + ++ E+++L ++
Sbjct: 1 YEKIAQIGEGTYGQVYKA--RNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKL 55
Query: 476 RHPNLVTLIGTCPE----SRSLVFEY--------LRNGSLEDCLACKNKKSPLRWQTRMQ 523
RHPN+V L S +VFEY L + ++ K ++ Q
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMK-----Q 108
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
+ L YLHSN I+H ++K S +LI+ + KL+DFG ++
Sbjct: 109 LLE----GLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY---TKRNSADYT 159
Query: 584 NESNNDSASV----YIDPEYL--ETGKLTPESDVYSFGIILLRLLTGRPVLR 629
N V Y PE L T + PE D++S G IL L G+P+ +
Sbjct: 160 NR-------VITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
+IG G +G V+ G LR + VA+K + P KF E +L + HPN+V LIG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 487 CPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
C + + +V E ++ G L + + L+ + +Q+ + + + YL S IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESK--HCIH 117
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK 604
+L L+ K+SDFG G + + PE L G+
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM-----KQIPVKWTAPEALNYGR 172
Query: 605 LTPESDVYSFGIIL 618
+ ESDV+SFGI+L
Sbjct: 173 YSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 16/193 (8%)
Query: 431 IGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTCP 488
+G+G +G V++G L+ VA+K PQ +KF +E +L + HPN+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 489 ESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
+ + +V E + G L + KK L+ + ++ A D + + YL S IH +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRD 118
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGKL 605
L L+ N K+SDFG + + E G + + S + + PE L G+
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSRQEDDG---IYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 606 TPESDVYSFGIIL 618
+ ESDV+S+GI+L
Sbjct: 172 SSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 430 KIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G G++G V+ GL + VA+K G F E +++ ++RHP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 489 --ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
E +V E ++ GSL + L L+ + +A+ V S + YL + IH +
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETG 603
L VL+ N K++DFG +I + A I PE
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREG---------AKFPIKWTAPEAALYN 179
Query: 604 KLTPESDVYSFGIILLRLLT-GR 625
+ + +SDV+SFGI+L ++T GR
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
++G G++G V+ G R + VAIK + G S F E +V+ ++ HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 489 ESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
+ + L V E++ NG L + L + ++ L + + DVC + YL N IH +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRD 125
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETG 603
L L+ + K+SDFG + E T +S A + PE
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG---------AKFPVKWSPPEVFNFS 176
Query: 604 KLTPESDVYSFGIILLRLLT 623
K + +SDV+SFG+++ + T
Sbjct: 177 KYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+G G+YG VY G+ + L VA+K + +F E V+ ++HPNLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
++ E++ G+L D L + + + + +A+ + SA+ YL IH
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHR 128
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLET 602
+L L+ N K++DFG L+ G++ A A I PE L
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHA--------GAKFPIKWTAPESLAY 179
Query: 603 GKLTPESDVYSFGIILLRLLT 623
K + +SDV++FG++L + T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (191), Expect = 2e-15
Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFP----SYG-PQSHLKFQNEVEVLSRVRHPNL 480
K+GEG YG VY+ R VA+K G P + L+ E+ +L ++HPN+
Sbjct: 6 KLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKHPNI 60
Query: 481 VTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRM--QIASDVCSALIYLH 536
V L+ R LVFEY L+ L + + Q+ L Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL----LRGLAYCH 115
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGF--FHLIPQGESTGNSALCNESNNDSASV- 593
S+ I+H +LKP +LI+ + KL+DFG IP + V
Sbjct: 116 SH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-------------LRTYTHEVV 160
Query: 594 ---YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLR 629
Y PE L K + D++S G I ++TG+P+
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G+G +G V+ G VAIK G S F E +V+ ++RH LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 489 ESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E +V EY+ GSL D L + K LR + +A+ + S + Y+ +H +L
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMN--YVHRDL 128
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP 607
+ + +L+ N K++DFG LI E T + PE G+ T
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGA------KFPIKWTAPEAALYGRFTI 182
Query: 608 ESDVYSFGIILLRLLT 623
+SDV+SFGI+L L T
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 430 KIGEGRYGNVYRG-----LLRHLHVAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTL 483
K+G+G +G V RG + + VA+K S + F E ++ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 484 IGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G +V E GSL D L K+ T A + + + YL S
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLESKR--F 118
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
IH +L +L+ ++ K+ DFG +PQ E E + + PE L T
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM----EEHLKVPFAWCAPESLRT 174
Query: 603 GKLTPESDVYSFGIILLRLLT 623
+ SDV+ FG+ L + T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 431 IGEGRYGNV--YR--------GLLRHLHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPN 479
+GEG +G V Y G + VA+K G Q+ ++ E+ +L + H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 480 LVTLIGTCPE----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
+V G C E L+ EY+ GSL D L K L + A +C + YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYL 123
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
HS IH +L VL+D + K+ DFG +P+G + DS +
Sbjct: 124 HSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV----REDGDSPVFWY 177
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLT 623
E L+ K + SDV+SFG+ L LLT
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 430 KIGEGRYGNVYRGLLRHLH-VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
++G G++G V G R + VAIKM G S +F E +V+ ++ H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 489 ESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
+ R +V EY+ NG L + L K+ + +++ DVC + YL S + IH +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQ--FIHRD 125
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLT 606
L L+D K+SDFG + E T + + + PE L K +
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG------SKFPVRWSPPEVLLYSKFS 179
Query: 607 PESDVYSFGIILLRLLT 623
+SDV++FG+++ + +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQ--SHLKFQNEVEVLSRVRHPNLVTLIG 485
KIG G +G VY L +A+K + + +E++VL ++HPNLV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 486 T-CPESRSLVF-EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+ +F EY G+LE+ ++ + L + L YLHS+ I+
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEE--LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA--SVYIDPEYLE 601
H ++KP+ + +D N KL DFG + N+ E A Y+ PE +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKN-----NTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 602 TGKLTPE---SDVYSFGIILLRLLTGRP 626
GK +D++S G ++L + TG+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 30/274 (10%)
Query: 431 IGEGRYGNVYRGLLRH-----LHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
IG G +G V RG L+ + VAIK S Y + F +E ++ + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G +SR ++ E++ NG+L+ L + + + M + + + YL +E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM--LRGIAAGMKYL--SEMNY 127
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES--TGNSALCNESNNDSASVYIDPEYL 600
+H +L +L+++N K+SDFG + S T S+L + PE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL----GGKIPIRWTAPEAI 183
Query: 601 ETGKLTPESDVYSFGIILLRLLT--GRPVLRI-KKDVKCALEKRNFNSVLDSSAGDWPVA 657
K T SDV+S+GI++ +++ RP + +DV A+E+ D P A
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ----DYRLPPPMDCPTA 239
Query: 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
L L L C + +R RP +I S L+ +
Sbjct: 240 ----LHQLMLDCWQKDRNARPKF-GQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G G++G V+ G + VA+K G S F E +++ ++RH LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 489 ESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E +V EY+ GSL D L ++ L+ + +A+ V + + Y+ IH +L
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMN--YIHRDL 128
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP 607
+ + +L+ K++DFG LI E T + PE G+ T
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGA------KFPIKWTAPEAALYGRFTI 182
Query: 608 ESDVYSFGIILLRLLT-GR 625
+SDV+SFGI+L L+T GR
Sbjct: 183 KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 431 IGEGRYGNVYRGLLRH-------LHVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G G +G VY GL R L VA+K P S Q F E ++S+ H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 483 LIGTCPES--RSLVFEYLRNGSLEDCL-ACKNKK---SPLRWQTRMQIASDVCSALIYLH 536
LIG E R ++ E + G L+ L + + S L + + A DV YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 537 SNEPCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGE--STGNSALCNESNNDSA 591
N IH ++ L+ K++DFG I + G A+
Sbjct: 134 ENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK----- 186
Query: 592 SVYIDPEYLETGKLTPESDVYSFGIIL 618
++ PE G T ++DV+SFG++L
Sbjct: 187 --WMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 449 VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRS--LVFEYLRNGSLE 504
VA+K + F+ E+E+L ++H N+V G C R+ LV EYL GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 505 DCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSD 564
D L + + L + + AS +C + YL S +H +L +L+++ K+ D
Sbjct: 96 DYL--QKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGD 151
Query: 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
FG ++PQ + ES + PE L K + SDV+SFG++L L T
Sbjct: 152 FGLTKVLPQDKEYYKVREPGES----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G G++G V+ G H VAIK G S F E ++ +++HP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 489 -ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E ++ EY+ NGSL D L + L + +A+ + + ++ IH +L
Sbjct: 72 QEPIYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDL 128
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETGK 604
+ + +L+ K++DFG LI E T + A I PE + G
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAR---------EGAKFPIKWTAPEAINYGT 179
Query: 605 LTPESDVYSFGIILLRLLT-GR 625
T +SDV+SFGI+L ++T GR
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 431 IGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRV-RHPNLVTLI 484
IGEG +G V + ++ + AIK Y + H F E+EVL ++ HPN++ L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 485 GTCPESRS---LVFEYLRNGSLEDCL------------ACKNKK-SPLRWQTRMQIASDV 528
G C E R L EY +G+L D L A N S L Q + A+DV
Sbjct: 75 GAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
+ YL + IH +L +L+ N+ +K++DFG S G ++
Sbjct: 134 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYVKKTMG 183
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRL--LTGRP 626
++ E L T SDV+S+G++L + L G P
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC-P 488
IGEG +G V +G VA+K + F E V++++ H NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 489 ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLK 548
+V E + G+L + L + + Q +Q + DV + YL S + ++H +L
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK--LVHRDLA 127
Query: 549 PSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPE 608
+L+ + +K+SDFG + G NS L + PE L+ K + +
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMG--VDNSKL--------PVKWTAPEALKHKKFSSK 177
Query: 609 SDVYSFGIILLRLLT-GR---PVLRIKKDVKCALEK 640
SDV+S+G++L + + GR P + + K+VK +EK
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 430 KIGEGRYGNVYRGLLRHLH---------VAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPN 479
++GE +G +Y+G HL+ VAIK PQ +FQ E +++ + HPN
Sbjct: 12 ELGECAFGKIYKG---HLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 480 LVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNK--------------KSPLRWQTRMQ 523
+V L+G + + ++FEYL G L + L ++ KS L +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
IA + + + YL S+ +H +L +LI K+SD G I +
Sbjct: 129 IAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR----- 181
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ + ++ PE + GK + +SD++SFG++L + +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
++GEG +G V+ +L VA+K + FQ E E+L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLAC-------------KNKKSPLRWQTRMQIASD 527
G C + L VFEY+++G L L + K L + IAS
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCN 584
+ S ++YL S +H +L L+ AN K+ DFG + + G++ L
Sbjct: 132 IASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 187
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ PE + K T ESDV+SFG+IL + T
Sbjct: 188 ------PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
F+ K+GEG YG+VY+ + + VAIK+ P + E+ +L + P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVK 62
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHS 537
G+ ++ L V EY GS+ D + NK L T +IA+ L YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TL---TEEEIAAILYQTLKGLEYLHS 117
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV---- 593
N+ IH ++K +L++ +KL+DFG S ++ +V
Sbjct: 118 NK--KIHRDIKAGNILLNEEGQAKLADFGV------------SGQLTDTMAKRNTVIGTP 163
Query: 594 -YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE ++ ++D++S GI + + G+P
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 431 IGEGRYGNVY---RGLLRHLHVAIKMFPSYGPQSHLKFQN-------EVEVLSRVRHPNL 480
I +G YG V+ + + AIK+ ++ + +N E ++LS+ + P +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-YAIKVIK----KADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V L + ++L V EYL G D + L +++ AL YLHSN
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGG---DLASLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----Y 594
IIH +LKP +LID+N KL+DFG + + ++ D V Y
Sbjct: 113 G--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN---DDEKEDKRIVGTPDY 167
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
I PE + + D +S G IL L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQN----EVEVLSRVRHPNLV 481
+IGEG +G V++ + VA+K + N E++ L +HP +V
Sbjct: 7 RIGEGAHGIVFKA--KDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVV 62
Query: 482 TLIG--TCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLH 536
L+ LV EY+ L + L ++++ PL Q+ S + + Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYM-PSDLSEVL--RDEERPL---PEAQVKSYMRMLLKGVAYMH 116
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
+N I+H +LKP+ +LI A+ K++DFG L + E S + Y
Sbjct: 117 ANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------ATRWYRA 168
Query: 597 PEYL-ETGKLTPESDVYSFGIILLRLLTGRP 626
PE L K P D+++ G I LL G P
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G G +G V L++ A+K G Q H+ +E E+L HP +V
Sbjct: 1 LGVGGFGRVE--LVKVKSKNRTFALKCVKKRHIVETGQQEHIF--SEKEILEECNHPFIV 56
Query: 482 TLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L T + + + EY G L L + + R IA V A YLH+
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIAC-VVLAFEYLHNRG 113
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
II+ +LKP +L+D+N KL DFGF + G+ T C Y+ PE
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--WTFCGTPE------YVAPEI 163
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
+ D +S GI+L LLTGRP
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 38/233 (16%)
Query: 417 ELNEATNNFEPSWKIGEGRYGNVYRGLL-------RHLHVAIKMFPSYGPQS-HLKFQNE 468
E+N +T F ++GE R+G VY+G L + VAIK +F++E
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 469 VEVLSRVRHPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLAC-------------KNKK 513
+ SR++HPN+V L+G + + S++F Y + L + L K K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
S L + I + + + + +L S+ ++H +L VL+ K+SD G F +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 574 GES---TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ GNS L ++ PE + GK + +SD++S+G++L + +
Sbjct: 177 ADYYKLMGNSLL--------PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 431 IGEGRYGNVYRGLLRH-------LHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G+G +G VY GL + VAIK + + + ++F NE V+ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 483 LIGTCP-ESRSLV-FEYLRNGSLEDCLACK-------NKKSPLRWQTRMQIASDVCSALI 533
L+G +LV E + G L+ L + P Q +Q+A+++ +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNESNNDS 590
YL + + +H +L ++ + K+ DFG I + + G L
Sbjct: 134 YLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-------- 183
Query: 591 ASV-YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
V ++ PE L+ G T +SDV+SFG++L + T
Sbjct: 184 -PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 431 IGEGRYGNVYRGLL-----RHLHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
IG G +G V G L R + VAIK + Y + F +E ++ + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSNE 539
G +S+ +V EY+ NGSL+ L +K ++ T +Q+ + S + YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQF-TVIQLVGMLRGIASGMKYL--SD 124
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI---PQGESTGNSALCNESNNDSASVYID 596
+H +L +L+++N K+SDFG ++ P+ T +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-------TRGGKIPIRWTA 177
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRI-KKDVKCALEKRNFNSVLDSSAGD 653
PE + K T SDV+S+GI++ +++ RP + +DV A+E+ + D
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE----GYRLPAPMD 233
Query: 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
P A L L L C + +R RP +I S+L+ L
Sbjct: 234 CPAA----LHQLMLDCWQKDRNERPKF-EQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/274 (24%), Positives = 124/274 (45%), Gaps = 32/274 (11%)
Query: 431 IGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
IG G +G V+RG+L+ + VAIK P Y + F +E ++ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G + + ++ EY+ NG+L+ L ++ + + + + + YL ++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNY 128
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLI---PQGESTGNSALCNESNNDSASVYIDPEY 599
+H +L +L+++N K+SDFG ++ P+G T S + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-------TSGGKIPIRWTAPEA 181
Query: 600 LETGKLTPESDVYSFGIILLRLLT--GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657
+ K T SDV+SFGI++ +++ RP + ++ D P+
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRLPAPMD 234
Query: 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+ L L+C + +R RP V +I ++L+ L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 72/296 (24%), Positives = 117/296 (39%), Gaps = 48/296 (16%)
Query: 431 IGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVT 482
+GEG +G V + L VA+KM S L+ +E +L +V HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 483 LIGTCPESRS--LVFEYLRNGSLEDCLACKNK---------------------KSPLRWQ 519
L G C + L+ EY + GSL L K + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 520 TRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579
+ A + + YL E ++H +L VL+ K+SDFG + + +S
Sbjct: 128 DLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS--- 182
Query: 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRIKKDVKCA 637
S ++ E L T +SDV+SFG++L ++T G P I
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----- 235
Query: 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693
+R FN + + P +E++ +L L C + RP ++I LE + V
Sbjct: 236 --ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G+G +G V+ G VAIK G F E +++ ++RH LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 489 ESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E +V E++ GSL D L + K L+ + +A+ + + Y+ IH +L
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMN--YIHRDL 128
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP 607
+ + +L+ N K++DFG LI E T + PE G+ T
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGA------KFPIKWTAPEAALYGRFTI 182
Query: 608 ESDVYSFGIILLRLLT 623
+SDV+SFGI+L L+T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQN---EVEVLSRVRHPNLVTLI 484
+IG G +G VY R + + VAIK G QS+ K+Q+ EV L ++RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G + LV EY GS D L K PL+ I L YLHS+
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH--ER 136
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-IDPEY-- 599
IH ++K +L+ KL+DF G+++L + +N+ + Y + PE
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADF------------GSASLVSPANSFVGTPYWMAPEVIL 184
Query: 600 -LETGKLTPESDVYSFGIILLRLLTGRPVL 628
++ G+ + DV+S GI + L +P L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 431 IGEGRYGNVY------RGLLRHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+GEG +G V G VA+K P G + E+E+L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 484 IGTCPE----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G C E L+ E+L +GSL++ L K+ + + +++ A +C + YL S +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+H +L VL+++ K+ DFG I T + + DS + PE
Sbjct: 130 --YVHRDLAARNVLVESEHQVKIGDFGLTKAI----ETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 600 LETGKLTPESDVYSFGIILLRLLT 623
L K SDV+SFG+ L LLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 430 KIGEGRYGNVYRGL--LRHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
KIG+G G VY + VAIK M P+ L NE+ V+ +HPN+V + +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII-NEILVMRENKHPNIVNYLDS 84
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIAS---DVCSALIYLHSN 538
L V EYL GSL D + +T M QIA+ + AL +LHSN
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ +IH ++K +L+ + KL+DFGF I +S ++ + ++ PE
Sbjct: 135 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-------GTPYWMAPE 185
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ P+ D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQN---------EVEVLSRVRHP 478
KIGEG YG VY R L VAIK L+F++ E+++L + HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKI-------KLRFESEGIPKTALREIKLLKELNHP 58
Query: 479 NLVTLIGTCPESRS--LVFEYLRNGSLED-CLACKNKKSPLRWQTRMQIASDVCSALIYL 535
N++ L+ LVFE++ D K+++ L + L +
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
HS+ I+H +LKP +LI+ KL+DFG + + Y
Sbjct: 115 HSHG--ILHRDLKPENLLINTEGVLKLADFGLARSF----GSPVRPYTHYV---VTRWYR 165
Query: 596 DPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDV 634
PE L K + D++S G I LL+ RP+ K ++
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK--FQNEVEVLSRVRHPNLVTL 483
+GEG YG V + +H VAIK F +K E+ +L ++RH NLV L
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 484 IGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
I + LVFE++ + L+D N L + + + + HS+
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV--YIDPEY 599
IIH ++KP +L+ + KL DFGF + A E D + Y PE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL---------AAPGEVYTDYVATRWYRAPEL 171
Query: 600 L----ETGKLTPESDVYSFGIILLRLLTGRPVL 628
L + G+ D+++ G ++ +LTG P+
Sbjct: 172 LVGDTKYGRAV---DIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 431 IGEGRYGNVYRGL------LRHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G VY+G+ + VAIK+ + GP+++++F +E +++ + HP+LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 484 IGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+G C + LV + + +G L D + K + Q + + ++YL E +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYV--HEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRL 130
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV---YIDPEY 599
+H +L VL+ + K++DFG L+ E E N D + ++ E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDE--------KEYNADGGKMPIKWMALEC 182
Query: 600 LETGKLTPESDVYSFGIILLRLLT--GRP 626
+ K T +SDV+S+G+ + L+T G+P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQ---NEVEVLSRVRHPNLVT 482
IG+G +G V + +R + K YG + + Q +EV +L ++HPN+V
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 483 LIGTC--PESRSL--VFEYLRNGSLEDCLA-CKNKKSPLRWQTRMQIASDVCSALIYLH- 536
+++L V EY G L + CK ++ + + +I + + AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 537 --SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
++H +LKP+ + +DAN KL DFG ++ S + + Y
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-------GTPYY 176
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE L +SD++S G ++ L P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 431 IGEGRYGNVYRGLLRHLH-VAIK---MFPS---YGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G+G YG VY GL +A+K + S + + K Q EV++L ++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 484 IGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
+GTC + S+ E++ GS+ L N+ PL + + + YLH+N C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNN--C 122
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
++H ++K + V++ N KL DFG + G + +S + + ++ PE +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT-PYWMAPEVIN 181
Query: 602 TGKLTPESDVYSFGIILLRLLTGRPVL 628
+SD++S G + + TG+P L
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPN 479
++GEG G+V + L++ + A+K P + E+E+ + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 480 LVTLIGTCPE----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM--QIASDVCSALI 533
+V G + S + EY GSL D + K KK R ++ +IA V L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
YLHS + IIH ++KPS +L+ KL DFG GE + A S
Sbjct: 120 YLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGV-----SGELVNSLA----GTFTGTSF 168
Query: 594 YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
Y+ PE ++ + SDV+S G+ LL + R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 431 IGEGRYGNVYRGL--LRHLHVAIKM--FPSYGPQSHLKFQ--------NEVEVLSRVRHP 478
IG+G YG VY L +A+K P+ H Q +E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 479 NLVTLIG--TCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
N+V +G T E S+ EY+ GS+ CL Q V L YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-I 595
S I+H +LK +L+DA+ K+SDFG + + + +++ + SV+ +
Sbjct: 126 SKG--ILHRDLKADNLLVDADGICKISDFGI------SKKSDDIYDNDQNMSMQGSVFWM 177
Query: 596 DPEYLETGK--LTPESDVYSFGIILLRLLTGR 625
PE + + + + D++S G ++L + GR
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT- 486
KIGEG G V + VA+K Q NEV ++ +HPN+V + +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 487 -CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVC----SALIYLHSN 538
+ +V E+L G+L D + TRM QIA+ VC AL +LH+
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIAT-VCLAVLKALSFLHAQ 134
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND--------S 590
+IH ++K +L+ ++ KLSDFGF C + + +
Sbjct: 135 G--VIHRDIKSDSILLTSDGRVKLSDFGF---------------CAQVSKEVPRRKSLVG 177
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + E D++S GI+++ ++ G P
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 424 NFEPSWKIGEGRYGNVY--RGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPN 479
+E +G G +G V+ R V IK P L QNE +VL + HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
++ E ++L V EY G+L + + K S L T + + AL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 538 NEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
I+H +LK +L+D + K+ DFG I + S+ + A YI
Sbjct: 120 KL--ILHRDLKTQNILLDKHKMVVKIGDFG----ISKILSSKSKA----YTVVGTPCYIS 169
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS-VLDSSAGDW- 654
PE E +SD+++ G +L L + +K A E N + VL +G +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFA 219
Query: 655 PVAE--AEQLAHLALRCCENNRLNRPDLVSEIWS 686
P+++ + L L L + RP L S+I +
Sbjct: 220 PISDRYSPDLRQLILSMLNLDPSKRPQL-SQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 468 EVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E++++ R P +V+ G + + E++ GSL+ K P+ + +IA
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD---RIYKKGGPIPVEILGKIA 109
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
V L YL+ N I+H ++KPS +L+++ KL DFG GE L N
Sbjct: 110 VAVVEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGE------LINS 157
Query: 586 SNND--SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
+ S Y+ PE ++ GK T +SDV+S GI ++ L G+
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 428 SWK----IGEGRYGNVYRGLLRH--LHVAIKMFP----SYGPQSHLK-FQNEVEVLSRVR 476
W+ +G G +G+VY GL A+K Q +K + E+ +LS+++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 477 HPNLVTLIGTCPESRSL-VF-EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
HPN+V +GT E +L +F E + GSL L K + L Y
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEY 117
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSALCNESNNDSASV 593
LH +H ++K + +L+D N KL+DFG ++ + +S S
Sbjct: 118 LHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA--------KSFKGSP-Y 166
Query: 594 YIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + + G +D++S G +L + TG+P
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKF-QNEVEVLSRVRHPNLVTLIGT 486
IG G VY L + VAIK Q+ + + EV+ +S+ HPN+V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
L V YL GSL D + + L + +V L YLHSN IH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIH 125
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV---------YI 595
++K +L+ + K++DFG SA + + + V ++
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGV------------SASLADGGDRTRKVRKTFVGTPCWM 173
Query: 596 DPEYLETGK-LTPESDVYSFGIILLRLLTGRP 626
PE +E ++D++SFGI + L TG
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 42/285 (14%)
Query: 422 TNNFEPSWKIGEGRYGNVYRG--LLRHLHVA---IKMFPSYGPQSHLKFQNEVEVLSRVR 476
NF+ KIG+G++ VY+ LL VA +++F ++ E+++L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 477 HPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLA-CKNKKSPLR----WQTRMQIASDVC 529
HPN++ + + E+ L V E G L + K +K + W+ +Q+ C
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
SAL ++HS I+H ++KP+ V I A KL D G + +S +
Sbjct: 117 SALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV------- 167
Query: 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649
Y+ PE + +SD++S G +L + + +K N S+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--------GDKMNLYSLCKK 219
Query: 650 -SAGDWPVAEA----EQLAHLALRCCENNRLNRPDLVSEIWSVLE 689
D+P A E+L L RC + RPD I VL+
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPD----ISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
++GEG +G V+ +L VA+K + F E E+L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCL----------ACKNKKSPLRWQTRMQIASDVCS 530
G C E L VFEY+++G L L A N+ + L + IA + +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNESN 587
++YL S +H +L L+ N K+ DFG + + G++ L
Sbjct: 132 GMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML----- 184
Query: 588 NDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ PE + K T ESDV+S G++L + T
Sbjct: 185 ---PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 430 KIGEGRYGNVY----RGLLRHLH------------VAIKMF-PSYGPQSHLKFQNEVEVL 472
K+GEG++G V+ GL L VA+KM + F E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 473 SRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPL---------RWQTR 521
SR+++PN++ L+G C L + EY+ NG L L+ + +S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 522 MQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES---TG 578
+ +A + S + YL S +H +L L+ ++ K++DFG + G+ G
Sbjct: 132 LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ L ++ E + GK T SDV++FG+ L + T
Sbjct: 190 RAVL--------PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGT 486
+IG+G +G VY+G+ VAIK+ + ++ Q E+ VLS+ P + G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
+ L + EYL GS D L K PL I ++ L YLHS IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--IH 124
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK 604
++K + VL+ KL+DFG + + N+ + ++ PE ++
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAPEVIKQSA 177
Query: 605 LTPESDVYSFGIILLRLLTGRP 626
++D++S GI + L G P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 69/224 (30%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH----VAIK---MFPSYG--PQSHLKFQNEVEVLSR 474
FE +IGEG YG VYR R VA+K M P S L+ E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLR---EITLLLN 62
Query: 475 VRHPNLVTL----IGTCPESRSLVFEYLRN--GSLEDCLACKNKKSPLRWQTRMQIASDV 528
+RHPN+V L +G +S LV EY SL D N +P + +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQL 117
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSALCNE 585
L YLH N IIH +LK S +L+ K++DFG + L + + L
Sbjct: 118 LRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW-- 173
Query: 586 SNNDSASVYIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRPVL 628
Y PE L T D+++ G IL LL +P+L
Sbjct: 174 --------YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK--FQNEVEVLSRVRHPNLVTL 483
KIGEG YG V++ R+ VAIK F +K E+ +L +++HPNLV L
Sbjct: 8 KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 484 IGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
I R LVFEY + L + + +I A+ + H + C
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHN-C 121
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLI--PQGESTGNSALCNESNNDSASVYIDPEY 599
I H ++KP +LI KL DFGF ++ P + T A Y PE
Sbjct: 122 I-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA---------TRWYRAPEL 171
Query: 600 L--ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634
L +T + P DV++ G + LLTG+P+ K DV
Sbjct: 172 LVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHL----HVAIKMFP-----SYGPQSHLKFQNEVEVLSR 474
+ E +G G +G V+ L+R + A+K+ + H+ NE VL
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHV--HNEKRVLKE 57
Query: 475 VRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
V HP ++ L T + R L + EY+ G L L + S T + AS++ AL
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCAL 114
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
YLHS E I++ +LKP +L+D KL+DFGF + T LC
Sbjct: 115 EYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGTPE----- 163
Query: 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLR 629
Y+ PE +++ D ++ GI++ +L G P
Sbjct: 164 -YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 429 WK----IGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLK-----FQNEVEVLSRVRH 477
W+ +G+G +G VY + +A+K P K + E+++L ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 478 PNLVTLIG--TCPESRSLVFEYLRNGSLEDCLACKN--KKSPLRWQTRMQIASDVCSALI 533
+V G E+ S+ EY+ GS++D L ++ R TR QI +
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QI----LEGVE 118
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
YLHSN I+H ++K + +L D+ KL DF G S +C+ +
Sbjct: 119 YLHSNM--IVHRDIKGANILRDSAGNVKLGDF--------GASKRLQTICSSGTGMKSVT 168
Query: 594 ----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + ++DV+S G ++ +LT +P
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT- 486
KIGEG G V +H VA+KM Q NEV ++ +H N+V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 487 -CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIAS---DVCSALIYLHSNE 539
E ++ E+L+ G+L D ++ QTR+ QIA+ V AL YLHS
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS----------QTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+IH ++K +L+ + KLSDFGF I + S + ++ PE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-------GTPYWMAPEV 188
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
+ E D++S GI+++ ++ G P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 424 NFEPSWKIGEGRYGNVYRG--LLRHLHVAIK---MFPSYGPQSHLKFQNEVEVLSRVRHP 478
NF KIG G++ VYR LL + VA+K +F ++ E+++L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCLA-CKNKKSPLRWQTRMQIASDVCSALIYL 535
N++ + E L V E G L + K +K + +T + +CSAL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
HS ++H ++KP+ V I A KL D G + +S + Y+
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-------GTPYYM 173
Query: 596 DPEYLETGKLTPESDVYSFGIILLRL 621
PE + +SD++S G +L +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 431 IGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
+G+G YG VY R L + +AIK P + E+ + S ++H N+V +G+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 489 ESR--SLVFEYLRNGSLEDCLACKNKKSPLRW--QTRMQIASDVCSALIYLHSNEPCIIH 544
E+ + E + GSL L ++K PL+ QT + + L YLH N+ I+H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVH 131
Query: 545 GNLKPSKVLIDANFGS-KLSDFG----FFHLIPQGES-TGNSALCNESNNDSASVYIDPE 598
++K VL++ G K+SDFG + P E+ TG Y+ PE
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ------------YMAPE 179
Query: 599 YLETGK--LTPESDVYSFGIILLRLLTGRP 626
++ G +D++S G ++ + TG+P
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF---PSYGPQSHLKFQ--NEVEVLSRVR 476
+E K+GEG Y VY+ + VAIK + + F E+++L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 477 HPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
HPN++ L+ +LVFE++ LE + K+K L L Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI--KDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV- 593
LHSN I+H +LKP+ +LI ++ KL+DFG S G+ + + V
Sbjct: 118 LHSNW--ILHRDLKPNNLLIASDGVLKLADFGL------ARSFGSP-----NRKMTHQVV 164
Query: 594 ---YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
Y PE L + D++S G I LL P L
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 418 LNEATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLS 473
L + T FE IGEG YG VY+ RH VAIK+ + + E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA--RHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILR 57
Query: 474 RV-RHPNLVTLIG--------TCPESRSLVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQ 523
+ HPN+ T G + LV E GS+ D + + K L+ +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
I + L YLH N+ +IH ++K +L+ N KL DFG
Sbjct: 118 ILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 430 KIGEGRYGNVYRGL--LRHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
KIG+G G VY + VAIK M P+ L NE+ V+ ++PN+V + +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDS 84
Query: 487 --CPESRSLVFEYLRNGSLEDCLA--CKNKKSPLRWQTRMQIASDVC----SALIYLHSN 538
+ +V EYL GSL D + C ++ QIA+ VC AL +LHSN
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAA-VCRECLQALDFLHSN 134
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ +IH ++K +L+ + KL+DFGF I +S ++ + ++ PE
Sbjct: 135 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-------GTPYWMAPE 185
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ P+ D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 54/235 (22%)
Query: 430 KIGEGRYG--------------------NVYRGLLRHLHVAIKMF-PSYGPQSHLKFQNE 468
K+GEG++G NV +G R L VA+K+ P + F E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFLKE 69
Query: 469 VEVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACK---NKKSP-------- 515
V++LSR++ PN++ L+G C + L + EY+ NG L L+ +K+
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 516 -----LRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570
+ + + + +A + S + YL S +H +L L+ N K++DFG
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 571 IPQGES---TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLL 622
+ G+ G + L ++ E + GK T SDV++FG+ L +L
Sbjct: 188 LYAGDYYRIQGRAVL--------PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 66/238 (27%)
Query: 430 KIGEGRYGNVY-------RGLLRHLH-----------VAIKMFPSYGPQSHLK--FQNEV 469
K+GEG++G V+ + VA+K+ + + F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDASDNAREDFLKEV 70
Query: 470 EVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSL---------EDCLACKNKKSPLRW 518
++LSR+ PN+ L+G C L + EY+ NG L E N KS L +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS-LSF 129
Query: 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578
T + +A+ + S + YL S +H +L L+ N+ K++DFG
Sbjct: 130 STLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGM----------- 176
Query: 579 NSALCNESNNDSASVYID-------P------EYLETGKLTPESDVYSFGIILLRLLT 623
S N +S Y P E + GK T +SDV++FG+ L +LT
Sbjct: 177 -------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 22/159 (13%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN--EVEVLSRVR---H 477
+EP +IG G YG VY+ H VA+K + L EV +L R+ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 478 PNLVTLIGTCPESRS-------LVFEYLRNGSLEDCLACKNKKSP--LRWQTRMQIASDV 528
PN+V L+ C SR+ LVFE++ +D +K P L +T +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567
L +LH+N CI+H +LKP +L+ + KL+DFG
Sbjct: 118 LRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGL 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 430 KIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL--IGT 486
K+G G++G V+ G + VA+K G S F E ++ ++H LV L + T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 487 CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
E ++ EY+ GSL D L ++ + + ++ + + Y+ IH +
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRD 128
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETG 603
L+ + VL+ + K++DFG +I E T + A I PE + G
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAR---------EGAKFPIKWTAPEAINFG 179
Query: 604 KLTPESDVYSFGIILLRLLT 623
T +SDV+SFGI+L ++T
Sbjct: 180 SFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 431 IGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPNLV 481
+GEG +G V + L VA+KM + L +E+E++ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQIAS 526
L+G C + L V EY +G+L D L + + L + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 527 DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSALC 583
V + +L S + IH +L VL+ + K++DFG H I T N L
Sbjct: 140 QVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ ++ PE L T +SDV+SFG++L + T
Sbjct: 198 VK--------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 430 KIGEGRYGNVYRG----LLRHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+IG G +G V G + V +K S P L F EV+ + HPN++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ--IASDVCSALIYLHSNEP 540
G C ES LV E+ G L++ L Q + +A +V S L++LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
IH +L + A+ K+ D+G E + + ++ PE +
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLAL-----EQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 601 E-------TGKLTPESDVYSFGIILLRLLT 623
E T +S+++S G+ + L T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 42/220 (19%)
Query: 429 WKI----GEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
W+I G+G +G VY+ + L A K+ + F E+++LS +HPN+V
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA---SDVCSALIYLHS 537
L L + E+ G+L+ + + L T QI + AL +LHS
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELER--GL---TEPQIRYVCRQMLEALNFLHS 121
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID- 596
++ +IH +LK +L+ + KL+DFG SA N+S +I
Sbjct: 122 HK--VIHRDLKAGNILLTLDGDVKLADFGV------------SAK-NKSTLQKRDTFIGT 166
Query: 597 -----PEYL--ETGKLTP---ESDVYSFGIILLRLLTGRP 626
PE + ET K P ++D++S GI L+ L P
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQN---EVEVLSRVRHPNLVTLI 484
+IG G +G VY H + VA+K G Q++ K+Q+ EV+ L +++HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G + + LV EY GS D L K PL+ I L YLHS+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH--NM 142
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-IDPEY-- 599
IH ++K +L+ KL+DF G+++ + +N+ + Y + PE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADF------------GSASKSSPANSFVGTPYWMAPEVIL 190
Query: 600 -LETGKLTPESDVYSFGIILLRLLTGRPVL 628
++ G+ + DV+S GI + L +P L
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 50/148 (33%), Positives = 72/148 (48%), Gaps = 22/148 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKF-QNEVEVLSRVRHPNLVTLI 484
+IG G YG+VY+ R + VAIK+ P + Q E+ +L RHPN+V
Sbjct: 10 RIGSGTYGDVYKA--RDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC----SALIYLHSN 538
G+ L V EY GSL+D + + PL + +QIA VC L YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIY--QVTRGPL---SELQIAY-VCRETLKGLAYLHET 120
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFG 566
IH ++K + +L+ + KL+DFG
Sbjct: 121 G--KIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 431 IGEGRYGNVYRGLL-----RHLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLI 484
IG+G +G VY G L + +H A+K + +F E ++ HPN+++L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 485 GTCPESRSL---VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSN 538
G C S V Y+++G L + + +S T + V + YL S
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ +H +L ++D +F K++DFG I E ++ N + ++ E
Sbjct: 118 K--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---YSVHNHTGAKLPVKWMALE 172
Query: 599 YLETGKLTPESDVYSFGIILLRLLT 623
L+T K T +SDV+SFG++L L+T
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 430 KIGEGRYGNVY----RGLLRHLH--------------VAIKMFPS-YGPQSHLKFQNEVE 470
K+GEG++G V+ G+ + + VA+KM + F E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 471 VLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCL--------ACKNKKSPLRWQT 520
++SR++ PN++ L+ C S L + EY+ NG L L A K + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES---T 577
+ +A+ + S + YL S +H +L L+ N+ K++DFG + G+
Sbjct: 132 LIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
G + L ++ E + GK T SDV++FG+ L +LT
Sbjct: 190 GRAVL--------PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
KIG+G G V+ + VAIK P+ L NE+ V+ +++PN+V + +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII-NEILVMKELKNPNIVNFLDS 84
Query: 487 --CPESRSLVFEYLRNGSLEDCLA--CKNKKSPLRWQTRMQIASDVC----SALIYLHSN 538
+ +V EYL GSL D + C ++ QIA+ VC AL +LH+N
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEA---------QIAA-VCRECLQALEFLHAN 134
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ +IH ++K VL+ + KL+DFGF I +S ++ + ++ PE
Sbjct: 135 Q--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-------GTPYWMAPE 185
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ P+ D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 430 KIGEGRYGNVYRGL--LRHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
KIG+G G VY + VAI+ M P+ L NE+ V+ ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDS 85
Query: 487 --CPESRSLVFEYLRNGSLEDCLA--CKNKKSPLRWQTRMQIASDVC----SALIYLHSN 538
+ +V EYL GSL D + C ++ QIA+ VC AL +LHSN
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAA-VCRECLQALEFLHSN 135
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ +IH ++K +L+ + KL+DFGF I +S S ++ PE
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPE 186
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ P+ D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 431 IGEGRYGNVYRGLLRHL--------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G G +G VY G + VA+K Q +F E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 482 TLIGTC--PESRSLVFEYLRNGSLEDCL-ACKNKKSP---LRWQTRMQIASDVCSALIYL 535
L+G C E + ++ E + G L L + ++ L + + I DV +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGS-----KLSDFGFFHLIPQGESTGNSALCNESNNDS 590
IH +L L+ K+ DFG I + + E
Sbjct: 123 EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-----SDYYRKEGEGLL 175
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ PE L GK T +SDV+SFG+++ +LT
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 30/268 (11%)
Query: 430 KIGEGRYGNVYRGLL-RHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+G G++G V+ +H VA+K M P G S F E V+ ++H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 488 P-ESRSLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
E ++ E++ GSL D L + K PL + ++ + + ++ IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--YIHR 126
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL 605
+L+ + +L+ A+ K++DFG +I E T + PE + G
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA------KFPIKWTAPEAINFGSF 180
Query: 606 TPESDVYSFGIILLRLLT-GR---PVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661
T +SDV+SFGI+L+ ++T GR P + + ++ ALE+ ++ E+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRMPRPENC--------PEE 231
Query: 662 LAHLALRCCENNRLNRPDLVSEIWSVLE 689
L ++ +RC +N RP I SVL+
Sbjct: 232 LYNIMMRCWKNRPEERPTF-EYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 424 NFEPSWKIGEGRYGNVYRG--LLRHLHVAIK---MFPSYGPQSHLKFQNEVEVLSRVRHP 478
NF+ KIG G++ VYR LL VA+K +F ++ E+++L ++ HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCLA-CKNKKSPLRWQTRMQIASDVCSALIYL 535
N++ + + E L V E G L + K +K + +T + +CSA+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
HS ++H ++KP+ V I A KL D G + +S + Y+
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-------GTPYYM 173
Query: 596 DPEYLETGKLTPESDVYSFGIILLRL 621
PE + +SD++S G +L +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 431 IGEGRYGNVYRGL--LRHLHVAIKM--FPSYGPQSHLK-------FQNEVEVLSRVRHPN 479
IG G +G+VY G+ +A+K PS S + E+ +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 480 LVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V +G+ ++ L EY+ GS+ L N + L YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
IIH ++K + +L+D G K+SDFG + + S + + ++ P
Sbjct: 125 RG--IIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAP 181
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGR 625
E ++ T ++D++S G +++ +LTG+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK-FQNEVEVLSRVRH---PNLVT 482
IG G YG VYRG H+ VA+K+ P + Q EV +LS++R PN+
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
G+ + L + EY GS+ + K P+ + I +V AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG- 121
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
+IH ++K + +L+ KL DFG L+ Q S S ++ PE +
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-------KRSTFVGTPYWMAPEVI 173
Query: 601 ETGKL-TPESDVYSFGIILLRLLTGRP 626
GK ++D++S GI + + TG P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 426 EPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPN 479
IGEG++G+VY+G+ + VA+K + P KF E ++ + HP+
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 480 LVTLIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
+V LIG E+ +V E G L L NK S L + + + + +AL YL S
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGELRSYLQ-VNKYS-LDLASLILYSYQLSTALAYLESK 126
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----- 593
+H ++ VL+ + KL DFG S + + AS
Sbjct: 127 R--FVHRDIAARNVLVSSPDCVKLGDFGL------------SRYLEDESYYKASKGKLPI 172
Query: 594 -YIDPEYLETGKLTPESDVYSFGIILLRLL 622
++ PE + + T SDV+ FG+ + +L
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 431 IGEGRYGNVYRGLL------RHLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G V++G+ + VAIK G Q+ + + + + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 484 IGTCP-ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+G CP S LV + GSL D + + + L Q + + + YL E +
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLE--EHRM 130
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H NL +L+ ++ +++DFG L+ + +E + ++ E +
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDD---KKYFYSEHK--TPIKWMALESILF 185
Query: 603 GKLTPESDVYSFGIILLRLLT 623
G+ T +SDV+S+G+ + +++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 71/238 (29%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 402 ALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVY--RGLLRHLHVAIKMFPSYGP 459
A S P + E F E E F +IG G +G VY R + + VAIK G
Sbjct: 6 AGSLKDPEIAELFFKEDPEKL--FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 63
Query: 460 QSHLKFQN---EVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKS 514
QS+ K+Q+ EV+ L R++HPN + G + LV EY GS D L K
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK-- 120
Query: 515 PLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574
PL+ I L YLHS+ +IH ++K +L+ KL+DF
Sbjct: 121 PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADF--------- 169
Query: 575 ESTGNSALCNESNNDSASVY-IDPEY---LETGKLTPESDVYSFGIILLRLLTGRPVL 628
G++++ + +N+ + Y + PE ++ G+ + DV+S GI + L +P L
Sbjct: 170 ---GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQN--------EVEVLS 473
NF+ K+GEG Y VY+G R VA+K + HL + E+ ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALK-------EIHLDAEEGTPSTAIREISLMK 53
Query: 474 RVRHPNLVTL---IGTCPESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
++H N+V L I T E++ LVFEY+ + L+ + + L T +
Sbjct: 54 ELKHENIVRLHDVIHT--ENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL--IPQGESTGNSALCNESN 587
+ + H N ++H +LKP +LI+ KL+DFG IP N +
Sbjct: 111 KGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIP----------VNTFS 158
Query: 588 NDSASV-YIDPEYLETGKLTPES-DVYSFGIILLRLLTGRPVLR 629
N+ ++ Y P+ L + S D++S G I+ ++TGRP+
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 49/232 (21%)
Query: 468 EVEVLSRVRHPNLVTLIG-TCPESRSLVF-EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E+ +++R+ HP+++ ++G TC +S +F E++ GS+ L +K + +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYT 109
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLID--------ANFGS------KLSDFGFFHLI 571
+ L YLH N+ IIH ++K + +LID A+FG+ K + G F
Sbjct: 110 EQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--- 164
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
QG+ G A ++ PE L + DV+S G +++ + T +P
Sbjct: 165 -QGQLLGTIA------------FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-- 209
Query: 632 KDVKCALEKRNFNSVL---DSSAGDWPVAE--AEQLAHLALRCCENNRLNRP 678
A + N +++ S+ + E + L + LRC E +RP
Sbjct: 210 -----AEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGT 486
KIG+G +G V++G+ VAIK+ + ++ Q E+ VLS+ P + G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
+ L + EYL GS D L + PL I ++ L YLHS + IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--IH 124
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK 604
++K + VL+ + KL+DFG + + N+ + ++ PE ++
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAPEVIKQSA 177
Query: 605 LTPESDVYSFGIILLRLLTGRP 626
++D++S GI + L G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 16/195 (8%)
Query: 431 IGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+G G +G+V +G+ + VA+K + +F E V++++ HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 485 GTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G C E LV E G L L K+ + ++A V + YL S +
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLK---KRREIPVSDLKELAHQVAMGMAYLESKH--FV 117
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
H +L VL+ +K+SDFG + + G+ + + PE + G
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFG----MSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 604 KLTPESDVYSFGIIL 618
K + +SDV+S+G+ L
Sbjct: 174 KFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQN---EVEVLSRVRHPNLVTLI 484
+IG G +G VY R + VAIK G QS+ K+Q+ EV L ++RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G + LV EY GS D L K PL+ + L YLHS+ +
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--M 136
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-IDPEY-- 599
IH ++K +L+ KL DF G++++ +N + Y + PE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDF------------GSASIMAPANXFVGTPYWMAPEVIL 184
Query: 600 -LETGKLTPESDVYSFGIILLRLLTGRPVL 628
++ G+ + DV+S GI + L +P L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 34/155 (21%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMF---------PSYGPQSHLKFQNEVEVLSRVR 476
KIGEG YG VY+ R VA+K PS + E+ +L +
Sbjct: 6 KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIR-------EISLLKELN 56
Query: 477 HPNLVTL--IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSA 531
HPN+V L + LVFE+L + L+ + SPL I S +
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM----DSSPLTGLDPPLIKSYLYQLLQG 111
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
+ Y HS+ ++H +LKP +LID KL+DFG
Sbjct: 112 IAYCHSHR--VLHRDLKPQNLLIDREGALKLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 42/179 (23%)
Query: 412 EFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHL----HVAIKM---------FPSYG 458
EF F + + +E KIG+G +G V++ RH VA+K FP
Sbjct: 4 EFPFCD---EVSKYEKLAKIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFP--- 55
Query: 459 PQSHLKFQNEVEVLSRVRHPNLVTLIGTC-----PESRS-----LVFEYLRNGSLEDCLA 508
+ E+++L ++H N+V LI C P +R LVFE+ + L L+
Sbjct: 56 ----ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS 110
Query: 509 CKNKK-SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
KN K + + M++ + + L Y+H N+ I+H ++K + +LI + KL+DFG
Sbjct: 111 NKNVKFTLSEIKKVMKM---LLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLK--------FQNEVEVLSRVRHPN 479
IG+G +G VY+ + + VAIK L+ Q E++ LS+ R P
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIK-------VIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+ G+ + L + EY GS D L K L I +V L YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHE 116
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS---ASVY 594
IH ++K + +L+ KL+DFG G+ T S ++ +
Sbjct: 117 EGK--IHRDIKAANILLSEEGDVKLADFGV-----SGQLTSTM-----SKRNTFVGTPFW 164
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE ++ ++D++S GI + L G P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G+G +G VY G+ + + VAIK + + ++F NE V+ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKK-------SPLRWQTRMQIASDVCSAL 532
L+G + + ++ E + G L+ L + +P + +Q+A ++ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSALCNESNNDS 590
YL++N+ +H +L ++ +F K+ DFG I + + G L
Sbjct: 133 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------- 183
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ PE L+ G T SDV+SFG++L + T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 9e-10
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 61/229 (26%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIK-MFPSYGPQSHLKFQN---------EVEVLSRVR- 476
K+G+G YG V++ + R VA+K +F + F+N E+ L +
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDA--------FRNATDAQRTFREIMFLQELGD 65
Query: 477 HPNLVTLIGTCPESRS----LVFEYL--------RNGSLEDCLACKNKKSPLRWQTRMQI 524
HPN+V L+ LVFEY+ R LED K + +Q
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-----HKRYIMYQ----- 115
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
+ AL Y+HS +IH +LKPS +L++++ KL+DFG + + E N
Sbjct: 116 ---LLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE-------N 163
Query: 585 ESNND-----SASVYIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRPV 627
N + Y PE L + + T D++S G IL +L G+P+
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 55/214 (25%), Positives = 81/214 (37%), Gaps = 22/214 (10%)
Query: 467 NEVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
NE +L + HP LV L + + + LV + L G L L+ K K S Q +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS--EEQVKF-W 105
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALC 583
++ AL YLHS IIH ++KP +L+D ++DF + P +T S
Sbjct: 106 ICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG-- 161
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK--KDVKCALEKR 641
Y+ PE L + D +S G+ L G+ R K+
Sbjct: 162 -------TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ 214
Query: 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRL 675
VL + W EA + L RL
Sbjct: 215 ETADVLYPAT--WST-EAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 439 VYRGLLRHLHVAIKMF--PSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGTCPE------ 489
+Y+G+ + V I+ F G + + +NE++ L R+ N++ + G +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS--NEPCIIHGNL 547
SL+ EY G L + L +K+ L ++T++ +A D C L L+ N+P + NL
Sbjct: 96 RLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNL 149
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKL 605
L+ N+ K+ G ++ N + VY + L +
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSS----------PPFKNVNFMVYFSYKMLNDIFSEY 199
Query: 606 TPESDVYSFGIILLRLLTGR 625
T + D+YS G++L + TG+
Sbjct: 200 TIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 431 IGEGRYGNVYRGLLRH-----LHVAIKMFPSYG-PQSHLK-FQNEVEVLSRVRHPNLVTL 483
+GEG +G+V G L L VA+K S ++ F +E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 484 IGTCPESRSL--------VFEYLRNGSLEDCL-----ACKNKKSPLRWQTRMQIASDVCS 530
IG C E+ SL + ++++G L L +K PL QT ++ D+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIAL 124
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS 590
+ YL + IH +L ++ + ++DFG I G+ +
Sbjct: 125 GMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+I E L T +SDV++FG+ + + T
Sbjct: 181 ---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E++VL P +V G S+ E++ GSL+ L K + P ++ IA
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIA 107
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSALCN 584
V L YL I+H ++KPS +L+++ KL DFG LI +S NS +
Sbjct: 108 --VLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGT 161
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
S Y+ PE L+ T +SD++S G+ L+ + GR
Sbjct: 162 RS-------YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 431 IGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQNEVE--------VLSRVRHPNL 480
I +G +G+VY + + AIK+ +S + +N+V ++ + P +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK----KSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 481 VTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
L + + LV EYL G DC + L Q ++V + LH
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGG---DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDP 597
IIH ++KP +LID KL+DFG S E+ + Y+ P
Sbjct: 117 G--IIHRDIKPENLLIDQTGHLKLTDFGL------------SRNGLENKKFVGTPDYLAP 162
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E + SD +S G ++ L G P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYR------GLL---RHLHVAIKMFPSYGPQSHLKFQNEVEVLS 473
++FE ++G G G V++ GL+ + +H+ IK P + E++VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK------PAIRNQIIRELQVLH 58
Query: 474 RVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
P +V G S+ E++ GSL+ L K + P + ++ IA V
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIA--VIKG 115
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSALCNESNNDS 590
L YL I+H ++KPS +L+++ KL DFG LI +S NS + S
Sbjct: 116 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS---- 167
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
Y+ PE L+ + +SD++S G+ L+ + GR
Sbjct: 168 ---YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 39/251 (15%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH-----VAIKMFPSYGPQSHLKFQN--EVEVLSRVR- 476
+E +IGEG YG V++ R L VA+K + + EV VL +
Sbjct: 3 YECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 477 --HPNLVTLIGTCPESRS-------LVFEYLRNGSLEDCLACKNKKSP---LRWQTRMQI 524
HPN+V L C SR+ LVFE++ + L K P + +T +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTETIKDM 115
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
+ L +LHS+ ++H +LKP +L+ ++ KL+DFG + + + +
Sbjct: 116 MFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN 644
Y PE L D++S G I + +P+ R DV L K +
Sbjct: 172 ------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI-LD 223
Query: 645 SVLDSSAGDWP 655
+ DWP
Sbjct: 224 VIGLPGEEDWP 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 66/216 (30%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 420 EATNNFEPSWKIGEGRYGNV--YRGLLRHLHVAIK--MFPSYGPQSHLKFQNEVEVLSRV 475
E TN + +G G +G V R L +VAIK M P P + E+++L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 476 RHPNLVTL--IGTCP-ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
RH N+++L I P E V E L L L + PL Q + L
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSR----PLEKQFIQYFLYQILRGL 121
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
Y+HS ++H +LKPS +LI+ N K+ DFG I + TG S
Sbjct: 122 KYVHS--AGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYV---------STR 169
Query: 593 VYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPV 627
Y PE + T K E D++S G I +L G+P+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 424 NFEPSWKIGEGRYGNVY--RGLLRHLHVAIKMF----PSYG-PQSHLKFQNEVEVLSRVR 476
NF+ KIGEG YG VY R L VA+K + G P + ++ E+ +L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELN 57
Query: 477 HPNLVTLIGTCPESRSL--VFEYLRNGSLE---DCLACKNKKSPLRWQTRMQIASDVCSA 531
HPN+V L+ L VFE+L + L+ D PL Q+
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL----LQG 112
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
L + HS+ ++H +LKP +LI+ KL+DFG
Sbjct: 113 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT- 486
KIGEG G V +H VA+K Q NEV ++ H N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 487 -CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIAS---DVCSALIYLHSNE 539
+ +V E+L G+L D + TRM QIA+ V AL YLH+
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+IH ++K +L+ ++ KLSDFGF + + E +L ++ PE
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV------GTPYWMAPEV 189
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
+ E D++S GI+++ ++ G P
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 34/164 (20%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH----VAIK--MFPSYG---PQSHLKFQNEVEVLSRV 475
+E +IGEG YG VY+ R L+ VA+K P P S L+ E+ +L ++
Sbjct: 1 YEELAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR---EIALLKQL 55
Query: 476 R---HPNLVTLIGTCPESR-------SLVFEYLR---NGSLEDCLACKNKKSPLRWQTRM 522
HPN+V L+ C R +LVFE++ L C ++ R
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR- 114
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
Q+ + +LHS+ I+H +LKP +L+ ++ K++DFG
Sbjct: 115 QL----LRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQN--EVEVLSRVRHP 478
N FE +GEG YG V + + VAIK F +K E+++L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
N+V L L VFEY+ LE N P + ++ + + A+ + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY---QLIKAIHWCH 117
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
N+ I+H ++KP +LI N KL DFGF + S G++A N + + Y
Sbjct: 118 KND--IVHRDIKPENLLISHNDVLKLCDFGF----ARNLSEGSNA--NYTEYVATRWYRS 169
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVL 628
PE L D++S G IL L G+P+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH-----------LHVAIKMFPSYGPQSHLKFQNEVEV 471
++FE ++G G G V + ++H +H+ IK P + E++V
Sbjct: 5 DDFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIK------PAIRNQIIRELQV 56
Query: 472 LSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
L P +V G S+ E++ GSL+ L + K+ P ++ IA V
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILGKVSIA--VL 113
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSALCNESNN 588
L YL I+H ++KPS +L+++ KL DFG LI +S NS + S
Sbjct: 114 RGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS-- 167
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
Y+ PE L+ + +SD++S G+ L+ L GR
Sbjct: 168 -----YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQS---HLKFQ 466
S SEL E N +IG G G VY+ + H A+K+ YG +
Sbjct: 72 SLSEL-ERVN------RIGSGAGGTVYK--VIHRPTGRLYALKVI--YGNHEDTVRRQIC 120
Query: 467 NEVEVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
E+E+L V HPN+V + + + E++ GSLE + L +
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIADEQFL-----ADV 173
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A + S + YLH I+H ++KPS +LI++ K++DFG ++ Q CN
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-----CN 226
Query: 585 ESNNDSASVYIDPEYLET----GKLTPES-DVYSFGIILLRLLTGR 625
S A Y+ PE + T G + D++S G+ +L GR
Sbjct: 227 SSVGTIA--YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGT 486
+IG+G +G V++G+ VAIK+ + ++ Q E+ VLS+ P + G+
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSNEPC 541
+ L + EYL GS D L + P QIA+ ++ L YLHS +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL----RAGPF---DEFQIATMLKEILKGLDYLHSEKK- 122
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
IH ++K + VL+ KL+DFG + + N+ + ++ PE ++
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAPEVIQ 174
Query: 602 TGKLTPESDVYSFGIILLRLLTGRP 626
++D++S GI + L G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 40/271 (14%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLR-HLHV-AIKMFPSYGPQSHLKFQ--NEVEVLSRVRHPN 479
+FE KIG+G +G V++ + + V A+K + + +E VL+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLR----WQTRMQIASDVCSALI 533
++ + + L V EY NG L L + PL W+ +QI L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILL----GLA 115
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
+LHS + I+H ++K + +DA K+ D G + L +++ N + ++
Sbjct: 116 HLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGV------------AKLLSDNTNFANTI 161
Query: 594 -----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648
Y+ PE E +SDV++ G++L TG+ AL + V
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGVFP 219
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679
+ + ++QLA L +C + RPD
Sbjct: 220 PVSQMY----SQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT- 486
KIGEG G V ++ VA+K Q NEV ++ +H N+V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 487 -CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIAS---DVCSALIYLHSNE 539
+ +V E+L G+L D + TRM QIA+ V AL LH+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+IH ++K +L+ + KLSDFGF + + S + ++ PE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-------GTPYWMAPEL 187
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE D++S GI+++ ++ G P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 466 QNEVEVLSRVRHPNLVTLIGTCPESRSLV--FEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523
NE+ +LS ++HPN++ + +L+ EY G+L D + + K + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQKGQLFEEEMVLW 105
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
+ SA+ Y+H I+H ++K + + KL DFG ++ S + +
Sbjct: 106 YLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV- 162
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
Y+ PE + K +SD+++ G +L LLT
Sbjct: 163 ------GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 60/285 (21%), Positives = 113/285 (39%), Gaps = 41/285 (14%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQ-SHLKFQNEVEVLSRV 475
N + +G G +G V+ + + V +K + +F+ E+++ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 476 RHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCL------ACKNKKSPLRWQTRMQIASD 527
H N+V L+G C E+ ++ EY G L+ L K K PL + ++ + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN 587
+ + +L + +H +L L+ + K+S + NS N
Sbjct: 126 IALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSL------SKDVYNSEYYKLRN 177
Query: 588 NDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647
++ PE ++ + +SDV+SFG+++ + T + + VL
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDEEVL 228
Query: 648 -DSSAGD--WPVAEA--EQLAHLALRCCENNRLNRP---DLVSEI 684
AG PV E +L L RC N +RP +LVS +
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G+G +G VY G R + VA+K S + ++F NE V+ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKS-------PLRWQTRMQIASDVCSAL 532
L+G + + +V E + +G L+ L ++ P Q +Q+A+++ +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSALCNESNNDS 590
YL++ + +H +L ++ +F K+ DFG I + + G L
Sbjct: 133 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRL--LTGRPVLRIKKDVKCALEKRNFNSVLD 648
++ PE L+ G T SD++SFG++L + L +P + + + V+D
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKFVMD 236
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694
D P E++ L C + N RP + + + + L S
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 67/257 (26%), Positives = 114/257 (44%), Gaps = 29/257 (11%)
Query: 431 IGEGRYGNVYRG--LLRHLHVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+G G G VY+ LL +A+K+ P + + +E+E+L + P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 488 -PESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
E+R S+ E++ GSL+ +K P R+ +A V L YL S + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD-----VYRKIPEHVLGRIAVA--VVKGLTYLWSLK--ILHR 119
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE--SNNDSASVYIDPEYLETG 603
++KPS +L++ KL DFG ++ L N + Y+ PE +
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGV-----------STQLVNSIAKTYVGTNAYMAPERISGE 168
Query: 604 KLTPESDVYSFGIILLRLLTGR-PVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE-AEQ 661
+ SDV+S GI + L GR P +I+K+ + + ++D PV + +E+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228
Query: 662 LAHLALRCCENNRLNRP 678
H +C RP
Sbjct: 229 FVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYG------PQSHLKFQNEVEVLSR 474
+E IG G YG VY+ ++ AIK F QS + E+ +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR---EIALLRE 58
Query: 475 VRHPNLVTLIGTCPE----SRSLVFEYLRNGSLEDCLA-CKNKKSPLRWQ--TRM--QIA 525
++H N+V+L+ E S L+F+Y + D K + R M +
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLIPQGESTGNSA 581
+ + + YLHSN ++H +LKP+ +L+ K+ D G L N+
Sbjct: 115 WQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-------NAP 165
Query: 582 LCNESNNDSASV---YIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPV 627
L ++ D V Y PE L + T D+++ G I LLT P+
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 74/247 (29%), Positives = 106/247 (42%), Gaps = 36/247 (14%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF----PSYG-PQSHLKFQNEVEVLSRVR 476
+E KIGEG YG V++ R H VA+K G P S L+ E+ +L ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57
Query: 477 HPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
H N+V L + +LVFEY + +C P ++ M + L +
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM---FQLLKGLAF 114
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV- 593
HS+ ++H +LKP +LI+ N KL+DFG + G C SA V
Sbjct: 115 CHSHN--VLHRDLKPQNLLINKNGELKLADFGL------ARAFGIPVRCY-----SAEVV 161
Query: 594 ---YIDPEYLETGKLTPES-DVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLD 648
Y P+ L KL S D++S G I L GRP+ DV L KR F +
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQL-KRIFRLLGT 219
Query: 649 SSAGDWP 655
+ WP
Sbjct: 220 PTEESWP 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 15/177 (8%)
Query: 449 VAIKMFPSYGPQSHLKF---QNEVEVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSL 503
VA+K + S Q E+ +++HPN++ + + L V + GS
Sbjct: 28 VAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563
ED L + L I DV +AL Y+HS IH ++K S +L+ + LS
Sbjct: 87 ED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLS 143
Query: 564 DFGFFHLIPQGESTGNSALCNESNNDSASV--YIDPEYLETGKL--TPESDVYSFGI 616
G + + + + ++ S ++ PE L+ +SD+YS GI
Sbjct: 144 --GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 40/241 (16%)
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLRHL----HVAIK--MFPSYGPQSHLKFQNEVEVLSR 474
++E K+GEG +G VY+ R + VA+K + + + E+++L +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA--RQIKTGRVVALKKILMHNEKDGFPITALREIKILKK 63
Query: 475 VRHPNLVTLI----------GTCPESRSLVFEYLR---NGSLEDCLACKNKKSPLRWQTR 521
++HPN+V LI S +V Y+ +G LE N L T
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKL---TE 114
Query: 522 MQIAS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG----FFHLIPQG 574
QI + + YLH N I+H ++K + +LID K++DFG + P
Sbjct: 115 SQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 575 ESTGNSALCNESNNDSASVYIDPEY-LETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633
+ G +N Y PE L + T D++ G + + T RP+L+ K D
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232
Query: 634 V 634
+
Sbjct: 233 I 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 27/152 (17%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMF---------PSYGPQSHLKFQNEVEVLSRVR 476
KIGEG YG VY+G R+ VA+K PS + E+ +L ++
Sbjct: 7 KIGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIR-------EISLLKELQ 57
Query: 477 HPNLVTLIGTC-PESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
HPN+V L ESR L+FE+L + L+ L K + + + +++
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
HS ++H +LKP +LID KL+DFG
Sbjct: 117 CHSRR--VLHRDLKPQNLLIDNKGVIKLADFG 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 431 IGEGRYGNVYRGLLRH----LHVAIK-MFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLI 484
+GEG +G+V G L L VA+K M + +S ++ F +E + HPN++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 485 GTCPE--------SRSLVFEYLRNGSLED-CLACKNKKSPLRWQTRM--QIASDVCSALI 533
G C + S ++ ++++G L L + P T+M + +D+ S +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
YL S IH +L +++ N ++DFG I G+ +
Sbjct: 127 YLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK----- 179
Query: 594 YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+I E L T +SDV+SFG+ + + T
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 430 KIGEGRYGNVYRG---LLRHLHVAIKMF----PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
K+GEG Y V++G L +L VA+K P + ++ EV +L ++H N+VT
Sbjct: 12 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVT 67
Query: 483 L--IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L I +LVFEYL + + C N S + M + L Y H +
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK- 123
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE-- 598
I+H +LKP +LI+ KL+DFG + S +N+ +++ P
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGL--------ARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVL 628
L + + + D++ G IL + TGRP+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQN---EVEVLSRVRHPNLVTLIG- 485
++G+G YG+VY+ L R V + M KF E+++L + P +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 486 -TCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
+ + EY+ GSL+ A + +I V L +L E IIH
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEHNIIH 126
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK 604
++KP+ VL++ N KL DFG +GN N Y+ PE +++G
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGV---------SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 605 L------TPESDVYSFGIILLRLLTGR 625
T +SDV+S G+ +L + GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH----VAIKM--FPSYGPQSHLKFQNEVEVLSRVRH 477
+F+ K+G+G YG+VY+ ++ L A+K S + NE+ +L+ V H
Sbjct: 1 DFKVLKKLGKGSYGSVYK--VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH 58
Query: 478 PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLA-CKNKKSPLRWQTRMQIASDVCSALIY 534
PN+++ + L V EY G L ++ K K+ + Q +I + L
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
LH + I+H +LK + +L+ AN K+ D G ++ N A Y
Sbjct: 119 LHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMA----KTQIGTPHY 167
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE + + +SD++S G +L + T P
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 431 IGEGRYGNVYRGLLRH------------LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHP 478
+G+G + N+Y+G+LR + V +K+ S S L F ++S++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS-LAFFETASLMSQLSHK 61
Query: 479 NLVTLIGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+LV L G C + +V EY++ G L+ L + L W ++ +A + SAL YL
Sbjct: 62 HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 538 NEPCIIHGNLKPSKVLI---DANFGS----KLSDFGFFHLIPQGESTGNSALCNESNNDS 590
+ ++HGN+ +L+ N G KLSD G IP + +
Sbjct: 120 KK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG----IPIT-------VLSREERVE 166
Query: 591 ASVYIDPEYLETG--KLTPESDVYSFGIILL 619
+I PE + G LT +D +SFG LL
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 431 IGEGRYGNVYR----GLLRH-----LHVAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPN 479
+GEG +G V R G+ + + VA+KM L +E+E++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSP-------------LRWQTRMQI 524
++ L+G C + L + EY G+L + L + P L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSA 581
A V + YL S CI H +L VL+ + K++DFG H I + T N
Sbjct: 140 AYQVARGMEYLESRR-CI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRP 626
L ++ PE L T +SDV+SFGI++ + T G P
Sbjct: 198 L--------PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQN-----EVEVLSRVRH 477
N+ E +IG G G VY+ +R M ++ K +N +++V+ +
Sbjct: 15 NDLENLGEIGSGTCGQVYK--MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD 72
Query: 478 -PNLVTLIGT---------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
P +V G C E S + L K + P+ ++
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLL----------KRIQGPIPEDILGKMTVA 122
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN 587
+ AL YL +IH ++KPS +L+DA+ KL DFG + ++ SA C
Sbjct: 123 IVKALHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC---- 177
Query: 588 NDSASVYIDPEYLETGKLTPE----SDVYSFGIILLRLLTGR 625
+ Y+ PE ++ P+ +DV+S GI L+ L TG+
Sbjct: 178 ----AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 430 KIGEGRYGNVYRGLLR---HLHVAIKMFPSYGPQSHLKFQ--NEVEVLSRVRHPNLVTL- 483
K+GEG Y VY+G+ R L VA+K+ S + + F E +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQL-VALKVI-SMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 484 -IGTCPESRSLVFEYLRNGSLEDCLACKNKKSP--LRWQTRMQIASDVCSALIYLHSNEP 540
I E+ + VFEY+ LA + P L + L Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE-- 598
I+H +LKP +LI KL+DFG + S +++ +++ P
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGL--------ARAKSIPSQTYSSEVVTLWYRPPDV 174
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640
L + D++ G I + +L G+P DV LEK
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 423 NNFEPSWKIGEGRYGNVYR----GLLRH---LHVAIKMFPSYGPQSHLK-FQNEVEVLSR 474
NN +G G +G V GL + + VA+KM S + +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 475 V-RHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
+ H N+V L+G C ++ EY G L + L + ++S L + + + V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKG 153
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
+ +L S CI H +L VL+ K+ DFG L + NDS
Sbjct: 154 MAFLASKN-CI-HRDLAARNVLLTHGKIVKICDFG---------------LARDIMNDSN 196
Query: 592 SV----------YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
V ++ PE + T ESDV+S+GI+L + +
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 430 KIGEGRYGNVYRG---LLRHLHVAIKMF----PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
K+GEG Y V++G L +L VA+K P + ++ EV +L ++H N+VT
Sbjct: 13 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 483 L--IGTCPESRSLVFEYLRNG---SLEDC---LACKNKKSPLRWQTRMQIASDVCSALIY 534
L I +S +LVFEYL ++DC ++ N K L + L Y
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAY 119
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
H + ++H +LKP +LI+ KL+DFG + S +N+ +++
Sbjct: 120 CHRRK--VLHRDLKPQNLLINERGELKLADFGL--------ARAKSVPTKTYSNEVVTLW 169
Query: 595 IDPE--YLETGKLTPESDVYSFGIILLRLLTGRPVL 628
P L + + + + D++ G I + +GRP+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 430 KIGEGRYGNVYRG---LLRHLHVAIKMF----PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
K+GEG Y VY+G L +L VA+K P + ++ EV +L ++H N+VT
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 483 L--IGTCPESRSLVFEYLRNG---SLEDC---LACKNKKSPLRWQTRMQIASDVCSALIY 534
L I +S +LVFEYL L+DC + N K L R L Y
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR---------GLNY 119
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
H + ++H +LKP +LI+ KL+DFG + S +N+ +++
Sbjct: 120 CHRRK--VLHRDLKPQNLLINERGELKLADFGL--------ARAKSIPTKTYSNEVVTLW 169
Query: 595 IDPE--YLETGKLTPESDVYSFGIILLRLLTGRPVL 628
P L + + + D++ G I + TGRP+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 19/221 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQ--NEVEVLSRVRHPNLVTL 483
++G G +G V +G+ + VA+K+ + LK + E V+ ++ +P +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 484 IGTCP-ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG C ES LV E G L L KNK + + ++ V + YL
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQ-KNKH--VTEKNITELVHQVSMGMKYLEETN--F 116
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +L VL+ +K+SDFG + E+ + +++ + PE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA----KTHGKWPVKWYAPECMNY 172
Query: 603 GKLTPESDVYSFGIILLRLLT--GRPVLRIK-KDVKCALEK 640
K + +SDV+SFG+++ + +P +K +V +E
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 431 IGEGRYGNVYRGLL---------RHLHVAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPN 479
+GEG +G V + + VA+KM L +E+E++ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQI 524
++ L+G C + L + EY G+L + L CK + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSA 581
A V + YL S + IH +L VL+ + K++DFG H I + T N
Sbjct: 140 AYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
L ++ PE L T +SDV+SFG++L + T
Sbjct: 198 L--------PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 55/206 (26%), Positives = 79/206 (38%), Gaps = 26/206 (12%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
++G+G YG V+ + VA+K H+ E ++L+ + LV
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL--TERDILTTTKSEWLVK 65
Query: 483 LIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L+ E L EY+ G L N R +A A+ LH E
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFE-AVDALH--EL 120
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
IH +LKP LIDA+ KL+DFG L + NS + + Y+ PE L
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFG---LSKGIVTYANSVV-------GSPDYMAPEVL 170
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRP 626
D +S G +L L G P
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 431 IGEGRYGNVYRGLLRHLHV--AIKMFPS-YGPQSHLKFQNEVEVLSRVRH-PNLVTLIG- 485
IG G +G V + L + A+K S + + +++V+ R P +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 486 TCPESRSLVFEYLRNGSLEDC--LACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
E + L + SL+ + KS + + +IA AL YL E II
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL-KEELKII 130
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNS--ALCNESNNDSASVYIDPEYL 600
H ++KPS +L+D N KL DFG L+ +S + A C Y+ PE +
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRP--------YMAPERI 179
Query: 601 ETGKLTP---ESDVYSFGIILLRLLTGR 625
+ SDV+S GI L + TG+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 57/238 (23%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQN-----------E 468
+E +I EG YG VYR R VA+K LK + E
Sbjct: 6 EYEKLNRIEEGTYGVVYRA--RDKKTGEIVALK---------KLKMEKEKEGFPITSLRE 54
Query: 469 VEVLSRVRHPNLVTL----IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
+ +L +++HPN+VT+ +G+ + +V EY+ + L+ + + K P +
Sbjct: 55 INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCL 111
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLI--PQGESTGNSA 581
+ S + +LH N I+H +LK S +L++ N G K+ DFG P T
Sbjct: 112 MLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQL-- 166
Query: 582 LCNESNNDSASV----YIDPE-YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634
V Y PE L + + D++S G I LLT +P+ K ++
Sbjct: 167 -----------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 424 NFEPSWKI----GEGRYGNVYRGLLRHLHV--AIKMFPSYGPQSHLKFQNEVEVLSRVRH 477
N E W+I G+G +G VY+ + V A K+ + + + E+++L+ H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 478 PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
PN+V L+ +L + E+ G++ D + + ++ Q R+ + AL YL
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYL 119
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY- 594
H N+ IIH +LK +L + KL+DFG S N+ ++ + Y
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYW 169
Query: 595 IDPEYL--ETGKLTP---ESDVYSFGIILLRLLTGRP 626
+ PE + ET K P ++DV+S GI L+ + P
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 41/152 (26%), Positives = 62/152 (40%), Gaps = 15/152 (9%)
Query: 430 KIGEGRYGNVYRGL----LRHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+IG G +G V G V +K + S Q +KF E + ++H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 485 GTCPESRS--LVFEYLR----NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
G C E LV E+ G L C + RM A ++ L++LH N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKN 119
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570
IH +L L+ A+ K+ D+G H
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 30/168 (17%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E VL RHP L +L + L F EY+ G L L+ + S R TR
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR--TRF-YG 101
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+++ SAL YLHS + I++ +LK +++D + K++DFG LC E
Sbjct: 102 AEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFG---------------LCKE 144
Query: 586 SNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
D+A++ Y+ PE LE D + G+++ ++ GR
Sbjct: 145 GITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 23/168 (13%)
Query: 466 QNEVEVLSRV-RHPNLVTLIGTCPESRSLVF---EYLRNGSLE-DCLACKNKKSPLRWQT 520
E VL+ +HP L L +C +++ +F EY+ G L P +
Sbjct: 43 MTEKRVLALAGKHPFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---RA 98
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN- 579
R A+++ L +LH II+ +LK VL+D+ K++DFG + +G G
Sbjct: 99 RF-YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFG---MCKEGILGGVT 152
Query: 580 -SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
S C + YI PE L P D ++ G++L +L G+
Sbjct: 153 TSTFCGTPD------YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 431 IGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G VY+G+ + VAIK+ + P+++ + +E V++ V P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 484 IGTCPESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+G C S LV + + G L D + + K + Q + + + YL E +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLE--EVRL 130
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +L VL+ + K++DFG L+ E+ E + D V I LE+
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDET--------EYHADGGKVPIKWMALES 182
Query: 603 ---GKLTPESDVYSFGIILLRLLT 623
+ T +SDV+S+G+ + L+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 430 KIGEGRYGNVYRGLLRHL----HVAIKM----FPSYGPQSHLKFQNEVEVLSRVR-HPNL 480
KIGEG + V + + + AIK F S ++L E++ L R+ HPN+
Sbjct: 6 KIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNL---REIQALRRLSPHPNI 60
Query: 481 VTLI----GTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
+ LI +LVFE L + +L + + K +K PL + + +L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFE-LMDMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI----PQGESTGNSALCNESNNDSAS 592
N I H ++KP +LI + KL+DFG I P E S
Sbjct: 118 RNG--IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYI------------STR 162
Query: 593 VYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRP 626
Y PE L T G P+ D+++ G + +L+ P
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 424 NFEPSWKIGEGRYGNVY--RGLLRHLHVAIKM--FPSYGPQSHLKFQNEVEVLSRVRHPN 479
+E KIGEG +G +Y + H IK + + EV +L++++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+VT + E+ L V EY G D + N++ + + ++ V +L H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 538 NEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
++ I+H ++K + + N +KL DFG + +S + C Y+
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCV-----GTPYYLS 170
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLT 623
PE + ++D++S G +L L T
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVEVLSRVRHP 478
+++E ++G G YG+VY+ R+LH A+K+ Q E+ ++ +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA---SDVCSALI 533
N+V G+ E + EY GSL+D + PL + +QIA + L
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIY---HVTGPL---SELQIAYVCRETLQGLA 120
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
YLHS +H ++K + +L+ N KL+DFG
Sbjct: 121 YLHSKGK--MHRDIKGANILLTDNGDVKLADFG 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 431 IGEGRYGNVYRGLL--------------------------RHLHVAIKMFPSYGPQSHLK 464
+G+G N+Y G L R L V +K+ L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 465 FQNEVEVLSRVRHPNLVTLIGTC---PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
F ++S+V H +L + G C E+ +V E++ +G L+ CL + + P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119
Query: 522 MQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581
+ +A + SAL YL ++HGN+ +L+ A G F L G S A
Sbjct: 120 ITVAQQLASALSYLEDKN--LVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFT--A 174
Query: 582 LCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRL 621
L E + +I PE + G L+ +D +SFG LL +
Sbjct: 175 LSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVEVLSRVRHPN 479
+FE +IG G YG+VY+ R+++ AIK+ + Q E+ ++ +H N
Sbjct: 10 DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V G+ L E+ GSL+D + PL ++ + L YLHS
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
+H ++K + +L+ N KL+DFG
Sbjct: 125 KGK--MHRDIKGANILLTDNGHVKLADFG 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 15/169 (8%)
Query: 460 QSHLKFQNEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLR 517
Q+H+ + V +L ++HP LV L + E V +Y+ G L + ++ L
Sbjct: 39 QNHIMAERNV-LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLE 95
Query: 518 WQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577
+ R A++V SA+ YLHS II+ +LKP +L+D+ L+DFG + E T
Sbjct: 96 PRARF-YAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152
Query: 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
S C Y+ PE L D + G +L +L G P
Sbjct: 153 -TSTFCGTPE------YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 6e-07
Identities = 40/174 (22%), Positives = 86/174 (49%), Gaps = 18/174 (10%)
Query: 237 LLGTSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAM 296
+ + + + EE+++ LE+AK EA+ KK E + + N E + + +
Sbjct: 23 FVRKKIAEAKIKEAEEEAKRILEEAKKEAEAIKKEALLEAKEEIHKLRNEFEKELRERRN 82
Query: 297 QSLCVKEMSQR-KELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHS- 354
+ ++++ +R + EE L ++ + +++ + + +K KEL+ Q + E +L E
Sbjct: 83 E---LQKLEKRLLQKEENLDRKLELLEKREEELEKKEKELEQKQQELEKKEEELEELIEE 139
Query: 355 VVKELEEKIIS------AVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREA 402
++ELE IS A E+L+ ++ ++ R E A +++I++ K EA
Sbjct: 140 QLQELER--ISGLTAEEAKEILL--EKVEEEARHE---AAVLIKEIEEEAKEEA 186
|
Length = 520 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 59/228 (25%)
Query: 431 IGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------EVEVLSRVRHPN 479
IG+G YG V + H VAIK + + F++ E+++L +RHP+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIK-------KINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 480 LVTL--IGTCPESRS-----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
+V + I P R +VFE L L + + +P Q + + AL
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLY---QLLRAL 116
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
Y+H+ + H +LKP +L +A+ K+ DFG L + ND+ +
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFG---------------LARVAFNDTPT 159
Query: 593 VYIDPEYLET-------------GKLTPESDVYSFGIILLRLLTGRPV 627
+Y+ T K TP D++S G I +LTG+P+
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQ--NEVEVLSRVRHPNLVTL-- 483
K+GEG Y VY+G + VA+K + F E +L ++H N+VTL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 484 IGTCPESRSLVFEYLRNG---SLEDC---LACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
I ++ +LVFEYL ++DC L+ N + L R L Y H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCHQ 121
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
++H +LKP +LI KL+DFG + S +N+ +++ P
Sbjct: 122 RR--VLHRDLKPQNLLISERGELKLADFGL--------ARAKSVPSKTYSNEVVTLWYRP 171
Query: 598 E--YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640
L + + + D++ G I + TGRP+ DV+ L K
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 46/152 (30%), Positives = 65/152 (42%), Gaps = 14/152 (9%)
Query: 476 RHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALI 533
HP L L T L F EYL G L + + R R A +C L
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR--ARFYAAEIIC-GLQ 110
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
+LH II+ +LK VL+D + K++DFG GE ++ C +
Sbjct: 111 FLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPD------ 161
Query: 594 YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
YI PE L+ K D +SFG++L +L G+
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 431 IGEGRYGNVYRGLLRH----LHVAIKMFPSYGPQSHLKFQNEVE--------VLSRVRHP 478
IG+G +G V L +H A+K+ + + + E + +L V+HP
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQ----KKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
LV L + + V +Y+ G L L + ++S + R A+++ SAL YLH
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARF-YAAEIASALGYLH 113
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
S II+ +LKP +L+D+ L+DFG + T S C Y+
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFCGTPE------YLA 164
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L D + G +L +L G P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 431 IGEGRYGNVYRGLL---------RHLHVAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPN 479
+GEG +G V R VA+KM S + L +E+E++ + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACK-------------NKKSPLRWQTRMQI 524
++ L+G C + L + EY G+L + L + + L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSA 581
A V + YL S + IH +L VL+ + K++DFG H I + T N
Sbjct: 146 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRP 626
L ++ PE L T +SDV+SFG++L + T G P
Sbjct: 204 L--------PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 430 KIGEGRYGNVYRGLLRHL----HVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
KIGEG +G L++ IK P+ + + EV VLS ++HPN+V
Sbjct: 7 KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSN 538
+ E+ +L V +Y G D N + + + QI +C AL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPED-QILDWFVQICLALKHVHDR 120
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+ I+H ++K + + + KL DFG ++ NS + Y+ PE
Sbjct: 121 K--ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELARTCIGTPYYLSPE 171
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF-NSVLDSSAGDWP 655
E +SD+++ G +L + T +K A E N N VL G +P
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 431 IGEGRYGNVYRGLLRH-----LHVAIKMFPS--YGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G+G +G+V L+ VA+KM + + +F E + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 484 IGTCPESRS--------LVFEYLRNGSLED-CLACKNKKSP--LRWQTRMQIASDVCSAL 532
IG SR+ ++ ++++G L L + + P L QT ++ D+ S +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
YL S IH +L +++ N ++DFG I G+ AS
Sbjct: 127 EYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY---------RQGCAS 175
Query: 593 ----VYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
++ E L T SDV++FG+ + ++T
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL-- 483
K+G G YG+VY+ + A+K G + E+ +L ++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65
Query: 484 --IGTCPESRSLVFEYLRNG---SLEDCLACKNKKSPLRWQTRM--QIASDVCSALIYLH 536
+ L+F+Y + ++ A K K P++ M + + + YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 537 SNEPCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
+N ++H +LKP+ +L+ K++D GF L NS L ++ D
Sbjct: 126 AN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-------NSPLKPLADLDPVV 176
Query: 593 V---YIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKK-DVKCA 637
V Y PE L + T D+++ G I LLT P+ ++ D+K +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 466 QNEVEVLSRVRHPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRM 522
Q E V + + + +C ++ S LV EY+ G D + ++ L +
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHAR 99
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN--S 580
A+++C AL +LH E II+ +LK VL+DA+ KL+D+G + +G G+ S
Sbjct: 100 FYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTS 154
Query: 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633
C N YI PE L + D ++ G+++ ++ GR I D
Sbjct: 155 TFCGTPN------YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-06
Identities = 57/231 (24%), Positives = 86/231 (37%), Gaps = 62/231 (26%)
Query: 431 IGEGRYGNVYRGL--LRHLHVAIKMFPSYGPQSHLKFQN---------EVEVLSRVRHPN 479
IG G YG V + VAIK + F + E+++L +RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60
Query: 480 LVTLIG-TCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRM-QIASDVCSA 531
++ L+ P S +V E + L + + Q + QI
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQI----LRG 115
Query: 532 LIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS 590
L YLHS N +IH +LKPS +L+++N K+ DFG L + D
Sbjct: 116 LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFG---------------LARGVDPDE 157
Query: 591 ASVYIDPEYLET------------GKLTPESDVYSFGIILLRLLTGRPVLR 629
EY+ T + T D++S G I LLT +P+
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 28/198 (14%)
Query: 449 VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPNLVTLIGTCPESRSL--VFEYLRNGSLE 504
VA+KM + L +E+E++ + +H N++ L+G C + L + EY G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 505 DCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSK 551
+ L + + ++ + V + YL S + IH +L
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARN 167
Query: 552 VLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGKLTPESD 610
VL+ N K++DFG N ++ N V ++ PE L T +SD
Sbjct: 168 VLVTENNVMKIADFGL------ARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221
Query: 611 VYSFGIILLRLLT--GRP 626
V+SFG+++ + T G P
Sbjct: 222 VWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 431 IGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G VY+GL + VAIK + P+++ + +E V++ V +P++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 484 IGTCPESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+G C S L+ + + G L D + + K + Q + + + YL E +
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE--ERRL 130
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +L VL+ K++DFG L+ E E + + V I LE+
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADE--------KEYHAEGGKVPIKWMALES 182
Query: 603 ---GKLTPESDVYSFGIILLRLLT 623
T +SDV+S+G+ + L+T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/206 (22%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 431 IGEGRYGNVYRGL---------LRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G+G + +++G+ L V +K+ F ++S++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 482 TLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G C + +V EY++ GSL+ L + W ++++A + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+ HGN+ VL+ K + F L G S + L E + ++ PE
Sbjct: 121 --LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEILLERIP-WVPPEC 175
Query: 600 LETGK-LTPESDVYSFGIILLRLLTG 624
+E + L+ +D +SFG L + +G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 41/113 (36%), Positives = 56/113 (49%), Gaps = 25/113 (22%)
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSA 581
+IA + AL YLHS +IH ++KPS VLI+ N KL DFG +L+ T + A
Sbjct: 107 KIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-A 164
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPE---------SDVYSFGIILLRLLTGR 625
C Y+ PE ++ PE SDV+S GI ++ L TGR
Sbjct: 165 GCKP--------YMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 430 KIGEGRYGNVYRGLLRH----LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL-- 483
K+G G YG+VY+ + A+K G + E+ +L ++HPN+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65
Query: 484 --IGTCPESRSLVFEYLRNG---SLEDCLACKNKKSPLRWQTRM--QIASDVCSALIYLH 536
+ L+F+Y + ++ A K K P++ M + + + YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 537 SNEPCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
+N ++H +LKP+ +L+ K++D GF L NS L ++ D
Sbjct: 126 AN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-------NSPLKPLADLDPVV 176
Query: 593 V---YIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKK-DVKCA 637
V Y PE L + T D+++ G I LLT P+ ++ D+K +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 43/283 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLHV--AIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G+G +G VY+ + A K+ + + + E+E+L+ HP +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
++ E+ G++ D + + + Q ++ I + AL YLHS + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSMK--IIHR 134
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY-IDPEYL--ET 602
+LK VL+ + KL+DFG S N ++ + Y + PE + ET
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGV--------SAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 603 GKLTP---ESDVYSFGIILLRLLTGRP----------VLRIKKD--------VKCALEKR 641
K TP ++D++S GI L+ + P +L+I K K ++E R
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246
Query: 642 NF-NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSE 683
+F + LD P A A+ L H + +NR R +LV+E
Sbjct: 247 DFLKTALDKHPETRPSA-AQLLEHPFVSSVTSNRPLR-ELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 27/157 (17%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF---------PSYGPQSHLKFQNEVEVLS 473
+E KIGEG YG VY+ R + +A+K PS + E+ +L
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-------EISLLK 56
Query: 474 RVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCS 530
++H N+V L + LVFEYL + + + K+P +T + +
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY---QILR 113
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFG 566
+ Y HS+ ++H +LKP +LID + KL+DFG
Sbjct: 114 GIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFG 148
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 23/261 (8%)
Query: 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLI 484
++G G +G V +G+ + + VAIK+ + +S + E E++ ++ +P +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 485 GTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G C E+ LV E G L L+ K + + +++ V + YL +
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLE--GKNFV 117
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
H +L VL+ +K+SDFG + + +S S + PE +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFG----LSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 604 KLTPESDVYSFGIILLRLLT--GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661
K + SDV+S+GI + + +P ++K + ++ D P +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-------KRLDCPAECPPE 226
Query: 662 LAHLALRCCENNRLNRPDLVS 682
+ L C +RP+
Sbjct: 227 MYALMKDCWIYKWEDRPNFAK 247
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 45/244 (18%)
Query: 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKF 465
L + S L + FE +G G YG VY+G RH+ AIK+ +
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKG--RHVKTGQLAAIKVM-DVTEDEEEEI 59
Query: 466 QNEVEVLSRV-RHPNLVTLIGT----CPESRS----LVFEYLRNGSLEDCLACKNKKSPL 516
+ E+ +L + H N+ T G P LV E+ GS+ D L K + L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNAL 118
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
+ I ++ L +LH+++ +IH ++K VL+ N KL DFG + +
Sbjct: 119 KEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 577 TGNSAL------------CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG 624
N+ + C+E N D+ Y SD++S GI + + G
Sbjct: 177 RRNTFIGTPYWMAPEVIACDE-NPDATYDY-------------RSDIWSLGITAIEMAEG 222
Query: 625 RPVL 628
P L
Sbjct: 223 APPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSH----LKFQNEVEVLSRVRHPNLVTL 483
IGEG YG V + + VAIK P H + E+++L R +H N++ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 484 IGT-CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD--VC-------SALI 533
+ P S FE + + L ++ L + Q S+ + L
Sbjct: 69 LDIIRPPS----FESFNDVYIVQELM----ETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI-PQGESTGNSALCNESNNDSAS 592
Y+HS ++H +LKPS +L++ N K+ DFG + P+ + TG +
Sbjct: 121 YIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL---------TEY 169
Query: 593 V----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPV 627
V Y PE + K T D++S G IL +L+ RP+
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 33/230 (14%)
Query: 418 LNEATNNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVEVLS 473
L + FE +G G YG VY+G RH+ AIK+ G + + + E+ +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLK 57
Query: 474 RV-RHPNLVTLIGTCPESRS--------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
+ H N+ T G + LV E+ GS+ D + K + L+ + I
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAYI 116
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
++ L +LH ++ +IH ++K VL+ N KL DFG + + N+ +
Sbjct: 117 CREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-- 172
Query: 585 ESNNDSASVYIDPEYLETGKLTPE------SDVYSFGIILLRLLTGRPVL 628
++ PE + + P+ SD++S GI + + G P L
Sbjct: 173 -----GTPYWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 431 IGEGRYGNVYRGLLRH----LHVAIKMFPSYG-----PQSHLKFQNEVEVLSRVRHPNLV 481
IG+G +G V L RH A+K+ + H+ + V +L V+HP LV
Sbjct: 3 IGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59
Query: 482 TLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L + + L F +Y+ G L L + ++ L + R A+++ SAL YLHS
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFF--HLIPQGESTGNSALCNESNNDSASVYIDP 597
I++ +LKP +L+D+ L+DFG ++ G + S C Y+ P
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPE------YLAP 165
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E L D + G +L +L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN--SAL 582
A++V AL++LH + +I+ +LK +L+DA KL+DFG + +G G +
Sbjct: 102 AAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTF 156
Query: 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
C + YI PE L+ + P D ++ G+++ ++ G+P
Sbjct: 157 CGTPD------YIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKM----FPSYGPQSHLKFQNEVEVLSRV-RHPNLVT 482
++G+G +G+VY + VAIK F S+ +L+ EV+ L ++ HPN+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR---EVKSLRKLNEHPNIVK 62
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L E+ L VFEY+ G+L L K P I + L ++H +
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFG 566
H +LKP +L+ K++DFG
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFG 144
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 51/291 (17%)
Query: 423 NNFEPSWKIGEGRYGNVYRGL--LRHLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPN 479
+++E K+GEG Y VY+G + VA+K+ + + E +L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 480 LVTL--IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V L I E+ +LVFEY+ + C L + + L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
I+H +LKP +LI KL+DFG + S + +N+ +++ P
Sbjct: 122 RY--ILHRDLKPQNLLISDTGELKLADFGL--------ARAKSVPSHTYSNEVVTLWYRP 171
Query: 598 EYLETGKLTPES--DVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655
+ G + D++ G I + ++ G KD++ LE R F + + WP
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWP 230
Query: 656 ------------------------------VAEAEQLAHLALRCCENNRLN 676
V AE LA L+C NRL+
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 33/156 (21%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306
L + ++RL ++I ++ EE V R + +E K + ++
Sbjct: 777 LEEALNDLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQK----------LNRLTL 826
Query: 307 RKELEELLAKEKQEVQR-TKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIIS 365
KE E +E QE + K Q KE++ + + LE +L E + +++LE +
Sbjct: 827 EKEYLEKEIQELQEQRIDLKEQIKSIEKEIENLNGKKEELEEELEELEAALRDLESR--- 883
Query: 366 AVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKRE 401
L K++RD+L + +R++ +++ I+++
Sbjct: 884 ----LGDLKKERDELEAQLRELERKIEELEAQIEKK 915
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E VL RHP L L L F EY G L L+ + + R +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YG 101
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+++ SAL YLHS + +++ ++K +++D + K++DFG LC E
Sbjct: 102 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFG---------------LCKE 144
Query: 586 SNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
+D A++ Y+ PE LE D + G+++ ++ GR
Sbjct: 145 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 477 HPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALI 533
HP LV L +C ++ S V E++ G D + ++ L + ++++ AL
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL-IPQGESTGNSALCNESNNDSAS 592
+LH E II+ +LK VL+DA KL+D+G I G++T S C N
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPN----- 161
Query: 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
YI PE L D ++ G+++ ++ GR
Sbjct: 162 -YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 431 IGEGRYGNVYR----GLLRHLHVAIKMFPSYGPQSHLK---FQNEVEVLSRVRHPNLVTL 483
+G+G +G VY R L F P++ + + E+++L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 484 IGTCPESR-----SLVFEYLRNGSLEDCLACKN--KKSPLRWQTRMQIASDVCSALIYLH 536
G C R ++ EY+ GS++D L +S R TR + + YLH
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-----QILEGMSYLH 123
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN----DSAS 592
SN I+H ++K + +L D+ KL DF G S +C
Sbjct: 124 SN--MIVHRDIKGANILRDSAGNVKLGDF--------GASKRLQTICMSGTGIRSVTGTP 173
Query: 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + ++DV+S G ++ +LT +P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 418 LNEATNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVE---VL 472
L + T+ +E IG+G YG VY+ + A+K+ P S + + E E +
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQ 73
Query: 473 SRVRHPNLVTLIGTCPESRS-------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ-- 523
S HPN+V G ++ LV E GS+ + + K L R+
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEA 128
Query: 524 -IASDVCSALI---YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579
I+ + AL+ +LH+N IIH ++K + +L+ G KL DFG +
Sbjct: 129 MISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV-------SAQLT 179
Query: 580 SALCNESNNDSASVYIDPEYLETGKLTPES-----DVYSFGIILLRLLTGRPVL 628
S + + ++ PE + + S DV+S GI + L G P L
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------V 471
+FE I G YG VY L+RH A+K + +L +N+++ +
Sbjct: 1 EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKIN----KQNLILRNQIQQVFVERDI 54
Query: 472 LSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQT-RMQIASDV 528
L+ +P +V++ + R L V EY+ G DC L RM A V
Sbjct: 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETV 111
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
AL YLH+ I+H +LKP +LI + KL+DFG L G + + L
Sbjct: 112 L-ALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFG---LSKIGLMSLTTNLYEGHIE 165
Query: 589 DSASVYID------PEY------LETGKLTPESDVYSFGIILLRLLTG 624
++D PEY L G P D ++ GIIL L G
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 28/120 (23%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 19 TIFVAVGKNVEKNKTTVFWALQNFA--GKKISLLHVHKPSHVFAFKESKCAVNGLKQHAD 76
I VAV + E+++ + WA + G ++ LLHV P A + ++ L++ A
Sbjct: 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAE----LLEEEAR 55
Query: 77 KIQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLL 136
+ + L++AGV+ ++V + + + + I+E + +VMG+ + LL
Sbjct: 56 AL--LEALREALAEAGVKVETV-VLEGDPAEAILEAAEELGADLIVMGSRGRSGLRRLLL 112
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 468 EVEVLSRVR-HPNLVTLIGTC---PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523
E +LS R HP L L C P+ V E++ G L + +KS + R +
Sbjct: 45 EKRILSLARNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARAR 99
Query: 524 I-ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGNSA 581
A+++ SAL++LH II+ +LK VL+D KL+DFG I G++T S
Sbjct: 100 FYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--ST 155
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG 624
C + YI PE L+ P D ++ G++L +L G
Sbjct: 156 FCGTPD------YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSY---GPQSHLKFQNEV 469
+L ++E IG G +G V L+RH A+K+ + F E
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 470 EVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
++++ P +V L + R L V EY+ G L + ++ N P +W R A +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKW-ARFYTA-E 150
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCNES 586
V AL +HS IH ++KP +L+D + KL+DFG + +G ++A+
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 587 NNDSASVYIDPEYLET----GKLTPESDVYSFGIILLRLLTG 624
YI PE L++ G E D +S G+ L +L G
Sbjct: 209 -------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 431 IGEGRYGNVY----RGLLRHLHVAIKMFPSYGPQSHLK---FQNEVEVLSRVRHPNLVTL 483
+G+G +G VY R L V F P++ + + E+++L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 484 IGTC--PESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G P R S+ E++ GS++D L L + + + YLHSN
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----Y 594
I+H ++K + +L D+ KL DF G S +C S SV +
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDF--------GASKRLQTIC-LSGTGMKSVTGTPYW 175
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE + ++D++S G ++ +LT +P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 56/230 (24%)
Query: 431 IGEGRYGNVYRGLLRHL--HVAIKM---------FPSYGPQSHLKFQNEVEVLSRVRHPN 479
IGEG YG VY+ + VA+K FP + E+++L ++ H N
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFP-------ITAIREIKILRQLNHRN 67
Query: 480 LVTLIGTCPESRS------------LVFEYLRN---GSLEDCLACKNKKSPLRWQTRMQI 524
+V L + + LVFEY+ + G LE L ++ I
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED---------HI 118
Query: 525 AS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581
S + L Y H +H ++K S +L++ KL+DFG L ES
Sbjct: 119 KSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES----- 171
Query: 582 LCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLR 629
N +++ P L G + P DV+S G IL L T +P+ +
Sbjct: 172 --RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 431 IGEGRYGNVYRGLLRHLHVAIKMFPSYG---PQSHLKFQN---EVEVLSRVRHPNLVTLI 484
+GEG +G R LL + + + P+S ++ E +L++++HPN+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPL-RWQTRMQIASDVCSALIYLHSNEPC 541
+ L V EY G L + K ++ L T +Q +C + ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR-- 120
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
++H ++K + + N KL DFG L+ + + + Y+ PE E
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-------GTPYYVPPEIWE 173
Query: 602 TGKLTPESDVYSFGIILLRLLT 623
+SD++S G IL L T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 431 IGEGRYGNVY----RGLLRHLHVAIKMFPSYGPQSHLK------FQNEVEVLSRVRHPNL 480
+G G +G VY R L A+K P + P S + E+++L +RH +
Sbjct: 10 LGRGAFGEVYLCYDADTGREL--AVKQVP-FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 481 VTLIGTC--PESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
V G PE + S+ EY+ GS++D L L + + + YLH
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
SN I+H ++K + +L D+ KL DFG I +G + ++
Sbjct: 124 SN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----KSVTGTPYWMS 177
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + ++DV+S ++ +LT +P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSHLKFQN------EVEVLS 473
+FE +G G +G V + +H + AIK + LK + E +L
Sbjct: 19 DFEMGETLGTGSFGRVR--IAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILM 73
Query: 474 RVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRM--QIASDVC 529
+ HP +V ++ + + + F E++ G L + LR R +A
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL---------FTHLRKAGRFPNDVAKFYH 124
Query: 530 SALI----YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+ L+ YLHS + II+ +LKP +L+D K++DFGF +P T LC
Sbjct: 125 AELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LCGT 178
Query: 586 SNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE +++ D ++ G++L + G P
Sbjct: 179 PE------YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 30/168 (17%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E VL RHP L L + L F EY G L L+ + S R R A
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR--ARFYGA 102
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ SAL YLHS + +++ +LK +++D + K++DFG LC E
Sbjct: 103 -EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFG---------------LCKE 144
Query: 586 SNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
+D A++ Y+ PE LE D + G+++ ++ GR
Sbjct: 145 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 9/101 (8%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A+++ L +LHS II+ +LK V++D + K++DFG G++ S C
Sbjct: 102 AAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCG 158
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
+ YI PE L+ K T D +SFG++L +L G+
Sbjct: 159 TPD------YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 466 QNEVEVLSRV-RHPNLVTLIGTCPESRSLVF---EYLRNGSLEDCLACKNKKSPLRWQTR 521
Q E V + HP LV L +C ++ S +F EY+ G D + ++ L +
Sbjct: 43 QTEKHVFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHA 98
Query: 522 MQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-- 579
++++ AL YLH E II+ +LK VL+D+ KL+D+G + +G G+
Sbjct: 99 RFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTT 153
Query: 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
S C N YI PE L D ++ G+++ ++ GR
Sbjct: 154 STFCGTPN------YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 27/182 (14%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E E+L+ + HP L TL + L +Y G L L + K L + A
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-LSEEVARFYA 109
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG------------FFHLIPQ 573
++V AL YLH I++ +LKP +L+ + LSDF L
Sbjct: 110 AEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 574 GESTGNSALCNESNNDSASV----------YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ +++ +E+ ++ S YI PE + D ++ GI+L +L
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 624 GR 625
G
Sbjct: 228 GT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 37/243 (15%)
Query: 412 EFSFSELNEATNNFEPSWKIGEGRYGNVYRGL--LRHLHVAIK--------MFPSYGPQS 461
FS SE +GEG YG V + L VAIK + Q
Sbjct: 3 SFSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQL 57
Query: 462 ------HLKFQNEVEVLSRVRHPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLACKNKK 513
H E+++++ ++H N++ L+ E +LV + + L+ + ++K
Sbjct: 58 VGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRK 113
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG----FFH 569
L I + + L LH +H +L P+ + I++ K++DFG + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 570 LIPQGESTGNSALCNESNNDSASV---YIDPEYL-ETGKLTPESDVYSFGIILLRLLTGR 625
+ + + S V Y PE L K D++S G I LLTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 626 PVL 628
P+
Sbjct: 232 PLF 234
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTL 483
IG G +G V L+RH A+K+ + F E ++++ P +V L
Sbjct: 51 IGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
+ + L V EY+ G L + ++ N P +W ++V AL +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFY--TAEVVLALDAIHSMG-- 162
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
+IH ++KP +L+D + KL+DFG + + + + YI PE L+
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE------TGMVRCDTAVGTPDYISPEVLK 216
Query: 602 T----GKLTPESDVYSFGIILLRLLTG 624
+ G E D +S G+ L +L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 26/167 (15%)
Query: 468 EVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E VL++V P +V L + PE LV ++ G L L + + R R A
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR--ARFYTA 100
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+C AL LH +I+ +LKP +L+D L DFG L N
Sbjct: 101 ELLC-ALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKL-------------NM 144
Query: 586 SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++D + Y+ PE L T D ++ G++L +LTG P
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E VL RHP L L + L F EY G L L+ + S R +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YG 101
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+++ SAL YLHS E +++ +LK +++D + K++DFG LC E
Sbjct: 102 AEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFG---------------LCKE 145
Query: 586 SNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
D A++ Y+ PE LE D + G+++ ++ GR
Sbjct: 146 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-05
Identities = 30/155 (19%), Positives = 76/155 (49%), Gaps = 2/155 (1%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEM-S 305
LT E ++ + +LE+ ++E + + EE+ K N + + K + + +
Sbjct: 258 LTAELQELEEKLEELRLE-VSELEEEIEELQKELYALANEISRLEQQKQILRERLANLER 316
Query: 306 QRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIIS 365
Q +ELE L + + ++ + + ++L+ ++++ +LE +L E + ++ELE ++
Sbjct: 317 QLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEAELEELEAELEELESRLEE 376
Query: 366 AVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
E L + + K QL ++ + + ++ ++R
Sbjct: 377 LEEQLETLRSKVAQLELQIASLNNEIERLEARLER 411
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 17/170 (10%)
Query: 460 QSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLR 517
Q H+ + V +L V+HP LV L + + L F +++ G L + ++S
Sbjct: 39 QKHIMAERNV-LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPE 95
Query: 518 WQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL-IPQGES 576
+ R A ++ SAL YLHS I++ +LKP +L+D+ L+DFG I Q ++
Sbjct: 96 PRARFYAA-EIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152
Query: 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
T + C Y+ PE + D + G +L +L G P
Sbjct: 153 T--TTFCGTPE------YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 431 IGEGRYGNVYRGLLRHLH---VAIKMFPSYGPQSHLKFQNEVE-------VLSRVRHPNL 480
+G G +G V ++ VAIK F +S + Q +V+ +L+ + HP
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFE----KSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V L G+ + L V E++ G L +NK+ P A+ + YL S
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQSL 150
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
I++ +LKP +L+D + K++DFGF ++ T LC YI PE
Sbjct: 151 N--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTLCGTPE------YIAPE 198
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
L +D ++ GI + +L G P
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|188306 TIGR03319, RNase_Y, ribonuclease Y | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 38/170 (22%)
Query: 251 EEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKEL 310
EE ++ +E+AK EA+ KK + +EAK +V +++ +E+ +R+
Sbjct: 31 EELAKRIIEEAKKEAETLKK-------------EALLEAKEEVHKLRAELERELKERR-- 75
Query: 311 EELLAKEKQEVQRT------KNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKI- 363
EL E++ +QR DK + L+ + + S E L E ++EL +
Sbjct: 76 NELQRLERRLLQREETLDRKMESLDKKEENLEKKEKELSNKEKNLDEKEEELEELIAEQR 135
Query: 364 -----IS------AVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREA 402
IS A E+L+ ++ ++ R E A + +++I++ K EA
Sbjct: 136 EELERISGLTQEEAKEILL--EEVEEEARHE---AAKLIKEIEEEAKEEA 180
|
Members of this family are RNase Y, an endoribonuclease. The member from Bacillus subtilis, YmdA, has been shown to be involved in turnover of yitJ riboswitch [Transcription, Degradation of RNA]. Length = 514 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 42/216 (19%)
Query: 433 EGRYGNVYRGLLRHLH------VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIG 485
EG +G ++ G+L V +K + + + E +L + H N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 486 TC---PESRSLVFEYLRNGSL----EDC-LACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
C E +++ Y+ G+L + C L N L Q + +A + + YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL----------CNESN 587
+IH ++ +ID K++D +AL C N
Sbjct: 136 RG--VIHKDIAARNCVIDEELQVKITD---------------NALSRDLFPMDYHCLGDN 178
Query: 588 NDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ ++ E L + + SDV+SFG++L L+T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 32/167 (19%), Positives = 84/167 (50%), Gaps = 14/167 (8%)
Query: 247 LTDEEEKSQSRLEQ--AKIEAKNSKKMVYEEVVKRWKEEDNAVEA-----KCKVKAMQSL 299
L +E E+ QSRLE+ ++E + +E ++ +EE ++E K +++ ++
Sbjct: 728 LEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEK 787
Query: 300 CVKEMSQRKELEELL-------AKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAES 352
+ +ELEE L ++E++ + + ++ +E++ ++++ LE +L E
Sbjct: 788 RQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDEL 847
Query: 353 HSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIK 399
++ELE+++ E L + ++++L E + ++++ ++
Sbjct: 848 EEELEELEKELEELKEELEELEAEKEELEDELKELEEEKEELEEELR 894
|
Length = 1163 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 60/220 (27%), Positives = 87/220 (39%), Gaps = 54/220 (24%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
E +L V+HP +V LI L + EYL G L L ++ T
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYL 106
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
S++ AL +LH II+ +LKP +L+DA KL+DFG LC E
Sbjct: 107 SEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFG---------------LCKE 149
Query: 586 SNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP----------- 626
S ++ Y+ PE L D +S G ++ +LTG P
Sbjct: 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209
Query: 627 --VLRIK-----------KDVKCALEKRNFNSVLDSSAGD 653
+L+ K +D+ L KRN +S L + GD
Sbjct: 210 DKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD 249
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 32/156 (20%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 247 LTDEEEKSQSRLE--QAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEM 304
L +E E+ Q L +I +K + +E +E + + Q ++
Sbjct: 279 LEEEIEELQKELYALANEISRLEQQKQIL-------RERLANLERQLEELEAQLEELE-- 329
Query: 305 SQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKII 364
S+ EL E LA+ +++++ K + + EL LE +L E S ++ELEE++
Sbjct: 330 SKLDELAEELAELEEKLEELKEELESLEAEL-------EELEAELEELESRLEELEEQLE 382
Query: 365 SAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
+ + + + L E + R+ ++ +R
Sbjct: 383 TLRSKVAQLELQIASLNNEIERLEARLERLEDRRER 418
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 36/242 (14%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMFP---SYGPQSHLKFQNEVEVLSRVRHPNLV 481
IG+G G VY L + VA+K S P +F E ++ + + HP +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 482 TLIGTCPESRSLVFE--YLRNGSLEDCL----ACKNKKSPLRWQTR----MQIASDVCSA 531
+ C + + + Y+ +L+ L ++ L +T + I +C+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKL-SDFGFFHLIPQGESTGNSALCNESNNDS 590
+ Y+HS ++H +LKP +L+ FG + D+G E +E N
Sbjct: 126 IEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 591 ASV-----------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE 639
+S+ Y+ PE L + +D+Y+ G+IL ++LT R KK K +
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 640 KR 641
Sbjct: 243 DV 244
|
Length = 932 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 15/172 (8%)
Query: 467 NEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
NE ++L +V +V+L + LV + G L+ + N P + R
Sbjct: 42 NEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIF 99
Query: 525 -ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
A+ + L +LH + I++ +LKP VL+D + ++SD G + G+ A
Sbjct: 100 YAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157
Query: 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK 635
Y+ PE L+ D ++ G L ++ GR R +K+
Sbjct: 158 PG--------YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 467 NEVEVL-SRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCL-ACKNKKSPLRWQTRM 522
+EV ++ ++RHPN+V T E+ L V + + L + + K KK +
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582
I + AL YLH E I+H +L P+ +++ + ++DFG Q ES S +
Sbjct: 117 NIFVQMVLALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVV 174
Query: 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627
+Y PE ++ ++DV++FG IL ++ T +P
Sbjct: 175 -------GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 431 IGEGRYGNVYRGLLR--------HLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNL 480
+G+G +G V+ L+R L+ A+K+ + + ++ + E ++L+ V HP +
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLY-AMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 481 VTL--IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V L L+ ++LR G L L+ K+ + +++ AL +LHS
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHS- 116
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
II+ +LKP +L+D KL+DFG E S C Y+ PE
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVE------YMAPE 168
Query: 599 YLETGKLTPESDVYSFGIILLRLLTG 624
+ T +D +SFG+++ +LTG
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 67/241 (27%)
Query: 420 EATNNFEPSWKIGEGRYGNV--YRGLLRHLHVAIKMFPSYGPQSHLKFQN---------E 468
E + P IG G YG V + + VAIK + F N E
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-------KIANAFDNRIDAKRTLRE 54
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS-----LVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
+++L + H N++ + I P + +V+E L + L + +S QT
Sbjct: 55 IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII-----RSS---QT- 104
Query: 522 MQIASDVCS--------ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
++ D C L Y+HS ++H +LKPS +L++AN K+ DFG
Sbjct: 105 --LSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGL------ 154
Query: 574 GESTGNSALCNESNNDSASVYI------DPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
A D + Y+ PE L + T DV+S G I LL +P
Sbjct: 155 -------ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
Query: 627 V 627
+
Sbjct: 208 L 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYG----PQSHLKFQNEVEVLSRVRHPNLVT 482
IG G +G V L+RH A+K+ + S F E ++++ +V
Sbjct: 51 IGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAF-FWEERDIMAHANSEWIVQ 107
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L + + L V EY+ G L + ++ N P +W R A +V AL +HS
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKW-ARFYTA-EVVLALDAIHSMG- 162
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
IH ++KP +L+D + KL+DFG + ++ G + YI PE L
Sbjct: 163 -FIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANG---MVRCDTAVGTPDYISPEVL 215
Query: 601 ET----GKLTPESDVYSFGIILLRLLTGRP 626
++ G E D +S G+ L +L G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 468 EVEVLSRV-RHPNLVTLIGTCPESRSLVF--EYLRNGSL----EDCLACKNKKSPLRWQT 520
E VLS HP L L T +L F EYL G L + C ++
Sbjct: 45 EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF---- 100
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
A+++ L +LHS I++ +LK +L+D + K++DFG G++ +
Sbjct: 101 ---YAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
Query: 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR 625
C + YI PE L K D +SFG++L +L G+
Sbjct: 156 -FCGTPD------YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 46/174 (26%), Positives = 66/174 (37%), Gaps = 45/174 (25%)
Query: 470 EVLSRVRHPNLVTLIGTC---PESRSLVFEYLRNGSL-----EDCLACKNKKSPLRWQTR 521
E + RHP LV L C + V EY G L D + + R
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----------EPR 102
Query: 522 MQI-ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
A+ V L YLH N+ I++ +LK +L+D K++DFG
Sbjct: 103 AVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFG-------------- 146
Query: 581 ALCNES--NNDSASVYI-DPEYLETGKLTPES-----DVYSFGIILLRLLTGRP 626
LC E D S + PE+L LT S D + G+++ +L G
Sbjct: 147 -LCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 10/109 (9%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A+++ L LH ++ +LKP +L+D ++SD G IP+GES
Sbjct: 108 AAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--- 162
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633
Y+ PE L + T D + G ++ ++ G+ R +K+
Sbjct: 163 -----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 33/222 (14%)
Query: 417 ELNEATNNFEPSWKIGEGRYGNVYRGL--LRHLHVAIKMFPSYGPQS--HLKFQ-NEVEV 471
E+ E N P +G G YG+V L VA+K S QS H K E+ +
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRL 69
Query: 472 LSRVRHPNLVTLIGTCPESRSL-------VFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
L ++H N++ L+ +RSL + +L L + + C+ L +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFL 125
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
+ L Y+HS + IIH +LKPS + ++ + K+ DFG E TG A
Sbjct: 126 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVA--- 179
Query: 585 ESNNDSASVYIDPE-YLETGKLTPESDVYSFGIILLRLLTGR 625
Y PE L D++S G I+ LLTGR
Sbjct: 180 ------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 46/177 (25%), Positives = 69/177 (38%), Gaps = 42/177 (23%)
Query: 468 EVEVLSRVRHPNLVTLIG-------TC---PESRSLVFEYL---RNGSLEDCLACKNKKS 514
E +L + HP+++ L G TC P ++ ++ YL RN ++ D LA
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA------ 186
Query: 515 PLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLI 571
I V A+ YLH N IIH ++K + I+ L DFG F I
Sbjct: 187 ---------IERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL 628
+ G + + PE L P D++S GI+L + T L
Sbjct: 236 NANKYYGWAGTIATNA---------PELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 16/153 (10%)
Query: 424 NFEPSWKIGEGRYGNVYRGL--LRHLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPN 479
++P IG G YG V + VAIK P P + E+++L +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 480 LVTL--IGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALI 533
++ + I P + +V + L L + PL + + L
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLK 121
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
Y+HS +IH +LKPS +L++ + ++ DFG
Sbjct: 122 YIHS--ANVIHRDLKPSNLLVNEDCELRIGDFG 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 56/250 (22%), Positives = 89/250 (35%), Gaps = 68/250 (27%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-------------VAIKMFPSYGPQSHLKFQNEV 469
++FE IG G +G V+ L+R IK Q + E
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKR-----NQI-AHVRAER 52
Query: 470 EVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQI--- 524
++L+ P +V L + + L V EY+ G L + R +
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPE 100
Query: 525 ------ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF------FHLIP 572
+++ AL +H IH ++KP +LIDA+ KL+DFG
Sbjct: 101 ETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 573 QGESTGNSALCNESNN-----------DSASV-----YIDPEYLETGKLTPESDVYSFGI 616
+ ++ L ++ + S YI PE L E D +S G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 617 ILLRLLTGRP 626
IL +L G P
Sbjct: 219 ILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 11/112 (9%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A+++C L LH I++ +LKP +L+D + ++SD G +P+G++
Sbjct: 108 AAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--- 162
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVLRIKKDVK 635
Y+ PE ++ + T D ++ G +L ++ G+ P + KK +K
Sbjct: 163 -----GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 40/142 (28%), Positives = 59/142 (41%), Gaps = 25/142 (17%)
Query: 493 LVFEYLRNGSLEDCLACKNKKSPLR----WQTRMQIASDVCSALIYLHSNEPCIIHGNLK 548
LV +Y G L L+ + P + M IA D L Y +H ++K
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--------VHRDIK 129
Query: 549 PSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCNESNNDSASVYIDPEYLET----- 602
P +L+D N +L+DFG L+ G + A+ YI PE L+
Sbjct: 130 PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-------YISPEILQAMEDGK 182
Query: 603 GKLTPESDVYSFGIILLRLLTG 624
GK PE D +S G+ + +L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 11/87 (12%)
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H ++KP VL+D N +L+DFG + Q + +S + YI PE L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD------YISPEILQA 177
Query: 603 -----GKLTPESDVYSFGIILLRLLTG 624
GK PE D +S G+ + +L G
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
E E+L +V P +V L ES++ LV + G L+ + ++ L + +
Sbjct: 43 EKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHY 100
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
++ + +++LHS + I++ ++KP VL+D +LSD G + G++ A N
Sbjct: 101 SAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633
Y+ PE L+ + D ++ G + ++ GR + K+
Sbjct: 159 G--------YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234501 TIGR04211, SH3_and_anchor, SH3 domain protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 22/101 (21%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 303 EMSQRKELEEL---LAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKEL 359
S R+ L EL LA+ ++E+ + Q + +E Q ++ + S LE +L + +
Sbjct: 61 TPSARERLPELQQELAELQEELAELQEQLAELQQENQELKQELSTLEAELERLQKELARI 120
Query: 360 EEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
++ +A+EL ++ +LR E ++ ++ +R
Sbjct: 121 KQLSANAIEL----DEENRELREELAELKQENEALEAENER 157
|
Members of this protein family have a signal peptide, a strongly conserved SH3 domain, a variable region, and then a C-terminal hydrophobic transmembrane alpha helix region. Length = 198 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 25/110 (22%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A+++ L +LHS II+ +LK V++DA K++DFG +C
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFG---------------MCK 149
Query: 585 ESNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
E+ + YI PE + D ++FG++L +L G+P
Sbjct: 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 37/141 (26%), Positives = 56/141 (39%), Gaps = 13/141 (9%)
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
+H ++KP VL+D N +L+DFG L+ G N A+ YI PE L+
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD-------YISPEILQ 176
Query: 602 -----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
G+ PE D +S G+ + +L G + V+ + N V
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236
Query: 657 AEAEQLAHLALRCCENNRLNR 677
+E + L C RL R
Sbjct: 237 SEEAKDLIRRLICSPETRLGR 257
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 26/137 (18%), Positives = 63/137 (45%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306
L E E+ + R+ Q E + + E + + E+ EA+ +++ +++ + +
Sbjct: 738 LEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEE 797
Query: 307 RKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISA 366
K L E L + + E+ + + L++++ + +A E +L + ++EL E I S
Sbjct: 798 LKALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESL 857
Query: 367 VELLISFKQKRDQLRIE 383
+ ++ ++L E
Sbjct: 858 AAEIEELEELIEELESE 874
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 31/154 (20%), Positives = 81/154 (52%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306
L + EK + L+ K E ++ + ++ E + + E E K ++ A++ + S+
Sbjct: 679 LEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSR 738
Query: 307 RKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISA 366
+ELEE L + ++E++ + + ++ +EL+++++ + L+ ++ E + L+E++
Sbjct: 739 LEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEEL 798
Query: 367 VELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
E L +++ D L E + ++R +++ I+
Sbjct: 799 EEELEEAERRLDALERELESLEQRRERLEQEIEE 832
|
Length = 1163 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 25/215 (11%)
Query: 424 NFEPSWKIGEGRYGNVY--RGLLRHLH---VAIKMFPSYGPQSHLKFQN----EVEVLSR 474
NFE +G G YG V+ R + H A+K+ K E +VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 475 VRH-PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
VR P LVTL L + +Y+ G L L + + + R+ IA ++ A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL-YQREHFTES-EVRVYIA-EIVLA 117
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
L +LH + II+ ++K +L+D+ L+DFG E + C
Sbjct: 118 LDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE---- 171
Query: 592 SVYIDPEYLETGKLTPES--DVYSFGIILLRLLTG 624
Y+ PE + G + D +S G++ LLTG
Sbjct: 172 --YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNES 586
+C AL Y+HS C H +LKP +LID N + KL DFG + G+ + S +C+
Sbjct: 179 LCRALAYIHSKFIC--HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYICSR- 234
Query: 587 NNDSASVYIDPE-YLETGKLTPESDVYSFGIILLRLLTGRPVL 628
Y PE L T D++S G I+ ++ G P+
Sbjct: 235 ------FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|225288 COG2433, COG2433, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 24/115 (20%), Positives = 55/115 (47%), Gaps = 15/115 (13%)
Query: 250 EEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ-RK 308
E++ E+ +I + EE V+R +EE++ ++ + ++ ++ +E+ +
Sbjct: 404 REKEGTEEEERREITVYEKRIKKLEETVERLEEENSELKRE--LEELK----REIEKLES 457
Query: 309 ELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKI 363
ELE + + +V++ + E++ + LE +L E V+ELE K+
Sbjct: 458 ELERFRREVRDKVRKDR--------EIRARDRRIERLEKELEEKKKRVEELERKL 504
|
Length = 652 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 37/227 (16%)
Query: 424 NFEPSWKIGEGRYGNV----YRGLLRHLHVAIKMFPSYGPQSHL--KFQNEVEVLSRVR- 476
+E ++G+G YG V VAIK + + L + E+++L R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 477 HPNLVTLIGTCPESRSLVFEYLRNG-----SLEDCLACKNKKS--PLRWQTRMQIAS--- 526
H N+ L +VF N L + + +S PL T S
Sbjct: 61 HKNITCLYDM-----DIVFPGNFNELYLYEELMEADLHQIIRSGQPL---TDAHFQSFIY 112
Query: 527 DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSALC 583
+ L Y+HS ++H +LKP +L++A+ K+ DFG F P GE+ G
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFM--- 166
Query: 584 NESNNDSASVYIDPE-YLETGKLTPESDVYSFGIILLRLLTGRPVLR 629
+ + Y PE L T DV+S G IL LL +PV +
Sbjct: 167 --TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 30/160 (18%), Positives = 70/160 (43%), Gaps = 27/160 (16%)
Query: 260 QAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKE-LEELLAKEK 318
+A++EA N E ++ + + + +E++ ++E+ +R + EE L+ K
Sbjct: 37 KAELEALNKALEALEIELEDLENQVSQLESE----------IQEIRERIKRAEEKLSAVK 86
Query: 319 QEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRD 378
E + E+Q +++ ++LE +LAE +++LE++I E L ++
Sbjct: 87 DERELRALNI-----EIQIAKERINSLEDELAELMEEIEKLEKEIEDLKERLERLEKNLA 141
Query: 379 QLRIECGNAQRRVRD-----------IKKSIKREALSFFQ 407
+ +R+ +K+ + E LS ++
Sbjct: 142 EAEARLEEEVAEIREEGQELSSKREELKEKLDPELLSEYE 181
|
Length = 239 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMF-PSYGPQSHLKFQ-NEVE 470
F + ++ +E IG+G YG V++ L + A+K+ P + ++ + N ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 471 VLSRVRHPNLVTLIG-------TCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523
LS HPN+V G + LV E GS+ D + K L+ RM+
Sbjct: 70 ALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERME 122
Query: 524 ------IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577
I + L +LH N+ IH ++K + +L+ G KL DFG
Sbjct: 123 EPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGV---------- 170
Query: 578 GNSALCNESNNDSASV----YIDPEYLETGKLTPES-----DVYSFGIILLRLLTGRPVL 628
++ L + + SV ++ PE + + + DV+S GI + L G P L
Sbjct: 171 -SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 33/171 (19%)
Query: 468 EVEVLSRVRHPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNK-KSPLRWQTRMQ 523
E VL+ P +T + +C ++ V EY+ G L + K K P +
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVF 105
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
A+++ L +LH II+ +LK V++D+ K++DFG +C
Sbjct: 106 YAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFG---------------MC 148
Query: 584 NESNNDSASV--------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
E D + YI PE + D +++G++L +L G+P
Sbjct: 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 29/112 (25%), Positives = 51/112 (45%), Gaps = 11/112 (9%)
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A+++C L L I++ +LKP +L+D ++SD G IP+GE+
Sbjct: 108 AAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--- 162
Query: 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVLRIKKDVK 635
Y+ PE + K T D + G ++ ++ G+ P + K+ VK
Sbjct: 163 -----GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 48/225 (21%)
Query: 425 FEPSWKIGEGRYGNVY-----RGLLRHLHVAIKMFPSYGPQSHLKFQN---------EVE 470
EP IG G +G V+ R R VA+K P+ FQN E++
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKR---VALKKMPNV-------FQNLVSCKRVFRELK 51
Query: 471 VLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD--- 527
+L +H N+++ + FE + + + + K + Q ++SD
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFEEIY--VVTELMQSDLHKIIVSPQ---PLSSDHVK 106
Query: 528 -----VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582
+ L YLHS I+H ++KP +L+++N K+ DFG + ES
Sbjct: 107 VFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES------ 158
Query: 583 CNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGR 625
+ + Y PE L G T D++S G I LL R
Sbjct: 159 KHMTQEVVTQYYRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.71 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.66 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.54 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.47 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.68 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.16 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.62 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.32 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| KOG2042 | 943 | consensus Ubiquitin fusion degradation protein-2 [ | 96.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.58 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=474.49 Aligned_cols=273 Identities=47% Similarity=0.759 Sum_probs=237.8
Q ss_pred CccccCHHHHHHHhcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee
Q 044673 409 GLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487 (780)
Q Consensus 409 ~~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~ 487 (780)
....|++.+|..||++|+..+.||+||||.||+|.+.+ +.||||++.....+...+|.+|+.+|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999976 88999988775443145699999999999999999999999
Q ss_pred cCC---CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CccccCCCCCCceEecCCCCcccc
Q 044673 488 PES---RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-PCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 488 ~~~---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
.+. .+||||||+||+|.++|+..... +|+|..|++||.++|.||+|||... ||||||||||+|||||.++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 643 68999999999999999865444 8999999999999999999999965 499999999999999999999999
Q ss_pred cccccccccC-CCCCCCCcccccCCC-CCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCcc---------ch
Q 044673 564 DFGFFHLIPQ-GESTGNSALCNESNN-DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRI---------KK 632 (780)
Q Consensus 564 DFGla~~~~~-~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~---------~~ 632 (780)
|||||+..+. .... ... .||++|+||||+.++.++.|+|||||||+|+||+||++|.+. ..
T Consensus 220 DFGLa~~~~~~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred CccCcccCCccccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 9999976653 2110 111 899999999999999999999999999999999999988763 23
Q ss_pred hHHHHHHhccccccccCcC--CCCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 633 DVKCALEKRNFNSVLDSSA--GDWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 633 ~~~~~~~~~~~~~~ld~~~--~~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+....+..+.+.+++|+.. +.++. .....+..++.+|++.+|..||+| .+|+..|+.+
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m-~~Vv~~L~~~ 352 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM-SQVVKELEGI 352 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH-HHHHHHHHhh
Confidence 4456677889999999985 46664 678889999999999999999999 8898888765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=414.64 Aligned_cols=256 Identities=33% Similarity=0.495 Sum_probs=215.4
Q ss_pred CcccccccCCceEEEEeeecCee-EEEEEccCCCch--hHHHHHHHHHHhhcCCCCceeeEeeeecCC---CeeEEEecc
Q 044673 426 EPSWKIGEGRYGNVYRGLLRHLH-VAIKMFPSYGPQ--SHLKFQNEVEVLSRVRHPNLVTLIGTCPES---RSLVFEYLR 499 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~~~~-VAiK~l~~~~~~--~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---~~LV~Ey~~ 499 (780)
.....||.|+||+||+|.++++. ||||++...... ....|.+|+.+|.+++|||||+++|+|.+. .++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34455999999999999999988 999999764322 256899999999999999999999999765 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-CcccccccccccccCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~~~~~~~ 578 (780)
+|+|.++|+.. ....+++..+++|+.+||.||.|||+.+| ||||||||+||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--- 198 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc---
Confidence 99999999754 46789999999999999999999999997 99999999999999998 99999999998765321
Q ss_pred CCcccccCCCCCCcccCChhhhc--cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 579 NSALCNESNNDSASVYIDPEYLE--TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.....+..+... +.....+..|.
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v-----~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV-----VVGGLRPPIPK 269 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhcCCCCCCCc
Confidence 1234478999999999999 669999999999999999999999999877763322111 11222334455
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCC
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCV 696 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~ 696 (780)
.+...+..|+.+||..||..||++ .+++..|+.+.....
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f-~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSF-LEIVSRLESIMSHIS 308 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCH-HHHHHHHHHHHHhhc
Confidence 577889999999999999999999 999999999865443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=376.09 Aligned_cols=243 Identities=27% Similarity=0.469 Sum_probs=198.6
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
..++|.....||.|+||.||+|+++ +..||||.+... ......-+..|+.+|+.++|||||.|++++... .+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999999999999985 678999988765 455666788999999999999999999999554 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC------CCccccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN------FGSKLSDFGFF 568 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~------~~~Kl~DFGla 568 (780)
||||.||+|.++|. +.+.+++.+...++.||+.||+|||+++ ||||||||.||||+.+ -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999996 4457999999999999999999999999 9999999999999765 34799999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
+.+.... ...+.+|++.|||||+++.++|+.|.|+||+|+|||+++||++||......+-......-..++
T Consensus 163 R~L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~- 233 (429)
T KOG0595|consen 163 RFLQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV- 233 (429)
T ss_pred hhCCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-
Confidence 9986432 2245789999999999999999999999999999999999999998666544332211111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...|...+..+.+|...-+..+|.+|-+.
T Consensus 234 ---~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~ 262 (429)
T KOG0595|consen 234 ---PVLPAELSNPLRELLISLLQRNPKDRISF 262 (429)
T ss_pred ---CchhhhccCchhhhhhHHHhcCccccCch
Confidence 12223334456677777777787777665
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.44 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=204.4
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEee-eecCC---CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIG-TCPES---RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g-~~~~~---~~LV 494 (780)
.+|.++++||.|.||.|||+.. ++..||.|.+... +.........|+.+|++|+|||||+.++ .|.+. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688889999999999999876 5788999988742 3445567889999999999999999998 44332 5799
Q ss_pred EEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ccccCCCCCCceEecCCCCcccccccccccc
Q 044673 495 FEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEP--CIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~--~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
||||.+|+|..++.. +.....+++.++++++.|+|.||..+|..-| .|+||||||+||+|+.+|++||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999954 4566779999999999999999999999655 4999999999999999999999999999998
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~ 649 (780)
..... .....+|||.||+||.+...+|+.||||||+||++|||+.-++||...+-.. ..+..|.+
T Consensus 179 ~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~------ 245 (375)
T KOG0591|consen 179 SSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY------ 245 (375)
T ss_pred cchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC------
Confidence 64321 2356799999999999999999999999999999999999999998775433 22333322
Q ss_pred cCCCCC-HHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWP-VAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+..| ...+..|..|+..|+..||..||+.
T Consensus 246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1123 5678999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=372.25 Aligned_cols=242 Identities=25% Similarity=0.399 Sum_probs=203.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccC-CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC---CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES---RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~-~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---~~LV~Ey 497 (780)
++.....||+|..|+|||+.++ +.-+|+|++.. ..+....++.+|++++...+||+||.+||+|... .+++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445678999999999999997 56799999854 3345667899999999999999999999998432 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++|||++++. ..+.+++...-+|+.+|++||.|||. .+ ||||||||+|||++..|.+||||||.++.+...
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999994 44779999999999999999999996 77 999999999999999999999999999876532
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc----hhHHHHHHhccccccccCcCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK----KDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~----~~~~~~~~~~~~~~~ld~~~~ 652 (780)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+... ...... +..+++...+
T Consensus 233 -------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L-----l~~Iv~~ppP 300 (364)
T KOG0581|consen 233 -------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL-----LCAIVDEPPP 300 (364)
T ss_pred -------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-----HHHHhcCCCC
Confidence 124678999999999999999999999999999999999999998753 111111 2334554455
Q ss_pred CCCHH-HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVA-EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..|.. .++++..++..||+.||..||+. .+++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~-~qLl 333 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSA-KQLL 333 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCH-HHHh
Confidence 55665 88999999999999999999999 5553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=386.92 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=209.4
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccC---CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPS---YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~---~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
..|...+.||+|||+.||.+.. .|..||+|++.+ .....+....+||+|.++|.|||||+++++|.|. .|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588899999999999999987 477899999976 2455667889999999999999999999999876 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|+|++|+|..++. ...++++.++..+..||+.||.|||+.+ |||||||..||||++++++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999984 5678999999999999999999999999 9999999999999999999999999998886432
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. +..+.+||+-|+|||++....++..+||||+|||||-||+|+|||...+ ++....+... .....|
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~------~~Y~~P 238 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKL------NEYSMP 238 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHh------cCcccc
Confidence 1 2356799999999999999999999999999999999999999997543 3333222222 223446
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+.+..+|+..+|..||.+||++ ++|+.
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl-~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSL-DEVLD 268 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCH-HHHhc
Confidence 6677889999999999999999999 77753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=370.27 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=200.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|..+..||+|+||.||++.-+ |..+|+|++++... ........|-++|....+|+||+||.+|.+. .|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 589999999999999999999875 56799999987433 3345678999999999999999999999765 6899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||++||++..+|. +.+.|++.....++.+++.|+..||+.| ||||||||+|+|||.+|++||+|||||..+...
T Consensus 220 MEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999995 6678999998899999999999999999 999999999999999999999999999654221
Q ss_pred CCC----------------CCCccc-----c-------------------cCCCCCCcccCChhhhccCCCCcchhHHHH
Q 044673 575 EST----------------GNSALC-----N-------------------ESNNDSASVYIDPEYLETGKLTPESDVYSF 614 (780)
Q Consensus 575 ~~~----------------~~~~~~-----~-------------------~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~ 614 (780)
... ...... . ....+|||-|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 000000 0 023589999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 615 GIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 615 Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
|||+||||.|.|||...+.....-..-+....+...... ..+.+..+||.+|+. ||.+|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV---DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC---cccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999998776654433333333323222111 234778999999999 9999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.46 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=198.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchh-------HHHHHHHHHHhhcCCCCceeeEeeeec--CCC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS-------HLKFQNEVEVLSRVRHPNLVTLIGTCP--ESR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~-------~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~ 491 (780)
+.|...+.||+|+||.|-+|..+ +..||||+++...... .....+|++||++|+|||||+++++|. +..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 56778899999999999999875 6789999997632111 123469999999999999999999994 456
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC---CCccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN---FGSKLSDFGFF 568 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~---~~~Kl~DFGla 568 (780)
|+||||+.||+|.+.+. ..+.+.+.....+++|++.|+.|||+.| |+||||||+||||..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 89999999999999996 4456888888999999999999999999 9999999999999766 77999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCC---CcchhHHHHHHHHHHHHhCCCCCccch---hHHHHHHhcc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL---TPESDVYSFGIILLRLLTGRPVLRIKK---DVKCALEKRN 642 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~ksDVwS~Gvil~eLltG~~p~~~~~---~~~~~~~~~~ 642 (780)
+...... .+.+.+||+.|.|||++.++.+ ..++|+||+|||||-+|||.+||.... .....+..|.
T Consensus 327 K~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 327 KVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred hccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 9875321 3466899999999999987653 348899999999999999999997432 2344555554
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+... ...| ...+++..+|+.++|..||.+||+. ++++
T Consensus 399 y~f~----p~~w-~~Iseea~dlI~~mL~VdP~~R~s~-~eaL 435 (475)
T KOG0615|consen 399 YAFG----PLQW-DRISEEALDLINWMLVVDPENRPSA-DEAL 435 (475)
T ss_pred cccc----Chhh-hhhhHHHHHHHHHhhEeCcccCcCH-HHHh
Confidence 4321 1122 2567889999999999999999999 5553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=379.12 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=210.1
Q ss_pred CCcccccccCCceEEEEeeecCe-eEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHL-HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~-~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+...+.||+|-||.||.|.+++. .||+|.+... ......|.+|+.+|++|+|+|||+|+|+|..+ .+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34567899999999999999875 8999999874 34557899999999999999999999999664 58999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.++|.. .....+...+.+.++.|||.|++||++++ +|||||-.+|||+++++.+||+|||||+...++...
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~---- 359 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT---- 359 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCcee----
Confidence 99999963 35677899999999999999999999999 999999999999999999999999999965433221
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcCCCCCHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..... +...++.|. ....|..+
T Consensus 360 --~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--------Rlp~P~~C 429 (468)
T KOG0197|consen 360 --ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--------RLPRPEGC 429 (468)
T ss_pred --ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------cCCCCCCC
Confidence 1223344567999999999999999999999999999999 8888875543 333444332 33456678
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+.+|+..||..+|.+|||+ ..+...|+.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF-~~L~~~l~~~~ 462 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTF-ETLREVLEDFF 462 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCH-HHHHHHHHHhh
Confidence 8999999999999999999999 78888888774
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.45 Aligned_cols=237 Identities=26% Similarity=0.337 Sum_probs=198.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|..++.||+|+||+||.++.+ ++-+|+|++++... .......+|..||.+++||.||+|+..|++. .|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999875 46699999976322 3445678999999999999999999999664 6899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+.||.|..+|. +.+.+++.....++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||||+.....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999995 5567899989999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~ 652 (780)
.. .+.+.+||+.|||||++.+.+|+..+|+|||||++||||||.+||...+.... .+..+. ..
T Consensus 179 ~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------~~ 243 (357)
T KOG0598|consen 179 GD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------LP 243 (357)
T ss_pred CC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------CC
Confidence 21 12447999999999999999999999999999999999999999986654322 111121 22
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCc
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
..|...+.+..+++.+.+..+|.+|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 23333567788999999999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.71 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=207.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+|++||+|+.. +..+|||++.+.- .....-...|-++|.+| .||.||+|+..|+|. .|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 468999999999999999999875 5789999986521 12223356899999999 799999999999776 689
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|+||++||+|.++|. +.+.|++.....++.+|+.||+|||++| ||||||||+|||||.||++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999995 5578999999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCC------CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 574 GESTG------NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 574 ~~~~~------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
..... ..........+||..|++||++..+..++.+|+|+||||||+|+.|.|||...++.....+ ++
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk------I~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK------IQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH------HH
Confidence 43221 1111112457999999999999999999999999999999999999999998776443322 11
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.....||...++...+|+.+.|..||.+|++. .+|
T Consensus 301 -~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~-~qI 335 (604)
T KOG0592|consen 301 -ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTS-QQI 335 (604)
T ss_pred -HhcccCCCCCCHHHHHHHHHHHccCccccccH-HHH
Confidence 12345666777889999999999999999998 544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=341.09 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=199.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
+.|+.+-++|+|+||.|||++.+ |..||||++.... +.-.+--.+|+.+|++++|||+|.|+.+|.. ..+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999986 5779999987533 2334457899999999999999999999954 4689999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
||+..-|+++= .....++......+++|++.|+.|+|+++ +|||||||+|||+..+|.+||||||+|+.+..+.
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 99986665543 23445888999999999999999999999 9999999999999999999999999999886321
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH----hcccc-------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE----KRNFN------- 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~----~~~~~------- 644 (780)
..+|..+.|.+|.|||.+.+ .+|++.+|||++||++.||+||.|.|...+++..... -|++.
T Consensus 156 ------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 156 ------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred ------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 23467889999999999988 6899999999999999999999999988887764421 11110
Q ss_pred ---cccc----Cc-------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ---SVLD----SS-------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ---~~ld----~~-------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+. |. ...+ +..+.-+.+++..|+++||.+|++- ++++
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc-~qll 282 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSC-EQLL 282 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccH-HHHh
Confidence 0000 00 0011 1345578999999999999999987 5554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.70 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=206.7
Q ss_pred ccccCHHHHHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchh---HHHHHHHHHHhhcCCCCceeeEeee
Q 044673 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQS---HLKFQNEVEVLSRVRHPNLVTLIGT 486 (780)
Q Consensus 410 ~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~---~~~f~~Ev~il~~l~HpnIv~l~g~ 486 (780)
...++.++| ++.....||+|++|.||+|.+++..||||++....... ...|.+|+.+|.+++|||||+++|+
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 334455555 33444679999999999999999999999997643322 4678899999999999999999999
Q ss_pred ecC------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCC
Q 044673 487 CPE------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 487 ~~~------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~ 559 (780)
|.+ ..++||||+++|+|.+++. ....++|...+.|+.+++.||.|||+. + ++||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYK 161 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCc
Confidence 855 2469999999999999995 345789999999999999999999984 7 889999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK-- 635 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~-- 635 (780)
+||+|||+++.+.... ....||..|+|||++.+ +.++.++|||||||++|||+||+.||...+...
T Consensus 162 ~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 162 LKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred EEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999988654211 23467889999999976 689999999999999999999999998654322
Q ss_pred HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 636 CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 636 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+..+.. ....|...+..+.+++.+||+.||.+||++ .+++..|+.+.
T Consensus 232 ~~i~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~ell~~l~~~~ 280 (283)
T PHA02988 232 DLIINKNN-------SLKLPLDCPLEIKCIVEACTSHDSIKRPNI-KEILYNLSLYK 280 (283)
T ss_pred HHHHhcCC-------CCCCCCcCcHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHH
Confidence 11111111 112333456789999999999999999999 99999998774
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.24 Aligned_cols=255 Identities=23% Similarity=0.390 Sum_probs=203.4
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...++||+|+||.||+|.+. +..||||++.... ......|.+|+.++.++ +|||||+++|+|.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 367899999999999999999742 2469999987533 23346789999999999 899999999998542
Q ss_pred -CeeEEEeccCCChhhHHhhhCC---------------------------------------------------------
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNK--------------------------------------------------------- 512 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~--------------------------------------------------------- 512 (780)
.++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCC
Q 044673 513 --KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS 590 (780)
Q Consensus 513 --~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~g 590 (780)
..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .......+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcch-----hcccCCCC
Confidence 245889999999999999999999999 999999999999999999999999999865422111 11223456
Q ss_pred CcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH---HHHHhccccccccCcCCCCCHHHHHHHHHHH
Q 044673 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK---CALEKRNFNSVLDSSAGDWPVAEAEQLAHLA 666 (780)
Q Consensus 591 t~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~---~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~ 666 (780)
+..|+|||++.+..++.++|||||||+||||+| |.+||....... ..+..+. ....|...+..+.+|+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li 310 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATPEIYRIM 310 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--------CCCCCCCCCHHHHHHH
Confidence 778999999999999999999999999999997 999997543211 1111111 1112334556799999
Q ss_pred HHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 667 LRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 667 ~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+||..+|.+||++ .++++.|+.+.
T Consensus 311 ~~cl~~dp~~RPs~-~el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTF-SALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCH-HHHHHHHHHHH
Confidence 99999999999999 89999999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.25 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee--cCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~--~~LV~ 495 (780)
..+|...+.||+|+||.||++... +...|||.+..........+.+|+.+|++++|||||+.+|.. .+. .+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346777889999999999999986 478999987654333356688999999999999999999963 443 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~ 574 (780)
||+++|+|.+++.... ++|++..+.++..||+.||.|||+++ ||||||||+||||+. ++.+||+|||+++.....
T Consensus 96 Ey~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999996322 27999999999999999999999999 999999999999999 799999999998876520
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccc-hhHHHHHHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIK-KDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~-~~~~~~~~~~~~~~~ld~~~~ 652 (780)
...........||+.|||||++..+. ..+++|||||||+++||+||++||... ......+..+. ....+
T Consensus 172 ----~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~-----~~~~P 242 (313)
T KOG0198|consen 172 ----GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR-----EDSLP 242 (313)
T ss_pred ----cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-----cCCCC
Confidence 11112234578999999999998643 345999999999999999999999863 33333322222 11234
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+|...+.+..+++.+|+..+|..||++ .+++.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta-~eLL~ 275 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTA-EELLE 275 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCH-HHHhh
Confidence 6777788899999999999999999999 66654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.46 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=199.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~L 493 (780)
.+.|..+.+||+|.||.||+|+.. +..||+|++..+. .....-..+||.||++|.||||++|.+...+ ..||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356778889999999999999885 5679999987654 4455567799999999999999999997743 3689
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|+|||++ +|.-++. ...-.++..++.-++.|++.||.|||+.+ |+|||||.+|||||++|++||+|||||+++..
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999988 7887774 33446999999999999999999999999 99999999999999999999999999998864
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----c----ccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----R----NFN 644 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~----~~~ 644 (780)
.... ..|..+-|++|.|||.+.+. .|++++|+||.||||.||++|+|.|....++...-.. | ..+
T Consensus 271 ~~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 271 SGSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCc------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 4322 25778899999999999875 6999999999999999999999999988877543211 1 111
Q ss_pred cccc-Cc------CCCCC-------HHHHHHHHHHHHHchhhCCCCCcch
Q 044673 645 SVLD-SS------AGDWP-------VAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 645 ~~ld-~~------~~~~p-------~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+ +. ...+. ...+....+|+..+|.+||.+|.++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA 394 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA 394 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH
Confidence 1111 00 00111 1224567789999999999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=358.17 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=208.6
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCe
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRS 492 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~ 492 (780)
.+.....+.+....+||+|.||+||+|.|.| .||||++.-... ...+.|.+||.++++-||-||+-+.|+|.. ...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 3333444566677899999999999999976 699999986543 345679999999999999999999999954 457
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+|.-+|+|-+|+.+|+... ..|...+.+.||.|||.|+.|||.++ |||||||..||+|.+++.|||+||||+..-.
T Consensus 464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 8999999999999998433 56888999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETG---KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
.- ..........|...|||||+++-+ +|++.|||||||||+|||+||..||...+.-.-.+..|.-.-..|.
T Consensus 540 ~w-----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 540 RW-----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred ee-----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 21 111223456788899999999743 6899999999999999999999999843322211111211111111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+ ..-..++..+.+|+..||..+|.+||.+ .+|+..|+.+.
T Consensus 615 s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F-~~il~~l~~l~ 654 (678)
T KOG0193|consen 615 S--KIRSNCPKAMKRLLSDCWKFDREERPLF-PQLLSKLEELL 654 (678)
T ss_pred h--hhhccCHHHHHHHHHHHHhcCcccCccH-HHHHHHHHHhh
Confidence 1 1123466789999999999999999999 89999888774
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.92 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch--hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ--SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~--~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
..|...++||+|.||.||+|... |+.||||.+...... -.....+|+..|+.++||||+.|+++|+.. ..||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 45777889999999999999984 678999998764322 234567999999999999999999999765 468999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
||+. +|+..+. ++.-.|+..++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9976 8999884 56678999999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC-
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW- 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~- 654 (780)
. .+..+.|.+|.|||.+.+ ..|+..+|+||.|||+.||+-|.|.|.+.+++...-.. +..+-.|....|
T Consensus 157 ~-------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~WP 227 (318)
T KOG0659|consen 157 I-------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQWP 227 (318)
T ss_pred c-------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccCc
Confidence 1 234478899999998875 47999999999999999999999999888877644210 111111111122
Q ss_pred ----------------------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 ----------------------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 ----------------------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+..+.+|+..++.+||.+|.+. +++++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita-~qaL~ 280 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA-SQALK 280 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccH-HHHhc
Confidence 23456678999999999999999999 66643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.10 Aligned_cols=235 Identities=25% Similarity=0.356 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||.|+||+|-+.+.+ +.-+|+|++....- .......+|..+|+.+.||++++|++.|.+. .+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 367899999999999999999876 46799999976432 2334567899999999999999999999776 5689
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||++||.|..+|. +.+++++.....+|.+|+.||.|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999995 5678999999999999999999999999 999999999999999999999999999887532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
+.+.+||+.|+|||++++.+|+.++|+|||||++|||+.|.+||...+..... ..++ ...-.+
T Consensus 198 ----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY------~KI~-~~~v~f 260 (355)
T KOG0616|consen 198 ----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY------EKIL-EGKVKF 260 (355)
T ss_pred ----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH------HHHH-hCcccC
Confidence 24578999999999999999999999999999999999999999877764322 1111 122346
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCc
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
|...+..+.+|+...++.|...|-
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhhh
Confidence 777888899999999999999883
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=371.09 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=212.2
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
.+-...+.||+|.||+||+|...+ +-||||.++..... .+.+|++|+++|..++|||||+|+|+|.++ .|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445556789999999999998743 45999999986655 788999999999999999999999999554 68
Q ss_pred eEEEeccCCChhhHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 493 LVFEYLRNGSLEDCLACKN-----------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+|+|||..|||..+|.... ..++|+..+.+.||.|||.|+.||-++. +|||||-.+|+|+.++..||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEE
Confidence 9999999999999995321 1345999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccC-CCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccch--hHHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNES-NNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKK--DVKCA 637 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~--~~~~~ 637 (780)
|+||||++.+.... .+... ...-...||+||.+..++||++||||||||||||++| |+.|+.... +|...
T Consensus 644 IsDfGLsRdiYssD------YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSD------YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred ecccccchhhhhhh------hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999998764322 12211 3344668999999999999999999999999999998 888876544 34444
Q ss_pred HHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 638 ~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
+..|++ ...|..++.++..|++.||+.+|.+||++ ++|-..|+....
T Consensus 718 i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF-~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSF-KEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHHHHHh
Confidence 555543 34566788999999999999999999999 999999998743
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=353.29 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=205.0
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC----Cc-hhHHHHHHHHHHhhcCC-CCceeeEeeeecC--C
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY----GP-QSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--S 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~----~~-~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~ 490 (780)
..++|...+.||+|+||+||.|... +..||||++... .. .....+.+|+.+++.++ ||||++++.++.. .
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999874 678999977653 11 23445668999999999 9999999999843 4
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFH 569 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~ 569 (780)
.++||||+.||+|.+++. ..+++.+....+++.|+++|+.|||+.+ |+||||||+|||||.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 679999999999999996 3678999999999999999999999999 9999999999999999 999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCC-CC-cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGK-LT-PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
..... .....+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...+....... +
T Consensus 170 ~~~~~-------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i 235 (370)
T KOG0583|consen 170 ISPGE-------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------I 235 (370)
T ss_pred ccCCC-------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------H
Confidence 77311 11235679999999999999877 86 689999999999999999999987554332211 1
Q ss_pred cCcCCCCCHHH-HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 648 DSSAGDWPVAE-AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 648 d~~~~~~p~~~-~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.......|... +.++..|+.+|+..+|..|+++ .+|+ .-.-++
T Consensus 236 ~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~-~~i~-~h~w~~ 279 (370)
T KOG0583|consen 236 RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITL-LEIL-EHPWFQ 279 (370)
T ss_pred hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCH-HHHh-hChhhc
Confidence 12222334344 7889999999999999999999 7776 344343
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.04 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=199.2
Q ss_pred cCCCcccccccCCceEEEEeeec------------------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR------------------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTL 483 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~------------------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l 483 (780)
++|...++||+|+||.||++.++ +..||+|.+.... ......|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57888899999999999999753 2369999987643 3345679999999999999999999
Q ss_pred eeeecC--CCeeEEEeccCCChhhHHhhhC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccC
Q 044673 484 IGTCPE--SRSLVFEYLRNGSLEDCLACKN----------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545 (780)
Q Consensus 484 ~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHr 545 (780)
+++|.+ ..++||||+++|+|.+++.... ....++|..++.|+.||+.||.|||+.+ |+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~ 162 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHR 162 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 999854 3689999999999999985321 1235889999999999999999999999 9999
Q ss_pred CCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh--
Q 044673 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-- 623 (780)
Q Consensus 546 DlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-- 623 (780)
||||+|||++.++.+||+|||+++.+..... ........++..|+|||++..+.++.++|||||||++|+|++
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999876542211 111233456788999999998999999999999999999997
Q ss_pred CCCCCccchhHHHHHHhcc-ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 624 GRPVLRIKKDVKCALEKRN-FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 624 G~~p~~~~~~~~~~~~~~~-~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
|..||...+.......... +...........|..++..+.+|+.+||..+|.+||++ .+|...|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~-~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF-SDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHh
Confidence 5567764433221110000 00000001111223455779999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.66 Aligned_cols=238 Identities=26% Similarity=0.412 Sum_probs=203.7
Q ss_pred cCCCcccccccCCceEEEEeeecC--eeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|-....||+|.||.||||+-++ ..||||.+.+.+. .....+.+|++|++.++|||||.++.+|... .++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567778899999999999998764 5699999877543 3445688999999999999999999999665 578999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+.| +|..+|. ..+.|++..+..|+.+++.||.|||+++ |+|||+||.||||+.+|++|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 9987 9999995 5567999999999999999999999999 9999999999999999999999999999875422
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
...+...||+.|||||...++.|+..+|.||+|||+||+.+|+|||...... ..++ .+......||.
T Consensus 155 ------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-~Lv~------~I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 ------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-QLVK------SILKDPVKPPS 221 (808)
T ss_pred ------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-HHHH------HHhcCCCCCcc
Confidence 2346789999999999999999999999999999999999999999744322 1111 12223446888
Q ss_pred HHHHHHHHHHHHchhhCCCCCcch
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+..+..++...+..||..|-+.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccH
Confidence 899999999999999999999887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=350.53 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=206.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 498 (780)
..|..-.+||+|+.|.||.+... +..||||++.........-..+|+.+|+..+|||||.++..| .+....|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 34666678999999999999764 567999999887666677788999999999999999999887 45578899999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+||+|.|.+. ...+++.++..|+.+++.||.|||..+ |+|||||.+||||+.+|.+||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999883 455999999999999999999999999 99999999999999999999999999987754322
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
.....+||+.|||||+.....|++|.||||||++.+||+-|.|||-..+..+.......-. ......|...
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng----~P~lk~~~kl 495 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPKLKNPEKL 495 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC----CCCcCCcccc
Confidence 3456799999999999999999999999999999999999999998766655432211100 1122345567
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..|.+++.+||+.|+..||++ .+++
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA-~eLL 521 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASA-KELL 521 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCH-HHHh
Confidence 8899999999999999999999 6765
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.54 Aligned_cols=241 Identities=21% Similarity=0.317 Sum_probs=194.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.++.+++||||++++++|.+. .++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3777889999999999999874 6789999886432 22334678999999999999999999988554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888532 2346899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~ 654 (780)
......||..|+|||++.+..++.++|||||||+||+|+||++||....... ..+... +......+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-----VKEDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-----hhcccccC
Confidence 1134568999999999999999999999999999999999999997544311 111110 11111223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+...+..+.+|+.+||..||.+||+.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 44556789999999999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.41 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=201.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchh-HHHHHHHHHHhhcCC-CCceeeEeeeecCC---CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVR-HPNLVTLIGTCPES---RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~-~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~---~~LV 494 (780)
.++|...++||.|.||.||+|.-. +..||||.++..-... ..-=.+||..|++|+ |||||+|..++-|. .++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 467888999999999999999874 6679999886532222 122358999999999 99999999998554 4789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||||+. +|+.++. .+..++++..+..|++||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.+...
T Consensus 89 fE~Md~-NLYqLmK--~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMK--DRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhhhh-hHHHHHh--hcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccC
Confidence 999976 8999885 34778999999999999999999999999 999999999999999999999999999987532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhc-cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc----c-------
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLE-TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR----N------- 642 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~----~------- 642 (780)
..+|..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-+|.|.+.+++....+.- .
T Consensus 164 --------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 --------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred --------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 2357788999999999875 6779999999999999999999999998888766544211 0
Q ss_pred ----ccccccCc--------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 ----FNSVLDSS--------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ----~~~~ld~~--------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+...+.-. ....-...+.++++++.+||..||.+||++ .+.++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-~~al~ 290 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-SQALQ 290 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-HHHhc
Confidence 00001100 001112356789999999999999999999 66654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.46 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=203.9
Q ss_pred cCCCcccccccCCceEEEEeeec--C----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--H----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
.+|...+.||+|+||.||+|.+. + ..||||++.... ......|.+|+.+++.++||||++++|+|... .++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 56999999999999999999863 2 248999987543 34456799999999999999999999999554 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 87 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999852 3456899999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... .......++..|++||++....++.++|||||||++|||+| |.+||....... ..+..+ ..
T Consensus 163 ~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~--------~~ 229 (316)
T cd05108 163 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------ER 229 (316)
T ss_pred Ccc-----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC--------CC
Confidence 211 11122345678999999999999999999999999999998 999997544322 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...|..++..+..++.+||..+|.+||++ .+++..|..+..
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHc
Confidence 11222345678999999999999999999 899988887743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=328.08 Aligned_cols=250 Identities=23% Similarity=0.251 Sum_probs=198.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeee----ecCCCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGT----CPESRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~----~~~~~~L 493 (780)
.++|..+++|++|.||.||+|+.. +..||+|+++.... .....-.+||.+|.+++|||||.+-.+ -.+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467889999999999999999986 56799999876432 223456799999999999999998554 4566899
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||||+. +|...+.. ...++...+..-+..|++.||.|||.++ |+||||||+|+|+.+.|.+||+||||||.+..
T Consensus 155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999988 88888863 3468999999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH----hcccccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE----KRNFNSVLD 648 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~----~~~~~~~ld 648 (780)
+. ..+|..+-|.+|.|||.+.+. .|++..|+||+|||+.||++++|.|.+.......-. -|...+-+-
T Consensus 230 p~-------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 230 PL-------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred Cc-------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 42 235778899999999998865 699999999999999999999999987766543211 111111110
Q ss_pred C--------------------cCCCCCHH-HHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 649 S--------------------SAGDWPVA-EAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 649 ~--------------------~~~~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
+ ....++.. .++.-.+|+...+..||++|-++ ++.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA-~~~ 358 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA-EDG 358 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH-HHh
Confidence 0 01111111 34667889999999999999999 544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.97 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=201.0
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV 494 (780)
++|...+.||+|+||.||+|.+. +..||+|++.... ......|.+|+.++.+++||||++++|++.. ..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999763 4579999987643 2334578999999999999999999999854 46899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....++|..++.++.+++.||.|||+.+ ++||||||+|||++.++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999999853 2357999999999999999999999999 999999999999999999999999986543211
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
. ........++..|+|||++.++.++.++|||||||++|++++ |.+||....... ..+..+. .
T Consensus 161 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--------~ 226 (266)
T cd05064 161 A------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------R 226 (266)
T ss_pred c------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------C
Confidence 1 111122345678999999999999999999999999999875 999997554332 1222111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...|...+..+.+++.+||+.+|.+||++ .++.+.|..+
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~-~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRF-SQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCH-HHHHHHHHhh
Confidence 11233456679999999999999999999 8999888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.31 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=200.7
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|..+ +|||||+++|+|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 357899999999999999999742 3579999987533 33445788999999999 899999999999554
Q ss_pred CeeEEEeccCCChhhHHhhhC-----------------------------------------------------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKN----------------------------------------------------------- 511 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 511 (780)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 679999999999999985321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 512 -------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 512 -------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
....++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 1135899999999999999999999999 999999999999999999999999999866432111
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH---HHHHhccccccccCcCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK---CALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~---~~~~~~~~~~~ld~~~~~~ 654 (780)
.......++..|+|||++.+..++.++|||||||++|+|+| |.+||....... ..+..+. ....
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 338 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------RMLS 338 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--------cCCC
Confidence 11123345677999999999999999999999999999998 889986543221 1222111 1111
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
|...+.++.+|+.+||+.+|.+||++ .+|++.|+.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~-~eil~~l~~ 373 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTF-KQIVQLIEQ 373 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHh
Confidence 22335679999999999999999999 899998885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.48 Aligned_cols=233 Identities=24% Similarity=0.337 Sum_probs=194.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47888999999999999999885 6789999986421 22345688999999999999999999988655 56899
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++.....|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999985 3457899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..... +..+ ...
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~---------~~~ 216 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG---------KLE 216 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------CcC
Confidence 12346899999999999888999999999999999999999999765443211 1111 123
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
+|...+..+.+|+.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 44455677999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.48 Aligned_cols=238 Identities=24% Similarity=0.412 Sum_probs=201.0
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCChhh
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLED 505 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~~ 505 (780)
+.-||.|+-|.||+|.+.+..||||+++.... .++.-|++|+||||+.+.|+|... .|+|||||+.|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 34599999999999999999999998865322 567789999999999999999766 469999999999999
Q ss_pred HHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccccc
Q 044673 506 CLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585 (780)
Q Consensus 506 ~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~ 585 (780)
.|. ...++.......|..+||.|+.|||.++ |||||||.-|||+..+..+||+|||.++.+..- . ..
T Consensus 202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S-------Tk 268 (904)
T KOG4721|consen 202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S-------TK 268 (904)
T ss_pred HHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh-h-------hh
Confidence 994 4566888888999999999999999999 999999999999999999999999998876532 1 23
Q ss_pred CCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHH
Q 044673 586 SNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHL 665 (780)
Q Consensus 586 ~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l 665 (780)
...+||..|||||++...+.+.|+|||||||||||||||..|+...+...-.|.-|. ...-...|..+++-|.-|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs-----NsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS-----NSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC-----CcccccCcccCchHHHHH
Confidence 567899999999999999999999999999999999999999975554322222121 111234566788889999
Q ss_pred HHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 666 ALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 666 ~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+.+||.-.|++||++ .+|+.-|+-.
T Consensus 344 ~Kqcw~sKpRNRPSF-rqil~HldIa 368 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSF-RQILLHLDIA 368 (904)
T ss_pred HHHHHhcCCCCCccH-HHHHHHHhhc
Confidence 999999999999999 8898888754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.18 Aligned_cols=256 Identities=24% Similarity=0.295 Sum_probs=207.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchh-HHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~-~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
.++|.....||.|..+.||+|+.. +..||||++....... ...+++|+..++.++|||||+++..|.. ..++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 478999999999999999999884 6789999998754443 4678899999999999999999998844 4678999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
||.+||+.+++...-. ..+++..+..|+.+++.||.|||++| .||||||+.|||||.+|.+||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G- 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG- 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeecccC-
Confidence 9999999999964333 34999999999999999999999999 9999999999999999999999999986665422
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc--ccccccCcC-
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN--FNSVLDSSA- 651 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~--~~~~ld~~~- 651 (780)
..........+||++|||||+++. .+|+.|+|||||||+..||.+|..||......+..+..-+ ....+ ...
T Consensus 181 --~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~ 257 (516)
T KOG0582|consen 181 --DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGL 257 (516)
T ss_pred --ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccC
Confidence 222223367799999999999653 4799999999999999999999999998888776654322 11111 111
Q ss_pred -CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 652 -GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 652 -~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+........+..++..||+.||.+||+. ++++
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptA-skLl 291 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTA-SKLL 291 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCH-HHHh
Confidence 11122345689999999999999999999 6554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=346.02 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=199.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|.....||+|+||.||+|... +..||||++.... ......+.+|+.++..++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47889999999999999999885 5789999986421 22345688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999995 3457899999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC-cCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS-SAGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~-~~~~~ 654 (780)
......||+.|+|||++.+..++.++|||||||+||+|+||.+||...+..............+.. .....
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence 123457899999999999999999999999999999999999999765543322111111111111 11110
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+..+.+++.+|+..+|.+||++ .+++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~-~~ll~ 256 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSL-EDIKN 256 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCH-HHHHh
Confidence 12346778999999999999999998 66653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.30 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~ 491 (780)
++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.+ +|||||+++|+|.+. .
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 57999999999999999998752 2469999997543 33345688999999999 899999999999654 6
Q ss_pred eeEEEeccCCChhhHHhhhC------------------------------------------------------------
Q 044673 492 SLVFEYLRNGSLEDCLACKN------------------------------------------------------------ 511 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~------------------------------------------------------------ 511 (780)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 79999999999999985321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccc
Q 044673 512 -------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584 (780)
Q Consensus 512 -------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 584 (780)
...++++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-----~~~ 270 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-----YVV 270 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----eee
Confidence 1235899999999999999999999999 99999999999999999999999999976543211 111
Q ss_pred cCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHH
Q 044673 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663 (780)
Q Consensus 585 ~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 663 (780)
.....++..|+|||++.++.++.++|||||||++|+|+| |++||............. . .......|...+..+.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~l~ 345 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--K---RGYQMSRPDFAPPEIY 345 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH--H---cccCccCCCCCCHHHH
Confidence 122345678999999998999999999999999999997 999997543221111100 0 0001112223456799
Q ss_pred HHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 664 HLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 664 ~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+++.+||+.+|.+||++ .+|++.|+.+
T Consensus 346 ~li~~cl~~dp~~RPs~-~~l~~~l~~~ 372 (374)
T cd05106 346 SIMKMCWNLEPTERPTF-SQISQLIQRQ 372 (374)
T ss_pred HHHHHHcCCChhhCcCH-HHHHHHHHHH
Confidence 99999999999999999 8999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.98 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=203.9
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
++|.....||+|+||.||+|...+ ..||+|.+.... ......|.+|+.++.+++||||+++++++.+. .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999998743 459999987543 23455789999999999999999999998653 67
Q ss_pred eEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC
Q 044673 493 LVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~ 559 (780)
++|||+++|+|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCCc
Confidence 99999999999999964221 156899999999999999999999999 999999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--H
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--C 636 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~ 636 (780)
+||+|||+++....... ........+++.|+|||++..+.++.++|||||||++|||+| |..||....... .
T Consensus 163 ~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 163 VKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred EEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999876532211 111234456788999999998999999999999999999998 999987544322 1
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.+..+ .....|...+..+.+|+.+||+.+|.+||++ .+|...|+.
T Consensus 238 ~i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-~~i~~~l~~ 282 (283)
T cd05048 238 MIRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRF-KDIHTRLRS 282 (283)
T ss_pred HHHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHhc
Confidence 22221 1122344567889999999999999999999 899988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.11 Aligned_cols=244 Identities=39% Similarity=0.612 Sum_probs=191.4
Q ss_pred ccccccCCceEEEEeeec------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 428 SWKIGEGRYGNVYRGLLR------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
...||.|.||.||+|.+. +..|+||++.... ......|.+|++++++++||||++++|+|.+ ..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999998 5789999996643 3346789999999999999999999999964 357999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.++|... ....+++..++.|+.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-- 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-- 158 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc--
Confidence 999999999743 3567999999999999999999999999 99999999999999999999999999877622111
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p 655 (780)
........+...|+|||.+....++.++||||||+++|||+| |+.||...+... ..+..+.. ...|
T Consensus 159 ---~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------~~~~ 227 (259)
T PF07714_consen 159 ---YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------LPIP 227 (259)
T ss_dssp ---EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------TTSB
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ceec
Confidence 112233456778999999999999999999999999999999 788886554322 22222211 1223
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
...+..+..++.+||..+|.+||++ .++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~-~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSF-QEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--H-HHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCH-HHHHhcC
Confidence 3456679999999999999999999 8888765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.82 Aligned_cols=235 Identities=20% Similarity=0.312 Sum_probs=195.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++||||+++++++.+. .++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367889999999999999999885 5789999986421 22345688999999999999999999998554 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999985 3456899999999999999999999999 999999999999999999999999998765421
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~ 652 (780)
. ....||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... +..+ ..
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---------~~ 232 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---------RL 232 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------Cc
Confidence 1 2346899999999999999999999999999999999999999765543221 1111 11
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+|...+..+.+|+.+||+.||.+||+.
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2233355678999999999999999974
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.36 Aligned_cols=255 Identities=24% Similarity=0.424 Sum_probs=201.3
Q ss_pred HhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-- 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-- 490 (780)
++++|+..+.||+|+||.||+|.+.+ ..||||++.... ......|.+|+.+++.++||||++++++|.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999987642 469999986532 23456789999999999999999999998654
Q ss_pred CeeEEEeccCCChhhHHhhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK-------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
.++||||+++|+|.+++..... ...+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEEC
Confidence 6799999999999999854221 235789999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~ 642 (780)
|||+++.+...... .......++..|+|||++.++.++.++|||||||++|+|+| |.+||......... ..
T Consensus 162 dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-~~-- 233 (277)
T cd05062 162 DFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-RF-- 233 (277)
T ss_pred CCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH--
Confidence 99998765422111 11123355778999999999999999999999999999999 78888654432211 10
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+........+...+..+.+++.+|++.+|.+||++ .+++..|+
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~ 276 (277)
T cd05062 234 ---VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIK 276 (277)
T ss_pred ---HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHhh
Confidence 01111112233445679999999999999999999 88888775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.53 Aligned_cols=232 Identities=21% Similarity=0.260 Sum_probs=188.8
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+.||+|+||.||++... +..||||++... .......+.+|+.++++++||||++++++|.+. .++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 678999998752 223345678999999999999999999988554 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ....+++.....|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC------
Confidence 9999985 3457899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..... ... ......+|...+..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~------~~~~~~~p~~~~~~ 221 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELI------LMEEIRFPRTLSPE 221 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HHH------HcCCCCCCCCCCHH
Confidence 1123457999999999999999999999999999999999999999754432211 110 01112334456778
Q ss_pred HHHHHHHchhhCCCCCcc
Q 044673 662 LAHLALRCCENNRLNRPD 679 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs 679 (780)
+.+|+.+||+.||.+||+
T Consensus 222 ~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHccCCHHHcCC
Confidence 999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.26 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=202.8
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|.+. ...||||.+.... ......|.+|+.++++++||||+++++++.+. .++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57899999999999999999874 2469999987543 33456799999999999999999999988544 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ..+.+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999853 3347999999999999999999999999 999999999999999999999999999877421
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... .......++..|+|||++.+..++.++||||||+++|+|+| |..||....... ..+..+ ..
T Consensus 160 ~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~ 226 (266)
T cd05033 160 EAT-----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG--------YR 226 (266)
T ss_pred ccc-----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC--------CC
Confidence 111 11122345678999999998899999999999999999998 999986443222 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+...+..+.+++.+|++.+|.+||++ .+|+..|+.+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~-~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTF-SQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 11233455678999999999999999999 9999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.56 Aligned_cols=246 Identities=26% Similarity=0.448 Sum_probs=198.9
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|...+.||+|+||.||++.+.. ..+|+|.+... ......|.+|+.+|++++||||++++++|.+. .++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999998864 57999987643 33456789999999999999999999998554 679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++.. ....++|..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05114 83 NGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-- 156 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee--
Confidence 9999999853 2346899999999999999999999999 999999999999999999999999998765322111
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 656 (780)
......++..|+|||++.+..++.++||||||+++|+|+| |++||...+..... +..+. ....|.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~--------~~~~~~ 224 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--------RLYRPK 224 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCCCC
Confidence 1123345668999999998889999999999999999999 89999765543322 11111 111223
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
..+..+.+++.+||..+|.+||++ .+++..|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~-~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTF-AELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 345678999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=326.07 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=201.7
Q ss_pred cCCCcccccccCCceEEEEeeec--Ce----eEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HL----HVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
++|...+.||+|+||.||+|.+. +. .|++|.+..... .....+..|+.+++++.||||++++|+|.+. .+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46788899999999999999873 33 488888764322 2345688899999999999999999998654 5689
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+++|+|.+++.. ....++|..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999963 3456999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... ...+...++..|++||++.++.++.++|||||||++|||+| |..||....... ..+..+...
T Consensus 163 ~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05111 163 DKK-----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL------- 230 (279)
T ss_pred Ccc-----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 211 11234557778999999999999999999999999999998 999997544322 222222111
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+...+..+..++.+|+..+|..||++ .++...|..+.
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rps~-~el~~~l~~~~ 269 (279)
T cd05111 231 -AQPQICTIDVYMVMVKCWMIDENVRPTF-KELANEFTRMA 269 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHH
Confidence 1112234567889999999999999999 89999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=345.86 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=206.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.+-|+..+.||.|+-|.|-.|++. |..+|||++.... ........+|+-||+-+.|||++.||+++.+. .|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 366888899999999999999885 7789999997653 22344577999999999999999999999664 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
.||+++|.|.++|. ..++|++++..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+-..+
T Consensus 91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999996 5678999999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLT-PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
. ...+.+|++.|.+||++.+.+|. .++||||.|||||.||||+.||+..+. +..+.+ +......
T Consensus 166 k--------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-r~LLlK------V~~G~f~ 230 (786)
T KOG0588|consen 166 K--------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-RVLLLK------VQRGVFE 230 (786)
T ss_pred c--------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-HHHHHH------HHcCccc
Confidence 2 23457999999999999999886 599999999999999999999995443 322211 1222344
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.|...+.+..+|+.+|+..||.+|.++ .+|++
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~-~eI~k 262 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITT-EEILK 262 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccH-HHHhh
Confidence 577788899999999999999999999 77754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=340.17 Aligned_cols=231 Identities=23% Similarity=0.306 Sum_probs=189.0
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||+|+||.||+|... +..||+|++... .......+.+|+.+|.+++||||++++++|.+. .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 567999998642 233456688999999999999999999988554 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-------
Confidence 99985 3456899999999999999999999999 99999999999999999999999999875432111
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 663 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... .. ++. ....+|...+..+.
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~-----~~~-~~~~~~~~~~~~~~ 221 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-RK-----ILQ-EPLRFPDGFDRDAK 221 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-HH-----HHc-CCCCCCCcCCHHHH
Confidence 123457899999999999999999999999999999999999999755432211 11 011 11223445667789
Q ss_pred HHHHHchhhCCCCCcch
Q 044673 664 HLALRCCENNRLNRPDL 680 (780)
Q Consensus 664 ~l~~~Cl~~~p~~RPs~ 680 (780)
+++.+||..||.+||++
T Consensus 222 ~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 222 DLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHHHHcCCCHHHcCCC
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.42 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=203.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|+..+.||+|-||.||.|+.+ +..||+|++.+.. .+...++.+|++|-+.|+||||+++||+|.|. .||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999986 4569999986532 23345788999999999999999999999876 5899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||.++|+|...|.. .....+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||.+..-+.
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 999999999999963 24556888889999999999999999999 99999999999999999999999998755431
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
....+.+||+-|++||...+..++..+|+|++|++.||+|.|.+||.....-....+ +......+
T Consensus 177 --------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-------I~k~~~~~ 241 (281)
T KOG0580|consen 177 --------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-------IRKVDLKF 241 (281)
T ss_pred --------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH-------HHHccccC
Confidence 123567899999999999999999999999999999999999999975553222111 11122234
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|...+....+++.+|+..+|.+|..+ .+++
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l-~~v~ 271 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLAL-TEVM 271 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccH-HHHh
Confidence 56677889999999999999999998 5554
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.50 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=202.0
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|...++||+|+||.||+|... +..||+|.+... ......|.+|+.++++++||||+++++++.+. .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 57889999999999999999875 467999988653 23456799999999999999999999988554 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 159 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-- 159 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCcee--
Confidence 99999998633 3456899999999999999999999999 999999999999999999999999999876432111
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 656 (780)
......++..|+|||++..+.++.++|||||||++|+|+| |..||....... ..+..+. . ...+.
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~ 227 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-----R---MPRME 227 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-----C---CCCCC
Confidence 1123346678999999998899999999999999999999 999996543322 2222111 0 01112
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+..+.+++.+|+..+|.+||++ +++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTF-DYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 345678999999999999999999 999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.67 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=196.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|...+.||+|+||.||+|..+ +..||||++.... ......+.+|+.++++++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999985 5679999986532 23345688999999999999999999998554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999987766542 3456899999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc--------------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN-------------- 642 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~-------------- 642 (780)
. ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..........
T Consensus 156 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 156 A------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred c------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 1 12345689999999999988999999999999999999999999976543322111000
Q ss_pred ----ccccccCcC-------CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ----FNSVLDSSA-------GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ----~~~~ld~~~-------~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.....+.. ..+....+..+.+|+.+||+.||.+||++ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-~~~l 282 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-EQCL 282 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 000000000 01111245679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=324.67 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=202.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.+|...++||+|+||.||+|.+. +..||+|.+... ......|.+|+.++..++||||++++++|.+. .++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999885 678999998753 33456789999999999999999999998544 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999998532 3456899999999999999999999999 999999999999999999999999998766432111
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......++..|+|||++.+..++.++|||||||++|+|+| |.+||...+.... .... ........|..
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~-----~~~~~~~~~~~ 229 (263)
T cd05052 161 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELL-----EKGYRMERPEG 229 (263)
T ss_pred -----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHH-----HCCCCCCCCCC
Confidence 1112334567999999999999999999999999999998 9999865433221 1110 00111223344
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+..+.+++.+|+..+|.+||++ .++.+.|+.+
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 262 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSF-AEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCH-HHHHHHHHhh
Confidence 56789999999999999999999 8999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.38 Aligned_cols=235 Identities=23% Similarity=0.332 Sum_probs=193.5
Q ss_pred hcCCCcccccccCCceEEEEeeecC---eeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH---LHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~---~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|.+.+ ..||+|.+... .......+.+|+.++..++|||||+++++|.+. .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998643 47999988542 223345688999999999999999999999665 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999985 3456899999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
. .....||+.|+|||++.+..++.++|||||||++|+|+||.+||...+....... +.. ....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~-~~~~ 246 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILE-GIIY 246 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------Hhc-CCCC
Confidence 1 1235789999999999988899999999999999999999999986654321111 111 1112
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCc
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
+|...+..+.+++.+|++.+|.+|+
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcC
Confidence 3444556788999999999999996
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=340.81 Aligned_cols=231 Identities=20% Similarity=0.275 Sum_probs=187.6
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+.||+|+||.||++... +..||+|++... .......+.+|+.+++.++||||++++++|.+. .++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999874 678999998652 223345678899999999999999999988544 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 9998885 3457899999999999999999999999 99999999999999999999999999875322111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
......||+.|+|||++.++.++.++|||||||++|+|+||+.||...+..... ... . .....+|...+..
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~~-----~-~~~~~~p~~~~~~ 221 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELI-----L-MEEIRFPRTLSPE 221 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHH-----h-cCCCCCCCCCCHH
Confidence 123456899999999999999999999999999999999999999755432211 110 0 0111234456678
Q ss_pred HHHHHHHchhhCCCCCc
Q 044673 662 LAHLALRCCENNRLNRP 678 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RP 678 (780)
+.+++.+||..+|.+||
T Consensus 222 ~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 222 AKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHccCCHHHhC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.74 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=205.8
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...+.||+|+||.||++... +..+|+|.+..........|.+|+.++.+++||||++++++|.+. .++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999752 345899998776555667799999999999999999999998643 679
Q ss_pred EEEeccCCChhhHHhhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 494 VFEYLRNGSLEDCLACKN----------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEec
Confidence 999999999999985321 2235999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHh
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEK 640 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~ 640 (780)
|||+++....... ........++..|+|||++.+..++.++|||||||++|+|+| |.+||....... ..+..
T Consensus 163 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 163 DFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999876542211 111233456778999999998899999999999999999999 999987544322 22222
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
+... ..+...+..+.+|+.+|++.+|.+||++ .++...|+.+..
T Consensus 238 ~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNI-KEIHSLLQNLAK 281 (288)
T ss_pred CCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHHH
Confidence 2211 1122345679999999999999999999 899999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.63 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=205.6
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
.+|.....||+|+||.||+|... +..|++|.+..........|.+|+.++++++||||++++++|.+. .++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46778889999999999999753 245899998776555567799999999999999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 494 VFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
||||+++|+|.+++.... ....++|..++.|+.+|+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcE
Confidence 999999999999985321 1245899999999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CA 637 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~ 637 (780)
||+|||++........ ........++..|+|||++.+..++.++|||||||++|+|+| |++||...+... ..
T Consensus 163 ~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 163 KIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999876542211 111234456788999999999999999999999999999999 999986544322 11
Q ss_pred HHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 638 ~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+. ....+...+..+.+++.+|++.+|.+||++ .+|++.|+.+.
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~v~~~l~~~~ 283 (291)
T cd05094 238 ITQGR--------VLERPRVCPKEVYDIMLGCWQREPQQRLNI-KEIYKILHALG 283 (291)
T ss_pred HhCCC--------CCCCCccCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHH
Confidence 11111 112233355679999999999999999999 99999999884
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.92 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=202.9
Q ss_pred hcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCCc-hhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~-- 490 (780)
.++|...++||+|+||.||+|.+.+ ..||||++..... .....|.+|+.+|+++. |||||+++|+|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4788899999999999999998632 3599999975432 33467999999999996 99999999999654
Q ss_pred CeeEEEeccCCChhhHHhhhC-----------------------------------------------------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKN----------------------------------------------------------- 511 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 511 (780)
.+|||||+++|+|.++|....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 679999999999999886421
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC
Q 044673 512 ----------------------------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN 557 (780)
Q Consensus 512 ----------------------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~ 557 (780)
....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~ 273 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCC
Confidence 1235889999999999999999999999 9999999999999999
Q ss_pred CCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--
Q 044673 558 FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV-- 634 (780)
Q Consensus 558 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~-- 634 (780)
+.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 274 ~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999865422111 11223456788999999998899999999999999999997 88888643211
Q ss_pred -HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 635 -KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 635 -~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+..+ .....+...+..+.+++.+||..+|.+||++ .+|.+.|+.+
T Consensus 349 ~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~l~~l 397 (400)
T cd05105 349 FYNKIKSG--------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSF-LHLSDIVESL 397 (400)
T ss_pred HHHHHhcC--------CCCCCCccCCHHHHHHHHHHCccCHhHCcCH-HHHHHHHHHH
Confidence 1111111 1112233456779999999999999999999 8999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.06 Aligned_cols=243 Identities=23% Similarity=0.402 Sum_probs=196.6
Q ss_pred ccccCCceEEEEeeec----CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEeccCCC
Q 044673 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLRNGS 502 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~~gs 502 (780)
.||+|+||.||+|.+. +..||+|++.... ......|.+|+.+++.+.||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5999999999999763 4679999986532 2345679999999999999999999999854 4679999999999
Q ss_pred hhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcc
Q 044673 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582 (780)
Q Consensus 503 L~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~ 582 (780)
|.+++. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 82 L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~----~ 152 (257)
T cd05116 82 LNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY----Y 152 (257)
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----e
Confidence 999985 3346899999999999999999999999 999999999999999999999999999876432211 0
Q ss_pred cccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHHH
Q 044673 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 583 ~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
.......++..|+|||.+..+.++.++|||||||++|||+| |.+||....... ..+..+. ....|...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--------~~~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--------RMECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------CCCCCCCCC
Confidence 11122345678999999988889999999999999999998 999997544321 2222211 122344566
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+.+++.+|+..+|.+||++ ..|...|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~-~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGF-AVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCH-HHHHHHHhc
Confidence 789999999999999999999 889888874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.77 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=191.1
Q ss_pred cCCCcccccccCCceEEEEeeec---CeeEEEEEccCCC--chhHHHHHHHHHHhhcC---CCCceeeEeeeec------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRV---RHPNLVTLIGTCP------ 488 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~------ 488 (780)
++|.....||+|+||.||+|... +..||||.+.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 4679999886432 22234566788777766 6999999999883
Q ss_pred -CCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 489 -ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 489 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
...++||||++ |+|.+++... ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 12579999996 6899988532 2345899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc-----
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN----- 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~----- 642 (780)
++...... ......||+.|+|||++....++.++|||||||++|+|+||++||..............
T Consensus 157 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 157 ARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred eEeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 97654221 12345689999999999988999999999999999999999999986554332211000
Q ss_pred ----cc-------ccccCcCC----CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ----FN-------SVLDSSAG----DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ----~~-------~~ld~~~~----~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+. ..+..... .+....+..+.+|+.+|++.+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~~~l 285 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSAL 285 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-HHHh
Confidence 00 00000000 0011234567899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=336.60 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=196.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|.....||+|+||.||++... +..||+|++.... ......|.+|+.+|++++||||++++++|.+. .++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 68999999999999999999885 5679999987542 33456799999999999999999999998543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++|+|.+++. ....+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999999985 334689999999999999999999985 6 9999999999999999999999999987653211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhcc-------cc---
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRN-------FN--- 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~-------~~--- 644 (780)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.... .+.... ..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 1234689999999999998999999999999999999999999964432211 110000 00
Q ss_pred ----------------------------ccccCcCCCCC-HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 ----------------------------SVLDSSAGDWP-VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 ----------------------------~~ld~~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+........+ ...+..+.+|+.+||+.||.+||++ .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-~ell~ 300 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-KMLMN 300 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-HHHhc
Confidence 00000001111 1245679999999999999999999 76653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.70 Aligned_cols=237 Identities=22% Similarity=0.272 Sum_probs=191.6
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+.||+|+||.||++... +..||||++... .......+.+|+.+++.++||||+++++++.+. .++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 678999998653 223445788999999999999999999988554 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 9999885 3457999999999999999999999999 99999999999999999999999999875322111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..... ... ......+|...+..
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~------~~~~~~~p~~~~~~ 221 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELI------LMEDIKFPRTLSAD 221 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHh------ccCCccCCCCCCHH
Confidence 123457899999999999999999999999999999999999999755432211 110 11112334456678
Q ss_pred HHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 662 LAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
+.+|+.+||..+|.+|| ++ .+++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~-~~il 249 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDA-KEIM 249 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCH-HHHh
Confidence 99999999999999997 55 5554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=346.36 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=200.6
Q ss_pred HHHhcCCCcccccccCCceEEEEeeecC--eeEEEEEccCCC---chhHHHHHHHHHHhhcCC-CCceeeEeeeecC--C
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYG---PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--S 490 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~ 490 (780)
.-..++|...+.||+|.||+|+++.+++ .-+|||++++.. ..+......|..|+.-.. ||.++.|+.+|.. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3345899999999999999999999875 569999998753 344566778888888775 9999999999954 4
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.|+||||+.||++..+. ....+++.....++.+|+.||.|||+++ ||+||||.+|||||.+|++||+|||||+.
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccc
Confidence 68899999999955544 4567999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
.... ...+++.+||+.|||||++.+..|+..+|+|||||+|||||+|.+||...+.-... ..++. .
T Consensus 518 ~m~~-------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~-d 583 (694)
T KOG0694|consen 518 GMGQ-------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVN-D 583 (694)
T ss_pred cCCC-------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhc-C
Confidence 4311 12346789999999999999999999999999999999999999999877653322 11111 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+|...+.+...++.+.+..+|.+|-.+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 223566678888999999999999999765
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.40 Aligned_cols=245 Identities=23% Similarity=0.421 Sum_probs=196.8
Q ss_pred ccccCCceEEEEeeec----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccCCCh
Q 044673 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNGSL 503 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~gsL 503 (780)
.||+|+||.||+|.+. +..||+|++.... ......|.+|+.++++++||||++++++|... .++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 3469999987643 23346799999999999999999999998544 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++.. ....+++..+++++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~ 153 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YK 153 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccc----ee
Confidence 999853 3457999999999999999999999999 999999999999999999999999998765432211 11
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
..+...++..|+|||++.+..++.++|||||||++|+|++ |.+||....... ..+..+. ....|...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 225 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------RLDCPAECPP 225 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------CCCCCCCCCH
Confidence 1122334678999999998889999999999999999996 999997544322 1222221 1223445567
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+.+++.+||..+|.+||++ .+|.+.|+.+
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~-~~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNF-AKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCH-HHHHHHHhhh
Confidence 89999999999999999999 8898888753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.62 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=201.9
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
++|...+.||+|+||.||+|.+. +..||||.+...... ....|.+|+++|.+++||||+++++++.+. .+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 56888899999999999999763 257999998765443 456899999999999999999999998554 67
Q ss_pred eEEEeccCCChhhHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 493 LVFEYLRNGSLEDCLACKN-----------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeEE
Confidence 9999999999999996421 2345899999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CAL 638 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~ 638 (780)
|+|||+++.+...... .......+++.|+|||++.++.+++++|||||||++|+|+| |..||...+... ..+
T Consensus 163 l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 163 IGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred ECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999998765322110 11123456788999999999999999999999999999999 999986444322 111
Q ss_pred HhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 639 EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 639 ~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
..+.. ...+...+..+.+++.+||..+|.+||++ .+|++.|+
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~eil~~l~ 279 (280)
T cd05049 238 TQGRL--------LQRPRTCPSEVYDIMLGCWKRDPQQRINI-KDIHERLQ 279 (280)
T ss_pred HcCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHhh
Confidence 11111 11223455679999999999999999999 89988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.22 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=192.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------CCe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------SRS 492 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------~~~ 492 (780)
+|...++||+|+||.||+|... +..||||.+... .......+.+|+.++++++||||+++++++.. ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999874 678999988642 22344568899999999999999999998732 247
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||+. ++|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68988884 3456999999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH-------------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA------------- 637 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~------------- 637 (780)
..... ........||..|+|||++.+ ..++.++|||||||++|+|+||++||...+.....
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 22111 111234678999999999876 67899999999999999999999999654432211
Q ss_pred ----HHhcccccccc----CcCCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 638 ----LEKRNFNSVLD----SSAGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 638 ----~~~~~~~~~ld----~~~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+........+. .....+ ....+..+.+++.+||..+|.+||++ .+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA-EEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH-HHHhc
Confidence 00000000000 000000 01234567899999999999999999 67653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=322.79 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=197.7
Q ss_pred CCcccccccCCceEEEEeeecC----eeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------C
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRH----LHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--------S 490 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--------~ 490 (780)
|...+.||+|+||.||+|.+.. ..||+|.+... .......|.+|+.+++.++||||++++++|.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456789999999999998753 25999988653 23445678999999999999999999998732 2
Q ss_pred CeeEEEeccCCChhhHHhhh---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACK---NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
.++||||+++|+|.+++... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 46899999999999987422 23345899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhcccc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFN 644 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~ 644 (780)
++.+...... .......+++.|++||++.+..++.++|||||||++|+|++ |++||....... ..+..+.
T Consensus 159 ~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 231 (272)
T cd05075 159 SKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-- 231 (272)
T ss_pred ccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 9876432211 11123345678999999999999999999999999999999 889997544322 1122211
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 645 SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 645 ~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
....+...+..+.+++.+||+.+|.+||++ .+++..|+.+
T Consensus 232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l~~~ 271 (272)
T cd05075 232 ------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF-ETLRCELEKA 271 (272)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 111122345678999999999999999999 8999888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.42 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=201.2
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~ 492 (780)
.+|.....||+|+||.||+|.. .+..||||.+..........|.+|+.++++++||||++++++|.. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788889999999999999874 256799999887666666789999999999999999999998732 357
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||+++|+|.+++.. ....++|..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999999852 2356899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccc--------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNF-------- 643 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~-------- 643 (780)
..... ........++..|+|||++.++.++.++|||||||++|||++|..|+...... ...+.....
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32211 01112223455699999999889999999999999999999987765422211 111100000
Q ss_pred cccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 644 NSVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 644 ~~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+.. .....+...+..+.+|+.+||..+|.+||++ .+|+..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF-SELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHhc
Confidence 001111 1111122345679999999999999999999 9999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.48 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=199.6
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~L 493 (780)
.+|+....||+|+||.||+|.+ .+..||+|.+.... ......|.+|+.++++++||||+++++++.. ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999975 23679999987533 3344678999999999999999999999854 4689
Q ss_pred EEEeccCCChhhHHhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC
Q 044673 494 VFEYLRNGSLEDCLACKN--------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~ 559 (780)
||||+++|+|.+++.... ....+++...+.++.+++.||.|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCCc
Confidence 999999999999985321 1235889999999999999999999999 999999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HH
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KC 636 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~ 636 (780)
+||+|||+++.+...... .......++..|+|||++.++.++.++|||||||++|+|+| |.+||...... ..
T Consensus 163 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 163 VKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred EEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999765422111 11233445678999999998889999999999999999999 99998654321 12
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+..+. ....+...+..+.+++.+|+..+|.+||++ .+|.+.|.
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 281 (283)
T cd05090 238 MVRKRQ--------LLPCSEDCPPRMYSLMTECWQEGPSRRPRF-KDIHTRLR 281 (283)
T ss_pred HHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHhh
Confidence 222111 112233455679999999999999999999 88887775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.83 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=192.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...++||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999884 67899999875332 2334677999999999999999999998554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++ |+|.+++. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMD--KHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 57877774 23456899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc-----cccc-----
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR-----NFNS----- 645 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~-----~~~~----- 645 (780)
.......||+.|+|||++.+ ..++.++|||||||++|+|+||.+||....+....+... ....
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 11234568899999999865 458899999999999999999999997654433222110 0000
Q ss_pred -----cccCcCC--CCCH---------HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 -----VLDSSAG--DWPV---------AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 -----~ld~~~~--~~p~---------~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..++... ..|. ..+..+.+|+.+|++.||.+||++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-~~~l 286 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-QAAL 286 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-HHHh
Confidence 0000000 0000 123467899999999999999999 6664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=353.62 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=200.3
Q ss_pred CCCcccccccCCceEEEEeeec---CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
.|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+|+.++|||||+++++|.+ ..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999764 45689998765555555678899999999999999999999854 367999999
Q ss_pred cCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 499 RNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 499 ~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++|+|.++|... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~- 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS- 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-
Confidence 999999988532 34567999999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
........||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... .. ++.......|..
T Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-~~-----~~~~~~~~~~~~ 294 (478)
T PTZ00267 225 ----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-QQ-----VLYGKYDPFPCP 294 (478)
T ss_pred ----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-----HHhCCCCCCCcc
Confidence 11224457999999999999999999999999999999999999999755432211 11 111111123344
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+..+.+++.+||..+|..||++ .+++
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~-~~~l 321 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTT-QQLL 321 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCH-HHHH
Confidence 56779999999999999999998 5554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=363.36 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=208.4
Q ss_pred CCCcccccccCCceEEEEeeecC-------eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
+-...+.||+|.||.||.|...+ ..||||.+... +.+...+|.+|..+|++++|||||+|+|.|.+. .++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999998842 24999999774 456678899999999999999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKN----KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
++|||++|+|..+|.... ....|+..+.+.|+.+||.|+.||++++ +|||||-.+|+||+....+||+|||||+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999995321 2557999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCCcccccCC-CCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESN-NDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~-~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
.+..... +.... ..-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+.... ++
T Consensus 851 Diy~~~y------yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~ 918 (1025)
T KOG1095|consen 851 DIYDKDY------YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VL 918 (1025)
T ss_pred hhhhchh------eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HH
Confidence 5543221 11111 133457999999999999999999999999999999 8999987765443321 11
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.....+.|..++..+.+|++.||..+|.+||++ ..+++.+..+..
T Consensus 919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F-~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSF-RTIVEQDPAISN 963 (1025)
T ss_pred hCCccCCCCCCChHHHHHHHHHccCChhhCccH-HHHHhhhhhhhh
Confidence 112334566788899999999999999999999 788888877743
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.54 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=192.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|..++||||++++++|.+. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999884 6789999986421 22345678999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999985 3456999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCCc-------------------------------ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC
Q 044673 576 STGNSA-------------------------------LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG 624 (780)
Q Consensus 576 ~~~~~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG 624 (780)
...... ........||+.|+|||++.+..++.++|||||||++|+|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100000 0011134699999999999999999999999999999999999
Q ss_pred CCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 625 RPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 625 ~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.+||...+..............+. . ......+..+.+++.+|+. +|.+|++
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~--~-~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQ--F-PDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccC--C-CCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 999986654332211111111111 0 0111235567888999986 8999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.94 Aligned_cols=251 Identities=29% Similarity=0.394 Sum_probs=196.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--------------hhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--------------QSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--------------~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
.+.|.....||+|.||.|-+|+.. +..||||++.+... .......+|+.||++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 588999999999999999999874 67899999864211 11246789999999999999999999
Q ss_pred eecC----CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 486 TCPE----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 486 ~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+..+ ..|||+|||..|.+...= .....|+..+.+.++.+++.||.|||.++ ||||||||+|+||+.+|++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEE
Confidence 8743 468999999998876532 23333999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCC----CCcchhHHHHHHHHHHHHhCCCCCccchhHHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK----LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA 637 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~ 637 (780)
|+|||.+..++....... .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.........
T Consensus 251 IsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred eeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999987754322211 12234479999999999988743 346889999999999999999999765544322
Q ss_pred HHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 638 ~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
-+ ..+..+. .+..| ++...+.+|++++|+.||..|-++ .+|.
T Consensus 329 ~K--Ivn~pL~--fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l-~~ik 370 (576)
T KOG0585|consen 329 DK--IVNDPLE--FPENP-EINEDLKDLIKRLLEKDPEQRITL-PDIK 370 (576)
T ss_pred HH--HhcCccc--CCCcc-cccHHHHHHHHHHhhcChhheeeh-hhhe
Confidence 11 1111111 11222 467789999999999999999988 5553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=321.67 Aligned_cols=311 Identities=21% Similarity=0.322 Sum_probs=230.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhhh---ccCCCccccCHHHHHHHhcCCCcccccccCCceE
Q 044673 362 KIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALS---FFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGN 438 (780)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ei~~at~~f~~~~~IG~G~~G~ 438 (780)
.+.+..++-..++-++..|+.|..+.+.+.+++.+...-.... .....-.+| .+-....++|-.++.||+|||+.
T Consensus 401 tlaEYhEqeEIfKLRlgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEdnSQF--kDHptLn~RYLlLhLLGrGGFSE 478 (775)
T KOG1151|consen 401 TLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQF--KDHPTLNDRYLLLHLLGRGGFSE 478 (775)
T ss_pred cHHHHHhHHHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccchhhh--ccCcchHHHHHHHHHhccccHHH
Confidence 3445555555667777778887777777766665432111100 000000111 11112235677788999999999
Q ss_pred EEEeee--cCeeEEEEEccCCC-------chhHHHHHHHHHHhhcCCCCceeeEeeee---cCCCeeEEEeccCCChhhH
Q 044673 439 VYRGLL--RHLHVAIKMFPSYG-------PQSHLKFQNEVEVLSRVRHPNLVTLIGTC---PESRSLVFEYLRNGSLEDC 506 (780)
Q Consensus 439 Vyk~~~--~~~~VAiK~l~~~~-------~~~~~~f~~Ev~il~~l~HpnIv~l~g~~---~~~~~LV~Ey~~~gsL~~~ 506 (780)
||++.+ ...-||||+..... ..-++...+|..|.+.|.||-||++|++| .+..|-|+|||+|.+|+-+
T Consensus 479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY 558 (775)
T KOG1151|consen 479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY 558 (775)
T ss_pred HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence 999986 35679999864321 11123456899999999999999999998 4567899999999999999
Q ss_pred HhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCcccccccccccccCCCCCCCCccc
Q 044673 507 LACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 507 L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
|. ....+++.+...|+.||+.||.||...+|||||-||||.||||-+ -|.+||+||||++.+..+.........
T Consensus 559 LK---QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGme 635 (775)
T KOG1151|consen 559 LK---QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGME 635 (775)
T ss_pred HH---hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCccccee
Confidence 94 556799999999999999999999999999999999999999943 477999999999998765443334444
Q ss_pred ccCCCCCCcccCChhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC--HH
Q 044673 584 NESNNDSASVYIDPEYLETG----KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP--VA 657 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p--~~ 657 (780)
.+....||.+|++||.+.-+ +.+.|+||||+|||+|++|.|+.||+........+.... ++...--.+| +.
T Consensus 636 LTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT---IlkAtEVqFP~KPv 712 (775)
T KOG1151|consen 636 LTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT---ILKATEVQFPPKPV 712 (775)
T ss_pred eecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc---hhcceeccCCCCCc
Confidence 56678999999999988654 477899999999999999999999997666555554433 3333222222 24
Q ss_pred HHHHHHHHHHHchhhCCCCCcch
Q 044673 658 EAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.+...++.+||++.-.+|.+.
T Consensus 713 VsseAkaFIRRCLaYRKeDR~DV 735 (775)
T KOG1151|consen 713 VSSEAKAFIRRCLAYRKEDRIDV 735 (775)
T ss_pred cCHHHHHHHHHHHHhhhhhhhhH
Confidence 56778899999999999999877
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.84 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=200.2
Q ss_pred CCcccccccCCceEEEEeeecC-----eeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
|...+.||+|+||.||+|.+.. ..||||.+.... ......|.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5667899999999999998742 569999987532 33456799999999999999999999987331
Q ss_pred -CeeEEEeccCCChhhHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN---KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
.++|+||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 478999999999999985432 2346899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNS 645 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~ 645 (780)
+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |.+||...........
T Consensus 159 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~------ 227 (273)
T cd05035 159 LSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY------ 227 (273)
T ss_pred ceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------
Confidence 99876432211 01122334677999999988889999999999999999999 8899875543221111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+.+......|...+..+.+++.+|+..+|.+||++ .+++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF-TKLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 11111112233456789999999999999999999 8999988865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=337.65 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=201.7
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC---
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--- 490 (780)
++|.+.+.||+|+||.||+|...+ ..||+|++.... ......+..|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 478899999999999999997532 569999987532 23345678899999999 899999999988432
Q ss_pred CeeEEEeccCCChhhHHhhhCC----------------------------------------------------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK---------------------------------------------------------- 512 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 512 (780)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 4689999999999999853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCc
Q 044673 513 KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592 (780)
Q Consensus 513 ~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~ 592 (780)
..+++|..+..|+.+|+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+...... .......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----hhccCCCCCc
Confidence 237899999999999999999999999 999999999999999999999999999876432111 1123345677
Q ss_pred ccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh---HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHH
Q 044673 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD---VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALR 668 (780)
Q Consensus 593 ~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~ 668 (780)
.|+|||++.+..++.++|||||||+||+|+| |.+||..... ....+..+.. ...|...+..+.+++.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------MRAPEYATPEIYSIMLD 311 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------CCCCccCCHHHHHHHHH
Confidence 8999999999999999999999999999998 9999864322 1222222211 11122345679999999
Q ss_pred chhhCCCCCcchHHHHHHHHHHHH
Q 044673 669 CCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 669 Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
||+.+|.+||++ .++++.|+++.
T Consensus 312 cl~~~p~~RPs~-~ell~~l~~~~ 334 (337)
T cd05054 312 CWHNNPEDRPTF-SELVEILGDLL 334 (337)
T ss_pred HccCChhhCcCH-HHHHHHHHHHH
Confidence 999999999999 89999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.95 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=200.6
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--CCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~ 492 (780)
.+|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.++.+++||||+++++++.+ ..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999863 356999999754332 34568899999999999999999999854 357
Q ss_pred eEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC
Q 044673 493 LVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~ 559 (780)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCc
Confidence 8999999999999985321 1245899999999999999999999999 999999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHH
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCAL 638 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~ 638 (780)
+||+|||+++....... ........+++.|+|||++.++.++.++|||||||++|||+| |.+||........ .
T Consensus 163 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-I 236 (283)
T ss_pred eEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Confidence 99999999876542211 111233456778999999998899999999999999999998 8888865433211 1
Q ss_pred HhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 639 EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 639 ~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
. .+.+......|...+..+.+|+.+|++.+|..||++ .+|+..|+
T Consensus 237 ~-----~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-~~i~~~l~ 281 (283)
T cd05091 237 E-----MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-KDIHSRLR 281 (283)
T ss_pred H-----HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHhh
Confidence 1 111222223344566779999999999999999999 89988876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.56 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=199.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.++..++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999986 7889999986521 23445688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999999963 367999999999999999999999999 9999999999999999999999999997664322
Q ss_pred CC----------------------CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh
Q 044673 576 ST----------------------GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 576 ~~----------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
.. ............||+.|+|||++.+..++.++|||||||+||+|+||++||...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00 00001122346799999999999999999999999999999999999999986654
Q ss_pred HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcc-hHHHHHH
Q 044673 634 VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD-LVSEIWS 686 (780)
Q Consensus 634 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs-~~~ev~~ 686 (780)
.............+. .+.. ...+..+.+|+.+|+. +|.+||+ + .+++.
T Consensus 236 ~~~~~~i~~~~~~~~--~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~-~~ll~ 284 (350)
T cd05573 236 QETYNKIINWKESLR--FPPD-PPVSPEAIDLICRLLC-DPEDRLGSF-EEIKS 284 (350)
T ss_pred HHHHHHHhccCCccc--CCCC-CCCCHHHHHHHHHHcc-ChhhcCCCH-HHHhc
Confidence 332211111111111 0111 1146778999999997 9999999 6 66653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=321.71 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.++|...+.||+|+||.||+|.+. +..||||.+.... .....|.+|+.++++++||||++++++|... .++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 467888999999999999999875 4679999987543 3456789999999999999999999998554 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999985322 346899999999999999999999999 999999999999999999999999999876522111
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p 655 (780)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||......... +..+ . ....+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~-------~~~~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-Y-------RMPCP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C-------CCCCC
Confidence 1112223457999999998899999999999999999999 99999754432211 1111 0 01122
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
...+..+.+++.+|+..+|.+||++ .++...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~-~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTF-ETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHhc
Confidence 3345779999999999999999999 899988874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.70 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=201.5
Q ss_pred CCCcccccccCCceEEEEeeecC-------eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
+|...+.||+|+||.||+|.... ..|++|.+..... .....|.+|+.+++.++||||++++++|.+. .++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998632 4589998875432 3346789999999999999999999998543 679
Q ss_pred EEEeccCCChhhHHhhhC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCce
Q 044673 494 VFEYLRNGSLEDCLACKN---------------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKV 552 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NI 552 (780)
|+||+++|+|.+++.... ...++++..++.++.+++.||.|||+.+ |+||||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheE
Confidence 999999999999885321 1246899999999999999999999999 99999999999
Q ss_pred EecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccc
Q 044673 553 LIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIK 631 (780)
Q Consensus 553 LLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~ 631 (780)
|+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998765322111 11123345678999999988889999999999999999999 99999754
Q ss_pred hhHH--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 632 KDVK--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 632 ~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.... ..+..+ .....|...+..+..++.+|++.+|.+||++ .+++..|+.+.
T Consensus 234 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~-~~i~~~l~~~~ 287 (290)
T cd05045 234 APERLFNLLKTG--------YRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKMM 287 (290)
T ss_pred CHHHHHHHHhCC--------CCCCCCCCCCHHHHHHHHHHccCCcccCCCH-HHHHHHHHHHH
Confidence 4322 111111 1111233455679999999999999999999 99999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.17 Aligned_cols=239 Identities=23% Similarity=0.383 Sum_probs=203.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV 494 (780)
..+|.+...||+|.||+|-++... +..||||.++++ +.++...+.+|++|++.|+||||+.+|.+|.. ...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 357888889999999999999864 788999998764 34556678899999999999999999999955 45789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||..+|.|+||+. ..+.|++.+...++.||.+|+.|+|.++ +||||||.+|||||.|+++||+||||+.++...
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999996 5567999999999999999999999999 999999999999999999999999999887643
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLT-PESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ld~~~ 651 (780)
. ...+.+|++-|.+||++.+.+|. +.+|-|||||+||-|+.|.-||++.+.. ...+..|.+.+.-.
T Consensus 207 k--------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~--- 275 (668)
T KOG0611|consen 207 K--------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET--- 275 (668)
T ss_pred c--------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC---
Confidence 2 23567899999999999998874 7999999999999999999999877653 34455555543222
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
+....-|+.+||-.||.+|.++ .+|
T Consensus 276 -------PSdA~gLIRwmLmVNP~RRATi-eDi 300 (668)
T KOG0611|consen 276 -------PSDASGLIRWMLMVNPERRATI-EDI 300 (668)
T ss_pred -------CchHHHHHHHHHhcCcccchhH-HHH
Confidence 2346789999999999999988 444
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=321.64 Aligned_cols=246 Identities=25% Similarity=0.423 Sum_probs=198.1
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|.....||+|+||.||+|.+.+ ..||||.+.... .....|.+|+.++.+++||||++++++|.+. .++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457788899999999999998765 469999887532 3456799999999999999999999998554 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++.. ....+++..++.|+.+|+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 83 NGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 9999999853 2336899999999999999999999999 99999999999999999999999999876543211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 656 (780)
.......++..|++||++.++.++.++|||||||++|+|+| |..||...+.... .+..+. ....+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 224 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL--------RLYRPH 224 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC--------CCCCCC
Confidence 11122345678999999998889999999999999999999 9999975543221 111111 111122
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
..+..+.+++.+||..+|.+||++ .+++..|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~-~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTF-QQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCH-HHHHHhh
Confidence 345779999999999999999999 7887665
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.59 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=201.9
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~ 500 (780)
++|...++||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++|||++++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46888999999999999999875 46799999876432 345799999999999999999999988544 6899999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....+++..+..|+.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 158 (260)
T cd05070 85 GSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--- 158 (260)
T ss_pred CcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcccc---
Confidence 9999998632 2346899999999999999999999999 999999999999999999999999999776432111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......++..|+|||++.+..++.++||||||+++|+|+| |.+||...+....... +........+...+
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~ 229 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ------VERGYRMPCPQDCP 229 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCCCCCCCcCC
Confidence 1122345667999999988899999999999999999999 8999975443221111 11111122334456
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+.+|+.+|+..+|.+||++ .++.+.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~~ 259 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTF-EYLQSFLED 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCH-HHHHHHHhc
Confidence 779999999999999999999 888888763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.21 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--C---eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--H---LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~---~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
+++|...+.||+|+||.||+|... + ..||+|.+... .......|.+|+.++++++||||+++++++.+. .++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999874 2 36999998754 234456799999999999999999999998543 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999999852 3467999999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
.... .........+..|+|||++..+.++.++|||||||++|+|+| |+.||...+... ..+..+ .
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~--------~ 227 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG--------F 227 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC--------C
Confidence 2111 111112233557999999998889999999999999999998 999996544322 111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
....+...+..+.+++.+|+..+|.+||++ .+|+..|+.+
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRF-VDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 112233455778999999999999999999 8999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.45 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=206.7
Q ss_pred HhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
...+|...++||.|+||.||+|... +..||+|.+..........+..|+.+++.++||||+++++++.+. .++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3467888999999999999999885 577999999876555667899999999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999632 3456899999999999999999999999 99999999999999999999999999876643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
......++..|++||++..+.++.++||||||+++|+|++ |+.||...+....... +........|.
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~ 227 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ------ITAGYRMPCPA 227 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH------HHhCCcCCCCC
Confidence 1123446678999999998899999999999999999998 8999975443221111 01111112234
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+..+.+++.+|+..+|.+||++ .++.+.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~-~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSF-KALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHhc
Confidence 556779999999999999999999 899999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.53 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=202.8
Q ss_pred cCCCcccccccCCceEEEEeeec--Ce----eEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HL----HVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV 494 (780)
++|...++||+|+||.||+|.+. +. .||+|++.... ......+.+|+.++..+.||||++++++|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 57888999999999999999863 32 48999987533 3345678899999999999999999999854 46799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 87 TQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 999999999999852 3456999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~ 651 (780)
... .......++..|++||++.++.++.++|||||||++|||+| |.+||...... ...+..+..
T Consensus 163 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 229 (279)
T cd05109 163 ETE-----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-------- 229 (279)
T ss_pred cce-----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc--------
Confidence 211 11122345678999999998899999999999999999998 99998754321 122222111
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+...+..+.+++.+||..+|..||++ .+++..|+.+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~l~~~l~~~~ 269 (279)
T cd05109 230 LPQPPICTIDVYMIMVKCWMIDSECRPRF-RELVDEFSRMA 269 (279)
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 11123355678999999999999999999 88999888774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.72 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=193.3
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++.+++|||||+++++|.+. .++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999875 5679999986532 23345688999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999985 3456899999999999999999999999 99999999999999999999999999864421100
Q ss_pred CC----------------------------------------CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHH
Q 044673 577 TG----------------------------------------NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGI 616 (780)
Q Consensus 577 ~~----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gv 616 (780)
.. ....+......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00 00000112457999999999999889999999999999
Q ss_pred HHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHH--chhhCCCCCcchHHHHH
Q 044673 617 ILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALR--CCENNRLNRPDLVSEIW 685 (780)
Q Consensus 617 il~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~--Cl~~~p~~RPs~~~ev~ 685 (780)
++|||+||++||...+..............+. .. .....+.++.+|+.+ |+..+|..||++ .+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~-~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLH--IP-PQVKLSPEAVDLITKLCCSAEERLGRNGA-DDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccC--CC-CCCCCCHHHHHHHHHHccCcccccCCCCH-HHHh
Confidence 99999999999976554332222111111010 00 111245567788877 556677779998 6664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=338.51 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=191.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||||++.... ......+.+|+.++.+++||||+++++++.+. .+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999875 5789999986522 22335678899999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999995 3457999999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCCC----------------------------CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 576 STGN----------------------------SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 576 ~~~~----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
.... ..........||+.|+|||++.+..++.++|||||||+||||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000001245799999999999999999999999999999999999999
Q ss_pred CccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHch--hhCCCCCcchHHHHHH
Q 044673 628 LRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCC--ENNRLNRPDLVSEIWS 686 (780)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl--~~~p~~RPs~~~ev~~ 686 (780)
|..................+. .+.+ ...+..+.+++.+++ ..+|..||++ .+++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~--~p~~-~~~s~~~~~li~~l~~~~~~r~~r~~~-~ei~~ 292 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLI--FPPE-VPISEKAKDLILRFCCEWEHRIGAPGV-EEIKT 292 (363)
T ss_pred CCCCCHHHHHHHHHcCcCccc--CCCc-CCCCHHHHHHHHHHcCChhhcCCCCCH-HHHhC
Confidence 976554332211111111010 0110 113445666666633 3445567888 66643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.16 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=203.8
Q ss_pred cCCCcccccccCCceEEEEeeecC-----ee-EEEEEccC---CCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LH-VAIKMFPS---YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~-VAiK~l~~---~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~ 491 (780)
++-...++||+|+||.||+|.+.- .. ||||.... .......+|.+|.+++++++|||||+|||++.+ ..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999998841 23 89998875 334567789999999999999999999999844 46
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
+||||+|.||+|.++|. +....++..++++++.+++.||.|||+.+ +|||||-.+|+|++.++.+||+||||++.-
T Consensus 237 ~ivmEl~~gGsL~~~L~--k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLK--KNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 89999999999999995 23336999999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
..... ......-...|+|||.+.++.|+.++|||||||++||+++ |..||............ +....
T Consensus 313 ~~~~~-------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI-----~~~~~ 380 (474)
T KOG0194|consen 313 SQYVM-------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI-----VKNGY 380 (474)
T ss_pred cceee-------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH-----HhcCc
Confidence 31100 0111234567999999999999999999999999999999 88898766543221110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
....|...+..+..+..+||..+|.+||+| .++.+.|+.+...
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm-~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTM-STIKKKLEALEKK 423 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCH-HHHHHHHHHHHhc
Confidence 222344567778899999999999999999 8999999988543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=349.59 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=204.6
Q ss_pred cCCCcccccccCCceEEEEeeec-C-eeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeec-----CC----
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-H-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP-----ES---- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~-----~~---- 490 (780)
.+..+.+.|.+|||+.||.+... + ..||+|++...+........+||++|++|. |||||.+++.+. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45667788999999999999885 3 789999887667777788899999999997 999999999431 11
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+|.||||.||+|-|++..+.... |++.++++|++++|.|+.+||..+|||||||||-+||||+.+|..||||||-+.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 248999999999999997554444 9999999999999999999999999999999999999999999999999998854
Q ss_pred ccCCCCCCCC--cccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccc
Q 044673 571 IPQGESTGNS--ALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS 645 (780)
Q Consensus 571 ~~~~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~ 645 (780)
.......... ..-..-...-|+.|++||.+. +.+++.|+|||+|||+||-|+....||+.... ..
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------la 265 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------LA 265 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------ee
Confidence 3221111000 000111234578899999874 56789999999999999999999999974321 12
Q ss_pred cccCc--CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 646 VLDSS--AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 646 ~ld~~--~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
|++.. .+. ...++..|.+||..||+.||..||++ -+|+..+.+|.
T Consensus 266 Ilng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI-~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 ILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNI-YQVLEEIFELA 312 (738)
T ss_pred EEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCH-HHHHHHHHHHh
Confidence 33322 111 13788999999999999999999999 77888887774
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.72 Aligned_cols=232 Identities=25% Similarity=0.324 Sum_probs=187.6
Q ss_pred cccccCCceEEEEeee-----cCeeEEEEEccCC----CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 429 WKIGEGRYGNVYRGLL-----RHLHVAIKMFPSY----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+.||+|+||.||++.. .+..||||++... .......+.+|+.+|+.++||||++++++|.+. .++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 3567999998642 122345678999999999999999999988554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999985 3456888999999999999999999999 99999999999999999999999999875432111
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......||+.|+|||++.+..++.++|||||||+||+|+||++||...+....... +... ....|..
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~------~~~~-~~~~~~~ 222 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK------ILKG-KLNLPPY 222 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH------HHcC-CCCCCCC
Confidence 12345789999999999988899999999999999999999999976554332111 1111 1123444
Q ss_pred HHHHHHHHHHHchhhCCCCCcc
Q 044673 658 EAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.+..+.+++.+|++.+|.+||+
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCC
Confidence 5677899999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.12 Aligned_cols=242 Identities=28% Similarity=0.452 Sum_probs=193.6
Q ss_pred ccccCCceEEEEeee--cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCChh
Q 044673 430 KIGEGRYGNVYRGLL--RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLE 504 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~ 504 (780)
.||+|+||.||+|.+ .++.||+|.+.... ......|.+|+.++++++||||++++++|.+. .++||||+++|+|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 699999999999987 46789999876532 33456799999999999999999999998554 57999999999999
Q ss_pred hHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccc
Q 044673 505 DCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584 (780)
Q Consensus 505 ~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 584 (780)
+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... ..
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~ 152 (252)
T cd05084 82 TFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-----ST 152 (252)
T ss_pred HHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccccccc-----cc
Confidence 99852 3456899999999999999999999999 999999999999999999999999998754321100 00
Q ss_pred cCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHHHHH
Q 044673 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 585 ~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
.....++..|+|||++.++.++.++|||||||++|+|++ |.+||....... ..+..+ .....|...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG--------VRLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC--------CCCCCcccCCHH
Confidence 111233457999999999999999999999999999998 889986444321 111111 111233345678
Q ss_pred HHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 662 LAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+.+++.+|+..+|.+||++ .++...|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~-~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSF-STVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCH-HHHHHHHh
Confidence 9999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.43 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=200.3
Q ss_pred hcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~ 491 (780)
+++|...+.||+|+||.||+|.+.+ ..||+|.+.... ......|.+|+.++++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 5779999999999999999998853 568999887543 3334569999999999999999999998854 36
Q ss_pred eeEEEeccCCChhhHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---Cccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNK----KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSD 564 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~D 564 (780)
++||||+++|+|.+++..... ...++|..++.|+.+|+.||.|||+.+ ++||||||+|||++.++ .+||+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEecc
Confidence 799999999999999864321 236999999999999999999999999 99999999999998765 589999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccc
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~ 643 (780)
||+++.+...... .......++..|+|||++.++.++.++|||||||++|+|+| |..||...........
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---- 233 (277)
T cd05036 163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---- 233 (277)
T ss_pred CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 9999876321110 11122334567999999999999999999999999999997 9999975443221110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+.......+|...+..+.+++.+|++.+|.+||++ .+|++.|.
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-~~vl~~l~ 276 (277)
T cd05036 234 --VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-ATILERIQ 276 (277)
T ss_pred --HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHhh
Confidence 01111223344556789999999999999999999 88887764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.24 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=202.5
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~~ 500 (780)
++|...++||+|+||.||+|.+.+ ..||+|++.... .....|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 568899999999999999998754 579999987532 234678999999999999999999998754 46799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--- 158 (262)
T cd05071 85 GSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 158 (262)
T ss_pred CcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccccc---
Confidence 9999999532 2346899999999999999999999999 999999999999999999999999999776432211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......++..|++||++.++.++.++|||||||++|+|+| |.+||........ +... ........+...+
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~-----~~~~~~~~~~~~~ 229 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQV-----ERGYRMPCPPECP 229 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHH-----hcCCCCCCccccC
Confidence 1123446778999999998899999999999999999999 8889865433221 1110 0011111233456
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
..+.+++.+|++.+|.+||++ .++...|+..
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~-~~~~~~l~~~ 260 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTF-EYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHHHccCCcccCCCH-HHHHHHHHHh
Confidence 778999999999999999999 8999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=359.74 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=206.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...++||+|+||.||+|... +..||||++.... ......|.+|+.++++++||||++++++|.+. .++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 67999999999999999999874 6789999987532 23356799999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 496 EYLRNGSLEDCLACKN--------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
||++||+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999986321 1235678889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-----------CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 568 FHLIPQGESTG-----------NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 568 a~~~~~~~~~~-----------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
++......... ...........||+.|+|||++.+..++.++|||||||++|+|+||++||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 98762111000 0001112335799999999999999999999999999999999999999975433221
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
... . .+.++.........+..+.+++.+|+..+|.+||+..+++...|+....
T Consensus 240 ~~~-~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYR-D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1 1111111111123456789999999999999998877999999988754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.80 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=188.3
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++... .++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 4679999986521 22334556677777654 799999999998544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++.....|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999885 3456899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........ .......|...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-------~~~~~~~~~~~~~ 221 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-------LNDRPHFPRWISK 221 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCCCCCCCCCH
Confidence 1123457899999999999989999999999999999999999999765543222111 0111223444567
Q ss_pred HHHHHHHHchhhCCCCCcchHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.+.+++.+||..+|.+||++..++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHH
Confidence 789999999999999999984444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=327.41 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||+|...+ ..||+|.+... .......+.+|+.++.++ +||||++++++|.+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4678889999999999999998642 46999998753 233445688999999999 799999999998554
Q ss_pred CeeEEEeccCCChhhHHhhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC
Q 044673 491 RSLVFEYLRNGSLEDCLACK-------------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN 557 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~ 557 (780)
.++||||+++|+|.+++... .....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTED 168 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCC
Confidence 57999999999999998632 23457999999999999999999999999 9999999999999999
Q ss_pred CCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH-
Q 044673 558 FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK- 635 (780)
Q Consensus 558 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~- 635 (780)
+.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred CeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999999876432111 01122345678999999998899999999999999999998 999987544322
Q ss_pred -HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 636 -CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 636 -~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
..+..+ .....|...+..+.+|+.+|+..+|.+||++ .+++..|+.+
T Consensus 244 ~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKEG--------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-KQLVEDLDRM 291 (293)
T ss_pred HHHHHcC--------CcCCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHHHHh
Confidence 111111 1122344556789999999999999999999 8999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.49 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=192.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||.|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 5789999986532 22345678999999999999999999998655 5699999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 89888852 3346889999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hh-c-----------
Q 044673 578 GNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EK-R----------- 641 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~-~----------- 641 (780)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+...... .. +
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1234567899999998865 568999999999999999999999997544322110 00 0
Q ss_pred ---cccccccCcC-C----CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 ---NFNSVLDSSA-G----DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ---~~~~~ld~~~-~----~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+...+.+.. . ......+..+.+|+.+|+..||.+||++ .+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-~~~l 283 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-EAAL 283 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-HHHh
Confidence 0000000000 0 0001234568899999999999999999 6664
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.13 Aligned_cols=259 Identities=22% Similarity=0.392 Sum_probs=198.9
Q ss_pred cCCCcccccccCCceEEEEeeecC----------------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH----------------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~----------------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
++|...++||+|+||.||++...+ ..||+|.+.... ......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987632 248999987643 334457999999999999999999999
Q ss_pred eecC--CCeeEEEeccCCChhhHHhhhC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe
Q 044673 486 TCPE--SRSLVFEYLRNGSLEDCLACKN---------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI 554 (780)
Q Consensus 486 ~~~~--~~~LV~Ey~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL 554 (780)
+|.. ..++||||+++|+|.+++.... ....++|..++.++.+++.||.|||+.+ ++||||||+|||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence 9854 4679999999999999985322 1235789999999999999999999999 9999999999999
Q ss_pred cCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCccch
Q 044673 555 DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRIKK 632 (780)
Q Consensus 555 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt--G~~p~~~~~ 632 (780)
+.++.+||+|||+++.+..... ........++..|+|||++..+.++.++|||||||++|+|+| |..||....
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999876542211 111233455778999999998999999999999999999998 567876543
Q ss_pred hHHHHHHhccc-cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 633 DVKCALEKRNF-NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 633 ~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
..........+ ...........+...+..+.+|+.+|+..+|.+||++ ++|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF-NKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHh
Confidence 32211110100 0000000111122345689999999999999999999 89988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.69 Aligned_cols=244 Identities=29% Similarity=0.439 Sum_probs=199.8
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec-C--CCeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP-E--SRSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~-~--~~~LV~Ey~~ 499 (780)
.+|...+.||+|+||.||+|...+..||+|.+.... ....|.+|+.++++++|||++++++++. + ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 478888999999999999999999999999986532 3457899999999999999999999763 2 3579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 99999998632 2345899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 656 (780)
....++..|+|||++.+..++.++|||||||++|+|+| |++||....... ..+..+. ....+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CCCCCC
Confidence 22334567999999998899999999999999999998 999986543221 1222111 112233
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+..+.+++.+|+..+|.+||++ .++.+.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSF-LQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHhc
Confidence 456779999999999999999999 899888874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.60 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=202.1
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
++|.....||+|+||.||+|...+ ..||+|.+.... ......|.+|+.++..++||||+++++++.+. .+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578889999999999999998753 569999987543 34456789999999999999999999998554 67
Q ss_pred eEEEeccCCChhhHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 493 LVFEYLRNGSLEDCLACKN-------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
+||||+++|+|.+++.... ....++|..++.|+.|++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEECCc
Confidence 9999999999999996432 1235889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcccc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFN 644 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~ 644 (780)
|+++.+...... .......++..|+|||++.++.++.++|||||||++|+|+| |.+||...+..... ...
T Consensus 164 g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~--- 234 (277)
T cd05032 164 GMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KFV--- 234 (277)
T ss_pred ccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-HHH---
Confidence 998765432111 11233456788999999998899999999999999999998 99998654432211 100
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 645 SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 645 ~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+......|...+..+.+++.+|++.+|.+||++ .+++..|+
T Consensus 235 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~ 276 (277)
T cd05032 235 --IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-LEIVSSLK 276 (277)
T ss_pred --hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHhc
Confidence 1111122233446789999999999999999999 88888775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=351.81 Aligned_cols=257 Identities=20% Similarity=0.258 Sum_probs=205.0
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES- 490 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~- 490 (780)
.++....++|...+.||+|+||.||+|.. .+..||||++... .......+.+|+.++..++|+||++++..+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 44445568999999999999999999987 4688999998653 334456788999999999999999998766211
Q ss_pred ---------CeeEEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 491 ---------RSLVFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 491 ---------~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
.++||||+++|+|.++|... ....++++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.+
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCE
Confidence 35899999999999998643 23457999999999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~ 640 (780)
||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||+|+||+.||...+..... ..
T Consensus 183 kL~DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~-~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-HK 256 (496)
T ss_pred EEEecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HH
Confidence 99999999876432111 1123467999999999999999999999999999999999999999765432211 11
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
++.......|...+..+.+++.+||..+|.+||++ .+++.
T Consensus 257 -----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~-~ell~ 296 (496)
T PTZ00283 257 -----TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS-SKLLN 296 (496)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-HHHHh
Confidence 11111112334456779999999999999999999 66654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.59 Aligned_cols=239 Identities=21% Similarity=0.276 Sum_probs=192.0
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCC-ceeeEeeeecC--CCeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHP-NLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~Hp-nIv~l~g~~~~--~~~LV~ 495 (780)
+|...+.||+|+||.||+|... +..||||++... .......+..|+.++..+.|+ +|+.+++++.+ ..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999886 457999998652 223445688899999999765 57888888754 467999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999885 3456899999999999999999999999 9999999999999999999999999986432111
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+........ . .....+|
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~-~~~~~~~ 221 (324)
T cd05587 156 K-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------M-EHNVSYP 221 (324)
T ss_pred C-------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-cCCCCCC
Confidence 0 123456899999999999999999999999999999999999999765543221111 0 1112334
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
...+..+.+++.+|+..+|.+||+..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 44567789999999999999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.21 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=197.9
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
.+|...+.||+|+||.||+|.+.+ ..+|+|++.... .....|.+|+.++++++||||+++++++.+. .++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788899999999999998754 479999886432 2345788999999999999999999998554 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+++|.+++.. ....+++..++.|+.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 83 NGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 9999999853 2347899999999999999999999999 99999999999999999999999999876542211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
.......++..|+|||++.+..++.++||||||+++|+|+| |++||............. ... ....|...
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~---~~~~~~~~ 226 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---AGY---RLYRPKLA 226 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH---cCC---cCCCCCCC
Confidence 01112234567999999999999999999999999999999 899997554432221110 001 11223345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
+..+.+++.+|+..+|.+||++ .+++..|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~-~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAF-KKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCH-HHHHHHh
Confidence 6789999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=327.58 Aligned_cols=243 Identities=19% Similarity=0.275 Sum_probs=194.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
+|...++||+|+||.||++... +..||||.+.... ......+.+|+.++++++||||++++++|.+ ..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999874 6789999986532 1223457889999999999999999999854 3689999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988532 3356999999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... .+...+.......+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (285)
T cd05605 158 --------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQEEYSE 226 (285)
T ss_pred --------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcccccCc
Confidence 123468899999999998899999999999999999999999997543311100 000111112223344
Q ss_pred HHHHHHHHHHHHchhhCCCCCcch
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+..+.+|+.+|+..||.+||+.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCC
Confidence 567789999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.28 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=197.4
Q ss_pred cccccCCceEEEEeeec--C---eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR--H---LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~---~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~g 501 (780)
++||+|+||.||+|.+. + ..||+|.+..... .....|.+|+.+++.+.|||||++++++... .++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999763 2 5699999876443 3456789999999999999999999998544 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ....+++..+..++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 81 PLLKYLK---KRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred cHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 9999995 3347899999999999999999999999 999999999999999999999999999876432211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
........++..|+|||.+.++.++.++|||||||++|+|+| |.+||...+... ..+..+. ....|...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 223 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--------RLPRPEEC 223 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------cCCCCCCC
Confidence 111122334567999999998999999999999999999998 999997554322 1121111 11223345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+..+.+++.+|+..+|.+||++ .++...|+.+
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTF-SELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCH-HHHHHHHHhc
Confidence 5678999999999999999999 8999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.55 Aligned_cols=231 Identities=21% Similarity=0.261 Sum_probs=186.3
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+.||+|+||.||++... +..||+|++... .......+..|+.++..++||||++++++|.+. .++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 678999998652 223345678899999999999999999988554 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
+|.+++. ....+++..+..|+.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 9999885 34579999999999999999999997 68 99999999999999999999999999875422111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......||+.|+|||++.++.++.++|||||||+||+|+||+.||...+..... ... .......|...+.
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i------~~~~~~~p~~~~~ 221 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELI------LMEEIRFPRTLSP 221 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHH------hcCCCCCCCCCCH
Confidence 113356899999999999999999999999999999999999999755432211 110 0111123344567
Q ss_pred HHHHHHHHchhhCCCCCc
Q 044673 661 QLAHLALRCCENNRLNRP 678 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RP 678 (780)
.+.+|+.+||+.||.+||
T Consensus 222 ~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred HHHHHHHHHhhcCHHHhC
Confidence 789999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.54 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=199.2
Q ss_pred CCcccccccCCceEEEEeee------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCee
Q 044673 425 FEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSL 493 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~L 493 (780)
|...+.||+|+||.||++.. .+..||+|.+.... ......|.+|+.+|++++||||++++++|.. ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 24679999987543 2345678899999999999999999998843 2479
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ..+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999852 35999999999999999999999999 99999999999999999999999999887643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-HHHHHHh-------ccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-VKCALEK-------RNFNS 645 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-~~~~~~~-------~~~~~ 645 (780)
.... ........++..|++||++..+.++.++||||||+++|+|+||..|+..... ....+.. ..+..
T Consensus 160 ~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 160 GHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 2111 0111223456679999999988899999999999999999999999864322 1111100 00111
Q ss_pred cccCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 646 VLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 646 ~ld~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.++.. ....|...+..+.+++.+|++.+|.+||++ ++++..|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF-RSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH-HHHHHHHHHhh
Confidence 11111 111233456789999999999999999999 89999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.23 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=199.9
Q ss_pred cCCCcccccccCCceEEEEeeecC----eeEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV 494 (780)
++|.....||+|+||.||+|.... ..+++|.+... .......|.+|+.++.++ +||||++++++|.+. .++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998743 24788888753 233456789999999999 799999999998654 5799
Q ss_pred EEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 495 FEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeEE
Confidence 99999999999995321 1235899999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHh
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEK 640 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~ 640 (780)
|+|||++...... ........+..|+|||++.+..++.++|||||||++|+|+| |.+||....... ....
T Consensus 160 l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~~ 230 (297)
T cd05089 160 IADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEK 230 (297)
T ss_pred ECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH
Confidence 9999997643211 01111233457999999998889999999999999999998 999996544322 1111
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
+........|...+..+.+|+.+|+..+|.+||++ .+++..|+.+..
T Consensus 231 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~~~ 277 (297)
T cd05089 231 -----LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF-AQISVQLSRMLE 277 (297)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 11111112233455678999999999999999999 899999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.18 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=202.0
Q ss_pred hcCCCcccccccCCceEEEEeeecC------------------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH------------------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVT 482 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~------------------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~ 482 (780)
.++|.....||+|+||.||+|.... ..||+|.+.... ......|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3678999999999999999987642 348999987643 334567899999999999999999
Q ss_pred EeeeecCC--CeeEEEeccCCChhhHHhhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCce
Q 044673 483 LIGTCPES--RSLVFEYLRNGSLEDCLACKN--------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKV 552 (780)
Q Consensus 483 l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NI 552 (780)
++++|.+. .++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence 99998653 679999999999999986422 1236899999999999999999999999 99999999999
Q ss_pred EecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCcc
Q 044673 553 LIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRI 630 (780)
Q Consensus 553 LLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt--G~~p~~~ 630 (780)
|++.++.++|+|||+++.+...... .......++..|+|||++.++.++.++|||||||++|+|++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eecCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998765422111 11234456778999999998899999999999999999998 6778865
Q ss_pred chhHHHHHHhccc-cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 631 KKDVKCALEKRNF-NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 631 ~~~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
............. ...-.......+...+..+.+++.+|++.+|.+||++ .+|++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-~el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF-REIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH-HHHHHHhc
Confidence 4432211111111 0000011112233455789999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.08 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=201.3
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
.+|...++||+|+||.||++... +..||+|.+..........|.+|+.+++.++||||+++++++.+. .++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999998642 357999998876666677899999999999999999999998654 579
Q ss_pred EEEeccCCChhhHHhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 494 VFEYLRNGSLEDCLACKNK------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCEE
Confidence 9999999999999863221 135899999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHh
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEK 640 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~ 640 (780)
|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|+|+| |.+||............
T Consensus 163 L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 163 IGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred ECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 999999876542211 011123345678999999999999999999999999999998 99998654332211111
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
........|...+..+.+++.+||..+|.+||++ .+|...|+
T Consensus 238 ------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~l~~~l~ 279 (280)
T cd05092 238 ------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI-KDIHSRLQ 279 (280)
T ss_pred ------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHh
Confidence 1111111223355678999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.79 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=202.9
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~ 500 (780)
++|.....||.|+||.||+|...+..||||.+..... ...+|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 5788899999999999999999999999999976543 56779999999999999999999999854 46799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----- 156 (256)
T cd05039 85 GSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----- 156 (256)
T ss_pred CcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc-----
Confidence 9999998532 2236999999999999999999999999 9999999999999999999999999987663211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCCCCCHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~ 657 (780)
....++..|+|||++.++.++.++||||||+++|+|++ |..||........ .+..+ .....|..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 223 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------YRMEAPEG 223 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC--------CCCCCccC
Confidence 12234567999999998899999999999999999997 9999875543221 11111 01122334
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.+..+.+++.+|+..+|.+||++ .+++..|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTF-KQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCH-HHHHHHHhc
Confidence 56779999999999999999999 899988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.45 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=194.1
Q ss_pred cccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeec--C-CCeeEEEecc
Q 044673 429 WKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--E-SRSLVFEYLR 499 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~-~~~LV~Ey~~ 499 (780)
+.||+|+||.||+|.+. ...||||.+.... ......|.+|+.+++.++||||++++++|. + ..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999863 2569999986432 334567889999999999999999999873 2 2579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++.. ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-- 154 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-- 154 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce--
Confidence 9999999853 2345788889999999999999999999 999999999999999999999999998765422110
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
.........++..|+|||++.+..++.++|||||||++|||+| |.+||...+....... +........+...
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 227 (262)
T cd05058 155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY------LLQGRRLLQPEYC 227 (262)
T ss_pred -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HhcCCCCCCCCcC
Confidence 0111123456778999999998899999999999999999999 5677764433221110 1111111222334
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+.+++.+||..+|.+||++ .+++..|+.+.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~-~~il~~l~~~~ 260 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTF-SELVSRIEQIF 260 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHh
Confidence 5679999999999999999999 89999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.25 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=199.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--Ce--eEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HL--HVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~--~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|.....||+|+||.||+|.+. +. .+|+|.+... .......|.+|+.++.++ +||||++++++|.+. .++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 367888999999999999999874 33 4688877653 234456788999999999 899999999998654 579
Q ss_pred EEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 494 VFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcE
Confidence 999999999999996432 1246899999999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALE 639 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~ 639 (780)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|+|+| |.+||...+..... .
T Consensus 164 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-E 234 (303)
T ss_pred EeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-H
Confidence 99999998643211 01122234667999999988889999999999999999998 99999644432211 1
Q ss_pred hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 640 KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 640 ~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
. +........|...+..+.+|+.+|+..+|..||++ .+++..|+.+.
T Consensus 235 ~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il~~l~~~~ 281 (303)
T cd05088 235 K-----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRML 281 (303)
T ss_pred H-----HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 1 01111111223345678999999999999999999 88988888774
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.32 Aligned_cols=236 Identities=21% Similarity=0.258 Sum_probs=187.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHh---hcCCCCceeeEeeeecCC--CeeE
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVL---SRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il---~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.++ +.++||||+++++++.+. .++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999875 5789999986421 22234566666554 567899999999998544 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999998874 356999999999999999999999999 999999999999999999999999998653211
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. .......||+.|+|||++.+..++.++|||||||++|+|+||++||...+....... +.. .....
T Consensus 155 ~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~~-~~~~~ 220 (324)
T cd05589 155 G-------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVN-DEVRY 220 (324)
T ss_pred C-------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCCCC
Confidence 1 112345789999999999999999999999999999999999999976543221111 000 11123
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
|...+..+.+++.+||..+|.+||+.
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 44456778999999999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.76 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=202.4
Q ss_pred HhcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-- 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-- 490 (780)
..++|...++||+|+||.||+|..+ +..||+|.+.... ......|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999999753 2479999886543 23345688999999999999999999998543
Q ss_pred CeeEEEeccCCChhhHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKN-------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
.++||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEEC
Confidence 689999999999999996422 1345678899999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~ 642 (780)
|||+++.+...... .......++..|+|||++.++.++.++|||||||++|||++ |.+||....... ...
T Consensus 162 Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~--- 232 (288)
T cd05061 162 DFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLK--- 232 (288)
T ss_pred cCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---
Confidence 99998865432111 11122345678999999999999999999999999999999 788986544322 111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+.+......+...+..+.+++.+|++.+|.+||++ .++++.|+..
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~~ 278 (288)
T cd05061 233 --FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF-LEIVNLLKDD 278 (288)
T ss_pred --HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhh
Confidence 111111112233445789999999999999999999 8888888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.68 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=198.6
Q ss_pred cccccCCceEEEEeeecC-----eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~g 501 (780)
+.||+|+||.||+|.+.. ..||||.+..... .....|.+|+.++++++||||+++++++.+. .++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998742 3699999987655 5567899999999999999999999988663 46899999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++..... ..++|...+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 99999964322 57899999999999999999999999 999999999999999999999999999877532211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
........++..|+|||++.+..++.++|||||||++|+|+| |.+||...+.......... .......|...+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 228 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-----EGERLERPEACPQ 228 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----cCCcCCCCccCCH
Confidence 111223567788999999999899999999999999999999 9999965443321111111 1111112334567
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+.+++.+|+..+|.+||++ .+++..|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~-~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTF-AALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCH-HHHHHHhc
Confidence 79999999999999999999 88887764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=333.10 Aligned_cols=238 Identities=19% Similarity=0.264 Sum_probs=192.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~ 495 (780)
+|.....||+|+||.||+|... +..||||++.... ......+..|..++..+ +||+|+++++++.+. .++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999885 4679999987532 22334567788888877 589999999988554 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999885 3456899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. ......||+.|+|||++.++.++.++|||||||++|+|+||++||...+....... +.. ....+|
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~------i~~-~~~~~p 221 (323)
T cd05616 156 V-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IME-HNVAYP 221 (323)
T ss_pred C-------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCCCCC
Confidence 1 12345789999999999999999999999999999999999999976554322111 111 112344
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcch
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+..+.+++.+|++.+|.+|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 5567789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.93 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=205.5
Q ss_pred hcCCCcccccccCCceEEEEeeecC------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC---CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~ 491 (780)
.++|.....||+|+||.||+|.+.. ..|++|++.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998753 679999887542 3345668899999999999999999998743 46
Q ss_pred eeEEEeccCCChhhHHhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKK-----SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
+++++|+++|+|.+++...... ..+++..++.|+.+++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCCC
Confidence 7999999999999998643222 56999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNF 643 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~ 643 (780)
+++.+...... .......++..|+|||++....++.++|||||||++|+++| |++||...+..... +..+
T Consensus 163 ~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 235 (280)
T cd05043 163 LSRDLFPMDYH-----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235 (280)
T ss_pred CcccccCCceE-----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence 99865432111 11123356778999999998889999999999999999999 99999755433211 1111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.....+...+..+.+++.+|+..+|..||++ .+++..|+.+.
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~~~~~l~~~~ 277 (280)
T cd05043 236 ------YRLAQPINCPDELFAVMACCWALDPEERPSF-SQLVQCLTDFH 277 (280)
T ss_pred ------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHH
Confidence 1111233345678999999999999999999 99999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.72 Aligned_cols=236 Identities=19% Similarity=0.278 Sum_probs=188.8
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||+|+||.||++... +..||+|.+.... ......|..|+.++++++||||+++++++.+. .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999874 5789999986432 12335678899999999999999999988554 6799999999999
Q ss_pred hhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcc
Q 044673 504 EDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582 (780)
Q Consensus 504 ~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~ 582 (780)
.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~------ 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------ 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc------
Confidence 9887532 24457999999999999999999999999 99999999999999999999999999876543211
Q ss_pred cccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCcCCCCCHHHHH
Q 044673 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 583 ~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......||+.|+|||++.++.++.++|||||||++|+|+||+.||....... ..+.. .++.. ...+|...+.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RILND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hhccc-CCCCcccCCH
Confidence 1234578999999999999999999999999999999999999997543211 11111 11111 1233445677
Q ss_pred HHHHHHHHchhhCCCCCcch
Q 044673 661 QLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.+++.+|++.+|.+||++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCC
Confidence 89999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=333.16 Aligned_cols=233 Identities=24% Similarity=0.308 Sum_probs=189.4
Q ss_pred cccccCCceEEEEeee-----cCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 429 WKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
+.||+|+||.||++.. .+..||+|++.... ......+.+|+.+|++++||||++++++|.+. .++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 35789999987532 22345677899999999999999999998554 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence 999999985 3456999999999999999999999999 99999999999999999999999999876532211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+....... +.. .....|...+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~~-~~~~~p~~~~ 222 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------ILK-AKLGMPQFLS 222 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HHc-CCCCCCCCCC
Confidence 12345789999999999988899999999999999999999999976554322211 000 1112344456
Q ss_pred HHHHHHHHHchhhCCCCCcch
Q 044673 660 EQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+.+|+.+||+.||.+||++
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a 243 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGA 243 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCC
Confidence 778999999999999999996
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.08 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=201.3
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV 494 (780)
++|...+.||+|+||.||+|.+. +..||+|.+.... ......|..|+.++.+++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888899999999999999863 2369999986533 2345678999999999999999999999854 36799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++.+++.|+.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999953 3356899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... ........++..|++||++.++.++.++|||||||++|++++ |..||....... ..+..+ ..
T Consensus 160 ~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------~~ 227 (267)
T cd05066 160 PEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--------YR 227 (267)
T ss_pred cce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC--------Cc
Confidence 111 111122334567999999998899999999999999999887 999986543221 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+...+..+.+++.+|++.+|.+||++ .+++..|+.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKF-EQIVSILDKL 266 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCH-HHHHHHHHhh
Confidence 12233455678999999999999999999 8999988864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.63 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=202.3
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~~ 500 (780)
++|...++||+|+||.||+|... +..||+|.+.... .....|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 57888999999999999999874 5789999987543 345678999999999999999999998854 46899999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....+++..+..|+.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---- 157 (260)
T cd05067 85 GSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---- 157 (260)
T ss_pred CCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCCc----
Confidence 9999998533 3457899999999999999999999999 99999999999999999999999999876642211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCCCCCHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.......++..|+|||++.++.++.++||||||+++|+|+| |++||...+.... .+..+. ....+..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05067 158 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY--------RMPRPDN 227 (260)
T ss_pred --ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--------CCCCCCC
Confidence 11123345678999999999999999999999999999999 9999975443221 111110 0111223
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.+..+.+++.+|+..+|.+||++ +++...|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~~ 259 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTF-EYLRSVLED 259 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCH-HHHHHHhhc
Confidence 45679999999999999999999 899888874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.49 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=204.2
Q ss_pred cCCCcccccccCCceEEEEeeecC-----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~ 495 (780)
++|...+.||+|+||.||+|.+.. ..||||...... ......|.+|+.+++++.||||++++++|.+. .++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 467888999999999999998743 369999887654 34556799999999999999999999998654 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 86 ELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999953 2346899999999999999999999999 9999999999999999999999999987664321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. ...+...++..|+|||++....++.++|||||||++|+|++ |.+||................ ....
T Consensus 162 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------~~~~ 229 (270)
T cd05056 162 Y------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------RLPM 229 (270)
T ss_pred c------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------cCCC
Confidence 1 11223345567999999988889999999999999999996 999997554432221111100 1112
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
|...+..+.+++.+|+..+|.+||++ .+++..|+.++
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~~~~l~~~~ 266 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRF-TELKAQLSDIL 266 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 33456689999999999999999999 89999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.27 Aligned_cols=264 Identities=26% Similarity=0.446 Sum_probs=218.3
Q ss_pred ccCHHHHHHHhcCC---------CcccccccCCceEEEEeeec--C---eeEEEEEccCCC-chhHHHHHHHHHHhhcCC
Q 044673 412 EFSFSELNEATNNF---------EPSWKIGEGRYGNVYRGLLR--H---LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR 476 (780)
Q Consensus 412 ~~~~~ei~~at~~f---------~~~~~IG~G~~G~Vyk~~~~--~---~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~ 476 (780)
.++++|=.+|...| .+.+.||.|-||.||+|.++ + ..||||.|+... ...+..|+.|..||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 56777766666544 35578999999999999985 2 569999998744 445678999999999999
Q ss_pred CCceeeEeeeecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe
Q 044673 477 HPNLVTLIGTCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI 554 (780)
Q Consensus 477 HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL 554 (780)
||||++|.|+.... ..+|.|||+||+|+.+|. .+.+.+++.+...++++|+.|+.||-+.+ +|||||-..|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR--~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLR--QNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHh--hcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee
Confidence 99999999998554 468999999999999995 44567999999999999999999999999 9999999999999
Q ss_pred cCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccch-
Q 044673 555 DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKK- 632 (780)
Q Consensus 555 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~- 632 (780)
+.|..+|++||||+|.+.++... .+.+....-...|.|||.+...++|.+||||||||||||.++ |..|+-...
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ccceEEEeccccceeecccCCCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 99999999999999988654322 111222233467999999999999999999999999999987 888875333
Q ss_pred -hHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 633 -DVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 633 -~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+|..+++.| ....-|++++..|.+|++.||+.|+..||.+ .+|+..|+.|.
T Consensus 841 QdVIkaIe~g--------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F-~qiV~~lDklI 892 (996)
T KOG0196|consen 841 QDVIKAIEQG--------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKF-AQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHhc--------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCH-HHHHHHHHHHh
Confidence 343444333 3344577889999999999999999999999 99999999984
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.97 Aligned_cols=256 Identities=22% Similarity=0.350 Sum_probs=204.2
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
++|...+.||+|+||.||+|.. .+..||||.+... .......|.+|+.+++.++||||+++++++.+ ..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 4688999987542 23334568899999999999999999998854 467999
Q ss_pred EeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||+++|+|.+++... .....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999999988532 23456899999999999999999999999 999999999999999999999999998876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-HHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-VKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-~~~~~~~~~~~~~ld~~~~~ 653 (780)
.. ......|++.|+|||++.+..++.++|+||||+++|+|+||+.||..... ....... +.....+ ..
T Consensus 160 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~--~~ 228 (267)
T cd08228 160 TT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--IEQCDYP--PL 228 (267)
T ss_pred hH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--HhcCCCC--CC
Confidence 11 11234688899999999988899999999999999999999999854321 1111111 1110111 11
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+...+..+.+++.+||..+|.+||++ .+|++.|+.++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDI-GYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCH-HHHHHHHHHhc
Confidence 122455779999999999999999999 99999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.25 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=190.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...++||+|+||.||++... +..||+|++... .......|..|+.++..++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999886 467999998642 122234588999999999999999999998554 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999963 2356899999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
. .......||+.|+|||++. .+.++.++|||||||+||+|++|++||...+............. ...
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~ 228 (332)
T cd05623 157 T------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQ 228 (332)
T ss_pred c------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--ccc
Confidence 1 1123457999999999986 34688999999999999999999999976554332211100000 000
Q ss_pred CCCCCHHHHHHHHHHHHHchhhC--CCCCcchHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENN--RLNRPDLVSEIW 685 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~--p~~RPs~~~ev~ 685 (780)
....+...+..+.+|+.+|+..+ +..||++ .+++
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~-~~~~ 264 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGI-EDFK 264 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCH-HHHh
Confidence 11111234567888888887553 3446777 5554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.01 Aligned_cols=233 Identities=22% Similarity=0.279 Sum_probs=188.1
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++... .......+..|..++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 568999998752 223345677899999888 699999999988544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 99999885 3457999999999999999999999999 99999999999999999999999999865321111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........ . ......|...+.
T Consensus 152 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i------~-~~~~~~~~~~~~ 221 (318)
T cd05570 152 ---TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI------L-EDEVRYPRWLSK 221 (318)
T ss_pred ---cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH------H-cCCCCCCCcCCH
Confidence 112346899999999999999999999999999999999999999765543221110 0 011123334567
Q ss_pred HHHHHHHHchhhCCCCCcch
Q 044673 661 QLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.+|+.+||..+|.+||++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 78999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.86 Aligned_cols=247 Identities=20% Similarity=0.290 Sum_probs=189.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.|...++||+|+||.||+|... +..||||++.... ......+.+|+.++++++|||||+++++|.+. .+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999874 5679999986522 22345688999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999985 3356889999999999999999999999 99999999999999999999999999854321000
Q ss_pred CC----------------------------------------CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHH
Q 044673 577 TG----------------------------------------NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGI 616 (780)
Q Consensus 577 ~~----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gv 616 (780)
.. ...........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 617 ILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 617 il~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
+||||+||++||...+..............+. .+ .....+..+.+++.+++ .+|.+|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p-~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLH--IP-PQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--CC-CcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999987655443322221111110 11 11233556777777765 48999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.43 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=196.5
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|...+.||+|+||.||+|.. .+..||+|++..........+.+|+.++++++||||++++++|.+. .++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5799999999999999999987 3678999998765444556788999999999999999999998544 57899999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 89 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 9999999885 3457899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
......|+..|+|||++. .+.++.++|||||||++|+|+||++||............. ...+.+.....+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCCCCCCCCccc
Confidence 113346888999999884 4457889999999999999999999986443322111000 000111111112
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+++.+||..+|.+||++ ++++.
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~-~~il~ 264 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTA-ERLLT 264 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCH-HHHhc
Confidence 2345678999999999999999999 77764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.31 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCceEEEEeeecC---------eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH---------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~ 490 (780)
.++|...+.||+|+||.||++...+ ..||+|.+.... ......+.+|+.++.++ +||||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3678999999999999999997532 459999987542 34456788999999999 799999999998554
Q ss_pred --CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ...++|.+++.|+.|++.||.|||+.+ ++||||||+|||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~ 174 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT 174 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc
Confidence 5799999999999999964321 235899999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred CCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999998765421110 01122234567999999998899999999999999999998 88898654432
Q ss_pred H--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 635 K--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 635 ~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. ..+..+. ....|...+..+.+++.+|+..+|.+||++ .+|+..|+++..
T Consensus 250 ~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHHH
Confidence 1 1111111 112334456789999999999999999999 999999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.97 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=194.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||+|+||.||++.+. +..||+|.+... .......|.+|+.++++++|||||+++++|.+. .++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 68999999999999999999885 567999988653 233456789999999999999999999998554 6799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++|+|.+++. ....+++.....++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 85 MDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred CCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999985 345689999999999999999999974 6 9999999999999999999999999987653211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHH---hccccc------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALE---KRNFNS------ 645 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~---~~~~~~------ 645 (780)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||........ .+. .+....
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1234688999999999988899999999999999999999999874432111 100 000000
Q ss_pred ---------------------------cccCcCCCCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 ---------------------------VLDSSAGDWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ---------------------------~ld~~~~~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+........+. ..+.++.+|+.+||+.||.+||++ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~-~ell 297 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL-KQLM 297 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH-HHHh
Confidence 00000000110 134578999999999999999999 6664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.26 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=189.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||||++... .......|.+|+.++..++||||++++++|.+. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999875 578999998642 222345688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999999953 2456899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
. .......||+.|+|||++.. +.++.++|||||||++|+|++|+.||...+................
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 228 (331)
T cd05597 157 T------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-- 228 (331)
T ss_pred C------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc--
Confidence 1 11123468999999999863 4578899999999999999999999976543322111100011111
Q ss_pred CCCCCHHHHHHHHHHHHHchhh--CCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCEN--NRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~--~p~~RPs~~~ev~~ 686 (780)
........+..+.+++.+|+.. +|..||++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~-~~~l~ 265 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGL-QDFKD 265 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCH-HHHhc
Confidence 0011112455677788876654 44447777 55543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.19 Aligned_cols=235 Identities=22% Similarity=0.261 Sum_probs=186.9
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||++... +..||||++... .......+..|..++.++ +||||++++++|.+. .++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999885 568999998752 223345688999999998 699999999998654 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ...++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----- 150 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----- 150 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC-----
Confidence 99999885 3457999999999999999999999999 9999999999999999999999999986432111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-------HHHHHhccccccccCcCCC
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-------KCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-------~~~~~~~~~~~~ld~~~~~ 653 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+. ..+.. ....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~-~~~~ 223 (329)
T cd05588 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF----QVILE-KQIR 223 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH----HHHHc-CCCC
Confidence 1123457899999999999999999999999999999999999999632110 00000 00111 1112
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.|...+..+.+++.+||..||.+||+.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 333456678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.82 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=200.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||+|... +..|++|.+... .......|.+|+.++++++||||++++++|.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778889999999999999874 678999987642 344566799999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998643 3467999999999999999999999999 99999999999999999999999999886643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......|+..|+|||++.++.++.++|+|||||++++|+||+.||...+....... +........+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK------IIRGVFPPVSQM 224 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCCCCccc
Confidence 11234678899999999999999999999999999999999999976653221111 011111122224
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+++.+|++.+|.+||++ .++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~-~~ll~ 252 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDT-FQLLR 252 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCH-HHHhh
Confidence 56779999999999999999999 66643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=315.86 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~ 500 (780)
++|....+||+|+||.||+|.+.+ ..||+|.+.... .....|.+|+.++++++|||++++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 467888899999999999998764 479999886532 3346788999999999999999999988544 6799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....++|..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~--- 158 (260)
T cd05069 85 GSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT--- 158 (260)
T ss_pred CCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCccc---
Confidence 9999999632 2345899999999999999999999999 999999999999999999999999999776432111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......++..|++||++.++.++.++|||||||++|+|+| |.+||........... +........+...+
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~ 229 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ------VERGYRMPCPQGCP 229 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCcccC
Confidence 1122345678999999998899999999999999999999 8999975443221111 00111112233456
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..+.+++.+||..+|.+||++ .+|.+.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 259 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTF-EYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 779999999999999999999 889888874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=340.51 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=191.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...++||+|+||.||++... +..||||++... .......+.+|+.++.+++|||||+++++|.+. .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999874 678999988642 122345688999999999999999999999654 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999985 3456899999999999999999999999 9999999999999999999999999996432110
Q ss_pred CCC--------CCc--------------------------------ccccCCCCCCcccCChhhhccCCCCcchhHHHHH
Q 044673 576 STG--------NSA--------------------------------LCNESNNDSASVYIDPEYLETGKLTPESDVYSFG 615 (780)
Q Consensus 576 ~~~--------~~~--------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~G 615 (780)
... ... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0001124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCC---cchHHHHH
Q 044673 616 IILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNR---PDLVSEIW 685 (780)
Q Consensus 616 vil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~R---Ps~~~ev~ 685 (780)
|+||||+||++||...+..............+. .+. ....+..+.+|+.+|+. +|.+| |++ .+++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~-~~~l 303 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLY--FPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGA-HEIK 303 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--CCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCH-HHHh
Confidence 999999999999976554322211111111010 011 11245678899999997 66665 577 5543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.53 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=188.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||+|+||.||+|.+. +..||||++.... ......|.+|+.+++.++||||++++++|.+. .++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566788999999999999875 6789999986532 23346789999999999999999999999654 5789999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999986533 3567788899999999999999999 99999999999999999999999999987642211
Q ss_pred CCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHHHHhccccccccCc
Q 044673 578 GNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCALEKRNFNSVLDSS 650 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~~~~~~~~~~ld~~ 650 (780)
......||..|+|||++.. ...+.++|||||||++|+|++|+.||..... .......... ..
T Consensus 224 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----~~ 292 (353)
T PLN00034 224 ------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----SQ 292 (353)
T ss_pred ------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----cC
Confidence 1234578999999998743 2345689999999999999999999973221 1111111100 11
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSA-MQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 112233456779999999999999999999 66654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=332.17 Aligned_cols=232 Identities=22% Similarity=0.297 Sum_probs=186.8
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++... .......+..|..++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999885 468999998652 223445677899999876 799999999998554 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 99999885 3456899999999999999999999999 99999999999999999999999999875422111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...+........ .. .....|...+.
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i------~~-~~~~~p~~~~~ 221 (321)
T cd05591 152 ---TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI------LH-DDVLYPVWLSK 221 (321)
T ss_pred ---cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CCCCCCCCCCH
Confidence 123456899999999999989999999999999999999999999866543221110 00 01112333456
Q ss_pred HHHHHHHHchhhCCCCCcc
Q 044673 661 QLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs 679 (780)
.+.+++.+|+..+|.+||+
T Consensus 222 ~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred HHHHHHHHHhccCHHHcCC
Confidence 7899999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=305.34 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=209.0
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec-------CCCe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP-------ESRS 492 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~-------~~~~ 492 (780)
-++|.+.+.||+|||+-||.+.. .+..+|+|++...+.++.....+|++..++++|||+++++.++- ...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 36899999999999999999874 35679999988776777888999999999999999999999872 1257
Q ss_pred eEEEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
|++.|...|+|.|.+...+ ++..+++.+.+.|+.+||+||.+||...||+.||||||+|||+.+.+.++|.|||.++..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999999996544 445799999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCCC--CCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc
Q 044673 572 PQGEST--GNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646 (780)
Q Consensus 572 ~~~~~~--~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ 646 (780)
+..-.. .............|..|.|||.+. +...+.++|||||||+||.|+.|..||...-. ..|.+.-.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSlaLA 254 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSLALA 254 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeEEEe
Confidence 432111 111111122345677899999986 34578899999999999999999999963211 11222222
Q ss_pred ccCcCCCCCH--HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 647 LDSSAGDWPV--AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 647 ld~~~~~~p~--~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+......||. ..++.+..|+.+|++.||..||++ .+++..++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-~~ll~~~d~L 300 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-PELLSKLDDL 300 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-HHHHHHHHhh
Confidence 2221122221 267889999999999999999999 8998888765
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.01 Aligned_cols=237 Identities=23% Similarity=0.316 Sum_probs=187.9
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999885 4679999986531 22344567788888764 899999999998554 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 99999885 3456899999999999999999999999 99999999999999999999999999875321111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+... .+..... .....|...+.
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~i~~------~~~~~~~~~~~ 221 (316)
T cd05619 152 ---KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQSIRM------DNPCYPRWLTR 221 (316)
T ss_pred ---ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------CCCCCCccCCH
Confidence 1234568999999999999899999999999999999999999997654322 1111111 11122333556
Q ss_pred HHHHHHHHchhhCCCCCcchHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.+.+++.+|+..+|.+||++..++
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHH
Confidence 789999999999999999994344
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=335.81 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=189.5
Q ss_pred CCCcccccccCCceEEEEeee-----cCeeEEEEEccCC----CchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--C
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSY----GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--R 491 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~----~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~ 491 (780)
+|...+.||+|+||.||++.. .+..||+|++... .......+..|+.++.+++ ||||+++++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 578889999999999999875 3577999998642 1223456789999999995 99999999988654 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++. ....+++.....|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 79999999999999985 3456899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhcccccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSVLD 648 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ld 648 (780)
...... ......||+.|+|||++.+. .++.++|||||||+||+|+||+.||...... ...+... +.
T Consensus 156 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----~~- 224 (332)
T cd05614 156 LSEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR----IL- 224 (332)
T ss_pred cccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH----Hh-
Confidence 322111 12345789999999999765 4788999999999999999999999643211 1111110 00
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
......|...+..+.+++.+|+..||.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 11122333456778999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=312.82 Aligned_cols=246 Identities=28% Similarity=0.482 Sum_probs=200.5
Q ss_pred cccccCCceEEEEeeec-----CeeEEEEEccCCCchh-HHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~~~~-~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..|++|.+....... ...+.+|+.++..++||||+++++++.+. .++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999886 6689999987654333 67889999999999999999999998654 5799999999
Q ss_pred CChhhHHhhhCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 501 GSLEDCLACKNK------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 501 gsL~~~L~~~~~------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|+|.+++..... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999964321 377999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.. ........++..|+|||.+....++.++|||||||++|+|++ |.+||........... +.+.....
T Consensus 159 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~ 227 (262)
T cd00192 159 DY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY------LRKGYRLP 227 (262)
T ss_pred cc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCCCC
Confidence 21 112234567888999999998899999999999999999999 6999976543221111 11112223
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
.|...+..+.+++.+|+..+|.+||++ .+++..|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l 261 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTF-SELVERL 261 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 344557789999999999999999999 8887766
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.23 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=200.4
Q ss_pred cCCCcccccccCCceEEEEeeecC-----eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|.+.. ..||||.+... .......|..|+.+++++.||||+++++++.+. .++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788899999999999998742 35999998754 344456899999999999999999999998554 5789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ..+.+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999853 3456899999999999999999999999 999999999999999999999999998766432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ...........+..|+|||++.++.++.++|||||||++||+++ |.+||...+......... ......
T Consensus 160 ~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~------~~~~~~ 231 (269)
T cd05065 160 TSD--PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE------QDYRLP 231 (269)
T ss_pred ccc--cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH------cCCcCC
Confidence 211 01111111122457999999999999999999999999999887 999986544322111100 001111
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+...+..+.+++.+|+..+|.+||++ .+++..|+.+
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~ 268 (269)
T cd05065 232 PPMDCPTALHQLMLDCWQKDRNARPKF-GQIVSTLDKM 268 (269)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 233455678999999999999999999 8998888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=336.54 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~-- 490 (780)
.++|...++||+|+||.||+|.+.+ ..||||++.... ......|.+|+.+|.++. |||||+++|+|...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 4578888999999999999998643 469999997542 223456889999999997 99999999999654
Q ss_pred CeeEEEeccCCChhhHHhhhC-----------------------------------------------------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKN----------------------------------------------------------- 511 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 511 (780)
.++||||+++|+|.++|+...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 679999999999999996421
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 512 ------------------------------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 512 ------------------------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
....++|...+.|+.+++.||.|||+.+ ++||||||+|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~ 273 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe
Confidence 1135788899999999999999999998 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++.+...... .......++..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999765322111 11123456788999999998889999999999999999998 88898654332
Q ss_pred HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 635 KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 635 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
....... ........|...+..+.+|+.+||..+|..||++ .+|+..|+.+
T Consensus 349 ~~~~~~~-----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~ell~~L~~~ 399 (401)
T cd05107 349 EQFYNAI-----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-SQLVHLVGDL 399 (401)
T ss_pred HHHHHHH-----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHH
Confidence 2111100 0001112233456789999999999999999999 8999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.23 Aligned_cols=233 Identities=23% Similarity=0.285 Sum_probs=188.2
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++... .......+..|..++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 578999998642 223445677899998877 699999999998554 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----- 150 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----- 150 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-----
Confidence 99999885 3456899999999999999999999999 9999999999999999999999999987542111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||++||...+....... +.. .....|...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i~~-~~~~~~~~~~~ 221 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------ILN-DEVVYPTWLSQ 221 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------Hhc-CCCCCCCCCCH
Confidence 112345789999999999998999999999999999999999999976554322111 010 11122334567
Q ss_pred HHHHHHHHchhhCCCCCcch
Q 044673 661 QLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.+++.+|++.||.+||+.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 78999999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.57 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=203.3
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
++|...+.||.|+||.||+|.. .+..||||.+.... ......|.+|+.+++.++||||++++++|.+ ..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788889999999999999986 46789999876422 2334578899999999999999999998854 357999
Q ss_pred EeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||+++++|.+++... .....+++..++.|+.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999988642 23457899999999999999999999999 999999999999999999999999998766432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld~~~~~ 653 (780)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|..||.....- ...... +.....+ ..
T Consensus 160 ~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~--~~ 228 (267)
T cd08229 160 TT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK--IEQCDYP--PL 228 (267)
T ss_pred Cc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh--hhcCCCC--CC
Confidence 11 112346888999999999888999999999999999999999998643221 111110 0010111 01
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+...+..+.+++.+|+..+|.+||++ .+|++.++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDI-TYVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCH-HHHHHHHhhh
Confidence 112356789999999999999999999 8999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=340.44 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=192.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+|++++||||+++++.|.+. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 5789999986421 22345688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ..+.+++.....|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999995 3456889999999999999999999999 9999999999999999999999999985432100
Q ss_pred CC------------------------------------CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHH
Q 044673 576 ST------------------------------------GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILL 619 (780)
Q Consensus 576 ~~------------------------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~ 619 (780)
.. .....+......||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 000001112357999999999999999999999999999999
Q ss_pred HHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCc---chHHHHH
Q 044673 620 RLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRP---DLVSEIW 685 (780)
Q Consensus 620 eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RP---s~~~ev~ 685 (780)
+|+||++||..................+.. ......+..+.+++.+|+ .+|.+|+ ++ .+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~-~ell 299 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHI---PSQAKLSREASDLILRLC-CGAEDRLGKNGA-DEIK 299 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccC---CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH-HHHh
Confidence 999999999866543322221111111110 111124556777888866 4999999 55 4443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.62 Aligned_cols=235 Identities=23% Similarity=0.276 Sum_probs=186.2
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||+|++... .......+..|+.++.++ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 567999998753 223345677899998877 799999999988544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----
Confidence 99998885 3457999999999999999999999999 99999999999999999999999999875321111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-------HHHHHHhccccccccCcCCC
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-------VKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-------~~~~~~~~~~~~~ld~~~~~ 653 (780)
......||..|+|||++.+..++.++|||||||++|+|+||++||..... ....+.. .+......
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-----~i~~~~~~ 223 (329)
T cd05618 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-----VILEKQIR 223 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH-----HHhcCCCC
Confidence 12345789999999999999999999999999999999999999952110 0000000 01111122
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.|...+..+.+++.+||..||.+||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 344556778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.93 Aligned_cols=252 Identities=26% Similarity=0.454 Sum_probs=200.3
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|.....||+|+||.||++... +..||+|++.... ......|.+|+.++++++||||++++++|.+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 468999999999999999999863 4679999987543 33456799999999999999999999998654 6
Q ss_pred eeEEEeccCCChhhHHhhhC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCce
Q 044673 492 SLVFEYLRNGSLEDCLACKN-------------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKV 552 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NI 552 (780)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ni 161 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNC 161 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhhe
Confidence 89999999999999985321 1235889999999999999999999999 99999999999
Q ss_pred EecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccc
Q 044673 553 LIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIK 631 (780)
Q Consensus 553 LLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~ 631 (780)
|++.++.+||+|||++..+...... .......++..|+|||++.++.++.++|||||||++|+|++ |..||...
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred EecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998765322111 01122334567999999998899999999999999999998 88887543
Q ss_pred hhHH--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 632 KDVK--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 632 ~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.... ..+..+.. ...|...+..+.+++.+|++.+|.+||++ .+++..|+
T Consensus 237 ~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~el~~~l~ 287 (288)
T cd05050 237 AHEEVIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSF-ASINRILQ 287 (288)
T ss_pred CHHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHhh
Confidence 3221 12222211 12233456779999999999999999999 88988876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.35 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=191.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------C-
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--------S- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--------~- 490 (780)
..+|...++||+|+||.||+|... +..||||.+.... ....+|+.+|+.++|||||++++++.. .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999874 5789999885432 234579999999999999999887521 1
Q ss_pred -CeeEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-Ccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGF 567 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGl 567 (780)
.++||||+++ +|.+++.. ......+++.....|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecccc
Confidence 3479999985 67666642 234567999999999999999999999999 99999999999999665 699999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~ 642 (780)
|+.+.... ......||+.|+|||++.+. .++.++|||||||+||+|+||.+||............ +.
T Consensus 218 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 218 AKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred chhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 98664321 11235688999999998654 6899999999999999999999999765443221110 00
Q ss_pred ------------ccccccCc------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH--HHHHHH
Q 044673 643 ------------FNSVLDSS------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW--SVLEAL 691 (780)
Q Consensus 643 ------------~~~~ld~~------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~--~~L~~l 691 (780)
+..+--+. ...+|...+.++.+|+.+||..+|.+||++ .+++ +.++.+
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta-~e~l~hp~f~~~ 357 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP-IEALADPFFDDL 357 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH-HHHhCChhHHhh
Confidence 00000000 011223345679999999999999999999 6665 344444
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.47 Aligned_cols=237 Identities=24% Similarity=0.306 Sum_probs=188.3
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||+|.+.... ......+..|..++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999885 5689999986521 22344567788888764 899999999998654 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----- 150 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-----
Confidence 99999885 3456899999999999999999999999 9999999999999999999999999986432111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+... .+..... .....|...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~~~------~~~~~~~~~~~ 221 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRV------DTPHYPRWITK 221 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------CCCCCCCCCCH
Confidence 11234578999999999999999999999999999999999999997554322 1111110 11122333556
Q ss_pred HHHHHHHHchhhCCCCCcchHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.+.+++.+||+.||.+||++.+++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHH
Confidence 789999999999999999984444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=340.16 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...++||+|+||.||++... +..||+|++... .......|.+|+.+++.++||||+++++++.+. .++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 568999999999999999999875 578999998642 122344578999999999999999999998655 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999884 235788889999999999999999999 999999999999999999999999998765422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC-
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETG----KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS- 649 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~- 649 (780)
.. .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...+....... ++..
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~~ 263 (370)
T cd05596 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDHK 263 (370)
T ss_pred Cc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCC
Confidence 11 112345799999999998653 478899999999999999999999986654322211 1110
Q ss_pred cCCCCCH--HHHHHHHHHHHHchhhCCCC--CcchHHHHH
Q 044673 650 SAGDWPV--AEAEQLAHLALRCCENNRLN--RPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~--~~~~~l~~l~~~Cl~~~p~~--RPs~~~ev~ 685 (780)
....+|. ..+..+.+|+.+|+..+|.+ ||++ .+++
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~-~ell 302 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGV-DEIK 302 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCH-HHHh
Confidence 0111222 34678899999999988887 9998 6663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.63 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=200.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.-|.....||+|.||.||+|.+. +..||||++.... .......++|+.+|.++++|||.++||.+..+ ..++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666788999999999999986 4679999998643 34456788999999999999999999988554 4689999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
|.||++.+.|. ....+++....-|+.+++.||.|||..+ .+|||||++||||..+|.+||+|||.+-.+....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-- 165 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechh--
Confidence 99999999994 4555688888899999999999999999 9999999999999999999999999987664322
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc-CCCCCH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS-AGDWPV 656 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~-~~~~p~ 656 (780)
....+.+||+.|||||++....|+.|+||||||++.+||.+|.||+...+..+. ..++... .+....
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LFLIPKSAPPRLDG 233 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EEeccCCCCCcccc
Confidence 223567999999999999988999999999999999999999999986665322 1122221 222223
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+++..||..||..||++ .+++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA-~~LL 261 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSA-KELL 261 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCH-HHHh
Confidence 566779999999999999999998 4444
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.92 Aligned_cols=244 Identities=22% Similarity=0.273 Sum_probs=188.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
++|...+.||+|+||.||++... +..||||... ...+.+|+.+|++++|||||+++++|.. ..++|+||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 67999999999999999999875 5679999753 2346799999999999999999998854 357999998
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
. ++|.+++. ....+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++......
T Consensus 166 ~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--- 236 (391)
T PHA03212 166 K-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--- 236 (391)
T ss_pred C-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc---
Confidence 5 68888874 3356899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh----------HHHHHHh-cc-----
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD----------VKCALEK-RN----- 642 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~----------~~~~~~~-~~----- 642 (780)
........||+.|+|||++.+..++.++|||||||+||+|+||++||..... ....+.. +.
T Consensus 237 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 237 ---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ---ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1112345799999999999999999999999999999999999977642210 0111100 00
Q ss_pred -------cccc---------ccC-cCCCCC--HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 -------FNSV---------LDS-SAGDWP--VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 -------~~~~---------ld~-~~~~~p--~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+... ..+ ....|. ...+..+.+|+.+||..||.+||++ .+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-~elL 374 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-EALL 374 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-HHHh
Confidence 0000 000 011111 1245678999999999999999999 6665
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=315.32 Aligned_cols=234 Identities=24% Similarity=0.380 Sum_probs=185.3
Q ss_pred ccccCCceEEEEeeec--------------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCee
Q 044673 430 KIGEGRYGNVYRGLLR--------------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSL 493 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~--------------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~L 493 (780)
.||+|+||.||+|.+. ...|++|.+..........|.+|+.+++.++||||++++++|.+ ..++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 6899999999999853 23589999876555555678999999999999999999999854 3679
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-------ccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-------SKLSDFG 566 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~-------~Kl~DFG 566 (780)
||||+++|+|..++.. ...++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999988752 3456999999999999999999999999 999999999999987664 8999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhc-cCCCCcchhHHHHHHHHHHHH-hCCCCCccchhHHHH-HHhccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-TGKLTPESDVYSFGIILLRLL-TGRPVLRIKKDVKCA-LEKRNF 643 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~ksDVwS~Gvil~eLl-tG~~p~~~~~~~~~~-~~~~~~ 643 (780)
++...... ....++..|+|||++. +..++.++|||||||+||+|+ +|..||......... ...+..
T Consensus 158 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 158 IPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 97654311 2245778899999987 466899999999999999998 588888644322111 111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
. ........+.+|+.+||+.+|.+||++ .+|+..|
T Consensus 227 -----~----~~~~~~~~~~~li~~cl~~dp~~Rp~~-~~il~~~ 261 (262)
T cd05077 227 -----M----LVTPSCKELADLMTHCMNYDPNQRPFF-RAIMRDI 261 (262)
T ss_pred -----c----CCCCChHHHHHHHHHHcCCChhhCcCH-HHHHHhc
Confidence 0 011124568999999999999999999 8887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=313.69 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=205.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
+++|...+.||+|+||.||+|... +..||+|.++.. .......+.+|+.++++++||||+++++++.+. .++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 368999999999999999999985 688999987632 233356789999999999999999999998554 5789
Q ss_pred EEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||+++|+|.+++... .....+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999988532 33456899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccccccccCcCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld~~~~ 652 (780)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...... +......
T Consensus 159 ~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~ 226 (267)
T cd08224 159 KTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-----IEKCDYP 226 (267)
T ss_pred CCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh-----hhcCCCC
Confidence 211 112346788899999999888999999999999999999999998543311 111110 0001111
Q ss_pred CCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 653 DWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 653 ~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..|. ..+..+.+++.+|+..+|..||++ .+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~-~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDI-SYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCH-HHHHHHHHHhc
Confidence 1222 455678999999999999999999 89999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.85 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=194.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-----C--CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-----S--RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-----~--~~LV 494 (780)
.|...+.+|.|+||.||+|.+. +..||||..-.+... -.+|+.+|+.+.|||||+|+.+|.. . .+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667889999999999999986 467999987543221 1279999999999999999988721 1 2489
Q ss_pred EEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCccccccccccccc
Q 044673 495 FEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIP 572 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~~ 572 (780)
|||||. +|...+.. ...+..++.-.+.-+.+||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 999988 88888843 223566777888899999999999999999 9999999999999977 899999999999886
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH------------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE------------ 639 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~------------ 639 (780)
.+... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|+|.|.+.+.+..+..
T Consensus 178 ~~epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 178 KGEPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred cCCCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 44322 233456779999988765 699999999999999999999999987776544321
Q ss_pred --hcccc--ccccCc--CCC----CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH--HHHHHHHh
Q 044673 640 --KRNFN--SVLDSS--AGD----WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW--SVLEALRV 693 (780)
Q Consensus 640 --~~~~~--~~ld~~--~~~----~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~--~~L~~l~~ 693 (780)
..+.. +...+. ... +....+.++.+|+.+++..+|..|.+. .+++ +.++.++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~-~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA-LEALAHPFFDELRD 314 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH-HHHhcchhhHHhhC
Confidence 11111 111111 111 344567889999999999999999988 4443 45555553
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.34 Aligned_cols=257 Identities=21% Similarity=0.369 Sum_probs=203.2
Q ss_pred hcCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~ 490 (780)
.++|.....||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+ +||||++++++|.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 367888899999999999999742 2369999987532 34456789999999999 899999999998554
Q ss_pred --CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~ 171 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT 171 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc
Confidence 5799999999999999964321 245899999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++.+...... .......++..|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred CCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999876432111 11223345678999999998889999999999999999998 78888654332
Q ss_pred HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 635 KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 635 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.. ..... .......|...+..+.+++.+||..+|.+||++ .+++..|+++.
T Consensus 247 ~~-~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~e~l~~l~~~~ 297 (304)
T cd05101 247 EL-FKLLK-----EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF-KQLVEDLDRIL 297 (304)
T ss_pred HH-HHHHH-----cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHHH
Confidence 21 11110 001111233456779999999999999999999 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.98 Aligned_cols=243 Identities=28% Similarity=0.454 Sum_probs=193.5
Q ss_pred ccccCCceEEEEeeec-CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCChhh
Q 044673 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLED 505 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~~ 505 (780)
+||+|+||.||+|... +..||+|.+..... .....|.+|+.++++++||||++++++|.+. .++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999875 56799999876443 3345689999999999999999999998554 679999999999999
Q ss_pred HHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccccc
Q 044673 506 CLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585 (780)
Q Consensus 506 ~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~ 585 (780)
++.. ....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 82 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~~ 151 (250)
T cd05085 82 FLRK--KKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SSS 151 (250)
T ss_pred HHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecccccc------ccC
Confidence 8853 3356899999999999999999999999 99999999999999999999999999875432111 111
Q ss_pred CCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHH
Q 044673 586 SNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAH 664 (780)
Q Consensus 586 ~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 664 (780)
....++..|+|||++.++.++.++||||||+++|+++| |..||.............. ......+...+..+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK------GYRMSCPQKCPDDVYK 225 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc------CCCCCCCCCCCHHHHH
Confidence 22344567999999999999999999999999999999 9999965443221111100 0111122335678999
Q ss_pred HHHHchhhCCCCCcchHHHHHHHHH
Q 044673 665 LALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 665 l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
++.+|+..+|.+||++ .++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~-~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKF-SELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCH-HHHHHHhc
Confidence 9999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=334.24 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=192.8
Q ss_pred CCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------Ce
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------RS 492 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------~~ 492 (780)
+|+..+.||+|+||.||++.. .+..||||.+... .......+.+|+.+++.++||||+++++++.+. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999986 4688999998653 223456788999999999999999999998543 47
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+|+||+. ++|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 8999996 57887774 3457999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----c------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----R------ 641 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~------ 641 (780)
.... ...+...+|..|+|||++.+. .++.++|||||||++|+|+||++||...+.....-.. +
T Consensus 155 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 155 PDES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred cCcc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 2211 112345678899999998764 5789999999999999999999999755432211000 0
Q ss_pred -------ccccccc-Cc-C------CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 -------NFNSVLD-SS-A------GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 -------~~~~~ld-~~-~------~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+.. +. . .......+..+.+|+.+|++.||.+||++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~l~ 287 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-ADALA 287 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-HHHhc
Confidence 0000000 00 0 01112235678999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.78 Aligned_cols=245 Identities=27% Similarity=0.469 Sum_probs=192.3
Q ss_pred ccccCCceEEEEeeecC----eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 430 KIGEGRYGNVYRGLLRH----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
.||+|+||.||+|.+.. ..+++|.+.... ......|.+|+.++.++ +||||++++++|... .++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998753 247899887533 34456789999999999 799999999999654 57999999999
Q ss_pred ChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 502 SLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 502 sL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
+|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCCc
Confidence 9999986322 1235899999999999999999999999 999999999999999999999999997
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
...... ........+..|+|||++....++.++|||||||++|+|+| |.+||...+..... .. +.
T Consensus 160 ~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~-----~~ 225 (270)
T cd05047 160 RGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EK-----LP 225 (270)
T ss_pred cccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HH-----Hh
Confidence 532210 01112234567999999988889999999999999999997 99999654332111 10 00
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.......+...+..+.+++.+|+..+|.+||++ .+++..|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRM 268 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHh
Confidence 111111222345678999999999999999999 8999998865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=323.10 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=201.5
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+++++ +||||++++++|...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 367999999999999999999752 2469999987543 23345789999999999 799999999998544
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+++|+|.+++... ....+++.++..|+.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCccccc
Confidence 67999999999999998632 2234899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH---HHHhcccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC---ALEKRNFNSV 646 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~---~~~~~~~~~~ 646 (780)
+...... .......++..|+|||++.++.++.++|||||||++|+|+| |.+||........ .+..+.
T Consensus 191 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~---- 261 (302)
T cd05055 191 IMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY---- 261 (302)
T ss_pred ccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC----
Confidence 6432110 11123356778999999999999999999999999999998 9999865433221 111110
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
....+...+..+.+++.+|+..+|.+||++ .+++..|+.+
T Consensus 262 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ell~~l~~~ 301 (302)
T cd05055 262 ----RMAQPEHAPAEIYDIMKTCWDADPLKRPTF-KQIVQLIGKQ 301 (302)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHhh
Confidence 111122345679999999999999999999 8999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.37 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch--hHHHHHHHHHHhhcCCCCc-eeeEeeeecC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ--SHLKFQNEVEVLSRVRHPN-LVTLIGTCPE------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~--~~~~f~~Ev~il~~l~Hpn-Iv~l~g~~~~------- 489 (780)
...|....+||+|.||+||+|+.. |..||+|++...... -...-.+|+.+|..++|+| ||.|++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777788999999999999875 677999998764332 2344579999999999999 9999999854
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKK-SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
..+|||||++. +|.+++...... ..++...+..+..||+.||+|||+++ |+||||||.|||++.+|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 24589999966 899999643321 45777899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc----c
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR----N 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~----~ 642 (780)
|+.+..+.. ..+...+|.+|.|||++.+. .|++..|+||+|||++||+++++.|....+........ .
T Consensus 167 Ara~~ip~~-------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 167 ARAFSIPMR-------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred HHHhcCCcc-------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 997653322 25677899999999999876 79999999999999999999999998887755443211 1
Q ss_pred c-----cccc-----cCcCCCCC--HHH----H---HHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 F-----NSVL-----DSSAGDWP--VAE----A---EQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~-----~~~l-----d~~~~~~p--~~~----~---~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. ..+. +...+.|+ ... . ....+++.+|++.+|.+|.+. ..++
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa-~~al 300 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA-KGAL 300 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH-HHHh
Confidence 0 0000 00112221 111 1 368899999999999999998 4443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.07 Aligned_cols=252 Identities=24% Similarity=0.438 Sum_probs=200.9
Q ss_pred cCCCcccccccCCceEEEEeeec--C----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--H----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV 494 (780)
++|...+.||+|+||.||+|.+. + ..||+|.+.... ......|.+|+.+++.++||||++++|+|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 56788899999999999999873 3 257999887543 2334578899999999999999999999854 45799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 87 TQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccCc
Confidence 999999999999852 3446899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
... .......++..|++||++.+..++.++|||||||++|+|+| |..||..... ....+..+.. .
T Consensus 163 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~---- 230 (303)
T cd05110 163 EKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER---L---- 230 (303)
T ss_pred ccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---C----
Confidence 111 11223456778999999998899999999999999999998 8899864332 2222222110 0
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+...+..+..++.+|+..+|.+||++ .+++..|..+.
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~l~~~l~~~~ 269 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKF-KELAAEFSRMA 269 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 1112244578999999999999999999 88999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.20 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=196.6
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecC-------
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE------- 489 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~------- 489 (780)
.+++.|...+.||+|+||.||+|... +..||+|.+.... .....+.+|+.++.++ +||||++++++|.+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999874 5789999986532 3456788999999998 69999999999843
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..++||||+++|+|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 24699999999999999863 23456899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~ 643 (780)
....... .......|+..|+|||++. ...++.++|||||||++|+|++|.+||..............
T Consensus 159 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~- 230 (272)
T cd06637 159 AQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 230 (272)
T ss_pred eeccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-
Confidence 7653211 1123456889999999986 34588899999999999999999999975443322211110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..... ..+...+..+.+|+.+||..+|.+||++ .+++
T Consensus 231 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il 267 (272)
T cd06637 231 --NPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPTT-EQLM 267 (272)
T ss_pred --CCCCC--CCCCCcCHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 00111 1111244578999999999999999999 6664
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=315.96 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=200.9
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
|++.+++++.....||+|+||.||+|.+. +..||+|.+..........|.+|+.++++++||||++++++|.+. .+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556788888899999999999999875 467999998776666667899999999999999999999998654 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPL--RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFH 569 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~ 569 (780)
+|+||+++++|.+++... ..++ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999632 2345 88899999999999999999999 999999999999986 6789999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGK--LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
....... ......|+..|+|||++.+.. ++.++||||||+++|+|++|++||............. ..
T Consensus 158 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~----~~ 226 (268)
T cd06624 158 RLAGINP-------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----GM 226 (268)
T ss_pred ecccCCC-------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh----hh
Confidence 6532111 112345788999999987654 7889999999999999999999996443221111100 01
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.......|......+.+++.+|+..+|.+||++ .+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~ll~ 264 (268)
T cd06624 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASA-HDLLQ 264 (268)
T ss_pred hccCCCCCcccCHHHHHHHHHHcCCCchhCCCH-HHHHh
Confidence 111223444566789999999999999999999 66643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.17 Aligned_cols=257 Identities=24% Similarity=0.295 Sum_probs=202.0
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEcc--CCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC---
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--- 489 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~--~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--- 489 (780)
+.......|.....||+|+||.|..+... +..||||.+. .......++-.+|+.+|+.++|+||+.++..+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 33344567777889999999999999885 6789999987 3555666778899999999999999999998843
Q ss_pred ----CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 490 ----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 490 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
+.|+|+|+| ..+|...+. ....|+......+.+|+++||.|+|+.+ |+||||||+|+|++.+..+|||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccc
Confidence 247999999 558999884 4455999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH------
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL------ 638 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~------ 638 (780)
|||+..... ......|..+.|.+|.|||++.. ..|+...||||.||||.|||+|++.|.+.+.+....
T Consensus 170 GLAR~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 170 GLARYLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred cceeecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 999988543 12233467888999999998764 579999999999999999999999998766543221
Q ss_pred -----------HhccccccccCc--CCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 639 -----------EKRNFNSVLDSS--AGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 639 -----------~~~~~~~~ld~~--~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+....+... .+.-| ........+|+.+||..||.+|+|. ++.+
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita-~eAL 308 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA-EEAL 308 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH-HHHh
Confidence 100111111110 01111 1345678899999999999999999 5553
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.14 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=199.1
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEeccCC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLRNG 501 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~~g 501 (780)
++|...+.||+|+||.||+|...+..||+|.+... .....|.+|+.++++++|||++++++++.. ..++||||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 46888899999999999999988899999998653 234578899999999999999999998844 468999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 84 ~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~------- 153 (254)
T cd05083 84 NLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG------- 153 (254)
T ss_pred CHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc-------
Confidence 999998633 2346899999999999999999999999 999999999999999999999999998754321
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......+..|+|||++.++.++.++|+|||||++|+|++ |++||...+... ..+..+. ....+...
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 222 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------RMEPPEGC 222 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------CCCCCCcC
Confidence 112234567999999998899999999999999999998 999997544322 2222211 11122345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+..+.+++.+|+..+|..||++ .++...|+
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSF-HKLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCH-HHHHHHHc
Confidence 6778999999999999999999 88887775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=320.10 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=198.3
Q ss_pred cCCCcccccccCCceEEEEeeec------------------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR------------------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTL 483 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~------------------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l 483 (780)
++|...++||+|+||.||++.+. ...||+|++.... ......|.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57889999999999999998542 2358999987543 3345679999999999999999999
Q ss_pred eeeecC--CCeeEEEeccCCChhhHHhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceE
Q 044673 484 IGTCPE--SRSLVFEYLRNGSLEDCLACKNK--------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVL 553 (780)
Q Consensus 484 ~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NIL 553 (780)
++++.+ ..++||||+++|+|.+++..... ...+++.....++.+++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence 999854 46799999999999999864221 134888999999999999999999999 999999999999
Q ss_pred ecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCccc
Q 044673 554 IDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRIK 631 (780)
Q Consensus 554 Ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt--G~~p~~~~ 631 (780)
++.++.++|+|||+++.+...... .......++..|++||+...+.++.++|||||||++|||+| |..||...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EcCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999998765322110 11123345678999999988899999999999999999998 67888644
Q ss_pred hhHHHHHHhccc-cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 632 KDVKCALEKRNF-NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 632 ~~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.........+.+ ...........|..++..+.+|+.+||+.+|.+||++ .+|.+.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF-QEIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 332211111110 0000000111122345779999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.16 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=199.6
Q ss_pred cCCCcccccccCCceEEEEeee-------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecC---C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL-------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE---S 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~-------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~---~ 490 (780)
++|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|.++ +||||++++++|.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999974 24679999997543 23345688999999999 68999999998843 2
Q ss_pred CeeEEEeccCCChhhHHhhhCC----------------------------------------------------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK---------------------------------------------------------- 512 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 512 (780)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 5789999999999999853210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccC
Q 044673 513 ------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNES 586 (780)
Q Consensus 513 ------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~ 586 (780)
...++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hhhcC
Confidence 134789999999999999999999999 99999999999999999999999999876532211 11122
Q ss_pred CCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH---HHHHHhccccccccCcCCCCCHHHHHHH
Q 044673 587 NNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV---KCALEKRNFNSVLDSSAGDWPVAEAEQL 662 (780)
Q Consensus 587 ~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~---~~~~~~~~~~~~ld~~~~~~p~~~~~~l 662 (780)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+. ....|...+..+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--------CCCCCCCCCHHH
Confidence 3345678999999998899999999999999999997 89998643321 11111111 111122234568
Q ss_pred HHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 663 AHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 663 ~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+++.+||+.+|.+||++ .+|+..|+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~-~eil~~l~~~~ 340 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTF-SELVEHLGNLL 340 (343)
T ss_pred HHHHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 999999999999999999 89999998773
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.60 Aligned_cols=239 Identities=19% Similarity=0.274 Sum_probs=191.3
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV~ 495 (780)
+|...+.||+|+||.||+|... +..||||++... .......+..|..++..+. ||+|+++++++.+ ..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999874 578999998752 1233456778999998886 5678888888754 367999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999885 3456999999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. ......||+.|+|||++.++.++.++|||||||++|+|+||++||...+..... .. ++. ....+|
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-~~-----i~~-~~~~~p 221 (323)
T cd05615 156 V-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-QS-----IME-HNVSYP 221 (323)
T ss_pred c-------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HH-----HHh-CCCCCC
Confidence 1 123456899999999999999999999999999999999999999765432211 10 111 112234
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
...+..+.+++.+|++.+|.+|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 45567789999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.29 Aligned_cols=248 Identities=22% Similarity=0.257 Sum_probs=195.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|.....||+|+||.||++... +..||||++.... ......|.+|+.++..++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999874 6789999987532 22345688999999999999999999988554 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999999999853 2357999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc------cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE------TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
.. ......||+.|+|||++. ...++.++|||||||++|+|+||+.||..................+.
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 229 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK- 229 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC-
Confidence 11 123357899999999986 45688999999999999999999999976554332211111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+ .....+..+.+|+.+|+. +|.+||++ .+++
T Consensus 230 -~~-~~~~~~~~~~~li~~ll~-~p~~R~t~-~~l~ 261 (330)
T cd05601 230 -FP-EDPKVSSDFLDLIQSLLC-GQKERLGY-EGLC 261 (330)
T ss_pred -CC-CCCCCCHHHHHHHHHHcc-ChhhCCCH-HHHh
Confidence 01 111345678899999998 99999999 5553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.33 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=190.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||+|++... .......|.+|+.++..++||||+.+++++.+. .++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999875 467999998642 122344588999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999963 2356899999999999999999999999 9999999999999999999999999987664321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
. .......||+.|+|||++.+ +.++.++|||||||+||+|+||+.||...+..............+ .
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~ 228 (331)
T cd05624 157 T------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--Q 228 (331)
T ss_pred c------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--c
Confidence 1 11123568999999999875 568899999999999999999999997655432221110000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCC--CcchHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLN--RPDLVSEI 684 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~--RPs~~~ev 684 (780)
........+..+.+++.+|+..++.+ |+++ .++
T Consensus 229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~-~~~ 263 (331)
T cd05624 229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGI-EDF 263 (331)
T ss_pred CCCccccCCHHHHHHHHHHccCchhhcCCCCH-HHH
Confidence 11111234567888999988865433 4455 444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.87 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=208.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC---CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES---RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---~~LV 494 (780)
.++|..++.||+|+||.++..+.+ ...+++|.+.... ...+..-.+|+.++++++|||||...+.|.+. .|+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999977664 5789999876533 33344578999999999999999999999554 4689
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|+|++||+|.+.|.+.+ +.-++++.+..|+.|++.|+.|||++. |+|||||+.|||+..++.+||+|||+|+.+..+
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999997544 566899999999999999999999988 999999999999999999999999999998754
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.. ......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+...-..+. ...... ..
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki--~~~~~~----Pl 226 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI--NRGLYS----PL 226 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH--hhccCC----CC
Confidence 31 224578999999999999999999999999999999999999999876654332221 111222 34
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
|..++.+|..++..|+..+|..||+. .+++..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa-~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSA-LELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCH-HHHhhC
Confidence 55678889999999999999999999 677654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.03 Aligned_cols=251 Identities=25% Similarity=0.470 Sum_probs=210.0
Q ss_pred CCCcccccccCCceEEEEeeecC------eeEEEEEccC-CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCC-eeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESR-SLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~-~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~-~LV~ 495 (780)
.....++||+|-||.||+|.+.. ..||||..+. ....+.+.|.+|.-++++++|||||+|+|.|.+.. .+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 33445689999999999998742 3599999987 44566788999999999999999999999998764 6999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|.++-|.|..+|. .++..|+..+...+++||+.||.|||+.+ +|||||-..|||+...--+||+||||+|.+..+.
T Consensus 470 EL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999996 35567888999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. +..+...-...|||||-+.-..++.+||||.|||++||+|. |..||..... ..-+..+-.......
T Consensus 546 y------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------sDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 546 Y------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------SDVIGHIENGERLPC 613 (974)
T ss_pred h------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------cceEEEecCCCCCCC
Confidence 2 22233344567999999999999999999999999999997 8999875432 112223333345567
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
|..++..|..|..+||..+|.+||.+ .++...|..+
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrf-tei~~~lsdv 649 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRF-TEIKAILSDV 649 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcH-HHHHHHHHHH
Confidence 88899999999999999999999999 7777777665
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.94 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=187.2
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHH-HhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVE-VLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~-il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||+|++.... ......+..|.. +++.++||||++++++|.+. .++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999884 5789999986421 122344555654 67889999999999988554 6799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++.....|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----- 150 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----
Confidence 99998885 3456888999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||.+||...+... .... ++. .....|.....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~-----i~~-~~~~~~~~~~~ 221 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-MYDN-----ILH-KPLQLPGGKTV 221 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-HHHH-----Hhc-CCCCCCCCCCH
Confidence 11234578999999999998899999999999999999999999997654322 1111 111 11123334566
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+.+++.+|++.+|.+||+....+.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 78999999999999999987434433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.51 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=199.1
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~ 491 (780)
..|...+.||+|+||.||++.+ .+..||+|.+.... ......|.+|+.++++++||||++++++|.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3577889999999999999874 25679999987543 33446799999999999999999999998543 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++.. ....++|..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccc
Confidence 799999999999999853 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH-HHHH--hcc------
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK-CALE--KRN------ 642 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~-~~~~--~~~------ 642 (780)
...... ........++..|+|||++.++.++.++|||||||++|+|+|++.|........ .... .+.
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 432211 011223456778999999998889999999999999999999876643211000 0000 000
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+.+......+...+..+.+|+.+|++.+|.+||++ .+++..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-QNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-HHHHHHHHhh
Confidence 00000011111123456789999999999999999999 8999988864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=317.37 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=183.3
Q ss_pred ccccCCceEEEEeeec--------------------------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeE
Q 044673 430 KIGEGRYGNVYRGLLR--------------------------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~--------------------------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l 483 (780)
+||+|+||.||+|.+. ...||+|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999752 13589999876544445678899999999999999999
Q ss_pred eeeecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---
Q 044673 484 IGTCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF--- 558 (780)
Q Consensus 484 ~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~--- 558 (780)
+|+|.+. .++||||+++|+|.+++.. ..+.+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999554 5799999999999998852 3457899999999999999999999998 99999999999998654
Q ss_pred ----CcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHH-hCCCCCccch
Q 044673 559 ----GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLL-TGRPVLRIKK 632 (780)
Q Consensus 559 ----~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLl-tG~~p~~~~~ 632 (780)
.+|++|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|.+||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3799999987543211 12356778999998875 56899999999999999985 7999986543
Q ss_pred hHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 633 DVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 633 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
....... +.. ....|......+.+++.+||+.+|.+||++ .+|+..|
T Consensus 227 ~~~~~~~-------~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~il~~L 273 (274)
T cd05076 227 PSEKERF-------YEK-KHRLPEPSCKELATLISQCLTYEPTQRPSF-RTILRDL 273 (274)
T ss_pred hHHHHHH-------HHh-ccCCCCCCChHHHHHHHHHcccChhhCcCH-HHHHHhh
Confidence 3211100 000 001111223468999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.61 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=194.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
|.....||+|+||.||+|... +..+++|.+..........|.+|+.+++.++||||++++++|.+. .++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 466778999999999999885 467899998765555667899999999999999999999988544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++.. ...++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----- 157 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 157 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence 999998753 3457999999999999999999999999 9999999999999999999999999987553211
Q ss_pred cccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 581 ALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.......|+..|+|||++. +..++.++|||||||++|+|++|++||...+............ .+ ....|
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~~~ 231 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP-TLAQP 231 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC---CC-CCCCc
Confidence 1123356888999999984 3457889999999999999999999997665443322211100 00 01112
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...+..+.+++.+||..+|.+||++ .++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~-~~i 259 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTT-TQL 259 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 2345678999999999999999999 555
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=320.66 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=199.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
.+|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+++.++||||+++++.|.+ ..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999863 67899999876555556778999999999999999999998854 467999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 9999999884 245899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......|++.|+|||++.+..++.++|||||||++|+|+||++||.............. . .......+...
T Consensus 172 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--~--~~~~~~~~~~~ 242 (296)
T cd06654 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--N--GTPELQNPEKL 242 (296)
T ss_pred -----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--C--CCCCCCCcccc
Confidence 11234688899999999988899999999999999999999999976544222111100 0 00011123345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..+.+++.+||..+|..||++ .+++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~-~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSA-KELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCH-HHHhh
Confidence 6678999999999999999999 66654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.88 Aligned_cols=250 Identities=20% Similarity=0.361 Sum_probs=198.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch---------hHHHHHHHHHHhhcCCCCceeeEeeeecC--C
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ---------SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--S 490 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~---------~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~ 490 (780)
+|.....||+|+||.||+|... +..||+|.+...... ....|.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999874 578999987643221 12458899999999999999999999854 3
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+++++|.+++. ...++++..+..++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 679999999999999995 3457899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
+......... ........|+..|+|||++.++.++.++|||||||++|+|+||+.||...+.......... ..
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~ 228 (267)
T cd06628 156 LEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------NA 228 (267)
T ss_pred cccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------cC
Confidence 7532211111 1112234588899999999988899999999999999999999999976554433222111 11
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....|...+..+.+++.+||+.+|.+||++ .++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il~ 263 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTA-AELLK 263 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCH-HHHhh
Confidence 122333456778999999999999999999 66653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.87 Aligned_cols=234 Identities=24% Similarity=0.304 Sum_probs=186.8
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||+|++.... ......+.+|+.++.++ +||||+.+++++.+. .++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 5679999987532 23345688999999888 699999999988544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----
Confidence 99999885 3456999999999999999999999999 99999999999999999999999999875321111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHhccccccccCcCCCC
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~~~~~~~ld~~~~~~ 654 (780)
......||+.|+|||++.+..++.++|||||||+||+|+||++||..... ...... .+. ......
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~-----~~~-~~~~~~ 222 (327)
T cd05617 152 ---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ-----VIL-EKPIRI 222 (327)
T ss_pred ---ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH-----HHH-hCCCCC
Confidence 12345789999999999999999999999999999999999999963211 111111 001 111223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
|...+..+.+++.+||..||.+||+.
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 44456778999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.77 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=202.1
Q ss_pred cCCCcccccccCCceEEEEeeec------CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC----CC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR------HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~ 491 (780)
.+|...+.||+|+||.||+|.+. +..||||.+...... ....|.+|+.+++.+.||||++++++|.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999864 467999998765443 46679999999999999999999999855 36
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++.. ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 799999999999999953 3346999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--------Hhccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--------EKRNF 643 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--------~~~~~ 643 (780)
...... ........++..|++||++.+..++.++||||||+++++|+||..|+.........+ ....+
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 532111 111122345567999999998899999999999999999999998875422110000 00000
Q ss_pred cccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 644 NSVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 644 ~~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+.. .....+...+..+.+|+.+|+..+|.+||++ .+|+.+|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF-ADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH-HHHHHHHhhc
Confidence 000110 0111123345679999999999999999999 9999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.13 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=199.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-----hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-----QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-----~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+. .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999863 67899998764321 1234688999999999999999999998554 578
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++++|.+++. ....+++.....++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999885 3456899999999999999999999999 99999999999999999999999999876542
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.... ........|+..|+|||++.+..++.++||||||+++|+|++|++||...+......... .......
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~ 227 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTNPQ 227 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-----ccCCCCC
Confidence 2111 011133567889999999999889999999999999999999999997544433221111 1111223
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.|...+..+.+++.+||..+|.+||++ .+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~ll~ 259 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSA-EELLR 259 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCH-HHHhh
Confidence 344566779999999999999999999 67654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.12 Aligned_cols=234 Identities=24% Similarity=0.314 Sum_probs=185.0
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHH-HhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVE-VLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~-il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++.... ......+..|.. +++.++||||+++++++.+. .++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999884 6789999986421 122344555555 56789999999999988543 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----- 150 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-----
Confidence 99999885 3457899999999999999999999999 9999999999999999999999999986532111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... .. ++... ...+...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~-----i~~~~-~~~~~~~~~ 221 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-DN-----ILNKP-LRLKPNISV 221 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-HH-----HHcCC-CCCCCCCCH
Confidence 1123457899999999999999999999999999999999999999765432211 11 11111 112223466
Q ss_pred HHHHHHHHchhhCCCCCcchH
Q 044673 661 QLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
.+.+++.+|++.+|.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 789999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=330.21 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=192.3
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
..++|...+.||+|+||.||++... +..||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 678999998642 23345678899999999999999999998842
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 24799999975 5666553 24788999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-cc--
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-RN-- 642 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~~-- 642 (780)
+...... ......||..|+|||++.+..++.++|||||||++|+|+||+.||...+..... +.. +.
T Consensus 171 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 171 RTACTNF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred cccccCc--------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 7543211 123457899999999999999999999999999999999999999755432110 000 00
Q ss_pred ----------ccccc-----------cCcCCCC--------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 ----------FNSVL-----------DSSAGDW--------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ----------~~~~l-----------d~~~~~~--------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..... ......| +......+.+|+.+||..||.+||++ .+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~l~ 314 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-DEALR 314 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-HHHhc
Confidence 00000 0000011 11124568999999999999999999 67654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=330.85 Aligned_cols=249 Identities=19% Similarity=0.252 Sum_probs=193.0
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
..++|...+.||+|+||.||++... +..||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999874 577999998653 23345678899999999999999999998743
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 24799999975 6777663 24889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-c---
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-R--- 641 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~--- 641 (780)
+...... ......||..|+|||++.+..++.++|||||||+||+|+||+.||...+..... +.. +
T Consensus 174 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 174 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred cccCCCC--------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 7653211 123457899999999999999999999999999999999999999755432211 000 0
Q ss_pred -------------------cc-----c----ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 -------------------NF-----N----SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 -------------------~~-----~----~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+ . ..+-+.....+......+.+|+.+|+..||.+||++ .+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-~e~L~ 317 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-DEALQ 317 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-HHHhc
Confidence 00 0 000000011111234578899999999999999999 66643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.18 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=202.2
Q ss_pred cCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC-
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~- 490 (780)
++|...++||+|+||.||++... ...||+|.+.... ......|.+|+.++.++ +||||++++++|.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999998752 2469999987532 33456788999999999 699999999998654
Q ss_pred -CeeEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
.++||||+++|+|.+++.... ....++|..+..|+.|++.||.|||+.+ ++||||||+|||++.
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~ 169 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTE 169 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcC
Confidence 579999999999999996422 1245899999999999999999999999 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK 635 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~ 635 (780)
++.+||+|||+++........ .......++..|+|||++.++.++.++|||||||++|+|+| |..||.......
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999766421110 01112234567999999998899999999999999999999 889986543221
Q ss_pred --HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 636 --CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 636 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+..+ .....|...+..+.+++.+|+..+|..||++ .+++..|+.+..
T Consensus 245 ~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLREG--------HRMDKPSNCTHELYMLMRECWHAVPTQRPTF-KQLVEALDKVLA 295 (314)
T ss_pred HHHHHHcC--------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHH
Confidence 111111 1112233455678899999999999999999 899999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.87 Aligned_cols=238 Identities=20% Similarity=0.295 Sum_probs=186.8
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||+|+||.||++... +..||+|.+.... ......+..|++++.+++||||+++++++.+. .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 6789999886421 12233456799999999999999999988554 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------- 149 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------- 149 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--------
Confidence 9888532 3345899999999999999999999999 9999999999999999999999999987654221
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhccccccccCcCCCCCHHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
......|+..|+|||++.++.++.++|||||||++|+|+||++||...... ...+........+.. .....+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCHH
Confidence 113356889999999999989999999999999999999999999743221 111111111111111 01134567
Q ss_pred HHHHHHHchhhCCCCCcchHHHH
Q 044673 662 LAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
+.+|+.+||+.||.+||++ .++
T Consensus 226 ~~~li~~~L~~~P~~R~~~-~~~ 247 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGS-REK 247 (277)
T ss_pred HHHHHHHHhccCHhhCCCC-ccc
Confidence 8999999999999999999 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.49 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=202.5
Q ss_pred cCCCcccccccCCceEEEEeeecC------eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV 494 (780)
.+|...+.||+|+||.||+|.+.. ..||+|.+..... .....|.+|+.++++++||||++++++|.. ..++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 567888999999999999998642 3589998876433 345678999999999999999999999855 46799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 87 TQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 999999999999852 3456999999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... .......++..|++||.+..+.++.++|||||||++|||+| |++||....... ..+..+. .
T Consensus 163 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~ 229 (279)
T cd05057 163 EKE-----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--------R 229 (279)
T ss_pred ccc-----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC--------C
Confidence 211 11122334567999999988889999999999999999999 999997654322 2222111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+..++.+||..+|..||++ .+++..|+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~-~~l~~~l~~~~ 269 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTF-KELINEFSKMA 269 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHH
Confidence 11122344578999999999999999999 88999998873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.30 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=192.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||++... +..||+|++... .......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999885 567999998642 223345688999999999999999999998654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 122 ~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999884 235888999999999999999999999 999999999999999999999999999876422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETG----KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
.. .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...+...... .+++..
T Consensus 196 ~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~ 263 (370)
T cd05621 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHK 263 (370)
T ss_pred Cc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC
Confidence 11 112346799999999998754 37889999999999999999999997655432221 111111
Q ss_pred -CCCCCH--HHHHHHHHHHHHchhhCCC--CCcchHHHHHH
Q 044673 651 -AGDWPV--AEAEQLAHLALRCCENNRL--NRPDLVSEIWS 686 (780)
Q Consensus 651 -~~~~p~--~~~~~l~~l~~~Cl~~~p~--~RPs~~~ev~~ 686 (780)
...+|. ..+..+.+++.+|+..++. .||++ .+++.
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~-~e~l~ 303 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGV-EEIKQ 303 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCH-HHHhc
Confidence 112222 3466788889999975443 38888 55543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.71 Aligned_cols=240 Identities=20% Similarity=0.301 Sum_probs=192.1
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
|...+.||+|+||+||+|.+. +..||+|.+.... ......+.+|+.+|++++||||+.+++++.+. .++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999885 6789999986532 22334578899999999999999999888544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988532 3346999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p 655 (780)
......|+..|+|||++.+..++.++|+|||||++|+|+||..||........ .+.. .+.. ....++
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----~~~~-~~~~~~ 225 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----RVLE-TEEVYS 225 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhhc-cccccC
Confidence 11234689999999999989999999999999999999999999975443211 1111 0111 111233
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcch
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+..+.+|+.+|++.+|.+||+.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCC
Confidence 3455678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=318.39 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=189.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcC---CCCceeeEeeeecCC------
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRV---RHPNLVTLIGTCPES------ 490 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~~~------ 490 (780)
+|...+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+ +||||++++++|.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999885 5779999886532 12234566777777665 699999999987431
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+++ +|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 4799999975 888887532 2345899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc-------
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN------- 642 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~------- 642 (780)
...... ......||..|+|||++.+..++.++|||||||++|+|++|++||..............
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 664221 12345688999999999988999999999999999999999999975543221111000
Q ss_pred --ccc-------cccCcCC----CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 --FNS-------VLDSSAG----DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 --~~~-------~ld~~~~----~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.. ...+... ......+..+.+++.+|++.||.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~~l 283 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-FRAL 283 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-HHHh
Confidence 000 0000000 0111345678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.55 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=200.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|....+||+|+||.||+|.+. +..|++|.+..... ...|.+|+.++++++||||+++++++.+. .++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 67899999999999999999985 57899999875422 67899999999999999999999998554 57899999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++++|.+++. .....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~--~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999985 23467999999999999999999999999 99999999999999999999999999876643211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......|+..|++||++.+..++.++||||||+++|+|+||++||.............. ........+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPPPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CCCCCCCchhhc
Confidence 11234578889999999988999999999999999999999999976544332221111 000111123345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+.+++.+|++.+|.+||++ .+++.
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~-~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSA-IQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCH-HHHhc
Confidence 5679999999999999999999 76653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=329.69 Aligned_cols=249 Identities=19% Similarity=0.242 Sum_probs=193.0
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
..++|...+.||+|+||.||++... +..||||.+... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4579999999999999999999864 678999998653 23344678899999999999999999998742
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccc
Confidence 24799999975 6666663 24889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hh-c---
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EK-R--- 641 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~-~--- 641 (780)
+...... ......||..|+|||++.+..++.++|||||||++|+|+||+.||...+...... .. +
T Consensus 167 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 167 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred ccCCCcc--------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 7653211 1234578999999999998899999999999999999999999997554322110 00 0
Q ss_pred -------------------cccccc------c---CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 -------------------NFNSVL------D---SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 -------------------~~~~~l------d---~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+. + +....++...+..+.+|+.+|+..||.+||++ .+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-~ell~ 310 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DEALQ 310 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-HHHhc
Confidence 000000 0 00011122235678999999999999999999 77654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.24 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=201.4
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~ 500 (780)
++|...++||+|+||.||+|.+. +..||+|.+... ......|.+|+.++++++||||+++++++.+. .+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 67889999999999999999864 467999988753 23456789999999999999999999988654 4799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--- 158 (260)
T cd05073 85 GSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--- 158 (260)
T ss_pred CcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc---
Confidence 9999998632 3456899999999999999999999998 999999999999999999999999998766432111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcCCCCCHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......++..|++||++..+.++.++|+|||||++|+++| |++||...+.. ...+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05073 159 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------RMPRPEN 227 (260)
T ss_pred ---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------CCCCccc
Confidence 1122345677999999998889999999999999999999 99999754432 22222111 1111223
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.+..+.+++.+|+..+|.+||++ .++...|+.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~L~~ 259 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTF-EYIQSVLDD 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCH-HHHHHHHhc
Confidence 45679999999999999999999 889888874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.44 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=188.8
Q ss_pred cccccCCceEEEEeeecC----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLRH----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
+.||+|+||.||+|.+.+ ..+|+|.+.... ......|.+|+.++++++||||++++|+|.+. .++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997642 469999887543 23445788999999999999999999998654 57999999999
Q ss_pred ChhhHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 502 SLEDCLACKN--KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 502 sL~~~L~~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 9999996432 2345678888999999999999999999 99999999999999999999999999865432111
Q ss_pred CcccccCCCCCCcccCChhhhccC-------CCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHH--hccccccccC
Q 044673 580 SALCNESNNDSASVYIDPEYLETG-------KLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALE--KRNFNSVLDS 649 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~--~~~~~~~ld~ 649 (780)
........|+..|+|||++... .++.++|||||||++|+|++ |++||........... .+......+
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK- 232 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC-
Confidence 1112334577889999998632 35789999999999999996 9999975443322111 111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+......+..+.+++.+|+ .+|.+||++ ++|+..|.
T Consensus 233 --~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~-~~l~~~l~ 268 (269)
T cd05087 233 --PRLKLPLSDRWYEVMQFCW-LQPEQRPSA-EEVHLLLS 268 (269)
T ss_pred --CccCCCCChHHHHHHHHHh-cCcccCCCH-HHHHHHhc
Confidence 1112234556888999998 689999999 88987764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.17 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=186.4
Q ss_pred ccccCCceEEEEeeec----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCC
Q 044673 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGS 502 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gs 502 (780)
.||+|+||.||+|... ...+|+|.+.... ......|.+|+.+++.++||||++++++|.+. .++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999753 2468999876533 23445788999999999999999999998654 679999999999
Q ss_pred hhhHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 503 LEDCLACKNK--KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 503 L~~~L~~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY--- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhe---
Confidence 9999964322 233578888999999999999999999 999999999999999999999999998654322110
Q ss_pred cccccCCCCCCcccCChhhhcc-------CCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCC
Q 044673 581 ALCNESNNDSASVYIDPEYLET-------GKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
.......++..|+|||++.. ..++.++|||||||++|+|++ |.+||........... .......+...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ-VVREQDIKLPKP 233 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-HhhccCccCCCC
Confidence 01123445678999998753 356789999999999999999 7888865443221111 001111111122
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
.++...+..+..++..|+ .+|.+||++ ++|.+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~-~~v~~~l 267 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTA-EEVHELL 267 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCH-HHHHHHh
Confidence 233345566778888888 599999999 8888776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.78 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=193.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.++.+++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5778899999999999999874 6789999886432 22345688999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++ |+|.+++........+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 97 689888864444467999999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc----------
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN---------- 642 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~---------- 642 (780)
.......+++.|+|||++.+. .++.++|||||||++|+|+||++||............ +.
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 112334678889999988654 5789999999999999999999999765443222110 00
Q ss_pred ----ccccccCc----CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ----FNSVLDSS----AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ----~~~~ld~~----~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+....+.. ........+.++.+++.+||..||.+||++ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~~ll 280 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-KKAL 280 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-HHHh
Confidence 00000000 000111245678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.08 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=184.9
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHH-HhhcCCCCceeeEeeeecC--CCeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVE-VLSRVRHPNLVTLIGTCPE--SRSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~-il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||||++... .......+..|.. +++.++||||+++++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999874 678999998642 1223345566665 4677999999999998854 36799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----- 150 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----- 150 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-----
Confidence 99998885 3457899999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.++.++.++|||||||++|+|+||++||...+..... ... +... ...+...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~~-----~~~~-~~~~~~~~~ 221 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-DNI-----LHKP-LVLRPGASL 221 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-HHH-----HcCC-ccCCCCCCH
Confidence 1123457899999999999999999999999999999999999999765432211 110 1100 111223456
Q ss_pred HHHHHHHHchhhCCCCCcchH
Q 044673 661 QLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
.+.+++.+|+..+|.+||++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCC
Confidence 788999999999999999883
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.70 Aligned_cols=235 Identities=28% Similarity=0.455 Sum_probs=186.1
Q ss_pred cccccCCceEEEEeeecCe------------eEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec-CCCeeEE
Q 044673 429 WKIGEGRYGNVYRGLLRHL------------HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP-ESRSLVF 495 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~~------------~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~-~~~~LV~ 495 (780)
+.||+|+||.||+|.+... .|++|.+...... ...|.+|+.++++++||||++++|+|. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 3699999999999998643 3888887654332 678999999999999999999999885 3467999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-------Cccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-------GSKLSDFGFF 568 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-------~~Kl~DFGla 568 (780)
||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999863 2237899999999999999999999999 99999999999999888 7999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNS 645 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~ 645 (780)
..... .....++..|+|||++... .++.++|||||||++|+|++ |..||.............
T Consensus 156 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 156 ITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred ccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 76532 1123456679999999876 78999999999999999999 577776443211110000
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
... ..|......+.+++.+|+..+|.+||++ .++++.|
T Consensus 221 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l 258 (259)
T cd05037 221 --DQH--RLPMPDCAELANLINQCWTYDPTKRPSF-RAILRDL 258 (259)
T ss_pred --cCC--CCCCCCchHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 000 1111122678999999999999999999 7887765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.64 Aligned_cols=247 Identities=20% Similarity=0.294 Sum_probs=197.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
++|...++||.|+||.||+|... +..|++|.+..........|.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999875 57899999987666667789999999999999999999998744 367999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--- 164 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--- 164 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc---
Confidence 99999888742 3356999999999999999999999999 9999999999999999999999999986543211
Q ss_pred CCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.......++..|+|||++. ...++.++|||||||++|+|+||.+||...+........... ..+. ..
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~ 236 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPT-LS 236 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCcc-CC
Confidence 1123456788999999985 345788999999999999999999999765543322221110 0110 11
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+...+..+.+++.+||..+|.+||++ .+++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il 267 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSA-AQLL 267 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCH-HHHh
Confidence 122345678999999999999999999 6664
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.73 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=195.4
Q ss_pred cccccCCceEEEEeeecC--------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 429 WKIGEGRYGNVYRGLLRH--------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~--------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+.||+|+||.||+|.... ..||||.+.... ......|.+|+.+++.++||||++++++|.+. .++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998742 469999876532 24456799999999999999999999998543 6799999
Q ss_pred ccCCChhhHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-----Cccccccccc
Q 044673 498 LRNGSLEDCLACKN----KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-----GSKLSDFGFF 568 (780)
Q Consensus 498 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-----~~Kl~DFGla 568 (780)
+++|+|.+++.... ....++|..++.++.+++.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999996422 2345899999999999999999999999 99999999999999887 8999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
+.+...... .......++..|+|||++.++.++.++|||||||++|+|+| |..||...+........ .
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~------~ 227 (269)
T cd05044 159 RDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV------T 227 (269)
T ss_pred ccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH------h
Confidence 765422111 11123345678999999999999999999999999999998 99998754433222111 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.......+...+..+.+++.+||..+|.+||++ .+|.+.|+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF-DRIQEILQ 268 (269)
T ss_pred cCCccCCcccchHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 111112233456789999999999999999999 88988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.35 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=197.4
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
.+|...+.||+|+||.||+|.+. +..+|+|.+... ......|.+|+.+++++.|||++++++++.+. .++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778889999999999999875 678999988653 23345789999999999999999999998543 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++.. ...++++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 155 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--- 155 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcc---
Confidence 9999999852 3356899999999999999999999999 99999999999999999999999999876542211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 656 (780)
.......++..|+|||++.++.++.++||||||+++|+|++ |.+||........ .+..+ ..... |.
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~------~~ 224 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG--FRLYK------PR 224 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC--CCCCC------CC
Confidence 01122335678999999998899999999999999999998 9999975443221 11111 01111 22
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
..+..+.+|+.+||..+|.+||++ .++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~-~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSF-SLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCH-HHHHHhh
Confidence 235679999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.92 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=204.2
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchh-HHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~-~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 498 (780)
....+..+||+|-||.|..+...+ ..||||+++...... +..|..|+.+|.+++|||||.|+|+| .+..|+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 344556789999999999999887 899999999866544 47899999999999999999999999 44578999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|..+|.... .+.+.-....+|+.||++|++||.+.+ +|||||-+.|+|+|.++++||+|||++|-+......
T Consensus 618 EnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy- 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY- 693 (807)
T ss_pred hcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCce-
Confidence 9999999996432 122455667789999999999999999 999999999999999999999999999866433211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCccchhHHHHHHhccccccccC----cCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT--GRPVLRIKKDVKCALEKRNFNSVLDS----SAG 652 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt--G~~p~~~~~~~~~~~~~~~~~~~ld~----~~~ 652 (780)
......+-...|||||.+.-++++.+||||+||++|||+++ ...||....+-...-..+ .+++. ...
T Consensus 694 ----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~---~~~~~~~~~~~l 766 (807)
T KOG1094|consen 694 ----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG---EFFRDQGRQVVL 766 (807)
T ss_pred ----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh---hhcCCCCcceec
Confidence 12233455678999999999999999999999999999886 567886544322211111 22221 123
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
..|.-++..+.+++++||..+-.+||++ +++...|..
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsF-e~lh~~lq~ 803 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSF-EQLHLFLQE 803 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCH-HHHHHHHHH
Confidence 4466778889999999999999999999 788777764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.26 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=195.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
++|...++||+|+||.||+|... +..||+|.+..........+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888899999999999999874 67899999876544555678899999999999999999998854 357999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ..+.+++...+.++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--- 160 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence 9999999885 3457999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAGD 653 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~~ 653 (780)
.......|+..|+|||++. .+.++.++|||||||++|+|++|.+||.......... ....+. +....
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 232 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----PPKLK 232 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----CCccc
Confidence 1123456889999999984 4568899999999999999999999986443322111 111111 11000
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....+..+.+++.+|+..+|.+||++ .+++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~-~~ll 263 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTA-EKLL 263 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCH-HHHh
Confidence 111234568899999999999999999 6664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.27 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=199.4
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.+|...+.||.|+||.||+|.. .+..||||.+..........+.+|+.+++.++||||++++++|.+. .++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999986 4678999998765555567789999999999999999999998543 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 9999999884 245899999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......|+..|+|||.+.+..++.++|||||||++|+|+||++||...+........... .......|...
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPEKL 241 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCcccCCcccC
Confidence 112346888999999999888999999999999999999999999866554332211100 00011123345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+.+++.+||..+|.+||++ .+++
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~-~~il 267 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSA-KELL 267 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCH-HHHh
Confidence 5678899999999999999999 5554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.29 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=203.9
Q ss_pred cCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC-
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~- 490 (780)
.+|...+.||+|+||.||++... ...||+|.+.... ......|.+|+.++.++ +||||++++++|.+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999752 1368999887532 33456789999999999 799999999999654
Q ss_pred -CeeEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
.+++|||+++|+|.+++.... ....++|..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~ 169 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTE 169 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcC
Confidence 578999999999999986422 1235899999999999999999999999 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK 635 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~ 635 (780)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||+|++ |.+||...+...
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999998765422111 11122344567999999999999999999999999999999 888886544322
Q ss_pred HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 636 CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 636 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
.. .. +........|...+..+.+++.+|++.+|.+||++ .+++..|+.+....
T Consensus 245 ~~-~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LF-KL-----LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-KQLVEDLDRVLTVT 297 (334)
T ss_pred HH-HH-----HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHhhhc
Confidence 11 11 01111112233455679999999999999999999 99999999886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.24 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=191.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||||++... .......+.+|+.++..++||||+++++++.+. .+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999875 578999998642 122345688899999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999985 3456899999999999999999999999 9999999999999999999999999987553211
Q ss_pred CCCC----------------------------CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 576 STGN----------------------------SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 576 ~~~~----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
.... ..........||+.|+|||++.+..++.++|||||||++|+|+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011235799999999999999999999999999999999999999
Q ss_pred CccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 628 LRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
|..................+. .+. ....+..+.+++.+|+. +|.+|++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~--~p~-~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLV--FPP-EVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCHHHHHHHHHcCCCcee--cCC-CCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 976554332211111111111 000 01134567788888764 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=319.26 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=190.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
|...+.||+|+||.||++... +..||||.+.... ......+.+|+.++++++|||++.+++.+.+. .++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999885 5689999886432 22234577899999999999999999988543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988532 2346899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.....||..|+|||++.++.++.++|||||||++|+|++|++||......... ......++......+..
T Consensus 158 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 158 -------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQEEYSEK 227 (285)
T ss_pred -------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhhhhcCcc
Confidence 12346899999999999999999999999999999999999999753221000 00011111111112334
Q ss_pred HHHHHHHHHHHchhhCCCCCcch
Q 044673 658 EAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+..+.+|+.+||+.+|.+||++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCC
Confidence 55678999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.65 Aligned_cols=239 Identities=26% Similarity=0.422 Sum_probs=201.1
Q ss_pred ccccCCceEEEEeeecCe--eEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCCe--eEEEeccCCChhh
Q 044673 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLED 505 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~~~--~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~~--LV~Ey~~~gsL~~ 505 (780)
.||+|.||+||-|++.++ .+|||-+.........-+..|+.+.++|+|.|||+.+|+|.++.+ +.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999998765 479999988766777778999999999999999999999988765 6899999999999
Q ss_pred HHhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCcccccccccccccCCCCCCCCcc
Q 044673 506 CLACKNKKSPL--RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKLSDFGFFHLIPQGESTGNSAL 582 (780)
Q Consensus 506 ~L~~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl~DFGla~~~~~~~~~~~~~~ 582 (780)
+|. ..-+|| ++.+.-.+..||+.||.|||.+. |||||||-+|+|++ -.|.+||+|||.++.+..- .
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------n 730 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------N 730 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccC-------C
Confidence 995 345666 88999999999999999999999 99999999999996 5789999999998766321 1
Q ss_pred cccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH-HHhccccccccCcCCCCCHHHH
Q 044673 583 CNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA-LEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 583 ~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~-~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
..+.+..||..|||||++..| +|+++.|||||||++.||.||+|||........+ ..-|-++ .-+..|.+.+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPeels 805 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEELS 805 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHHHH
Confidence 123567899999999999876 5899999999999999999999999754443333 3333332 2345688889
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+...++++|++.+|.+||++ .+++
T Consensus 806 aeak~FilrcFepd~~~R~sA-~~LL 830 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSA-KDLL 830 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccH-HHhc
Confidence 999999999999999999999 5554
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.74 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=201.7
Q ss_pred hcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
.++|...++||+|+||.||+|.+.+ ..||||.+.... .....|.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3678899999999999999998754 679999987543 345678999999999999999999999865 367999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++++|.+++... ....+++..+..|+.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.....
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-- 158 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhh--
Confidence 999999999632 2346899999999999999999999999 99999999999999999999999999876643111
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.......++..|+|||++.++.++.++||||||+++|+|+| |+.||......... ... ........|..
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~-----~~~~~~~~~~~ 228 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-EQV-----ERGYRMPRPPN 228 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH-----HcCCCCCCCCC
Confidence 11122234567999999998899999999999999999999 99999654432211 111 00001112223
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.+..+.+++.+|+..+|..||++ .++...|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~l~~ 260 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTF-EYLQSFLED 260 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCH-HHHHHHHhc
Confidence 45679999999999999999999 899888874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.53 Aligned_cols=234 Identities=23% Similarity=0.310 Sum_probs=183.8
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHH-HhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVE-VLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~-il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||+|+||.||+|... +..||+|++.... ......+..|.. +++.++||||+++++++.+. .++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 4679999986421 122234444544 56789999999999988544 5799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----
Confidence 99999985 3456788888999999999999999999 9999999999999999999999999987542211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||...+....... +... ....+...+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~~-~~~~~~~~~~ 221 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILNK-PLQLKPNITN 221 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH------HHhC-CcCCCCCCCH
Confidence 112345799999999999999999999999999999999999999976544322111 0010 1112224566
Q ss_pred HHHHHHHHchhhCCCCCcchH
Q 044673 661 QLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
.+.+++.+|++.+|.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCC
Confidence 789999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.76 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=193.2
Q ss_pred HHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
....++|...+.||+|+||.||++... +..||+|++... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 334589999999999999999999885 567999998642 123345578999999999999999999998655 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++. ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 119 ~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 119 YMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 78999999999999884 235788899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETG----KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
..... .......||+.|+|||++... .++.++|||||||+||+|++|++||...+........-.....+
T Consensus 193 ~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266 (371)
T ss_pred CcCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 42211 112345799999999998753 37889999999999999999999998665432221100000000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCC---CcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLN---RPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~---RPs~~~ev~~ 686 (780)
. .. .+...+..+.+++.+|+. +|.. ||++ .+++.
T Consensus 267 ~--~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~-~ei~~ 303 (371)
T cd05622 267 T--FP-DDNDISKEAKNLICAFLT-DREVRLGRNGV-EEIKR 303 (371)
T ss_pred c--CC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCH-HHHhc
Confidence 0 01 112356678899999997 4443 6777 55554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.46 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=203.3
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeec-
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCP- 488 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~- 488 (780)
+.++.+..++++|.....||+|+||.||++... +..+|+|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677788899999999999999999999874 5789999886532 2345688999999999 6999999999872
Q ss_pred ----C--CCeeEEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 489 ----E--SRSLVFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 489 ----~--~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+ ..++||||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEE
Confidence 1 257999999999999987532 23457899999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
|+|||+++.+.... .......|++.|+|||++.. ..++.++|||||||++|+|+||++||...+....
T Consensus 165 l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred EccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999987664221 11234468999999999853 4578899999999999999999999976554333
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....... ..+. ...|...+..+..|+.+||+.+|.+||++ .+++.
T Consensus 238 ~~~~~~~---~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell~ 282 (286)
T cd06638 238 LFKIPRN---PPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTV-SDLLQ 282 (286)
T ss_pred Hhhcccc---CCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCH-HHHhh
Confidence 2211110 0000 01122234568999999999999999999 77754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.94 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=198.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||.|+||.||+|... +..||+|.+.... ......|.+|+.+++.++||||+++++++.+. .++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999874 5789999987543 33456788999999999999999999998654 5699999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++.. .++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 999999999852 37999999999999999999999999 9999999999999999999999999998775321
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.......|+..|++||++.+..++.++|||||||++|+|+||++||...+......... .......+..
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 221 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNPPSLEGN 221 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh------hcCCCCCccc
Confidence 11234568889999999999889999999999999999999999997654332211100 0011111111
Q ss_pred -HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 658 -EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 658 -~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+++.+|+..+|.+||++ .+++.
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~-~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSA-KELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCH-HHHhh
Confidence 45678999999999999999999 66643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.69 Aligned_cols=235 Identities=24% Similarity=0.367 Sum_probs=185.8
Q ss_pred ccccCCceEEEEeeecC---------eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 430 KIGEGRYGNVYRGLLRH---------LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
.||.|+||.||+|.... ..||+|.+..........|.+|+.+++.+.||||++++++|.. ..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 69999999999997642 3488898866544555678999999999999999999999854 468999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC--------ccccccccccc
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--------SKLSDFGFFHL 570 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~--------~Kl~DFGla~~ 570 (780)
++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++..
T Consensus 82 ~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 82 KFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999863 3346899999999999999999999999 999999999999988766 58899998754
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhC-CCCCccchhHHHHHHhcccccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTG-RPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
... .....++..|+|||++.+. .++.++|||||||++|+|++| .+|+...+..........
T Consensus 158 ~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 158 VLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred cCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 421 1224577889999999864 588999999999999999998 466654433221110000
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
....|......+.+++.+||+.+|.+||++ .++++.|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l 257 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSF-RAIIRDL 257 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 111222334678999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.97 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.+|...+.||+|+||.||+|.. .+..||+|.+..........+.+|+.+++.++||||++++++|.+. .++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999986 4688999998765555567788999999999999999999998554 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ...+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 9999999884 245899999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......+++.|++||++.+..++.++|||||||++|+|+||++||...+.......... ........|...
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~ 241 (297)
T cd06656 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNPERL 241 (297)
T ss_pred -----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----CCCCCCCCcccc
Confidence 11234678899999999998899999999999999999999999975543222111000 001111223445
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..+.+++.+||..+|..||++ .+++.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~-~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSA-KELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 6678899999999999999999 66643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.80 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=197.5
Q ss_pred CCCcccccccCCceEEEEeee-cCeeEEEEEccCCC------chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL-RHLHVAIKMFPSYG------PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~-~~~~VAiK~l~~~~------~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
+|.....||.|+||.||+|.. .+..+|||.+.... ......+.+|+.+|++++||||++++++|.+. .++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999987 46779999876432 11234688999999999999999999999655 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ...++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999995 3356899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.... ..........|+..|+|||++.+..++.++|||||||++|+|+||.+||...+............... ...
T Consensus 156 ~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 230 (265)
T cd06631 156 GLHG-THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----PRL 230 (265)
T ss_pred cccc-cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----CCC
Confidence 1111 11111234568899999999998889999999999999999999999997655443322211111111 112
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+...+..+.+++.+|+..+|.+||++ .+++
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~-~~~l 260 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSA-LQLL 260 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCH-HHHh
Confidence 33456778999999999999999999 6664
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=354.00 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=196.9
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC----CC
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SR 491 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~ 491 (780)
...++|.+..+||+|+||.||++... +..||+|.+... .......|..|+.+|.+|+|||||+++++|.+ ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999885 467999988643 23345678999999999999999999998732 25
Q ss_pred eeEEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CccccCCCCCCceEecC---------
Q 044673 492 SLVFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNE-----PCIIHGNLKPSKVLIDA--------- 556 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~ivHrDlKp~NILLd~--------- 556 (780)
+|||||+++|+|.++|... .....+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 7999999999999998642 23467999999999999999999999854 24999999999999964
Q ss_pred --------CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCC
Q 044673 557 --------NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRP 626 (780)
Q Consensus 557 --------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~ 626 (780)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..+++++||||||||||+|+||++
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 2348999999997664221 1134578999999999864 458899999999999999999999
Q ss_pred CCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 627 VLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 627 p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
||...+.....+...... .+.. ....+..+.+|+.+||..+|..||++ .+++
T Consensus 242 PF~~~~~~~qli~~lk~~--p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa-~QlL 293 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRG--PDLP----IKGKSKELNILIKNLLNLSAKERPSA-LQCL 293 (1021)
T ss_pred CCCcCCcHHHHHHHHhcC--CCCC----cCCCCHHHHHHHHHHhcCChhHCcCH-HHHh
Confidence 997655443332211100 0000 11235679999999999999999999 6776
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.57 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=196.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||++.+. +..||+|.+... .......|.+|+.++.+++||||+++++++... .++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999885 678999988653 233456789999999999999999999988543 5789999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|..++........+++..+..++.+++.||.|||+ .+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999988533234579999999999999999999996 47 9999999999999999999999999987653211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCC------CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGK------LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
.....|+..|+|||++.++. ++.++|+|||||++|+|+||+.||......... ..+..+.+..
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~ 226 (286)
T cd06622 158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVDGD 226 (286)
T ss_pred --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhhcC
Confidence 12346788899999986543 588999999999999999999999643321111 0111122222
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....|...+..+.+++.+|+..+|.+||++ .+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTY-AQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCH-HHHhc
Confidence 223444567789999999999999999999 66643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.63 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=201.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|.....||.|+||.||+|... +..+++|.+..........+.+|+.++++++||||+++++++.+. .+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67888999999999999999874 567999998765555667899999999999999999999988544 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++++|.+++.. ...++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 99999998852 2357999999999999999999999999 99999999999999999999999999876542110
Q ss_pred CCcccccCCCCCCcccCChhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG---KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
......++..|++||++.+. .++.++|||||||++|+|+||++||...+.......... . .+.+.....+
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 229 (262)
T cd06613 157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-S-NFPPPKLKDK 229 (262)
T ss_pred -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-c-cCCCccccch
Confidence 11334678889999999776 889999999999999999999999976554332221111 1 0111111223
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+..+.+++.+|+..+|..||++ .+|+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~-~~il 258 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTA-TKLL 258 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 3456789999999999999999999 6664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.70 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=198.0
Q ss_pred CCcccccccCCceEEEEeeec-----CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
|...+.||+|+||.||+|.+. +..||||++... .......+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556778999999999999863 467999998653 233456788999999999999999999987431
Q ss_pred -CeeEEEeccCCChhhHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN---KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
.+++++|+++|+|.+++.... ....+++.....++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 257899999999998875321 2235899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNF 643 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~ 643 (780)
+++....... ........+++.|++||.+..+.++.++|||||||++|+|++ |++||...+.... .+..+.
T Consensus 159 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 232 (273)
T cd05074 159 LSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN- 232 (273)
T ss_pred ccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9886542211 111123345677999999998889999999999999999999 8999875543221 111111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
....+...+..+.+++.+|+..+|.+||++ .+++..|+.+
T Consensus 233 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~-~~~~~~l~~~ 272 (273)
T cd05074 233 -------RLKQPPDCLEDVYELMCQCWSPEPKCRPSF-QHLRDQLELI 272 (273)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 111223455689999999999999999999 8999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.53 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=191.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
++|.....||+|+||.||+|... +..||+|++... .......|.+|+.++.+++||||++++++|.. ..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778889999999999999873 577999998653 23345679999999999999999999999854 35799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|..+. .+++.....++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999996542 4788899999999999999999999 999999999999999999999999998765321
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH-HHhccccccccCcCCCC-C
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA-LEKRNFNSVLDSSAGDW-P 655 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~-~~~~~~~~~ld~~~~~~-p 655 (780)
......||..|+|||++.+..++.++|||||||++|+|+||+.||......... ........+.+...... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence 123457889999999999889999999999999999999999999642211000 00000011111111111 1
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+++.+|++.+|..||++ .+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~-~eil~ 252 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAP-ENLMD 252 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCH-HHHhc
Confidence 1244578999999999999999999 66643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.82 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=191.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
++|...++||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999875 5679999987533 2233467899999999999999999999854 46799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 78887742 3446899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-cc-----cccc-
Q 044673 578 GNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-RN-----FNSV- 646 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~~-----~~~~- 646 (780)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||...+..... ... +. +..+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123467889999998865 46889999999999999999999999754432111 000 00 0000
Q ss_pred -----ccCcCC--------CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 647 -----LDSSAG--------DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 647 -----ld~~~~--------~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+.... ......+..+.+|+.+|+..||.+||++ .+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-EEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-HHHhc
Confidence 000000 0011235578899999999999999999 66643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.02 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=198.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|....+||.|+||.||+|.+. +..||+|.+..........|.+|+.++++++||||+++++++.+. .++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 367888999999999999999885 578999998766556667899999999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++.. ...++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999998853 2356999999999999999999999999 99999999999999999999999999765532111
Q ss_pred CCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
......|+..|++||++. +..++.++|||||||++|+|++|++||...+........... .....
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~ 228 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS----EPPTL 228 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC----CCCCc
Confidence 123356888999999975 345778999999999999999999999765544332221110 00011
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..|...+..+.+++.+||+.+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il 260 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTA-AELL 260 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCH-HHHh
Confidence 1122345678999999999999999999 6563
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.08 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=196.0
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.|+..+.||+|+||.||+|.+. +..||+|.+.... ......|.+|+.++++++||||++++++|.+. .++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566778999999999999874 5789999987533 33445788999999999999999999998554 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ..++++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 9999999884 356899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
.......|+..|+|||++.+..++.++|||||||++|+|+||++|+.......... .+........+...
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~ 225 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIPKNSPPTLEGQY 225 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhhcCCCCCCCccc
Confidence 11123467889999999999899999999999999999999999986443222111 01111122233345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..+.+++.+|+..+|.+||++ .+++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~-~~il~ 252 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTA-KELLK 252 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCH-HHHHH
Confidence 6779999999999999999999 77765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.05 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=194.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||++... +..||+|.+.... ......+.+|++++.+++||||++++++|.+. .++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47889999999999999999875 5678999886532 33345688999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++|+|.+++. ...++++..+..++.+++.||.|||+ .+ ++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999995 33678999999999999999999997 57 9999999999999999999999999987553211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhcccccccc------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLD------ 648 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld------ 648 (780)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||...+.... .+.. .......
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRP 225 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCccc
Confidence 1234688899999999888899999999999999999999999864332111 1100 0000000
Q ss_pred -----------------------CcCCCCC-HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 649 -----------------------SSAGDWP-VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 649 -----------------------~~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..| ...+..+.+++.+|+..+|.+||++ .+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~ll~ 286 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-KELTK 286 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 0000001 1245579999999999999999999 66644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.22 Aligned_cols=243 Identities=33% Similarity=0.499 Sum_probs=195.4
Q ss_pred cccccCCceEEEEeeec-CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCChh
Q 044673 429 WKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLE 504 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~ 504 (780)
++||+|+||.||++.+. +..||+|.+...... ....|.+|+.+++++.||||+++++++.+. .++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999886 688999988764333 566899999999999999999999998654 57999999999999
Q ss_pred hHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccc
Q 044673 505 DCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584 (780)
Q Consensus 505 ~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 584 (780)
+++.. ....+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-----VS 151 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcce-----ec
Confidence 99853 2346899999999999999999999999 999999999999999999999999998765321110 11
Q ss_pred cCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHHHHH
Q 044673 585 ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 585 ~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
.....++..|+|||++.++.++.++|+|||||++|+|+| |..||....... ..+..+ .....|...+..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 223 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG--------YRMPAPQLCPEE 223 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC--------CCCCCCccCCHH
Confidence 112234567999999998899999999999999999999 888886544322 111111 011123345678
Q ss_pred HHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 662 LAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
+.+++.+|+..+|.+||++ .+++..|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~-~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSF-SEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCH-HHHHHHhh
Confidence 9999999999999999999 88988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=319.23 Aligned_cols=256 Identities=20% Similarity=0.210 Sum_probs=189.2
Q ss_pred cccccccC--CceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 427 PSWKIGEG--RYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 427 ~~~~IG~G--~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
...+||+| +||+||++... +..||||.+.... ......+.+|+.+++.++|||||+++++|.+ ..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 78999999875 5789999987532 2233457789999999999999999999844 367999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++... ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998532 2345899999999999999999999999 9999999999999999999999998754432111110
Q ss_pred CCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hccccccccCc----
Q 044673 579 NSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLDSS---- 650 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld~~---- 650 (780)
...........++..|+|||++.+ ..++.++|||||||++|+|+||+.||........... .+.....++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 000111123456778999999976 4589999999999999999999999975433221111 11111111100
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 ---------------------------------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ---------------------------------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...........+.+|+.+|++.||.+||++ .+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-STLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-HHHhc
Confidence 000112335678999999999999999999 77754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.77 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=197.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
+|...++||+|+||.||++... +..||+|.+... .......+.+|+.+++.++||||+++++++.+. .++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999874 577999988542 233456788999999999999999999998554 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.. .....+++...+.++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 99999998853 23456899999999999999999999999 99999999999999999999999999876643211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCCCCH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 656 (780)
......|+..|+|||++.+..++.++|+||||+++|+|++|.+||...+..... +..+... ..|.
T Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (255)
T cd08219 156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PLPS 222 (255)
T ss_pred -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CCCc
Confidence 112356888999999999888999999999999999999999999865543221 1111111 1223
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+..+.+++.+||+.+|.+||++ .+++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~-~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSA-TTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCH-HHHhh
Confidence 345678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.09 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=196.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-----chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-----PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-----~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~ 491 (780)
.+|...+.||+|+||.||+|... +..||||.+.... ......|.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999874 5789999875321 12245688999999999999999999988652 4
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++. ....+++.....++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 68999999999999985 3345889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
...... ........|+..|+|||++.+..++.++|||||||++|+|++|++||........... . ...+..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~----~~~~~~ 227 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-I----ATQPTN 227 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-H----hcCCCC
Confidence 321111 0112334688899999999888899999999999999999999999975543332211 1 111223
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..|......+.+++.+|+ .+|..||++ ++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~-~~il 259 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIF-VEAKLRPSA-DELL 259 (265)
T ss_pred CCCchhhCHHHHHHHHHHh-cChhhCCCH-HHHh
Confidence 3445566778889999999 499999999 6664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.00 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=194.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-----chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-----PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-----~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~ 491 (780)
.+|.....||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999874 6789999876422 1233568899999999999999999998754 24
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++++||+++++|.+++. ....+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 68999999999999985 3346899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
....... .......++..|+|||++.+..++.++|||||||++|+|+||++||............. .....
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----~~~~~ 227 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----TQPTN 227 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----cCCCC
Confidence 3211110 11123457889999999998889999999999999999999999997554333221111 11112
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...|......+..++ +||..+|.+||++ .+|+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~-~eil 259 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSA-EELL 259 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCH-HHHh
Confidence 333444555666766 7888999999999 6664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.36 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=197.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||++... +..||+|++.... ......|.+|+++++.++||||++++++|.+. .+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888899999999999999885 6789999876532 34456789999999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++|+|.+++. ..+++++..+..++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999885 34579999999999999999999997 47 9999999999999999999999999986543211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH------HHHHhccccccccCc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK------CALEKRNFNSVLDSS 650 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~------~~~~~~~~~~~ld~~ 650 (780)
.....|+..|++||++.++.++.++|||||||++|+|+||+.||....... ..+. ..+..+....
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQEP 229 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhcc
Confidence 123568899999999988899999999999999999999999997543210 0000 0011111111
Q ss_pred CCCCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 651 AGDWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 651 ~~~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
....+. ..+..+.+|+.+|+..+|..||++ .+++..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-~e~~~~ 266 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTP-QQLCAM 266 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCH-HHHhcC
Confidence 112222 255679999999999999999999 777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.16 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=197.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC-C--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-S--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~--~~LV~E 496 (780)
+|...+.||.|+||.||++... +..||+|.+.... ......+.+|+.++++++|||++++++.+.. . .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999874 5679999986432 2345568899999999999999999998753 2 469999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++++|.+++... ...++++.+++.++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998632 3456899999999999999999999999 99999999999999999999999999876642211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~ 654 (780)
......|++.|+|||++.++.++.++|||||||++++|+||+.||...+.... .+..+.+ ...
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------PPM 222 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------CCC
Confidence 12345678899999999999999999999999999999999999975543221 1111111 122
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+...+..+.+++.+|+..+|.+||++ .+++
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~-~~~l 252 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSV-KSIL 252 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCH-HHHh
Confidence 33456789999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.09 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=188.6
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCC------CceeeEeeee
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH------PNLVTLIGTC 487 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H------pnIv~l~g~~ 487 (780)
+++...+++|...++||+|+||.||+|... +..||||++.... .....+..|+.++..++| +++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455789999999999999999999874 5679999986532 223345667777777654 4588998888
Q ss_pred cCC---CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCC-----
Q 044673 488 PES---RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANF----- 558 (780)
Q Consensus 488 ~~~---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~----- 558 (780)
... .|+|||++ +++|.+++. ...++++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccc
Confidence 543 57899987 778988885 33579999999999999999999997 58 99999999999998765
Q ss_pred -----------CcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 559 -----------GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 559 -----------~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
.+||+|||++..... ..+...||+.|+|||++.+..++.++|||||||+||||+||++|
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 489999998754321 12346789999999999999999999999999999999999999
Q ss_pred CccchhHHHHH--Hh--cccc-------------ccccCc---C-CCCC--------------HHHHHHHHHHHHHchhh
Q 044673 628 LRIKKDVKCAL--EK--RNFN-------------SVLDSS---A-GDWP--------------VAEAEQLAHLALRCCEN 672 (780)
Q Consensus 628 ~~~~~~~~~~~--~~--~~~~-------------~~ld~~---~-~~~p--------------~~~~~~l~~l~~~Cl~~ 672 (780)
|...+...... .. +.+. .+.+.. . ...+ ......+.+|+.+||..
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 97655432111 00 0000 000000 0 0000 01234578999999999
Q ss_pred CCCCCcchHHHHHH
Q 044673 673 NRLNRPDLVSEIWS 686 (780)
Q Consensus 673 ~p~~RPs~~~ev~~ 686 (780)
||.+||++ .+++.
T Consensus 425 dP~~R~ta-~e~L~ 437 (467)
T PTZ00284 425 DRQKRLNA-RQMTT 437 (467)
T ss_pred ChhhCCCH-HHHhc
Confidence 99999999 77653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.70 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=190.1
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
..++|.....||.|+||.||+|... +..||||.+.... ......+.+|+.+|++++||||++++++|..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999874 5679999986532 2234567899999999999999999988742
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..+++++++ +++|.+++. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccc
Confidence 236888887 789988773 346999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF 643 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~ 643 (780)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+........ +..
T Consensus 166 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 166 RQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred eecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 765321 123568999999999876 56899999999999999999999999754432211100 000
Q ss_pred -------------cccccCcCCCCCH--------HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 -------------NSVLDSSAGDWPV--------AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 -------------~~~ld~~~~~~p~--------~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+.. ....+. .....+.+|+.+|+..||.+||++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-~ell 296 (343)
T cd07878 236 SPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-SEAL 296 (343)
T ss_pred CHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 000000 000110 123457899999999999999999 6665
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.86 Aligned_cols=249 Identities=23% Similarity=0.266 Sum_probs=199.8
Q ss_pred cCCCcccccccCCceEEEEeeecC--eeEEEEEccCCCchh---HHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQS---HLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~~~---~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|..+++||.|.-|+||++.+++ ..+|+|++.+..... ..+.+.|-+||+.+.||.++.||..|... .||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567788899999999999999986 579999997643332 34566799999999999999999999654 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|||+||+|...+++ .....++...+..++.+|+.||+|||-.| ||.|||||+||||.++|++.|+||.|+.......
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999998863 45567999999999999999999999999 9999999999999999999999999985432100
Q ss_pred -CC----------------------------C--------------------CCcccccCCCCCCcccCChhhhccCCCC
Q 044673 576 -ST----------------------------G--------------------NSALCNESNNDSASVYIDPEYLETGKLT 606 (780)
Q Consensus 576 -~~----------------------------~--------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 606 (780)
.. . .....+....+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 0 0011223446899999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 607 PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 607 ~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.++|||+|||+|||||.|..||.+.+.-..... -+..+ ..+..| ..+..+.+||.+.|..||.+|-..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-----Iv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-----IVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-----HhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999987765443321 11111 223333 567789999999999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.23 Aligned_cols=194 Identities=25% Similarity=0.433 Sum_probs=157.6
Q ss_pred ccccccCCceEEEEeeec----CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCeeEEEecc
Q 044673 428 SWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSLVFEYLR 499 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV~Ey~~ 499 (780)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|++++||||+++++++.. ..++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999863 3679999986532 23456799999999999999999998833 2468999986
Q ss_pred CCChhhHHhhh------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----cCCCCcccccccccc
Q 044673 500 NGSLEDCLACK------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI----DANFGSKLSDFGFFH 569 (780)
Q Consensus 500 ~gsL~~~L~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL----d~~~~~Kl~DFGla~ 569 (780)
+ +|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 4 788776421 12235899999999999999999999999 9999999999999 466789999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCcc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRI 630 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~ 630 (780)
.+..... .........||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus 161 ~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 7643211 11223456789999999998764 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.08 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=199.5
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--CCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~ 492 (780)
++|.....||+|+||.||+|... ...|++|.+...... ....|.+|+.++++++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999863 246999988764433 45679999999999999999999999965 467
Q ss_pred eEEEeccCCChhhHHhhhCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKK------SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
+||||+++|+|.+++...... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999643321 26999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNF 643 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~ 643 (780)
++....... ........++..|++||.+.++.++.++||||||+++|+|++ |..||........ ....+.+
T Consensus 163 ~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 163 LSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred cccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 986543211 112233456778999999988889999999999999999999 7888864433221 1111111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.. ..+...+..+.+++.+|+..+|.+||++ .+++..|.
T Consensus 237 ~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~-~~~l~~l~ 274 (275)
T cd05046 237 EL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSF-SELVSALG 274 (275)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHhc
Confidence 10 0122345679999999999999999999 88887764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.63 Aligned_cols=244 Identities=22% Similarity=0.369 Sum_probs=198.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
..|+..++||.|+||.||+|.+. +..||||.+.... ......|.+|+.++++++||||++++++|.+. .++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999874 6789999886532 34456789999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++. ..++++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999884 346899999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......++..|+|||++.+..++.++|||||||++|+|+||.+||........... +........+..
T Consensus 157 ------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (277)
T cd06640 157 ------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------IPKNNPPTLTGE 224 (277)
T ss_pred ------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh------hhcCCCCCCchh
Confidence 12334678889999999988899999999999999999999999975443221110 001111223445
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+++.+||+.+|.+||++ .+++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~-~~il~ 252 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTA-KELLK 252 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCH-HHHHh
Confidence 67789999999999999999999 66643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.27 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=157.2
Q ss_pred ccccccCCceEEEEeeec----CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCeeEEEecc
Q 044673 428 SWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSLVFEYLR 499 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV~Ey~~ 499 (780)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|++++||||++++++|.. ..++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 3579999887532 23457799999999999999999998832 2478999987
Q ss_pred CCChhhHHhhh------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----cCCCCcccccccccc
Q 044673 500 NGSLEDCLACK------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI----DANFGSKLSDFGFFH 569 (780)
Q Consensus 500 ~gsL~~~L~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL----d~~~~~Kl~DFGla~ 569 (780)
+ +|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5 777776321 12345899999999999999999999999 9999999999999 567889999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCcc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRI 630 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~ 630 (780)
.+...... ........||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus 161 ~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76432211 1122345789999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.44 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=203.3
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecC
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE 489 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~ 489 (780)
++..++..++++|.....||+|+||.||++... +..+|+|.+.... .....+.+|+.++.++ +|||+++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 456777788999999999999999999999874 6789999986532 2345677899999999 79999999998842
Q ss_pred -------CCeeEEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 490 -------SRSLVFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 490 -------~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
..++||||+++|+|.+++... .....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEE
Confidence 257999999999999988532 23457899999999999999999999998 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCC-----CCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK-----LTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
|+|||++..+..... ......|+..|+|||++..+. ++.++|||||||++|+|+||++||...+....
T Consensus 169 l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred Eeecccchhcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 999999876542211 112346888999999986543 68899999999999999999999976554333
Q ss_pred HHH--hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 637 ALE--KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 637 ~~~--~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... .+....+ ..+......+.+++.+|++.+|.+||++ .+++
T Consensus 242 ~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~il 285 (291)
T cd06639 242 LFKIPRNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSV-THLL 285 (291)
T ss_pred HHHHhcCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCH-HHHh
Confidence 221 1111111 1122344579999999999999999999 6664
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.83 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=194.5
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRN 500 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~ 500 (780)
|+...+||+|+||.||++... +..||||.+..........+.+|+.++..++||||++++++|.. ..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999874 68899999876544556678899999999999999999998844 46799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
++|.+++. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+.....
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---- 172 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---- 172 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence 99999773 246899999999999999999999999 99999999999999999999999999876542211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......|+..|+|||++.+..++.++|||||||++|+|++|++||................ .... ..+...+.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~ 245 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKL-KNAHKISP 245 (297)
T ss_pred ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CCCc-cccCCCCH
Confidence 1233568899999999998899999999999999999999999997554433221111100 0000 11112345
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+.+++.+|++.+|.+||++ .+++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~-~~ll~ 270 (297)
T cd06659 246 VLRDFLERMLTREPQERATA-QELLD 270 (297)
T ss_pred HHHHHHHHHhcCCcccCcCH-HHHhh
Confidence 68899999999999999999 66655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=315.57 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=191.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|....+||.|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999875 5789999886432 22345677999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++ ++|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 589888853 3456899999999999999999999999 99999999999999999999999999876432211
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H------hccccccc
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E------KRNFNSVL 647 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~------~~~~~~~l 647 (780)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||...+...... . ...+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 11234568899999988654 57889999999999999999999997554321110 0 00000000
Q ss_pred cC------cCCC--------CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 648 DS------SAGD--------WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 648 d~------~~~~--------~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.. .... +....+..+.+|+.+|+..||.+||++ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-~eil 284 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-EEAM 284 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-HHHh
Confidence 00 0000 011235578899999999999999999 6664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.12 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-----chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-----PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-----~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
+|...+.||+|+||.||+|... +..|++|.+.... ......|.+|+.+++.++||||+++++++.+. .++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999999999884 6789999876432 22446789999999999999999999998654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++++|.+++. ...++++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999985 3456899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|++||............+... ....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~ 222 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----ELPP 222 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----cCCC
Confidence 1 123456888999999987776 8999999999999999999999997665443333222111 1112
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.|......+.+++.+|+..+|.+||++ .+++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~~l 253 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTA-AELL 253 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCH-HHHh
Confidence 233456778999999999999999999 6664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=304.92 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--C--CeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--S--RSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~--~~LV~ 495 (780)
+|...+.||.|+||.||++... +..||+|.+... .......+..|+.++++++||||+++++++.. . .+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999874 578999988643 23345678899999999999999999997742 2 47899
Q ss_pred EeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 496 EYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLH-----SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH-----~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
||+++|+|.+++... ....++++..++.++.+++.||.||| +.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998542 23567999999999999999999999 777 9999999999999999999999999988
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
....... ......|+..|++||++.+..++.++||||||+++++|++|+.||...+... ... .+...
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-----~~~~~ 225 (265)
T cd08217 159 ILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LAS-----KIKEG 225 (265)
T ss_pred cccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHH-----HHhcC
Confidence 7643221 1123468889999999998889999999999999999999999997654221 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....|...+..+.+++.+|+..+|.+||++ .+|++
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~-~~il~ 261 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPST-EELLQ 261 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCH-HHHhh
Confidence 2223444566789999999999999999999 67654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.61 Aligned_cols=246 Identities=18% Similarity=0.240 Sum_probs=189.3
Q ss_pred cCCCcccccccCCceEEEEeeec----CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.+|....+||+|+||.||++... +..||+|.+... ..+.+|+.+|++++|||||++++++... .|+|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 57999999999999999998753 356999988643 2345899999999999999999988543 679999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+. ++|.+++. ...++++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+.....
T Consensus 167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 985 68888883 4567999999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHhccc-------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEKRNF------- 643 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~~~~------- 643 (780)
. .......||+.|+|||++.+..++.++|||||||+||+|++|+.||..... ....+.....
T Consensus 241 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 241 T-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred c-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 1 112346799999999999999999999999999999999999999854321 1111110000
Q ss_pred ----------cccccCcCCCC--C-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 ----------NSVLDSSAGDW--P-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ----------~~~ld~~~~~~--p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..........+ | ......+.+++.+||..+|.+||++ .+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa-~e~l 373 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA-QDIL 373 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH-HHHh
Confidence 00000000001 1 0124568889999999999999999 6664
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.34 Aligned_cols=245 Identities=28% Similarity=0.505 Sum_probs=196.5
Q ss_pred CCcccccccCCceEEEEeeecC------eeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
|.....||.|+||.||++.... ..||+|++...... ....|.+|+.++..++||||+++++++.+ ..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999998864 67999999765433 56689999999999999999999999865 367999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999853221 12899999999999999999999999 9999999999999999999999999987765331
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~ 652 (780)
.. ......+++.|+|||.+.+..++.++||||||+++++|++ |.+||...+.... ....+. ..
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~ 223 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--------RL 223 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CC
Confidence 11 1112336788999999988889999999999999999999 8899875433221 111111 11
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
..+...+..+.+++.+|+..+|.+||++ .+++..
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~ll~~ 257 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTF-SELVEI 257 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCH-HHHHhh
Confidence 1222356779999999999999999999 777664
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=320.93 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=207.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch---hHHHHHHHHHHhhcCC-CCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ---SHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~---~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~L 493 (780)
...|...+.||.|.||.||++... +..+|+|.+...... ....+.+|+.+|+++. |||||.++++|.+. .++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467888899999999999999885 577999999764433 3457889999999998 99999999999665 479
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC----CCcccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN----FGSKLSDFGFFH 569 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~----~~~Kl~DFGla~ 569 (780)
|||++.||.|.|.+... .+++.....++.+++.++.|||+.+ |+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999744 2999999999999999999999999 9999999999999543 579999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~l 647 (780)
..... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||........ .+..+++
T Consensus 188 ~~~~~--------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---- 255 (382)
T KOG0032|consen 188 FIKPG--------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---- 255 (382)
T ss_pred EccCC--------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC----
Confidence 87541 124567999999999999999999999999999999999999999987775433 3333433
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+...+.|+ ..+..+.+++.+|+..||..|+++ .++++
T Consensus 256 ~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta-~~~L~ 292 (382)
T KOG0032|consen 256 DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTA-AQALQ 292 (382)
T ss_pred CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCH-HHHhc
Confidence 33445565 448889999999999999999999 66655
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.90 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=198.1
Q ss_pred CCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|+..+.||.|+||.||.+.. ++..|++|.+... .......|.+|+.++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999998887776 4678999987643 344556789999999999999999999999655 4689999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999986332 456899999999999999999999999 99999999999999999999999999887643221
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p 655 (780)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......... +..+.+. ..+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--------PVV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 123456889999999998888899999999999999999999999765432221 1112111 112
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+++.+|+..+|.+||++ .+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~-~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTA-DEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCH-HHHhh
Confidence 3345678999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.33 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=197.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47888999999999999999885 4679999886532 22345688999999999999999999998655 47999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ...++++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999995 3356999999999999999999999999 9999999999999999999999999987421111
Q ss_pred CC--------CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 576 ST--------GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 576 ~~--------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
.. ............|+..|+|||++....++.++|+|||||++|+|+||..||....... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccC
Confidence 00 0001111223467889999999988889999999999999999999999997543321 11111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+.. +...+..+..++.+|+..+|.+||+. ..+.+.|+
T Consensus 235 ~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~-~~~~~ll~ 272 (305)
T cd05609 235 WPEG---DEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQ 272 (305)
T ss_pred CCCc---cccCCHHHHHHHHHHhccChhhccCc-cCHHHHHh
Confidence 1111 11345678999999999999999997 44555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.08 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=209.4
Q ss_pred cCCCcccccccCCceEEEEeeecC--eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
-+..--++||-|-||.||.|.|+. ..||||.++.+. -...+|+.|..+|+.++|||+|+|+|+|... .|+|.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 344556789999999999999974 679999998753 4567899999999999999999999999543 68999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
.+|+|.|||... +...++.-..++++.||.+|+.||...+ +|||||-..|.|+.+|..+||+||||++++..+..+.
T Consensus 346 ~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 999999999533 3455777888999999999999999999 9999999999999999999999999999986543221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. ........|.|||-+....++.|||||+|||+|||+.| |..|+...+. +-..+++|- ..+-|
T Consensus 423 H------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--------RM~~P 488 (1157)
T KOG4278|consen 423 H------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--------RMDGP 488 (1157)
T ss_pred c------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc--------cccCC
Confidence 1 12233567999999999999999999999999999998 8888876543 223334332 33456
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..++..+..|++.||+.+|.+||++ .++-+.++.|-
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsF-aeiHqafEtmf 524 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSF-AEIHQAFETMF 524 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccH-HHHHHHHHHHh
Confidence 6788899999999999999999999 89999999884
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.76 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=196.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV~ 495 (780)
++|...++||.|+||.||+|... +..||+|.+.... ......|.+|++++++++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999984 5789999887532 2345678999999999999999999998843 257999
Q ss_pred EeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||+++|+|.+++... .....+++.....|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999999987532 24566899999999999999999999999 999999999999999999999999998655321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-----H--HHHHHhccccccc
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-----V--KCALEKRNFNSVL 647 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-----~--~~~~~~~~~~~~l 647 (780)
. .....++..|++||.+.+..++.++|||||||++|+|+||..||..... . ...+.......+-
T Consensus 159 ~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 159 L---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred c---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 1 1234567889999999999999999999999999999999999975521 1 1111110100000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..... ...+..+.+++.+|+..+|.+||++ .+++.
T Consensus 230 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~-~eil~ 265 (287)
T cd06621 230 DEPGNG--IKWSEEFKDFIKQCLEKDPTRRPTP-WDMLE 265 (287)
T ss_pred cCCCCC--CchHHHHHHHHHHHcCCCcccCCCH-HHHHh
Confidence 010100 1235678999999999999999999 66643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.60 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=201.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|+..+.||.|+||.||+|... +..||+|++.... ......+.+|+.+++.++||||+++++.+.+. .++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999873 5689999986532 23556789999999999999999999988543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++++|.+++........+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999964433457999999999999999999999999 999999999999999999999999998776533211
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC--
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW-- 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~-- 654 (780)
. ........|+..|++||++... .++.++|+|||||++|+|+||+.||...+........... ..+.....
T Consensus 159 ~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (267)
T cd06610 159 T---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGAD 232 (267)
T ss_pred c---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccc
Confidence 0 0112344688899999999877 7899999999999999999999999765543322221110 01111111
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+..+.+++.+|+..+|..||++ .+++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~-~~ll 262 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTA-EELL 262 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 12456778999999999999999998 6664
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.44 Aligned_cols=246 Identities=31% Similarity=0.465 Sum_probs=193.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHH--HHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHL--KFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~--~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
|...+.||+|+||+||++... +..||+|.+......... ...+|+.++.+++||||+++++++.+. .++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999986 457999999876443332 345699999999999999999998543 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++++|.+++. ....+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred cccccccccc---cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc----
Confidence 9999999996 4567899999999999999999999999 999999999999999999999999998754111
Q ss_pred CCcccccCCCCCCcccCChhhhc-cCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE-TGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~p 655 (780)
........++..|+|||++. +..++.++||||||+++++|++|..||..... ................... .
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ--S 226 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS--H
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc--c
Confidence 11234567889999999998 78899999999999999999999999986621 1112211111111111100 0
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
......+.+++.+||+.+|.+||++ .+++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~-~~l~ 255 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSA-EELL 255 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTH-HHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 0113789999999999999999999 6664
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.00 Aligned_cols=247 Identities=18% Similarity=0.337 Sum_probs=185.7
Q ss_pred ccccCCceEEEEeeec-C---eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCC
Q 044673 430 KIGEGRYGNVYRGLLR-H---LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGS 502 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~-~---~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gs 502 (780)
.||+|+||.||+|... + ..+++|.+.... ......|.+|+.+++.++||||++++++|.+. .++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999753 2 346777766533 34456899999999999999999999999654 589999999999
Q ss_pred hhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 503 LEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 503 L~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~----- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY----- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchh-----
Confidence 999996432 2345777888899999999999999999 99999999999999999999999999754321110
Q ss_pred ccccCCCCCCcccCChhhhcc-------CCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccccccccCcC
Q 044673 582 LCNESNNDSASVYIDPEYLET-------GKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~-------~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
........|+..|+|||++.. ..++.++|||||||++|||++ |.+||......... +..+....+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ- 233 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc-
Confidence 011134567889999998753 245789999999999999997 57788644432211 1112222222222
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
++......+.+++..|+ .+|.+||++ .+|++.|
T Consensus 234 --~~~~~~~~~~~l~~~c~-~~P~~Rp~~-~~i~~~l 266 (268)
T cd05086 234 --LELPYSERWYEVLQFCW-LSPEKRATA-EEVHRLL 266 (268)
T ss_pred --cCCCCcHHHHHHHHHHh-hCcccCCCH-HHHHHHh
Confidence 22234567888999999 689999999 8888776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.14 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=197.1
Q ss_pred CCCcccccccCCceEEEEeeecC---eeEEEEEccCC----------CchhHHHHHHHHHHhhc-CCCCceeeEeeeecC
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH---LHVAIKMFPSY----------GPQSHLKFQNEVEVLSR-VRHPNLVTLIGTCPE 489 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~---~~VAiK~l~~~----------~~~~~~~f~~Ev~il~~-l~HpnIv~l~g~~~~ 489 (780)
+|.....||+|+||.||+|.+.+ ..+|+|.+... .......+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999854 67999987532 12234557889998875 799999999999855
Q ss_pred C--CeeEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
. .++||||+++++|.+++.. ......+++..++.++.+++.||.|||+ .+ ++||||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 4 5799999999999998853 2345679999999999999999999996 56 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--Hhccc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNF 643 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~ 643 (780)
|++....... ......|+..|++||++.++.++.++||||||+++|+|++|++||...+...... ..+..
T Consensus 159 g~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence 9987654321 1234568889999999998889999999999999999999999997554332211 11111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+.. ....+..+.+++.+|++.||.+||++ .++...++
T Consensus 231 ----~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~-~e~~~~~~ 268 (269)
T cd08528 231 ----EPLP---EGMYSEDVTDVITSCLTPDAEARPDI-IQVSAMIS 268 (269)
T ss_pred ----CcCC---cccCCHHHHHHHHHHCCCCCccCCCH-HHHHHHhc
Confidence 1111 11235678999999999999999999 88887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.31 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=206.0
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
.+=|+..+.||+|.|+.|-++++ .|..||||++.+.. ......+.+||..|+-++|||||+||.+... ..|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35688888999999999998875 68899999997643 3345678899999999999999999999854 478999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~ 574 (780)
|.-++|+|.|+|.. ....|++....+++.||+.|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++..+.+.
T Consensus 97 ELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999963 4456999999999999999999999999 999999999988754 577999999998766543
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLT-PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
. ..++.+|++.|-|||++.+..|+ +++||||||||||-|++|++||...++-+. +..++|-. ..
T Consensus 173 ~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LTmImDCK-Yt 237 (864)
T KOG4717|consen 173 K--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LTMIMDCK-YT 237 (864)
T ss_pred c--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hhhhhccc-cc
Confidence 2 23567899999999999999987 589999999999999999999987776543 23344432 34
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.|...+.+..+||..||..||++|.++ ++|
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAsl-EeI 267 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASL-EEI 267 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccH-HHH
Confidence 578899999999999999999999998 655
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.93 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=200.6
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecC
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE 489 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~ 489 (780)
.+..++..+.+.|.....||.|+||.||+|... +..||+|++.... .....+..|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677889999999999999999999984 5789999886532 3445688999999999 69999999999832
Q ss_pred --------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 490 --------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 490 --------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEE
Confidence 247999999999999988532 3346889999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|+|+||.+||........
T Consensus 162 l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 162 LVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred EeeCcchhhhhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 999999876532111 123456888999999886 34678899999999999999999999965443322
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...... ...+. ..+...+..+.+++.+||..+|.+||++ .+++
T Consensus 235 ~~~~~~---~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~ell 277 (282)
T cd06636 235 LFLIPR---NPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPST-EQLL 277 (282)
T ss_pred hhhHhh---CCCCC--CcccccCHHHHHHHHHHhCCChhhCcCH-HHHh
Confidence 211100 00110 1112345679999999999999999999 6664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.10 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=194.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|.....||+|+||.||+|... +..||+|++.... ......|.+|+.++++++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999885 6789999886432 22345688999999999999999999998654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998888763 3456999999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh-cccccc--------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK-RNFNSV-------- 646 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~-~~~~~~-------- 646 (780)
......++..|+|||++.+ ..++.++|||||||++|+|+||++||...+........ ..+..+
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1123457788999999876 45789999999999999999999999765543222110 000000
Q ss_pred ---------ccCc-CCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 ---------LDSS-AGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 ---------ld~~-~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+. ....+ ...+..+.+|+.+|+..+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~eil 281 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-EELL 281 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-HHHh
Confidence 0000 00000 1235678999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.29 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=195.0
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
.|.....||+|+||.||++... +..||||.+..........|.+|+.++++++||||+++++.|.+ ..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3344467999999999999874 67899999876555556678999999999999999999998754 4679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+++|.+++. ...+++..+..++.+|+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--- 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--- 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---
Confidence 999999884 245899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+....... +...+.+.. ..+...+
T Consensus 174 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~ 245 (292)
T cd06658 174 ----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRV-KDSHKVS 245 (292)
T ss_pred ----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcc-ccccccC
Confidence 11234688899999999888899999999999999999999999975544322111 011111111 1122345
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+..++.+|+..+|.+||++ .+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~-~~il~ 271 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATA-QELLQ 271 (292)
T ss_pred HHHHHHHHHHccCChhHCcCH-HHHhh
Confidence 678899999999999999999 66654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.44 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=198.2
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES------- 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~------- 490 (780)
++++|...+.||+|+||.||+|... +..|++|++..... ....|.+|+.+++++ .||||++++++|.+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5689999999999999999999985 46799999876432 346789999999999 699999999998432
Q ss_pred -CeeEEEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCccc
Confidence 479999999999999885422 3467999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~ 643 (780)
....... .......|+..|+|||++.. ..++.++|||||||+||+|+||++||.............
T Consensus 161 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-- 231 (275)
T cd06608 161 AQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-- 231 (275)
T ss_pred eecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh--
Confidence 7654221 11234568889999998854 346789999999999999999999997544332221110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.. .. .....+...+..+.+|+.+|+..||.+||++ .+++.
T Consensus 232 ~~-~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-~~ll~ 271 (275)
T cd06608 232 RN-PP-PTLKSPENWSKKFNDFISECLIKNYEQRPFM-EELLE 271 (275)
T ss_pred cc-CC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCH-HHHhc
Confidence 00 00 0111222355679999999999999999999 66643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.32 Aligned_cols=229 Identities=21% Similarity=0.287 Sum_probs=180.8
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC---CCCceeeEeeeecCC--CeeEEEeccC
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV---RHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
||+|+||.||+|... +..||||++.... ......+..|..++... .||||+++++++.+. .++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999874 6789999986421 12234456677777766 699999999988544 6899999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---- 151 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---- 151 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC----
Confidence 99999885 3456899999999999999999999999 99999999999999999999999999875422111
Q ss_pred cccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCCCCC-H
Q 044673 581 ALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWP-V 656 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p-~ 656 (780)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||...+.... .+..+.. .+| .
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------~~~~~ 219 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV---------RFPKN 219 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------CCCCc
Confidence 12345789999999998764 489999999999999999999999976543221 1111111 111 1
Q ss_pred HHHHHHHHHHHHchhhCCCCCcch
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+..+.+++.+||..+|.+||+.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 245678899999999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.66 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=197.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch---hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ---SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~---~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||.+...... ....+..|++++..+.||||+++++.+.+. .++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999885 578999998754322 445688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+.+|+|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999998852 23457999999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCCCC----------------------cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh
Q 044673 576 STGNS----------------------ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 576 ~~~~~----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
..... .........||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11000 00011234688899999999988899999999999999999999999976554
Q ss_pred HHHHHHhccccccccCcCCCCCH--HHHHHHHHHHHHchhhCCCCCcchH
Q 044673 634 VKCALEKRNFNSVLDSSAGDWPV--AEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 634 ~~~~~~~~~~~~~ld~~~~~~p~--~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
...... +... ...++. ..+..+.+++.+|+..+|.+||+..
T Consensus 238 ~~~~~~------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 238 DETFSN------ILKK-EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred HHHHHH------HhcC-CccCCCccccCHHHHHHHHHHccCCHhHCCCch
Confidence 332211 1111 111111 2567899999999999999999953
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.18 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=193.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|...++||+|+||.||+|.+. +..||+|++..... .....|.+|+.+++.++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999985 57899998765322 2345688999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++++|.++.. ....++|..++.++.+|+.||.|||+.+ ++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999988764 3345899999999999999999999999 99999999999999999999999999876643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cccc-------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFN------- 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~------- 644 (780)
..+...++..|+|||++.+ ..++.++|||||||++|+|+||++||............ +.+.
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1233467889999999875 45788999999999999999999999754432211100 0000
Q ss_pred ---ccc----cCcCC------CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ---SVL----DSSAG------DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ---~~l----d~~~~------~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+. .+... ..+...+..+.+++.+|+..+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-~~il 281 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-SQLL 281 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-HHHh
Confidence 000 00000 0011345679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.00 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=201.4
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-----Cch---hHHHHHHHHHHhhcC-CCCceeeEeeeecC
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-----GPQ---SHLKFQNEVEVLSRV-RHPNLVTLIGTCPE 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-----~~~---~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~ 489 (780)
..++|.....||.|+.+.|.++..+ +..+|+|++... ++. -...-.+|+.||+++ .||||++|.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3467888889999999999998775 567899987532 111 123356899999998 59999999999976
Q ss_pred C--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
. .++|+|.|+.|.|.|+|. ..-.+++....+|+.++..|+.|||..+ ||||||||+|||+|+|.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccce
Confidence 6 458999999999999995 4567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHH
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLET------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALE 639 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~ 639 (780)
+..+..+.. ....+||++|+|||.+.. .+|+..+|.|++|||||-||.|.|||.-..... ..+.
T Consensus 170 a~~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 170 ACQLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred eeccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 988865432 356799999999998853 468889999999999999999999996544322 2334
Q ss_pred hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 ~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.|++. ...++|. +.+....+|+.+||+.||.+|.+. .+++
T Consensus 242 eGkyq----F~speWa-dis~~~KdLIsrlLqVdp~~Rita-ke~L 281 (411)
T KOG0599|consen 242 EGKYQ----FRSPEWA-DISATVKDLISRLLQVDPTKRITA-KEAL 281 (411)
T ss_pred hcccc----cCCcchh-hccccHHHHHHHHHeeCchhcccH-HHHh
Confidence 45443 2334553 567789999999999999999998 6664
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.59 Aligned_cols=248 Identities=21% Similarity=0.366 Sum_probs=196.3
Q ss_pred CCCcccccccCCceEEEEeee--cCeeEEEEEccCCCc------hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
+|+....||+|+||.||+|.. .+..||+|.+..... .....|.+|+.++++++||||++++++|.+. .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999986 467899998864321 1345788999999999999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-Cccccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIP 572 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~ 572 (780)
||||+++++|.+++. ...++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++ .+||+|||++..+.
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999985 3457899999999999999999999999 99999999999998776 59999999987765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH---HHHHHhccccccccC
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV---KCALEKRNFNSVLDS 649 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~---~~~~~~~~~~~~ld~ 649 (780)
...... ........|+..|+|||++.+..++.++||||||+++++|++|..||...... ....... ...
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~ 227 (268)
T cd06630 156 AKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-----SAT 227 (268)
T ss_pred cccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-----ccC
Confidence 321110 01122346888999999998888999999999999999999999999643321 1111100 001
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....|...+..+.+++.+|+..+|..||++ .+++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~ll 262 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPS-RELL 262 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCH-HHHh
Confidence 1233455567789999999999999999999 6654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.68 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=189.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
..+|.+...||+|+||.||+|.+. +..||||.... ..+.+|+.+|++++|||||++++++.. ..+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999986 46799996432 245689999999999999999998754 36799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+. |+|.+++.. ...+++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 688888752 3347999999999999999999999999 999999999999999999999999999876422111
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCC-ccc---------hhHHHHHHhccccc-c
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL-RIK---------KDVKCALEKRNFNS-V 646 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~-~~~---------~~~~~~~~~~~~~~-~ 646 (780)
.......||..|+|||++.+..++.++|||||||+||||++|..|+ ... ..+...+....... .
T Consensus 317 -----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 317 -----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred -----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1112457999999999999999999999999999999999987654 211 11112222111100 0
Q ss_pred cc----------------------CcCCCCCH--HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 647 LD----------------------SSAGDWPV--AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 647 ld----------------------~~~~~~p~--~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+. .....|.. .....+.+|+.+||..||.+||++ .+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa-~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA-AELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH-HHHhh
Confidence 00 00111221 223468899999999999999999 66654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.80 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=201.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||+|... +..|+||++..... .....|.+|+.++.+++||||+++++++... .++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999885 67899999876543 4456799999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++.. ..++++..++.++.+++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999999953 3679999999999999999999999 99 99999999999999999999999999876643221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch--hHHHHHHhccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK--DVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~--~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. .....++..|+|||++.++.++.++|+||||+++|+|+||++||.... ........ +........
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 223 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICDGPPPSL 223 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----HhcCCCCCC
Confidence 1 123467888999999999999999999999999999999999997654 22221111 111112223
Q ss_pred CHH-HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PVA-EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+.. .+..+..++.+|+..+|..||++ .+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~-~~ll~ 255 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSA-AELLQ 255 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCH-HHHHh
Confidence 333 56789999999999999999999 66654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=294.68 Aligned_cols=241 Identities=24% Similarity=0.413 Sum_probs=195.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccC--CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPS--YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~--~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++.|+.-..||+|.|+.||++... |..+|+|++.. ....+.+++.+|+.|.+.|+|||||+|.....+. .+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 357777788999999999998774 66788887643 3345677889999999999999999999988654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla~~~~ 572 (780)
|+|.||+|..-|..+ ...++...-....||+.||.|+|.++ |||||+||.|+||-. ..-+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766433 45677888889999999999999999 999999999999943 3448999999998876
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHHHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~~~~~~~~~~ld~~ 650 (780)
.... ....+||++|||||++...+|+..+|||+.|||||-||.|.+||...+. .-..+..|. .|-.
T Consensus 165 ~g~~--------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~----yd~~ 232 (355)
T KOG0033|consen 165 DGEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA----YDYP 232 (355)
T ss_pred Cccc--------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----cCCC
Confidence 2211 2356899999999999999999999999999999999999999976332 222233332 3333
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.|+ ..+++..+|+.+||..||.+|-+.
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta 261 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITA 261 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccH
Confidence 44565 567788999999999999999887
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.26 Aligned_cols=257 Identities=13% Similarity=0.140 Sum_probs=183.7
Q ss_pred cCCCcccccccCCceEEEEeeecCe-----eEEEEEccCCCchhH-----------HHHHHHHHHhhcCCCCceeeEeee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHL-----HVAIKMFPSYGPQSH-----------LKFQNEVEVLSRVRHPNLVTLIGT 486 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~-----~VAiK~l~~~~~~~~-----------~~f~~Ev~il~~l~HpnIv~l~g~ 486 (780)
+.|...++||+|+||.||+|.+.+. .+|+|+......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6799999999999999999987543 567776433222111 112234455667789999999987
Q ss_pred ecCCC------eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 487 CPESR------SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 487 ~~~~~------~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
+.... +++++++.. ++.+.+. .....++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcE
Confidence 64332 456666543 5666653 2334678889999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL-- 638 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~-- 638 (780)
||+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||+|+||++||..........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999998764322111111112233579999999999999999999999999999999999999997553211111
Q ss_pred -HhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHH
Q 044673 639 -EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688 (780)
Q Consensus 639 -~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L 688 (780)
..+-+..+..... .+...+..+.+++..|+..+|.+||++ .++.+.|
T Consensus 246 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~-~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDY-DALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCH-HHHHHhh
Confidence 1111111111110 011235679999999999999999999 8887765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=321.38 Aligned_cols=187 Identities=20% Similarity=0.279 Sum_probs=158.6
Q ss_pred hcCCCcccccccCCceEEEEeeecC--eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
..+|...+.||+|+||.||+|...+ ..||+|+.... .+..|+.++++++|||||+++++|.+. .++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3579999999999999999999864 57999985432 234699999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+. |+|.+++. ....+++|..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 YS-SDLYTYLT--KRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred cC-CcHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 95 68888875 34567999999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
......||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus 212 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 212 ------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 11335689999999999999999999999999999999986444
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.65 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=199.8
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
+|...+.||+|+||.||++... +..|++|++..........+.+|+.++++++|||++++++++.+ ..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999985 67899999977554466789999999999999999999998854 3679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+++|.+++... ...+++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999998532 257999999999999999999999999 99999999999999999999999999877653221
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
.....|+..|++||++.+..++.++||||||+++++|+||++||...+.......... .+.....++...+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 224 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEKWS 224 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcccccC
Confidence 2345678889999999988899999999999999999999999976543332221111 1111111222235
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+.+++.+|+..+|..||++ .+++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~-~~~l 249 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTA-EQLL 249 (253)
T ss_pred HHHHHHHHHHccCChhhCCCH-HHHh
Confidence 679999999999999999999 6665
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.15 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=193.6
Q ss_pred CCCcccccccCCceEEEEeee--cCeeEEEEEccCCCc---h-------hHHHHHHHHHHhhcCCCCceeeEeeeecCC-
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP---Q-------SHLKFQNEVEVLSRVRHPNLVTLIGTCPES- 490 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~---~-------~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~- 490 (780)
+|...+.||+|+||.||+|.. .+..||||.+..... . ....|.+|+.++++++|||+++++++|.+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999976 367899998753111 0 124578899999999999999999998554
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+++|+|.+++. ...++++..+..|+.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLR---TYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 579999999999999985 3367999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGK--LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
...... .........|+..|+|||++.... ++.++|+||||+++|+|++|..||...+............ .
T Consensus 157 ~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~ 229 (272)
T cd06629 157 KSDDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--S 229 (272)
T ss_pred cccccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--c
Confidence 643211 111223456888999999987654 8899999999999999999999997544433222211100 0
Q ss_pred cCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
... ........+..+.+++.+|+..+|..||++ .+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTA-RELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCH-HHHhh
Confidence 000 111112346789999999999999999998 66643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.71 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=195.2
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
|...+.||.|+||.||+|... +..||||.+.... ......|.+|+.++++++||||++++++|.+. .++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667788999999999999864 5789999876432 23446788999999999999999999998554 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. ...+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 999999884 346899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
.......|+..|++||++.+..++.++|+|||||++|+|+||.+||............ ........+...+
T Consensus 156 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~ 226 (277)
T cd06641 156 ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI------PKNNPPTLEGNYS 226 (277)
T ss_pred ---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH------hcCCCCCCCcccC
Confidence 1123346788899999999888999999999999999999999999754432211110 0111112233455
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+.+++.+|+..+|..||++ .+++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~-~~~l~ 252 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTA-KELLK 252 (277)
T ss_pred HHHHHHHHHHccCChhhCcCH-HHHHh
Confidence 678999999999999999999 66655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.32 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=194.8
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCC---CCceeeEeeeecCC--CeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVR---HPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~~~--~~LV~ 495 (780)
.|+..+.||.|+||.||+|.+. +..||||.+... .......+.+|+.++++++ |||+++++++|.+. .++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5778889999999999999974 678999998653 2344567889999999997 99999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++. ..++++...+.++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999884 237999999999999999999999999 9999999999999999999999999987765322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. ......|+..|+|||++.++ .++.++|||||||++|+|++|.+||............ ... ....+
T Consensus 156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~---~~~~~ 222 (277)
T cd06917 156 S-------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKS---KPPRL 222 (277)
T ss_pred c-------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---ccC---CCCCC
Confidence 1 12334688899999998765 4688999999999999999999999765443222110 000 11111
Q ss_pred CH-HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PV-AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+. ..+..+.+++.+|+..+|.+||++ .+++.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSA-EELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCH-HHHhh
Confidence 21 145678999999999999999999 66643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.54 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=195.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec--CCCeeEEEecc
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ESRSLVFEYLR 499 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~~LV~Ey~~ 499 (780)
.|...+.||+|+||.||+|... +..|++|.+..........+.+|+.+++.++||||+++++++. +..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444568999999999999864 5789999887654455667889999999999999999999874 44679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+++|.+++.. .++++..+..|+.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 9999999852 56899999999999999999999999 99999999999999999999999998876542211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
......|++.|+|||++.+..++.++|||||||++|+|++|++||...+........ .... +.....+...+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~ 242 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---RDNL-PPKLKNLHKVS 242 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---HhcC-CCCCcccccCC
Confidence 112346888999999999888999999999999999999999998755433221110 0001 11111122355
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+.+++.+||..+|.+||++ .+++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~-~~il 267 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATA-AELL 267 (285)
T ss_pred HHHHHHHHHHcccChhhCcCH-HHHc
Confidence 679999999999999999999 6664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.35 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|+..++||+|+||.||++... +..||+|.+... .......+.+|+.++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999998874 678999988642 233456789999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++++|.+++.. .....+++..++.|+.+++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999998853 22346899999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......|++.|+|||++.++.++.++|+|||||++++|+||+.||...+....... ++.......|..
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK------IIRGSYPPVSSH 224 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH------HhcCCCCCCccc
Confidence 11234578889999999988899999999999999999999999975443221111 111111222334
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+++.+|++.+|.+||++ .+|+.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~-~~vl~ 252 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSV-NSILE 252 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCH-HHHhh
Confidence 56779999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.38 Aligned_cols=244 Identities=24% Similarity=0.373 Sum_probs=196.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||.|+||.||++... +..||+|.+.... ......|.+|++++++++||||++++++|... .++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788889999999999999986 6789999887643 34456789999999999999999999988554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++... ..++++.....++.+++.||.|||+ .+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999998532 2678999999999999999999999 88 99999999999999999999999999866532111
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch----hHHHHHHhccccccccCcCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK----DVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~----~~~~~~~~~~~~~~ld~~~~ 652 (780)
....++..|++||++.+..++.++||||||+++|+|+||+.||.... .....+. .++.....
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ-----YIVNEPPP 222 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----HHhcCCCC
Confidence 11567888999999999899999999999999999999999996542 1111111 11111111
Q ss_pred CCCHH-HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVA-EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+.. .+..+.+++.+|+..+|.+||++ .+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~ll 255 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSY-KELL 255 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCH-HHHh
Confidence 22222 56779999999999999999999 6664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=304.35 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=201.5
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
..+++|.....||+|+||.||+|.+. +..|++|++..... ....|.+|+.++++++|||+++++++|.. ..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34678899999999999999999986 67899999876443 56678899999999999999999998854 467999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++.... ..+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999996322 47999999999999999999999999 9999999999999999999999999976553221
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. ......++..|++||++.+..++.++|||||||++|+|+||+.||...+........... . .. ....+
T Consensus 171 ~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~--~~~~~ 239 (286)
T cd06614 171 S-------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-G-IP--PLKNP 239 (286)
T ss_pred h-------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-CC--CCcch
Confidence 1 112345778899999998888999999999999999999999999866554322211110 0 00 01112
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+++.+|++.+|..||++ .+++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~-~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSA-EELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCH-HHHhh
Confidence 2245679999999999999999999 66753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.64 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=195.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||++... +..||||.+... .......|.+|+.+|++++||||+++++.+.+. .++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999998874 577999988653 233456789999999999999999999987543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999632 2446899999999999999999999999 9999999999999865 4579999999887643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
.....|+..|+|||.+.+..++.++||||||+++|+|+||+.||...+........ ........+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 223 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI------MSGTFAPISD 223 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH------HhcCCCCCCC
Confidence 12346788999999999888999999999999999999999999765433222111 1111111222
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+++.+||..+|.+||++ .+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~-~~ll 251 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQL-SQIM 251 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 356679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.01 Aligned_cols=237 Identities=27% Similarity=0.367 Sum_probs=193.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhH---HHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSH---LKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~---~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
.-|..++-||.|+||.||.+.+. ...||||.+.-.+.+.. ..+..||..|.+++|||+|.+-|+|.. ...|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34777888999999999999874 46799999987665544 456789999999999999999999843 356999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|||- ||-.|+|. -...||.+.++..|..+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|....+
T Consensus 106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9995 58888884 24568999999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
....+||++|||||++. .|.|+-|+|||||||+..||.-.+||+-..+......... -++--.-..+
T Consensus 179 ---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtLqs~ 248 (948)
T KOG0577|consen 179 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSN 248 (948)
T ss_pred ---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCCCCc
Confidence 24578999999999985 5889999999999999999999999987666544332211 1110000123
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+.++.+..++..||+.=|.+||+.
T Consensus 249 ----eWS~~F~~Fvd~CLqKipqeRpts 272 (948)
T KOG0577|consen 249 ----EWSDYFRNFVDSCLQKIPQERPTS 272 (948)
T ss_pred ----hhHHHHHHHHHHHHhhCcccCCcH
Confidence 346779999999999999999987
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.02 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=196.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|+..+.||+|+||.||+|.+. +..||||.+... .......+.+|+.++++++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999885 568999988653 233356789999999999999999999998544 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++++.+..++. ....+++..+..++.+|+.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999877776653 3456899999999999999999999999 99999999999999999999999999887653221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc----cc-------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN----FN------- 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~----~~------- 644 (780)
.......++..|+|||++.+. .++.++||||||+++|+|++|++||.............. +.
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 112345678889999999888 889999999999999999999999976544332221100 00
Q ss_pred ---------ccccCcC-----CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ---------SVLDSSA-----GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ---------~~ld~~~-----~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+... ..++...+..+.+++.+||..+|.+||++ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il 283 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-DELL 283 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-HHHh
Confidence 0000000 01222346789999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.91 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=191.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|+....||.|+||.||+|... +..||||.+.... ......|.+|+.++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999874 6789999886532 22345788999999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+. ++|.+++... ....+++..++.++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6898888532 3456899999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc----cccc-------
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR----NFNS------- 645 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~----~~~~------- 645 (780)
......++..|+|||++.+.. ++.++|||||||++|+|+||+.||...+......... ....
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 113345688899999887644 6889999999999999999999997554432221100 0000
Q ss_pred -----------cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 -----------VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 -----------~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.............+..+.+++.+|++.||.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~l 279 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-KAAL 279 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-HHHh
Confidence 00000000011234567899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.94 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=197.4
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
++|...+.||+|+||.||+|.. .+..||+|.+..........|.+|+.++++++||||++++++|.+ ..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6889999999999999999976 467899999875545556678999999999999999999999844 468999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 9999999984 235889999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......|++.|++||++..+.++.++|||||||++|++++|++||...+........... .......+...
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPEKL 241 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC----CCCCCCCcccc
Confidence 112346888899999998888999999999999999999999999755432211110000 00001112234
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+.+++.+||..+|.+||++ .+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~-~~il 267 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSA-KELL 267 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 5678999999999999999999 6664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.38 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=190.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|.....||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||+++++++.+. .++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368899999999999999999874 67899999865322 2234577899999999999999999998654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++ +|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9985 89998853 2347899999999999999999999999 99999999999999999999999999875432111
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----------ccccc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----------RNFNS 645 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----------~~~~~ 645 (780)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+.. ..+..
T Consensus 159 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 159 -------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred -------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 1122346788999999875 45889999999999999999999999654422111110 00000
Q ss_pred cc------cCcCCCC---------C-HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 VL------DSSAGDW---------P-VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ~l------d~~~~~~---------p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+. ......+ + ......+.+++.+|++.+|.+||++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-~e~l 286 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-AEAM 286 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-HHHh
Confidence 00 0000000 0 0112567899999999999999999 6654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.68 Aligned_cols=250 Identities=25% Similarity=0.298 Sum_probs=192.7
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch-----hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-----SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-----~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
+|...+.||+|+||.||+|... +..||||.+...... ....+..|+.++++++||||+++++++.+. .++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999874 678999998754322 234577899999999999999999999664 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+ +|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 9999999852 2247999999999999999999999999 999999999999999999999999998776432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc-----------
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN----------- 642 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~----------- 642 (780)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..............
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 156 NR-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred Cc-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 11 1223456788999998865 4578999999999999999999988865544321110000
Q ss_pred ----ccccccCc------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 ----FNSVLDSS------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ----~~~~ld~~------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
........ ........+..+.+++.+||..+|.+||++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-RQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-HHHhh
Confidence 00000000 000112345678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=299.48 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=195.7
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.++++++||||+++++++.+. .++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999874 67899999876433 3567799999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++++|.+++. ....+++..+..|+.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999985 3346889999999999999999999999 999999999999999999999999998776533211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCccchh-HHHHHHhccccccccCcCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGK---LTPESDVYSFGIILLRLLTGRPVLRIKKD-VKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~ksDVwS~Gvil~eLltG~~p~~~~~~-~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ......++..|++||++.+.. ++.++||||||+++|++++|+.||...+. ......... ...+..+.
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 100 012356788999999998766 88999999999999999999999964422 211111111 01111111
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ ...+..+.+++.+|++.+|.+||++ .+++
T Consensus 230 ~-~~~~~~~~~li~~~l~~~p~~R~~~-~~i~ 259 (264)
T cd06626 230 S-LQLSPEGKDFLDRCLESDPKKRPTA-SELL 259 (264)
T ss_pred c-cccCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 1 1236678899999999999999999 6653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.97 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=194.1
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
+|+..++||.|+||.||+|... +..||||.+..... .....+.+|+.++++++||||++++++|.+. .++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999984 67899998875432 2345677899999999999999999998654 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++ +|.+++.......++++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 85 88888864444467999999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc---------------c
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR---------------N 642 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~---------------~ 642 (780)
......++..|++||++.+. .++.++|||||||++|+|+||++||...+......... .
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 12334578889999988654 57889999999999999999999997554332111000 0
Q ss_pred cccccc-------CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNSVLD-------SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~~ld-------~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...... ..........+..+.+++.+|++.+|.+||++ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~~l 279 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-HDAL 279 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-HHHh
Confidence 000000 00001112335678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.86 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=204.7
Q ss_pred CcccccccCCceEEEEeeecC-----eeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEec
Q 044673 426 EPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYL 498 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~ 498 (780)
...++||+|.||.|++|.|+. ..||||.+..+... ....|.+|+.+|.+|+|||+|+|||...+. ..+|+|.+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELa 192 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELA 192 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhc
Confidence 344679999999999999952 46999999876554 567899999999999999999999999865 45899999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+.|||.++|.. .....|.......++.|||.|+.||...+ +|||||-..||||-..-.+|||||||.+.+..+....
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999975 56677888899999999999999999999 9999999999999999999999999999887554322
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcccccccc-CcCCCCCH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLD-SSAGDWPV 656 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld-~~~~~~p~ 656 (780)
. ......-.+.|+|||.+..+.++.+||||+|||+||||+| |.-||-......-. . .+| .....-|.
T Consensus 270 v----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-~------~iD~~erLpRPk 338 (1039)
T KOG0199|consen 270 V----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-K------NIDAGERLPRPK 338 (1039)
T ss_pred E----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-H------hccccccCCCCC
Confidence 1 1223344678999999999999999999999999999998 67888766544322 1 122 22344577
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+++.+.+++..||..+|.+||++ ..|.
T Consensus 339 ~csedIY~imk~cWah~paDRptF-sair 366 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTF-SAIR 366 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccH-HHHH
Confidence 889999999999999999999999 6665
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.89 Aligned_cols=249 Identities=24% Similarity=0.267 Sum_probs=188.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999884 6789999886432 22234677899999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++ |+|.+++.. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 97 478777742 3456999999999999999999999999 99999999999999999999999999876542211
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc-------------cc
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR-------------NF 643 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~-------------~~ 643 (780)
......++..|+|||++.+. .++.++|||||||++|+|+||..|+.........+... ..
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 12334678899999998765 47899999999999999999988754322221111100 00
Q ss_pred cccccCc-CC------CC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 NSVLDSS-AG------DW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ~~~ld~~-~~------~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+.. .. .| ....+..+.+++.+||..+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-~~il 279 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-EEAL 279 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-HHHh
Confidence 0000000 00 00 11245678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.80 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=189.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHH-hhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEV-LSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~i-l~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
++|.....||+|+||.||+|... +..||||.+.... ......+..|+.+ ++.++||||+++++++.+ ..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999885 6789999886532 2334556667765 566789999999999854 4679999
Q ss_pred eccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 497 YLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 497 y~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|++ |+|.+++... .....+++..++.++.||+.||.|||+. + ++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888887532 2346799999999999999999999986 7 999999999999999999999999998765321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhcc----CCCCcchhHHHHHHHHHHHHhCCCCCccchh-HHHHHHhccccccccC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLET----GKLTPESDVYSFGIILLRLLTGRPVLRIKKD-VKCALEKRNFNSVLDS 649 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-~~~~~~~~~~~~~ld~ 649 (780)
. ..+...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..... ...... .+..
T Consensus 158 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~ 223 (283)
T cd06617 158 V--------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ------VVEE 223 (283)
T ss_pred c--------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH------HHhc
Confidence 1 1133467888999998864 4568899999999999999999999964321 111110 1111
Q ss_pred cCCCCC-HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 SAGDWP-VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....| ...+..+.+++.+||..+|.+||++ .+++.
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY-PELLQ 260 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 111111 1245679999999999999999999 66643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=307.11 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=191.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~ 495 (780)
..|...+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999874 6789999886432 2334568899999999999999999999854 467999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||++ |+|.+++.. ...++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 577776642 2346999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
....|+..|+|||++. .+.++.++||||||+++|+|+||++||...+.......... .. .+..
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~--~~~~- 234 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-ND--SPTL- 234 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CC--CCCC-
Confidence 2345778899999874 45688999999999999999999999976554332211110 00 0110
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+...+..+.+++.+||..+|..||++ .+++.
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il~ 266 (307)
T cd06607 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSS-EELLK 266 (307)
T ss_pred -CchhhCHHHHHHHHHHhcCChhhCcCH-HHHhc
Confidence 122345679999999999999999999 66654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.15 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=202.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeEEEecc
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLR 499 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV~Ey~~ 499 (780)
-|+++.+||+|+||.||++.++ |..||||.+.-. .+..+...|+.|+.++..|++|++||.+ ..+..+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677889999999999999886 678999998763 4567788999999999999999999976 345789999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
.|+..|++. .+..+|++.++..|+...+.||.|||... -||||||..||||+-+|.+||+|||.|..+..
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD------ 181 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD------ 181 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhh------
Confidence 999999985 45678999999999999999999999988 89999999999999999999999999866542
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc-ccCcCCCCCHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV-LDSSAGDWPVAE 658 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~-ld~~~~~~p~~~ 658 (780)
+.....+..||+.|||||++..-.|+.+.||||||++..||.-|+||+...+..+.. +.-. -.|....-|...
T Consensus 182 -TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----FMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 182 -TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----FMIPTKPPPTFKKPEEW 255 (502)
T ss_pred -hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----EeccCCCCCCCCChHhh
Confidence 223345678999999999999999999999999999999999999999876654322 1111 112223446677
Q ss_pred HHHHHHHHHHchhhCCCCCcch
Q 044673 659 AEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+.++.+++..||-.+|..|-+.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA 277 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTA 277 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHH
Confidence 8899999999999999999877
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.12 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||+|+||.||+|.+. +..||+|.+.... ......|.+|+.++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999874 6789999987543 23356789999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+ +++|.+++.. ...++++..++.++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 9999999853 2367999999999999999999999999 99999999999999999999999999877643221
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-cc--------c-
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-RN--------F- 643 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~~--------~- 643 (780)
.......|+..|+|||++.+. .++.++|||||||++++|+||.+||......... +.. +. +
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345688899999998654 4689999999999999999999888655432211 110 00 0
Q ss_pred -----cccccCcC-----CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 -----NSVLDSSA-----GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 -----~~~ld~~~-----~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.. ..........+.+++.+|+..+|.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-~~~l 280 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-AEAL 280 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-HHHh
Confidence 00000000 00111335789999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.08 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=195.7
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||.|+||.||+|... +..||+|.+... .......+.+|+.++++++||||+++++.|.+. .++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999885 578999988653 223455788999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-cccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-SKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~-~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++... ....+++..+..|+.+++.||.|||+.+ ++||||||+||+++.++. +||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998632 3346899999999999999999999999 999999999999998864 69999999876643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
......|++.|+|||++.+..++.++|+||||+++++|++|..||...+........ ....+.+ .+.
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~----~~~ 224 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYFAP----ISP 224 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccCCC----CCC
Confidence 112345888999999999888999999999999999999999999755433222111 1111111 122
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+..+.+++.+|+..+|.+||++ .+++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~-~~ll~ 253 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSI-TSILK 253 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCH-HHHhh
Confidence 345679999999999999999999 66643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.04 Aligned_cols=236 Identities=25% Similarity=0.336 Sum_probs=193.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|.....||+|+||.||++... +..||+|++.... ......+.+|+.+++++.||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999884 5789999986422 23345688999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999985 3357899999999999999999999999 999999999999999999999999998765422
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.....|++.|++||++.+..++.++||||||+++|+|+||+.||...+....... . .. .....|
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~-----~~-~~~~~~ 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-I-----LE-GKVRFP 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H-----hc-CCccCC
Confidence 1234688899999999888899999999999999999999999976553221111 0 00 011223
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcch
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+..+.+++.+||..+|.+||+.
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCc
Confidence 3446778999999999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.60 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=200.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC----CeeEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSLVF 495 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~LV~ 495 (780)
+|...+.||+|+||.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+.+. .++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999986 67899999876432 4466789999999999999999999998654 56999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 99999999999863 338999999999999999999999999 9999999999999999999999999988765332
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.. .......++..|++||++.+..++.++||||||+++++|++|..||............-.. .......|
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 226 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----SGEPPEIP 226 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----cCCCcCCC
Confidence 10 1123456788999999999888999999999999999999999999765522211111100 01122334
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+..+.+++.+|+..+|.+||++ .+++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~-~~ll 255 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTA-DELL 255 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCH-HHHh
Confidence 4557789999999999999999999 6664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.40 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=191.1
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++++|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++.+. .++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 67899999865332 2234677999999999999999999998654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+. ++|.+++. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMI--QHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67777664 23356888999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc-----c-------
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR-----N------- 642 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~-----~------- 642 (780)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||.+||.........+... .
T Consensus 158 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 158 Q-------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C-------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 1 11234568899999998754 57889999999999999999999997554432221110 0
Q ss_pred -------cc-ccccCc-CCC----CC-HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 -------FN-SVLDSS-AGD----WP-VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 -------~~-~~ld~~-~~~----~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.. ...... ... |. ......+.+++.+|+..+|.+||++ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-QDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-HHHh
Confidence 00 000000 000 00 0124578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.62 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=192.8
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
.+.+|.|+++.||++...+..||||++... .......+.+|+.+++.++||||+++++++.+. .+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344566677788888778899999998754 334556799999999999999999999988543 5789999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++... ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+............
T Consensus 87 ~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9998633 2345889999999999999999999999 999999999999999999999999998765422211111112
Q ss_pred ccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh--ccccccccC----------
Q 044673 584 NESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK--RNFNSVLDS---------- 649 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~--~~~~~~ld~---------- 649 (780)
......++..|+|||++.. ..++.++|||||||++|+|++|+.||.........+.. +.....++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 2234567788999999876 35889999999999999999999999765543332221 111111110
Q ss_pred ---------------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 ---------------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ---------------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....+......+.+++.+||..+|.+||++ .++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-SQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-HHHhc
Confidence 0011122345678999999999999999999 66653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.24 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=190.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
|+..+.||.|++|.||+|... +..||||++.... ......|.+|+.++++++|||++++++++.+. .++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999874 7889999886532 22335688999999999999999999998654 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+ ++|.+++.... ...+++..++.++.+++.||.|||+.+ ++||||+|+|||++.++.++|+|||+++.+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68999885322 246899999999999999999999998 99999999999999999999999999876532211
Q ss_pred CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cccc--------c
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFN--------S 645 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~--------~ 645 (780)
......++..|+|||++.+. .++.++||||||+++|+|+||++||...+........ +... .
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11234568889999988664 5788999999999999999999999765543322110 0000 0
Q ss_pred c------c----cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 V------L----DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ~------l----d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ + ...........+..+.+++.+|++.+|.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~il 278 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-KAAL 278 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-HHHh
Confidence 0 0 000011112334678899999999999999999 6665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.61 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=196.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-----CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC----C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~ 491 (780)
.+|...+.||+|+||.||+|... +..||+|.+... .......|.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999874 578999987532 123345788999999999999999999998542 4
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++|+||+++++|.+++. ...++++.....|+.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 68999999999999985 3345889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
...... ........|+..|+|||++.+..++.++|+|||||++|+|+||++||............. ..+..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQPTK 227 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCCCC
Confidence 321110 011123468889999999998889999999999999999999999997654443322111 11112
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...|...+..+.+++.+|+. +|..||+. .++
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~-~~~ 258 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTA-EFL 258 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccH-HHH
Confidence 23455667889999999999 67999998 544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.58 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=190.4
Q ss_pred CCCcccccccCCceEEEEeeec----CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----Ce
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RS 492 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~ 492 (780)
.|....+||+|+||.||+|... +..||+|.+.... ......+.+|+.++.+++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999984 4789999987632 33345678999999999999999999999654 57
Q ss_pred eEEEeccCCChhhHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC----CCCccccccc
Q 044673 493 LVFEYLRNGSLEDCLACK--NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA----NFGSKLSDFG 566 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~----~~~~Kl~DFG 566 (780)
+||||+++ +|.+.+... .....+++...+.|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 666665322 22347899999999999999999999999 999999999999999 9999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHH----------
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVK---------- 635 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~---------- 635 (780)
+++.+...... ........+++.|+|||++.+. .++.++|||||||++++|+||++||.......
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 158 LARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred cccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99876432211 1122345678899999988764 58899999999999999999999996433211
Q ss_pred --HHHH---------------hcccccccc-CcCCCCC-----------HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 636 --CALE---------------KRNFNSVLD-SSAGDWP-----------VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 636 --~~~~---------------~~~~~~~ld-~~~~~~p-----------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+. ...+....+ .....++ ...+..+.+++.+|+..+|.+||++ .+++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-~eil 311 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA-EEAL 311 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH-HHHh
Confidence 0000 000000000 0001111 0234578899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.53 Aligned_cols=238 Identities=23% Similarity=0.286 Sum_probs=195.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
+|...++||.|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999885 6789999986532 23456789999999999999999999988554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+.+++|.+++.. ..++++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 9999999999852 357999999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHHHHhccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~ 654 (780)
......|+..|++||++.+..++.++|+||||+++|+|++|..||..... ....... ........
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK------QETADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH------hccccccC
Confidence 11335678889999999988899999999999999999999999975543 1111111 11012223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
|...+..+.+++.+|+..+|.+||+.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCc
Confidence 33455789999999999999999999
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.40 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=189.4
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
+|.....||+|+||.||++... +..||||.+.... ......|.+|+.++.++. ||||+++++++.+ ..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566778999999999999885 5789999886532 344567889999999996 9999999998844 35789999
Q ss_pred ccCCChhhHHhh--hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 498 LRNGSLEDCLAC--KNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 498 ~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+.. +|.++... ......+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55554321 12346799999999999999999999974 7 999999999999999999999999998765422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETG---KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
. ......|++.|+|||++.+. .++.++|||||||++|+|+||++||.........+....... .....
T Consensus 162 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 232 (288)
T cd06616 162 I--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD-PPILS 232 (288)
T ss_pred C--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC-CCcCC
Confidence 1 11234678889999999876 689999999999999999999999975543222221111000 00011
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+...+..+.+|+.+|+..+|.+||++ .+|+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~i~ 265 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKY-KELL 265 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 11122356789999999999999999999 6664
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.84 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=191.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCC-CCceeeEeeeecC--C-----
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--S----- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~----- 490 (780)
++|+..+.||+|+||.||+|.+. +..||||.+.... ......+.+|+.++++++ ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999874 6789999876532 223456889999999995 6999999998743 2
Q ss_pred CeeEEEeccCCChhhHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK--KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGF 567 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGl 567 (780)
.++||||+++ +|.+++..... ..++++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 4799999985 78888754322 356899999999999999999999999 999999999999998 89999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc----
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN---- 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~---- 642 (780)
++.+..... ..+...+++.|+|||++.+ ..++.++||||||+++|+|+||.+||..............
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 158 GRAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred ceecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 876532211 1223456788999998865 4578999999999999999999999976555433221100
Q ss_pred ccc-cc----c-Cc---CCCC--------CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNS-VL----D-SS---AGDW--------PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~-~l----d-~~---~~~~--------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... .. . .. ...+ ....+..+.+++.+|+..+|.+||++ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-~eil 289 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-KAAL 289 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-HHHh
Confidence 000 00 0 00 0000 01245678999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.27 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=201.9
Q ss_pred cCCCcccccccCCceEEEEeeecCee--EEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~--VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 498 (780)
+.|.++.-||.|+||+||++..+.+. .|-|++...+......|.-|++||+.+.||+||+|++.| .....+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34556667999999999999987554 477888877777788899999999999999999999865 44467899999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
.||-.+.++. .-..+|.+.++..++++++.||.|||+.+ |||||||..|||+.-+|.++|+|||.+....
T Consensus 112 ~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 112 GGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred CCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccch------
Confidence 9999998875 34567999999999999999999999999 9999999999999999999999999864321
Q ss_pred CCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.+........||++|||||+.. ..+|+.++|||||||+|.||.-+.||....+.+...+...+- +|...-
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS----ePPTLl 256 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLL 256 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc----CCCccc
Confidence 1222345678999999999875 357999999999999999999999999888887766543321 122222
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
-|...+..+.+++.+||..||..||+. .++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~a-aql 286 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPA-AQL 286 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCH-HHH
Confidence 345567789999999999999999987 444
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=303.98 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=192.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeec----CCCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCP----ESRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~----~~~~L 493 (780)
.++|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.++.+++||||+++++++. ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888999999999999999985 57899998864322 22345778999999999999999999874 34689
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+. ++|.+++... ...+++.....|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 v~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999997 4999988532 346999999999999999999999999 99999999999999999999999999886643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh------------
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK------------ 640 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~------------ 640 (780)
... ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||............
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred Ccc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 211 11334578889999998754 4689999999999999999999999755433211100
Q ss_pred -----------cccccccc-CcCCCCCHH-HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 -----------RNFNSVLD-SSAGDWPVA-EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 -----------~~~~~~ld-~~~~~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
........ .....++.. .+..+.+++.+|+..+|.+||++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-~ell 288 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-EDAL 288 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-HHHh
Confidence 00000000 001112222 36678999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.40 Aligned_cols=231 Identities=26% Similarity=0.338 Sum_probs=189.7
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||.|+||.||++... +..||+|++.... ......|.+|+.+++.++||||+++++++.+. .++|+||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999987 6889999986532 23446789999999999999999999998554 6799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++. +...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 99995 3356899999999999999999999999 9999999999999999999999999987664321
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch--hHHHHHHhcccccccc-CcCCCCCHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK--DVKCALEKRNFNSVLD-SSAGDWPVAEAE 660 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~--~~~~~~~~~~~~~~ld-~~~~~~p~~~~~ 660 (780)
......|+..|++||++....++.++|+||||+++|+|++|..||.... ..... . .+.+ ......|...+.
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~ 221 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-N-----DILKGNGKLEFPNYIDK 221 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-H-----HHhccCCCCCCCcccCH
Confidence 1123467888999999988889999999999999999999999997655 22111 1 1111 122333444467
Q ss_pred HHHHHHHHchhhCCCCCcch
Q 044673 661 QLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+.+++.+||..+|.+||++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHHHHHHccCChhhCcCC
Confidence 89999999999999999995
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.37 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=192.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------~ 491 (780)
+++|...++||+|+||.||+|... +..||||.+.... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999874 6789999986432 23445688999999999999999999887432 4
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++|+||+.+ +|.+++. ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 789999975 7877773 356999999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H---h---c
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E---K---R 641 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~---~---~ 641 (780)
...... ........||..|+|||++.+ ..++.++|||||||++|+|+||++||...+...... . . .
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 432111 111234568899999998754 468899999999999999999999996543221110 0 0 0
Q ss_pred cccccccC------------cCCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 NFNSVLDS------------SAGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 ~~~~~ld~------------~~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+. ....+ ....+..+.+++.+||+.+|.+||++ .+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~e~l~ 291 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-EEALA 291 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-HHHhc
Confidence 00000000 00001 01235678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.16 Aligned_cols=234 Identities=21% Similarity=0.306 Sum_probs=186.4
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~gsL 503 (780)
||+|+||+||++... +..||+|.+.... ......|..|+.+|++++||||+++++++.. ..|+||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999764 6789999886422 2234457789999999999999999998854 46899999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++.... ...+++..++.++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-------- 149 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-------- 149 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--------
Confidence 99986332 246899999999999999999999999 9999999999999999999999999987654211
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhccccccccCcCCCCCHHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
......++..|++||++.++.++.++|||||||++++|++|+.||...... ...+..... ......|...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCCHH
Confidence 112345778899999999888999999999999999999999999654321 111111111 1111223345677
Q ss_pred HHHHHHHchhhCCCCCcch
Q 044673 662 LAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs~ 680 (780)
+.+++.+||+.+|.+||+.
T Consensus 225 ~~~li~~~l~~~p~~R~~~ 243 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGC 243 (277)
T ss_pred HHHHHHHHccCChhHccCC
Confidence 8999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.51 Aligned_cols=248 Identities=19% Similarity=0.252 Sum_probs=192.6
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
..++|...+.||+|+||.||+|... +..||||.+... .......+.+|+.++++++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999874 678999998642 23344567899999999999999999998742
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..++||||+. |+|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 2479999996 488887741 2889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HH------
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LE------ 639 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~------ 639 (780)
+...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 7654221 123346788999999999999999999999999999999999999754422110 00
Q ss_pred ----------------hcc------ccccccCc-----CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 ----------------KRN------FNSVLDSS-----AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 ----------------~~~------~~~~ld~~-----~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... +..+.... ....+...+..+.+++.+||+.||.+||++ .+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~eiL 309 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-DDAL 309 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 000 00000000 000012345678899999999999999999 6665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.67 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=191.4
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.|...+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++|||+++++++|.+. .++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999874 6789999986432 23345688999999999999999999998544 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++ |+|.+++.. ...+++|..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 997 578777742 3456999999999999999999999999 999999999999999999999999998654321
Q ss_pred CCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||.............. .. ....
T Consensus 179 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~----~~~~ 244 (317)
T cd06635 179 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NE----SPTL 244 (317)
T ss_pred ---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cc----CCCC
Confidence 2346788899999974 45688999999999999999999999865443221111000 00 0001
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+...+..+.+++.+|++.+|.+||++ .+++..+-
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~il~~~~ 279 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTS-EELLKHMF 279 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCH-HHHHhChh
Confidence 112345668999999999999999999 77766444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.13 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=202.8
Q ss_pred ccCHHHHHHHh-cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 412 EFSFSELNEAT-NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 412 ~~~~~ei~~at-~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
++.+-|....| +.|+.-+.||+||||.||-+..+ |..+|+|.+.+. ...+..--.+|-.||.+++.|.||.|-.
T Consensus 173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 44444444333 67888899999999999987764 667899877542 1233344678999999999999999988
Q ss_pred ee--cCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 486 TC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 486 ~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
+| ++..|||+..|.||+|.-+|.... .+.+++.....++.+|+.||.+||+.. ||.|||||+|||||++|++.|+
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRIS 329 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRIS 329 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEee
Confidence 88 566899999999999999997433 367999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~ 643 (780)
|.|||..++.... ....+||.+|||||++..+.|+...|+|||||+||||+.|+.||.....-. +...+
T Consensus 330 DLGLAvei~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEv 398 (591)
T KOG0986|consen 330 DLGLAVEIPEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEV 398 (591)
T ss_pred ccceEEecCCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHH
Confidence 9999988864432 244589999999999999999999999999999999999999997443211 11111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+......+|...+++...|....|..||.+|-.-
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1112222334566677888899999999999998643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=330.55 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=196.6
Q ss_pred HHhcCCCcccccccCCceEEEEeeecC--eeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
-..++|.+++.||+|+||.|...+.++ ..+|+|++++. ......-|..|-+||..-+.++||.|..+|.|. .|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 335799999999999999999998864 56999999873 233456799999999999999999999999876 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
||||||+||+|-.+|. +..++++.-...++.+|+.||.-||+.| +|||||||+|||||.+|++||+|||.|-.+.
T Consensus 152 lVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 8999999999999995 3447999999999999999999999999 9999999999999999999999999987665
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
.+.. ......+|||-|++||++.. |.|++.+|+||+||++||||.|..||...+-+...-..-+-..
T Consensus 227 ~dG~------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~-- 298 (1317)
T KOG0612|consen 227 ADGT------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE-- 298 (1317)
T ss_pred CCCc------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh--
Confidence 3322 23456799999999999962 6799999999999999999999999997776655422211111
Q ss_pred cCcCCCCC--HHHHHHHHHHHHHchhhCCCCCcc
Q 044673 648 DSSAGDWP--VAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 648 d~~~~~~p--~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
...+| ...+.+..+||.+.+. +|..|-.
T Consensus 299 ---~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 299 ---SLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred ---hcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 12233 3466777888877664 4445543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.72 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=199.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|.....||+|+||.||+|... +..|++|.+..... .....+.+|++++++++|||++++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778889999999999999874 57899999876543 4556799999999999999999999988554 5689999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++++|.+++. ...++++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999985 3367999999999999999999999999 999999999999999999999999999876532211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.....++..|++||++.+..++.++||||||+++|+|++|.+||............. .......|..
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 222 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------QDDHPPLPEG 222 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------ccCCCCCCCC
Confidence 233467889999999988888999999999999999999999997555433222211 1111223334
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+..+..++.+|+..+|.+||++ .+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~-~~~l 249 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTA-KQLL 249 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCH-HHHh
Confidence 56789999999999999999999 6664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.05 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=191.4
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----CeeEEE
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSLVFE 496 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~LV~E 496 (780)
|...+.||.|+||.||+|... +..||+|.+.... ......+.+|+.++++++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999885 5789999987642 33345688999999999999999999998544 679999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++ +|.+++.. ....+++..++.++.+|+.||.|||+.+ ++|+||+|+|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 88888852 2357999999999999999999999999 99999999999999999999999999877643221
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc---------cc--
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN---------FN-- 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~---------~~-- 644 (780)
...+...++..|+|||.+.+ ..++.++||||||+++|+|+||++||.............. +.
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 11233456788999997764 4578999999999999999999999975553321110000 00
Q ss_pred -cc-----ccCcC------CCCCHH-HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 -SV-----LDSSA------GDWPVA-EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 -~~-----ld~~~------~~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+ ..+.. ...... ++..+.+++.+|+..+|.+||++ .+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-DQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-HHHhh
Confidence 00 00000 000001 26678999999999999999999 66643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=349.67 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=199.2
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE- 489 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~- 489 (780)
+++.++. ..|.....||+|+||.||+|.. .+..||||.+...... ...|+.++++++|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3444443 4577888999999999999986 4688999998653321 2356889999999999999999954
Q ss_pred -CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 -SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
..++||||+++|+|.+++. .++|..+.+|+.+++.||.|||.. .++|+||||||+|||++.++.+++. ||.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 3679999999999999994 389999999999999999999955 2359999999999999999888875 665
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch--------hHHHHHH
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK--------DVKCALE 639 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~--------~~~~~~~ 639 (780)
...... .....||..|+|||++.+..++.++|||||||++|||+||++||+... ++.....
T Consensus 829 ~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 897 (968)
T PLN00113 829 PGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897 (968)
T ss_pred cccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence 433211 123367889999999999999999999999999999999999985321 1111112
Q ss_pred hccccccccCcC---CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 640 KRNFNSVLDSSA---GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 640 ~~~~~~~ld~~~---~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.......+|+.. ...+..+..++.+++.+|++.+|.+||++ .+|++.|+.+..
T Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-~evl~~L~~~~~ 953 (968)
T PLN00113 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA-NDVLKTLESASR 953 (968)
T ss_pred ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH-HHHHHHHHHhhc
Confidence 222333444432 12344666788999999999999999999 899999998743
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.42 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=186.8
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCceeeEeeeecCC----CeeEEE
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES----RSLVFE 496 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~----~~LV~E 496 (780)
|...++||+|+||.||+|... +..||+|.+.... ........+|+.++.++. |||+++++++|.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999874 6789999887532 223334567999999986 99999999998543 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|++ |+|.+.+.. ....++|..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++.+.....
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 578777742 3357999999999999999999999999 999999999999999 9999999999876642211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccccc----cc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFNS----VL 647 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~~----~l 647 (780)
.....++..|+|||++.+ +.++.++|||||||++|+|++|.+||...+........ +.... .+
T Consensus 155 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 155 --------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred --------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 123457889999997654 55788999999999999999999999755433211100 00000 00
Q ss_pred cC---cCCCC-----------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DS---SAGDW-----------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~---~~~~~-----------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.. ....+ ....+..+.+++.+||..+|.+||++ .+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-KQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH-HHHhh
Confidence 00 00011 12346789999999999999999999 66643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.99 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=191.8
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccCCCh
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRNGSL 503 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~gsL 503 (780)
..+||+|+||.||+|... +..||||.+..........|.+|+.++++++||||++++++|.+ ..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 67899999866555566779999999999999999999998844 46799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++. ...+++.....++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------- 171 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------- 171 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc-------
Confidence 99873 345899999999999999999999999 99999999999999999999999999876542211
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCCCCCHHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPVAEAEQ 661 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~ 661 (780)
......|++.|++||++.+..++.++|+||||+++|+|+||.+||........ .+..+ +..... .....+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~ 245 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPKLK-NLHKVSPS 245 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----CCcccC-CcccCCHH
Confidence 11234678899999999888899999999999999999999999975543321 11111 111110 11124556
Q ss_pred HHHHHHHchhhCCCCCcchHHHHHH
Q 044673 662 LAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 662 l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+.+++.+|+..+|.+||++ .+++.
T Consensus 246 l~~li~~~l~~~P~~R~~~-~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATA-AELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCH-HHHhc
Confidence 8899999999999999999 66543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.14 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=190.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|....+||+|+||.||+|... +..||||.+.... ......+.+|+.++++++||||++++++|...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 468999999999999999999874 6789999875432 22234567899999999999999999988432
Q ss_pred ---CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 491 ---RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 491 ---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
.++||||+.+ +|.+.+.. ....+++.+...++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 2799999965 78887742 3346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHh--cc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEK--RN 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~--~~ 642 (780)
+..+....... ........++..|+|||++.+. .++.++||||||+++|+|+||++||...+..... +.. +.
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 166 ARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred cccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 98764322111 1112334678889999988664 4788999999999999999999999755432211 000 00
Q ss_pred ccc-c---------cc----CcC-------CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNS-V---------LD----SSA-------GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~-~---------ld----~~~-------~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.. + .+ +.. ..++......+.+|+.+|+..+|.+||++ .+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-~e~l 305 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-DTAL 305 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-HHHh
Confidence 000 0 00 000 00111123567799999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.19 Aligned_cols=235 Identities=20% Similarity=0.388 Sum_probs=185.6
Q ss_pred cccccCCceEEEEeeecCe--eEE---EEEcc-CCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC----CeeEEEec
Q 044673 429 WKIGEGRYGNVYRGLLRHL--HVA---IKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSLVFEYL 498 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~~--~VA---iK~l~-~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~LV~Ey~ 498 (780)
..||+|+|-+||||.+..+ .|| ||.-. ..++....+|..|+.+|+.|.|||||++|.++.+. ..+|.|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 4799999999999998643 343 22211 12345567899999999999999999999998543 34799999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccccccCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~~~~~~~ 577 (780)
..|+|..|+. +...++.+....|+.||+.||.|||++.|||||||||.+||+++.+ |.|||+|+|||++.....
T Consensus 126 TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 126 TSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred cCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999995 4566888999999999999999999999999999999999999865 789999999999886432
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH---hccccccccCcCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE---KRNFNSVLDSSAGDW 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~---~~~~~~~ld~~~~~~ 654 (780)
.....|||.|||||... ..|+..+||||||++|+||+|+..|+..-.......+ .|....-+..
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k----- 267 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK----- 267 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc-----
Confidence 23478999999999987 7799999999999999999999999974443322211 2211111111
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
-.-.++..+|.+|+.. ..+||++ .+++
T Consensus 268 --V~dPevr~fIekCl~~-~~~R~sa-~eLL 294 (632)
T KOG0584|consen 268 --VKDPEVREFIEKCLAT-KSERLSA-KELL 294 (632)
T ss_pred --cCCHHHHHHHHHHhcC-chhccCH-HHHh
Confidence 1134688999999999 8999999 5554
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=303.51 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=186.5
Q ss_pred ccccC--CceEEEEeee--cCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCC
Q 044673 430 KIGEG--RYGNVYRGLL--RHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNG 501 (780)
Q Consensus 430 ~IG~G--~~G~Vyk~~~--~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~g 501 (780)
.||.| +||.||++.+ .+..||||++.... ......|.+|+.+++.++||||++++++|... .++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 8999999987 47899999986532 23346788999999999999999999999544 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.+.............
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999886432 345899999999999999999999999 9999999999999999999999998764432211111111
Q ss_pred ccccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccc---------------
Q 044673 582 LCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN--------------- 644 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~--------------- 644 (780)
........++..|++||++.++ .++.++|||||||++|+|++|++||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1111123456679999999764 47899999999999999999999997543322221110000
Q ss_pred ------------------------ccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ------------------------SVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ------------------------~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+.+. .....+...+..+.+|+.+||..||.+||++ .+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta-~e~l 306 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA-SSLL 306 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 00000 0011122456789999999999999999999 7774
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.91 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=186.8
Q ss_pred HHHHHHHhcCCCccccc--ccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecC
Q 044673 415 FSELNEATNNFEPSWKI--GEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE 489 (780)
Q Consensus 415 ~~ei~~at~~f~~~~~I--G~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~ 489 (780)
..++....++|...+.+ |+|+||.||++... +..+|+|.+....... .|+.+...+ +||||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556777777776 99999999999874 5679999886532111 122222222 69999999999844
Q ss_pred --CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-Cccccccc
Q 044673 490 --SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFG 566 (780)
Q Consensus 490 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFG 566 (780)
..++||||+++|+|.+++. ...+++|..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 4679999999999999985 2348999999999999999999999999 99999999999999998 99999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ 646 (780)
+++..... ....|+..|+|||++.+..++.++|||||||++|+|+||+.||.......... ..+...
T Consensus 156 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~ 222 (267)
T PHA03390 156 LCKIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLLKR 222 (267)
T ss_pred cceecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHHHh
Confidence 98765321 12357889999999999899999999999999999999999997433211000 000011
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.. .....+...+..+.+++.+||+.+|.+||+..++++
T Consensus 223 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 223 QQ-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred hc-ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 11 111222346678999999999999999996425554
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.16 Aligned_cols=231 Identities=20% Similarity=0.292 Sum_probs=177.6
Q ss_pred ccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhh---cCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLS---RVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~---~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
.||+|+||.||++... +..||||.+.... ......+.+|..++. ..+||||+.+++++.. ..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 6789999886532 122233445554443 3479999999998854 4679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. ....+++.....|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999885 3456999999999999999999999999 9999999999999999999999999986543211
Q ss_pred CcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccccccccCcCCCCCHH
Q 044673 580 SALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.....||..|+|||.+.+ ..++.++|||||||++|+|+||..||...... ...+..... ......|..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCccc
Confidence 123468999999999874 45889999999999999999999999643221 111111111 111122334
Q ss_pred HHHHHHHHHHHchhhCCCCCcc
Q 044673 658 EAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.+..+.+++.+|+..||.+||+
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcC
Confidence 5678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.98 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=194.0
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC------
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------ 489 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------ 489 (780)
.+.++|.....||+|+||.||+|... +..||||.+.... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999984 5789999986532 2234567789999999999999999998854
Q ss_pred ------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 490 ------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 490 ------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
..++|+||+++ +|.+.+.. ....+++..+..|+.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeC
Confidence 34699999986 67776642 3457999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~ 642 (780)
|||++..+..... .......++..|++||++.+ ..++.++|||||||++|+|++|++||...+..........
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999887643221 01122345778999998865 3578999999999999999999999986554432211000
Q ss_pred ---------cccc--------ccCcC------CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ---------FNSV--------LDSSA------GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ---------~~~~--------ld~~~------~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+ .+... .......+..+.+++.+||..+|.+||++ .+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-~~il 297 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-EEAL 297 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 0000 00000 00011235679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.25 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=189.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|.....||+|+||.||+|... +..||+|.+.... ......|.+|+.++++++||||+++++++.+. .++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999875 5789999886532 22345688999999999999999999998654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~~ 575 (780)
|++ ++|.+++... ....+++.....++.+|+.||.|||+.+ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5788777422 2334688889999999999999999999 999999999999985 5568999999997654221
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc-ccccc--
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN-FNSVL-- 647 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~-~~~~l-- 647 (780)
. ..+...+++.|+|||++.+. .++.++|||||||++|+|+||++||............ +. .....
T Consensus 158 ~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 R-------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred c-------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 1 11334678899999998764 5789999999999999999999999755433221110 00 00000
Q ss_pred -----c--CcCCCC--------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 -----D--SSAGDW--------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 -----d--~~~~~~--------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+ .....| ....+..+.+++.+|+..+|.+||++ .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-RAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 0 000011 11235668899999999999999999 66643
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=306.49 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=190.3
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccC--CCchhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPS--YGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~--~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV~E 496 (780)
..|..+++||.||.+.||++... .+.+|+|.+.. .+.+...-|.+|+..|.+|. |.+||.||+|--. ..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 56888999999999999999875 46688886544 34455677999999999996 9999999998633 3578999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|-+ -+|..+|..+.. ....| -+..+..|++.|+.++|+.+ |||.||||+|+||= .|.+||+|||+|..+..+.
T Consensus 441 ~Gd-~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT- 513 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT- 513 (677)
T ss_pred ccc-ccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCccc-
Confidence 964 489999964332 23335 56678999999999999999 99999999999994 5789999999998886442
Q ss_pred CCCCcccccCCCCCCcccCChhhhccC-----------CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETG-----------KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS 645 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~ 645 (780)
+.......+||+-||+||.+... +.+.+|||||||||||+|+.|++||+....+. .++..
T Consensus 514 ----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-----aKl~a 584 (677)
T KOG0596|consen 514 ----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-----AKLHA 584 (677)
T ss_pred ----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----HHHHh
Confidence 22334567999999999988532 25679999999999999999999998554332 22344
Q ss_pred cccCcC-CCCCHH-HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 VLDSSA-GDWPVA-EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ~ld~~~-~~~p~~-~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.||.. -++|.. ...++.+++..||..||++||++ .+++
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si-~eLL 625 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI-PELL 625 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCc-HHHh
Confidence 555532 122211 11229999999999999999999 6663
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.21 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=194.0
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||.|+||.||++... +..|++|.+..... .....+.+|+.++.+++||||+++++.+.+. .++||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 67899999875433 3456788999999999999999999888554 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC-CCcc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG-NSAL 582 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~-~~~~ 582 (780)
.+++.. ...+++..+..|+.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.......... ....
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 999963 237899999999999999999999999 9999999999999999999999999987653221100 0001
Q ss_pred cccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH--HH
Q 044673 583 CNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE--AE 660 (780)
Q Consensus 583 ~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~--~~ 660 (780)
.......++..|++||++....++.++||||||+++|+|+||..||............. . ....+|... +.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~-~~~~~~~~~~~~~ 228 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------N-GKIEWPEDVEVSD 228 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CCcCCCccccCCH
Confidence 12234567888999999988889999999999999999999999997555332211110 0 111233333 67
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+..++.+|++.+|..||++ ..+.+.|+
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~-~~~~~~l~ 256 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGA-KSIEEIKN 256 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCC-ccHHHHhc
Confidence 89999999999999999999 66666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.84 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=193.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC----Ce
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES----RS 492 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~----~~ 492 (780)
.++|...+.||+|+||.||+|.+. +..||||.+... .......+.+|+.+++++ +||||++++++|... .+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 578899999999999999999874 678999987542 233445677899999999 999999999988432 47
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||++ ++|..++.. ..++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 589888842 27899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hh-c------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EK-R------ 641 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~-~------ 641 (780)
...... .........||..|++||++.+ ..++.++||||||+++|+|+||++||.......... .. +
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 159 ELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 322110 0112234568899999998765 457889999999999999999999996543321110 00 0
Q ss_pred -------cccccccC-------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 -------NFNSVLDS-------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 -------~~~~~ld~-------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+++. .........+..+.+++.+|++.+|..||++ .+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-~~il~ 294 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-EEALE 294 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-HHHhh
Confidence 00001110 0001111246779999999999999999999 66664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=302.04 Aligned_cols=251 Identities=26% Similarity=0.289 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~L 493 (780)
.++|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+ ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 578999999999999999999884 67899998864322 223356789999999999999999998843 2579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 78888753 2367999999999999999999999999 99999999999999999999999999887643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc-----ccc-
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF-----NSV- 646 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~-----~~~- 646 (780)
... ..+...++..|+|||++.+ ..++.++|||||||++|+|++|++||...+........... ...
T Consensus 161 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 161 PAK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred ccC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 211 1123345778999999865 45789999999999999999999999765543321110000 000
Q ss_pred --cc------C-cCCCCC--------HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 --LD------S-SAGDWP--------VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 --ld------~-~~~~~p--------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
++ . .....+ ...+..+.+++.+|+..||.+||++ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-~~il 288 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-EEAL 288 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-HHHh
Confidence 00 0 000000 1135667899999999999999999 6665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.43 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=189.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|.....||+|+||.||+|.+. +..||||.+.... ......+..|+.++.+.. ||||++++++|.+. .++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 367888999999999999999987 7889999987532 233455777888777775 99999999998654 57899
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||+. ++|.+++.. ...++++..+..|+.+++.||.|||+ .+ |+||||+|+|||++.++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 477777643 23479999999999999999999997 47 999999999999999999999999998765422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCC----CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGK----LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.........+.. ++...
T Consensus 169 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~ 235 (296)
T cd06618 169 KA--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-----ILQEE 235 (296)
T ss_pred Cc--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH-----HhcCC
Confidence 11 12335778899999987553 788999999999999999999999753322111111 11111
Q ss_pred CC--CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AG--DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~--~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.. .+....+..+.+++.+||..+|..||++ .+++.
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-~~il~ 272 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY-RELLQ 272 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHhc
Confidence 11 1111345679999999999999999999 66643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.48 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=190.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------- 490 (780)
++|.....||+|+||.||+|... +..||||++... .......+.+|+.++++++||||++++++|...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 78999999999999999999864 678999988642 122345688999999999999999999988532
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++|+||+.+ +|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 3789999964 676654 236899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hhc-----
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EKR----- 641 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~~----- 641 (780)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+...... ...
T Consensus 167 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 167 ADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred CCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 4321 123467888999999876 468899999999999999999999997654322111 000
Q ss_pred ---------cccccccC--c--CCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH--HHHHHH
Q 044673 642 ---------NFNSVLDS--S--AGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW--SVLEAL 691 (780)
Q Consensus 642 ---------~~~~~ld~--~--~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~--~~L~~l 691 (780)
........ . ...+ ....+..+.+++.+||+.||.+||++ .+++ +.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-TEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-HHHhcCcchhhc
Confidence 00000000 0 0000 01234568899999999999999999 7776 335443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.61 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=191.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
+++|...++||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999875 57899998754322 2234577999999999999999999876321
Q ss_pred ---CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 491 ---RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 491 ---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
.++|+||+.+ +|...+. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~--~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE--NPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence 3689999875 6776664 23457999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCC----cccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H
Q 044673 568 FHLIPQGESTGNS----ALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E 639 (780)
Q Consensus 568 a~~~~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~ 639 (780)
++........... .....+...|++.|+|||++.+. .++.++|||||||++|+|++|++||...+.....- .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9766432211110 11122345678889999988654 58899999999999999999999997555432111 0
Q ss_pred h-cc-----------cccccc-CcCCCCC-------HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 K-RN-----------FNSVLD-SSAGDWP-------VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 ~-~~-----------~~~~ld-~~~~~~p-------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. +. +....+ ......+ ......+.+++.+|+..+|.+||++ .+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~-~ell 306 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA-SDAL 306 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH-HHHh
Confidence 0 00 000000 0000011 1123568899999999999999998 5654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.77 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=193.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|.....||+|+||.||+|... +..||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999874 678999988642 233345677899999999999999999987432
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+. ++|.+++. ....+++..+..|+.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 479999996 68888874 3467999999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H-------
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E------- 639 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~------- 639 (780)
..... .......++..|+|||++.. ..++.++|||||||++|+|++|++||...+...... .
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 54221 11233467888999998865 468899999999999999999999997544321110 0
Q ss_pred -------hccccccc-------cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 640 -------KRNFNSVL-------DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 640 -------~~~~~~~l-------d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
.......+ +..........+..+.+++.+|++.+|.+||++ .+++.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-EEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-HHHHcC
Confidence 00000000 000001112346778999999999999999999 777543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.89 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=199.5
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|...+.||.|+||.||++... +..|++|.+..... .....+.+|++++++++|||++++++.+.+. .++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999986 67899999876432 4566788999999999999999999987544 5689999
Q ss_pred ccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++.... ....+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999986422 2477999999999999999999999999 9999999999999999999999999987664321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
.......|++.|+|||++....++.++|+||||+++++|++|..||...+....... .........|.
T Consensus 158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~ 225 (258)
T cd08215 158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------ILKGQYPPIPS 225 (258)
T ss_pred ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH------HhcCCCCCCCC
Confidence 112234688899999999988899999999999999999999999975543221111 11111122233
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+++.+|+..+|.+||++ .+++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~-~~ll 253 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSI-AQIL 253 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 455778999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.36 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=193.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC------CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~~ 491 (780)
.++|...+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+|++++||||++++++|.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999874 6789999986532 2345567889999999999999999988742 24
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+. |+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 79999995 68988884 3456999999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H-hc-----
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E-KR----- 641 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~-~~----- 641 (780)
...... .........|+..|++||++.. ..++.++|||||||++|+|++|++||...+...... . .|
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 432111 1111234578889999999865 468899999999999999999999996544321110 0 00
Q ss_pred --------cccccccC----cCCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 --------NFNSVLDS----SAGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 --------~~~~~ld~----~~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+....+. ....| ....+..+.+++.+|++.+|.+||++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~l 292 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-EQAL 292 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH-HHHH
Confidence 00000000 01111 12346779999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=317.18 Aligned_cols=196 Identities=31% Similarity=0.462 Sum_probs=169.8
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--------Ce
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--------RS 492 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--------~~ 492 (780)
.|.....||+||||.||+|+++ |..||||.++..+ .......-+|+++|++++|||||++++.-.+. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445567999999999999975 6789999998744 34456688999999999999999999875332 45
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC--CC--Cccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA--NF--GSKLSDFGFF 568 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~--~~--~~Kl~DFGla 568 (780)
+|||||.+|||...|....+...|++.+.+.++.+++.||.|||.++ ||||||||.||++-. +| .-||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 89999999999999987778888999999999999999999999999 999999999999932 23 3699999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhc-cCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLE-TGKLTPESDVYSFGIILLRLLTGRPVLR 629 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~ksDVwS~Gvil~eLltG~~p~~ 629 (780)
+-++++. ..+...||..|++||... .+.|+.-+|.|||||++|++.||..||.
T Consensus 172 rel~d~s--------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS--------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC--------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9887543 236789999999999998 4889999999999999999999999984
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.85 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=191.6
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------ 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------ 490 (780)
..++|...+.||+|+||.||+|... +..||||.+... .......+.+|+.+|++++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999874 678999988542 222345688999999999999999999988432
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.++||||+ +++|.+++. ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 27899998 779988873 356899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc-----
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN----- 642 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~----- 642 (780)
...... .....+++.|++||++.+ ..++.++|+|||||++|+|++|++||...+..........
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 765321 123467888999999876 4588999999999999999999999975543322111000
Q ss_pred ------------ccccccC-------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ------------FNSVLDS-------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ------------~~~~ld~-------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....... ....+....+..+.+++.+|+..+|.+||++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~-~~~l 296 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA-AEAL 296 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 0000000 0000111234568899999999999999999 6665
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=306.65 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=194.2
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeec
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~ 488 (780)
....++..++++|.....||+|+||.||+|... +..||+|.+... .......+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345667778899999999999999999999863 678999998642 2223456889999999999999999999874
Q ss_pred CC--------CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 489 ES--------RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 489 ~~--------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
.. .+++++++ +++|.+++. ...+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCE
Confidence 21 35677765 789988874 235899999999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA-- 637 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~-- 637 (780)
||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||...+.....
T Consensus 160 kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 160 KILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred EEeccccccccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999998754321 123467888999998866 56889999999999999999999999644332111
Q ss_pred -HHh-cc-cccc---------------ccC----cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 638 -LEK-RN-FNSV---------------LDS----SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 638 -~~~-~~-~~~~---------------ld~----~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... +. ...+ +.. .........+..+.+++.+|++.+|.+||+. .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l 298 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-AQAL 298 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH-HHHh
Confidence 000 00 0000 000 0000001134568899999999999999998 5554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=296.14 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=189.8
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
|...+.||+|+||.||+|... +..|+||.+..... .....+.+|+..+++++ ||||++++++|.+. .++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999984 56799998865322 23334567999999999 99999999998543 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999886322 357899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc----------------
Q 044673 579 NSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR---------------- 641 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~---------------- 641 (780)
......++..|+|||++.. ..++.++|+||||+++++|+||++||.............
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 1123467888999998754 457899999999999999999999996554332221100
Q ss_pred ---cccccccCcC----CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 ---NFNSVLDSSA----GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ---~~~~~ld~~~----~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....+.... .......+..+.+++.+|++.+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~ 278 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-SQAL 278 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-HHHh
Confidence 0000000000 01111224679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=289.23 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=197.9
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|....+||+|+||.||++... +..+|+|.+... .......+.+|+.++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999774 567999988653 233456788999999999999999999887554 5799999
Q ss_pred ccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++++|.+++... .....+++..++.++.+++.||.|||+.+ ++||||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999998542 23467899999999999999999999999 9999999999999999999999999998765321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCH
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
.....|+..|++||++.+..++.++|+||||+++|+|++|++||...+........ .....+..+.
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~ 223 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV------QRGKYPPIPP 223 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCCCCCCch
Confidence 12345788899999999989999999999999999999999999765543211111 1111122233
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+++.+|+..+|.+||++ .+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~-~~~l 251 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNC-DKIL 251 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 556779999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.55 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=167.9
Q ss_pred hcCCCcccccccCCceEEEEeeec------CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecC-C--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR------HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-S-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~-- 490 (780)
...|+...+||+|.||.||+|.-. ...+|||++..... .-...-.+|+.+++.++|||||.|..+|.. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999643 23689999976422 122345689999999999999999998854 2
Q ss_pred CeeEEEeccCCChhhHHhh--hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC----CCccccc
Q 044673 491 RSLVFEYLRNGSLEDCLAC--KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN----FGSKLSD 564 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~----~~~Kl~D 564 (780)
.+|++||.+. +|..+|+. ......++......|++||+.|+.|||++. |+||||||+|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 4689999988 78877742 334467999999999999999999999999 9999999999999877 8999999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
||++|++..+-. +.......+-|++|.|||.+.+. .||++.|||+.|||+.||||-.|.|...
T Consensus 180 lGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999875432 23334567789999999998875 6999999999999999999999988643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.76 Aligned_cols=222 Identities=21% Similarity=0.273 Sum_probs=178.2
Q ss_pred cCCCcccccccCCceEEEEeeecC--eeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.-|..++.||-|+||.|.++.... .-+|+|.|.+.+ .........|-+||.....++||+||..|.|. .|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 467888899999999999987643 458999887632 22344577899999999999999999999765 67899
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc---
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP--- 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~--- 572 (780)
+|++||++..+|. +.+.+.+.....++.++..|+.+.|..| +|||||||+|||||.+|++||+|||||+-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999996 4567888888888999999999999999 9999999999999999999999999996441
Q ss_pred CCCCCCC-----------------C---------------cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHH
Q 044673 573 QGESTGN-----------------S---------------ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLR 620 (780)
Q Consensus 573 ~~~~~~~-----------------~---------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~e 620 (780)
....... . ..+.....+||+-|+|||++....|+.-+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1000000 0 0011123579999999999999999999999999999999
Q ss_pred HHhCCCCCccchhHHHHHHhccccccccC
Q 044673 621 LLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 621 LltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
|+.|++||..........+..++...++-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~ 892 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHI 892 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcccc
Confidence 99999999866665555555555555654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.29 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeec--CCCee
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ESRSL 493 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~~L 493 (780)
.-++.|.+...||+|.|++|.+|.+. ++.||||.+.+.. ......+.+|+.+|..++|||||+|+.+.. ...||
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44689999999999999999999874 7889999997643 334456899999999999999999999874 45789
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||..+|.+.++|. +.+.+.......++.|+.+|++|||+.+ |||||||..|||||.+.++||+|||++.++..
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999996 4455666888999999999999999999 99999999999999999999999999988863
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC---
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS--- 649 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~--- 649 (780)
.. ...+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-. .+-++
T Consensus 208 ~~--------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----------~Lr~rvl~ 269 (596)
T KOG0586|consen 208 GL--------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----------ELRPRVLR 269 (596)
T ss_pred cc--------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------cccchhee
Confidence 32 2246789999999999998876 47999999999999999999999854321 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....|...+.++.+++.+++-.+|.+|+++ +++.
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~-dqim 304 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPC-DQIM 304 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCH-HHhh
Confidence 1112344456678899999999999999998 5553
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.88 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=189.2
Q ss_pred CCCcccccccCCceEEEEeee-----cCeeEEEEEccCCC----chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--C
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG----PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--R 491 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~~----~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~ 491 (780)
+|.....||.|+||.||++.. ++..||+|++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999876 46789999986532 12345678999999999 599999999988654 4
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++. ...++++.....++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 69999999999999985 3356889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
...... ......|+..|+|||++..+ .++.++||||||+++|+|+||..||........... +...+..
T Consensus 156 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~ 226 (290)
T cd05613 156 HEDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE---ISRRILK 226 (290)
T ss_pred cccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH---HHHHhhc
Confidence 432111 11235688899999998753 477899999999999999999999964322110000 0000111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
....+|......+..++.+|+..+|.+||+.
T Consensus 227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred cCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 1123344566788999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=290.48 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=192.7
Q ss_pred CCCcccccccCCceEEEEeeecC--eeEEEEEccCC-----CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~-----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
+|...++||+|+||.||++.... ..+++|++... .......+..|+.++++++||||+++++++.+. .++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998753 34566655431 223345677899999999999999999988543 6799
Q ss_pred EEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||+++++|.+++.. ......+++..++.++.+++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998854 234567999999999999999999999999 999999999999975 5699999999877643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ......|+..|++||++.+..++.++|+||||+++|+|++|..||........... +.......
T Consensus 158 ~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~------~~~~~~~~ 224 (260)
T cd08222 158 SCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR------IVEGPTPS 224 (260)
T ss_pred Ccc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHcCCCCC
Confidence 211 12234678889999999888899999999999999999999999975544332211 11111222
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+...+..+.+++.+|+..+|.+||++ .+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il 255 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSA-AEIL 255 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCH-HHHh
Confidence 344566789999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=290.69 Aligned_cols=236 Identities=22% Similarity=0.234 Sum_probs=183.0
Q ss_pred cccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHh-hcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 429 WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVL-SRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il-~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
+.||.|+||.||+|... +..||||++..... .....+..|..++ ....|||+++++++|.+. .++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999874 67899999865322 1223345555544 455899999999998654 6799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++. ...++++..+..|+.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99999985 3356899999999999999999999999 99999999999999999999999999875432
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCCCCHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~~ 658 (780)
.....|+..|++||.+.+..++.++||||||+++|+|+||.+||...+..... +..+... . ....+...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN----W-PEEVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----C-CCcccccC
Confidence 12345778899999998888999999999999999999999999755432211 1111110 0 00111134
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..+.+++.+|+..+|.+||+. ..+.+
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~-~~~~~ 247 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGA-NGYQE 247 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCC-CcHHH
Confidence 5779999999999999999976 43433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.09 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=198.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV 494 (780)
++|.....||+|+||.||+|... +..||+|++... .......+..|+.++++++ ||||+++++++.+. .++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888899999999999999884 688999998652 2233456889999999999 99999999998554 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ....+++..++.|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999995 3347999999999999999999999999 999999999999999999999999998766432
Q ss_pred CCCCC-------------CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 575 ESTGN-------------SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 575 ~~~~~-------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
..... ..........|+..|++||++....++.++|+||||++++++++|+.||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 21100 00122234567889999999988889999999999999999999999998665433221111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.....+|...+..+.+++.+|+..+|.+||++
T Consensus 236 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 236 -------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred -------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 11122344456779999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.65 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=189.1
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcC---CCCceeeEeeeecC--C-----
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRV---RHPNLVTLIGTCPE--S----- 490 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~~--~----- 490 (780)
|+..+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.++.++ .||||++++++|.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999985 57899999864322 2234566788877766 59999999999843 2
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+++|||+.+ +|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 5689999974 898888532 2346999999999999999999999999 99999999999999999999999999877
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hhccc----
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EKRNF---- 643 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~~~~---- 643 (780)
+..... .....++..|++||++.+..++.++|||||||++|+|+||.+||.......... .....
T Consensus 157 ~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 157 YSFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred ccCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 643211 123357888999999998899999999999999999999999997655432211 10000
Q ss_pred --c-------ccccCcCCCC----CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 --N-------SVLDSSAGDW----PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 --~-------~~ld~~~~~~----p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. .......... ....+..+.+++.+||+.+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~il 282 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-FEAL 282 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-HHHh
Confidence 0 0000000000 11345678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.42 Aligned_cols=236 Identities=21% Similarity=0.279 Sum_probs=181.2
Q ss_pred ccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHH---hhcCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEV---LSRVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~i---l~~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
.||+|+||.||++... +..||||.+..... .....+..|..+ ++...||||+.+++++.+ ..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 57899998865321 222234445443 444579999999998854 3579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999885 3457999999999999999999999999 9999999999999999999999999987553211
Q ss_pred CcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHH-HHHHhccccccccCcCCCCCHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVK-CALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ...... .......+|..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----hhccCCCCCCc
Confidence 1234688999999999755 58999999999999999999999997542111 000100 11112234444
Q ss_pred HHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
.+..+.+++.+|+..+|..|| ++ .+++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~-~~ll 253 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGA-QEVK 253 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCH-HHHH
Confidence 567899999999999999999 66 4553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.17 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=192.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
|.....||.|++|.||+|... +..+++|.+..... .....+.+|+.++++++||||+++++++.+. .++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999874 67899998865322 3456788999999999999999999988554 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++ +|.+++.. ...++++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 75 88888753 2357999999999999999999999999 9999999999999999999999999987765332
Q ss_pred CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc---------ccccccc
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR---------NFNSVLD 648 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~---------~~~~~ld 648 (780)
.......++..|++||.+.+. .++.++|+||||+++|+|+||++||...+......... .+....+
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 011234578889999998876 78999999999999999999999997655433211100 0000000
Q ss_pred ---------C-----cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 649 ---------S-----SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 649 ---------~-----~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ .........+..+.+++.+|+..+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~ll 278 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-EQAL 278 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-HHHh
Confidence 0 0000112346789999999999999999999 6664
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.38 Aligned_cols=240 Identities=25% Similarity=0.357 Sum_probs=189.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
..|...+.||+|+||.||+|... +..||+|.+... .......+.+|+.+++.++|||++++++++.+. .++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999874 577999987642 223345688999999999999999999988543 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+. |+|.+.+.. ...++++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 688877742 3456899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~ 650 (780)
....|+..|+|||++. .+.++.++|||||||++|+|+||..||...+..... +..+.. +.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PA 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----CC
Confidence 2345788899999975 356888999999999999999999998654432211 111111 00
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. .+...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 234 ~--~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~ll~ 266 (308)
T cd06634 234 L--QSGHWSEYFRNFVDSCLQKIPQDRPTS-EVLLK 266 (308)
T ss_pred c--CcccccHHHHHHHHHHhhCCcccCCCH-HHHhh
Confidence 0 112345678999999999999999999 66654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.87 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=193.6
Q ss_pred CCCcccccccCCceEEEEeee-----cCeeEEEEEccCCC----chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--C
Q 044673 424 NFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG----PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--R 491 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~~----~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~ 491 (780)
+|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.++.++ +||||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999875 34679999886421 22345688999999999 599999999888544 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++. ....+++.....++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 79999999999999985 2356899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGK--LTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVL 647 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~l 647 (780)
...... ......|+..|++||++.+.. .+.++||||||+++|+|+||..||....... ..+.....
T Consensus 156 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---- 225 (288)
T cd05583 156 LAEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL---- 225 (288)
T ss_pred cccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----
Confidence 432111 112345788999999987665 7889999999999999999999996432211 11111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
. .....|...+..+.+++.+|++.+|.+||++ ..+...|+
T Consensus 226 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~-~~~~~~l~ 265 (288)
T cd05583 226 K-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIKN 265 (288)
T ss_pred c-cCCCCCcccCHHHHHHHHHHhcCCHhhccCc-chHHHHhc
Confidence 1 1122333455678999999999999999998 66666555
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=294.47 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=196.9
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhc--CCCCceeeEeeeecC------CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSR--VRHPNLVTLIGTCPE------SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~--l~HpnIv~l~g~~~~------~~~LV 494 (780)
........||+|.||.||||.+.+..||||+++. +....|++|-+|.+- +.|+||+.++++-.. +..||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445566899999999999999999999999974 567789999888776 479999999998632 24599
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCccccCCCCCCceEecCCCCcccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-------EPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-------~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
++|-++|+|.++|. ...++|....+|+..+++||+|||+. +|+|+|||||+.||||.+|+++.|+||||
T Consensus 287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999994 45799999999999999999999973 56899999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCC-CC-----cchhHHHHHHHHHHHHhCCCCCc--cchhH----H
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK-LT-----PESDVYSFGIILLRLLTGRPVLR--IKKDV----K 635 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-----~ksDVwS~Gvil~eLltG~~p~~--~~~~~----~ 635 (780)
|..+......+ .....+||..|||||++.+.. +. .+.||||+|.|||||++.-..+. ...+. +
T Consensus 363 Al~~~p~~~~~-----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 363 ALRLEPGKPQG-----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eEEecCCCCCc-----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 98886443222 223478999999999997642 22 36899999999999999654331 11110 0
Q ss_pred HHHHh----cccc--ccccCcCCCCCH-----HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 636 CALEK----RNFN--SVLDSSAGDWPV-----AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 636 ~~~~~----~~~~--~~ld~~~~~~p~-----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
.-+.. +.+. .+-+...+.||. .....|.+.+..||..|+.-|-|. .=|.+.+..+...
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA-~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA-GCVEERMAELMML 506 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh-HHHHHHHHHHhcc
Confidence 00000 0000 111222334443 235678999999999999999999 6677777777543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=304.74 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=190.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC----------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES---------- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---------- 490 (780)
++|...+.||.|+||.||+|... +..||+|.+..........+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999874 578999998765555567788999999999999999999876432
Q ss_pred ------CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccc
Q 044673 491 ------RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLS 563 (780)
Q Consensus 491 ------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~ 563 (780)
.++||||++ ++|.+++. ...+++.....++.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 469999997 58888773 346899999999999999999999999 999999999999974 5678999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~ 642 (780)
|||+++.+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||...+..........
T Consensus 158 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99998765322111 011123467889999998754 4678899999999999999999999975544322211000
Q ss_pred c---------c--------ccc-cCcCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 F---------N--------SVL-DSSAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~---------~--------~~l-d~~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. . ... .......| ...+..+.+++.+|+..+|.+||++ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ell 298 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-EEAL 298 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-HHHh
Confidence 0 0 000 00001111 1234678899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=301.94 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=191.9
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC---
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--- 489 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--- 489 (780)
++..++++|...+.||.|+||.||++... +..||||.+... .......+.+|+.++.+++||||++++++|..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456889999999999999999999864 578999987542 22334568899999999999999999998843
Q ss_pred CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
..++|+||+ +++|.+++. ..++++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 357999998 568988873 346888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--H-------
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--E------- 639 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~------- 639 (780)
..... .....++..|++||++.+ ..++.++|||||||++|+|+||++||.......... .
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 54321 123456788999998866 568999999999999999999999996544321110 0
Q ss_pred --------hccccccccCc--CCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 640 --------KRNFNSVLDSS--AGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 640 --------~~~~~~~ld~~--~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.+....++... ....| ...+..+.+++.+|++.+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-~el 285 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-AEA 285 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 00000000000 00111 1235679999999999999999999 555
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=302.39 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=195.4
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------Ce
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------RS 492 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------~~ 492 (780)
+|.....||.|+||.||+|... +..||||.+.... ......|.+|+.+++.++||||+++++++.+. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 5789999887643 33456789999999999999999999988543 47
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||++ ++|.+++. ...++++..+..|+.+++.||.|||+.+ |+||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999998 48888884 3348999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH---h-cc-----
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE---K-RN----- 642 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~---~-~~----- 642 (780)
..... ........++..|+|||++.+. .++.++|+||||+++|+|+||++||...+....... . +.
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 33210 0112345678899999999887 789999999999999999999999976554321110 0 00
Q ss_pred --------ccccccCc--C-----CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 --------FNSVLDSS--A-----GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 --------~~~~ld~~--~-----~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+... . .......+..+.+++.+||+.+|.+||++ .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~ll~ 288 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-DEALA 288 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-HHHHh
Confidence 00000000 0 00011245678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.93 Aligned_cols=239 Identities=25% Similarity=0.362 Sum_probs=187.1
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
|....+||+|+||.||+|... +..|++|.+.... ......+.+|+.+++.++|||+++++++|.+. .++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999873 6789999886432 22345688999999999999999999998654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+. |+|.+++.. ...++++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 578777742 3457999999999999999999999999 99999999999999999999999998754321
Q ss_pred CCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||...+........... ........
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-- 243 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSN-- 243 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCcc--
Confidence 12346888999999984 456889999999999999999999998765443322211110 00000111
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+++.+|++.+|..||++ .+++
T Consensus 244 --~~~~~l~~li~~~l~~~P~~Rp~~-~~~l 271 (313)
T cd06633 244 --EWTDSFRGFVDYCLQKIPQERPAS-AELL 271 (313)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 233568899999999999999999 6554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=322.90 Aligned_cols=255 Identities=18% Similarity=0.251 Sum_probs=179.6
Q ss_pred HhcCCCcccccccCCceEEEEeeecCe---eEEEE------------------EccCCCchhHHHHHHHHHHhhcCCCCc
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRHL---HVAIK------------------MFPSYGPQSHLKFQNEVEVLSRVRHPN 479 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~~---~VAiK------------------~l~~~~~~~~~~f~~Ev~il~~l~Hpn 479 (780)
..++|....+||+|+||.||++.++.. .+++| .+. ........|.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 357899999999999999999876421 11212 111 11223456889999999999999
Q ss_pred eeeEeeeecC--CCeeEEEeccCCChhhHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 480 LVTLIGTCPE--SRSLVFEYLRNGSLEDCLACKN--KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 480 Iv~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
||++++++.+ ..++|++++. ++|.+++.... ............|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 9999999854 4578999985 56777664221 1222345667789999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCC-CCccch--
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP-VLRIKK-- 632 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~-p~~~~~-- 632 (780)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|.. |+....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 999999999999987643211 11234578999999999999999999999999999999999874 443211
Q ss_pred hHHHH---HHhcc-----cc-------ccccCc----CC-CCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 633 DVKCA---LEKRN-----FN-------SVLDSS----AG-DWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 633 ~~~~~---~~~~~-----~~-------~~ld~~----~~-~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..... +.... +. ..++.. .. ..+ ......+.+++.+||..||.+||++ .+++.
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-~elL~ 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-AELLA 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-HHHhh
Confidence 11111 11000 00 000000 00 000 0123456778999999999999999 66653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=308.65 Aligned_cols=196 Identities=27% Similarity=0.375 Sum_probs=166.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-C-----CceeeEeeee--cCCCee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-H-----PNLVTLIGTC--PESRSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-H-----pnIv~l~g~~--~~~~~L 493 (780)
.|.+...||+|.||.|-+|... +..||||+++.. .....+-..|+.+|..|+ | -|+|+++++| ....||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7788999999999999999886 467999999874 233445567999999997 3 4899999998 456899
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC--CCcccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN--FGSKLSDFGFFHLI 571 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~--~~~Kl~DFGla~~~ 571 (780)
|+|.+.. +|.++|. .++..+|+......|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|...
T Consensus 266 VfELL~~-NLYellK-~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLK-NNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999965 9999995 345667999999999999999999999999 9999999999999643 36999999998876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~ 634 (780)
.... ....-+..|.|||++.+.+|+.+.|+||||||++||+||.|.|.+.+.+
T Consensus 342 ~q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCcc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 4321 1445677899999999999999999999999999999999999766653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.51 Aligned_cols=257 Identities=20% Similarity=0.269 Sum_probs=189.5
Q ss_pred cCCCc-ccccccCCceEEEEeeec--CeeEEEEEccCCCchh--------------HHHHHHHHHHhhcCCCCceeeEee
Q 044673 423 NNFEP-SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS--------------HLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 423 ~~f~~-~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~--------------~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
++|.. .+.||.|+||.||+|... +..||||.+....... ...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 466999999999999864 6789999876432111 124779999999999999999999
Q ss_pred eecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 486 TCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 486 ~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
++... .++||||+. |+|.+++. ....+++.....++.|++.||.|||+.+ ++||||+|+|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEEC
Confidence 98543 679999997 68998884 3456899999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCC-------CcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHH
Q 044673 564 DFGFFHLIPQGESTGN-------SALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVK 635 (780)
Q Consensus 564 DFGla~~~~~~~~~~~-------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~ 635 (780)
|||+++.......... ..........++..|+|||++.+. .++.++|||||||++|+|+||++||...+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976642111000 001112234568889999998764 46899999999999999999999997665432
Q ss_pred HHHHh----cc-----ccccc--------cCc----CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 636 CALEK----RN-----FNSVL--------DSS----AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 636 ~~~~~----~~-----~~~~l--------d~~----~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..... +. +.... ... ........+..+.+++.+|+..+|.+||++ .+++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-KEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-HHHhc
Confidence 21100 00 00000 000 000011235678899999999999999999 66653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.61 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=192.4
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++++++||||+++++++.+. .++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556778999999999999885 6789999987643 33346788999999999999999999998554 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+ ++|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 8 5899998632 257999999999999999999999999 99999999999999999999999999876643211
Q ss_pred CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc------------ccc
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN------------FNS 645 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~------------~~~ 645 (780)
......++..|+|||++.+. .++.++|||||||++|+|++|++||.............. +..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 11234457789999998776 789999999999999999999999976554322111000 000
Q ss_pred c--ccCcCCCCC--------HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 V--LDSSAGDWP--------VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ~--ld~~~~~~p--------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ .+.....++ ...+..+.+++.+||..+|.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~~l 277 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-KEAL 277 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH-HHHh
Confidence 0 000011110 1225679999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=299.49 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=187.8
Q ss_pred CCCcccccccCCceEEEEeeec----CeeEEEEEccCC--CchhHHHHHHHHHHhhcCC-CCceeeEeeeec------CC
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR----HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP------ES 490 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~------~~ 490 (780)
+|...+.||+|+||.||++... +..||||.+... .......+.+|+.++.+++ ||||+++++++. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999985 457999988642 2223456889999999995 999999998652 12
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+++++|+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 457788875 68988884 4567999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-c----
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-R---- 641 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~---- 641 (780)
+...... .........||..|+|||++.+ ..++.++|||||||++|+|++|++||...+..... +.. +
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 6432211 1111234578999999998765 46899999999999999999999999754422110 000 0
Q ss_pred -ccccc-----------ccCc-CCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 -NFNSV-----------LDSS-AGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 -~~~~~-----------ld~~-~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+..+ +... ...+ .......+.+++.+|+..+|.+||++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-EEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 00000 0000 0000 01134678999999999999999999 6653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.73 Aligned_cols=238 Identities=22% Similarity=0.263 Sum_probs=195.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeec--CCCeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ESRSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~~LV 494 (780)
.++|+.++.||+|.||+|.+++-+ +.-+|||++++... .....-..|-.+|...+||.+..|-..|+ +..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478999999999999999998775 56799999987432 23344567889999999999999988884 457999
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||..||.|.-+|. +...+++.....+..+|++||.|||+.+ ||.||||.+|+|||.+|++||+|||||+.--..
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999999995 4456788777788999999999999999 999999999999999999999999998743211
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
...+...+||+.|+|||++....|+..+|+|.+|||+|||++|+.||...+.-+. -+++-.....+
T Consensus 322 -------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed~kF 387 (516)
T KOG0690|consen 322 -------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMEDLKF 387 (516)
T ss_pred -------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhhccC
Confidence 1234568999999999999999999999999999999999999999986554221 11222222346
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCc
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
|...+.+...|+...|..+|++|-
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhc
Confidence 667777888899999999999994
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.16 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=208.0
Q ss_pred CCcccccccCCceEEEEeeec------CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEE
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR------HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFE 496 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~E 496 (780)
+...++||+|+||+||+|.|- +.+||||++... +.+...+|..|+-+|.+++|||+++|+|+|... ..||.+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 344678999999999999882 367999998763 455677899999999999999999999999655 568999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
||+.|+|.|++. ....++..+..+.|.+||++|+.|||... +|||||-.+|||+..-..+||.|||+++++..+..
T Consensus 778 ~mP~G~LlDyvr--~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVR--EHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999995 45677888999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccch--hHHHHHHhccccccccCcCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKK--DVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~--~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... .....-.+.|||=|.+....|+.+||||||||++|||+| |..|+.... ++...++.|. ...
T Consensus 854 ey~-----~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------RLs 920 (1177)
T KOG1025|consen 854 EYS-----APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------RLS 920 (1177)
T ss_pred ccc-----ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------cCC
Confidence 321 222333556999999999999999999999999999998 788876443 2333444332 233
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
-|..++.++.-++.+||..|+..||.+ +++...+.++-
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~f-kel~~~fs~~a 958 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTF-KELAEEFSRMA 958 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccH-HHHHHHHHHHh
Confidence 466788889999999999999999999 88888888773
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.60 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=195.6
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhc--CCCCceeeEeeeecC------CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSR--VRHPNLVTLIGTCPE------SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~--l~HpnIv~l~g~~~~------~~~LV 494 (780)
......+.||+|.||.||+|.|+|..||||+|... +...|.+|.+|... |||+||+.++++-.. +.+||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 45667788999999999999999999999999764 34567788888776 599999999988622 24699
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCccccCCCCCCceEecCCCCccccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS------NEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~------~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.+|-++|||.|+|. ...++-...++++..+|+||++||. .+|.|.|||||+.|||+.+||.+.|+|+|||
T Consensus 288 TdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999994 3679999999999999999999995 3578999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCC----CC--cchhHHHHHHHHHHHHhC----------CCCCccch
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK----LT--PESDVYSFGIILLRLLTG----------RPVLRIKK 632 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~--~ksDVwS~Gvil~eLltG----------~~p~~~~~ 632 (780)
-...... ..........+||..|||||++.... +. ..+||||||.|+||+.-. ++||...-
T Consensus 364 v~h~~~t---~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 364 VRHDSDT---DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred EEecccC---CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 7665332 22233456789999999999986432 21 358999999999998762 46665322
Q ss_pred h----HHHHHHhccccccccCc-CCCCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 633 D----VKCALEKRNFNSVLDSS-AGDWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 633 ~----~~~~~~~~~~~~~ld~~-~~~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+ ++.+ .+--..+-+.|. ...|.. .....+.+++..||..||.-|-++ -.+-+.|..+
T Consensus 441 p~DPs~eeM-rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA-LriKKtl~~l 503 (513)
T KOG2052|consen 441 PSDPSFEEM-RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA-LRIKKTLAKL 503 (513)
T ss_pred CCCCCHHHH-hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH-HHHHHHHHHH
Confidence 1 1211 111111122222 223433 455679999999999999999988 4566666655
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=301.22 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=191.3
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-----
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----- 490 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----- 490 (780)
...++|.....||+|+||.||+|... +..||||++... .......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999885 578999988642 223345677899999999999999999876322
Q ss_pred ---CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 491 ---RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 491 ---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
.++|+||+ +++|.+++. ..++++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccc
Confidence 57899998 679999884 256999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccc--
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN-- 644 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~-- 644 (780)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|+||++||................
T Consensus 165 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 165 ARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred ccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 8765321 123467888999999865 367899999999999999999999996544322111000000
Q ss_pred ---------------ccccC----cCCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ---------------SVLDS----SAGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ---------------~~ld~----~~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+.. ....+ ....+..+.+++.+|+..+|.+||++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-~ell 296 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-AEAL 296 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-HHHh
Confidence 00000 00000 01235679999999999999999999 6663
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-34 Score=331.05 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=196.0
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLV 494 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV 494 (780)
.+-++....+||.|.||.||-|... |.-.|+|-+.... ........+|+.+|..|+|||+|+.||+- .+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3456777889999999999999874 4557888765432 22334577999999999999999999975 4457899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||||.+|+|.+.+. .+..+++.....+-.|++.|+.|||+++ ||||||||+|||||.+|.+|++|||.|..+..+
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999984 4455677777788999999999999999 999999999999999999999999999887644
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETG---KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
.. ..........||+.|||||++.+. +..-+.||||+|||++||.||+.||...+.-+..+-.- --...
T Consensus 1388 ~~---~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-----~~gh~ 1459 (1509)
T KOG4645|consen 1388 AQ---TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-----AAGHK 1459 (1509)
T ss_pred hh---cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-----hccCC
Confidence 21 111223467899999999999753 35568999999999999999999997554333222111 11123
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
+..|...+.+-.+++.+|++.||+.|.++ .++
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~-~ql 1491 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTA-SQL 1491 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHH-HHH
Confidence 45566678888999999999999999766 444
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=281.11 Aligned_cols=232 Identities=26% Similarity=0.332 Sum_probs=189.6
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
||.|+||.||++... +..||+|.+..... .....+..|+.++++++||||+++++.+.+. .++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999885 67899999865322 2455788999999999999999999988654 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.+++. ....+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99995 3346899999999999999999999999 9999999999999999999999999987664321 1
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 663 (780)
......++..|++||.+.+...+.++|+||||+++|+|++|..||...+..... ... .. .....|...+..+.
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~~-----~~-~~~~~~~~~~~~l~ 221 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-EKI-----LK-DPLRFPEFLSPEAR 221 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHH-----hc-CCCCCCCCCCHHHH
Confidence 123456788899999998888999999999999999999999999765532211 110 11 11223444467789
Q ss_pred HHHHHchhhCCCCCcchH
Q 044673 664 HLALRCCENNRLNRPDLV 681 (780)
Q Consensus 664 ~l~~~Cl~~~p~~RPs~~ 681 (780)
+++.+|+..+|.+||++.
T Consensus 222 ~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 222 DLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHhcCCHhhCCCcc
Confidence 999999999999999993
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=318.68 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=186.0
Q ss_pred HHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeec--------
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCP-------- 488 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~-------- 488 (780)
+-..+|..+..||+||||.||+++. +|..+|||+++... ........+|+.+|++|+|||||+++.++-
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3457899999999999999999986 58999999987643 333456789999999999999997753210
Q ss_pred --------------------------------------------------------------------------------
Q 044673 489 -------------------------------------------------------------------------------- 488 (780)
Q Consensus 489 -------------------------------------------------------------------------------- 488 (780)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C---------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 044673 489 ------------------------E---------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535 (780)
Q Consensus 489 ------------------------~---------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~L 535 (780)
+ ..|+=||||+...|.+++....-.. .-...++++.+|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 0124567888877777774322111 3567889999999999999
Q ss_pred HcCCCccccCCCCCCceEecCCCCccccccccccccc---C--------CCCCCCCcccccCCCCCCcccCChhhhccC-
Q 044673 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP---Q--------GESTGNSALCNESNNDSASVYIDPEYLETG- 603 (780)
Q Consensus 536 H~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~---~--------~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~- 603 (780)
|+.+ ||||||||.||+||.+..+||+|||+|+... . ............|..+||.-|+|||++...
T Consensus 714 H~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 HDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999 9999999999999999999999999998721 0 011111122245778999999999999765
Q ss_pred --CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCc
Q 044673 604 --KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 604 --~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
.|+.|+|+|||||||+||+. ||+..-+-... ++++.+..- .+++......-+.++.++++.||.+||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccCC
Confidence 49999999999999999985 46533322222 222322221 233344555678899999999999999
Q ss_pred chHHHHH
Q 044673 679 DLVSEIW 685 (780)
Q Consensus 679 s~~~ev~ 685 (780)
++ .+++
T Consensus 864 tA-~eLL 869 (1351)
T KOG1035|consen 864 TA-TELL 869 (1351)
T ss_pred CH-HHHh
Confidence 99 5554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=280.86 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=194.6
Q ss_pred cccCHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcC-CCCceeeEeee
Q 044673 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRV-RHPNLVTLIGT 486 (780)
Q Consensus 411 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l-~HpnIv~l~g~ 486 (780)
-.|+-++++ .+..||.|.||+|+|-.++ +...|||.++.... ....+|+.|.++..+- +.||||++||+
T Consensus 59 ~~F~~~~Lq-------dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQ-------DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHH-------HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 355554444 3456999999999998875 67799999987544 5677899999877665 68999999998
Q ss_pred e-cCCC-eeEEEeccCCChhhHHhh--hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcc
Q 044673 487 C-PESR-SLVFEYLRNGSLEDCLAC--KNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 487 ~-~~~~-~LV~Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~K 561 (780)
+ .++. .+.||.|.- ||+.+... ......+++...-.|....+.||.||-.. + |||||+||+|||||..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEe
Confidence 6 5554 488999854 66654321 22456789998889999999999999864 5 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE 639 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~ 639 (780)
|||||++-.+... ...+..+|...|||||.+.. .+|+.+|||||||++|+|+.||+.|+...+.+-..+.
T Consensus 209 LCDFGIcGqLv~S--------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLVDS--------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred eecccchHhHHHH--------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 9999998766422 12356688888999998853 3599999999999999999999999998887655543
Q ss_pred ---hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 640 ---KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 640 ---~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.|....++.+. .....+..+.+++.-|+-.|..+||.. ..+
T Consensus 281 ~Vv~gdpp~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky-~~L 324 (361)
T KOG1006|consen 281 QVVIGDPPILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKY-DDL 324 (361)
T ss_pred HHHcCCCCeecCcc---cccccCHHHHHHHHHHhhcccccCcch-hhh
Confidence 23222222111 112467889999999999999999998 444
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=280.08 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=199.7
Q ss_pred CHHHHHHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC
Q 044673 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES 490 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~ 490 (780)
+|.|+-..|+. .||+|+||.|-.+.. .+..+|||++.+.....+.+..+||+++.+.+ |+||+.|+.+|.+.
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 46676666654 599999999987754 57889999999887778888999999999996 99999999999765
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---cccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDF 565 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DF 565 (780)
.|||||-|.||+|-.+|.. ..-+++.+.-++..+|+.||.|||..+ |.||||||+|||-..... +|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeecc
Confidence 6899999999999999963 345889999999999999999999999 999999999999965443 799999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~ 640 (780)
.|..-+...............+++|+..|||||+.. ...|+.++|.||||||||-||+|.+||...-...+.|.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 997654333222233334456789999999999763 235899999999999999999999999754433333333
Q ss_pred ccc---------cccccCcCCCCCH----HHHHHHHHHHHHchhhCCCCCcch
Q 044673 641 RNF---------NSVLDSSAGDWPV----AEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 641 ~~~---------~~~ld~~~~~~p~----~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
|.. ..+. ....++|. ..+.+..+|+...+..++.+|-+.
T Consensus 304 Ge~Cr~CQ~~LFesIQ-EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQ-EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred CCccHHHHHHHHHHHh-ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence 321 1111 12223332 356677888888888999999877
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=277.07 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=195.0
Q ss_pred HHhcCCCccc-ccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC----C
Q 044673 420 EATNNFEPSW-KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES----R 491 (780)
Q Consensus 420 ~at~~f~~~~-~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~----~ 491 (780)
..|++|++.+ +||-|-.|+|-.+..+ +..+|+|++.. ...-++||++.-.. .|||||.++++|... .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3577888775 6899999999988876 46799999864 23445889887666 499999999988432 3
Q ss_pred e--eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccc
Q 044673 492 S--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFG 566 (780)
Q Consensus 492 ~--LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFG 566 (780)
| +|||+|+||.|...+..+ ...++++.+.-.|..||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccc
Confidence 3 699999999999999643 4567999999999999999999999999 999999999999964 5568999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHh
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEK 640 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~ 640 (780)
+|+..... ....+.+.|+.|.|||++...+|+..+|+||+||++|-||+|.|||...+. .+.-+..
T Consensus 210 FAK~t~~~--------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 210 FAKETQEP--------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred cccccCCC--------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 99765321 223567889999999999999999999999999999999999999975543 2222333
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|.+ +...++|. ..++...+++...|..+|.+|-++ .+++
T Consensus 282 gqy----~FP~pEWs-~VSe~aKdlIR~LLkt~PteRlTI-~~~m 320 (400)
T KOG0604|consen 282 GQY----EFPEPEWS-CVSEAAKDLIRKLLKTEPTERLTI-EEVM 320 (400)
T ss_pred cCc----cCCChhHh-HHHHHHHHHHHHHhcCCchhheeH-HHhh
Confidence 322 12223443 457788999999999999999999 6553
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=317.70 Aligned_cols=144 Identities=29% Similarity=0.394 Sum_probs=127.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV 494 (780)
.++|...++||+|+||.||+|.+. +..||||++.... ......|..|+.++..++||||+++++++.+ ..|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468899999999999999999986 6789999986532 2234678899999999999999999988854 46899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
|||+++|+|.+++. ....+++...+.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999985 3346889999999999999999999999 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=271.67 Aligned_cols=240 Identities=22% Similarity=0.366 Sum_probs=184.1
Q ss_pred cccccccCCceEEEEeeecC--eeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeEEEeccC
Q 044673 427 PSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
.+.-||.|..|.|+++..+. ...|||.+...+ ....++.+..+.++.+-+ .|.||+.+|+|-.+ ..+.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 34569999999999999975 779999887643 445567778888877765 89999999999443 4577887743
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
.++.+|. .-.+++++...-++...+..||.||.... .|+|||+||+|||||..|++||||||++-.+.+..
T Consensus 176 -C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk----- 246 (391)
T KOG0983|consen 176 -CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----- 246 (391)
T ss_pred -HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeeccc-----
Confidence 4555553 34567999999999999999999998753 29999999999999999999999999996664332
Q ss_pred cccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC--CCC
Q 044673 581 ALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG--DWP 655 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~--~~p 655 (780)
..+...|.+.|||||.+.. ..|+..+|||||||.|+||.||+.||...+--...+. .+++...+ ...
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-----kvln~ePP~L~~~ 318 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-----KVLNEEPPLLPGH 318 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-----HHHhcCCCCCCcc
Confidence 1356789999999999864 4689999999999999999999999976442221111 11111111 111
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...+..+.+++..||..|+.+||.. .++
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y-~~L 346 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKY-NKL 346 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcch-HHH
Confidence 2367889999999999999999998 544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=291.29 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=203.8
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeee--cCCCeeEEEeccCC
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLRNG 501 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~~~~LV~Ey~~~g 501 (780)
...||+|-||+||-|.++ |..||||++.+. ......++.+||.||.+++||.||.|---| ++..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 357999999999999886 678999998752 344557789999999999999999998877 45568899999776
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---CcccccccccccccCCCCCC
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~DFGla~~~~~~~~~~ 578 (780)
-|+-+|. ...+.|++..-..++.||+.||.|||..+ |||+||||+||||.... .+||||||+|+.++....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 6666664 35578999999999999999999999999 99999999999996543 489999999999874321
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
....+||+.|+|||++....|...-|+||.|||+|--|+|..||....++...+.+..+...-.| | .+.
T Consensus 723 ------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P----W-~ei 791 (888)
T KOG4236|consen 723 ------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP----W-SEI 791 (888)
T ss_pred ------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc----h-hhc
Confidence 25679999999999999999999999999999999999999999988888777766555433222 3 245
Q ss_pred HHHHHHHHHHchhhCCCCCcchH----------HHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLV----------SEIWSVLEALR 692 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~----------~ev~~~L~~l~ 692 (780)
+....+|+...|+..-++|.+.. -+.|..|..+.
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHH
Confidence 66788999999999888898762 23555666664
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=309.29 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=203.0
Q ss_pred cCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecC--
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE-- 489 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~-- 489 (780)
++....+.||+|.||.|++|... ...||||+++... ......|..|+++|+.+ +|||||.|+|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34445558999999999999764 3469999998643 34567799999999999 59999999999966
Q ss_pred CCeeEEEeccCCChhhHHhhhC------CC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 490 SRSLVFEYLRNGSLEDCLACKN------KK-------SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~------~~-------~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
..++|+||+..|+|.++|.... .. ..|+..+.+.+++|||.|+.||++.+ +|||||-.+|||+..
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITK 453 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecC
Confidence 3578999999999999996433 00 24999999999999999999999998 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCC--CcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccch-
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS--ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKK- 632 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~- 632 (780)
+..+||+|||+|+........ ......| ...|||||.+....|+.|||||||||+||||+| |..|+....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y------~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYY------RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCEEEEccccceeccCCCCce------EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999866433211 1112222 345999999999999999999999999999999 788887533
Q ss_pred --hHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 633 --DVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 633 --~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
++...+..|. ..+-|..+..++..+++.||..+|.+||++ .++.+.|+.+
T Consensus 528 ~~~l~~~l~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F-~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEELLEFLKEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTF-SECVEFFEKH 579 (609)
T ss_pred HHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHHHHH
Confidence 2222233332 334566678889999999999999999999 8899999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.30 Aligned_cols=216 Identities=19% Similarity=0.201 Sum_probs=173.4
Q ss_pred CCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCChhhHHhh
Q 044673 434 GRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLEDCLAC 509 (780)
Q Consensus 434 G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~ 509 (780)
|.||.||++... +..||+|.+.... .+.+|...+....||||+++++++.+. .++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999884 5779999987532 234556666667899999999988543 5799999999999999853
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCC
Q 044673 510 KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589 (780)
Q Consensus 510 ~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 589 (780)
..++++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++++|||++..+... .....
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 345999999999999999999999999 999999999999999999999999987655321 11234
Q ss_pred CCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHc
Q 044673 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRC 669 (780)
Q Consensus 590 gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~C 669 (780)
++..|+|||++.++.++.++||||||+++|+|++|++|+....... ........|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccCCcccCCHHHHHHHHHH
Confidence 5667999999988889999999999999999999998875332110 00011123334567799999999
Q ss_pred hhhCCCCCcch
Q 044673 670 CENNRLNRPDL 680 (780)
Q Consensus 670 l~~~p~~RPs~ 680 (780)
++.||.+||++
T Consensus 213 l~~dp~~R~~~ 223 (237)
T cd05576 213 LQFNPTERLGA 223 (237)
T ss_pred ccCCHHHhcCC
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=283.00 Aligned_cols=237 Identities=20% Similarity=0.291 Sum_probs=191.1
Q ss_pred cCCCcccccccCCceEEEEeeecCee--EEEEEccCCCc---hhHHHHHHHHHHhhcC-CCCceeeEeeeec--CCCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGP---QSHLKFQNEVEVLSRV-RHPNLVTLIGTCP--ESRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~--VAiK~l~~~~~---~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~--~~~~LV 494 (780)
.+|..+..||+|+||+|-+|.-+++. +|||+++++.. .+..--..|-.+|.-. +-|.+|.|..+|. +..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 57999999999999999999888754 99999987431 1222233566777665 5788999998884 567899
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+.||+|.-++. .-+.+.+.....+|.+|+-||-|||+.+ ||.||||.+|||||.+|++||+|||+++.--.+
T Consensus 429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999986 4456777888999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. ..+.+.+||+-|+|||++...+|+..+|+|||||+|||||.|++||+..+.-.... .+.+. .-.+
T Consensus 504 ~-------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~------aI~eh-nvsy 569 (683)
T KOG0696|consen 504 G-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------AIMEH-NVSY 569 (683)
T ss_pred C-------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHHc-cCcC
Confidence 1 12356799999999999999999999999999999999999999999776543221 11111 1235
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCc
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
|...+.+...+....+...|.+|-
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cccccHHHHHHHHHHhhcCCcccc
Confidence 667778888888899999998884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=291.38 Aligned_cols=238 Identities=24% Similarity=0.324 Sum_probs=201.5
Q ss_pred cCCCcccccccCCceEEEEeeecCee--EEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCCC--eeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESR--SLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~--VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~--~LV~ 495 (780)
.++..+-.||-||||.|=+...++.. +|+|.+++. ..........|-+||...+.|.||+||-.|.+.. |+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999998887654 788887652 3344556789999999999999999999998764 5789
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|-|-||.|...|. ..+.++..+...++..++.|+.|||..+ ||.|||||+|.|||.+|-+||.|||+|+.+....
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999995 4566888888899999999999999999 9999999999999999999999999999887544
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc-CCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS-AGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~-~~~~ 654 (780)
. +-+.+||+.|.|||++.....+..+|.||||+++||||||.|||...+.+... +.++... .-.|
T Consensus 575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~ILkGid~i~~ 640 (732)
T KOG0614|consen 575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NLILKGIDKIEF 640 (732)
T ss_pred c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HHHHhhhhhhhc
Confidence 3 24679999999999999999999999999999999999999999988876543 2222221 3357
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
|...+....+|+.+.|..+|..|-.
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 8888888999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=296.17 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=206.8
Q ss_pred CHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeee---
Q 044673 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTC--- 487 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~--- 487 (780)
.++.+..-++-|.+...||.|.||.||++... ++.+|+|++.... ....+...|.+||+.. .|||++.++|++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444455788999999999999999998764 6789999987653 3345567889999888 599999999987
Q ss_pred ----cCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 488 ----PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 488 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
.|...||||||.+||..|++.... +..+.|..+..|+.+++.||.+||.+. ++|||||-.||||+.++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEe
Confidence 345679999999999999986544 778999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-----CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-----KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL 638 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~ 638 (780)
|||.+..+.. +.....+..||++|||||++... .|+..+|+||||++..||--|.||+-..+.+..++
T Consensus 166 DFGvSaQlds-------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 166 DFGVSAQLDS-------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred eeeeeeeeec-------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 9999876642 23445667899999999998643 47789999999999999999999998777766553
Q ss_pred HhccccccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 639 EKRNFNSVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 639 ~~~~~~~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..- -.| ....-|..-+.++.+++..||..|...||++
T Consensus 239 ~Ip-----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~ 276 (953)
T KOG0587|consen 239 LIP-----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST 276 (953)
T ss_pred cCC-----CCCCccccchhhHHHHHHHHHHHHHhhccccCcch
Confidence 211 111 1223356678899999999999999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=265.62 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=194.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccC--CCchhHHHHHHHHHHhhcCCCCceeeEeeeec-----CC---
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPS--YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP-----ES--- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~--~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~-----~~--- 490 (780)
+.|....+||+|.||.||+|+.+ +..||+|+.-. ........-.+|+.+|..+.|+|++.|+..|. ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45667789999999999999886 45688886432 22333445679999999999999999999882 11
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.+|||.+|+. +|.-+|. +....++..++.++..++..||.|+|..+ |+|||+||+|+|++.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 4699999987 7887774 34467899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH----Hhccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL----EKRNF 643 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~----~~~~~ 643 (780)
+.+.... .....+++..+-|.+|.+||.+.+. .|+++.|||.-|||+.||+||.|.|.........- -.|.+
T Consensus 172 r~fs~~~---n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSK---NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cceeccc---ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 8876432 2234456778889999999998875 69999999999999999999999997665433211 01111
Q ss_pred cc-------------cc--cCcC-CCC--------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 644 NS-------------VL--DSSA-GDW--------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 644 ~~-------------~l--d~~~-~~~--------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.. -+ .|.. +.+ |.......++|+..++..||.+|++. ++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a-d~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA-DQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch-Hhhhc
Confidence 10 00 0000 000 11112367789999999999999998 66643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=263.46 Aligned_cols=232 Identities=28% Similarity=0.396 Sum_probs=187.5
Q ss_pred CceEEEEeeec--CeeEEEEEccCCCchh-HHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccCCChhhHHhh
Q 044673 435 RYGNVYRGLLR--HLHVAIKMFPSYGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRNGSLEDCLAC 509 (780)
Q Consensus 435 ~~G~Vyk~~~~--~~~VAiK~l~~~~~~~-~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~ 509 (780)
+||.||+|... +..||+|++....... ...|.+|+..+++++||||+++++++.. ..+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999985 4789999997654444 6789999999999999999999999864 46799999999999999853
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCC
Q 044673 510 KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589 (780)
Q Consensus 510 ~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 589 (780)
...+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 233899999999999999999999999 9999999999999999999999999988765321 123456
Q ss_pred CCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH---HHHHHHHHH
Q 044673 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA---EAEQLAHLA 666 (780)
Q Consensus 590 gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~---~~~~l~~l~ 666 (780)
++..|++||.+....++.++||||||+++++|++|.+||.............. ......+.. .+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG------KPKPPFPPPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh------ccCCCCccccccCCHHHHHHH
Confidence 78889999999988899999999999999999999999976333222221110 000111111 456799999
Q ss_pred HHchhhCCCCCcchHHHHHH
Q 044673 667 LRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 667 ~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+|+..+|.+||++ .++++
T Consensus 222 ~~~l~~~p~~Rp~~-~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTA-EEALQ 240 (244)
T ss_pred HHHccCCchhccCH-HHHhh
Confidence 99999999999999 66653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=245.67 Aligned_cols=197 Identities=26% Similarity=0.353 Sum_probs=164.4
Q ss_pred CCCcccccccCCceEEEEeeecC--eeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+|+...+||+|.||+||+|+..+ ..||+|.++.+. ..-...-.+|+-+|+.+.|.|||+|++..... ..||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56677899999999999998864 569999876533 33345678999999999999999999987544 4689999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
|.. +|..+.. .-++.++......++.|+++||.|+|+++ +.||||||.|.|++.||..|++|||+++.+..+.
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 965 7887774 34567889999999999999999999999 9999999999999999999999999999886542
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHh-CCCCCccch
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLT-GRPVLRIKK 632 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~ 632 (780)
......+-|.+|.+|.++-+. -|++..|+||-|||+.||.. |+|.|...+
T Consensus 156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 223455778999999998775 48889999999999999996 677776443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.03 Aligned_cols=234 Identities=24% Similarity=0.349 Sum_probs=187.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~E 496 (780)
+..|.....||.|+|+.|-++... +...++|++..... .-.+|+.++... .||||+++.+.|.+. .++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 677888888999999999998874 57799999976422 223677666666 599999999999876 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe-cCCCCcccccccccccccCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI-DANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL-d~~~~~Kl~DFGla~~~~~~~ 575 (780)
++.+|-|.+.+.. .+... ..+..|+.+|+.|+.|||.++ +|||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999998888742 22233 777889999999999999999 9999999999999 68999999999999877543
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
....+-|..|.|||++....|++++||||||++||+||||+.||.....-...... +. .+.+.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~-----i~---~~~~s 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR-----IQ---MPKFS 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh-----hc---CCccc
Confidence 13456678899999999999999999999999999999999999754432111111 11 12222
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...+....+|+.+||+.||.+||++ +++
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~-~~i 560 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGA-DEI 560 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcCh-hhh
Confidence 4567788999999999999999999 555
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=290.55 Aligned_cols=255 Identities=19% Similarity=0.263 Sum_probs=178.0
Q ss_pred hcCCCcccccccCCceEEEEeee------------------cCeeEEEEEccCCCchhHHHH--------------HHHH
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL------------------RHLHVAIKMFPSYGPQSHLKF--------------QNEV 469 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~------------------~~~~VAiK~l~~~~~~~~~~f--------------~~Ev 469 (780)
.++|...++||+|+||.||+|.+ .+..||||.+..........| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 67999999999999999999964 235699999875443333333 3467
Q ss_pred HHhhcCCCCce-----eeEeeeecC----------CCeeEEEeccCCChhhHHhhhCC---------------------C
Q 044673 470 EVLSRVRHPNL-----VTLIGTCPE----------SRSLVFEYLRNGSLEDCLACKNK---------------------K 513 (780)
Q Consensus 470 ~il~~l~HpnI-----v~l~g~~~~----------~~~LV~Ey~~~gsL~~~L~~~~~---------------------~ 513 (780)
.++.+++|.++ +.++|+|.. ..+|||||+++|+|.++|+.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777876654 677787732 35799999999999999864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcc
Q 044673 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593 (780)
Q Consensus 514 ~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 593 (780)
..++|..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~g~~tp~ 375 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------FNPLYGMLDPR 375 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCc------cCccccCCCcc
Confidence 23578889999999999999999999 99999999999999999999999999876532211 11122345789
Q ss_pred cCChhhhccCC----------------------CCcchhHHHHHHHHHHHHhCCC-CCccchhHHHHHHh--cccc--cc
Q 044673 594 YIDPEYLETGK----------------------LTPESDVYSFGIILLRLLTGRP-VLRIKKDVKCALEK--RNFN--SV 646 (780)
Q Consensus 594 Y~aPE~~~~~~----------------------~~~ksDVwS~Gvil~eLltG~~-p~~~~~~~~~~~~~--~~~~--~~ 646 (780)
|+|||.+.... ...+.||||+|||||+|++|.. |+.........+.. .... ..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 99999875432 1235799999999999999974 66532222111110 0000 00
Q ss_pred ccCcCCCCC--HHHHHHHHHHHHHchhhCC---CCCcchHHHHH
Q 044673 647 LDSSAGDWP--VAEAEQLAHLALRCCENNR---LNRPDLVSEIW 685 (780)
Q Consensus 647 ld~~~~~~p--~~~~~~l~~l~~~Cl~~~p---~~RPs~~~ev~ 685 (780)
......+++ ........+|+.+++..+| .+|+++ .+++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa-~eaL 498 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV-GQAL 498 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH-HHHh
Confidence 000111111 1245678899999999766 689999 6653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=263.21 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=189.2
Q ss_pred hcCCCcccccccCCceEEEEeeecC--eeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|..++.||+|+|++|-.+.+.. ..+|+|++++. ...+..-.+.|-.+..+. +||.+|-|..+|... .++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4789999999999999999998864 56999988652 223333455677777665 699999999999654 467
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|.||++||+|.-++. +...|++.....+..+|+.||.|||+.+ ||.||||.+|+|||..|++||+|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999998885 4556899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
+ ...+.+.+||+.|+|||++.+..|+..+|+|+|||+++||+.|+.||+....... --+.--+..++...
T Consensus 404 ~-------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq- 475 (593)
T KOG0695|consen 404 P-------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ- 475 (593)
T ss_pred C-------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-
Confidence 2 1224567999999999999999999999999999999999999999975431000 00000111222221
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
-..|...+-....++...+..||+.|-
T Consensus 476 iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 123445556677888888999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=293.40 Aligned_cols=253 Identities=20% Similarity=0.219 Sum_probs=163.9
Q ss_pred HhcCCCcccccccCCceEEEEeeec------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeee--------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT-------- 486 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~-------- 486 (780)
..++|...++||+|+||.||+|.+. +..||||.+...... ..+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999885 457999988653221 111111 1222223333333222
Q ss_pred ecCCCeeEEEeccCCChhhHHhhhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 487 CPESRSLVFEYLRNGSLEDCLACKNKK-----------------SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 487 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
..+..+|||||+++|+|.+++...... ....+..+..|+.||+.||.|||+.+ |+||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP 283 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP 283 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence 123467999999999999988532110 11123445679999999999999999 99999999
Q ss_pred CceEecC-CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC----------------------CCC
Q 044673 550 SKVLIDA-NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG----------------------KLT 606 (780)
Q Consensus 550 ~NILLd~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~ 606 (780)
+||||+. ++.+||+|||+|+.+..... .......||+.|+|||.+... .++
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999986 68899999999986542211 122346788999999965322 234
Q ss_pred cchhHHHHHHHHHHHHhCCCCCccchh-HHHHHHhccc-----cccccCcC-CCC------CHHHHHHHHHHHHHchhhC
Q 044673 607 PESDVYSFGIILLRLLTGRPVLRIKKD-VKCALEKRNF-----NSVLDSSA-GDW------PVAEAEQLAHLALRCCENN 673 (780)
Q Consensus 607 ~ksDVwS~Gvil~eLltG~~p~~~~~~-~~~~~~~~~~-----~~~ld~~~-~~~------p~~~~~~l~~l~~~Cl~~~ 673 (780)
.++|||||||+||||+++..++..... ....+..... ...+.+.. .+. .........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999997766542111 1111111110 00111110 000 0001223558999999999
Q ss_pred CCCCcchHHHHHH
Q 044673 674 RLNRPDLVSEIWS 686 (780)
Q Consensus 674 p~~RPs~~~ev~~ 686 (780)
|.+||++ .+++.
T Consensus 438 P~kR~ta-~e~L~ 449 (566)
T PLN03225 438 GRQRISA-KAALA 449 (566)
T ss_pred cccCCCH-HHHhC
Confidence 9999999 66643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=266.03 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=189.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCC--C----ceeeEeeeec--CCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH--P----NLVTLIGTCP--ESR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H--p----nIv~l~g~~~--~~~ 491 (780)
++.|.+...+|+|.||.|-.+..+ +..||||+++.... -+..-.-|+++|.++.+ | -+|.+.++|. ...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 789999999999999999998876 46799999976432 23334579999999942 3 3677778773 457
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---------------
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA--------------- 556 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~--------------- 556 (780)
|+|+|.+ |-|+.|+|. .++..+++...+..|++|++.++.|||+.+ ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk-~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLK-ENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhc-cCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccce
Confidence 8999988 559999994 345678999999999999999999999999 999999999999921
Q ss_pred -----CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 557 -----NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 557 -----~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
+..+||+|||-|+...... +..+.|..|.|||++.+-+++.++||||+||||+||.||...|...
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3347999999988764332 4467788999999999999999999999999999999999988765
Q ss_pred hhHHHH--HH------------hccccccccCcCCCCC-------------------------HHHHHHHHHHHHHchhh
Q 044673 632 KDVKCA--LE------------KRNFNSVLDSSAGDWP-------------------------VAEAEQLAHLALRCCEN 672 (780)
Q Consensus 632 ~~~~~~--~~------------~~~~~~~ld~~~~~~p-------------------------~~~~~~l~~l~~~Cl~~ 672 (780)
++.+.. ++ +..-.........+|| ..+..+|.+|+.++|..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 533211 10 0000000000011221 24456799999999999
Q ss_pred CCCCCcchHHHHH
Q 044673 673 NRLNRPDLVSEIW 685 (780)
Q Consensus 673 ~p~~RPs~~~ev~ 685 (780)
||.+|+++ .|++
T Consensus 393 DP~~RiTl-~EAL 404 (415)
T KOG0671|consen 393 DPARRITL-REAL 404 (415)
T ss_pred CccccccH-HHHh
Confidence 99999999 5553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=284.53 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=186.1
Q ss_pred CCCcccccccCCce-EEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEecc
Q 044673 424 NFEPSWKIGEGRYG-NVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 424 ~f~~~~~IG~G~~G-~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
-|.....+|.|+.| .||+|.+.++.||||++-. ......++||..|+.- .|||||++++.-.+. .|+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 35555678999987 5899999999999998854 2333456899999888 599999999887665 468889986
Q ss_pred CCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---C--CCcccccccccccccC
Q 044673 500 NGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---N--FGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 500 ~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~--~~~Kl~DFGla~~~~~ 573 (780)
. +|.|++... .......-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+..
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5 999999642 10011111344678899999999999999 999999999999976 3 4689999999998865
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCccchhHHHHHHhccccccccCcCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG-RPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
+.. ...+.....||.+|+|||++....-+.++||||||||+|+.+|| ..||+..-.-+.-+-.++..-..-....
T Consensus 664 ~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 664 GKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLP 739 (903)
T ss_pred Ccc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCc
Confidence 432 22335678899999999999998888899999999999999996 8999855443333333433221111122
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+| +..+||.+|+..+|..||++ .+|+
T Consensus 740 d~------eA~dLI~~ml~~dP~~RPsa-~~VL 765 (903)
T KOG1027|consen 740 DC------EAKDLISRMLNPDPQLRPSA-TDVL 765 (903)
T ss_pred hH------HHHHHHHHhcCCCcccCCCH-HHHh
Confidence 22 67899999999999999999 6664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-29 Score=239.08 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=160.6
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecC--CCeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE--SRSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~--~~~LV~ 495 (780)
.++......||+|+||.|-+-++ .|+-.|+|.+... ..+...+...|+++..+. ..|.+|.+||...+ ...+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 35555667899999998866555 5788999998753 345667788999987665 69999999997643 356889
Q ss_pred EeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 496 EYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 496 Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|.|.- ||+.+... .+....+++...-+|+..+..||.|||+. . +||||+||+|||++.+|.+||||||++-.+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 98854 77765422 34667899999999999999999999986 5 99999999999999999999999999877653
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc----CCCCcchhHHHHHHHHHHHHhCCCCCccch
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET----GKLTPESDVYSFGIILLRLLTGRPVLRIKK 632 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~ 632 (780)
.. ..+-..|...|||||.+.. ..|+.||||||||+++.||.+++.|+....
T Consensus 202 Si--------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SI--------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hh--------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 21 1233567778999998854 369999999999999999999999987443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=252.15 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=209.7
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeec
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~ 488 (780)
+|....++|.....+-+|.||.||+|.|+. ..|.+|.++... +-....|.+|--.|..+.|||+..+.|+|.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344444667777889999999999997752 347778776543 334556899999999999999999999984
Q ss_pred C---CCeeEEEeccCCChhhHHh-hh----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 489 E---SRSLVFEYLRNGSLEDCLA-CK----NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 489 ~---~~~LV~Ey~~~gsL~~~L~-~~----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
+ ..+.+|.++.-|+|..+|. |+ .....++-.+...++.|++.|+.|||+.+ +||.||-..|.++|+...+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeE
Confidence 4 3578999999999999996 22 23445777888899999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALE 639 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~ 639 (780)
||+|=.|+|.+.+... .|....-..+..||+||.+....|+.++|||||||+||||+| |+.|+...+..+..
T Consensus 436 kltDsaLSRDLFP~DY-----hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-- 508 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDY-----HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-- 508 (563)
T ss_pred EeccchhccccCcccc-----cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--
Confidence 9999999987654321 122233345667999999999999999999999999999998 89998876665432
Q ss_pred hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 640 KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 640 ~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+.|.....-|..++++|..++..||...|.+||++ +++..-|.++.
T Consensus 509 ----~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf-~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 ----HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSF-SQLVICLSEFH 556 (563)
T ss_pred ----HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHHH
Confidence 1122333334467789999999999999999999999 89988888774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=236.37 Aligned_cols=206 Identities=33% Similarity=0.523 Sum_probs=177.8
Q ss_pred cccCCceEEEEeeec--CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEeccCCChhh
Q 044673 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLRNGSLED 505 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~~gsL~~ 505 (780)
||+|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++++++++++.. ..++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 788999998865432 34678999999999999999999999865 5679999999999999
Q ss_pred HHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCCCCCCCCcccc
Q 044673 506 CLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQGESTGNSALCN 584 (780)
Q Consensus 506 ~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 584 (780)
++.... ..+++..++.++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 985321 46899999999999999999999999 999999999999999 89999999999877643211 1
Q ss_pred cCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHH
Q 044673 585 ESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663 (780)
Q Consensus 585 ~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 663 (780)
.....+...|++||.+... .++.++|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2335577789999999887 888999999999999999 4588
Q ss_pred HHHHHchhhCCCCCcchHHHHHH
Q 044673 664 HLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 664 ~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+++.+|+..+|.+||++ .+++.
T Consensus 192 ~~l~~~l~~~p~~R~~~-~~l~~ 213 (215)
T cd00180 192 DLIRKMLQKDPEKRPSA-KEILE 213 (215)
T ss_pred HHHHHHhhCCcccCcCH-HHHhh
Confidence 99999999999999999 67654
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=249.19 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=187.8
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------CC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------SR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------~~ 491 (780)
.+....+.||.|+||.||-..+ ++..||+|++... +-...+.|.+|+.+|+-++|.|++.+++.... ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3566788999999999998877 3788999988653 23345778999999999999999999886632 23
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
|.+.|.|.. +|..++. ...+|+...+.-+++||++||.|||+.+ |.||||||.|.|++.|...|||||||++..
T Consensus 133 YV~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccccccccc
Confidence 567788754 7888774 5567898999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH------------
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL------------ 638 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~------------ 638 (780)
..+... .++..+-|..|.|||++++. .|+.+.||||.|||+.|||..+..|...+.+...-
T Consensus 207 e~d~~~------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 207 DQRDRL------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred chhhhh------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 543322 23445667889999999875 69999999999999999999888886554433210
Q ss_pred -----HhccccccccCc--CCCC--------CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 639 -----EKRNFNSVLDSS--AGDW--------PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 639 -----~~~~~~~~ld~~--~~~~--------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+|.-..++... .+.. +....-+...+...++..+|..|.+. .+.+.
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~-~~A~~ 342 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV-EEALQ 342 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH-hhhcc
Confidence 112222222211 1111 11223345667777788888888877 44443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=235.76 Aligned_cols=243 Identities=21% Similarity=0.372 Sum_probs=187.5
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC----CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES----RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~----~~LV 494 (780)
+++|.+.+++|+|-|+.||.|.. ++..++||++++ ...+...+|+.||..|+ ||||++|++...+. ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999984 577899999985 44667889999999998 99999999998654 4699
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~~~ 573 (780)
+||+.|.+...+. +.|+-.++...+.+++.||.|+|+.| |+|||+||.|+++|.. -.++|+|+|||.+..+
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998877654 45777889999999999999999999 9999999999999975 4589999999998865
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCcc-chhHHHHHH------------
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRI-KKDVKCALE------------ 639 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~-~~~~~~~~~------------ 639 (780)
... ....+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-. .+.......
T Consensus 186 ~~e--------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 186 GKE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred Cce--------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 432 233456667889998865 4588899999999999999999988732 111111100
Q ss_pred -hccccccccCc---------CCCCCH--------HHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 640 -KRNFNSVLDSS---------AGDWPV--------AEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 640 -~~~~~~~ld~~---------~~~~p~--------~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
-+++.-.+|+. ...|.. -..++..+|+.+.|..|-.+|||. .|.
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa-kEa 319 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA-KEA 319 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch-HHH
Confidence 01111122321 122311 124678889999999999999998 554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=235.31 Aligned_cols=200 Identities=30% Similarity=0.453 Sum_probs=168.9
Q ss_pred CCcccccccCCceEEEEeeec--CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
|.....||.|+||.||+|... +..+|+|.+...... ....+.+|+..+.+++|+|++++++++.. ..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556788999999999999986 478999999865444 56788999999999999999999999864 4679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+++|.+++.... ..+++.....++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--
Confidence 999999985321 12899999999999999999999998 999999999999999999999999998877533200
Q ss_pred CcccccCCCCCCcccCChhhh-ccCCCCcchhHHHHHHHHHHHHhCCCCCcc-chhH
Q 044673 580 SALCNESNNDSASVYIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRPVLRI-KKDV 634 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~ksDVwS~Gvil~eLltG~~p~~~-~~~~ 634 (780)
......++..|++||.+ ....++.++|||+||+++++|++|++||.. .+..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 12334677789999998 666788899999999999999999999975 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=264.06 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=202.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec--CCCeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ESRSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~~LV~Ey 497 (780)
.++|....++|.|.||.|||++.. +...|+|+++.....+..-.++|+-+++..+|||||.++|.+. +...+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 478999999999999999999885 5679999998877777777889999999999999999999984 457899999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
|.+|+|.|..+ .+++|++.++.....+.+.||.|||+.+ -+|||||-.|||+.+.|.+|++|||.+-.+.
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhh-----
Confidence 99999999875 7889999999999999999999999999 8999999999999999999999999875443
Q ss_pred CCCcccccCCCCCCcccCChhhh---ccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYL---ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAG 652 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~ 652 (780)
.+........||+.|||||+. ..+.|..++|||++|+...||---++|....+..+... .+.. .++...
T Consensus 164 --ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~----~qpp~l 237 (829)
T KOG0576|consen 164 --ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG----FQPPTL 237 (829)
T ss_pred --hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC----CCCCcc
Confidence 223334567899999999976 46789999999999999999988888876555544322 2222 233222
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
..+..-...|-+++..|+-.+|++||+..
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChh
Confidence 22334466799999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=235.54 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=185.2
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccC--CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPS--YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~--~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------- 490 (780)
.+|-.+..+|.|.- .|--+.+ .+.+||||.+.. .......+-.+|..++..+.|+||++++.+|...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777788898887 5555554 378899997643 2233445667999999999999999999998432
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.|+|||||.. +|...+. -.++-.+...|++|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcc
Confidence 4689999965 8888775 34667888999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH-----------
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE----------- 639 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~----------- 639 (780)
-... ...+..+.|..|.|||++.+-.|.+.+||||+||++.||++|+-.|.+.+.......
T Consensus 168 e~~~--------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 168 EDTD--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cCcc--------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 4321 345778889999999999988899999999999999999999988764433211100
Q ss_pred -------h-------------ccccccccC----cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 640 -------K-------------RNFNSVLDS----SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 640 -------~-------------~~~~~~ld~----~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
. ..+...+.. ...+.+.-.+..+.+++.+||-.+|.+|-++ +++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv-~da 307 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV-DDA 307 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH-HHH
Confidence 0 001111111 0111122345678899999999999999998 555
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=228.19 Aligned_cols=237 Identities=21% Similarity=0.307 Sum_probs=175.9
Q ss_pred hcCCCcccccccCCceEEEEeeecC--eeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeee-ecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGT-CPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~-~~~~--~~LV~ 495 (780)
.+.|.+.+.||+|.||.+-++.+++ +.+++|-++.. .....+|.+|..---.| .|.||+.-|.. |... ..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3679999999999999999999974 67999988753 34567899998766666 48999988864 4333 34789
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe-cC-CCCcccccccccccccC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI-DA-NFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL-d~-~~~~Kl~DFGla~~~~~ 573 (780)
||+|.|+|..-+. ...+.+....+++.|+++||.|+|+.+ +||||||.+|||+ +. ...+||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999998773 355888899999999999999999999 9999999999999 33 34699999999765431
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccC-----CCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHhcc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETG-----KLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEKRN 642 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~~~ 642 (780)
.. ....-+..|.+||..... ...+.+|||.||+|+|.+|||++||..... -..++..+.
T Consensus 176 tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 176 TV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 10 111223458999977543 246789999999999999999999972211 112222222
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.. ..+......++.+.++..+-+..++++|--+
T Consensus 246 ~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 246 NP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred Cc-----cCchhhcccCHHHHHHHHHhcCCcccccchh
Confidence 21 2222222356678888889999999998444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=248.69 Aligned_cols=197 Identities=23% Similarity=0.297 Sum_probs=165.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC------CCceeeEeeeec--CCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR------HPNLVTLIGTCP--ESR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~------HpnIv~l~g~~~--~~~ 491 (780)
-+.|...-..|+|-|++|.+|... +..||||++... ..-++.=+.|++||.+|. --|+++|+..|. ...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 357777778899999999999874 678999999864 344555678999999995 347899988774 457
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHL 570 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~ 570 (780)
|||||-+. -+|.+.|......-.|....+..++.|+..||..|-.++ |+|.||||+|||++.+ ..+||||||.|..
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccc
Confidence 99999885 489999987777778999999999999999999999999 9999999999999865 5589999999887
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
...+.. +.+.-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+.
T Consensus 587 ~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 587 ASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 754432 3344566799999999999999999999999999999999888643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=250.51 Aligned_cols=193 Identities=23% Similarity=0.299 Sum_probs=162.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch---h-----HHHHHHHHHHhhcCC---CCceeeEeeeecC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ---S-----HLKFQNEVEVLSRVR---HPNLVTLIGTCPE 489 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~---~-----~~~f~~Ev~il~~l~---HpnIv~l~g~~~~ 489 (780)
.+|.....+|+|+||.|+.+.++ +..|+||++.+..-. . .-..-.|+.||..++ |+||++++.+|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 57899999999999999999985 567999998753110 0 112447999999997 9999999999977
Q ss_pred CC--eeEEEe-ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 490 SR--SLVFEY-LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 490 ~~--~LV~Ey-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
+. ||++|- -++-+|.|+|. ..+.+++.+...|+.||+.|+.+||+.+ |||||||-+|+.+|.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 64 578875 35678899884 5678999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLR 629 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~ 629 (780)
.+...... .....+||..|.|||++.+.+| +..-|||++|++||-++....||.
T Consensus 716 saa~~ksg---------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 88765432 2345789999999999998876 456899999999999999988875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=273.51 Aligned_cols=198 Identities=20% Similarity=0.213 Sum_probs=140.2
Q ss_pred cCCC-CceeeEeeeec-------C--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccc
Q 044673 474 RVRH-PNLVTLIGTCP-------E--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543 (780)
Q Consensus 474 ~l~H-pnIv~l~g~~~-------~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~iv 543 (780)
.++| +||+.++++|. + ..++++||+ +++|.++|. ....++++..++.|+.||+.||.|||+.+ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD--NPDRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh--cccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 4556 68888888871 1 234678887 569999995 23456999999999999999999999999 99
Q ss_pred cCCCCCCceEecC-------------------CCCcccccccccccccCCCCC---------CCCcccccCCCCCCcccC
Q 044673 544 HGNLKPSKVLIDA-------------------NFGSKLSDFGFFHLIPQGEST---------GNSALCNESNNDSASVYI 595 (780)
Q Consensus 544 HrDlKp~NILLd~-------------------~~~~Kl~DFGla~~~~~~~~~---------~~~~~~~~~~~~gt~~Y~ 595 (780)
||||||+||||+. ++.+||+|||+++........ ............||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 455677777777643210000 000000112346899999
Q ss_pred ChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCC
Q 044673 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRL 675 (780)
Q Consensus 596 aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~ 675 (780)
|||++.+..|+.++|||||||+||||++|.+|+.........+... .+.+. +.........++.+||..+|.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPPQ----ILLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcChh----hhhcCHHHHHHHHHhCCCChh
Confidence 9999999999999999999999999999999876432222111111 11111 111233456888999999999
Q ss_pred CCcchHHHHH
Q 044673 676 NRPDLVSEIW 685 (780)
Q Consensus 676 ~RPs~~~ev~ 685 (780)
+||++ .+++
T Consensus 255 ~Rps~-~eil 263 (793)
T PLN00181 255 CRPSM-SELL 263 (793)
T ss_pred hCcCh-HHHh
Confidence 99999 6664
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=233.08 Aligned_cols=128 Identities=27% Similarity=0.379 Sum_probs=105.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-----C---CceeeEeeeecC---
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-----H---PNLVTLIGTCPE--- 489 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-----H---pnIv~l~g~~~~--- 489 (780)
++|-..++||.|.|++||++.+. .+-||+|+.+.. ..-.+.-..|+.+|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999874 577999998753 222344568999999984 3 379999999932
Q ss_pred ---CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEec
Q 044673 490 ---SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLID 555 (780)
Q Consensus 490 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd 555 (780)
..|+|+||+ |.+|-.+|.. .....++...+..|+.||+.||.|||.. + |||-||||+||||-
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 258999998 5578887753 3456688999999999999999999985 6 99999999999993
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=235.94 Aligned_cols=199 Identities=27% Similarity=0.381 Sum_probs=160.0
Q ss_pred HhcCCCcccccccCCceEEEEeeecC-----eeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeee--cCCCe
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTC--PESRS 492 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~--~~~~~ 492 (780)
..+.|...++||+|.|++||++.+.. ..||+|.+...+ ......+|+++|..+. +.||+++.+++ .+..+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34678899999999999999998743 469999887643 3455779999999996 99999999998 45578
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLI 571 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~ 571 (780)
+|+||+++....+++. .++...+..+++.++.||.++|.+| ||||||||+|+|.+.. +.-.|+|||||...
T Consensus 112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999999883 3667899999999999999999999 9999999999999754 56789999999722
Q ss_pred cCCC------C-------C------------C---CCccc---------ccCCCCCCcccCChhhhcc-CCCCcchhHHH
Q 044673 572 PQGE------S-------T------------G---NSALC---------NESNNDSASVYIDPEYLET-GKLTPESDVYS 613 (780)
Q Consensus 572 ~~~~------~-------~------------~---~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS 613 (780)
.... . . . ....+ ......||++|.|||++.. +..++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1100 0 0 0 00000 0123579999999999865 45788999999
Q ss_pred HHHHHHHHHhCCCCCc
Q 044673 614 FGIILLRLLTGRPVLR 629 (780)
Q Consensus 614 ~Gvil~eLltG~~p~~ 629 (780)
.|||++-+++++.||.
T Consensus 264 ~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeehhhccccccc
Confidence 9999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=212.80 Aligned_cols=166 Identities=20% Similarity=0.211 Sum_probs=127.0
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++.. ...+++|..++.|+.|++.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc------
Confidence 789999953 3457999999999999999999999876 999999999999999 9998766421
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc-cccccccCcCCCCCHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR-NFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~-~~~~~ld~~~~~~p~~~~ 659 (780)
...||+.|+|||++.++.++.++|||||||++|||+||++||.........+... ......++.....+....
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVS 136 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHH
Confidence 1257899999999999999999999999999999999999997544322211110 000001111111222333
Q ss_pred H--HHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 660 E--QLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 660 ~--~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
. .+.+++.+|+..+|.+||++ .+++..+..+
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~-~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAA-NHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCH-HHHHHHHHHH
Confidence 3 69999999999999999999 8888877655
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=230.04 Aligned_cols=171 Identities=18% Similarity=0.143 Sum_probs=130.3
Q ss_pred HHhcCCCcccccccCCceEEEEeeec---CeeEEEEEccCC-----CchhHHHHHHHHHHhhcCCCCceeeEeeeecCCC
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESR 491 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~-----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~ 491 (780)
...++|.....||+|+||.||+|.+. +..||||++... .......|.+|+.+|.+++|||+|..+..+ ...
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-~~~ 93 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-GKD 93 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-CCc
Confidence 34578999999999999999999873 566899986532 122345689999999999999999544333 457
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCC-CCCceEecCCCCccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL-KPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDl-Kp~NILLd~~~~~Kl~DFGla~~ 570 (780)
+|||||++|++|.. +. ... ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+|||+|+.
T Consensus 94 ~LVmE~~~G~~L~~-~~---~~~------~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHL-AR---PHG------DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHH-hC---ccc------hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 89999999999963 21 111 1467889999999999999 999999 99999999999999999999998
Q ss_pred ccCCCCCCCC-cccccCCCCCCcccCChhhhccC
Q 044673 571 IPQGESTGNS-ALCNESNNDSASVYIDPEYLETG 603 (780)
Q Consensus 571 ~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~ 603 (780)
+......... .....+...+++.|++||++...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7543211110 11112466788899999998643
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=197.28 Aligned_cols=140 Identities=36% Similarity=0.559 Sum_probs=115.9
Q ss_pred eEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCccccc-ccCCHHHH--HHHHHHHHHHHHhhcCc
Q 044673 19 TIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAV-NGLKQHAD--KIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 19 ~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~-~~~~~~~~--~~~ll~~~~~~c~~~~V 93 (780)
+||||||+| +.|.+||+||++.+ .+++++++||.++....+........ ....+... .+++|+++...|...|+
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 79 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGV 79 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Confidence 599999999 99999999999877 58899999999875433321111000 01111111 17899999999999999
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhh-hcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLE-LKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~g-s~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
+++.+++++++++++|+++|+++++|+||||++|++++.|.++| | ||.+|+++||++|+|+||++|
T Consensus 80 ~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gss---va~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 80 QCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSD---VASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred eEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCc---hhHHHHhcCCCCceEEEEeCc
Confidence 99999999889999999999999999999999999999999997 5 999999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=211.58 Aligned_cols=247 Identities=22% Similarity=0.385 Sum_probs=196.2
Q ss_pred CCcccccccCCceEEEEeeecCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRN 500 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~ 500 (780)
.....+|.+...|..|+|+|.+..++.|++.-.. ..-...|..|.-.|+-+.||||+.++|+|... ..++..||+.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3345578999999999999999999999886432 23345699999999999999999999999544 5678899999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc--cccccccccCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS--DFGFFHLIPQGESTG 578 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~--DFGla~~~~~~~~~~ 578 (780)
|||+..|+.. ..-.++-.+..+++.++++|++|||+..|-|.---|.+..+++|++.+++|+ |--++.
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------- 341 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------- 341 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---------
Confidence 9999999732 2334667788999999999999999998745555689999999999998875 321110
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCC---cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLT---PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
......-.+.||+||.++..+-+ ..+|+|||.++||||.|..-||......++.++ -.+.......|
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~ip 411 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVHIP 411 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhccccccCC
Confidence 11223456789999999876543 478999999999999999999987777665533 22444455567
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+..+.+|+.-|+..||.+||.+ +.|+..|+.+.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkf-dmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKF-DMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCc-ceehhhHHHhc
Confidence 7888999999999999999999999 99999999873
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=215.20 Aligned_cols=263 Identities=21% Similarity=0.193 Sum_probs=192.5
Q ss_pred CCCcccccccCCceEEEEeeecC---eeEEEEEccCCCchhHHHHHHHHHHhhcCCC----CceeeEeeeec-CC--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRH---LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH----PNLVTLIGTCP-ES--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~---~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H----pnIv~l~g~~~-~~--~~L 493 (780)
+|...++||+|+||.||.+.... ..+|+|............+..|+.++..+.. +++..+++... .. .++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998754 3689998766433333367789999988873 57888877762 33 578
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-----CCccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-----FGSKLSDFGFF 568 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-----~~~Kl~DFGla 568 (780)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.+ ++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 98877 779999774333 577999999999999999999999999 9999999999999765 35899999999
Q ss_pred c--cccCCCCCCCCcccc-cCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhccc
Q 044673 569 H--LIPQGESTGNSALCN-ESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNF 643 (780)
Q Consensus 569 ~--~~~~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~ 643 (780)
+ .+............. .....||..|.++....+...+.+.|+||++.++.+|+.|..||...... ...+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 332221111011111 23456999999999999999999999999999999999999998644421 111111111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
...... .....+..+..+...+-..+...+|+. ..+...|.......
T Consensus 255 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy-~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDY-EKLAELLKDVFDSE 301 (322)
T ss_pred hhcccc----ccCCChHHHHHHHHHhhccCCcCCCCH-HHHHHHHHHHHHhc
Confidence 111111 111234556777777777899999999 77888877765443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-21 Score=205.49 Aligned_cols=257 Identities=31% Similarity=0.436 Sum_probs=193.0
Q ss_pred CCcccccccCCceEEEEeeecCeeEEEEEccCCCch---hHHHHHHHHHHhhcCCCC-ceeeEeeeecCCC--eeEEEec
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQ---SHLKFQNEVEVLSRVRHP-NLVTLIGTCPESR--SLVFEYL 498 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~---~~~~f~~Ev~il~~l~Hp-nIv~l~g~~~~~~--~LV~Ey~ 498 (780)
|.....||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++++++.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999887 77899988764332 367799999999999988 7999999985543 7999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-CcccccccccccccCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~~~~~~ 577 (780)
.++++.+++........++......++.+++.++.|+|..+ ++|||+||+|||++.++ .++++|||+++.+......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999976632111137889999999999999999999999 99999999999999998 6999999999865432211
Q ss_pred CCCcccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchh---HHHH---HHhcccccccc
Q 044673 578 GNSALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKCA---LEKRNFNSVLD 648 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~~---~~~~~~~~~ld 648 (780)
.... .......||..|++||.+.+ ..++...|+||+|++++++++|..||..... .... +..........
T Consensus 159 ~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 159 SSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1000 12356789999999999987 5788899999999999999999999876553 1111 11111110000
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
......+......+.+++..|+..+|..|.+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 0111111122357889999999999999998844343
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=187.96 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=189.5
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCC-CceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH-PNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H-pnIv~l~g~~~~~--~~LV~E 496 (780)
.++|..+++||.|+||.+|.|.. .|..||||+-... ..+.++..|..+...|+| +.|..+.-+..+. ..|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 47899999999999999999976 5789999987653 334566788889888876 4555555555443 569999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC---CCcccccccccccccC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN---FGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~---~~~Kl~DFGla~~~~~ 573 (780)
.+ |.||+|++.- ....++..+.+-++-|++.-++|+|..+ +|||||||+|+|..-+ ..+.++|||||+.+.+
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 7799998842 2345788999999999999999999999 9999999999999644 3478999999988765
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH-----HHhcccccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA-----LEKRNFNSVLD 648 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~-----~~~~~~~~~ld 648 (780)
................||..|.+-....+-..+..-|+-|+|.+|.++.-|..||......... +.+.++...+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 5444444555567788999999888877777888999999999999999999999765433221 22233333333
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.....+| .++.-.+..|-.+.-.+-|+.
T Consensus 247 ~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 247 VLCKGFP----AEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHhCCCc----HHHHHHHHHHhhcCCCCCCcH
Confidence 3444444 456677778888888888887
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=191.48 Aligned_cols=203 Identities=20% Similarity=0.268 Sum_probs=167.6
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCCC--eeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPESR--SLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~~--~LV~Ey 497 (780)
-+|...++||+|.||.++.|.. ++.+||||.-+..+ ...++..|....+.|. .++|...|.+-+++. .||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4799999999999999999975 68999999865432 2234556666666664 688888877766664 599998
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-----Cccccccccccccc
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-----GSKLSDFGFFHLIP 572 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-----~~Kl~DFGla~~~~ 572 (780)
+ |-||+|++. -....++..+..-||.|++.-+.|+|+.. +|.|||||+|+||..-+ .+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 779999874 23456899999999999999999999999 99999999999996543 47899999999987
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK 632 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~ 632 (780)
++...............||..||+=....+...+..-|+-|||=|++++|-|..||....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 766555555555667889999999999889999999999999999999999999997543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-21 Score=197.17 Aligned_cols=169 Identities=14% Similarity=0.137 Sum_probs=132.4
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHH---H------HHHHHHHhhcCCCCceeeEeeeec----
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHL---K------FQNEVEVLSRVRHPNLVTLIGTCP---- 488 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~---~------f~~Ev~il~~l~HpnIv~l~g~~~---- 488 (780)
.++|...+.||.|+||.||....++..+|||++......... . |.+|+..+.++.||+|..+..++.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 589999999999999999997777778999999764333222 2 679999999999999999877642
Q ss_pred ------CCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccc
Q 044673 489 ------ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKL 562 (780)
Q Consensus 489 ------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl 562 (780)
...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++.+| ++|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEE
Confidence 13579999999999988641 222 24569999999999999 99999999999999988 999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt 623 (780)
+|||.......... -.-+.....|..++|+||||++|..+..
T Consensus 176 iDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99998654421110 0114455567789999999999876653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=188.99 Aligned_cols=138 Identities=18% Similarity=0.195 Sum_probs=108.1
Q ss_pred ccccccCCceEEEEeeec-CeeEEEEEccCCCch--h-------HHHH-----------------HHHHHHhhcCCCCce
Q 044673 428 SWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQ--S-------HLKF-----------------QNEVEVLSRVRHPNL 480 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~--~-------~~~f-----------------~~Ev~il~~l~HpnI 480 (780)
...||+|+||.||+|... |..||||+++..... . ...| .+|+.+|.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999874 789999998653211 1 1122 349999999988776
Q ss_pred eeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCccccCCCCCCceEecCCCC
Q 044673 481 VTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL-HSNEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 481 v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~ivHrDlKp~NILLd~~~~ 559 (780)
.....+.....+|||||++++++...+. ...++++.....++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 4433333344589999999987765532 235789999999999999999999 6889 99999999999998 578
Q ss_pred cccccccccccc
Q 044673 560 SKLSDFGFFHLI 571 (780)
Q Consensus 560 ~Kl~DFGla~~~ 571 (780)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-20 Score=185.09 Aligned_cols=191 Identities=12% Similarity=0.054 Sum_probs=141.0
Q ss_pred CCcccccccCCceEEEEeeecCeeEEEEEccCCCch----hHHHHHHHHHHhhcCC-CCceeeEeeeecCCCeeEEEecc
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQ----SHLKFQNEVEVLSRVR-HPNLVTLIGTCPESRSLVFEYLR 499 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~----~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~~~LV~Ey~~ 499 (780)
+.....||+|+||+||.+.-.+.+++.+.+.....- ....|.+|+++|.+|. |+++++++++ +..+++|||+.
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~ 81 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLA 81 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeec
Confidence 345678999999999988777888888877654321 1225889999999995 5889999886 45689999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCC-CCCceEecCCCCcccccccccccccCCCCC-
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL-KPSKVLIDANFGSKLSDFGFFHLIPQGEST- 577 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDl-Kp~NILLd~~~~~Kl~DFGla~~~~~~~~~- 577 (780)
|++|...+. .. ...++.+++.+|.++|..+ |+|||| ||.|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPP----RG------DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhh----hh------hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999876441 11 1357789999999999999 999999 799999999999999999999855432110
Q ss_pred ---C--CCcccccCCCCCCcccCChhhhc--cCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 044673 578 ---G--NSALCNESNNDSASVYIDPEYLE--TGKLTPESDVYSFGIILLRLLTGRPVLR 629 (780)
Q Consensus 578 ---~--~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ksDVwS~Gvil~eLltG~~p~~ 629 (780)
. ............++.|++|+... ...--+..++++.|+-+|.++||..++-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00000011223677788887543 2222367799999999999999987764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-21 Score=219.60 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=180.6
Q ss_pred CCCcccccccCCceEEEEeeecCeeEEEEEccCCCc-hhHHHHHHHHHH--hhcCCCCceeeEeeeecC--CCeeEEEec
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGP-QSHLKFQNEVEV--LSRVRHPNLVTLIGTCPE--SRSLVFEYL 498 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~-~~~~~f~~Ev~i--l~~l~HpnIv~l~g~~~~--~~~LV~Ey~ 498 (780)
+|.....||.+.|=+|.+|..+...|+||++-...+ -.-..|.+.+.- ...++|||++++.-+-.. ..|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 566778899999999999999877799999866442 233444443333 445689999998766433 357888998
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC-CCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG-EST 577 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~-~~~ 577 (780)
.+ +|+|+|. ..+-|..-+...|+.|++.||.-+|..+ |+|||||.+|||+..-+.+.|+||--.+...-+ ...
T Consensus 104 kh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 104 KH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 76 8999994 5566888899999999999999999999 999999999999999999999999865433211 122
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcc---
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-----------KLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRN--- 642 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~--- 642 (780)
....+...| ...-.+|+|||.+... .++++.||||+||+++||++ |+|||.+..-..+- .|.
T Consensus 178 adf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr--~~~~~~ 254 (1431)
T KOG1240|consen 178 ADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR--SGNADD 254 (1431)
T ss_pred ccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh--ccCccC
Confidence 222222223 2334579999987542 27889999999999999998 79999866544332 221
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
...++.. . +...+..+++.|++.||..|-+. ++.++.
T Consensus 255 ~e~~Le~-I------ed~~~Rnlil~Mi~rdPs~RlSA-edyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEK-I------EDVSLRNLILSMIQRDPSKRLSA-EDYLQK 291 (1431)
T ss_pred HHHHHHh-C------cCccHHHHHHHHHccCchhccCH-HHHHHh
Confidence 1111111 0 11258899999999999999998 777655
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-20 Score=183.90 Aligned_cols=139 Identities=17% Similarity=0.185 Sum_probs=111.0
Q ss_pred ccccccCCceEEEEeeec-CeeEEEEEccCCCch---------------------h-----HHHHHHHHHHhhcCCCCce
Q 044673 428 SWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQ---------------------S-----HLKFQNEVEVLSRVRHPNL 480 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~---------------------~-----~~~f~~Ev~il~~l~HpnI 480 (780)
...||+|+||.||+|... +..||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 457999999999999875 889999998764211 0 1124578999999999987
Q ss_pred eeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCC
Q 044673 481 VTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 481 v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~ 559 (780)
.....+.....+|||||++++++..... ...+++......|+.+++.+|.+||+ .+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCC
Confidence 5544443345689999999886544322 23467888999999999999999999 89 99999999999999 889
Q ss_pred ccccccccccccc
Q 044673 560 SKLSDFGFFHLIP 572 (780)
Q Consensus 560 ~Kl~DFGla~~~~ 572 (780)
++|+|||+++.+.
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-20 Score=214.05 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=178.2
Q ss_pred CcccccccCCceEEEEeeec--CeeEEEEEcc----C-CCchh-HHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 426 EPSWKIGEGRYGNVYRGLLR--HLHVAIKMFP----S-YGPQS-HLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~----~-~~~~~-~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.....+|.|.||.|+..... ...++.|.+. . ..... ...+..|+-+-..+.|||++..+..+.+. ..-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35668999999977766542 2333444332 1 11111 11256788888889999998877666443 22359
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|||++ +|..++. ....++-.++--++.|++.|+.|||..+ |.||||||+|+++..+|.+||+|||.+..+..+.
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999885 2346777888899999999999999999 9999999999999999999999999987765332
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCc-chhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTP-ESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. ..........|+..|+|||++....|.+ ..||||.|+++..|++|+.||.....-...........-.....+.+
T Consensus 475 e---~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 475 E---KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred c---hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 1 1123345678999999999999999987 68999999999999999999975433221100000000000011111
Q ss_pred C--HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 P--VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p--~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ ...+.....++.++|+.+|.+|-++ .+|+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti-~~i~ 583 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITI-EQIL 583 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecH-HHHh
Confidence 1 2345677899999999999999999 6664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-20 Score=204.35 Aligned_cols=221 Identities=23% Similarity=0.237 Sum_probs=173.1
Q ss_pred cccCCceEEEEee-----ecCeeEEEEEccCCCc--hhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeEEEeccC
Q 044673 431 IGEGRYGNVYRGL-----LRHLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLVFEYLRN 500 (780)
Q Consensus 431 IG~G~~G~Vyk~~-----~~~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV~Ey~~~ 500 (780)
+|+|.||.|+... ..+.-+|+|++..... ........|..++..++ ||.+|++..++.. ..+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999643 2356688888765221 11225567888999997 9999999988844 46899999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|.|...+. ....+..........+++-++.++|+.+ |+|||+|++||++|.+|++|+.|||+++..-...
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 99998884 4445666677777888888999999999 9999999999999999999999999988764321
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
..+||..|||||++. .....+|+||||++++||+||..||.. +.... +-......|.....
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~---------Il~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKR---------ILKAELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHH---------HhhhccCCchhhhH
Confidence 128899999999998 567789999999999999999999986 21111 11122345667777
Q ss_pred HHHHHHHHchhhCCCCCcch
Q 044673 661 QLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+++..++..+|.+|-..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHhhCHHHHhcc
Confidence 88888889999999888543
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=165.40 Aligned_cols=136 Identities=18% Similarity=0.133 Sum_probs=102.7
Q ss_pred CCCeEEEEecCCcc--ccHHHHHHHhhhc-CCCeEEEEeecCCCCccccCCcccccccCCHHHHH--HHHHHHHHHHHhh
Q 044673 16 VEETIFVAVGKNVE--KNKTTVFWALQNF-AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADK--IQVFDQYLLLLSQ 90 (780)
Q Consensus 16 ~~~~I~VAVD~s~~--~S~~Al~wAl~~~-~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~--~~ll~~~~~~c~~ 90 (780)
|+++||||||+| + .|.+|++||+... .+++++|+||.++.................+.... ++.|.++...+..
T Consensus 1 m~~~ILv~vD~S-~~~~s~~al~~A~~la~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 79 (142)
T PRK15456 1 MYKTIIMPVDVF-EMELSDKAVRHAEFLAQDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTI 79 (142)
T ss_pred CCccEEEeccCC-chhHHHHHHHHHHHHHhcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999998 5 8999999998654 24689999999875321110000111111111111 5667777776666
Q ss_pred cCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 91 AGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 91 ~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
.+++++.++.+| ++++.|+++|+++++|+||||++|++ +.+.|+|| ++.+|+++++ |+|+||
T Consensus 80 ~~~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS---~a~~v~~~a~--~pVLvV 141 (142)
T PRK15456 80 DPSRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGS---NASSVIRHAN--LPVLVV 141 (142)
T ss_pred CCcceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCc---cHHHHHHcCC--CCEEEe
Confidence 678888777776 77899999999999999999999976 88899999 9999999999 999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=176.56 Aligned_cols=134 Identities=16% Similarity=0.199 Sum_probs=104.5
Q ss_pred CCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-----CCCceeeEeeeecCCC---e---e
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-----RHPNLVTLIGTCPESR---S---L 493 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-----~HpnIv~l~g~~~~~~---~---L 493 (780)
.+....||+|+||.||... .....+||++..........+.+|+.+++.+ .||||++++|++.+.. + +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECC-CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456789999999999622 2233479988765444567799999999999 5799999999996652 3 6
Q ss_pred EEEe--ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCccccCCCCCCceEecC----CCCccccccc
Q 044673 494 VFEY--LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL-IYLHSNEPCIIHGNLKPSKVLIDA----NFGSKLSDFG 566 (780)
Q Consensus 494 V~Ey--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~ivHrDlKp~NILLd~----~~~~Kl~DFG 566 (780)
|+|| +++|+|.+++.. ..+++. ..++.+++.++ .|||+++ ||||||||+|||++. ++.++|+|||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 668999999942 235555 35678888787 9999999 999999999999974 3479999954
Q ss_pred c
Q 044673 567 F 567 (780)
Q Consensus 567 l 567 (780)
.
T Consensus 155 G 155 (210)
T PRK10345 155 G 155 (210)
T ss_pred C
Confidence 3
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=160.98 Aligned_cols=136 Identities=13% Similarity=0.127 Sum_probs=102.2
Q ss_pred CCCeEEEEecCCccc--cHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHH---HHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEK--NKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADK---IQVFDQYLLLL 88 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~--S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~---~~ll~~~~~~c 88 (780)
|+++||||||+| +. |.+|++||++.+ .+++|+|+||.++.......+.............. ++.|..+...+
T Consensus 1 m~~~ILv~~D~s-~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 79 (144)
T PRK15005 1 MNRTILVPIDIS-DSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKF 79 (144)
T ss_pred CCccEEEecCCC-chhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHh
Confidence 578999999999 87 579999998755 68899999999864322111111111000011111 45666666666
Q ss_pred hhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 89 SQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 89 ~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
...++++++.+..| ++++.|+++++++++|+||||++ ++++.+.++|| ++.+|++++| |+|+||
T Consensus 80 ~~~~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS---~a~~vl~~a~--cpVlvV 143 (144)
T PRK15005 80 KLPTDRVHVHVEEG-SPKDRILELAKKIPADMIIIASH-RPDITTYLLGS---NAAAVVRHAE--CSVLVV 143 (144)
T ss_pred CCCCCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecc---hHHHHHHhCC--CCEEEe
Confidence 66677888877765 67899999999999999999999 46799999999 9999999999 999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.2e-18 Score=187.46 Aligned_cols=208 Identities=29% Similarity=0.441 Sum_probs=155.1
Q ss_pred hhcCCCCceeeEeeeecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCcc-ccCCCC
Q 044673 472 LSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI-IHGNLK 548 (780)
Q Consensus 472 l~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~i-vHrDlK 548 (780)
|+.+.|.|+.+++|.|-++ .+.|.+||..|+|.|.+.. ..-.++|.-...+..+|+.||.|||... | .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999654 4679999999999999963 4567999999999999999999999875 4 999999
Q ss_pred CCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-------CCCcchhHHHHHHHHHHH
Q 044673 549 PSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-------KLTPESDVYSFGIILLRL 621 (780)
Q Consensus 549 p~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~ksDVwS~Gvil~eL 621 (780)
+.|.++|.++.+||+|||+..+...... ........-..-|.|||.+... ..+.+.||||||++++|+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred cccceeeeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999876642000 0001112233459999998763 146789999999999999
Q ss_pred HhCCCCCccchhH------HHHHHhccccccccCcCCCCCH-HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 622 LTGRPVLRIKKDV------KCALEKRNFNSVLDSSAGDWPV-AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 622 ltG~~p~~~~~~~------~~~~~~~~~~~~ld~~~~~~p~-~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
++...||+..... ...+.+ .....+.|.. +.. +..+.+..++.+||..+|..||++ ..|-..++.+.
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i--~~~~e~~~~l~~l~~~cw~e~P~~rPs~-~~i~~~~~~~~ 225 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSI--ELLNELPPELLLLVARCWEEIPEKRPSI-EQIRSKLLTIN 225 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh-cCCCCcCcch--hhhhhcchHHHHHHHHhcccChhhCccH-HHHHhhhhhhc
Confidence 9999999753321 122222 1111122221 111 334479999999999999999999 77777776664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=169.56 Aligned_cols=132 Identities=23% Similarity=0.329 Sum_probs=110.3
Q ss_pred cccccCCceEEEEeeecCeeEEEEEccCCCch--------hHHHHHHHHHHhhcCCCCceeeEeee--ecCCCeeEEEec
Q 044673 429 WKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQ--------SHLKFQNEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYL 498 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~--------~~~~f~~Ev~il~~l~HpnIv~l~g~--~~~~~~LV~Ey~ 498 (780)
+.||+|++|.||+|.+.+..|++|+....... ....+.+|+.++..++|+|+.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999998899999986543211 12457899999999999988765555 455678999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
+|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988421 12 88899999999999999999 99999999999999 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-17 Score=165.45 Aligned_cols=129 Identities=23% Similarity=0.371 Sum_probs=105.6
Q ss_pred ccccCCceEEEEeeecCeeEEEEEccCCCc---h-----hHHHHHHHHHHhhcCCCCce--eeEeeeecCCCeeEEEecc
Q 044673 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGP---Q-----SHLKFQNEVEVLSRVRHPNL--VTLIGTCPESRSLVFEYLR 499 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~---~-----~~~~f~~Ev~il~~l~HpnI--v~l~g~~~~~~~LV~Ey~~ 499 (780)
.||+|+||.||+|.+.+..|++|....... . ....+.+|+.++..++|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 389999999999999999999998654221 1 12457789999999998764 4445555666789999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
|++|.+.+.. ... .++.+++.+|.+||+.+ ++|||++|.|||++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~---~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEE---GND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhh---cHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998742 111 78999999999999999 99999999999999 889999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8e-17 Score=154.42 Aligned_cols=133 Identities=18% Similarity=0.173 Sum_probs=95.8
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCH--HHHHHHHHHHHHHHHhhc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQ--HADKIQVFDQYLLLLSQA 91 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~~~~c~~~ 91 (780)
++++||||||+| +.|.+||.||+..+ .+++|+|+||..+.... . .+..+. .... +...++....+..++...
T Consensus 2 ~~~~ILvavD~S-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~-~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~ 77 (144)
T PRK15118 2 AYKHILIAVDLS-PESKVLVEKAVSMARPYNAKVSLIHVDVNYSDL-Y-TGLIDV-NLGDMQKRISEETHHALTELSTNA 77 (144)
T ss_pred CceEEEEEccCC-hhHHHHHHHHHHHHHhhCCEEEEEEEccChhhh-h-hhhhhc-chHHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999 99999999998866 58899999995432111 1 111111 0111 111133333444555677
Q ss_pred CceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 92 GVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 92 ~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
|+.+...++..++++++|+++|+++++|+||||+|| +.+. . +|| +|.+|+++|+ |+|+||.
T Consensus 78 ~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~-~-lgS---va~~v~~~a~--~pVLvv~ 138 (144)
T PRK15118 78 GYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFWS-K-LMS---SARQLINTVH--VDMLIVP 138 (144)
T ss_pred CCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHHH-H-HHH---HHHHHHhhCC--CCEEEec
Confidence 888766666666889999999999999999999997 4444 3 578 9999999999 9999995
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-16 Score=148.65 Aligned_cols=121 Identities=16% Similarity=0.182 Sum_probs=102.8
Q ss_pred eEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCceee
Q 044673 19 TIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQGD 96 (780)
Q Consensus 19 ~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~~e 96 (780)
+|+||||+| +.+++|++||+..+ .++.++++||.++... ...++ .++.++.+..++.+.++.+
T Consensus 1 ~Ilv~vd~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~-----------~~~~~--~~~~l~~~~~~~~~~~~~~- 65 (124)
T cd01987 1 RILVCISGG-PNAERLIRRAARLADRLKAPWYVVYVETPRLN-----------RLSEA--ERRRLAEALRLAEELGAEV- 65 (124)
T ss_pred CEEEEECCC-cchHHHHHHHHHHHHHhCCCEEEEEEecCccc-----------cCCHH--HHHHHHHHHHHHHHcCCEE-
Confidence 599999999 99999999998766 5889999999876421 01111 2677888888888887754
Q ss_pred EEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 97 SVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 97 ~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
.++.+++++++|+++++++++|+||||+++++++.|.++|| ++.+|+++| ..|+|||+
T Consensus 66 -~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs---~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 66 -VTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGS---LVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred -EEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhccc---HHHHHHHhC-CCCeEEEe
Confidence 46677889999999999999999999999999999999999 999999999 45999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=170.90 Aligned_cols=228 Identities=21% Similarity=0.303 Sum_probs=145.7
Q ss_pred CcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCC-----------CceeeE-eeeec
Q 044673 426 EPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRH-----------PNLVTL-IGTCP 488 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~H-----------pnIv~l-~g~~~ 488 (780)
.....||.|+|+.||.+.+. +..+|+|++.... ....+.+.+|.-....+.+ .-++.+ ++..+
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44567999999999999986 5889999864322 2345667777766655433 112221 11111
Q ss_pred ----------C-------CCeeEEEeccCCChhhHHh---hhCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCC
Q 044673 489 ----------E-------SRSLVFEYLRNGSLEDCLA---CKNK-KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547 (780)
Q Consensus 489 ----------~-------~~~LV~Ey~~~gsL~~~L~---~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDl 547 (780)
+ +.+++|+-+ .++|.+.+. .... ...+....++.+..|+++.+++||..+ +||+||
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi 171 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDI 171 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEeccc
Confidence 0 123566666 568888753 2222 234566778888899999999999999 999999
Q ss_pred CCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC--------CCCcchhHHHHHHHHH
Q 044673 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG--------KLTPESDVYSFGIILL 619 (780)
Q Consensus 548 Kp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~~~ksDVwS~Gvil~ 619 (780)
+|+|+|++.+|.++|+||+......... .+ ...+..|.+||..... .++.+.|.|+||+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY------RC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE------EG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee------ec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999998765443110 00 2334669999977542 4788999999999999
Q ss_pred HHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCC
Q 044673 620 RLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNR 677 (780)
Q Consensus 620 eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~R 677 (780)
.|.+|..||+....... .+....... +.++.+..|+..+|+.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~----------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD----------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGST----------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccc----------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999986543110 000122233 677889999999999999887
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-18 Score=184.92 Aligned_cols=172 Identities=20% Similarity=0.303 Sum_probs=134.7
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++.|++|.-++|.|+|.++......+|...+.|+.|++.|+.| .+ .+|+|+||.||+...+..+||+|||+...
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhheee
Confidence 56899999999999999877777788999999999999999999 67 99999999999999999999999999877
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccC
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
..... +........+...||..||+||.+.+..|+.|+||||||+||+||++ -..+|.. .+.+.+ -
T Consensus 406 ~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------~~t~~d---~ 472 (516)
T KOG1033|consen 406 QDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------IATLTD---I 472 (516)
T ss_pred cccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------HHhhhh---h
Confidence 65433 22223335677899999999999999999999999999999999998 2233321 111111 1
Q ss_pred cCCCCCHHHH---HHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWPVAEA---EQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p~~~~---~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+.||.... ..-..|+++++.+.|..||+.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 2233442221 234578999999999999955
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.9e-17 Score=169.14 Aligned_cols=142 Identities=18% Similarity=0.183 Sum_probs=110.8
Q ss_pred CCCcccccccCCceEEEEee---ecCeeEEEEEccCCCch------------------------hHHHHHHHHHHhhcCC
Q 044673 424 NFEPSWKIGEGRYGNVYRGL---LRHLHVAIKMFPSYGPQ------------------------SHLKFQNEVEVLSRVR 476 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~---~~~~~VAiK~l~~~~~~------------------------~~~~f~~Ev~il~~l~ 476 (780)
.|.....||+|+||.||+|. ..+..||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 25789999988653210 0123568999999997
Q ss_pred CCc--eeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe
Q 044673 477 HPN--LVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI 554 (780)
Q Consensus 477 Hpn--Iv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL 554 (780)
+.+ +.+++++ ...+|||||+++++|...+. ...++.......|+.+++.+|.+||+.+ .|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 633 4445543 34589999999988877552 2345666677899999999999999886 39999999999999
Q ss_pred cCCCCccccccccccccc
Q 044673 555 DANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 555 d~~~~~Kl~DFGla~~~~ 572 (780)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=191.92 Aligned_cols=194 Identities=24% Similarity=0.272 Sum_probs=149.0
Q ss_pred HHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCC---CCceeeEee--eecCCCee
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR---HPNLVTLIG--TCPESRSL 493 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~---HpnIv~l~g--~~~~~~~L 493 (780)
.....|.+.+.||+|+||+||+|... +..||+|+-+.-..= +|.-=.+++.+|+ -|.|..+.. .|.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 33568888999999999999999875 678999987653221 1212223344444 123333332 24777889
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-------CCCCccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-------ANFGSKLSDFG 566 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-------~~~~~Kl~DFG 566 (780)
|+||.+.|+|-|++. ..+.++|.....|+.+++.-+..||..+ ||||||||+|+||. .+..++|+|||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999999999994 6778999999999999999999999999 99999999999993 23458999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCC
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~ 626 (780)
-+-.+..-. . ........+|-.+-.+|...+..++...|.|.|..+++-||.|+.
T Consensus 847 ~siDm~lfp--~---~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFP--D---GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcC--C---CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 884332100 0 012345677888999999999999999999999999999999974
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.9e-17 Score=189.28 Aligned_cols=144 Identities=23% Similarity=0.315 Sum_probs=115.2
Q ss_pred CHHHHHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCC--Cc------hhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSY--GP------QSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~--~~------~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
++.........|...+.||+|+||.||+|.+.+..+++|+.... .. .....+.+|+.++..++|+|++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 34444444566677899999999999999987766666643221 11 12346889999999999999987766
Q ss_pred ee--cCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 486 TC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 486 ~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
++ .+..++||||+++++|.+++. .+..++.+++.+|.|||+.+ ++||||||+|||+ .++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEE
Confidence 55 446789999999999999883 45779999999999999999 9999999999999 67889999
Q ss_pred cccccccc
Q 044673 564 DFGFFHLI 571 (780)
Q Consensus 564 DFGla~~~ 571 (780)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-17 Score=189.78 Aligned_cols=210 Identities=26% Similarity=0.342 Sum_probs=145.0
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCCeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~~LV~Ey~~~ 500 (780)
.+|+.++.|..|+||.||...++ .+++|+|+ ++.. . -..+ +|.....|. .|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--l--ilRn---ilt~a~npf-------------vv------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--L--ILRN---ILTFAGNPF-------------VV------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc--h--hhhc---cccccCCcc-------------ee------
Confidence 78999999999999999999876 46788843 2211 0 0001 222223333 33
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC--
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG-- 578 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~-- 578 (780)
|+-.+.+ ++.++++-.. +.+++|||+.+ |||||+||+|.|+..-|++|++|||+++..-....+.
T Consensus 136 gDc~tll---k~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred chhhhhc---ccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 4545545 3445555433 66999999999 9999999999999999999999999986542211110
Q ss_pred ------CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 579 ------NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 579 ------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
..........+||+.|+|||++....|+..+|||++|+|+|+++.|..||.....-+.. ..++. ...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~vis-d~i 275 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVIS-DDI 275 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhh-hhc
Confidence 11122234568999999999999999999999999999999999999999765332111 00000 011
Q ss_pred CCCH---HHHHHHHHHHHHchhhCCCCCcc
Q 044673 653 DWPV---AEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 653 ~~p~---~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.||. ....+..+++.+.|+.+|..|--
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1221 23457889999999999999963
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=150.63 Aligned_cols=132 Identities=11% Similarity=0.073 Sum_probs=96.2
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCccccc-ccCCHHHHH--HHHHHHHHHHHhh
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAV-NGLKQHADK--IQVFDQYLLLLSQ 90 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~-~~~~~~~~~--~~ll~~~~~~c~~ 90 (780)
|+++||||||+| +.|.+|+++|+..+ .+++|+|+||.++...... +...+. ....+.... ++.|.++...+..
T Consensus 2 ~~k~ILvavD~S-~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 79 (142)
T PRK09982 2 AYKHIGVAISGN-EEDALLVNKALELARHNDAHLTLIHIDDGLSELYP-GIYFPATEDILQLLKNKSDNKLYKLTKNIQW 79 (142)
T ss_pred CceEEEEEecCC-cchHHHHHHHHHHHHHhCCeEEEEEEccCcchhch-hhhccchHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 678999999999 99999999998765 6899999999976532111 111111 111111111 4556666655432
Q ss_pred cCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 91 AGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 91 ~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
..++..+.. ++|++.|+++|++.++|+||||++ +++++|.+ + +|..|+++++ |+|+||.
T Consensus 80 --~~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~--~---va~~V~~~s~--~pVLvv~ 138 (142)
T PRK09982 80 --PKTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM--P---AYRGMINKMS--ADLLIVP 138 (142)
T ss_pred --CcceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH--H---HHHHHHhcCC--CCEEEec
Confidence 344554555 588999999999999999999986 88888877 3 9999999999 9999995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=161.35 Aligned_cols=136 Identities=20% Similarity=0.218 Sum_probs=107.7
Q ss_pred CCCcccccccCCceEEEEeeec-CeeEEEEEccCCCch----------------------hHHHHHHHHHHhhcCCCC--
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQ----------------------SHLKFQNEVEVLSRVRHP-- 478 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~----------------------~~~~f~~Ev~il~~l~Hp-- 478 (780)
.|...+.||+|+||.||+|... +..||||++...... ....+..|..++.++.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3777889999999999999884 789999987542210 112367889999999887
Q ss_pred ceeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC
Q 044673 479 NLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF 558 (780)
Q Consensus 479 nIv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~ 558 (780)
.+...++. ...++||||+++++|.+... . .....++.+++.++.++|+.+ |+||||||+|||++.++
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~---~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRV---L------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhccc---c------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCC
Confidence 44555553 34589999999999977542 0 234578899999999999998 99999999999999999
Q ss_pred Cccccccccccccc
Q 044673 559 GSKLSDFGFFHLIP 572 (780)
Q Consensus 559 ~~Kl~DFGla~~~~ 572 (780)
.++|+|||++..+.
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.8e-17 Score=136.08 Aligned_cols=71 Identities=45% Similarity=0.809 Sum_probs=62.7
Q ss_pred cCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 710 IPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 710 ~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
.|..|.|||+.++|.||+++.+|+|||+.+|+.|+..++.+||.|++++...+|+||++||++|++|+.+|
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~~ 71 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAEN 71 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHHC
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHHc
Confidence 48899999999999999999999999999999999998899999999999999999999999999999876
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.4e-16 Score=147.06 Aligned_cols=137 Identities=23% Similarity=0.332 Sum_probs=102.1
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
|+++|+||+|++ +.+..|++||+..+ .+++|+++||.++....+.......... ...+............+...+.
T Consensus 1 M~~~Ilv~~d~~-~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 78 (140)
T PF00582_consen 1 MYKRILVAIDGS-EESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESE-EEAEEEEQARQAEAEEAEAEGG 78 (140)
T ss_dssp -TSEEEEEESSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCEEEEEECCC-HHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccc-cccchhhhhhhHHHHHHhhhcc
Confidence 678999999999 99999999998866 6899999999987643221000000000 0000001111111144555666
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
......+..++++++|++++.++++|+||||+++++++.+.++|| ++.+|++++| |+|+||
T Consensus 79 ~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs---~~~~l~~~~~--~pVlvv 139 (140)
T PF00582_consen 79 IVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGS---VAEKLLRHAP--CPVLVV 139 (140)
T ss_dssp SEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHH---HHHHHHHHTS--SEEEEE
T ss_pred ceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCC---HHHHHHHcCC--CCEEEe
Confidence 677777788899999999999999999999999999999999999 9999999999 999998
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.1e-16 Score=162.23 Aligned_cols=200 Identities=18% Similarity=0.241 Sum_probs=138.4
Q ss_pred CCCceeeEeeeecCC-----------------------------CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHH
Q 044673 476 RHPNLVTLIGTCPES-----------------------------RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS 526 (780)
Q Consensus 476 ~HpnIv~l~g~~~~~-----------------------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 526 (780)
+|||||.+.++|-+. .||||.-.+. +|..+|. ....+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 699999998876221 1367665544 7888884 33456678888999
Q ss_pred HHHHHHHHHHcCCCccccCCCCCCceEe--cCCCC--cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc
Q 044673 527 DVCSALIYLHSNEPCIIHGNLKPSKVLI--DANFG--SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602 (780)
Q Consensus 527 ~i~~aL~~LH~~~~~ivHrDlKp~NILL--d~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 602 (780)
|++.|+.|||+++ |.|||+|++|||| |+++. ..|+|||.|-.-.. ...............|.-..||||+...
T Consensus 349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~-hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN-HGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccc-cccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 44443 68999998643221 1111111112334567778999999864
Q ss_pred CC--C----CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCC
Q 044673 603 GK--L----TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLN 676 (780)
Q Consensus 603 ~~--~----~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~ 676 (780)
.+ . -.|.|.|+.|.+-||+++...||...... .++..++.+ ...+..|..++..+.+|+...++.||.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~r~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDTRTYQE---SQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eechhhhhh---hhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 32 1 24899999999999999999999753221 111112221 1234456667788999999999999999
Q ss_pred CcchHHHHHHHHH
Q 044673 677 RPDLVSEIWSVLE 689 (780)
Q Consensus 677 RPs~~~ev~~~L~ 689 (780)
||+. .....+|.
T Consensus 501 Rvsp-~iAANvl~ 512 (598)
T KOG4158|consen 501 RVSP-NIAANVLN 512 (598)
T ss_pred cCCc-cHHHhHHH
Confidence 9876 44444443
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=142.49 Aligned_cols=129 Identities=15% Similarity=0.146 Sum_probs=108.5
Q ss_pred eEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCceee
Q 044673 19 TIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQGD 96 (780)
Q Consensus 19 ~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~~e 96 (780)
+|+||||++ +.+..|+.+|...+ .+.+|+++||.+++..... .......+..++.++.+...+.+.|++++
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~g~~~~ 73 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP------SQLEVNVQRARKLLRQAERIAASLGVPVH 73 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc------chhHHHHHHHHHHHHHHHHHhhhcCCceE
Confidence 599999999 99999999997755 6889999999986532211 00001112227899999999999999999
Q ss_pred EEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 97 SVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 97 ~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
..++.++++.++|++++.++++|+||||+++++.+.+.++|| ++.+|+++++ |+|++|
T Consensus 74 ~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs---~~~~v~~~~~--~pvlvv 131 (132)
T cd01988 74 TIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGG---VIDQVLESAP--CDVAVV 131 (132)
T ss_pred EEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCc---hHHHHHhcCC--CCEEEe
Confidence 888877789999999999999999999999999998999999 9999999999 999997
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=151.10 Aligned_cols=136 Identities=18% Similarity=0.244 Sum_probs=96.9
Q ss_pred ccccccCCceEEEEeeec-CeeEEEEEccCCCch--hHHHH----------------------HHHHHHhhcCCCCc--e
Q 044673 428 SWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQ--SHLKF----------------------QNEVEVLSRVRHPN--L 480 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~--~~~~f----------------------~~Ev~il~~l~Hpn--I 480 (780)
.+.||+|+||.||+|... +..||||++...... ....+ ..|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999886 788999988653221 11111 34555666654433 3
Q ss_pred eeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCC
Q 044673 481 VTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 481 v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~ 559 (780)
.+.+++ ...++||||+++|.+........ ... .....++.+++.++.++|. .+ |+||||||+||+++ ++.
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCc
Confidence 344443 34689999999965432211000 011 5677899999999999999 88 99999999999999 899
Q ss_pred ccccccccccccc
Q 044673 560 SKLSDFGFFHLIP 572 (780)
Q Consensus 560 ~Kl~DFGla~~~~ 572 (780)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.5e-15 Score=140.66 Aligned_cols=135 Identities=15% Similarity=0.179 Sum_probs=99.4
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
++++|+||+|+| ..+..||++|+..+ .+++++++||.++.......+... .....+ ...++....+..++.+.|+
T Consensus 2 ~~~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~l~~~~~~~~~ 78 (142)
T PRK10116 2 SYSNILVAVAVT-PESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPM-LEDLRS-VMQEETQSFLDKLIQDADY 78 (142)
T ss_pred CCceEEEEccCC-cchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHH-HHHHHH-HHHHHHHHHHHHHHHhcCC
Confidence 578999999999 99999999998765 588999999987643221111000 000101 1112222333445566788
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
..+..++..+++.++|++++++.++|+||||++|++++.+.+ | ++.+|+++++ |+|+||.
T Consensus 79 ~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~--s---~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 79 PIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS--C---SAKRVIASSE--VDVLLVP 138 (142)
T ss_pred CeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH--H---HHHHHHhcCC--CCEEEEe
Confidence 776666666788999999999999999999999999999864 5 8999999999 9999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-15 Score=139.67 Aligned_cols=132 Identities=18% Similarity=0.253 Sum_probs=111.7
Q ss_pred cccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCC--CceeeEeeeecC--CCeeEEEeccCCC
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH--PNLVTLIGTCPE--SRSLVFEYLRNGS 502 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~--~~~LV~Ey~~~gs 502 (780)
..+.||.|+++.||++...+..+++|....... ...|.+|+.++..++| +++.++++++.. ..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 356799999999999999888899999866433 5678899999999986 588898888754 5789999999887
Q ss_pred hhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CccccCCCCCCceEecCCCCccccccccccc
Q 044673 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-PCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 503 L~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
+..+ +......++.+++.+|.+||... ++++|||++|.|||++.++.++++|||+++.
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7653 55777889999999999999863 2599999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=151.64 Aligned_cols=132 Identities=16% Similarity=0.200 Sum_probs=104.3
Q ss_pred cccc-cCCceEEEEeeecCeeEEEEEccCCC-------------chhHHHHHHHHHHhhcCCCCce--eeEeeeecC---
Q 044673 429 WKIG-EGRYGNVYRGLLRHLHVAIKMFPSYG-------------PQSHLKFQNEVEVLSRVRHPNL--VTLIGTCPE--- 489 (780)
Q Consensus 429 ~~IG-~G~~G~Vyk~~~~~~~VAiK~l~~~~-------------~~~~~~f~~Ev~il~~l~HpnI--v~l~g~~~~--- 489 (780)
..|| .||.|+||+....+..++||.+...+ ......+.+|+.++.+++|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999998888899999774311 1233567899999999998875 666666422
Q ss_pred ---CCeeEEEeccC-CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 490 ---SRSLVFEYLRN-GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 490 ---~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
..++|+||++| ++|.+++. ..+++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~----~~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQ----EAPLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHh----cCCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEEC
Confidence 12499999997 68998874 2345543 3678999999999999 999999999999999999999999
Q ss_pred ccccc
Q 044673 566 GFFHL 570 (780)
Q Consensus 566 Gla~~ 570 (780)
|.++.
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98654
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-14 Score=153.09 Aligned_cols=140 Identities=10% Similarity=0.099 Sum_probs=109.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCccccc--ccCCHHHH--HHHHHHHHHHHHh
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAV--NGLKQHAD--KIQVFDQYLLLLS 89 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~--~~~~~~~~--~~~ll~~~~~~c~ 89 (780)
++++|+||+|+| +.|..|+.||+..+ .++.++++||.++... +..+...+. ....+... .++.|+.+...+.
T Consensus 2 ~~~~ILv~~D~s-~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 79 (305)
T PRK11175 2 KYQNILVVIDPN-QDDQPALRRAVYLAQRNGGKITAFLPIYDFSY-EMTTLLSPDEREAMRQGVISQRTAWIREQAKPYL 79 (305)
T ss_pred CcceEEEEcCCC-ccccHHHHHHHHHHHhcCCCEEEEEeccCchh-hhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 578999999999 99999999998855 6789999999865321 111111110 00111111 1556777777777
Q ss_pred hcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 90 QAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 90 ~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
..|++++..++..+++.++|+++|.++++|+||||++|.+++.+.++|| ++..|++++| |+|++|..+
T Consensus 80 ~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs---~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 80 DAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTP---TDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred hcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccCh---hHHHHHhcCC--CCEEEeccc
Confidence 8899999888876788999999999999999999999999999999999 9999999999 999999653
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.2e-13 Score=147.39 Aligned_cols=137 Identities=15% Similarity=0.108 Sum_probs=99.4
Q ss_pred CCCeEEEEecCCcccc-------HHHHHHHhhhc--C-CCeEEEEeecCCCCccccCCcccccccCCH--HHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEKN-------KTTVFWALQNF--A-GKKISLLHVHKPSHVFAFKESKCAVNGLKQ--HADKIQVFDQ 83 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S-------~~Al~wAl~~~--~-~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~ 83 (780)
..++|+||+|+| +.+ ..|+++|+..+ . ++.|+|+||.++...... . ..+.....+ +...++....
T Consensus 151 ~~~~Ilva~D~s-~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ 227 (305)
T PRK11175 151 EGGKILVAVNVA-SEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIA-I-ELPEFDPSVYNDAIRGQHLLA 227 (305)
T ss_pred CCCeEEEEeCCC-CCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhcc-c-cccccchhhHHHHHHHHHHHH
Confidence 357999999998 543 67999997643 4 889999999875431110 0 011100011 1111333444
Q ss_pred HHHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 84 YLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 84 ~~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
+..++...|+..+..++..++++++|+++|++.++|+||||++|++++.+.|+|| ++.+|++++| |+|++|.
T Consensus 228 l~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS---~a~~v~~~~~--~pVLvv~ 299 (305)
T PRK11175 228 MKALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGN---TAEHVIDHLN--CDLLAIK 299 (305)
T ss_pred HHHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecc---hHHHHHhcCC--CCEEEEc
Confidence 4555566688765455555688999999999999999999999999999999999 9999999999 9999995
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.2e-13 Score=123.86 Aligned_cols=126 Identities=27% Similarity=0.390 Sum_probs=104.8
Q ss_pred eEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHH--HHHHHHHHHHHHHhhcCce
Q 044673 19 TIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHA--DKIQVFDQYLLLLSQAGVQ 94 (780)
Q Consensus 19 ~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~--~~~~ll~~~~~~c~~~~V~ 94 (780)
+|+||+|++ ..++.++.||++.+ .+++|+++||.++....+. ...+.. ..++.|+.+...|...|++
T Consensus 1 ~ilv~i~~~-~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~~~~~~~~ 71 (130)
T cd00293 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPSSAA--------ELAELLEEEARALLEALREALAEAGVK 71 (130)
T ss_pred CEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch--------hHHHHHHHHHHHHHHHHHHHHhcCCCc
Confidence 589999999 99999999998866 6899999999876432211 111111 1178999999999888999
Q ss_pred eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 95 GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 95 ~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
+...+..+.+ +++|++++.++++|+||||+++++.+.+.+.|+ ++.+++++++ |+|++|
T Consensus 72 ~~~~~~~~~~-~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~---~~~~ll~~~~--~pvliv 130 (130)
T cd00293 72 VETVVLEGDP-AEAILEAAEELGADLIVMGSRGRSGLRRLLLGS---VAERVLRHAP--CPVLVV 130 (130)
T ss_pred eEEEEecCCC-HHHHHHHHHHcCCCEEEEcCCCCCccceeeecc---HHHHHHhCCC--CCEEeC
Confidence 9887777654 899999999999999999999999999999998 9999999987 999975
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-14 Score=169.10 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=177.1
Q ss_pred cCCCcccccccCCceEEEEeeec---CeeEEEEEccCCC--chhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV 494 (780)
..|...+.||+|.|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++...+ ..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46777788999999999876653 2346777665432 222233445777777887 9999999998744 46789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCccccCCCCCCceEecCCC-Cccccccccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH-SNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIP 572 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~ 572 (780)
.+|..+|++.+-+.. ......+....-.++.++..+|.|+| ..+ +.|+||||+|.+++.++ ..|++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988731 22224555667788999999999999 888 99999999999999999 99999999998776
Q ss_pred CCCCCCCCcccccCCCCC-CcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC-
Q 044673 573 QGESTGNSALCNESNNDS-ASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS- 649 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~- 649 (780)
.-.. .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... +.+......
T Consensus 177 ~~~g----~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~~ 247 (601)
T KOG0590|consen 177 NKNG----AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSNK 247 (601)
T ss_pred ccCC----cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecccc
Confidence 4111 1122334566 9999999998874 45678999999999999999999987443221 111111111
Q ss_pred ---cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 ---SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ---~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
....| ........++..+++..+|..|.++
T Consensus 248 ~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 248 GRFTQLPW-NSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred cccccCcc-ccCChhhhhcccccccCCchhcccc
Confidence 01111 1344567788888888999999887
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=141.28 Aligned_cols=197 Identities=25% Similarity=0.317 Sum_probs=138.0
Q ss_pred HHhhcCCCCceeeEeeeecCCC-------eeEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCc
Q 044673 470 EVLSRVRHPNLVTLIGTCPESR-------SLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541 (780)
Q Consensus 470 ~il~~l~HpnIv~l~g~~~~~~-------~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ 541 (780)
.-|-++-|.|||++..|+.+.. .++.|||..|+|..+|.. +.....+....-.+|+.||++||.|||+..||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3345667999999999886543 378999999999999965 33455677888889999999999999999999
Q ss_pred cccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHH
Q 044673 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRL 621 (780)
Q Consensus 542 ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eL 621 (780)
|+|+++..+-|++..||-+||+----. .+. ...............+-++|.+||+-.....+..+|||+||+..++|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~-s~h--~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPD-STH--PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcc-ccc--hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999999998887632111 110 00011111122345667889999998888888899999999999999
Q ss_pred HhCCCC-CccchhH--HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchH
Q 044673 622 LTGRPV-LRIKKDV--KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 622 ltG~~p-~~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
-.|..- -.....+ +..+.+ .++-... ..-..++..|++..|.+||++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~----~i~~len--------~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN----VIIGLEN--------GLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred HHheeccCCCcceeehhhhhhh----heeeccC--------ccccCcCcccccCCCCCCcchh
Confidence 887532 2222111 111111 1110000 1124568899999999999993
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4e-12 Score=122.09 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=111.3
Q ss_pred CCCCeEEEEec-CCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccc----cCCH-HHHHHHHHHHHHH
Q 044673 15 DVEETIFVAVG-KNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVN----GLKQ-HADKIQVFDQYLL 86 (780)
Q Consensus 15 ~~~~~I~VAVD-~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~----~~~~-~~~~~~ll~~~~~ 86 (780)
.++++|++++| ++ +.+..|+.+|+... .+..+.++||.++.............. ...+ .....+.+....+
T Consensus 3 ~~~~~il~~~d~~s-~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (154)
T COG0589 3 AMYKKILVAVDVGS-EAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKA 81 (154)
T ss_pred cccceEEEEeCCCC-HHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHH
Confidence 35789999999 99 99999999998855 677888999987754322111100000 0011 1112788889999
Q ss_pred HHhhcCcee-eEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 87 LLSQAGVQG-DSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 87 ~c~~~~V~~-e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
...+.|+.. +..+.+|.+....|++++.+.++|+||||++|++++.+.++|| ++.+|+++++ |+|++|.
T Consensus 82 ~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGs---vs~~v~~~~~--~pVlvv~ 151 (154)
T COG0589 82 LAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGS---VAEKVLRHAP--CPVLVVR 151 (154)
T ss_pred HHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeeh---hHHHHHhcCC--CCEEEEc
Confidence 999999984 7878888777899999999999999999999999999999999 9999999999 9999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=148.05 Aligned_cols=142 Identities=20% Similarity=0.271 Sum_probs=100.4
Q ss_pred cCCCcccccccCCceEEEEeee-cCeeEEEEEccCCCchh----------------------------------------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL-RHLHVAIKMFPSYGPQS---------------------------------------- 461 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~-~~~~VAiK~l~~~~~~~---------------------------------------- 461 (780)
..|+ ...||.|++|.||+|.+ +|..||||+.++.....
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 4455 36899999999999998 48899999986532110
Q ss_pred HHHHHHHHHHhhcCC-----CCce--eeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHH-HHH
Q 044673 462 HLKFQNEVEVLSRVR-----HPNL--VTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS-ALI 533 (780)
Q Consensus 462 ~~~f~~Ev~il~~l~-----HpnI--v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~-aL~ 533 (780)
...|.+|...+.+++ +|++ .+++..+....+|||||++|++|.+.+..... .+ .+..++..++. .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence 012455666555552 3332 22333234457899999999999987642211 12 24556776665 478
Q ss_pred HHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 534 ~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
.+|..+ ++|+|+||.||+++.++.++|+|||++..+.
T Consensus 272 ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 889999 9999999999999999999999999976553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-12 Score=127.08 Aligned_cols=129 Identities=18% Similarity=0.166 Sum_probs=100.1
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCcee-eEeeeecCCCeeEEEeccCCChhhH
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV-TLIGTCPESRSLVFEYLRNGSLEDC 506 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv-~l~g~~~~~~~LV~Ey~~~gsL~~~ 506 (780)
.+.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.+++ ++++++.+..++||||++|.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 35689999999999998888999999765422 233567899999998765544 5566666667899999999887653
Q ss_pred HhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--C-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 507 LACKNKKSPLRWQTRMQIASDVCSALIYLHSNE--P-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 507 L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
. . ....++.+++.+|..||..+ + .++|||++|.||+++ ++.++++|||.+.
T Consensus 82 ~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1 1 11245678999999999986 2 369999999999999 6689999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-11 Score=143.92 Aligned_cols=249 Identities=20% Similarity=0.217 Sum_probs=172.4
Q ss_pred HhcCCCcccccccCCceEEEEeeecC--eeEEEEEccC---CCchhHHHHHHHHHHhhcCCCCceeeEeee--ecCCCee
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFPS---YGPQSHLKFQNEVEVLSRVRHPNLVTLIGT--CPESRSL 493 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~---~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~--~~~~~~L 493 (780)
..++|.+.+-+-+|.+|.++.+.-.+ ...++|+... ..........++-.++-..+||-++..... |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34678888889999999999766542 2234443322 111222233344444444567777766655 4556789
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|++|+.+|+|...|+ +.++++..........+..+++|||... ++|+|++|.|+|...+++.+++|||+......
T Consensus 882 ~~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999886 3445555555556667778999999987 99999999999999999999999985432210
Q ss_pred C-CCCCC--------------------Cc---ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 044673 574 G-ESTGN--------------------SA---LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLR 629 (780)
Q Consensus 574 ~-~~~~~--------------------~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~ 629 (780)
- ..... .. ........||+.|.+||.+.+.......|+|++|+++++.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00000 00 011344678999999999999999999999999999999999999998
Q ss_pred cchhHHHHHHhccccccccC--cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 630 IKKDVKCALEKRNFNSVLDS--SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 630 ~~~~~~~~~~~~~~~~~ld~--~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
....-+.. ..++.. ....-|...+....+++.+.+..+|..|-.+
T Consensus 1037 a~tpq~~f------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1037 AETPQQIF------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred Ccchhhhh------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 65543322 112211 1223344566778889999999999999776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.3e-11 Score=134.98 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=166.6
Q ss_pred cCCCccccccc--CCceEEEEeee--c--CeeEEEEE--ccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCCC--
Q 044673 423 NNFEPSWKIGE--GRYGNVYRGLL--R--HLHVAIKM--FPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPESR-- 491 (780)
Q Consensus 423 ~~f~~~~~IG~--G~~G~Vyk~~~--~--~~~VAiK~--l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~~-- 491 (780)
..|.....+|. |.+|.||.+.. . ...+|+|. .....+.....=.+|+....+++ |+|.|+.+..+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35666778999 99999999987 3 45688887 33333333333346777777775 999999877776554
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCccccCCCCCCceEecCC-CCccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS----ALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFG 566 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFG 566 (780)
++=.|++ +.+|..+.+. ....++....+.+..+... ||.++|+.. ++|-|+||.||++..+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcc
Confidence 4455665 5688777652 2223555566666666666 999999999 9999999999999999 889999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCc-cchhHHHHHHhccccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLR-IKKDVKCALEKRNFNS 645 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~-~~~~~~~~~~~~~~~~ 645 (780)
+...+........ ..+ .....|...|++||.+. +-++..+|+|++|.++++-.+|..+.. .....+..++.+.
T Consensus 269 ~v~~i~~~~~~~~-~~~-~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSV-FKV-SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccc-eee-eecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 9988865432211 111 13346677799999875 558889999999999999999865543 2222222222111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.+. ++-......+..++..+++.+|..|++.
T Consensus 343 --ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 343 --IPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred --Cch--hhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 110 0111123456668999999999999877
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.7e-11 Score=134.71 Aligned_cols=141 Identities=13% Similarity=0.176 Sum_probs=92.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchh----------------------------------H---
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS----------------------------------H--- 462 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~----------------------------------~--- 462 (780)
..+|+. ..||.|++|.||+|.+. |..||||+.++.-... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 78999999999999984 7899999987532100 0
Q ss_pred ---HHHHHHHHHhhcCC----CCceeeE---eeeecCCCeeEEEeccCCChhhHHhhhCCC---CCCCHHHHHHHHHHHH
Q 044673 463 ---LKFQNEVEVLSRVR----HPNLVTL---IGTCPESRSLVFEYLRNGSLEDCLACKNKK---SPLRWQTRMQIASDVC 529 (780)
Q Consensus 463 ---~~f~~Ev~il~~l~----HpnIv~l---~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~---~~l~~~~~~~i~~~i~ 529 (780)
..|.+|+..+.+++ +.+.|.+ +.-+....+|||||++|+.+.+.-.-...+ ..+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 12445555555553 3333333 222234567999999999998753211111 11222222222333
Q ss_pred HHHHHHHcCCCccccCCCCCCceEecCCC----Cccccccccccccc
Q 044673 530 SALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGFFHLIP 572 (780)
Q Consensus 530 ~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGla~~~~ 572 (780)
++..+ ++|+|+||.||+++.++ .++++|||++..++
T Consensus 276 -----if~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 -----VFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34567 99999999999999888 89999999987664
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-10 Score=125.17 Aligned_cols=103 Identities=12% Similarity=0.174 Sum_probs=81.2
Q ss_pred CCCCeEEEEecCCccccHHHHHHHhhhc--C--CCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhh
Q 044673 15 DVEETIFVAVGKNVEKNKTTVFWALQNF--A--GKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQ 90 (780)
Q Consensus 15 ~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~--~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~ 90 (780)
.++++|||||||| +.|++|+++|++.+ . +++|++|||.++...... .. ......+++++.+.+.+.+
T Consensus 3 ~~ykkILVavDGS-e~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~------~~--~~~~~~eelle~~~~~~~~ 73 (357)
T PRK12652 3 MAANRLLVPVADS-VTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE------GQ--DELAAAEELLERVEVWATE 73 (357)
T ss_pred cccCeEEEEeCCC-HHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc------hh--HHHHHHHHHHHHHHHHHHH
Confidence 4788999999999 99999999998866 2 589999999986432111 00 1111126788888887765
Q ss_pred ------cCceeeEEEeec-------CchhhHHHHHHHhcCcceEEeecc
Q 044673 91 ------AGVQGDSVWIEK-------DNVEDGIVEVITQQNIRWLVMGAA 126 (780)
Q Consensus 91 ------~~V~~e~~vie~-------~~v~~~I~~~~~~~~id~lVmGs~ 126 (780)
.||++++.++++ +++++.|+++|+++++|+||||-.
T Consensus 74 ~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 74 DLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred hhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 599999988874 699999999999999999999985
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-10 Score=112.98 Aligned_cols=135 Identities=16% Similarity=0.104 Sum_probs=97.1
Q ss_pred cccccCCceEEEEeeec--------CeeEEEEEccCCC----------------------chhHHHHH----HHHHHhhc
Q 044673 429 WKIGEGRYGNVYRGLLR--------HLHVAIKMFPSYG----------------------PQSHLKFQ----NEVEVLSR 474 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~--------~~~VAiK~l~~~~----------------------~~~~~~f~----~Ev~il~~ 474 (780)
..||.|--+.||.|... +..+|||+.+... ......+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999764 2689999864210 01122233 79999999
Q ss_pred CCC--CceeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCccccCCCCCCc
Q 044673 475 VRH--PNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL-HSNEPCIIHGNLKPSK 551 (780)
Q Consensus 475 l~H--pnIv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~ivHrDlKp~N 551 (780)
+.. -++..++++ ...+|||||+.++.+..... ....++......+..+++.+|..| |..+ ||||||+|.|
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 853 345555554 56789999997754432111 122355556677889999999999 8999 9999999999
Q ss_pred eEecCCCCcccccccccccc
Q 044673 552 VLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 552 ILLd~~~~~Kl~DFGla~~~ 571 (780)
||++ ++.++|+|||.+...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 467999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-11 Score=97.54 Aligned_cols=63 Identities=56% Similarity=0.925 Sum_probs=60.4
Q ss_pred ccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHH
Q 044673 713 HFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEW 776 (780)
Q Consensus 713 ~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~ 776 (780)
.|.|||..++|.||++...|++|++++|..|+.. +.+||+|+.++...+|+||.+||++|++|
T Consensus 1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 3789999999999999999999999999999987 78999999999999999999999999999
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.7e-11 Score=132.08 Aligned_cols=236 Identities=22% Similarity=0.256 Sum_probs=165.9
Q ss_pred HHhcCCCcccccccCCceEEEEeeec---CeeEEEEEccCCCchhHH--HHHHHHHHhhcC-CCCceeeEeeeec--CCC
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYGPQSHL--KFQNEVEVLSRV-RHPNLVTLIGTCP--ESR 491 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~~~~~~--~f~~Ev~il~~l-~HpnIv~l~g~~~--~~~ 491 (780)
.-+.+|..+..||.|.|+.||+...+ +..+++|.+......... .-..|+-+...+ .|.+++..+..+. +..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34578999999999999999987654 567899987653332222 223566666666 4888888766553 346
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHL 570 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~ 570 (780)
++=-||+.++++...+. ....+....++++..+++.++.++|+.. ++|+|+||+||++.++ +..+++|||++..
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence 78889999999988763 3344677888999999999999999988 9999999999999886 8899999999764
Q ss_pred ccCCCCCCCCcccccCCCCCCccc-CChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCc-cchhHHHHHHhcccccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVY-IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLR-IKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~-~~~~~~~~~~~~~~~~~ld 648 (780)
+..... ....++..| .+|.......+..+.|+||||.-+.+.++|.+--. ...+ ..+..
T Consensus 417 ~~~~~~---------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~ 477 (524)
T KOG0601|consen 417 LAFSSG---------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRS 477 (524)
T ss_pred cceecc---------cccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeec
Confidence 321111 111122234 35555666678889999999999999999975322 1111 11111
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
......| .....+..+...+...++..||..
T Consensus 478 ~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~ 508 (524)
T KOG0601|consen 478 GDTPNLP-GLKLQLQVLLKVMINPDRKRRPSA 508 (524)
T ss_pred ccccCCC-chHHhhhhhhhhhcCCccccchhh
Confidence 1111222 223678888888888999999977
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=5e-10 Score=114.57 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=108.1
Q ss_pred cccccCCceEEEEeeecC-eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCC--CceeeEeeeecC-----CCeeEEEecc
Q 044673 429 WKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRH--PNLVTLIGTCPE-----SRSLVFEYLR 499 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~-----~~~LV~Ey~~ 499 (780)
..||.|.++.||++...+ ..+++|....... .....+.+|+.++..+++ .++.++++++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998875 7899998765322 134568899999999976 445777887765 3479999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE---------------------------------------- 539 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------------- 539 (780)
|+++.+.+. ...++...+..++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 998887652 145788888889999999999998531
Q ss_pred -------------C-ccccCCCCCCceEecC--CCCcccccccccc
Q 044673 540 -------------P-CIIHGNLKPSKVLIDA--NFGSKLSDFGFFH 569 (780)
Q Consensus 540 -------------~-~ivHrDlKp~NILLd~--~~~~Kl~DFGla~ 569 (780)
+ .++|||++|.|||++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 2 4799999999999998 5668899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.9e-10 Score=106.81 Aligned_cols=128 Identities=23% Similarity=0.358 Sum_probs=100.0
Q ss_pred ccccCCceEEEEeeecCeeEEEEE-ccCCC--c-----hhHHHHHHHHHHhhcCCC--CceeeEeeeecCCCeeEEEecc
Q 044673 430 KIGEGRYGNVYRGLLRHLHVAIKM-FPSYG--P-----QSHLKFQNEVEVLSRVRH--PNLVTLIGTCPESRSLVFEYLR 499 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~~~~VAiK~-l~~~~--~-----~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~~~~LV~Ey~~ 499 (780)
.|++|+-+.+|.+.+-+.++++|. +++.- + -....-.+|+.+|++++- -|...++.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 588999999999988887788874 33211 1 112345689999999863 3445667777888889999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
|..|.|.+... +..++..+-.-+.-||..+ ||||||.++||+|..+. +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999988421 3567788888889999999 99999999999997665 99999999764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-09 Score=103.67 Aligned_cols=141 Identities=21% Similarity=0.301 Sum_probs=102.6
Q ss_pred cccccccCCceEEEEeeecCeeEEEEE-ccCC-------CchhHHHHHHHHHHhhcCCCCce--eeEeeeecCCCeeEEE
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKM-FPSY-------GPQSHLKFQNEVEVLSRVRHPNL--VTLIGTCPESRSLVFE 496 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~-l~~~-------~~~~~~~f~~Ev~il~~l~HpnI--v~l~g~~~~~~~LV~E 496 (780)
....|-+|+-+.|+++.+.|....||. +.+. ..-...+..+|..+|.+++--.| ..++-+-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 566789999999999999999888884 3221 11234467789999999864333 2333333556789999
Q ss_pred eccC-CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---ccccccccccc
Q 044673 497 YLRN-GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGFFHL 570 (780)
Q Consensus 497 y~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGla~~ 570 (780)
|++| -++.+++.........+ .....++..|-..+.-||.++ |+||||..+||+|..++. +.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 47788875433333222 223678888999999999999 999999999999976654 47999999643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3e-09 Score=120.47 Aligned_cols=160 Identities=21% Similarity=0.274 Sum_probs=116.5
Q ss_pred CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCC--eeEEEeccCCChhhHHhhhCCCCCCCHHHHHH
Q 044673 446 HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523 (780)
Q Consensus 446 ~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~ 523 (780)
+.+|.|...............+-+.-|+.+|||||++++..+.... |||.|-+. -|..++.. ++......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHH
Confidence 5678887776654433445668889999999999999999986654 89999874 46777742 22456667
Q ss_pred HHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc
Q 044673 524 IASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602 (780)
Q Consensus 524 i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 602 (780)
.++||+.||.|||. .+ ++|++|.-+.|+++..|..||++|-++........ ......---.|.+|+.+..
T Consensus 109 Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhcCc
Confidence 78999999999984 56 99999999999999999999999998754431110 0001111123667765533
Q ss_pred CCCCcchhHHHHHHHHHHHHhC
Q 044673 603 GKLTPESDVYSFGIILLRLLTG 624 (780)
Q Consensus 603 ~~~~~ksDVwS~Gvil~eLltG 624 (780)
.. -..|.|-|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 235999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.8e-08 Score=103.33 Aligned_cols=253 Identities=17% Similarity=0.227 Sum_probs=163.8
Q ss_pred CcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceee--------EeeeecCC-CeeEE
Q 044673 426 EPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVT--------LIGTCPES-RSLVF 495 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~--------l~g~~~~~-~~LV~ 495 (780)
...+.||+||-+.+|----- ...+-|+.+.-...... +-+..|... .||-+-. |+|--... .-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45678999999999942111 12344665543222222 334444444 4553322 12221111 22566
Q ss_pred EeccCC-ChhhHH---hhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 496 EYLRNG-SLEDCL---ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 496 Ey~~~g-sL~~~L---~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
..+++- -..+++ .++...+...|.-.++.+..++.+.+-||..| .+-||++++|+|+.+++.+.|.|-.-....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeec
Confidence 665553 222222 22345667899999999999999999999999 999999999999999999998874422211
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCccch-------hHHHHH
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTG-RPVLRIKK-------DVKCAL 638 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~-------~~~~~~ 638 (780)
. ........+|...|.+||... +-.-+..+|.|.||+++++||.| +.||.... ..+..+
T Consensus 168 ~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 168 A--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred c--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 1 111223467889999999875 23456789999999999999987 89986433 233344
Q ss_pred Hhcccccccc------CcCCCCCHHH-HHHHHHHHHHchhh--CCCCCcchHHHHHHHHHHHHh
Q 044673 639 EKRNFNSVLD------SSAGDWPVAE-AEQLAHLALRCCEN--NRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 639 ~~~~~~~~ld------~~~~~~p~~~-~~~l~~l~~~Cl~~--~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..|.+...-+ +..+.||... +..+..|..+|+.. ++.-||+. +-++..|..++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a-~aW~aAl~al~~ 302 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA-KAWVAALDALRQ 302 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH-HHHHHHHHHHHH
Confidence 4555443333 2344566543 56788899999986 35689999 778888888764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.7e-08 Score=106.44 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=125.6
Q ss_pred ceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC------CCeeEEEeccC-CChhhH
Q 044673 436 YGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------SRSLVFEYLRN-GSLEDC 506 (780)
Q Consensus 436 ~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~~~LV~Ey~~~-gsL~~~ 506 (780)
-.+.||+.. +|..|++|+++.+.......--.-+++++++.|+|+|++..+|.. ..+|||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356888876 578899999965433333333456889999999999999887742 24689999987 688887
Q ss_pred HhhhC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 507 LACKN------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 507 L~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
.+... ....+++...|.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|+..++..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 65321 2335788999999999999999999999 888999999999999999999998887666432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~ 626 (780)
.. +-+. --.+-|.=.||.+++-|.||..
T Consensus 447 ~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 20 1111 1135689999999999999954
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.4e-08 Score=102.34 Aligned_cols=132 Identities=17% Similarity=0.102 Sum_probs=95.1
Q ss_pred CceEEEEeeecCeeEEEEEccCCCch-----------hHHHHHHHHHHhhcCCCCce--eeEeeeec-------CCCeeE
Q 044673 435 RYGNVYRGLLRHLHVAIKMFPSYGPQ-----------SHLKFQNEVEVLSRVRHPNL--VTLIGTCP-------ESRSLV 494 (780)
Q Consensus 435 ~~G~Vyk~~~~~~~VAiK~l~~~~~~-----------~~~~f~~Ev~il~~l~HpnI--v~l~g~~~-------~~~~LV 494 (780)
....|++..+.|..|.||........ ....+.+|...+.++..-+| ..++++.. ...+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33457788888889999976443211 11147789988888743332 23333331 125699
Q ss_pred EEeccCC-ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-------CCCccccccc
Q 044673 495 FEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-------NFGSKLSDFG 566 (780)
Q Consensus 495 ~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-------~~~~Kl~DFG 566 (780)
+|++++. +|.+++... ...+.+...+..++.+++..+.-||..+ |+|||++++|||++. ++.+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~-~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADW-ATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 899987421 1234556778899999999999999999 999999999999985 4678999999
Q ss_pred ccc
Q 044673 567 FFH 569 (780)
Q Consensus 567 la~ 569 (780)
.++
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.2e-08 Score=96.38 Aligned_cols=124 Identities=20% Similarity=0.271 Sum_probs=79.7
Q ss_pred EEEEeee-cCeeEEEEEccCCCc---------------------h-----hHHHHHHHHHHhhcCCCC--ceeeEeeeec
Q 044673 438 NVYRGLL-RHLHVAIKMFPSYGP---------------------Q-----SHLKFQNEVEVLSRVRHP--NLVTLIGTCP 488 (780)
Q Consensus 438 ~Vyk~~~-~~~~VAiK~l~~~~~---------------------~-----~~~~f~~Ev~il~~l~Hp--nIv~l~g~~~ 488 (780)
.||.|.. ++..||||+...... . ......+|...|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899987 578899998652100 0 112356899999999765 45555544
Q ss_pred CCCeeEEEecc--CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 489 ESRSLVFEYLR--NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY-LHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 489 ~~~~LV~Ey~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
...+|||||++ |..+..+.. . .++......++.+++..+.. +|..+ ||||||.+.|||++.+ .+.|+||
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~-~----~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKD-V----DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHH-C----GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred eCCEEEEEecCCCccchhhHHh-c----cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 35689999998 555544332 1 11133455677788875555 57999 9999999999999887 8999999
Q ss_pred cccccc
Q 044673 566 GFFHLI 571 (780)
Q Consensus 566 Gla~~~ 571 (780)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=115.90 Aligned_cols=125 Identities=15% Similarity=0.190 Sum_probs=100.6
Q ss_pred CCCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcC
Q 044673 15 DVEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAG 92 (780)
Q Consensus 15 ~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~ 92 (780)
...++|+|+|+++ ..|.+.+++|.+.+ .++.+++|||..+... ...... ++-+..+..+|.+.|
T Consensus 248 ~~~eriLV~v~~~-~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~-----------~~~~~~--~~~l~~~~~lA~~lG 313 (895)
T PRK10490 248 HTRDAILLCIGHN-TGSEKLVRTAARLAARLGSVWHAVYVETPRLH-----------RLPEKK--RRAILSALRLAQELG 313 (895)
T ss_pred CcCCeEEEEECCC-cchHHHHHHHHHHHHhcCCCEEEEEEecCCcC-----------cCCHHH--HHHHHHHHHHHHHcC
Confidence 3567999999999 99999999997755 6889999999876320 011111 334555667999888
Q ss_pred ceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 93 VQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 93 V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
.+ .+++.++||+++|++||.+++|+.||||.++++.+ ++.|| ++..+++.++ .-+|+||..
T Consensus 314 a~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~--~~~~s---~~~~l~r~~~-~idi~iv~~ 374 (895)
T PRK10490 314 AE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW--WRRES---FADRLARLGP-DLDLVIVAL 374 (895)
T ss_pred CE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC--ccCCC---HHHHHHHhCC-CCCEEEEeC
Confidence 76 55778999999999999999999999999998876 44677 9999999997 689999963
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.8e-08 Score=98.24 Aligned_cols=74 Identities=28% Similarity=0.495 Sum_probs=70.1
Q ss_pred ccccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
.+..|.+.+|.|..++|.+|+|...|.||++..|.++++.-..++|.|+.+|..-+++||++|+.+|..|+..|
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~n 278 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKEN 278 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHhc
Confidence 45789999999999999999999999999999999999987889999999999999999999999999998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.5e-07 Score=89.10 Aligned_cols=135 Identities=16% Similarity=0.105 Sum_probs=102.8
Q ss_pred cccCCceEEEEeeecCeeEEEEEccCC------CchhHHHHHHHHHHhhcCCCCc--eeeEeeeec---CC----CeeEE
Q 044673 431 IGEGRYGNVYRGLLRHLHVAIKMFPSY------GPQSHLKFQNEVEVLSRVRHPN--LVTLIGTCP---ES----RSLVF 495 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~~~~VAiK~l~~~------~~~~~~~f~~Ev~il~~l~Hpn--Iv~l~g~~~---~~----~~LV~ 495 (780)
-|+||.+.|++-.+.|..+-+|.-... -+.+...|.+|+..|.+|..-+ +.+.+ ++. .. .+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 577999999998888878888875421 1446778999999999986322 33444 332 11 35899
Q ss_pred EeccC-CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC--cccccccccc
Q 044673 496 EYLRN-GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--SKLSDFGFFH 569 (780)
Q Consensus 496 Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~--~Kl~DFGla~ 569 (780)
|-++| -+|.+++.. ....+.+...+..++.+++..|.-||+.+ +.|+|+.+.|||++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98864 588888742 22345677888999999999999999999 999999999999987677 8999997554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.9e-08 Score=112.01 Aligned_cols=148 Identities=22% Similarity=0.408 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCC-----CCCCcccCChhh
Q 044673 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN-----NDSASVYIDPEY 599 (780)
Q Consensus 525 ~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~-----~~gt~~Y~aPE~ 599 (780)
+.+++.||.|+|.. +.+||++|.|.+|.++.++..||+.|+.+.-...+.. .....++. ..-..-|.|||+
T Consensus 105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~---~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE---YPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCc---cccccCCCCCChhhccCcccccchh
Confidence 34455899999975 2399999999999999999999999998755432111 11111111 122345999999
Q ss_pred hccCCCCcchhHHHHHHHHHHHH-hCCCCCccchhHH-HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCC
Q 044673 600 LETGKLTPESDVYSFGIILLRLL-TGRPVLRIKKDVK-CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNR 677 (780)
Q Consensus 600 ~~~~~~~~ksDVwS~Gvil~eLl-tG~~p~~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~R 677 (780)
+.....++++|+|||||++|-+. .|++.+....... .....+ ..+.....++...+.++.+-+.+.+..++.-|
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 99988899999999999999999 5666554332211 111111 11222223344566778888888899999999
Q ss_pred cch
Q 044673 678 PDL 680 (780)
Q Consensus 678 Ps~ 680 (780)
|++
T Consensus 257 p~~ 259 (700)
T KOG2137|consen 257 PTL 259 (700)
T ss_pred cch
Confidence 966
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.6e-06 Score=100.37 Aligned_cols=129 Identities=15% Similarity=0.169 Sum_probs=108.4
Q ss_pred CCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCce
Q 044673 17 EETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQ 94 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~ 94 (780)
.++|+|+|+++ ..|.+-++||.+.+ .++..+.|||..|..... .+. +.+.|.....+|.+-|-
T Consensus 248 ~e~ilvcI~~~-~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~-----------~~~--~~~~l~~~~~Lae~lGa- 312 (890)
T COG2205 248 RERILVCISGS-PGSEKLIRRAARLASRLHAKWTAVYVETPELHRL-----------SEK--EARRLHENLRLAEELGA- 312 (890)
T ss_pred cceEEEEECCC-CchHHHHHHHHHHHHHhCCCeEEEEEeccccccc-----------cHH--HHHHHHHHHHHHHHhCC-
Confidence 47999999999 99999999997755 688999999998753210 111 25678888889888764
Q ss_pred eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeCcee
Q 044673 95 GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKGCLI 165 (780)
Q Consensus 95 ~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg~l~ 165 (780)
+++++.++|++++|++||..+++++||||.+.++.+.+.|.|+ .+..++++++ ...|++|..+.-.
T Consensus 313 -e~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~---l~~~L~~~~~-~idv~ii~~~~~~ 378 (890)
T COG2205 313 -EIVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGS---LADRLAREAP-GIDVHIVALDAPP 378 (890)
T ss_pred -eEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhccc---HHHHHHhcCC-CceEEEeeCCCCc
Confidence 5778899999999999999999999999999999999999998 9999999987 6789999766554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.1e-06 Score=89.63 Aligned_cols=105 Identities=23% Similarity=0.282 Sum_probs=79.4
Q ss_pred HHHHHHHHHHhhcCCCCc--eeeEeeeecC------CCeeEEEeccCC-ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHH
Q 044673 462 HLKFQNEVEVLSRVRHPN--LVTLIGTCPE------SRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532 (780)
Q Consensus 462 ~~~f~~Ev~il~~l~Hpn--Iv~l~g~~~~------~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL 532 (780)
.....+|...+..+..-. ....+++... ..+||+|++++. +|.+++.... .++...+..++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 445778888877775322 2333444322 236999999984 7999885321 255677889999999999
Q ss_pred HHHHcCCCccccCCCCCCceEecCCC---Ccccccccccccc
Q 044673 533 IYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSDFGFFHLI 571 (780)
Q Consensus 533 ~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~DFGla~~~ 571 (780)
.-||..+ |+|+|++|.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998887 7899999976643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-05 Score=79.61 Aligned_cols=104 Identities=22% Similarity=0.270 Sum_probs=83.3
Q ss_pred HHHHHHhhcCCC-CceeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-ccc
Q 044673 466 QNEVEVLSRVRH-PNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CII 543 (780)
Q Consensus 466 ~~Ev~il~~l~H-pnIv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~iv 543 (780)
..|.-++..+.+ +++.+++|+|. ..+|.||...+++...-........-+|..|.+||.+++..+.+|+...+ ++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 468888888876 69999999994 47899999987665321000122347899999999999999999998644 588
Q ss_pred cCCCCCCceEecCCCCcccccccccccc
Q 044673 544 HGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 544 HrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
-.|++|+|+-++++|.+|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 8999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.3e-06 Score=85.75 Aligned_cols=131 Identities=21% Similarity=0.228 Sum_probs=88.4
Q ss_pred CcccccccCCceEEEEeeec-CeeEEEEEccCCC----------------------chhHHHHHHHHHHhhcCCCC--ce
Q 044673 426 EPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYG----------------------PQSHLKFQNEVEVLSRVRHP--NL 480 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~----------------------~~~~~~f~~Ev~il~~l~Hp--nI 480 (780)
....+||-|--+.||.|... +.++|||.-+... ...+....+|.++|.+|..- .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 44578999999999999985 7899999653210 01123356889999888643 34
Q ss_pred eeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 481 VTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 481 v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
.+.+++ +..++||||++|-.|...- ++-...-.|+..|+.-+.-+-..| |||||+.+-|||++.+|.+
T Consensus 174 P~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCE
Confidence 444432 3356999999986665421 112222233444444444444667 9999999999999999999
Q ss_pred cccccccc
Q 044673 561 KLSDFGFF 568 (780)
Q Consensus 561 Kl~DFGla 568 (780)
.++||--+
T Consensus 242 ~vIDwPQ~ 249 (304)
T COG0478 242 VVIDWPQA 249 (304)
T ss_pred EEEeCccc
Confidence 99999644
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.6e-06 Score=93.75 Aligned_cols=142 Identities=23% Similarity=0.344 Sum_probs=92.6
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchh----------------------------------------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQS---------------------------------------- 461 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~---------------------------------------- 461 (780)
..|+. ..|+.++-|.||+|.+. |..||||+.++.-...
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 57999999999999997 8999999987432110
Q ss_pred HHHHHHHHHHhhcCC-----CCcee--eEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHH-HH
Q 044673 462 HLKFQNEVEVLSRVR-----HPNLV--TLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA-LI 533 (780)
Q Consensus 462 ~~~f~~Ev~il~~l~-----HpnIv--~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~a-L~ 533 (780)
...|.+|..-+.+++ .|++. +++--+.....|+|||++|-.+.+...-+. ..++ +..|+..++.+ +.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence 011345555555542 23321 222223455679999999999998853222 3344 33344444332 22
Q ss_pred HHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 534 ~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
-+=..+ ++|.|..|.||+++.+|.+.+.|||+...++
T Consensus 280 q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 222356 9999999999999999999999999976554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=81.47 Aligned_cols=134 Identities=16% Similarity=0.178 Sum_probs=90.7
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHH---------HHHHHHhhcCCC---CceeeEeeee--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKF---------QNEVEVLSRVRH---PNLVTLIGTC-- 487 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f---------~~Ev~il~~l~H---pnIv~l~g~~-- 487 (780)
.++|...+.+-......|.+-..++..+.+|............| .+.+..+.+++. -....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 36777777777777778888788899999998876443322222 234443444422 2222222221
Q ss_pred -----cCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccc
Q 044673 488 -----PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKL 562 (780)
Q Consensus 488 -----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl 562 (780)
.....|+|||++|..|.++.. ++. .++..+..++.-||..| ++|||..|+|++++.++ +++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEE
Confidence 223458999999988877542 222 25566778899999999 99999999999998655 899
Q ss_pred ccccccc
Q 044673 563 SDFGFFH 569 (780)
Q Consensus 563 ~DFGla~ 569 (780)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998644
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.5e-05 Score=80.81 Aligned_cols=136 Identities=14% Similarity=0.202 Sum_probs=79.1
Q ss_pred cccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce--eeEeeeecC--CCeeEEEeccCCC-h
Q 044673 429 WKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLIGTCPE--SRSLVFEYLRNGS-L 503 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI--v~l~g~~~~--~~~LV~Ey~~~gs-L 503 (780)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..-.+ .+.++++.+ ...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 469999999999842 4467889887533 23345789999988864333 444555432 3468999999863 1
Q ss_pred hhH--------------Hhh----hCC--CCCCCHHHHHHHH-H----------HHHH-HHHHHHc--CCCccccCCCCC
Q 044673 504 EDC--------------LAC----KNK--KSPLRWQTRMQIA-S----------DVCS-ALIYLHS--NEPCIIHGNLKP 549 (780)
Q Consensus 504 ~~~--------------L~~----~~~--~~~l~~~~~~~i~-~----------~i~~-aL~~LH~--~~~~ivHrDlKp 549 (780)
... +.. -.. ........+..-. . .+.. ...+|.. ..+.++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111 100 000 0111111111100 0 1111 1222322 223578999999
Q ss_pred CceEecCCCCcccccccccc
Q 044673 550 SKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~ 569 (780)
.||+++.++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.6e-05 Score=81.54 Aligned_cols=140 Identities=21% Similarity=0.271 Sum_probs=83.3
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCC--ceeeEeeeecC-----CCeeEEEeccC
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHP--NLVTLIGTCPE-----SRSLVFEYLRN 500 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hp--nIv~l~g~~~~-----~~~LV~Ey~~~ 500 (780)
++.|+.|..+.||+....+..+++|..... .....+.+|+.++..+... .+..++.++.. ..+++|+|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 357899999999999888789999997653 4556777899998888533 24556654321 13689999999
Q ss_pred CChhh----------------HHh---hh-CCCCCCCHHHHH---------HH------------HHHHHH-HHHHHHc-
Q 044673 501 GSLED----------------CLA---CK-NKKSPLRWQTRM---------QI------------ASDVCS-ALIYLHS- 537 (780)
Q Consensus 501 gsL~~----------------~L~---~~-~~~~~l~~~~~~---------~i------------~~~i~~-aL~~LH~- 537 (780)
..+.+ .+. .. ....++.+.... .. ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 111 11 111222221110 00 011222 3334432
Q ss_pred ---CCC-ccccCCCCCCceEec-CCCCcccccccccc
Q 044673 538 ---NEP-CIIHGNLKPSKVLID-ANFGSKLSDFGFFH 569 (780)
Q Consensus 538 ---~~~-~ivHrDlKp~NILLd-~~~~~Kl~DFGla~ 569 (780)
..+ .++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 133 699999999999999 56666799998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.5e-05 Score=80.51 Aligned_cols=137 Identities=17% Similarity=0.191 Sum_probs=82.4
Q ss_pred ccccCCc-eEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecC--CCeeEEEeccCCChhh
Q 044673 430 KIGEGRY-GNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--SRSLVFEYLRNGSLED 505 (780)
Q Consensus 430 ~IG~G~~-G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~~~LV~Ey~~~gsL~~ 505 (780)
.|-.|.+ ..||+....+..+.||+..... ...+.+|+.++..+. +--+.++++++.. ..++||||++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3555665 7899987777788889886543 334668888888874 3335566776654 4689999999987764
Q ss_pred HH-------------------hhhCC-CCCCC--HHHHHHHHHH--------------------HHHHHHHHHc-----C
Q 044673 506 CL-------------------ACKNK-KSPLR--WQTRMQIASD--------------------VCSALIYLHS-----N 538 (780)
Q Consensus 506 ~L-------------------~~~~~-~~~l~--~~~~~~i~~~--------------------i~~aL~~LH~-----~ 538 (780)
.. +.... ..++. +..++..... +...+..|-. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 11100 11111 0111110000 1111222211 1
Q ss_pred CCccccCCCCCCceEecCCCCcccccccccc
Q 044673 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 539 ~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.|.++|+|+.|.|||++.+..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2359999999999999998778899998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.4e-05 Score=87.35 Aligned_cols=137 Identities=19% Similarity=0.255 Sum_probs=90.2
Q ss_pred cccccCCceEEEEeeec-CeeEEEEEccCCCchh-------------------------------------HHHHHHHHH
Q 044673 429 WKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQS-------------------------------------HLKFQNEVE 470 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~-------------------------------------~~~f~~Ev~ 470 (780)
..||.-+.|.||+|+++ |..||||+-++.-... ...|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46999999999999996 6779999876432110 012444543
Q ss_pred Hhhc----CCCCc------eeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHH-HHcCC
Q 044673 471 VLSR----VRHPN------LVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY-LHSNE 539 (780)
Q Consensus 471 il~~----l~Hpn------Iv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~ 539 (780)
-..+ +.|-+ |.+++-.+.....|+||||+|..+.|...-.. ..++... |+..+.++... |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 3322 34555 44555556667889999999998888654322 2344443 33333333221 12346
Q ss_pred CccccCCCCCCceEecC----CCCccccccccccccc
Q 044673 540 PCIIHGNLKPSKVLIDA----NFGSKLSDFGFFHLIP 572 (780)
Q Consensus 540 ~~ivHrDlKp~NILLd~----~~~~Kl~DFGla~~~~ 572 (780)
++|+|=.|.|||++. ++.+.+-|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6779999999987654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=9.9e-05 Score=90.72 Aligned_cols=144 Identities=17% Similarity=0.241 Sum_probs=90.1
Q ss_pred ccccccCCceEEEEeeecC----eeEEEEEccCCC-chhHHHHHHHHHHhhcCC-CCce--eeEeeeecC-----CCeeE
Q 044673 428 SWKIGEGRYGNVYRGLLRH----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVR-HPNL--VTLIGTCPE-----SRSLV 494 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~-HpnI--v~l~g~~~~-----~~~LV 494 (780)
...|+.|.+..+|+....+ ..+++|+..... ......+.+|+.+|+.+. |+++ .+++++|.+ ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5678999999999876653 367888765432 223446889999999996 6665 777888865 36799
Q ss_pred EEeccCCChhh--------------------H---HhhhCC--------CCCCCHH--HHHHHH---------------H
Q 044673 495 FEYLRNGSLED--------------------C---LACKNK--------KSPLRWQ--TRMQIA---------------S 526 (780)
Q Consensus 495 ~Ey~~~gsL~~--------------------~---L~~~~~--------~~~l~~~--~~~~i~---------------~ 526 (780)
|||++|..+.+ . |+.... ..+..+. ...++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865322 1 111110 0111111 111111 1
Q ss_pred HHHHHHHHHHcCCC---------ccccCCCCCCceEecCC-C-Ccccccccccccc
Q 044673 527 DVCSALIYLHSNEP---------CIIHGNLKPSKVLIDAN-F-GSKLSDFGFFHLI 571 (780)
Q Consensus 527 ~i~~aL~~LH~~~~---------~ivHrDlKp~NILLd~~-~-~~Kl~DFGla~~~ 571 (780)
.+...+.+|..+-| .+||+|++|.|||++.+ + .+-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23334667755433 39999999999999853 3 3568999887654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=6.2e-05 Score=78.30 Aligned_cols=71 Identities=13% Similarity=0.133 Sum_probs=45.1
Q ss_pred cccccCCceE-EEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCC---ceeeEeeeecC-----CCeeEEEecc
Q 044673 429 WKIGEGRYGN-VYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHP---NLVTLIGTCPE-----SRSLVFEYLR 499 (780)
Q Consensus 429 ~~IG~G~~G~-Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hp---nIv~l~g~~~~-----~~~LV~Ey~~ 499 (780)
..|+.||... ||+. +..+++|..+.. .....+.+|..+|..+... -+...++.+.. ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 4688888775 9974 335778876542 2344678899999877531 23333444322 2378999999
Q ss_pred CCChh
Q 044673 500 NGSLE 504 (780)
Q Consensus 500 ~gsL~ 504 (780)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00031 Score=75.83 Aligned_cols=74 Identities=22% Similarity=0.129 Sum_probs=53.9
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCC---CceeeEeeeec-----CCCeeEEEecc
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH---PNLVTLIGTCP-----ESRSLVFEYLR 499 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H---pnIv~l~g~~~-----~~~~LV~Ey~~ 499 (780)
...||.|..+.||+-...+..+.+|..+.. .....|..|...|+.|.- ..+.+++++|. +..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 346999999999987665556777875431 123478899999988853 35777788774 23689999999
Q ss_pred CCCh
Q 044673 500 NGSL 503 (780)
Q Consensus 500 ~gsL 503 (780)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00029 Score=72.44 Aligned_cols=149 Identities=20% Similarity=0.244 Sum_probs=89.5
Q ss_pred CHHHHHHHhcCCCccc---ccccCCceEEEEeee-cCeeEEEEEccCCCchhH---------HHH---------------
Q 044673 414 SFSELNEATNNFEPSW---KIGEGRYGNVYRGLL-RHLHVAIKMFPSYGPQSH---------LKF--------------- 465 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~---~IG~G~~G~Vyk~~~-~~~~VAiK~l~~~~~~~~---------~~f--------------- 465 (780)
|++.|........+.. .|+.|--+.||+|.. .+..||||++........ ..|
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444444 455666778999886 478899999864221111 011
Q ss_pred HHHHHHhhcCCC--CceeeEeeeecCCCeeEEEeccCCC-hhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCc
Q 044673 466 QNEVEVLSRVRH--PNLVTLIGTCPESRSLVFEYLRNGS-LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPC 541 (780)
Q Consensus 466 ~~Ev~il~~l~H--pnIv~l~g~~~~~~~LV~Ey~~~gs-L~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ 541 (780)
..|+.-|.++.. -.+.+-+++. ...|||||+.... -.-.| ..-++...+...+..+++..+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 235555544421 1112222221 2459999996531 11111 11223333566777888888887766 77
Q ss_pred cccCCCCCCceEecCCCCcccccccccccc
Q 044673 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 542 ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
+||+||..=|||+. ++.+.|+|||-|...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999976544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=6.7e-06 Score=93.05 Aligned_cols=187 Identities=16% Similarity=0.117 Sum_probs=126.4
Q ss_pred hcCCCcccccccCCceEEEEeeecCee-EEEEEccCCCchhHHHHHHHHHHhhcCCCCc-eeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLH-VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN-LVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~-VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-Iv~l~g~~~~~--~~LV~Ey 497 (780)
+.-+...+-+++|+++++||.+...+. ...+.+.. .....-++++|.+++||| .+..++.+... ..++++|
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 334444456889999999988754322 22333322 134456899999999999 66666666444 3478999
Q ss_pred ccCC-ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+.+| +-.+... ...-.+..-+...+...-+.+|++||+.. =+|+| |||..+ +..|..||+....+....
T Consensus 316 ~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 8877 2222110 01111222334456666778999999874 58999 888765 678999999876654321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCcc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRI 630 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~ 630 (780)
......+|+.+++||+...+.+..+.|+|++|+--.++--|-+|-..
T Consensus 386 -------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 -------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred -------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 23556789999999999999999999999999876677777776543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00017 Score=75.93 Aligned_cols=136 Identities=14% Similarity=0.117 Sum_probs=79.9
Q ss_pred cccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEeccCCChhhH---
Q 044673 431 IGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEYLRNGSLEDC--- 506 (780)
Q Consensus 431 IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey~~~gsL~~~--- 506 (780)
+..|-.+.+|+...++..+++|+.............+|..+++.+..-.+ .++++.+. ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 55677789998887777899998654322211235689999988864333 34444443 5799999998765421
Q ss_pred --------------HhhhC-CCCCCCHHHHH-HHHHHH---------HHHHHHHHcC------CCccccCCCCCCceEec
Q 044673 507 --------------LACKN-KKSPLRWQTRM-QIASDV---------CSALIYLHSN------EPCIIHGNLKPSKVLID 555 (780)
Q Consensus 507 --------------L~~~~-~~~~l~~~~~~-~i~~~i---------~~aL~~LH~~------~~~ivHrDlKp~NILLd 555 (780)
||... ...+++...++ .+..++ ...+..+-.. .+.++|+|+.|.|||++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 11222322211 111111 1112222111 12589999999999999
Q ss_pred CCCCcccccccccc
Q 044673 556 ANFGSKLSDFGFFH 569 (780)
Q Consensus 556 ~~~~~Kl~DFGla~ 569 (780)
.++ +.|+||..+.
T Consensus 162 ~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 162 PQG-LKLIDWEYAS 174 (256)
T ss_pred CCC-CEEEeccccC
Confidence 877 7899998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00023 Score=69.37 Aligned_cols=129 Identities=18% Similarity=0.169 Sum_probs=89.0
Q ss_pred cccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCCeeEEEeccCCChhhH
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDC 506 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~~LV~Ey~~~gsL~~~ 506 (780)
....||+|++|.||+|.+.+..+|+|+-..++ .+..+..|+++|..+.--++-+=+..+. ...+.|||+.|-.|.+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg-~~~i~me~i~G~~L~~~ 102 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG-EDFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec-hhhhhhhhhcCcchhhh
Confidence 34579999999999999999999999877644 4566789999998887655544333322 23455999999888875
Q ss_pred HhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCC-CCceEecCCCCccccccccccc
Q 044673 507 LACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLK-PSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 507 L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlK-p~NILLd~~~~~Kl~DFGla~~ 570 (780)
-.. .+-+..+. ++..---|-..+ |-|+.|. |..++|-.++.+.|+||.-|+.
T Consensus 103 ~~~------~~rk~l~~----vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 103 EIG------GDRKHLLR----VLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhc------ccHHHHHH----HHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 521 12233333 333433344556 8888875 5555665666899999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00063 Score=68.74 Aligned_cols=131 Identities=21% Similarity=0.271 Sum_probs=87.9
Q ss_pred CcccccccCCceEEEEeeecCeeEEEEEccCCC----------------chhHHHHHHHHHHhhcCC------CCceeeE
Q 044673 426 EPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG----------------PQSHLKFQNEVEVLSRVR------HPNLVTL 483 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~----------------~~~~~~f~~Ev~il~~l~------HpnIv~l 483 (780)
+....||+|+.-.||.-- .+....||+..... .....++.+|+.-...+. +.+|.++
T Consensus 4 ~~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345679999999999522 34567889887654 123456667776666655 8899999
Q ss_pred eeeecCC--CeeEEEeccC--C----ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 484 IGTCPES--RSLVFEYLRN--G----SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 484 ~g~~~~~--~~LV~Ey~~~--g----sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
+|+.... .-+|+|.+.+ | +|.+++. ...++. .....+.+ -..||-... |+.+|++|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~---f~~~l~~~~--Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDE---FKRYLLDHH--IVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHH---HHHHHHHcC--CeecCCCcccEEEE
Confidence 9998665 4578887643 3 5677773 334555 33344444 445666677 99999999999995
Q ss_pred CCC----Cccccc-ccc
Q 044673 556 ANF----GSKLSD-FGF 567 (780)
Q Consensus 556 ~~~----~~Kl~D-FGl 567 (780)
.+. .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 432 466777 554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00017 Score=62.40 Aligned_cols=82 Identities=16% Similarity=0.184 Sum_probs=68.5
Q ss_pred EEEEecCCccccHHHHHHHhhhc-CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCceeeEE
Q 044673 20 IFVAVGKNVEKNKTTVFWALQNF-AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQGDSV 98 (780)
Q Consensus 20 I~VAVD~s~~~S~~Al~wAl~~~-~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~~e~~ 98 (780)
|+||++|+ ..|..++.||.+.. .+..++++|+.
T Consensus 1 ilv~~sgg-~dS~~~l~~~~~~~~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGG-LDSSVLLHLAKRLKSGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCC-HHHHHHHHHHHHHHhcCCCEEEEEeH---------------------------------------------
Confidence 68999999 99999999998863 45567777776
Q ss_pred EeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhh-hcchhHHHHHhhCCCCcEEE
Q 044673 99 WIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLE-LKSKKAIFVCQQAPISCHIW 157 (780)
Q Consensus 99 vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~g-s~s~va~~V~~~ap~~C~V~ 157 (780)
...+.+.+++.++++|.||+|+++.....+.+.| + ++..+++.++ |+|+
T Consensus 35 -----~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~---~~~~~~~~~~--~~vl 84 (86)
T cd01984 35 -----AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASA---NVLVVIKGAG--IPVL 84 (86)
T ss_pred -----HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchh---hhhhcccccC--Ccee
Confidence 3456788889999999999999999999888887 6 7788888887 7765
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00054 Score=68.87 Aligned_cols=135 Identities=24% Similarity=0.365 Sum_probs=97.5
Q ss_pred cCCCccccCHHHHHHHhcCCCcccccccCCc-eEEEEeeecCeeEEEEEccC---CCc------------------hhHH
Q 044673 406 FQPGLLEFSFSELNEATNNFEPSWKIGEGRY-GNVYRGLLRHLHVAIKMFPS---YGP------------------QSHL 463 (780)
Q Consensus 406 ~~~~~~~~~~~ei~~at~~f~~~~~IG~G~~-G~Vyk~~~~~~~VAiK~l~~---~~~------------------~~~~ 463 (780)
..|.+..|+. -+.+|..+..||.|.- |.||+...++..+|+|++.. ... .-..
T Consensus 25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 3455667776 2378999999999999 99999999999999999332 111 0112
Q ss_pred HHHHHHHHhhcCC---CCce--eeEeeee--c-CC-----------------CeeEEEeccCCChhhHHhhhCCCCCCCH
Q 044673 464 KFQNEVEVLSRVR---HPNL--VTLIGTC--P-ES-----------------RSLVFEYLRNGSLEDCLACKNKKSPLRW 518 (780)
Q Consensus 464 ~f~~Ev~il~~l~---HpnI--v~l~g~~--~-~~-----------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~ 518 (780)
-|..|.....+|. +.++ |+.+||. . +. ..+|.||++... .+.
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~- 166 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ- 166 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc-
Confidence 4788998888875 4455 8999986 1 00 136888876643 122
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 519 ~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
..-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 ---~~~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ---IRDIPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---hhHHHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 223567778889999999 999999999986 3589999953
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00043 Score=71.77 Aligned_cols=73 Identities=12% Similarity=0.206 Sum_probs=47.6
Q ss_pred cccccCCceEEEEeeec---CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc-eeeEeeeecCCCeeEEEeccCCChh
Q 044673 429 WKIGEGRYGNVYRGLLR---HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN-LVTLIGTCPESRSLVFEYLRNGSLE 504 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-Iv~l~g~~~~~~~LV~Ey~~~gsL~ 504 (780)
..|..|-...+|+.... +..|++|+...... ....-.+|+.++..+...+ ..++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45777778899988765 46788997754322 1122347888888885433 344455443 34899999987663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0029 Score=68.93 Aligned_cols=156 Identities=17% Similarity=0.219 Sum_probs=82.7
Q ss_pred cccCHHHHHHHhcCCCc-----ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-----CCCce
Q 044673 411 LEFSFSELNEATNNFEP-----SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-----RHPNL 480 (780)
Q Consensus 411 ~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-----~HpnI 480 (780)
..++..++......|.. ...|+.|....+|+....+..+++|++.... ......|+.++..| .-|.+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcc
Confidence 34555666555555543 3456667777899877666679999876222 22223344444444 23333
Q ss_pred eeE-----eeeecCCCeeEEEeccCCChh-----------hHH---hhhCC--------CCCCCH-HHHHHH--------
Q 044673 481 VTL-----IGTCPESRSLVFEYLRNGSLE-----------DCL---ACKNK--------KSPLRW-QTRMQI-------- 524 (780)
Q Consensus 481 v~l-----~g~~~~~~~LV~Ey~~~gsL~-----------~~L---~~~~~--------~~~l~~-~~~~~i-------- 524 (780)
+.- +....+..+++++|++|..+. ..| +.... ...+.| ...+.-
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 321 111233357899999987542 111 11110 011223 221111
Q ss_pred ----H-HHHHHHHHHHHcC----CC-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 525 ----A-SDVCSALIYLHSN----EP-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 525 ----~-~~i~~aL~~LH~~----~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
. ..+...+..+... -| .++|+|+.|.|||++.+...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1 1111222333211 23 59999999999999977666899999753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=8.6e-05 Score=91.10 Aligned_cols=158 Identities=15% Similarity=0.030 Sum_probs=118.5
Q ss_pred HHHHHHHhhcCCCCceeeEeeeecC----CCeeEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-
Q 044673 465 FQNEVEVLSRVRHPNLVTLIGTCPE----SRSLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSN- 538 (780)
Q Consensus 465 f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~- 538 (780)
...|++.++...|++++....-.++ ..+.+++|+.+|.+.+.|.. .+..+++...-+...-.....+..-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4567777778899998877665543 24689999999999998853 23445555555544444446666666653
Q ss_pred --CCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHH
Q 044673 539 --EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGI 616 (780)
Q Consensus 539 --~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gv 616 (780)
+...+|+++|+.|.+|+.+.++|++++|+.+...+... ......+++.|+.|++...-.++.++|+|..|+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 22689999999999999999999999999884332211 123456777899999998888999999999999
Q ss_pred HHHHHHhCCCCCc
Q 044673 617 ILLRLLTGRPVLR 629 (780)
Q Consensus 617 il~eLltG~~p~~ 629 (780)
-+|.+.-|.++|.
T Consensus 1429 ~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHhcccHHHH
Confidence 9999999988874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0029 Score=70.66 Aligned_cols=74 Identities=23% Similarity=0.196 Sum_probs=55.0
Q ss_pred cccccCCceEEEEeeecC--eeEEEEEccCC----C---chhHHHHHHHHHHhhcCC---CCceeeEeeeecCCCeeEEE
Q 044673 429 WKIGEGRYGNVYRGLLRH--LHVAIKMFPSY----G---PQSHLKFQNEVEVLSRVR---HPNLVTLIGTCPESRSLVFE 496 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~----~---~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~~~~~LV~E 496 (780)
..||.|.+..||+....+ ..|+||.-.+. + +....++..|.+.|..+. ..++.+++.+.++..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 468999999999998864 38999975421 1 224456778888888763 34677888887877899999
Q ss_pred eccCCC
Q 044673 497 YLRNGS 502 (780)
Q Consensus 497 y~~~gs 502 (780)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0013 Score=79.74 Aligned_cols=191 Identities=21% Similarity=0.246 Sum_probs=130.4
Q ss_pred HHHHHHHhhcCCCCceeeEeeeecCCCe------eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 044673 465 FQNEVEVLSRVRHPNLVTLIGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538 (780)
Q Consensus 465 f~~Ev~il~~l~HpnIv~l~g~~~~~~~------LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~ 538 (780)
..-|...+.++.|+|++.+++|-.+..+ +..+|+..-++...+. .-..++..+.+.+..++..||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3457778888999999999988754322 3458888888888874 556788889999999999999999998
Q ss_pred CCccccCCCCCC---ceEecCCCCcccc--cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCc--chhH
Q 044673 539 EPCIIHGNLKPS---KVLIDANFGSKLS--DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP--ESDV 611 (780)
Q Consensus 539 ~~~ivHrDlKp~---NILLd~~~~~Kl~--DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~--ksDV 611 (780)
. ..|.-+..+ +-..+..+...++ ||+.+..++..... ....-+..|.+||......+.. ..|+
T Consensus 306 ~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c--cceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHH
Confidence 6 555555444 4445566667776 88887766533211 1122334477888776555544 4799
Q ss_pred HHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 612 YSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 612 wS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|.+|..+..+..|..+-.....+.. +++.. ....+.+...+|+..+++.|+.. .+++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~~---------~l~~~-------~~~~~~d~~~~~~~~~~~~Rl~~-~~ll 432 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPVS---------LLDVL-------STSELLDALPKCLDEDSEERLSA-LELL 432 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchhh---------hhccc-------cchhhhhhhhhhcchhhhhccch-hhhh
Confidence 9999999999998765432211111 11111 11146778889999999999988 4443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0065 Score=65.30 Aligned_cols=139 Identities=18% Similarity=0.183 Sum_probs=83.9
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc--eeeEeeee--------cCCCeeEEEe
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN--LVTLIGTC--------PESRSLVFEY 497 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--Iv~l~g~~--------~~~~~LV~Ey 497 (780)
...|..|....+|+....+..+++|+... ........|+.++..+.+-+ +.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45677777789998877777899998865 22344556777777774322 44444322 2234689999
Q ss_pred ccCCChhh-----------H---HhhhCC--------CCCCCHHHHHH----------HHHHHHHHHHHHHc----CCC-
Q 044673 498 LRNGSLED-----------C---LACKNK--------KSPLRWQTRMQ----------IASDVCSALIYLHS----NEP- 540 (780)
Q Consensus 498 ~~~gsL~~-----------~---L~~~~~--------~~~l~~~~~~~----------i~~~i~~aL~~LH~----~~~- 540 (780)
++|..+.. . |+.... .....|..... ....+..++.++.. ..|
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 0 111000 01123332211 11123344555543 123
Q ss_pred ccccCCCCCCceEecCCCCcccccccccc
Q 044673 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 541 ~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 59999999999999998778899998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.013 Score=63.47 Aligned_cols=139 Identities=16% Similarity=0.193 Sum_probs=78.7
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc--eeeEeeee--------cCCCeeEEEe
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN--LVTLIGTC--------PESRSLVFEY 497 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--Iv~l~g~~--------~~~~~LV~Ey 497 (780)
...++.|-...+|+...++..+++|+...... ......|+.++..|.... +.+.+... .+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 34566666678998776666788898755321 233445667776664222 33444322 1224689999
Q ss_pred ccCCChhh-----------H---HhhhCCC--C-------CCCHHHHHH------------HHHHHHHHHHHHHcC----
Q 044673 498 LRNGSLED-----------C---LACKNKK--S-------PLRWQTRMQ------------IASDVCSALIYLHSN---- 538 (780)
Q Consensus 498 ~~~gsL~~-----------~---L~~~~~~--~-------~l~~~~~~~------------i~~~i~~aL~~LH~~---- 538 (780)
++|..+.. . ++..... . .-.|..... ....+...+.++...
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99865421 1 1111010 0 012221110 011233455555431
Q ss_pred CC-ccccCCCCCCceEecCCCCccccccccc
Q 044673 539 EP-CIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 539 ~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.| .++|+|+.+.||+++.++.+.|+||+.+
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 22 5999999999999999887789999964
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2042 consensus Ubiquitin fusion degradation protein-2 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0011 Score=79.19 Aligned_cols=71 Identities=25% Similarity=0.428 Sum_probs=67.4
Q ss_pred cccCCccccccccccccCccccc-CCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhh
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAA-DGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~-dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~ 779 (780)
...|..|..|+...+|.||++.. ++.|.+|..|..++.+ .+|+|..+.+|.+..+.||-.||.-|+.|.++
T Consensus 865 ~dvpdef~DPlm~Tlm~dPV~LP~Srv~vDRsti~rhlLs-~~tdPFNR~pLt~d~v~pn~eLK~kI~~~~~e 936 (943)
T KOG2042|consen 865 GDVPDEFLDPLMSTLMSDPVVLPSSRVTVDRSTIERHLLS-DCTDPFNREPLTEDMVSPNEELKAKIRCWIKE 936 (943)
T ss_pred ccCchhhhCccccccCCCCccCCcccccccHHHHHHHHhc-CCCCccccccCchhhcCCCHHHHHHHHHHHHH
Confidence 45899999999999999999998 9999999999999987 78999999999999999999999999999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0081 Score=64.15 Aligned_cols=29 Identities=31% Similarity=0.607 Sum_probs=24.3
Q ss_pred ccccCCCCCCceEecCCCC-cccccccccc
Q 044673 541 CIIHGNLKPSKVLIDANFG-SKLSDFGFFH 569 (780)
Q Consensus 541 ~ivHrDlKp~NILLd~~~~-~Kl~DFGla~ 569 (780)
.++|+|+.|.|||++.++. .-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997554 5699999754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0083 Score=66.21 Aligned_cols=138 Identities=13% Similarity=0.231 Sum_probs=80.6
Q ss_pred cccccCCceEEEEeeec------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey~~~g 501 (780)
..|-.|-.-.+|+..+. +..|++|+........ ..-.+|..++..+..-++ .+++++++.+ .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 34544666789987652 2568899876543222 223578888888864444 3556777554 689999877
Q ss_pred ChhhH-----------------HhhhC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-CC
Q 044673 502 SLEDC-----------------LACKN-K--KSPLRWQTRMQIASDV-----------------CSALIYL----HS-NE 539 (780)
Q Consensus 502 sL~~~-----------------L~~~~-~--~~~l~~~~~~~i~~~i-----------------~~aL~~L----H~-~~ 539 (780)
+|... +|... . ..+..|....++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 11111 0 1122233333333221 1112222 22 12
Q ss_pred C-ccccCCCCCCceEecC-CCCcccccccccc
Q 044673 540 P-CIIHGNLKPSKVLIDA-NFGSKLSDFGFFH 569 (780)
Q Consensus 540 ~-~ivHrDlKp~NILLd~-~~~~Kl~DFGla~ 569 (780)
+ .++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2 5899999999999986 4679999998754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 780 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-86
Identities = 91/319 (28%), Positives = 155/319 (48%), Gaps = 39/319 (12%)
Query: 401 EALSFFQPGLLEFSFSELNEATNNFEPSW------KIGEGRYGNVYRGLLRHLHVAIK-- 452
++L FSF EL TNNF+ K+GEG +G VY+G + + VA+K
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKL 62
Query: 453 --MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLEDCLA 508
M + +F E++V+++ +H NLV L+G + LV+ Y+ NGSL D L+
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 509 CKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568
C + PL W R +IA + + +LH E IH ++K + +L+D F +K+SDFG
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 569 HLIPQGESTGNSALCNESNNDSASV-----YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ T ++ + Y+ PE L G++TP+SD+YSFG++LL ++T
Sbjct: 181 RASEKFAQTVM----------TSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229
Query: 624 GRPVLRIKKDVKCAL--------EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRL 675
G P + ++ + L E++ +D D E + +A +C +
Sbjct: 230 GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289
Query: 676 NRPDLVSEIWSVLEALRVS 694
RP + ++ +L+ + S
Sbjct: 290 KRP-DIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-82
Identities = 90/296 (30%), Positives = 140/296 (47%), Gaps = 32/296 (10%)
Query: 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEV 471
+L EATNNF+ + IG G +G VY+G+LR VA+K Q +F+ E+E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 472 LSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLEDCLACKNK-KSPLRWQTRMQIASDV 528
LS RHP+LV+LIG C E L+++Y+ NG+L+ L + + W+ R++I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
L YLH IIH ++K +L+D NF K++DFG + + T +
Sbjct: 149 ARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT----------H 196
Query: 589 DSASV-----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---------V 634
S V YIDPEY G+LT +SDVYSFG++L +L R +
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 635 KCALEKRNFNSVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689
+ ++D + A + A++C + +RP + ++ LE
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP-SMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 4e-75
Identities = 96/300 (32%), Positives = 153/300 (51%), Gaps = 35/300 (11%)
Query: 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLK-FQNEVE 470
FS EL A++NF +G G +G VY+G L VA+K Q FQ EVE
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 471 VLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASD 527
++S H NL+ L G C R LV+ Y+ NGS+ CL + PL W R +IA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 528 VCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNES 586
L YLH + +P IIH ++K + +L+D F + + DFG L+ ++
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---------- 189
Query: 587 NNDSASV-----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-------- 633
+ + +V +I PEYL TGK + ++DV+ +G++LL L+TG+ + +
Sbjct: 190 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 634 ---VKCALEKRNFNSVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689
VK L+++ +++D G++ E EQL +AL C +++ + RP +SE+ +LE
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-KMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 37/240 (15%)
Query: 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVE 470
++ L + + GR+G V++ L + +VA+K+FP QS + + EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 471 VLSRVRHPNLVTLIGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI 524
L ++H N++ IG S L+ + GSL D L K + + W I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHI 126
Query: 525 ASDVCSALIYLHSN--------EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
A + L YLH + +P I H ++K VL+ N + ++DFG G+S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 577 TGNSALCNESNNDSASV----YIDPEYLETG-----KLTPESDVYSFGIILLRLLTGRPV 627
G++ V Y+ PE LE D+Y+ G++L L +
Sbjct: 187 AGDT---------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 78/266 (29%), Positives = 115/266 (43%), Gaps = 17/266 (6%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
KIG G +G V+R VA+K+ + + +F EV ++ R+RHPN+V +G
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
P + S+V EYL GSL L + L + R+ +A DV + YLH+ P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL 605
NLK +L+D + K+ DFG L + SA ++ PE L
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT-------PEWMAPEVLRDEPS 216
Query: 606 TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHL 665
+SDVYSFG+IL L T + + L+ P Q+A +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP-----QVAAI 271
Query: 666 ALRCCENNRLNRPDLVSEIWSVLEAL 691
C N RP + I +L L
Sbjct: 272 IEGCWTNEPWKRPS-FATIMDLLRPL 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+G+G +G + R + +K + ++ F EV+V+ + HPN++ IG
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ + + EY++ G+L + K+ S W R+ A D+ S + YLHS IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM--NIIHR 132
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID-------PE 598
+L L+ N ++DFG L+ ++ + + + PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG------ 652
+ + DV+SFGI+L ++ + R + L+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGR-------VNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 653 -DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694
+ P + +RCC+ + RP ++ LE LR+
Sbjct: 246 PNCP----PSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMH 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 31/238 (13%)
Query: 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVE 470
+E + SE + +N + IG GRYG VY+G L VA+K+F Q+ F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN---FINEKN 57
Query: 471 V--LSRVRHPNLVTLIGTC-------PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
+ + + H N+ I LV EY NGSL L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 522 MQIASDVCSALIYLHSN-------EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574
++A V L YLH+ +P I H +L VL+ + +SDFG +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 575 ESTGNSALCNESNNDSASV-YIDPEYLE-------TGKLTPESDVYSFGIILLRLLTG 624
N + ++ ++ Y+ PE LE + D+Y+ G+I +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 78/311 (25%), Positives = 120/311 (38%), Gaps = 35/311 (11%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489
+G G +G V + R VAIK S F E+ LSRV HPN+V L G C
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC-IIHGNLK 548
LV EY GSL + L M + YLHS +P +IH +LK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 549 PSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YIDPEYLETG 603
P +L+ A K+ DFG + C+ + + + ++ PE E
Sbjct: 133 PPNLLLVAGGTVLKICDFGT--------A------CDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 604 KLTPESDVYSFGIILLRLLTGR-PVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
+ + DV+S+GIIL ++T R P I + + + + P + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK-NLP----KPI 233
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEV 722
L RC + RP + EI ++ L G+ E + P P ++
Sbjct: 234 ESLMTRCWSKDPSQRPSM-EEIVKIMTHLM------RYFPGADEPLQYPCQHSLPPGEDG 286
Query: 723 MKDPQIAADGF 733
+P + F
Sbjct: 287 RVEPYVDFAEF 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+IG G +G VY+G VA+KM + PQ F+NEV VL + RH N++ +G
Sbjct: 31 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 488 -PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
++V ++ SL L ++ + + IA + YLH+ IIH +
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRD 145
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YIDPE---Y 599
LK + + + + K+ DFG + + S+ ++ PE
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEK---------SRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 600 LETGKLTPESDVYSFGIILLRLLTGR---PVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
++ + +SDVY+FGI+L L+TG+ + + + + + + + L + P
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP- 255
Query: 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+++ L C + R RP I + +E L
Sbjct: 256 ---KRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 42/299 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
IG+GR+G VY G VAI++ F+ EV + RH N+V +G C
Sbjct: 40 LIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
P +++ + +L + ++ K L QIA ++ + YLH+ I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHK 154
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL 605
+LK V D N ++DFG F + ++ N ++ PE +
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC--HLAPEIIRQLSP 211
Query: 606 ---------TPESDVYSFGIILLRLLTGR------PVLRIKKDVKCALEKRNFNSVLDSS 650
+ SDV++ G I L P I + + S
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-------GTGMKPNLS 264
Query: 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL---RVSCVFPVSCSGSKE 706
++++ + L C + RP +++ +LE L P S E
Sbjct: 265 QIGMG----KEISDILLFCWAFEQEERPTF-TKLMDMLEKLPKRNRRLSHPGHFWKSAE 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 40/205 (19%), Positives = 81/205 (39%), Gaps = 22/205 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+ E G +++G + + +K+ + + F E L HPN++ ++G C
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 488 ----PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+L+ ++ GSL + L + + ++ A D+ + +LH+ EP I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
L V+ID + +++S A ++ PE L+
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA------------WVAPEALQKK 183
Query: 604 KLTPE---SDVYSFGIILLRLLTGR 625
+D++SF ++L L+T
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-44
Identities = 70/303 (23%), Positives = 109/303 (35%), Gaps = 53/303 (17%)
Query: 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLK----F 465
LLE F+EL IG G +G VYR VA+K + +
Sbjct: 1 LLEIDFAELTLEE-------IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV 53
Query: 466 QNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523
+ E ++ + ++HPN++ L G C + LV E+ R G L L+ K + +
Sbjct: 54 RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVN 109
Query: 524 IASDVCSALIYLHSNEPC-IIHGNLKPSKVLIDANFGS--------KLSDFGFFHLIPQG 574
A + + YLH IIH +LK S +LI + K++DFG +
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 575 ESTGNS------ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL 628
+ A PE + + SDV+S+G++L LLTG
Sbjct: 170 TKMSAAGAYAWMA---------------PEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 629 RIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVL 688
R + A L + A L C + +RP + I L
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPE-----PFAKLMEDCWNPDPHSRPS-FTNILDQL 268
Query: 689 EAL 691
+
Sbjct: 269 TTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-44
Identities = 58/243 (23%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 404 SFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRG--LLRHLHVAIKMF------- 454
F + L + +E+ +IG+G +G V++G + VAIK
Sbjct: 7 EFPKSRLPTLADNEIEYEK-------QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 455 PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKS 514
+ + +FQ EV ++S + HPN+V L G +V E++ G L L +K
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAH 117
Query: 515 PLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-----ANFGSKLSDFGFFH 569
P++W ++++ D+ + Y+ + P I+H +L+ + + A +K++DFG
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--- 174
Query: 570 LIPQGESTGNSALCNESNNDSASV-----YIDPEYL--ETGKLTPESDVYSFGIILLRLL 622
L +S + + + ++ PE + E T ++D YSF +IL +L
Sbjct: 175 ------------LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 623 TGR 625
TG
Sbjct: 223 TGE 225
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEV--LSRVRHPNLVTLIGTC 487
+G+GRYG V+RG + +VA+K+F S + + E E+ +RH N++ I +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 488 ------PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-- 539
L+ Y GSL D L + + L + ++I + S L +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 540 ----PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-- 593
P I H +LK +L+ N ++D G + Q + + ++ V
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG-------NNPRVGT 180
Query: 594 --YIDPEYLETGKLTPE-------SDVYSFGIILLRLLTGRPVLRIKKDVK 635
Y+ PE L+ + + D+++FG++L + I +D K
Sbjct: 181 KRYMAPEVLD-ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 40/235 (17%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEV--LSRVRHPNLVTLIGTC 487
+IG+GRYG V+ G R VA+K+F + + E E+ +RH N++ I
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 488 PESR------SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN--- 538
+ L+ +Y NGSL D L K + L ++ +++A S L +LH+
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 539 ---EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-- 593
+P I H +LK +L+ N ++D G + + + V
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP-------PNTRVGT 209
Query: 594 --YIDPEYLETGKLTPES-------DVYSFGIILLRLLTGRPVLRIKKDVKCALE 639
Y+ PE L+ L D+YSFG+IL + I ++ +
Sbjct: 210 KRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 36/218 (16%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEV--LSRVRHPNLVTLIGTC 487
IG+GR+G V+RG R VA+K+F S + + E E+ +RH N++ I
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 488 PESR------SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-- 539
+ LV +Y +GSL D L + + + +++A S L +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 540 ----PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN------- 588
P I H +LK +L+ N ++D G T + A +
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 589 --DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG 624
D + E + +D+Y+ G++ +
Sbjct: 222 VLDDSINMKHFESFKR------ADIYAMGLVFWEIARR 253
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-34
Identities = 31/73 (42%), Positives = 39/73 (53%)
Query: 707 HRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPN 766
P +F CPI E+MKDP I + G TYE +I+ WL +GH T P + L H L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 767 YALHQAIIEWQQR 779
Y L I W +
Sbjct: 62 YVLKSLIALWCES 74
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 25/109 (22%), Positives = 44/109 (40%)
Query: 671 ENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPILQEVMKDPQIAA 730
++ N D+ + L ++ R IP + I E+M++P I
Sbjct: 64 SDDSQNGGDISKMKSKHDKYLMDMDELFSQVDEKRKKREIPDYLCGKISFELMREPCITP 123
Query: 731 DGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779
G TY+ + I L+ + P+T L L+PN A+ + I + Q
Sbjct: 124 SGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQE 172
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIK-MFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIG 485
+IG G + VY+GL + VA + +S + F+ E E+L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 486 ----TCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
T + +V E + +G+L+ L + ++ + + L +LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 540 PCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSA--SVY-I 595
P IIH +LK + I GS K+ D G + L S + + +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGL------------ATLKRASFAKAVIGTPEFM 197
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE E DVY+FG+ +L + T
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
+IG G +G V+ G LR + VA+K + P KF E +L + HPN+V LIG
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
C + + + V E ++ G L + + + LR +T +Q+ D + + YL S C IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIH 236
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLE 601
+L L+ K+SDFG G ++ V + PE L
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEALN 288
Query: 602 TGKLTPESDVYSFGIIL 618
G+ + ESDV+SFGI+L
Sbjct: 289 YGRYSSESDVWSFGILL 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 52/284 (18%), Positives = 95/284 (33%), Gaps = 60/284 (21%)
Query: 430 KIGEGRYGNVYRGLLRHLH---VAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL-- 483
I G G +Y L R+++ V +K + S ++ E + L+ V HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 484 IGTCPESRS-----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
+ +V EY+ SL+ L + ++ AL YLHS
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
+++ +LKP +++ KL D G I N +Y P
Sbjct: 202 G--LVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------------NSFGYLYGTPG 242
Query: 599 YL--E--TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654
+ E T +D+Y+ G L L P N +
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT---------------RNGRYVDGLPED 287
Query: 655 P--VAEAEQLAHLALRCCENNRLNRP----DLVSEIWSVLEALR 692
+ + L R + + R ++ +++ VL +
Sbjct: 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIK-MFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTL- 483
K+G G VY L+ VAIK +F ++ +F+ EV S++ H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 484 -IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ + LV EY+ +L + + PL T + + + + + H I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDMR--I 132
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----YIDP 597
+H ++KP +LID+N K+ DFG I + AL S + V Y P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFG----IAK-------ALSETSLTQTNHVLGTVQYFSP 181
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E + +D+YS GI+L +L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 43/217 (19%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG +G V VA+K P G + E+E+L + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 483 LIGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
G C E L+ E+L +GSL++ L K+ + + +++ A +C + YL S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID-- 596
+ +H +L VL+++ K+ DFG I + Y
Sbjct: 146 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----------------EYYTVKD 187
Query: 597 ----------PEYLETGKLTPESDVYSFGIILLRLLT 623
PE L K SDV+SFG+ L LLT
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G+G +G V+ G VAIK G S F E +V+ ++RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 489 ESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E +V EY+ GSL D L LR + +A+ + S + Y+ +H +L
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDL 306
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP 607
+ + +L+ N K++DFG LI E T + PE G+ T
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTA------RQGAKFPIKWTAPEAALYGRFTI 360
Query: 608 ESDVYSFGIILLRLLT 623
+SDV+SFGI+L L T
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 45/217 (20%)
Query: 430 KIGEGRYGNVYRGLLRHL------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG +G V VA+K GPQ ++ E+++L + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 483 LIGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
G C ++ + LV EY+ GSL D L + + + A +C + YLH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID-- 596
IH +L VL+D + K+ DFG +P+G Y
Sbjct: 154 H--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----------------EYYRVRE 195
Query: 597 ----------PEYLETGKLTPESDVYSFGIILLRLLT 623
PE L+ K SDV+SFG+ L LLT
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
++G+G +G+V VA+K GP FQ E+++L + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 484 IGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G LV EYL +G L D L + ++ L + +S +C + YL S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR- 146
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID--- 596
+H +L +L+++ K++DFG L+P + Y+
Sbjct: 147 -RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----------------YVVREP 189
Query: 597 ---------PEYLETGKLTPESDVYSFGIILLRLLT 623
PE L + +SDV+SFG++L L T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G+G +G V+ G VAIK G S F E +V+ ++RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 489 ESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
E +V EY+ GSL D L LR + +A+ + S + Y+ +H +L
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDL 389
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTP 607
+ + +L+ N K++DFG LI E T + PE G+ T
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTA------RQGAKFPIKWTAPEAALYGRFTI 443
Query: 608 ESDVYSFGIILLRLLT 623
+SDV+SFGI+L L T
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G G +G VY+GL + VAIK + P+++ + +E V++ V +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 483 LIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
L+G C S L+ + + G L D + + K + Q + + + YL
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR--R 137
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PE 598
++H +L VL+ K++DFG L+ E ++ + V I E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALE 189
Query: 599 YLETGKLTPESDVYSFGIIL 618
+ T +SDV+S+G+ +
Sbjct: 190 SILHRIYTHQSDVWSYGVTV 209
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 18/212 (8%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+GEG + V GL A+K + Q + Q E ++ HPN++ L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 488 PESRS------LVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
R L+ + + G+L + + K+K + L + + +C L +H+
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--K 153
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGNSALCNESNNDSASVYIDP 597
H +LKP+ +L+ L D G + +G + + + S Y P
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS-YRAP 212
Query: 598 EYLET---GKLTPESDVYSFGIILLRLLTGRP 626
E + +DV+S G +L ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 38/208 (18%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IG G G V G LR + VAIK Y + F +E ++ + HPN++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
G R V EY+ NGSL+ L + + + V + + YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL--G 171
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID----- 596
+H +L VL+D+N K+SDFG ++ +D + Y
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL---------------EDDPDAAYTTTGGKI 216
Query: 597 ------PEYLETGKLTPESDVYSFGIIL 618
PE + + SDV+SFG+++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 32/201 (15%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
+IG G++G V+ G VAIK G S F E EV+ ++ HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 489 ESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
E + V E++ +G L D L + ++ +T + + DVC + YL C+IH +
Sbjct: 74 EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRD 129
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS---------ALCNESNNDSASVYIDP 597
L L+ N K+SDFG + + T ++ + P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS---------------P 174
Query: 598 EYLETGKLTPESDVYSFGIIL 618
E + + +SDV+SFG+++
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLM 195
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
IG G +G VY+G+L+ + VAIK Y + + F E ++ + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 483 LIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L G + + + + EY+ NG+L+ L + K + + + + + YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM-- 166
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---- 596
+H +L +L+++N K+SDFG L +D + Y
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFG---------------LSRVLEDDPEATYTTSGGK 211
Query: 597 -------PEYLETGKLTPESDVYSFGIIL 618
PE + K T SDV+SFGI++
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVM 240
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+G G+YG VY G+ + L VA+K +F E V+ ++HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 488 PESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ E++ G+L D L + + + + +A+ + SA+ YL IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 342
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YIDPEYLETGK 604
NL L+ N K++DFG L+ T + + PE L K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYT-------AHAGAKFPIKWTAPESLAYNK 395
Query: 605 LTPESDVYSFGIILLRLLT 623
+ +SDV++FG++L + T
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 73/321 (22%), Positives = 127/321 (39%), Gaps = 41/321 (12%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G G +G V++G+ + V IK+ G QS + + + + H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 483 LIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
L+G CP S LV +YL GSL D + + + L Q + + + YL +
Sbjct: 80 LLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEEH--G 135
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PE 598
++H NL VL+ + +++DFG L+P + + A I E
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--------QLLYSEAKTPIKWMALE 187
Query: 599 YLETGKLTPESDVYSFGIILLRLLT--GRPVLRIK-KDVKCALEK--RNFNSVLDSSAGD 653
+ GK T +SDV+S+G+ + L+T P ++ +V LEK R L
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-----LAQ---- 238
Query: 654 WPVAEAEQLAHLALRCCENNRLNRP---DLVSEIWSVLEALRVSCVFPVSCSGSKEHRRI 710
P + + ++C + RP +L +E + V
Sbjct: 239 -PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297
Query: 711 PSHFVCPILQEVMKDPQIAAD 731
P L+EV +P++ D
Sbjct: 298 PHGLTNKKLEEVELEPELDLD 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFP-----SYGPQSHLKFQNEVEVLS 473
+FE +G+G++GNVY L R +A+K+ G + L+ EVE+ S
Sbjct: 9 EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLR--REVEIQS 64
Query: 474 RVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
+RHPN++ L G ++ L+ EY G++ L K S Q +++ +A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG-ESTGNSALCNESNNDS 590
L Y HS +IH ++KP +L+ + K++DFG+ P + LC +
Sbjct: 122 LSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLD--- 172
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE +E + D++S G++ L G+P
Sbjct: 173 ---YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 38/208 (18%)
Query: 430 KIGEGRYGNVYRGLL-----RHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G +G V G L + + VAIK Y + F E ++ + HPN++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
G +S+ + V EY+ NGSL+ L + + + + + S + YL
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM--G 167
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID----- 596
+H +L +LI++N K+SDFG ++ +D + Y
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVL---------------EDDPEAAYTTRGGKI 212
Query: 597 ------PEYLETGKLTPESDVYSFGIIL 618
PE + K T SDV+S+GI+L
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 42/216 (19%)
Query: 430 KIGEGRYGNVYRGLLRHLH------VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
++G+G +G+V L VA+K + F+ E+E+L ++H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 484 IGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G C + L+ EYL GSL D L + K + +Q S +C + YL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID--- 596
IH +L +L++ K+ DFG ++PQ + +
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----------------EFFKVKEP 176
Query: 597 ---------PEYLETGKLTPESDVYSFGIILLRLLT 623
PE L K + SDV+SFG++L L T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 30/198 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
IG+G +G+V G R VA+K Q F E V++++RH NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 489 ESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
E + +V EY+ GSL D L +S L ++ + DVC A+ YL N +H
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHR 141
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-----SALCNESNNDSASVYIDPEYL 600
+L VL+ + +K+SDFG + TG +A PE L
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------------PEAL 186
Query: 601 ETGKLTPESDVYSFGIIL 618
K + +SDV+SFGI+L
Sbjct: 187 REKKFSTKSDVWSFGILL 204
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 20/198 (10%)
Query: 430 KIGEGRYGNVYRGLLRH----LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
++G G +G+V +G+ R + VAIK+ + E +++ ++ +P +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 485 GTCP-ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G C E+ LV E G L L K+ + ++ V + YL +
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK--NFV 132
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYL 600
H +L VL+ +K+SDFG + +S + + + PE +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-------RSAGKWPLKWYAPECI 185
Query: 601 ETGKLTPESDVYSFGIIL 618
K + SDV+S+G+ +
Sbjct: 186 NFRKFSSRSDVWSYGVTM 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 22/206 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIK-MFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTL- 483
+G G G+VY VA+K M + P + Q E R++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 484 -IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
G + + L L ++ PL + I + SAL H+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG--A 155
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG-NSALCNESNNDSASV-YIDPEYL 600
H ++KP +L+ A+ + L DFG + T + + ++ Y+ PE
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--------GTLYYMAPERF 207
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRP 626
T +D+Y+ +L LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 429 WKIGEGRYGNVYRGLLRHLH--VAIK-MFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTL 483
+G G V+ H VA+K + P +L+F+ E + + + HP +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 484 --IGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
G +V EY+ +L D + + + P+ + +++ +D C AL + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-YID 596
N IIH ++KP+ ++I A K+ DFG I + + +++ ++ + Y+
Sbjct: 135 NG--IIHRDVKPANIMISATNAVKVMDFG----IARAIADSGNSV-TQTAAVIGTAQYLS 187
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + SDVYS G +L +LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 42/216 (19%)
Query: 430 KIGEGRYGNVYRGLLRHLH------VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
++G+G +G+V L VA+K + F+ E+E+L ++H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 484 IGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
G C + L+ EYL GSL D L + K + +Q S +C + YL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID--- 596
IH +L +L++ K+ DFG ++PQ + Y
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----------------EYYKVKEP 207
Query: 597 ---------PEYLETGKLTPESDVYSFGIILLRLLT 623
PE L K + SDV+SFG++L L T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 26/229 (11%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGT 486
+ EG + VY + + A+K S + + EV + ++ HPN+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 487 CPESRS---------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+ L+ L G L + L + PL T ++I C A+ ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV---- 593
+P IIH +LK +L+ KL DFG I SA + +
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 594 -YIDPEYLETGK---LTPESDVYSFGIILLRLLTGRP------VLRIKK 632
Y PE ++ + + D+++ G IL L + LRI
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 32/201 (15%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
++G G++G V G R VAIKM G S +F E +V+ + H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 489 ESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
+ R + + EY+ NG L + L + + + Q +++ DVC A+ YL S +H +
Sbjct: 90 KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRD 145
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS---------ALCNESNNDSASVYIDP 597
L L++ K+SDFG + E T + P
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------------P 190
Query: 598 EYLETGKLTPESDVYSFGIIL 618
E L K + +SD+++FG+++
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLM 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 30/198 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
IG+G +G+V G R VA+K Q F E V++++RH NLV L+G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 489 ESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
E + +V EY+ GSL D L +S L ++ + DVC A+ YL N +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHR 313
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-----SALCNESNNDSASVYIDPEYL 600
+L VL+ + +K+SDFG + TG +A PE L
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------------PEAL 358
Query: 601 ETGKLTPESDVYSFGIIL 618
K + +SDV+SFGI+L
Sbjct: 359 REKKFSTKSDVWSFGILL 376
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 47/221 (21%)
Query: 429 WKIGEGRYGNVYRGLLRHL-------HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
++GEG +G V+ +L VA+K + FQ E E+L+ ++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQIAS 526
G C + L VFEY+++G L L + K L + IAS
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 527 DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALC 583
+ S ++YL S +H +L L+ AN K+ DFG + + G++ L
Sbjct: 141 QIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML- 197
Query: 584 NESNNDSASVYIDP------EYLETGKLTPESDVYSFGIIL 618
P E + K T ESDV+SFG+IL
Sbjct: 198 -------------PIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 32/201 (15%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
++G G++G V G + VA+KM G S +F E + + ++ HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 489 ESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGN 546
+ + V EY+ NG L + L ++ L +++ DVC + +L S+ IH +
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRD 129
Query: 547 LKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGN------SALCNESNNDSASVYIDP 597
L L+D + K+SDFG + + S G SA P
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA---------------P 174
Query: 598 EYLETGKLTPESDVYSFGIIL 618
E K + +SDV++FGI++
Sbjct: 175 EVFHYFKYSSKSDVWAFGILM 195
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 430 KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G G +G VY+GL + VAIK + P+++ + +E V++ V +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 483 LIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
L+G C S L+ + + G L D + + K + Q + + + YL
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR--R 137
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PE 598
++H +L VL+ K++DFG L+ E E + + V I E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMALE 189
Query: 599 YLETGKLTPESDVYSFGIIL 618
+ T +SDV+S+G+ +
Sbjct: 190 SILHRIYTHQSDVWSYGVTV 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFP-----SYGPQSHLKFQNEVEVLS 473
++F+ +G+G++GNVY L R +A+K+ G + L+ E+E+ S
Sbjct: 14 DDFDIGRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69
Query: 474 RVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
+RHPN++ + + + L+ E+ G L L K+ + ++ + + A
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFD-EQRSATFMEE-LADA 126
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE-STGNSALCNESNNDS 590
L Y H + +IH ++KP +L+ K++DFG+ P T +C +
Sbjct: 127 LHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLD--- 177
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE +E + D++ G++ L G P
Sbjct: 178 ---YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
K+G G++G V+ H VA+K G S F E V+ ++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 489 ESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
+ ++ E++ GSL D L ++ S + ++ + + ++ IH +L
Sbjct: 254 KEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDL 310
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYLETGK 604
+ + +L+ A+ K++DFG +I E T A I PE + G
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREG---------AKFPIKWTAPEAINFGS 361
Query: 605 LTPESDVYSFGIIL 618
T +SDV+SFGI+L
Sbjct: 362 FTIKSDVWSFGILL 375
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+G G+YG VY G+ + L VA+K +F E V+ ++HPNLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 488 PESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ E++ G+L D L + + + + +A+ + SA+ YL IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI---DPEYLET 602
+L L+ N K++DFG L+ T ++ A I PE L
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---------GAKFPIKWTAPESLAY 186
Query: 603 GKLTPESDVYSFGIIL 618
K + +SDV++FG++L
Sbjct: 187 NKFSIKSDVWAFGVLL 202
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHL--KFQNEVEVLSRVRHPNLVTL 483
+G+G + + + A K+ P S + H K E+ + + H ++V
Sbjct: 49 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
G E +V E R SL + + + + ++ + YLH N
Sbjct: 107 HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN-- 160
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES---TGNSALCNESNNDSASVYIDP 597
+IH +LK + ++ + K+ DFG + LC N YI P
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPN------YIAP 210
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E L + E DV+S G I+ LL G+P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 40/232 (17%), Positives = 88/232 (37%), Gaps = 40/232 (17%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMF-----------------PSYGPQSHLKF 465
N++ + +G++ + + A+K + + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 466 QNEVEVLSRVRHPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNK-----KSPLR 517
+NE+++++ +++ +T G + +++EY+ N S+ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 518 WQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577
Q I V ++ Y+H+ + I H ++KPS +L+D N KLSDFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 578 GNSALCNESNNDSASVYIDPEYLETGKLT---PESDVYSFGIILLRLLTGRP 626
G ++ PE+ + + + D++S GI L +
Sbjct: 209 G---SRGTYE------FMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHL--KFQNEVEVLSRVRHPNLVTL 483
+G+G + + + A K+ P S + H K E+ + + H ++V
Sbjct: 23 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
G E +V E R SL + + + + ++ + YLH N
Sbjct: 81 HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN-- 134
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES---TGNSALCNESNNDSASVYIDP 597
+IH +LK + ++ + K+ DFG + LC N YI P
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPN------YIAP 184
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E L + E DV+S G I+ LL G+P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 46/219 (21%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
++GEG +G V+ +L VA+K + FQ E E+L+ ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 483 LIGTCPESR--SLVFEYLRNGSLEDCL------------ACKNKKSPLRWQTRMQIASDV 528
G C E R +VFEY+R+G L L PL + +AS V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNE 585
+ ++YL +H +L L+ K+ DFG I + G + L
Sbjct: 168 AAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 222
Query: 586 SNNDSASVYIDP------EYLETGKLTPESDVYSFGIIL 618
P E + K T ESDV+SFG++L
Sbjct: 223 -----------PIRWMPPESILYRKFTTESDVWSFGVVL 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IG+G +G VY G + AIK Q F E ++ + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
IG ++ Y+ +G L + ++ + + + V + YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---P 597
+H +L ++D +F K++DFG I E + A + +
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS------VQQHRHARLPVKWTAL 197
Query: 598 EYLETGKLTPESDVYSFGIILLRLLT 623
E L+T + T +SDV+SFG++L LLT
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 430 KIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP 488
++G G++G V+ G H VA+K G S F E ++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 489 ES-RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
+ ++ EY+ NGSL D L L + +A+ + + ++ IH +L
Sbjct: 79 QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDL 135
Query: 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS---------ALCNESNNDSASVYIDPE 598
+ + +L+ K++DFG LI E T A PE
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------------PE 180
Query: 599 YLETGKLTPESDVYSFGIIL 618
+ G T +SDV+SFGI+L
Sbjct: 181 AINYGTFTIKSDVWSFGILL 200
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G+G +G VY G+ + + VAIK + + ++F NE V+ ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL-------ACKNKKSPLRWQTRMQIASDVCSAL 532
L+G + + + E + G L+ L A +P +Q+A ++ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNESNND 589
YL++N+ +H +L ++ +F K+ DFG I + + G L
Sbjct: 152 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------- 202
Query: 590 SASV-YIDPEYLETGKLTPESDVYSFGIIL 618
V ++ PE L+ G T SDV+SFG++L
Sbjct: 203 --PVRWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHL--KFQNEVEVLSRVRHPNLVTL 483
+G+G + VY +H VAIKM ++ + + QNEV++ +++HP+++ L
Sbjct: 19 LGKGSFAGVY--RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTR---MQIASDVCSALIYLHS 537
E + LV E NG + L + K + R QI + ++YLHS
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMHQIIT----GMLYLHS 130
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGE--STGNSALCNESNNDSASVY 594
+ I+H +L S +L+ N K++DFG L E T LC N Y
Sbjct: 131 H--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCGTPN------Y 178
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
I PE ESDV+S G + LL GRP
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 41/212 (19%)
Query: 430 KIGEGRYGNVYRGLLR---------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
+G+G + +++G+ R V +K+ F ++S++ H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 481 VTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V G C LV E+++ GSL+ L K K+ + ++++A + +A+ +L N
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 539 EPCIIHGNLKPSKVLIDANFGS--------KLSDFGFFHLIPQGESTGNSALCNESNNDS 590
+IHGN+ +L+ KLSD G + D
Sbjct: 133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------------LPKDI 176
Query: 591 ASVYID---PEYLETGKL-TPESDVYSFGIIL 618
I PE +E K +D +SFG L
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/201 (25%), Positives = 78/201 (38%), Gaps = 23/201 (11%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
K+G+G +G V RG + VA+K P++ F EV + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 482 TLIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L G +V E GSL D L + + T + A V + YL S
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---P 597
IH +L +L+ K+ DFG +PQ + + V P
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-------EHRKVPFAWCAP 193
Query: 598 EYLETGKLTPESDVYSFGIIL 618
E L+T + SD + FG+ L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTL 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IG G +G VY G L +H A+K +F E ++ HPN+++L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
+G C S +V Y+++G L + + +N+ + + V + +L S +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---- 596
+H +L ++D F K++DFG + + + SV+
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDM--------------YDKEFDSVHNKTGAK 257
Query: 597 -------PEYLETGKLTPESDVYSFGIIL 618
E L+T K T +SDV+SFG++L
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 20/198 (10%)
Query: 430 KIGEGRYGNVYRGLLR----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
++G G +G+V +G+ R + VAIK+ + E +++ ++ +P +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 485 GTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G C LV E G L L K+ + ++ V + YL +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK--NFV 458
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---PEYL 600
H NL VL+ +K+SDFG + +S + + + PE +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-------RSAGKWPLKWYAPECI 511
Query: 601 ETGKLTPESDVYSFGIIL 618
K + SDV+S+G+ +
Sbjct: 512 NFRKFSSRSDVWSYGVTM 529
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 35/205 (17%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IGEG++G+V++G+ L VAIK KF E + + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 484 IGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG E+ ++ E G L L + +K L + + A + +AL YL S
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--RF 137
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGN------SALCNESNNDSASV 593
+H ++ VL+ +N KL DFG + ++ A
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA------------ 185
Query: 594 YIDPEYLETGKLTPESDVYSFGIIL 618
PE + + T SDV+ FG+ +
Sbjct: 186 ---PESINFRRFTSASDVWMFGVCM 207
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 35/205 (17%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
+GEG +G VY G+ + ++VA+K + KF +E ++ + HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 484 IGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG E + ++ E G L L + K+ L+ T + + +C A+ YL S
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESI--NC 134
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGN------SALCNESNNDSASV 593
+H ++ +L+ + KL DFG I + ++ +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS------------ 182
Query: 594 YIDPEYLETGKLTPESDVYSFGIIL 618
PE + + T SDV+ F + +
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCM 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IG G +G VY G L +H A+K +F E ++ HPN+++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
+G C S +V Y+++G L + + +N+ + + V + YL S +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID---- 596
+H +L ++D F K++DFG + + + SV+
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDM--------------YDKEYYSVHNKTGAK 193
Query: 597 -------PEYLETGKLTPESDVYSFGIIL 618
E L+T K T +SDV+SFG++L
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLL 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 54/219 (24%), Positives = 82/219 (37%), Gaps = 35/219 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+G+G NV+RG RH AIK+F + E EVL ++ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 485 GTCPESRS-----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
E + L+ E+ GSL L + L + + DV + +L N
Sbjct: 74 A-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 540 PCIIHGNLKPSKVLI----DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
I+H N+KP ++ D KL+DFG + E +L Y+
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEE------YL 182
Query: 596 DPEYLETGKL--------TPESDVYSFGIILLRLLTGRP 626
P+ E L D++S G+ TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-24
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 30/214 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
++G G +G V R H VAIK P++ ++ E++++ ++ HPN+V+
Sbjct: 21 RLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 485 GTCPESRS---------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
P+ L EY G L L L+ + SD+ SAL YL
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
H N IIH +LKP +++ K+ D G+ + QGE +
Sbjct: 138 HENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQ----- 188
Query: 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE LE K T D +SFG + +TG
Sbjct: 189 -YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 34/336 (10%), Positives = 80/336 (23%), Gaps = 54/336 (16%)
Query: 386 NAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR 445
+ +++ ++ + + S L++ + + G V+
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84
Query: 446 HL--HVAIKMFPSYGPQSHL---KFQNEVEVLSRVRHPNLVTLIGTCPESRS-------- 492
A+K+F S + +R+ +
Sbjct: 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144
Query: 493 --------------------LVFEYLRNGSLEDCLA----CKNKKSPLRWQTRMQIASDV 528
L+ LE + + + + +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
L S ++HG+ P + I + L D + + +
Sbjct: 204 IRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVT----- 256
Query: 589 DSASVYIDPEYL--ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646
Y E+L T T + + G+ + R+ + KR V
Sbjct: 257 -----YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 647 LDSSAGDWPVAEA--EQLAHLALRCCENNRLNRPDL 680
+ + + + + L R +R R
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 32/210 (15%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G G +G VY G + + VA+K Q L F E ++S+ H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 482 TLIGTCPESRSL--VFEYLRNGSLED----CLACKNKKSPLRWQTRMQIASDVCSALIYL 535
IG +S + E + G L+ ++ S L + +A D+ YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 536 HSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFHLIPQGE---STGNSALCNESNND 589
N IH ++ L+ +K+ DFG I + G + L
Sbjct: 157 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML------- 207
Query: 590 SASV-YIDPEYLETGKLTPESDVYSFGIIL 618
V ++ PE G T ++D +SFG++L
Sbjct: 208 --PVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 33/211 (15%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+G+G +G+V L+ + VA+KM +F E + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 483 LIGTCPESRS--------LVFEYLRNGSLEDCL---ACKNKKSPLRWQTRMQIASDVCSA 531
L+G SR+ ++ ++++G L L L QT ++ D+
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNESNN 588
+ YL S IH +L ++ + ++DFG I G+ S L
Sbjct: 150 MEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL------ 201
Query: 589 DSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
V ++ E L T SDV++FG+ +
Sbjct: 202 ---PVKWLALESLADNLYTVHSDVWAFGVTM 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 48/218 (22%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG +G+V G L+ L VA+K + + +F +E + HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 483 LIGTCPESRS-------LVFEYLRNGSLEDCL---ACKNKKSPLRWQTRMQIASDVCSAL 532
L+G C E S ++ +++ G L L + + QT ++ D+ +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
YL + +H +L ++ + ++DFG I S
Sbjct: 161 EYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKI-----------------YSGD 201
Query: 593 VY------------IDPEYLETGKLTPESDVYSFGIIL 618
Y I E L T +SDV++FG+ +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 55/226 (24%), Positives = 82/226 (36%), Gaps = 49/226 (21%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+G+G NV+RG RH AIK+F + E EVL ++ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 485 GTCPESRS-----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
E + L+ E+ GSL L + L + + DV + +L N
Sbjct: 74 A-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 540 PCIIHGNLKPSKVLI----DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-- 593
I+H N+KP ++ D KL+DFG E +D V
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA---------------ARELEDDEQFVSL 175
Query: 594 -----YIDPEYLETGKL--------TPESDVYSFGIILLRLLTGRP 626
Y+ P+ E L D++S G+ TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 32/210 (15%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+G G +G VY G + + VA+K Q L F E ++S+ H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL----ACKNKKSPLRWQTRMQIASDVCSALIYL 535
IG +S + E + G L+ L ++ S L + +A D+ YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 536 HSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFHLIPQGE---STGNSALCNESNND 589
N IH ++ L+ +K+ DFG I + G + L
Sbjct: 198 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML------- 248
Query: 590 SASV-YIDPEYLETGKLTPESDVYSFGIIL 618
V ++ PE G T ++D +SFG++L
Sbjct: 249 --PVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 48/221 (21%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
++GE R+G VY+G L VAIK +F++E + +R++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQIAS 526
L+G + + L +F Y +G L + L + KS L + + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 527 DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALC 583
+ + + YL S+ ++H +L VL+ K+SD G F + + GNS L
Sbjct: 136 QIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL- 192
Query: 584 NESNNDSASVYIDP------EYLETGKLTPESDVYSFGIIL 618
P E + GK + +SD++S+G++L
Sbjct: 193 -------------PIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 28/225 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL----HVAIKMFP-SYGPQSHLKFQNEVEVLSRVRH 477
+FEP +G G +G V+ ++ + AIK + K EV+ L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVF--EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 478 PNLVTLIGTCPESRS--------------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQ 523
P +V E + + + R +L+D + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583
I + A+ +LHS ++H +LKPS + + K+ DFG + Q E
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 584 NESNNDSASV-----YIDPEYLETGKLTPESDVYSFGIILLRLLT 623
+ Y+ PE + + + D++S G+IL LL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL----HVAIK---MFPSYGPQSHLKFQNEVEVLSRV 475
NF KIG G++ VYR L VA+K +F ++ E+++L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRA--ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 476 RHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSAL 532
HPN++ + E L V E G L + K +K + +T + +CSAL
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
++HS ++H ++KP+ V I A KL D G + + S
Sbjct: 150 EHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL------------GRFFSSKTTAAHS 195
Query: 593 V-----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y+ PE + +SD++S G +L + +
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 26/215 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKM--FPSYGPQSHLKFQNEVEVLSRVRHP 478
+ KIGEG +G IK + + + EV VL+ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
N+V + E+ SL V +Y G L + K + + +C AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV--- 593
+ I+H ++K + + + +L DFG + + N + + +
Sbjct: 143 DRK--ILHRDIKSQNIFLTKDGTVQLGDFGI------------ARVLNSTVELARACIGT 188
Query: 594 --YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE E +SD+++ G +L L T +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 34/230 (14%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSHLKFQNEVEVLSRVRH 477
++FE +G+G +G V + R+ + AIK + + +EV +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61
Query: 478 PNLVTLIGTCPESRS---------------LVFEYLRNGSLEDCLACKNKKSPLRWQTRM 522
+V E R+ + EY NG+L D + ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119
Query: 523 QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF---FHLIPQGESTGN 579
++ + AL Y+HS IIH +LKP + ID + K+ DFG H +
Sbjct: 120 RLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 580 SALCNESNNDSASV----YIDPEYLE-TGKLTPESDVYSFGIILLRLLTG 624
L S+N ++++ Y+ E L+ TG + D+YS GII ++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 40/208 (19%)
Query: 430 KIGEGRYGNVYRGLLR----HLHVAIKMF--PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
++G G +G V +G + VA+K+ + P + E V+ ++ +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 484 IGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG C LV E G L L + ++ + +++ V + YL +
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--NF 138
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID------ 596
+H +L VL+ +K+SDFG + E+ Y
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----------------YKAQTHGKW 182
Query: 597 ------PEYLETGKLTPESDVYSFGIIL 618
PE + K + +SDV+SFG+++
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLM 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
+G+G YG VY G L +AIK P + E+ + ++H N+V +G+
Sbjct: 30 LGKGTYGIVYAGR--DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
E+ + E + GSL L K QT + L YLH N I+H
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--QIVH 145
Query: 545 GNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----YIDPE 598
++K VLI+ G K+SDFG S N + + Y+ PE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGT------------SKRLAGINPCTETFTGTLQYMAPE 193
Query: 599 YLETGKL--TPESDVYSFGIILLRLLTGRP 626
++ G +D++S G ++ + TG+P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-22
Identities = 18/75 (24%), Positives = 26/75 (34%), Gaps = 1/75 (1%)
Query: 702 SGSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHC 761
S ++ P F P++ +M DP G + I L + T P L
Sbjct: 3 SAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLN-SPTDPFNRQMLTES 61
Query: 762 NLLPNYALHQAIIEW 776
L P L + I W
Sbjct: 62 MLEPVPELKEQIQAW 76
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH-VAIKM--FPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLI 484
+IG G V++ L AIK Q+ ++NE+ L++++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ +V E N L L KK + R ++ A+ +H + I
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG--I 148
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE-STGNSALCNESNNDSASVYIDPEYLE 601
+H +LKP+ LI + KL DFG + + S + N Y+ PE ++
Sbjct: 149 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN------YMPPEAIK 201
Query: 602 -----------TGKLTPESDVYSFGIILLRLLTGRP 626
K++P+SDV+S G IL + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 29/243 (11%), Positives = 64/243 (26%), Gaps = 60/243 (24%)
Query: 431 IGEGRYGNVYRGLLRHLH--VAIKMFPSYGP----------------------------Q 460
+G+ + + + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 461 SHLKFQNEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLR-NGSLED----CLACKNKK 513
HL+F +++ + ++ + S F Y R +L+ L+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
L R+Q+ V L LH ++H L+P +++D G L+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 574 GESTGNSALCNESNNDSASVYIDPEYL----------ETGKLTPESDVYSFGIILLRLLT 623
+ + PE +T D ++ G+ + +
Sbjct: 264 SAVS-----------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 624 GRP 626
Sbjct: 313 ADL 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 33/223 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKM--FPSYGPQSHLKFQNEVEVLSRVR 476
++E + IG G YG +R + K + S +EV +L ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQ--KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 477 HPNLVTLIGTCPESRS----LVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSA 531
HPN+V + + +V EY G L + ++ L + +++ + + A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 532 LIYLHS---NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
L H ++H +LKP+ V +D KL DFG + + N +
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL------------ARILNHDTS 171
Query: 589 DSASV-----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + Y+ PE + +SD++S G +L L P
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 46/224 (20%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
IGEG +G V++ L VA+KM FQ E +++ +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL---------------------ACKNKKSPLRW 518
L+G C + + +FEY+ G L + L PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--- 575
++ IA V + + YL + +H +L L+ N K++DFG I +
Sbjct: 174 AEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 576 STGNSALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
+ GN A+ + ++ PE + + T ESDV+++G++L
Sbjct: 232 ADGNDAI---------PIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 430 KIGEGRYGNVYRGLLR----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRV-RHPNLVTL 483
IGEG +G V + ++ + AIK H F E+EVL ++ HPN++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 484 IGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQIASDV 528
+G C L EY +G+L D L + S L Q + A+DV
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
+ YL + IH +L +L+ N+ +K++DFG L
Sbjct: 152 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL------ 203
Query: 589 DSASVYIDP------EYLETGKLTPESDVYSFGIIL 618
P E L T SDV+S+G++L
Sbjct: 204 --------PVRWMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 29/204 (14%), Positives = 56/204 (27%), Gaps = 48/204 (23%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTL- 483
G ++ L L VA+ G + + LSR+ P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 484 -IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ +V E++R GSL++ + ++ + +A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHRAG--V 150
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
PS+V + + L+ +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA---------------------------TMPDA---- 179
Query: 603 GKLTPESDVYSFGIILLRLLTGRP 626
P+ D+ G L LL R
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRW 200
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 41/219 (18%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSRV-RHPNL 480
+G G +G V L VA+KM PS +E++VLS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCL---------------ACKNKKSPLRWQTRMQ 523
V L+G C + EY G L + L ++ + L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG---ESTGNS 580
+ V + +L S IH +L +L+ +K+ DFG I GN+
Sbjct: 150 FSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 581 ALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
L V ++ PE + T ESDV+S+GI L
Sbjct: 208 RL---------PVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-22
Identities = 17/67 (25%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 710 IPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYAL 769
P F P++ +M DP G + I L + T P L L P L
Sbjct: 26 APDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLN-SPTDPFNRQTLTESMLEPVPEL 84
Query: 770 HQAIIEW 776
+ I W
Sbjct: 85 KEQIQAW 91
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 31/219 (14%)
Query: 424 NFEPSWKIGEGRYGN-VYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLV 481
+F P +G G G VYRG+ + VA+K P+ EV++L HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81
Query: 482 TLIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
T + R + E +L++ + + K + + S L +LHS
Sbjct: 82 RYFCTE-KDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 539 EPCIIHGNLKPSKVLI-----DANFGSKLSDFGFFHLIPQGESTGN--SALCNESNNDSA 591
I+H +LKP +LI + +SDFG + G + + S +
Sbjct: 138 N--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG---- 191
Query: 592 SVYIDPEYLE---TGKLTPESDVYSFGIILLRLLT-GRP 626
+I PE L T D++S G + +++ G
Sbjct: 192 --WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-22
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 39/207 (18%)
Query: 430 KIGEGRYGNVYRGLLR-----HLHVAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLVTL 483
IGEG++G+V++G+ + VAIK KF E + + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 484 IGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG E+ ++ E G L L + +K L + + A + +AL YL S
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--RF 512
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID------ 596
+H ++ VL+ +N KL DFG + + ++ Y
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-----------------EDSTYYKASKGKLP 555
Query: 597 -----PEYLETGKLTPESDVYSFGIIL 618
PE + + T SDV+ FG+ +
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCM 582
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH-VAIKM--FPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLI 484
+IG G V++ L AIK Q+ ++NE+ L++++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ + V E N L L KK + R ++ A+ +H + I
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG--I 129
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
+H +LKP+ LI + KL DFG + P S + N Y+ PE ++
Sbjct: 130 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN------YMPPEAIK 182
Query: 602 -----------TGKLTPESDVYSFGIILLRLLTGRP 626
K++P+SDV+S G IL + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 47/230 (20%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLSRVRHP 478
+F+ IG G +G V++ +H IK ++ K + EV+ L+++ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHV 64
Query: 479 NLVTLIGTCPESRS------------------LVFEYLRNGSLEDCLACKNKKSPLRWQT 520
N+V G + E+ G+LE + K + L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVL 123
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
+++ + + Y+HS + +I+ +LKPS + + K+ DFG
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGL------------V 169
Query: 581 ALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ S Y+ PE + + E D+Y+ G+IL LL
Sbjct: 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH-VAIKM--FPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLI 484
+IG G V++ L AIK Q+ ++NE+ L++++ + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ + V E N L L KK + R ++ A+ +H + I
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG--I 176
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
+H +LKP+ LI + KL DFG + P S + N Y+ PE ++
Sbjct: 177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN------YMPPEAIK 229
Query: 602 -----------TGKLTPESDVYSFGIILLRLLTGRP 626
K++P+SDV+S G IL + G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-21
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 2/73 (2%)
Query: 705 KEHRRIPSHFVCPILQEVMKDPQIAADG-FTYEGEAIRGWLKSGHNTSPMTNLKLEHCNL 763
+ + F+ PI+ +M DP + T + I L S T P L +
Sbjct: 14 ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQ-TDPFNRSPLTMDQI 72
Query: 764 LPNYALHQAIIEW 776
PN L + I W
Sbjct: 73 RPNTELKEKIQRW 85
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 47/218 (21%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPNL 480
+G G +G V + VA+KM S + +E+++L + H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 481 VTLIGTCPESRS---LVFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQI 524
V L+G C + ++ E+ + G+L L K L + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG---ESTGNSA 581
+ V + +L S + IH +L +L+ K+ DFG I + G++
Sbjct: 154 SFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 582 LCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
L + ++ PE + T +SDV+SFG++L
Sbjct: 212 L---------PLKWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 4e-21
Identities = 47/212 (22%), Positives = 74/212 (34%), Gaps = 23/212 (10%)
Query: 430 KIGEGR--YGNVYRGLLRHL----HVAIKMFP-SYGPQSHLKF-QNEVEVLSRVRHPNLV 481
IG+G V R+ +V ++ + F Q E+ V HPN+V
Sbjct: 32 VIGKGFEDLMTVNLA--RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLH 536
T L V ++ GS +D L C + + + IA V AL Y+H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGM---NELAIAYILQGVLKALDYIH 145
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
+H ++K S +LI + LS + + ++
Sbjct: 146 HMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 597 PEYLETGKL--TPESDVYSFGIILLRLLTGRP 626
PE L+ +SD+YS GI L G
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 430 KIGEGRYGNVYRGLLRHLH---------VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHP 478
+GEG +G V + VA+KM + L +E+E++ + +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQ 523
N++ L+G C + L + EY G+L + L + + + ++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNS 580
+ + YL S + IH +L VL+ N K++DFG I + T N
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 581 ALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
L V ++ PE L T +SDV+SFG+++
Sbjct: 220 RL---------PVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 430 KIGEGRYGNVYRGLLRHLH---------VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHP 478
+GEG +G V L VA+KM S + L +E+E++ + +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQ 523
N++ L+G C + L + EY G+L + L N + L + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNS 580
A V + YL S + IH +L VL+ + K++DFG I + T N
Sbjct: 196 CAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 581 ALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
L V ++ PE L T +SDV+SFG++L
Sbjct: 254 RL---------PVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 52/217 (23%), Positives = 82/217 (37%), Gaps = 35/217 (16%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH----VAIK--MFPSYGPQSHLKFQNEVEVLSRV-R 476
+F+ ++G G YG V++ R A+K M P GP+ + EV +V +
Sbjct: 58 SFQRLSRLGHGSYGEVFKV--RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 477 HPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
HP V L E L E SL+ C+ + L D AL +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQ--HCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
LHS ++H ++KP+ + + KL DFG + + V
Sbjct: 173 LHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--------------GTAGAGEVQ 216
Query: 595 I-DPEYL--E--TGKLTPESDVYSFGIILLRLLTGRP 626
DP Y+ E G +DV+S G+ +L +
Sbjct: 217 EGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 47/254 (18%), Positives = 87/254 (34%), Gaps = 34/254 (13%)
Query: 386 NAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR 445
+ +++ + + L E E + ++G G +G V+R
Sbjct: 22 SGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMK-- 78
Query: 446 HLH----VAIKMFPSYGPQSHLK--FQNEVEVLSRVRHPNLVTLIGTCPESRSL--VFEY 497
A+K + L+ E+ + + P +V L G E + E
Sbjct: 79 DKQTGFQCAVK-------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131
Query: 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN 557
L GSL + + L + L YLH+ I+HG++K VL+ ++
Sbjct: 132 LEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSD 186
Query: 558 FGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSA--SVY-IDPEYLETGKLTPESDVY 612
GS L DFG + + D + + PE + + D++
Sbjct: 187 -GSRAALCDFGH-----ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 613 SFGIILLRLLTGRP 626
S ++L +L G
Sbjct: 241 SSCCMMLHMLNGCH 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 51/224 (22%), Positives = 84/224 (37%), Gaps = 46/224 (20%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+GEG +G V + HL VA+KM + P +E VL +V HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCL---------------------ACKNKKSPLRW 518
L G C + L + EY + GSL L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG---E 575
+ A + + YL + ++H +L +L+ K+SDFG + +
Sbjct: 150 GDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 576 STGNSALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
+ V ++ E L T +SDV+SFG++L
Sbjct: 208 KRSQGRI---------PVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 9e-21
Identities = 35/273 (12%), Positives = 72/273 (26%), Gaps = 65/273 (23%)
Query: 404 SFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGP 459
S + G SEL E +G+ + +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA--TDQETGESFEVHVPYFTER 111
Query: 460 ----------------------------QSHLKFQNEVEVLSRVRHPNLVTLIGTC--PE 489
+ HL+F +++ + ++ +
Sbjct: 112 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW 171
Query: 490 SRSLVFEY-LRNGSLEDCL----ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIH 544
S F Y +L+ + + L R+Q+ V L LH ++H
Sbjct: 172 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVH 229
Query: 545 GNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL---- 600
L+P +++D G L+ F G + + S + PE
Sbjct: 230 TYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVS-----RGFEPPELEARRA 278
Query: 601 -------ETGKLTPESDVYSFGIILLRLLTGRP 626
+T D ++ G+++ +
Sbjct: 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 39/220 (17%), Positives = 67/220 (30%), Gaps = 31/220 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG + VY L+ +K+ P +E L +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 483 LIGTC--PESRSLVFEYLRNGSLED--CLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
LV E G+L + L + + + A + + +H
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 539 EPCIIHGNLKPSKVLI-----------DANFGSKLSDFGF-FHLIPQGESTGNSALCNES 586
E IIHG++KP ++ D + G L D G + + T +A C
Sbjct: 192 E--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE-- 247
Query: 587 NNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
S + E L + D + + +L G
Sbjct: 248 ----TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
++G+G +G VY+ ++ A K+ + + + E+E+L+ HP +V L+G
Sbjct: 26 ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 486 TCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSNEP 540
L + E+ G+++ + L T QI + AL +LHS
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIM--LELDRGL---TEPQIQVVCRQMLEALNFLHSKR- 137
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----Y-- 594
IIH +LK VL+ +L+DFG SA ++ S Y
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGV------------SAKNLKTLQKRDSFIGTPYWM 184
Query: 595 ----IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ E ++ ++D++S GI L+ + P
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 49/221 (22%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSRV-RHPNL 480
+G G +G V L VA+KM + +E++++S + +H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCL-----------ACKNKKSPLRWQTRMQIASD 527
V L+G C + + EY G L + L A S + + +S
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNS---- 580
V + +L S IH ++ VL+ +K+ DFG I GN+
Sbjct: 173 VAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 581 ---ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIIL 618
A PE + T +SDV+S+GI+L
Sbjct: 231 KWMA---------------PESIFDCVYTVQSDVWSYGILL 256
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
+ KIG+G G VY + VAI+ NE+ V+ ++PN+
Sbjct: 22 YTRFEKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYL 535
V + + L V EYL GSL D + ++ + QIA+ + AL +L
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCM---DEGQIAAVCRECLQALEFL 132
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-- 593
HSN+ +IH ++K +L+ + KL+DFGF A + +++
Sbjct: 133 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF------------CAQITPEQSKRSTMVG 178
Query: 594 ---YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + P+ D++S GI+ + ++ G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTL- 483
IG+G + V RH+ VAIK+ P S K EV ++ + HPN+V L
Sbjct: 23 IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 484 --IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
I T ++ L+ EY G + D L ++ + + SA+ Y H
Sbjct: 81 EVIET-EKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQK--R 134
Query: 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
I+H +LK +L+DA+ K++DFGF + G A C Y PE +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPP------YAAPELFQ 186
Query: 602 TGKL--TPESDVYSFGIILLRLLTGR 625
GK PE DV+S G+IL L++G
Sbjct: 187 -GKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 430 KIGEGRYGNVYRGLLRHLH---------VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHP 478
+GEG +G V + VA+KM + L +E+E++ + +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCL-------------ACKNKKSPLRWQTRMQ 523
N++ L+G C + L + EY G+L + L + + + ++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNS 580
+ + YL S + IH +L VL+ N K++DFG I + T N
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 581 ALCNESNNDSASV-YIDPEYLETGKLTPESDVYSFGIIL 618
L V ++ PE L T +SDV+SFG+++
Sbjct: 266 RL---------PVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
KIGEG G V R H VA+KM Q NEV ++ +H N+V +
Sbjct: 52 KIGEGSTGIVCLA--REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 486 TCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSNEP 540
+ L + E+L+ G+L D + + L QIA+ V AL YLH+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----SQVRL---NEEQIATVCEAVLQALAYLHAQG- 161
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----YI 595
+IH ++K +L+ + KLSDFGF A ++ S+ ++
Sbjct: 162 -VIHRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLVGTPYWM 208
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + E D++S GI+++ ++ G P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 35/218 (16%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLIGT 486
IG G V VAIK Q+ + E++ +S+ HPN+V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 487 CPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQ--TRMQIAS---DVCSALIYLHSNE 539
L V + L GS+ D + K + IA+ +V L YLH N
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV------ 593
IH ++K +L+ + +++DFG SA + + +
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGV------------SAFLATGGDITRNKVRKTFV 187
Query: 594 ----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRP 626
++ PE +E + ++D++SFGI + L TG
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 38/212 (17%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLI 484
KIG+G +G V++G VAIK+ + ++ Q E+ VLS+ P +
Sbjct: 29 KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 485 GTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHSNE 539
G+ + L + EYL GS D L + PL QIA+ ++ L YLHS +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPL---DETQIATILREILKGLDYLHSEK 139
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV-----Y 594
IH ++K + VL+ + KL+DFG + ++ + +
Sbjct: 140 --KIHRDIKAANVLLSEHGEVKLADFGV------------AGQLTDTQIKRNTFVGTPFW 185
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ PE ++ ++D++S GI + L G P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 62/210 (29%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
K+G G YG V + H+ AIK+ S S+ K EV VL + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+ R+ LV E + G L D + + I V S + YLH + I+
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKH--NIV 158
Query: 544 HGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YID 596
H +LKP +L+ + + K+ DFG SA+ + YI
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGL------------SAVFENQKKMKERLGTAYYIA 206
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L K + DV+S G+IL LL G P
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 38/233 (16%)
Query: 423 NNFEPSWKIGEGRYGNV-YRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNL 480
N +G G G V ++G + VA+K E+++L+ HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 481 VTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS----DVCSALIY 534
+ + + E N +L+D + KN + + S + +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGS-------------KLSDFGFFHLIPQGESTGNSA 581
LHS IIH +LKP +L+ + +SDFG + G+S+ +
Sbjct: 131 LHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 582 LCNESNNDSASVYIDPEYLE-------TGKLTPESDVYSFGIILLRLLT-GRP 626
L N S + PE LE +LT D++S G + +L+ G+
Sbjct: 189 LNNPSGTSG---WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 56/229 (24%)
Query: 430 KIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPNL 480
+G G +G V + VA+KM S + +E+++++++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 481 VTLIGTCPESRSL--VFEYLRNGSLEDCL--------------------ACKNKKSPLRW 518
V L+G C S + +FEY G L + L + + L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG---E 575
+ + A V + +L +H +L VL+ K+ DFG I
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 576 STGNSALCNESNNDSASVYIDP------EYLETGKLTPESDVYSFGIIL 618
GN+ L P E L G T +SDV+S+GI+L
Sbjct: 230 VRGNARL--------------PVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 49/223 (21%), Positives = 79/223 (35%), Gaps = 53/223 (23%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFP----SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG YG V A+K+ P + E+++L R+RH N++
Sbjct: 13 LGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 483 L---IGTCPESRS---LVFEYLRNGSLE--DCLACKNKKSPLRWQTR---MQIASDVCSA 531
L + E + +V EY G E D + K+ P Q Q+
Sbjct: 71 LVDVLYN--EEKQKMYMVMEYCVCGMQEMLDSVP--EKRFP-VCQAHGYFCQL----IDG 121
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
L YLHS I+H ++KP +L+ K+S G + + D
Sbjct: 122 LEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGV------------AEALHPFAADDT 167
Query: 592 -------SVYIDPEYLETGKL--TPESDVYSFGIILLRLLTGR 625
+ PE + D++S G+ L + TG
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 32/211 (15%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP---SYGPQSHLKFQNEVEVLSRVRHPNLVTLI 484
+G+G +G V + A+K+ EV++L ++ HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ LV E G L D + + +I V S + Y+H N I
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN--KI 147
Query: 543 IHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YI 595
+H +LKP +L+ + ++ DFG S S + YI
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGL------------STHFEASKKMKDKIGTAYYI 195
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L G + DV+S G+IL LL+G P
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCP 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 62/237 (26%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFP-------------------SYGPQSHLKFQN 467
IG+G YG V L + + A+K+ P ++ +
Sbjct: 21 IGKGSYGVVK--LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 468 -------EVEVLSRVRHPNLVTL--IGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPL 516
E+ +L ++ HPN+V L + P L VFE + G + + PL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPL 134
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
D+ + YLH + IIH ++KPS +L+ + K++DFG
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV--------- 183
Query: 577 TGNSALCNESNNDSASV-----YIDPEYLETGKLT---PESDVYSFGIILLRLLTGR 625
S S+ ++ ++ PE L + DV++ G+ L + G+
Sbjct: 184 ---SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 43/222 (19%), Positives = 77/222 (34%), Gaps = 19/222 (8%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIK--MFPSYGPQSHLKFQNEVEVLSRV-R 476
T F KIG G +G+V++ + R AIK P G EV + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 477 HPNLVTLIGTCPESRSL--VFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSALI 533
H ++V E + EY GSL D + S + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST----GNSALCNESNND 589
Y+HS ++H ++KPS + I + G+ ++
Sbjct: 130 YIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 590 SASV----YIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRP 626
++ E L E P++D+++ + ++ P
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLK-FQNEVEVLSRVRHP 478
F+ K+GEG YG+VY+ + + VAIK P +S L+ E+ ++ + P
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSP 84
Query: 479 NLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALI 533
++V G+ ++ L V EY GS+ D + + + L T +IA+ L
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTL---TEDEIATILQSTLKGLE 139
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
YLH IH ++K +L++ +KL+DFG + ++ +V
Sbjct: 140 YLHFMR--KIHRDIKAGNILLNTEGHAKLADFGV------------AGQLTDTMAKRNTV 185
Query: 594 -----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE ++ +D++S GI + + G+P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 31/243 (12%)
Query: 392 RDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH--V 449
D ++ + EA + + E + FE ++G G G V++ + +
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDD-------FEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 450 AIKMFPSYGPQSHLKF-QNEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDC 506
A K+ + E++VL P +V G S+ E++ GSL+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 507 LACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
L K + Q +++ V L YL I+H ++KPS +L+++ KL DFG
Sbjct: 122 L---KKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 567 FFHLIPQGESTGNSALCNESNNDS---ASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623
S +S +S Y+ PE L+ + +SD++S G+ L+ +
Sbjct: 178 V------------SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 624 GRP 626
GR
Sbjct: 226 GRY 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
+G+G +G V + R A+K+ S + EVE+L ++ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+S S +V E G L D + K+ +I V S + Y+H + I+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH--NIV 143
Query: 544 HGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YID 596
H +LKP +L+ + + K+ DFG S ++ + YI
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGL------------STCFQQNTKMKDRIGTAYYIA 191
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L G + DV+S G+IL LL+G P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
++G+G + V R + + L A K+ + K + E + +++HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC----SALIYLHSNE 539
+ E LVF+ + G L + + + S AS ++ Y HSN
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------ADASHCIQQILESIAYCHSNG 125
Query: 540 PCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
I+H NLKP +L+ + KL+DFG + E+ + Y+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG-----TPG-YLS 175
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L+ + D+++ G+IL LL G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSH---LKFQNEVEVLSRVRHPNLVTL 483
+G G +G V G H VA+K+ +S K + E++ L RHP+++ L
Sbjct: 19 LGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 484 ---IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPL--RWQTRMQIASDVCSALIYLHSN 538
I T P +V EY+ G L D + + + R + QI S A+ Y H +
Sbjct: 77 YQVIST-PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCHRH 130
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSALCNESNNDSASVYID 596
++H +LKP VL+DA+ +K++DFG +++ GE T C N Y
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----SCGSPN------YAA 178
Query: 597 PEYLETGKL--TPESDVYSFGIILLRLLTGR 625
PE + G+L PE D++S G+IL LL G
Sbjct: 179 PEVIS-GRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRH--LHVAIKMFP---------SYGPQSHLKFQNEVE 470
N+EP +G G V R + + A+K+ + EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 471 VLSRV-RHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
+L +V HPN++ L T + LVF+ ++ G L D L K S +TR +I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK--ETR-KIMRA 132
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN 587
+ + LH I+H +LKP +L+D + KL+DFGF + GE +C
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCG--- 185
Query: 588 NDSASVYIDPEYLETGKL------TPESDVYSFGIILLRLLTGRP 626
+ S Y+ PE +E E D++S G+I+ LL G P
Sbjct: 186 --TPS-YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 42/221 (19%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIK-------------MFPSYGPQSHLKFQNEVEVLSR 474
K+G G YG V + H AIK + H + NE+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 475 VRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
+ HPN++ L + + LV E+ G L + + + I + S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGI 159
Query: 533 IYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
YLH + I+H ++KP +L+ ++ K+ DFG S+ ++
Sbjct: 160 CYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGL------------SSFFSKDYKL 205
Query: 590 SASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ YI PE L+ K + DV+S G+I+ LL G P
Sbjct: 206 RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 22/155 (14%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKF---QNEVEVLSRVRH 477
F +IG G +G VY R + VAIK G QS+ K+ EV L ++RH
Sbjct: 56 FSDLREIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 478 PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSAL 532
PN + G + V EY GS D L + K PL ++IA+ L
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPL---QEVEIAAVTHGALQGL 167
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567
YLHS+ +IH ++K +L+ KL DFG
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-18
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFP--------SYGPQSHLKFQNEVEVLSRVRHPN 479
+G G G V R VAI++ + L + E+E+L ++ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 480 LVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
++ + ++ +V E + G L D + + L+ T + A+ YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 257
Query: 538 NEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
N IIH +LKP VL+ + + K++DFG ++ + LC + + Y
Sbjct: 258 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCG-----TPT-Y 307
Query: 595 IDPEYLETGKL---TPESDVYSFGIILLRLLTGRP 626
+ PE L + D +S G+IL L+G P
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 58/250 (23%), Positives = 87/250 (34%), Gaps = 61/250 (24%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
IG+G YG V + AIK+ P+ + + EV ++ ++ HPN+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 483 LIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRM------------------ 522
L + + LV E G L D L S + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 523 -------------------QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS--K 561
I + SAL YLH+ I H ++KP L N K
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIK 210
Query: 562 LSDFG---FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGI 616
L DFG F+ + GE G + + ++ PE L T P+ D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAG-----TPY-FVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 617 ILLRLLTGRP 626
+L LL G
Sbjct: 265 LLHLLLMGAV 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
+G+G +G V + R A+K+ S + EVE+L ++ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+S S +V E G L D + + + S ++ V S + Y+H + I+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN--IV 143
Query: 544 HGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
H +LKP +L+ + + K+ DFG Q +A YI PE L
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG-----TAY-YIAPEVL 195
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRP 626
G + DV+S G+IL LL+G P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G G +G V+R R + A K + + E++ +S +RHP LV L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ +++E++ G L + +A ++ + + ++ VC L ++H N +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHL 279
Query: 546 NLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
+LKP ++ + KL DFG + +S + +A + PE E
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAE-FAAPEVAEGK 331
Query: 604 KLTPESDVYSFGIILLRLLTGRP 626
+ +D++S G++ LL+G
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLS 354
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+G G + V+ R A+K +NE+ VL +++H N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 488 PESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRM--QIASDVCSALIYLHSNEPCI 542
ES + LV + + G L D + + + + + V SA+ YLH N I
Sbjct: 76 -ESTTHYYLVMQLVSGGELFDRILERGVYT-----EKDASLVIQQVLSAVKYLHENG--I 127
Query: 543 IHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+H +LKP +L + N ++DFG + G + C + Y+ PE
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---ACG-----TPG-YVAPEV 178
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
L + D +S G+I LL G P
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 48/229 (20%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLI 484
K+G G YG+VY+ + A+K G S + E+ +L ++HPN+++L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---EIALLRELKHPNVISLQ 84
Query: 485 GTCPESRS----LVFEYLRN---GSLEDCLACKNKKSPLRWQTRM------QIASDVCSA 531
L+F+Y + ++ A K K P++ M QI
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI----LDG 140
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGS----KLSDFGF---FHLIPQGESTGNSALCN 584
+ YLH+N ++H +LKP+ +L+ K++D GF F+ P L
Sbjct: 141 IHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SP---------LKP 188
Query: 585 ESNNDSASV---YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLR 629
++ D V Y PE L + T D+++ G I LLT P+
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
IG G +G V + + + A K P Y + +F+ E+E++ + HPN++ L T
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
++ LV E G L + + K M+ DV SA+ Y H + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK---DVLSAVAYCHKLN--VAHR 130
Query: 546 NLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YIDPE 598
+LKP L + KL DFG +A V Y+ P+
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGL------------AARFKPGKMMRTKVGTPYYVSPQ 178
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
LE G PE D +S G+++ LL G P
Sbjct: 179 VLE-GLYGPECDEWSAGVMMYVLLCGYP 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGT 486
K+G G +G+V+ R L IK + + E+EVL + HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 487 CPESRS--LVFEYLRNGSL-EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
+ + +V E G L E ++ + + L ++ + +AL Y HS ++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VV 146
Query: 544 HGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
H +LKP +L + K+ DFG L E + N+A +A Y+ PE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-------GTAL-YMAPEVF 198
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRP 626
+ +T + D++S G+++ LLTG
Sbjct: 199 K-RDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 35/220 (15%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE-------V 471
+F+ +GEG + V L R L AIK+ + H+ +N+V V
Sbjct: 30 EDFKFGKILGEGSFSTVV--LARELATSREYAIKILE----KRHIIKENKVPYVTRERDV 83
Query: 472 LSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
+SR+ HP V L T + L Y +NG L + TR A ++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--TRFYTA-EIV 140
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA-LC--NES 586
SAL YLH IIH +LKP +L++ + +++DFG ++ + +
Sbjct: 141 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ- 197
Query: 587 NNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE L SD+++ G I+ +L+ G P
Sbjct: 198 -------YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
++G+G + V R + + L A K+ + K + E + +++HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC----SALIYLHSNE 539
+ E LVF+ + G L + + + S AS ++ Y HSN
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------ADASHCIQQILESIAYCHSNG 148
Query: 540 PCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
I+H NLKP +L+ KL+DFG + E+ A + Y+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-------GTPG-YLS 198
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L+ + D+++ G+IL LL G P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 33/162 (20%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQN---------EV 469
+E KIGEG YG V++ R+ VAIK F + E+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKC--RNRDTGQIVAIKKF-------LESEDDPVIKKIALREI 53
Query: 470 EVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCL-ACKNKKSPLRWQTRM-QIA 525
+L +++HPNLV L+ R LVFEY + ++ L + ++ Q
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQT- 111
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567
A+ + H + IH ++KP +LI + KL DFGF
Sbjct: 112 ---LQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGF 148
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 39/207 (18%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G G +G V+R + + K + P +NE+ +++++ HP L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ L+ E+L G L D + + + C L ++H + I+H
Sbjct: 118 EDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHL 173
Query: 546 NLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASV----YIDPEY 599
++KP ++ + S K+ DFG + N + + PE
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGL------------ATKLNPDEIVKVTTATAEFAAPEI 221
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
++ + +D+++ G++ LL+G
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLS 248
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 32/209 (15%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
+GEG YG V L + VA+K+ + E+ + + H N+V G
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 486 TCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVCSALIYLHSNE 539
+ L EY G L D + + Q+ + ++YLH
Sbjct: 73 HR-REGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA----GVVYLHGIG 125
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-SALCNESNNDSASVYIDPE 598
I H ++KP +L+D K+SDFG + + +C Y+ PE
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP------YVAPE 177
Query: 599 YLETGKL--TPESDVYSFGIILLRLLTGR 625
L+ + DV+S GI+L +L G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP------SYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G G++ V + + A K S S + + EV +L +RHPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
TL L+ E + G L D LA K + ++ + + YLHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK---QILDGVHYLHSKR 128
Query: 540 PCIIHGNLKP------SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
I H +LKP K + + KL DFG H I G + +
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEF--KNIFG-----TPE- 176
Query: 594 YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + L E+D++S G+I LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 32/274 (11%)
Query: 372 SFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEATNNFEPSWKI 431
S + Q A++ K + P ++ E ++P I
Sbjct: 43 SLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVI 102
Query: 432 GEGRYGNVYRGLLRH--LHVAIKMFP--------SYGPQSHLKFQNEVEVLSRVR-HPNL 480
G G V R + R A+K+ + + E +L +V HP++
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 481 VTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
+TLI + S LVF+ +R G L D L K S +TR I + A+ +LH+N
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK--ETR-SIMRSLLEAVSFLHAN 219
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
I+H +LKP +L+D N +LSDFGF + GE LC + Y+ PE
Sbjct: 220 N--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCG-----TPG-YLAPE 269
Query: 599 YLETGKL------TPESDVYSFGIILLRLLTGRP 626
L+ E D+++ G+IL LL G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 36/217 (16%)
Query: 430 KIGEGRYGNVYRGLLRH--LHVAIKM-----FPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
IG+G + V R + R A+K+ F S S + E + ++HP++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 483 LIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS---DVCSALIYLHS 537
L+ T +VFE++ L + + + + + AL Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIV--KRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 538 NEPCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASV- 593
N IIH ++KP VL+ + S KL FG + ES +
Sbjct: 149 NN--IIHRDVKPHCVLLASKENSAPVKLGGFGV------------AIQLGESGLVAGGRV 194
Query: 594 ----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE ++ DV+ G+IL LL+G
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 49/174 (28%), Positives = 72/174 (41%), Gaps = 25/174 (14%)
Query: 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKF 465
L E S L + FE +G G YG VY+G RH+ AIK+ +
Sbjct: 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMD-VTGDEEEEI 67
Query: 466 QNEVEVLSRV-RHPNLVTLIG------TCPESRSL--VFEYLRNGSLEDCLACKNKKSPL 516
+ E+ +L + H N+ T G L V E+ GS+ D L K + L
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTL 126
Query: 517 RWQTRMQIAS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567
IA ++ L +LH ++ +IH ++K VL+ N KL DFG
Sbjct: 127 ---KEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGV 175
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 25/118 (21%), Positives = 42/118 (35%), Gaps = 3/118 (2%)
Query: 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRRIPSHFVCPIL 719
L A+ E A + E+ +P F+ P++
Sbjct: 839 RNLFVRAVDILGRKTGLASPEFIEKLLNF-ANKAEEQRKADEEEDLEYGDVPDEFLDPLM 897
Query: 720 QEVMKDPQI-AADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEW 776
+MKDP I A + I+ L S +T P + L+ ++ PN L Q I+ +
Sbjct: 898 YTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCF 954
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--------SYGPQSHLKFQNEVEVLSRVRHPN 479
+G G G V R VAIK+ + L + E+E+L ++ HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 480 LVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
++ + ++ +V E + G L D + + L+ T + A+ YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 132
Query: 538 NEPCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
N IIH +LKP VL+ + K++DFG ++ + LC Y
Sbjct: 133 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPT------Y 182
Query: 595 IDPEYLETGKL---TPESDVYSFGIILLRLLTGRP 626
+ PE L + D +S G+IL L+G P
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP------SYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G G++ V + + L A K S S + + EV +L +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
TL L+ E + G L D LA K S + ++ + + YLH+ +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNYLHTKK 135
Query: 540 PCIIHGNLKPSKVLI-DANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
I H +LKP +++ D N KL DFG H I G + + ++
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG-----TPE-FV 185
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + L E+D++S G+I LL+G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 47/214 (21%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+ +G GR+G V++ L +A K+ + G + + +NE+ V++++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 482 TLIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
L ES++ LV EY+ G L D ++ L + +C + ++H
Sbjct: 150 QLYDAF-ESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 539 EPCIIHGNLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASV--- 593
I+H +LKP +L K+ DFG + +
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGL------------ARRYKPREKLKVNFGTP 252
Query: 594 -YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE + ++ +D++S G+I LL+G
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 33/162 (20%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQN---------EV 469
+E +GEG YG V + R+ VAIK F + E+
Sbjct: 25 EKYENLGLVGEGSYGMVMKC--RNKDTGRIVAIKKF-------LESDDDKMVKKIAMREI 75
Query: 470 EVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCL-ACKNKKSPLRWQTRM-QIA 525
++L ++RH NLV L+ C + + LVFE++ + ++ D L N Q + QI
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQI- 133
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567
+ + + HS+ IIH ++KP +L+ + KL DFGF
Sbjct: 134 ---INGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/225 (22%), Positives = 81/225 (36%), Gaps = 59/225 (26%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKM--------FPSYGPQSHLKFQNEVEVLSRVRHP 478
+G G +G V+ V +K K E+ +LSRV H
Sbjct: 32 LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 479 NLVTL---IGTCPESRSLV----------FEYL-RNGSLEDCLACKNKKSPLRWQTRMQI 524
N++ + LV F ++ R+ L++ LA + Q
Sbjct: 90 NIIKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-----IFRQ----- 138
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSAL 582
+ SA+ YL IIH ++K ++I +F KL DFG + +G+ T
Sbjct: 139 ---LVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT----F 189
Query: 583 CNESNNDSASVYIDPEYLETGKL--TPESDVYSFGIILLRLLTGR 625
C Y PE L G PE +++S G+ L L+
Sbjct: 190 CGTIE------YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 39/212 (18%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSH---LKFQNEVEVLSRVRHPNLVTL 483
+G G +G V G +H VA+K+ +S K + E++ L RHP+++ L
Sbjct: 24 LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 484 ---IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVCSALIYLHS 537
I T P +V EY+ G L D + + ++R QI S + Y H
Sbjct: 82 YQVIST-PSDIFMVMEYVSGGELFDYICKNGRLDEK--ESRRLFQQILS----GVDYCHR 134
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSALCNESNNDSASVYI 595
+ ++H +LKP VL+DA+ +K++DFG +++ GE T C N Y
Sbjct: 135 H--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----SCGSPN------YA 182
Query: 596 DPEYLETGKL--TPESDVYSFGIILLRLLTGR 625
PE + G+L PE D++S G+IL LL G
Sbjct: 183 APEVIS-GRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 32/209 (15%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
+GEG YG V L + VA+K+ + E+ + + H N+V G
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 486 TCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVCSALIYLHSNE 539
+ L EY G L D + + Q+ + ++YLH
Sbjct: 73 HR-REGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA----GVVYLHGIG 125
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN-SALCNESNNDSASVYIDPE 598
I H ++KP +L+D K+SDFG + + +C Y+ PE
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP------YVAPE 177
Query: 599 YLETGKL--TPESDVYSFGIILLRLLTGR 625
L+ + DV+S GI+L +L G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 33/173 (19%), Positives = 61/173 (35%), Gaps = 9/173 (5%)
Query: 459 PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPL 516
P ++ + N V + L + R +L+D + +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGE 575
+ I + A+ +LHS ++H +LKPS + + K+ DFG + E
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 576 STGNSALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTG 624
+ V Y+ PE + + + D++S G+IL LL
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 21/75 (28%), Positives = 37/75 (49%)
Query: 704 SKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNL 763
++ R IP + I E+M++P I G TY+ + I L+ + +P+T L L
Sbjct: 199 KRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQL 258
Query: 764 LPNYALHQAIIEWQQ 778
+PN A+ + I +
Sbjct: 259 IPNLAMKEVIDAFIS 273
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 51/233 (21%)
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKM--------FPSYGPQSHLKFQNE 468
+++ F+ K+G G Y VY+G + VA+K PS + ++ E
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPS----TAIR---E 53
Query: 469 VEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIAS 526
+ ++ ++H N+V L LVFE++ + L+ + + + R +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 527 ---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLIPQGESTGNS 580
+ L + H N I+H +LKP +LI+ KL DFG F IP +
Sbjct: 113 FQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFS--- 166
Query: 581 ALCNESNNDSASV----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
+E V Y P+ L + + D++S G IL ++TG+P+
Sbjct: 167 ---SE-------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 53/232 (22%), Positives = 88/232 (37%), Gaps = 25/232 (10%)
Query: 407 QPGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK 464
Q G L N+ E ++G G G V++ R +A+K G + K
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 465 -FQNEVEVLSR-VRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQT 520
+++V+ + P +V GT + + E + E K + P+ +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERI 125
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
++ + AL YL +IH ++KPS +L+D KL DFG G +
Sbjct: 126 LGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGI-----SGRLVDDK 179
Query: 581 ALCNESNNDSASVY------IDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
A + + IDP +DV+S GI L+ L TG+
Sbjct: 180 A----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 61/226 (26%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFP-----SYGPQSHL-KFQNEVEVLSRVRH--P 478
+G G +G+VY G + VAIK +G + + EV +L +V
Sbjct: 51 LGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 479 NLVTL---IGTCPESRSLVFEY-----------LRNGSLEDCLACKNKKSPLRWQTRMQI 524
++ L P+S L+ E G+L++ LA WQ
Sbjct: 109 GVIRLLDWFER-PDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ----- 157
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALC 583
V A+ + H+ ++H ++K +LID N G KL DFG AL
Sbjct: 158 ---VLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGS------------GALL 200
Query: 584 NESNNDSAS---VYIDPEYLETGKLT-PESDVYSFGIILLRLLTGR 625
++ VY PE++ + + V+S GI+L ++ G
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 27/211 (12%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP------SYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G G++ V + + L A K S + + EV +L +V HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
TL L+ E + G L D LA K S + ++ + + YLH+ +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNYLHTKK 135
Query: 540 PCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
I H +LKP +++ KL DFG H I G + + ++
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG-----TPE-FV 185
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + L E+D++S G+I LL+G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 29/210 (13%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
++G+G + V R + A + + H K + E + ++HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 486 TCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC----SALIYLHSNE 539
+ E L+F+ + G L + + + S AS A+++ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSE-------ADASHCIQQILEAVLHCHQMG 130
Query: 540 PCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
++H NLKP +L+ KL+DFG + +GE + Y+
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAG-----TPG-YLS 181
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L D+++ G+IL LL G P
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSH---LKFQNEVEVLSRVRHPNLVTL 483
+GEG +G V H VA+K + ++ + E+ L +RHP+++ L
Sbjct: 17 LGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 484 ---IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVCSALIYLHS 537
I T P +V EY G L D + K + + + R QI A+ Y H
Sbjct: 75 YDVITT-PTDIVMVIEYA-GGELFDYIVEKKRMTE--DEGRRFFQQIIC----AIEYCHR 126
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE--STGNSALCNESNNDSASVYI 595
+ I+H +LKP +L+D N K++DFG +++ G T C N Y
Sbjct: 127 H--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT----SCGSPN------YA 174
Query: 596 DPEYLETGKL--TPESDVYSFGIILLRLLTGR 625
PE + GKL PE DV+S GI+L +L GR
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 43/218 (19%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIK------MFPSYGPQSHLKFQNEVEVLSRVR---- 476
+G+G +G V+ G L VAIK + + EV +L +V
Sbjct: 39 LGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 477 HPNLVTL---IGTCPESRSLVFEYLRNGS-LEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
HP ++ L T E LV E L D + +K PL V +A+
Sbjct: 97 HPGVIRLLDWFET-QEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVAAI 152
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
+ HS ++H ++K +LID G KL DFG AL ++
Sbjct: 153 QHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGS------------GALLHDEPYTDF 198
Query: 592 S---VYIDPEYLETGKLT-PESDVYSFGIILLRLLTGR 625
VY PE++ + + V+S GI+L ++ G
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP------SYGPQSHLKFQNEVEVLSRVRHPNLV 481
++G G++ V + + L A K S S + EV +L ++HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
TL L+ E + G L D LA K + ++ + + + YLHS +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK---QILNGVYYLHSLQ 134
Query: 540 PCIIHGNLKPSKVL-IDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
I H +LKP ++ +D N K+ DFG H I G + + ++
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFG-----TPE-FV 184
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + L E+D++S G+I LL+G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 34/235 (14%)
Query: 407 QPGLLEFSFSELNEATNNF----EPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ 460
G+ +L+ + F E IG G Y R + + ++ A+K+ +
Sbjct: 3 TVGVHSI-VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----K 57
Query: 461 SHLKFQNEVEVLSR-VRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLR 517
S E+E+L R +HPN++TL + + +V E ++ G L D + + S
Sbjct: 58 SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS--- 114
Query: 518 WQTRM--QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLI 571
R + + + YLH+ ++H +LKPS +L G+ ++ DFGF +
Sbjct: 115 --EREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ +A+ ++ PE LE D++S G++L +LTG
Sbjct: 171 RAENGLLMTPCY------TAN-FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 31/241 (12%)
Query: 403 LSFFQPGLLEFSFSELNEAT-NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGP 459
+S G L+ S + + T + + +IG G YG+V + + + +A+K S
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60
Query: 460 QSHLK-FQNEVEVLSR-VRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCL--ACKNKK 513
+ K +++V+ R P +V G + E + + S +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD 119
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
+ + +I AL +L N IIH ++KPS +L+D + KL DFG
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGI------ 172
Query: 574 GESTGNSALCNESNNDSASV----YIDPEYLETGKLTPE----SDVYSFGIILLRLLTGR 625
S +S + Y+ PE ++ SDV+S GI L L TGR
Sbjct: 173 ------SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
Query: 626 P 626
Sbjct: 227 F 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 56/223 (25%), Positives = 83/223 (37%), Gaps = 46/223 (20%)
Query: 431 IGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTC 487
+GEG + V + A+K+ + EVE+L + + H N++ LI
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRM--------QIASDVCSALIYLHS 537
E LVFE +R GS+ R + DV SAL +LH+
Sbjct: 81 EEEDRFYLVFEKMRGGSILS-----------HIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 538 NEPCIIHGNLKPSKVL-IDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASV- 593
I H +LKP +L N S K+ DF I C+ +
Sbjct: 130 KG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD------CSPISTPELLTP 181
Query: 594 -----YIDPEYLETGKLT-----PESDVYSFGIILLRLLTGRP 626
Y+ PE +E D++S G+IL LL+G P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+G G +G V+R + K G + + E+ +L+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF 70
Query: 488 PESRS---LVFEYLRNGSL-EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
ES ++FE++ + E L + + VC AL +LHS+ I
Sbjct: 71 -ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN--IG 124
Query: 544 HGNLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601
H +++P ++ S K+ +FG + G++ L + Y PE +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFT-----APE-YYAPEVHQ 176
Query: 602 TGKLTPESDVYSFGIILLRLLTGRP 626
++ +D++S G ++ LL+G
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 32/209 (15%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G G VYR + A+K+ + ++ E+ VL R+ HPN++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 488 PESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC----SALIYLHSNEP 540
E+ + LV E + G L D + K S + A+D A+ YLH N
Sbjct: 118 -ETPTEISLVLELVTGGELFDRIVEKGYYSE-------RDAADAVKQILEAVAYLHENG- 168
Query: 541 CIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
I+H +LKP +L + K++DFG ++ +C + Y P
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCG-----TPG-YCAP 219
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E L PE D++S GII LL G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 61/246 (24%), Positives = 97/246 (39%), Gaps = 73/246 (29%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE-------- 470
+ +E KIG+G +G V++ RH VA+K + +NE E
Sbjct: 17 SKYEKLAKIGQGTFGEVFKA--RHRKTGQKVALK---------KVLMENEKEGFPITALR 65
Query: 471 ---VLSRVRHPNLVTLIGTCPESRS----------LVFEYLRN---GSLEDCLACKNKKS 514
+L ++H N+V LI C S LVF++ + G L N
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLV 119
Query: 515 PLRWQTRMQIAS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FF 568
T +I + + L Y+H N I+H ++K + VLI + KL+DFG F
Sbjct: 120 KF---TLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 569 HLIPQGESTGNSALCNESNNDSASV----YIDPEYL--ETGKLTPESDVYSFGIILLRLL 622
L +++ + N V Y PE L E P D++ G I+ +
Sbjct: 175 SL---AKNSQPNRYTNR-------VVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMW 223
Query: 623 TGRPVL 628
T P++
Sbjct: 224 TRSPIM 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 50/228 (21%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH---VAIKM---------FPSYGPQSHLKFQNEVE 470
++ K+GEG YG VY+ + VA+K PS + ++ E+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPS----TAIR---EIS 71
Query: 471 VLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV 528
+L + HPN+V+LI R LVFE++ L+ L K+ L+ +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIKIYLYQL 128
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLIPQGESTGNSALCNE 585
+ + H + I+H +LKP +LI+++ KL+DFG F IP T +E
Sbjct: 129 LRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYT------HE 179
Query: 586 SNNDSASV----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
V Y P+ L K + D++S G I ++TG+P+
Sbjct: 180 -------VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 29/159 (18%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKM---------FPSYGPQSHLKFQNEV 469
+E KIGEG YG V++ ++ VA+K PS S L+ E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPS----SALR---EI 52
Query: 470 EVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
+L ++H N+V L + LVFE+ + L+ + L +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF--DSCNGDLDPEIVKSFLFQ 109
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
+ L + HS ++H +LKP +LI+ N KL++FG
Sbjct: 110 LLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFG 146
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 42/207 (20%), Positives = 79/207 (38%), Gaps = 21/207 (10%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRH-PNLVTLI 484
++G G++ V + + + A K G + +E+ VL + P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 485 GTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
+ L+ EY G + + + ++ + + YLH N I
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQNN--I 152
Query: 543 IHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+H +LKP +L+ + + K+ DFG I + + Y+ PE
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMG-----TPE-YLAPEI 204
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRP 626
L +T +D+++ GII LLT
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 33/211 (15%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGT 486
+G G G V R A+K+ K + EV+ + P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 487 CPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRM--QIASDVCSALIYLHSN 538
++ E + G L + ++ + R +I D+ +A+ +LHS+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQ---ERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 539 EPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
I H ++KP +L + + KL+DFGF Q C + Y+
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---PCY-----TPY-YV 196
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L K D++S G+I+ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 56/254 (22%), Positives = 95/254 (37%), Gaps = 67/254 (26%)
Query: 408 PGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKM---------F 454
PG + S + + + + K+GEG YG VY+ VAIK
Sbjct: 19 PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGV 76
Query: 455 PSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRN---GSLEDC--L 507
P + EV +L ++H N++ L + L+FEY N ++ +
Sbjct: 77 PGTAIR-------EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDV 129
Query: 508 ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-----KL 562
+ + KS +Q + + + HS +H +LKP +L+ + S K+
Sbjct: 130 SMRVIKS-FLYQL--------INGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 563 SDFG---FFHLIPQGESTGNSALCNESNNDSASV----YIDPEYLETGKL-TPESDVYSF 614
DFG F IP + T +E + Y PE L + + D++S
Sbjct: 179 GDFGLARAFG-IPIRQFT------HE-------IITLWYRPPEILLGSRHYSTSVDIWSI 224
Query: 615 GIILLRLLTGRPVL 628
I +L P+
Sbjct: 225 ACIWAEMLMKTPLF 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 55/213 (25%), Positives = 81/213 (38%), Gaps = 43/213 (20%)
Query: 431 IGEGRYGNVYRGLLRHL----HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTL--- 483
IG G +G L+R VA+K G Q E+ +RHPN+V
Sbjct: 28 IGSGNFGVAR--LMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 484 IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRM---QIASDVCSALIYLHSNEP 540
I T P +++ EY G L + + + S + R Q+ S + Y HS
Sbjct: 85 ILT-PTHLAIIMEYASGGELYERICNAGRFSED--EARFFFQQL----LSGVSYCHSM-- 135
Query: 541 CIIHGNLKPSKVLIDANFGS--KLSDFGFFHLIPQGE----STGNSALCNESNNDSASVY 594
I H +LK L+D + K+ DFG+ + G A Y
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------------Y 183
Query: 595 IDPEYLETGKL--TPESDVYSFGIILLRLLTGR 625
I PE L + +DV+S G+ L +L G
Sbjct: 184 IAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 49/218 (22%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGT 486
+GEG + + + + + A+K+ + Q E+ L HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 487 CPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRM--------QIASDVCSALIYLH 536
+ LV E L G L + R + + I + SA+ ++H
Sbjct: 75 FHDQLHTFLVMELLNGGELFE-----------RIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 537 SNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
++H +LKP +L + N K+ DFGF + L N +
Sbjct: 124 DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGF------------ARLKPPDNQPLKTP 169
Query: 594 -----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y PE L D++S G+IL +L+G+
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 42/173 (24%)
Query: 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQN----- 467
++ +E +GEG++ VY+ R + VAIK +K +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKK---------IKLGHRSEAK 52
Query: 468 ---------EVEVLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPL 516
E+++L + HPN++ L+ + LVF+++ LE + K+ L
Sbjct: 53 DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII--KDNSLVL 109
Query: 517 RWQTRMQIAS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566
T I + L YLH + I+H +LKP+ +L+D N KL+DFG
Sbjct: 110 ---TPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFG 157
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 46/226 (20%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKM---------FPSYGPQSHLKFQNEVEVL 472
+ KIGEG YG VY+ A+K PS + ++ E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS----TTIR---EISIL 54
Query: 473 SRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
++H N+V L + LVFE+L + L+ L + L T + +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLN 111
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLIPQGESTGNSALCNESN 587
+ Y H ++H +LKP +LI+ K++DFG F IP + T +E
Sbjct: 112 GIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYT------HE-- 160
Query: 588 NDSASV----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
+ Y P+ L K + D++S G I ++ G P+
Sbjct: 161 -----IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 50/228 (21%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN----------EVE 470
+ K+GEG Y VY+G + VA+K ++ ++ EV
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKE---------IRLEHEEGAPCTAIREVS 52
Query: 471 VLSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV 528
+L ++H N+VTL +S LVFEYL + L+ L + + + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQL 109
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG---FFHLIPQGESTGNSALCNE 585
L Y H ++H +LKP +LI+ KL+DFG IP NE
Sbjct: 110 LRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYD------NE 160
Query: 586 SNNDSASV----YIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
V Y P+ L + + D++ G I + TGRP+
Sbjct: 161 -------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 29/219 (13%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIK-MFPSYGPQSHLKFQNEVEV-LSRVRHP 478
++ EP ++G G YG V + +A+K + + Q + ++++ + V P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSLEDCLA-CKNKKSPLRWQTRMQIASDVCSALIYL 535
VT G + E + + SL+ +K + +IA + AL +L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA-LCNESNNDS---A 591
HS +IH ++KPS VLI+A K+ DFG S L ++ D
Sbjct: 126 HSKLS-VIHRDVKPSNVLINALGQVKMCDFGI------------SGYLVDDVAKDIDAGC 172
Query: 592 SVYIDPEYLETGKLTPE----SDVYSFGIILLRLLTGRP 626
Y+ PE + SD++S GI ++ L R
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 56/223 (25%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGT 486
+G G G V + + A+KM Q K + EVE+ R + P++V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 487 CPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRM----------QIASDVCS 530
+ +V E L G L R Q R +I +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFS-----------RIQDRGDQAFTEREASEIMKSIGE 172
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESN 587
A+ YLHS I H ++KP +L + + KL+DFGF + N
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------AKETTSHN 218
Query: 588 NDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + Y+ PE L K D++S G+I+ LL G P
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 58/247 (23%), Positives = 91/247 (36%), Gaps = 77/247 (31%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-----VAIKMFPSYGPQSHLKFQNEVE------- 470
+E +IGEG YG V++ R L VA+K ++ Q E
Sbjct: 11 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKR---------VRVQTGEEGMPLSTI 59
Query: 471 -------VLSRVRHPNLVTLIGTCPESRS-------LVFEYLRN---GSLEDC----LAC 509
L HPN+V L C SR+ LVFE++ L+ +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 510 KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG--- 566
+ K + Q+ L +LHS+ ++H +LKP +L+ ++ KL+DFG
Sbjct: 120 ETIKDMMF-----QL----LRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 567 FFHLIPQGESTGNSALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLL 622
+ AL + V Y PE L D++S G I +
Sbjct: 169 IYS-FQM-------ALTSV-------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
Query: 623 TGRPVLR 629
+P+ R
Sbjct: 214 RRKPLFR 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 63/246 (25%), Positives = 91/246 (36%), Gaps = 71/246 (28%)
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE------ 470
AT+ +EP +IG G YG VY+ R H VA+K ++ N
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKS---------VRVPNGGGGGGGLP 55
Query: 471 -----------VLSRVRHPNLVTLIGTCPESRS-------LVFEYLRNGSLEDCLACKNK 512
L HPN+V L+ C SR+ LVFE++ + L L
Sbjct: 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----D 110
Query: 513 KSPLRWQTRMQIAS---DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG--- 566
K+P I L +LH+N CI+H +LKP +L+ + KL+DFG
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLAR 168
Query: 567 FFHLIPQGESTGNSALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLL 622
+ AL V Y PE L D++S G I +
Sbjct: 169 IYS-YQM-------ALTPV-------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
Query: 623 TGRPVL 628
+P+
Sbjct: 214 RRKPLF 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHLH-VAIKMFPSYGPQSHLKFQN-EVEVLSRVRH 477
+ + IG G +G V++ L VAIK +F+N E++++ V+H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMRIVKH 91
Query: 478 PNLVTLIGTCPESRS--------LVFEYL-----RNGSLEDCLACKNKKSPLRWQTRM-Q 523
PN+V L + LV EY+ R + K L + M Q
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR--ASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 524 IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSAL 582
+ +L Y+HS I H ++KP +L+D G KL DFG SA
Sbjct: 150 L----LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG-------------SAK 190
Query: 583 CNESNNDSASVYI------DPEYLETGKL-TPESDVYSFGIILLRLLTGRP 626
+ + S YI PE + T D++S G ++ L+ G+P
Sbjct: 191 ILIAGEPNVS-YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 48/228 (21%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQN-EVEVLSRVRHP 478
++ + IG G +G VY+ L VAIK +F+N E++++ ++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHC 107
Query: 479 NLVTLIGTCPESRS--------LVFEYLR---NGSLEDCLACKNKKSPLRWQTRM-QIAS 526
N+V L S LV +Y+ K + + M Q+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 165
Query: 527 DVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNE 585
+L Y+HS I H ++KP +L+D + KL DFG SA
Sbjct: 166 --FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG-------------SAKQLV 208
Query: 586 SNNDSASVYI------DPEYLETGKL-TPESDVYSFGIILLRLLTGRP 626
+ S YI PE + T DV+S G +L LL G+P
Sbjct: 209 RGEPNVS-YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 58/257 (22%), Positives = 102/257 (39%), Gaps = 36/257 (14%)
Query: 385 GNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEAT--NNFEPSWKIGEGRYGNVYRG 442
GNA + ++ +E L+ + L+ + + F+ +G G +G V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVM-- 58
Query: 443 LLRHLH----VAIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSL 493
L++H A+K+ H NE +L V P LV L + ++ +L
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTL--NEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 494 --VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSK 551
V EY+ G + L + S R A+ + YLHS + +I+ +LKP
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH--ARF-YAAQIVLTFEYLHSLD--LIYRDLKPEN 171
Query: 552 VLIDANFGSKLSDFGFFHLIPQGESTGNSALCN--ESNNDSASVYIDPEYLETGKLTPES 609
+LID +++DFGF + T LC E + PE + +
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPE--------ALAPEIILSKGYNKAV 219
Query: 610 DVYSFGIILLRLLTGRP 626
D ++ G+++ + G P
Sbjct: 220 DWWALGVLIYEMAAGYP 236
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-12
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 9/78 (11%)
Query: 711 PSHFVCPILQEVMKDP-QIAADGFTYEGEAIRGWLKSGHNTS-----PMT---NLKLEHC 761
S F CPI +E MK P + G TYE +AI ++S P + +
Sbjct: 5 SSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKS 64
Query: 762 NLLPNYALHQAIIEWQQR 779
+L+ + AL +AI ++
Sbjct: 65 DLIQDEALRRAIENHNKK 82
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 52/230 (22%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVR- 476
++++ K+G G+Y V+ + + V +K+ P K + E+++L +R
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRG 89
Query: 477 HPNLVTL--IGTCPESR--SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD----- 527
PN++TL I P SR +LVFE++ N + Q +D
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDF---------------KQLYQTLTDYDIRF 134
Query: 528 ----VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFG---FFHLIPQGESTGN 579
+ AL Y HS I+H ++KP V+ID +L D+G F+H P E
Sbjct: 135 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVR 190
Query: 580 SALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVL 628
A + + PE L ++ D++S G +L ++ +
Sbjct: 191 VA---------SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 47/233 (20%), Positives = 82/233 (35%), Gaps = 54/233 (23%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE-------V 471
++FE IG G + V +++ A+K+ + + + EV V
Sbjct: 61 DDFEILKVIGRGAFSEVA--VVKMKQTGQVYAMKIMN----KWDMLKRGEVSCFREERDV 114
Query: 472 LSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
L + L LV EY G L L+ ++ P R +A ++
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIV 172
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
A+ +H +H ++KP +L+D +L+DFG C + D
Sbjct: 173 MAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFG---------------SCLKLRAD 215
Query: 590 SASV---------YIDPEYLE-------TGKLTPESDVYSFGIILLRLLTGRP 626
Y+ PE L+ TG PE D ++ G+ + G+
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-11
Identities = 42/255 (16%), Positives = 69/255 (27%), Gaps = 56/255 (21%)
Query: 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSH--------LK 464
FS T + KIGEG +G V++ + H VAIK+ GP +
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 465 FQNEVEVLSRV---------RHPNLVTLI------GTCPESRSLVFEYLR--NGSLEDCL 507
E+ + + R + L G+ P +++ GS D
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 508 A--------------------CKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547
+ + T I + ++L H +L
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDL 188
Query: 548 KPSKVLIDANFGSKLSD--------FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
VL+ KL L S L + V +D +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
Query: 600 LETGKLTPESDVYSF 614
G + D+Y
Sbjct: 249 FT-GDGDYQFDIYRL 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 48/231 (20%), Positives = 82/231 (35%), Gaps = 52/231 (22%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
++ IG G G V L +VAIK FQN E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRE 111
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQT 520
+ ++ V H N+++L + T ++ LV E + D C+ + L +
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM------DANLCQVIQMELDHER 165
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTGN 579
+ + + +LHS IIH +LKPS +++ ++ K+ DFG T
Sbjct: 166 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP- 222
Query: 580 SALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
V Y PE + D++S G I+ ++ +
Sbjct: 223 ------------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 52/222 (23%), Positives = 86/222 (38%), Gaps = 53/222 (23%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLV 481
IG G +G V L+RH A+K+ + F E ++++ P +V
Sbjct: 77 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 132
Query: 482 TLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQI--------ASDVCSA 531
L + R L V EY+ G L + + + ++V A
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLA 180
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF-FHLIPQGESTGNSALCN--ESNN 588
L +HS IH ++KP +L+D + KL+DFG + +G ++ +
Sbjct: 181 LDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPD--- 234
Query: 589 DSASVYIDPEYLET----GKLTPESDVYSFGIILLRLLTGRP 626
YI PE L++ G E D +S G+ L +L G
Sbjct: 235 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 58/256 (22%), Positives = 93/256 (36%), Gaps = 72/256 (28%)
Query: 414 SFSELNEATNNFEPSWK----------IGEGRYGNVYRGLLRHL--HVAIK-MFPSYGPQ 460
S LN A E S K G+G +G V G + VAIK +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------ 57
Query: 461 SHLKFQN----EVEVLSRVRHPNLVTL--IGTCPESRS-------LVFEYL--------R 499
+F+N ++ L+ + HPN+V L R +V EY+ R
Sbjct: 58 QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR 117
Query: 500 NGSLEDCLACKNKKSPLRWQTRM-QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF 558
N + P+ + + Q+ ++ LH + H ++KP VL++
Sbjct: 118 NYYRR-----QVAPPPILIKVFLFQL----IRSIGCLHLPSVNVCHRDIKPHNVLVNEAD 168
Query: 559 GS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI------DPEYLETGKL-TPESD 610
G+ KL DFG SA + + + YI PE + + T D
Sbjct: 169 GTLKLCDFG-------------SAKKLSPSEPNVA-YICSRYYRAPELIFGNQHYTTAVD 214
Query: 611 VYSFGIILLRLLTGRP 626
++S G I ++ G P
Sbjct: 215 IWSVGCIFAEMMLGEP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 48/241 (19%), Positives = 79/241 (32%), Gaps = 51/241 (21%)
Query: 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLK--FQN---- 467
+EL+ + + I G YG V G+ + VAIK + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 468 -----EVEVLSRVRHPNLVTLIGT-CPESRS------LVFEYLRNGSLEDCLACKNKK-S 514
E+ +L+ HPN++ L LV E +R L + + S
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 515 PLRWQTRM-QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
P Q M I L LH ++H +L P +L+ N + DF
Sbjct: 133 PQHIQYFMYHI----LLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFN------- 179
Query: 574 GESTGNSALCNESNNDSASV-------YIDPEY-LETGKLTPESDVYSFGIILLRLLTGR 625
L E D+ Y PE ++ T D++S G ++ + +
Sbjct: 180 --------LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 626 P 626
Sbjct: 232 A 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 50/217 (23%)
Query: 431 IGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE-------VLSRVRHPN 479
+G G +G V+ L+R H A+K+ + + +VE +LS V HP
Sbjct: 14 LGTGSFGRVH--LIRSRHNGRYYAMKVLK----KEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 480 LVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQI------ASDVCSA 531
++ + GT +++ + + +Y+ G L S LR R A++VC A
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGEL---------FSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 532 LIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN--ESNND 589
L YLHS + II+ +LKP +L+D N K++DFGF +P T LC +
Sbjct: 119 LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPD---- 168
Query: 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
YI PE + T D +SFGI++ +L G
Sbjct: 169 ----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 62/384 (16%), Positives = 137/384 (35%), Gaps = 51/384 (13%)
Query: 279 RWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAK------EKQEVQR--------T 324
R + ++ A K + L + +S+ + L E L +Q + + T
Sbjct: 19 RGSFDASSGPASRDRKYLARLKLPPLSKCEALRESLDLGFEGMCLEQPIGKRLFQQFLRT 78
Query: 325 KNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIEC 384
QH ++ + ++D ++A + + ++ + + + + + R
Sbjct: 79 HEQHGPALQLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGA 138
Query: 385 GNA--QRRVRDIKKSIKREALSFFQPG-----LLEFSFSELNEAT-NNFEPSWKIGEGRY 436
G+ Q +R + + + F L++ + E + F +G G +
Sbjct: 139 GDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGF 198
Query: 437 GNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRVRHPNLVTLIG 485
G V+ + A K + LK + + +L++V +V+L
Sbjct: 199 GEVF--ACQMKATGKLYACKKLN----KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 486 T--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQI-ASDVCSALIYLHSNEPCI 542
LV + G + + ++ +P + R + + S L +LH I
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--I 310
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
I+ +LKP VL+D + ++SD G + G++ ++ PE L
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPG------FMAPELLLG 363
Query: 603 GKLTPESDVYSFGIILLRLLTGRP 626
+ D ++ G+ L ++ R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARG 387
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 38/224 (16%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLKFQNEVE-------V 471
+FE IG G +G V +++ + A+K+ + + + E V
Sbjct: 74 EDFEILKVIGRGAFGEVA--VVKLKNADKVFAMKILN----KWEMLKRAETACFREERDV 127
Query: 472 LSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
L + TL + LV +Y G L L+ + P R +A ++
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMV 185
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN--ESN 587
A+ +H +H ++KP +L+D N +L+DFG + + + +S +
Sbjct: 186 IAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-- 241
Query: 588 NDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRP 626
YI PE L+ G+ PE D +S G+ + +L G
Sbjct: 242 ------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 5e-11
Identities = 76/500 (15%), Positives = 154/500 (30%), Gaps = 110/500 (22%)
Query: 326 NQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECG 385
+H K++ + A V+++ + I+S E+ K
Sbjct: 12 GEHQYQYKDI--LSVFEDAFVDNFDCKD--VQDMPKSILSKEEIDHIIMSKDAVSGT--- 64
Query: 386 NAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEA--TNNFEPSWKIGEGRYGNVYRGL 443
R+ S + E + F +L ++ L T +PS Y
Sbjct: 65 ---LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM------YIEQ 115
Query: 444 LRHLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGT--CPESRSLVFEYL 498
L+ ++F Y Q +LK + L +R V + G ++ + +
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQ---ALLELRPAKNVLIDGVLGSGKT-WVALDVC 171
Query: 499 RNGSLEDCLACK-------NKKSP-----LRWQTRMQIASDVCSA--------------- 531
+ ++ + K N SP + + QI + S
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 532 -----LIYLHSNEPC-IIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQGESTGNSALCN 584
L+ E C ++ N++ +K +A N K+ L+ +T + +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKA-WNAFNLSCKI-------LL----TTRFKQVTD 279
Query: 585 ESNNDSASVYIDPEYLETGKLTPES-DVYS--FGIILLRL----LTGRPVLRIKKDVKCA 637
+ + + +I ++ E + L LT P R+ A
Sbjct: 280 FLSAATTT-HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-RRLSI---IA 334
Query: 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697
R+ + D+ W ++L + L P +++ L VF
Sbjct: 335 ESIRDGLATWDN----WKHVNCDKLTTIIESSLNV--LE-PAEYRKMFDRLS------VF 381
Query: 698 PVSCSGSKEHRRIPSHFVCPIL--QEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTN 755
P IP+ + ++ + D + + + K + P
Sbjct: 382 P-------PSAHIPTILLS-LIWFDVIKSDVMVVVNKLHKYS-LVEKQPKESTISIPSIY 432
Query: 756 LKLEHCNLLPNYALHQAIIE 775
L+L L YALH++I++
Sbjct: 433 LEL-KVKLENEYALHRSIVD 451
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 61/505 (12%), Positives = 140/505 (27%), Gaps = 149/505 (29%)
Query: 51 HVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQGDSV------------ 98
V +V + L+Q +++ + +L+ G G +
Sbjct: 124 QVFAKYNVSRLQP----YLKLRQALLELRP-AKNVLIDGVLGS-GKTWVALDVCLSYKVQ 177
Query: 99 --------WIE--KDNVEDGIVEVITQQNIRWLVMG---AAADKHYSKKLL--ELKSKKA 143
W+ N + ++E+ Q + + + + +D + KL ++++
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEM--LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 144 IFVCQQAPISC-----HIW---------FCCKGCLIYTRSGSENRSELEISPTFLLMNSN 189
+ + +C ++ CK L+ TR + T + ++ +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 190 EEMKQSGHLKLESLGYRLGFPDVEEDADDELEETSCCSVQSSWSSN----SLLGTSKSTP 245
E L + ++ D E + N S++ S
Sbjct: 295 SM----TLTPDEVKSLLLKY--LDCRPQDLPREV--LTT------NPRRLSIIAESIRDG 340
Query: 246 LLT-----DEEEKSQSRLEQAKIEAKNSKKM--------VYEEVVK--------RW---- 280
L T + + ++ + + V+ W
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 281 KEEDNAVEAKCKVKAMQSLCVKEMSQRKE----LEELLAKEKQEVQRTKNQHDKTVKELQ 336
K + V K SL K Q KE + + + K +++ H V
Sbjct: 401 KSDVMVVVNKLHKY---SLVEK---QPKESTISIPSIYLELKVKLENEYALHRSIVDHYN 454
Query: 337 TVQ--DQNSAL-----------------EGQLAESHSVVKE-------LEEKII------ 364
+ D + + + E ++ + LE+KI
Sbjct: 455 IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514
Query: 365 ----SAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNE 420
S + L K + + +R V I + + + L+ +++L
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK-----IEENLICSKYTDLLR 569
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLR 445
E E + ++ + R
Sbjct: 570 IALMAE-----DEAIFEEAHKQVQR 589
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 49/229 (21%), Positives = 90/229 (39%), Gaps = 53/229 (23%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVR-------- 476
K+G G + V+ ++ + HVA+K+ Y + ++E+++L RV
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKED 81
Query: 477 ---HPNLVTLI------GTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
+++ L+ G +VFE L +L L K + + QI+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLA-LIKKYEHRGIPLIYVKQISKQ 139
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS------KLSDFGFFHLIPQGESTGNSA 581
+ L Y+H IIH ++KP VL++ K++D G +A
Sbjct: 140 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLG-------------NA 185
Query: 582 LCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
C + + S+ Y PE L +D++S ++ L+TG
Sbjct: 186 -CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 49/221 (22%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVRHP------ 478
IG+G +G V + + VAIK+ ++ Q+ Q EV +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 479 NLVTLIGT-------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSA 531
+V L C LVFE L +L D L + + A +C+A
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEMLSY-NLYDLL-RNTNFRGVSLNLTRKFAQQMCTA 169
Query: 532 LIYLHSNEPCIIHGNLKPSKVLI--DANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
L++L + E IIH +LKP +L+ K+ DFG S+ C
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-------------SS-CQLGQRI 215
Query: 590 SASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y PE L D++S G IL+ + TG P
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 51/232 (21%), Positives = 82/232 (35%), Gaps = 54/232 (23%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
++ IG G G V L +VAIK FQN E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRE 74
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQT 520
+ ++ V H N++ L + T +S +V E + D C+ + L
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMEL-DHE 127
Query: 521 RMQ-IASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF-HLIPQGESTG 578
RM + + + +LHS IIH +LKPS +++ ++ K+ DFG T
Sbjct: 128 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 579 NSALCNESNNDSASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
V Y PE + D++S G I+ ++ G
Sbjct: 186 -------------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 57/220 (25%), Positives = 86/220 (39%), Gaps = 51/220 (23%)
Query: 431 IGEGRYGNVYRG--LLRHLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVRH------PN 479
IG+G +G V + H HVA+KM + Q+ E+ +L +R N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 480 LVTLIGT-------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
++ ++ C + FE L +L + + KNK + A + L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELLSM-NLYELI-KKNKFQGFSLPLVRKFAHSILQCL 213
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDS 590
LH N IIH +LKP +L+ S K+ DFG S+ C E
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG-------------SS-CYEHQRVY 257
Query: 591 ASV----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y PE + + D++S G IL LLTG P
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 44/230 (19%), Positives = 84/230 (36%), Gaps = 47/230 (20%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
+ + +E IG G YG+V + VAIK F++ E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILRE 102
Query: 469 VEVLSRVRHPNLVTLIGTC-PESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
+ +L+R+ H ++V ++ P+ +V E + + + L +T
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTL 161
Query: 522 M-QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
+ + + Y+HS I+H +LKP+ L++ + K+ DFG + E+ +
Sbjct: 162 LYNL----LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 581 ALCNESNNDSASVYIDPEYLETGKLT----------PE----SDVYSFGI 616
+ +D V +LT PE + Y+ I
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 49/209 (23%)
Query: 430 KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGT 486
+G G G V + + A+KM K + EVE+ R + P++V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 487 CPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
+ +V E L G L + + ++ + +I + A+ YLHS
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSIN- 137
Query: 541 CIIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
I H ++KP +L + + KL+DFGF A
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------A---------------K 168
Query: 598 EYLETGKLTPESDVYSFGIILLRLLTGRP 626
E K D++S G+I+ LL G P
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYP 196
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 43/254 (16%), Positives = 81/254 (31%), Gaps = 49/254 (19%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
+N+ IG G YG VY ++ +VAIK F++ E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILRE 75
Query: 469 VEVLSRVRHPNLVTLIGTC-PESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
+ +L+R++ ++ L P+ +V E + L+ + +T
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTI 134
Query: 522 M-QIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG----FFHLIPQGES 576
+ + ++H + IIH +LKP+ L++ + K+ DFG
Sbjct: 135 LYNL----LLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 577 TGNSALCNESNNDSASVYIDPEYLET------------GKLTPESDVYSFGIILLRLLTG 624
++ ++ T T D++S G I LL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 625 RPVLRIKKDVKCAL 638
+ L
Sbjct: 249 LQSHINDPTNRFPL 262
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 45/233 (19%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLK--FQNEVEVLSRV 475
+++F+ +GEG YG V + VAIK + + E+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 476 RHPNLVTLIGT-CPESRS------LVFEY--------LRNGSLEDCLACKNKKSPLRWQT 520
+H N++T+ P+S ++ E + L D + +Q
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-----DHIQYFIYQ- 120
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
A+ LH + +IH +LKPS +LI++N K+ DFG L + +
Sbjct: 121 -------TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFG---LARIIDESAAD 168
Query: 581 ALCNESNNDSASVYID------PEY-LETGKLTPESDVYSFGIILLRLLTGRP 626
++ PE L + K + DV+S G IL L RP
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 57/231 (24%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------V 471
++FE IG+G +G V +++ A+K Y + +NEV +
Sbjct: 15 DHFEILRAIGKGSFGKVC--IVQKNDTKKMYAMK----YMNKQKCVERNEVRNVFKELQI 68
Query: 472 LSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRW 518
+ + HP LV L + E +V + L G L E+
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE------------- 115
Query: 519 QTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578
++ I ++ AL YL + IIH ++KP +L+D + ++DF ++P+
Sbjct: 116 TVKLFIC-ELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI- 171
Query: 579 NSALCNESNNDSASVYIDPEYLETGKLTPES---DVYSFGIILLRLLTGRP 626
+ + Y+ PE + K S D +S G+ LL GR
Sbjct: 172 -TTMAGTKP------YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 60/232 (25%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------V 471
N FE +G+G +G V L++ A+K+ + + ++EV V
Sbjct: 148 NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILK----KEVIVAKDEVAHTLTENRV 201
Query: 472 LSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSL------EDCLACKNKKSPLRWQTRMQ 523
L RHP L L + + V EY G L E + + R +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----------EDRAR 251
Query: 524 I-ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSAL 582
+++ SAL YLHS + +++ +LK +++D + K++DFG L
Sbjct: 252 FYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFG---------------L 295
Query: 583 CNE--SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
C E + + Y+ PE LE D + G+++ ++ GR
Sbjct: 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 40/256 (15%), Positives = 78/256 (30%), Gaps = 72/256 (28%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN-EVEVLSRVRHP 478
+ + +G G +G V A+K +++N E++++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHV 60
Query: 479 NLVTL---IGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV------- 528
N++ L T + + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 529 ------------------------------CSALIYLHSNEPCIIHGNLKPSKVLIDANF 558
A+ ++HS I H ++KP +L+++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKD 178
Query: 559 GS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI------DPEYLETGKL-TPESD 610
+ KL DFG SA + S + YI PE + TP D
Sbjct: 179 NTLKLCDFG-------------SAKKLIPSEPSVA-YICSRFYRAPELMLGATEYTPSID 224
Query: 611 VYSFGIILLRLLTGRP 626
++S G + L+ G+P
Sbjct: 225 LWSIGCVFGELILGKP 240
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 29/157 (18%), Positives = 67/157 (42%), Gaps = 6/157 (3%)
Query: 249 DEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCK-----VKAMQSLCVKE 303
+EEE ++ +L+ K+ A K E+ + ++++N + + K V + + +E
Sbjct: 965 EEEEAARQKLQLEKVTADGKIK-KMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEE 1023
Query: 304 MSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKI 363
+ K L +L K + + + + K K Q ++ LEG+ ++ H + EL+ +I
Sbjct: 1024 EEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQI 1083
Query: 364 ISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
L +++ + + + K I+
Sbjct: 1084 AELKAQLAKKEEELQAALARLEDETSQKNNALKKIRE 1120
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 30/158 (18%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 250 EEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKE 309
E E+ + RL K E + ++++E + +EE+ + + + + K MQ + Q +E
Sbjct: 910 EAEEMRVRLAAKKQELE---EILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEE 966
Query: 310 LEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNS-------ALEGQLAESHSVVKELEEK 362
E K + E + K ++ ++DQN+ LE ++++ + + E EEK
Sbjct: 967 EEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEK 1026
Query: 363 IISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
+ +L + +L + ++ ++++K ++
Sbjct: 1027 AKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK 1064
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 28/161 (17%), Positives = 60/161 (37%), Gaps = 7/161 (4%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306
LT E + + R+ ++ + K E E + ++K + +
Sbjct: 1002 LTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKI 1061
Query: 307 RKELEE-------LLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKEL 359
+++LE +A+ + ++ K Q K +ELQ + Q + ++EL
Sbjct: 1062 KRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIREL 1121
Query: 360 EEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
E I E L S K R++ + + + +K ++
Sbjct: 1122 ESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTELED 1162
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 14/124 (11%), Positives = 53/124 (42%)
Query: 277 VKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQ 336
+K ++E+ +++ + K ++ KELE+ + +E + + +
Sbjct: 850 LKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYA 909
Query: 337 TVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKK 396
++ L + E ++ E+E +I E + ++ +++ + + + ++ + +
Sbjct: 910 EAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEA 969
Query: 397 SIKR 400
+ ++
Sbjct: 970 ARQK 973
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 71/230 (30%)
Query: 431 IGEGRYGNVYRGLLRHLHV-------AIKMFPSYGPQSHLKFQNEVE------VLSRVRH 477
+G+G +G V+ L++ + A+K+ ++ LK ++ V +L V H
Sbjct: 32 LGQGSFGKVF--LVKKISGSDARQLYAMKVLK----KATLKVRDRVRTKMERDILVEVNH 85
Query: 478 PNLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRWQTRMQI 524
P +V L L+ ++LR G L E+ + +
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------------DVKFYL 132
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCN 584
A ++ AL +LHS II+ +LKP +L+D KL+DFG L
Sbjct: 133 A-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG---------------LSK 174
Query: 585 E--SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
E + A Y+ PE + T +D +SFG+++ +LTG
Sbjct: 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 61/224 (27%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRVRHPN 479
+G+G +G V L+R A+K+ + + ++EV VL RHP
Sbjct: 13 LGKGTFGKVI--LVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 480 LVTLIGT--CPESRSLVFEYLRNGSL------EDCLACKNKKSPLRWQTRMQI-ASDVCS 530
L L + V EY G L E + R + +++ S
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------EERARFYGAEIVS 116
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE--SNN 588
AL YLHS + +++ ++K +++D + K++DFG LC E S+
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFG---------------LCKEGISDG 159
Query: 589 DSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y+ PE LE D + G+++ ++ GR
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 47/232 (20%), Positives = 82/232 (35%), Gaps = 55/232 (23%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
E + +G G YG+V + + VAIK FQ+ E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRE 73
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQT 520
+ +L ++H N++ L + T S LV ++ K +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM------QTDLQKIMGLKFSEEK 127
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
+ + L Y+HS ++H +LKP + ++ + K+ DFG
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG-------------- 171
Query: 581 ALCNESNNDSAS-V----YIDPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
L ++ + V Y PE L D++S G I+ +LTG+
Sbjct: 172 -LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 46/238 (19%), Positives = 93/238 (39%), Gaps = 33/238 (13%)
Query: 404 SFFQPGLLEFSFSELNEAT-NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYG 458
S + L++ + E T N F +G+G +G V + A K
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC--ACQVRATGKMYACKKLE--- 218
Query: 459 PQSHLKFQNEVE-------VLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLAC 509
+ +K + +L +V +V+L ++ LV + G L+ +
Sbjct: 219 -KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI-- 275
Query: 510 KNKKSPLRWQTRMQI-ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568
+ + R A+++C L LH I++ +LKP +L+D + ++SD G
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+P+G++ Y+ PE ++ + T D ++ G +L ++ G+
Sbjct: 334 VHVPEGQTI--KGRVGTVG------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 46/253 (18%), Positives = 81/253 (32%), Gaps = 83/253 (32%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
+ + + +G G G V+ + VAIK + E
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS--------------LVFEY--------LRNGSLE 504
++++ R+ H N+V + I S+ +V EY L G L
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL 118
Query: 505 DCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLS 563
+ +Q + L Y+HS ++H +LKP+ + I+ + K+
Sbjct: 119 E-----EHARLFMYQ--------LLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIG 163
Query: 564 DFGFFHLIPQGESTGNSALCNESNNDSASV---------YIDPE-YLETGKLTPESDVYS 613
DFG A + + Y P L T D+++
Sbjct: 164 DFGL-------------ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 614 FGIILLRLLTGRP 626
G I +LTG+
Sbjct: 211 AGCIFAEMLTGKT 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 51/243 (20%), Positives = 85/243 (34%), Gaps = 72/243 (29%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
+ + IGEG YG V VAIK F++ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLRE 75
Query: 469 VEVLSRVRHPNLVTLIGT-CPESRS------LVFEY--------LRNGSLEDCLACKNKK 513
+++L R RH N++ + + +V + L+ L + +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN-----DHI 130
Query: 514 SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573
+Q + L Y+HS ++H +LKPS +L++ K+ DFG
Sbjct: 131 CYFLYQ--------ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL------ 174
Query: 574 GESTGNSALCNESNNDSASV---------YIDPEY-LETGKLTPESDVYSFGIILLRLLT 623
A + ++D Y PE L + T D++S G IL +L+
Sbjct: 175 -------ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 624 GRP 626
RP
Sbjct: 228 NRP 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 61/247 (24%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
+E K+G+G YG V++ + R VA+K FQN E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFRE 58
Query: 469 VEVLSRVR-HPNLVTLIGTC-PESRS---LVFEY--------LRNGSLEDCLACKNKKSP 515
+ +L+ + H N+V L+ ++ LVF+Y +R LE K
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP-----VHKQY 113
Query: 516 LRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575
+ +Q + + YLHS ++H ++KPS +L++A K++DFG
Sbjct: 114 VVYQ--------LIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 576 STGNSALCNESNNDSASVYIDP---EY------------LETGKLTPESDVYSFGIILLR 620
N+ + + N P +Y L + K T D++S G IL
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 621 LLTGRPV 627
+L G+P+
Sbjct: 224 ILCGKPI 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 70/240 (29%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
E + +G G YG V + VAIK FQ+ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRE 74
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS------LVFEY--------LRNGSLEDCLACKNK 512
+ +L +RH N++ L + T E+ LV + +++ L + ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE-----DR 129
Query: 513 KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572
L +Q + L Y+H+ IIH +LKP + ++ + K+ DFG
Sbjct: 130 IQFLVYQ--------MLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG------ 173
Query: 573 QGESTGNSALCNESNNDSAS-V----YIDPEY-LETGKLTPESDVYSFGIILLRLLTGRP 626
L +++++ V Y PE L + T D++S G I+ ++TG+
Sbjct: 174 ---------LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 70/240 (29%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQN---------E 468
E ++ +G G YG+V VA+K FQ+ E
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRE 78
Query: 469 VEVLSRVRHPNLVTL--IGTCPESRS------LVFEY--------LRNGSLEDCLACKNK 512
+ +L ++H N++ L + T S LV ++ L D +
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-----DH 133
Query: 513 KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572
L +Q + L Y+HS + IIH +LKPS + ++ + K+ DFG
Sbjct: 134 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG------ 177
Query: 573 QGESTGNSALCNESNND-----SASVYIDPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
L + ++ + Y PE L D++S G I+ LLTGR
Sbjct: 178 ---------LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 55/239 (23%), Positives = 86/239 (35%), Gaps = 71/239 (29%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV-------AIKMFPSYGPQSHLKFQNEVE----- 470
FE +G+G YG V+ +R + A+K+ ++ +
Sbjct: 17 ECFELLRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKK---AMIVRNAKDTAHTKAE 71
Query: 471 --VLSRVRHPNLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSP 515
+L V+HP +V LI L+ EYL G L ED
Sbjct: 72 RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---------- 121
Query: 516 LRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575
+A ++ AL +LH II+ +LKP ++++ KL+DFG
Sbjct: 122 ---TACFYLA-EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFG--------- 166
Query: 576 STGNSALCNES--NNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
LC ES + Y+ PE L D +S G ++ +LTG P
Sbjct: 167 ------LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 19/148 (12%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH-PNLVTLI-- 484
KIG G +G++Y G + VAIK+ L E ++ ++ + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 485 GTCPESRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G + +V E L G SLED ++K L +T + +A + S + Y+HS I
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSK--NFI 127
Query: 544 HGNLKPSKVLI----DANFGSKLSDFGF 567
H ++KP L+ N + DFG
Sbjct: 128 HRDVKPDNFLMGLGKKGN-LVYIIDFGL 154
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-08
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 712 SHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALH 770
SH +C I +V + P ++ +E + ++K P+TN L ++
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIVPSA 60
Query: 771 Q 771
Q
Sbjct: 61 Q 61
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 12/96 (12%)
Query: 430 KIGEGRYGNVYRGLLRHL-------HVAIKMFPSYGPQSHLK-FQNEVEVLSRV-RHPNL 480
+G G +G V + VA+KM S + +E+++L + H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 481 VTLIGTCPESRS---LVFEYLRNGSLEDCLACKNKK 513
V L+G C + ++ E+ + G+L L K +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 36/208 (17%), Positives = 72/208 (34%), Gaps = 19/208 (9%)
Query: 422 TNNFEPSWKIGE-GRYGNVYRGLLRHLHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRHPN 479
T P I E ++GN+ L + + + + + V + R +
Sbjct: 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155
Query: 480 LVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
+ + + E K L + + + V + +L S +
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAP--EDLYKDFLTLEHLICYSFQVAKGMEFLASRK 213
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE---STGNSALCNESNNDSASV-YI 595
IH +L +L+ K+ DFG I + G++ L + ++
Sbjct: 214 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---------PLKWM 262
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLT 623
PE + T +SDV+SFG++L + +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 49/260 (18%), Positives = 81/260 (31%), Gaps = 75/260 (28%)
Query: 430 KIGEGRYGNVY--RGLLRHLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVR-----HPN 479
K+G G + V+ + VA+K+ Y + +E+ +L VR PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRNSDPNDPN 99
Query: 480 ---LVTLI---------GT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
+V L+ GT C +VFE L + L K+ L +I
Sbjct: 100 REMVVQLLDDFKISGVNGTHIC-----MVFEVLGH-HLLK-WIIKSNYQGLPLPCVKKII 152
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST-------- 577
V L YLH+ + IIH ++KP +L+ N + +
Sbjct: 153 QQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 578 -----------------------------GNSALCNESNNDSAS--VYIDPEYLETGKLT 606
GN+ ++ + Y E L
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 607 PESDVYSFGIILLRLLTGRP 626
+D++S + L TG
Sbjct: 272 TPADIWSTACMAFELATGDY 291
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 29/169 (17%), Positives = 59/169 (34%), Gaps = 41/169 (24%)
Query: 430 KIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
IG+G +G +Y + +K+ PS E++ R P +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97
Query: 483 LIGTCPES---------------------RSLVFEYLRNG-SLEDCLACKNKKSPLRWQT 520
+ R ++ + G L+ K+ + T
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRK--T 153
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK--LSDFGF 567
+Q++ + L Y+H +E +HG++K S +L++ + L D+G
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/149 (24%), Positives = 59/149 (39%), Gaps = 19/149 (12%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH-PNLVTLI-- 484
+IGEG +G ++ G LL + VAIK P L+ E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74
Query: 485 GTCPESRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G LV + L G SLED L +K ++ T A + + + +H ++
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEK--SLV 128
Query: 544 HGNLKPSKVLIDANFGSK-----LSDFGF 567
+ ++KP LI + DFG
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 57/305 (18%), Positives = 108/305 (35%), Gaps = 54/305 (17%)
Query: 348 QLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKREALSFFQ 407
+ E + + I V+ + KQ L + ++ S
Sbjct: 113 IMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ-NLRGDVFQKFIESDKF 171
Query: 408 PGLLEFSFSELNEAT--NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQS 461
++ ELN N+F IG G +G VY R A+K +
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY--GCRKADTGKMYAMKCLD----KK 225
Query: 462 HLKFQNEVE-------VLSRV---RHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLAC 509
+K + +LS V P +V + P+ S + + + G L L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 510 KNKKSPLRWQTRMQI-ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568
+ + + M+ A+++ L ++H+ +++ +LKP+ +L+D + ++SD G
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLG-- 337
Query: 569 HLIPQGESTGNSALCNESNNDSASV------YIDPEYLETGKL-TPESDVYSFGIILLRL 621
L + + Y+ PE L+ G +D +S G +L +L
Sbjct: 338 -------------LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 622 LTGRP 626
L G
Sbjct: 385 LRGHS 389
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 19/155 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH-PN 479
NF KIG G +G + G L + +VAIK+ P L E ++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 480 LVTLI--GTCPESRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
+ + G C + ++V E L G SLED ++ L+ T + IA + S + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVH 122
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSK-----LSDFG 566
S +I+ ++KP LI + DF
Sbjct: 123 SK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 49/231 (21%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVRH-----PN 479
K+G+G +G V + + A+K+ Y + + E ++L ++++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 480 LVTLIGT-------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
+V G C L+FE L SL + + +N + + ++ AL
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPLGP-SLYEII-TRNNYNGFHIEDIKLYCIEILKAL 150
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN------------S 580
YL + H +LKP +L+D + K +
Sbjct: 151 NYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 581 ALCNESNNDSASV----YIDPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
A +S+ + + Y PE L G SD++SFG +L L TG
Sbjct: 209 A-TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSL 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 33/165 (20%)
Query: 430 KIGEGRYGNVYRG----------LLRHLHVAIKMFPSYGPQSH-LKF------QNEVEVL 472
G +Y + ++K+ G + F +V
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 473 SRVRH------PNLVTLIGTCPESRSLVFEYLRNG-SLEDCL-ACKNKKSPLRWQTRMQI 524
++ P + + R LV L G SL+ L R + +Q+
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER--SVLQV 164
Query: 525 ASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK--LSDFGF 567
A + AL +LH NE +HGN+ + +D S+ L+ +GF
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 35/147 (23%), Positives = 65/147 (44%), Gaps = 17/147 (11%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLI-- 484
KIG G +G +Y G + + VAIK+ L + E ++ ++ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 485 GTCPESRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G + LV + L G SLED ++K L+ T + +A + + + ++HS +
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSK--SFL 125
Query: 544 HGNLKPSKVLIDANFGSK---LSDFGF 567
H ++KP L+ + + DFG
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGL 152
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 52/227 (22%), Positives = 82/227 (36%), Gaps = 45/227 (19%)
Query: 430 KIGEGRYGNVYRGLLR---HLHVAIKMF---PSYGPQSHLKFQNEVEVLSRVRHP----- 478
+GEG +G V L VA+K+ Y + + E+ VL +++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 479 -NLVTLIGT-------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
V + C + FE L + + L +N P +A +C
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELLGK-NTFEFL-KENNFQPYPLPHVRHMAYQLCH 134
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG------NSALCN 584
AL +LH N+ + H +LKP +L + L + ++T SA
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TF 191
Query: 585 ESNNDSASV----YIDPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + + V Y PE LE G P DV+S G IL G
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFT 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 48/218 (22%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRV-RHP 478
+G+G +G V+ L AIK + + ++VE VLS HP
Sbjct: 25 LGKGSFGKVF--LAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
L + T E+ V EYL G L + +K R A ++ L +LH
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--ATFYAA-EIILGLQFLH 135
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE--SNNDSASV- 593
S I++ +LK +L+D + K++DFG +C E + +
Sbjct: 136 SKG--IVYRDLKLDNILLDKDGHIKIADFG---------------MCKENMLGDAKTNTF 178
Query: 594 -----YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
YI PE L K D +SFG++L +L G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 46/229 (20%), Positives = 79/229 (34%), Gaps = 70/229 (30%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRV-RHP 478
+G+G +G V L A+K+ + + ++VE VL+ + P
Sbjct: 28 LGKGSFGKVM--LSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRWQTRMQIA 525
L L + V EY+ G L E A
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-------------HAVFYAA 128
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ L +L S II+ +LK V++D+ K++DFG +C E
Sbjct: 129 -EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG---------------MCKE 170
Query: 586 --SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + YI PE + D ++FG++L +L G+
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/229 (22%), Positives = 80/229 (34%), Gaps = 70/229 (30%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRV-RHP 478
IG G Y V L+R A+++ + + +++ V + HP
Sbjct: 60 IGRGSYAKVL--LVRLKKTDRIYAMRVVK----KELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRWQTRMQIA 525
LV L V EY+ G L E+ R A
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-------------HARFYSA 160
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ AL YLH II+ +LK VL+D+ KL+D+G +C E
Sbjct: 161 -EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG---------------MCKE 202
Query: 586 --SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
D+ S YI PE L D ++ G+++ ++ GR
Sbjct: 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 32/164 (19%), Positives = 57/164 (34%), Gaps = 34/164 (20%)
Query: 430 KIGEGRYGNVYRG--LLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV------ 481
KIG G +G +Y + A + Q + +E++ RV + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 482 ---------------TLIGTCPESRSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIA 525
R +V E L G L+ N T +Q+
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ-NGTFKKS--TVLQLG 157
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK--LSDFGF 567
+ L Y+H NE +HG++K + +L+ + L+D+G
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGL 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 54/225 (24%), Positives = 87/225 (38%), Gaps = 62/225 (27%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRV-RHP 478
+G+G +G V L R A+K+ + + ++VE +LS HP
Sbjct: 31 LGKGSFGKVM--LARVKETGDLYAVKVLK----KDVILQDDDVECTMTEKRILSLARNHP 84
Query: 479 NLVTLIGTC--PESRSLVFEYLRNGSL------EDCLACKNKKSPLRWQTRMQI-ASDVC 529
L L P+ V E++ G L + R + A+++
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------EARARFYAAEII 134
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE--SN 587
SAL++LH II+ +LK VL+D KL+DFG +C E N
Sbjct: 135 SALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFG---------------MCKEGICN 177
Query: 588 NDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + YI PE L+ P D ++ G++L +L G
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 52/229 (22%), Positives = 80/229 (34%), Gaps = 70/229 (30%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSRV-RHP 478
IG G Y V L+R A+K+ + + +++ V + HP
Sbjct: 17 IGRGSYAKVL--LVRLKKTDRIYAMKVVK----KELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRWQTRMQIA 525
LV L V EY+ G L E+ R A
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-------------HARFYSA 117
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ AL YLH II+ +LK VL+D+ KL+D+G +C E
Sbjct: 118 -EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG---------------MCKE 159
Query: 586 --SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
D+ S YI PE L D ++ G+++ ++ GR
Sbjct: 160 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/228 (22%), Positives = 88/228 (38%), Gaps = 47/228 (20%)
Query: 430 KIGEGRYGNVYRGLLRHL---HVAIKMF---PSYGPQSHLKFQNEVEVLSRVRHP----- 478
+GEG +G V + HVA+K+ Y + ++E++VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 479 -NLVTLIGT-------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
V ++ C +VFE L S D + +N P R ++A +C
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELLGL-STYDFI-KENGFLPFRLDHIRKMAYQICK 129
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST-------GNSALC 583
++ +LHSN+ + H +LKP +L + ++ + + G++
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 584 NESNNDSASV----YIDPE-YLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + S V Y PE L G P DV+S G IL+ G
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 70/229 (30%)
Query: 431 IGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------VLSR-VRHP 478
IG+G +G V L RH A+K+ + + + E + VL + V+HP
Sbjct: 46 IGKGSFGKVL--LARHKAEEVFYAVKVLQ----KKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 479 NLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKSPLRWQTRMQIA 525
LV L + + V +Y+ G L E + R A
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-------------RARFYAA 146
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ SAL YLHS I++ +LKP +L+D+ L+DFG LC E
Sbjct: 147 -EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFG---------------LCKE 188
Query: 586 --SNNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+N + S Y+ PE L D + G +L +L G P
Sbjct: 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/197 (16%), Positives = 67/197 (34%), Gaps = 12/197 (6%)
Query: 212 VEEDADDELEETSCCSVQSSWSSNSLLGTSKSTPLLTDEEEKSQSRLEQAKIEAKNSKKM 271
V L E +Q T L + R AK E K K
Sbjct: 854 VRNKYQMMLREHKSIIIQKHVRGWLARVHYHRT-LKAIVYLQCCYRRMMAKRELKKLKIE 912
Query: 272 VYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKT 331
V+R+K+ +E K + +Q ++ + K L E + + +
Sbjct: 913 --ARSVERYKKLHIGLENK--IMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSD 968
Query: 332 VKELQTVQDQNSA-------LEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIEC 384
V+ L+ +++ L+ ++A+ + + + + + E +K + +QL E
Sbjct: 969 VERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSEL 1028
Query: 385 GNAQRRVRDIKKSIKRE 401
++ K+ + R
Sbjct: 1029 KEQNTLLKTEKEELNRR 1045
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 48/226 (21%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV----AIKMFPSYGPQSHLKFQNEVE-------V 471
+F +G+G +G V L A+K+ + + ++VE V
Sbjct: 341 TDFNFLMVLGKGSFGKVM--LSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRV 394
Query: 472 LSRV-RHPNLVTLIGT--CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV 528
L+ + P L L + V EY+ G L + + + A ++
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP-HAVFYAA-EI 451
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE--S 586
L +L S II+ +LK V++D+ K++DFG +C E
Sbjct: 452 AIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG---------------MCKENIW 494
Query: 587 NNDSASV------YIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ + YI PE + D ++FG++L +L G+
Sbjct: 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 20/105 (19%), Positives = 37/105 (35%), Gaps = 38/105 (36%)
Query: 274 EEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVK 333
E +++W+EE QRK L+EL A K Q + + K ++
Sbjct: 84 PESIRKWREE----------------------QRKRLQELDAASKVMEQEWREKAKKDLE 121
Query: 334 ELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRD 378
E Q + Q+ ++ + ++ F Q+ D
Sbjct: 122 EWNQRQSE------QVEKNKINNRIADKA----------FYQQPD 150
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 75/243 (30%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHV-------AIKMFPSYGPQSHLKFQNEVE----- 470
NFE +G G YG V+ L+R + A+K+ + ++ E
Sbjct: 54 ENFELLKVLGTGAYGKVF--LVRKISGHDTGKLYAMKVLKK---ATIVQKAKTTEHTRTE 108
Query: 471 --VLSRVRH-PNLVTLIGT--CPESRSLVFEYLRNGSL-----------EDCLACKNKKS 514
VL +R P LVTL L+ +Y+ G L E
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--------- 159
Query: 515 PLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574
+ ++ + ++ AL +LH II+ ++K +L+D+N L+DFG
Sbjct: 160 ----EVQIYVG-EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG-------- 204
Query: 575 ESTGNSALCNESNNDSASV---------YIDPEYLETGKL--TPESDVYSFGIILLRLLT 623
L E D Y+ P+ + G D +S G+++ LLT
Sbjct: 205 -------LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
Query: 624 GRP 626
G
Sbjct: 258 GAS 260
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A Length = 129 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 24/120 (20%), Positives = 51/120 (42%)
Query: 281 KEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQD 340
+ E K + ++ K ++RKELEE + QE + Q L ++
Sbjct: 10 EREKEMASMKEEFTRLKEALEKSEARRKELEEKMVSLLQEKNDLQLQVQAEQDNLADAEE 69
Query: 341 QNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVRDIKKSIKR 400
+ L + + VKE+ +++ E+ K+ +L EC +R + D++ ++ +
Sbjct: 70 RCDQLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLEDECSELKRDIDDLELTLAK 129
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 20/155 (12%), Positives = 63/155 (40%)
Query: 247 LTDEEEKSQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306
+ E+++ ++++ K + ++ K +E EAK + + +
Sbjct: 109 ALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARK 168
Query: 307 RKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISA 366
+E L + ++ + ++ + + +E++TV + +LE Q + + EE+I
Sbjct: 169 LVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVL 228
Query: 367 VELLISFKQKRDQLRIECGNAQRRVRDIKKSIKRE 401
+ L + + + ++ + D++ + +
Sbjct: 229 SDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQ 263
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.79 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.78 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.77 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.74 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.74 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.74 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.73 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.72 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.72 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.72 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.72 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.72 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.57 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.54 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.53 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.53 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.51 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.51 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.5 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.5 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.5 | |
| 2kr4_A | 85 | Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ri | 99.46 | |
| 2kre_A | 100 | Ubiquitin conjugation factor E4 B; U-box domain, E | 99.46 | |
| 1wgm_A | 98 | Ubiquitin conjugation factor E4A; ubiquitinating e | 99.46 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.44 | |
| 2f42_A | 179 | STIP1 homology and U-box containing protein 1; cha | 99.41 | |
| 3m62_A | 968 | Ubiquitin conjugation factor E4; armadillo-like re | 99.37 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 2yu4_A | 94 | E3 SUMO-protein ligase NSE2; SP-ring domain, struc | 99.21 | |
| 2bay_A | 61 | PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin l | 99.17 | |
| 2c2l_A | 281 | CHIP, carboxy terminus of HSP70-interacting protei | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 1t1h_A | 78 | Gspef-atpub14, armadillo repeat containing protein | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3htk_C | 267 | E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL- | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.97 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3ztg_A | 92 | E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mR | 97.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.37 | |
| 3fl2_A | 124 | E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 1z6u_A | 150 | NP95-like ring finger protein isoform B; structura | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.6 | |
| 2y43_A | 99 | E3 ubiquitin-protein ligase RAD18; DNA repair, met | 96.6 | |
| 1jm7_B | 117 | BARD1, BRCA1-associated ring domain protein 1; rin | 95.96 | |
| 3hct_A | 118 | TNF receptor-associated factor 6; cross-brace, bet | 95.96 | |
| 2ckl_A | 108 | Polycomb group ring finger protein 4; BMI1, RING1B | 95.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.69 | |
| 2ckl_B | 165 | Ubiquitin ligase protein RING2; BMI1, RING1B, poly | 95.65 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 95.62 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 95.34 | |
| 2fxo_A | 129 | Myosin heavy chain, cardiac muscle beta isoform; c | 95.23 | |
| 2egp_A | 79 | Tripartite motif-containing protein 34; ZF-C3HC4 d | 95.14 | |
| 3hcs_A | 170 | TNF receptor-associated factor 6; cross-brace, bet | 95.08 | |
| 2b9c_A | 147 | Striated-muscle alpha tropomyosin; alpha-helix, co | 95.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.92 | |
| 2csy_A | 81 | Zinc finger protein 183-like 1; ring finger protei | 94.74 | |
| 2ecw_A | 85 | Tripartite motif-containing protein 30; metal bind | 94.57 | |
| 2ecv_A | 85 | Tripartite motif-containing protein 5; metal bindi | 94.56 | |
| 1jm7_A | 112 | BRCA1, breast cancer type 1 susceptibility protein | 94.56 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 94.31 | |
| 3l11_A | 115 | E3 ubiquitin-protein ligase RNF168; E3 ligase, rin | 94.3 | |
| 2ecy_A | 66 | TNF receptor-associated factor 3; metal binding pr | 94.18 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 93.99 | |
| 3lrq_A | 100 | E3 ubiquitin-protein ligase TRIM37; structural gen | 93.95 | |
| 1rmd_A | 116 | RAG1; V(D)J recombination, antibody, MAD, ring fin | 93.62 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 92.89 | |
| 2yur_A | 74 | Retinoblastoma-binding protein 6; P53-associated c | 92.57 | |
| 4ayc_A | 138 | E3 ubiquitin-protein ligase RNF8; DNA damage, K63 | 92.46 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 92.43 | |
| 2ocy_A | 154 | RAB guanine nucleotide exchange factor SEC2; RAB, | 92.32 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 92.11 | |
| 2djb_A | 72 | Polycomb group ring finger protein 6; PCGF6, ring | 92.07 | |
| 3knv_A | 141 | TNF receptor-associated factor 2; cross-brace, alt | 91.92 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 91.62 | |
| 3qwe_A | 279 | GMIP, GEM-interacting protein; structural genomics | 91.6 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 89.47 | |
| 3ng2_A | 71 | RNF4, snurf, ring finger protein 4; ring domain, E | 88.84 | |
| 3bas_A | 89 | Myosin heavy chain, striated muscle/general contro | 87.89 | |
| 2ocy_A | 154 | RAB guanine nucleotide exchange factor SEC2; RAB, | 87.88 | |
| 2ysl_A | 73 | Tripartite motif-containing protein 31; ring-type | 87.75 | |
| 3ol1_A | 119 | Vimentin; structural genomics, PSI-2, protein stru | 87.57 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 86.84 | |
| 3u1c_A | 101 | Tropomyosin alpha-1 chain; anti-parallel coiled co | 86.28 | |
| 3u1c_A | 101 | Tropomyosin alpha-1 chain; anti-parallel coiled co | 86.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.11 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 85.95 | |
| 2fxo_A | 129 | Myosin heavy chain, cardiac muscle beta isoform; c | 85.74 | |
| 3mq7_A | 121 | Bone marrow stromal antigen 2; HIV, antiviral prot | 84.57 | |
| 2ect_A | 78 | Ring finger protein 126; metal binding protein, st | 84.05 | |
| 2xeu_A | 64 | Ring finger protein 4; transcription, zinc-finger, | 84.02 | |
| 1sur_A | 215 | PAPS reductase; assimilatory sulfate reduction, 3- | 84.0 | |
| 3s4r_A | 93 | Vimentin; alpha-helix, cytoskeleton, intermediate | 83.99 | |
| 1wt6_A | 81 | Myotonin-protein kinase; coiled-coil, kinase activ | 83.67 | |
| 3swk_A | 86 | Vimentin; cytoskeleton, intermediate filament, alp | 83.64 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.42 | |
| 3hnw_A | 138 | Uncharacterized protein; coiled-coil, structural g | 82.86 | |
| 2ct2_A | 88 | Tripartite motif protein 32; zinc-finger protein H | 82.76 | |
| 3q8t_A | 96 | Beclin-1; autophagy, ATG14L uvrag, apoptosis; 1.90 | 81.05 | |
| 1g25_A | 65 | CDK-activating kinase assembly factor MAT1; ring f | 80.94 | |
| 3u59_A | 101 | Tropomyosin beta chain; muscle contraction, actin, | 80.79 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.43 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=456.89 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=208.7
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~ 499 (780)
++|...++||+|+||+||+|.+++ .||||+++.. .......|.+|+.+|++++|||||+++|+|.+ ..+||||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCC
Confidence 578888999999999999999876 5999998753 33455789999999999999999999999955 4689999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
||+|.++|. ....+++|..++.|+.|||.||.|||+.+ ||||||||+||||+.++.+||+|||+|+........
T Consensus 115 gGsL~~~l~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-- 188 (307)
T 3omv_A 115 GSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-- 188 (307)
T ss_dssp SCBHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc--
Confidence 999999996 34467999999999999999999999999 999999999999999999999999999876432211
Q ss_pred CcccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchhHH---HHHHhccccccccCcCCC
Q 044673 580 SALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK---CALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~---~~~~~~~~~~~ld~~~~~ 653 (780)
...+...||+.|||||++.+ +.|+.++|||||||+||||+||++||...+... ..+..+. ..+....
T Consensus 189 ---~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~ 261 (307)
T 3omv_A 189 ---QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY----ASPDLSK 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC----CCCCSTT
T ss_pred ---eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCCccc
Confidence 12345689999999999964 469999999999999999999999997654332 2222221 2222334
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.+..++..+.+|+.+||+.||.+||++ .+|+..|+.++.
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~Le~l~~ 300 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLF-PQILSSIELLQH 300 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCH-HHHHHHHHHHHT
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhc
Confidence 445667789999999999999999999 999999998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=457.18 Aligned_cols=255 Identities=24% Similarity=0.435 Sum_probs=213.4
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...++||+|+||.||+|.+. +..||||+++..+......|.+|+.+|++++|||||+++|+|.+. .+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 467999999887777778899999999999999999999999654 679
Q ss_pred EEEeccCCChhhHHhhh----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 494 VFEYLRNGSLEDCLACK----------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
|||||++|+|.++|... .....|+|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEEC
Confidence 99999999999999643 23457999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHh
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEK 640 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~ 640 (780)
|||+|+....... ........||+.|||||++.++.|+.++|||||||+||||+| |++||...+... ..+..
T Consensus 171 DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 171 DFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred CcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999987643211 111234568999999999999999999999999999999999 899997655432 22222
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
+. ....|..++..+.+|+.+||+.||.+||++ .+|.+.|+.+..
T Consensus 246 ~~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 GR--------VLQRPRTCPQEVYELMLGCWQREPHMRKNI-KGIHTLLQNLAK 289 (299)
T ss_dssp TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CC--------CCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 22 233455667789999999999999999999 899999998854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=458.35 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=208.1
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...++||+|+||.||+|.+. +..||||+++..+......|.+|+.+|++++|||||+++|+|.+. .+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999874 467999999887777778899999999999999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 494 VFEYLRNGSLEDCLACKN------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
|||||++|+|.++|.... ...+|+|.+++.|+.||+.||.|||+.+ ||||||||+||||+.++.+|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEE
Confidence 999999999999996432 2357999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--AL 638 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~ 638 (780)
|+|||+|+.+..... ....+...||+.|||||++.+..|+.++|||||||+||||+| |++||...+.... .+
T Consensus 199 i~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp ECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred EcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999987643221 112245679999999999999999999999999999999999 8999976554322 22
Q ss_pred HhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 639 EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 639 ~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+ .....|..++..+.+|+.+||+.||.+||++ .+|++.|+.+..
T Consensus 274 ~~g--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 TQG--------RELERPRACPPEVYAIMRGCWQREPQQRHSI-KDVHARLQALAQ 319 (329)
T ss_dssp HHT--------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred HcC--------CCCCCcccccHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHhh
Confidence 222 1223455567789999999999999999999 999999998853
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=454.05 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=208.9
Q ss_pred CCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~L 493 (780)
++...++||+|+||.||+|.+. +..||||+++... ......|.+|+.+|++++|||||+|+|+|.+ ..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556789999999999999873 4679999997643 3345789999999999999999999999965 4689
Q ss_pred EEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCc
Q 044673 494 VFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGS 560 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~ 560 (780)
|||||++|+|.++|..... ...|+|..+++|+.|||.||.|||+.+ ||||||||+||||++++.+
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCE
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCCE
Confidence 9999999999999964321 346999999999999999999999999 9999999999999999999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CA 637 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~ 637 (780)
||+|||+|+.+..... ....+...||+.|||||++.++.|+.++|||||||+||||+| |++||...+... ..
T Consensus 185 Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 185 KISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp EECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred EECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999987643211 112345689999999999999999999999999999999999 899997655432 22
Q ss_pred HHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 638 ~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+..+ .....|..++..+.+|+.+||+.||.+||++ .+|++.|+.+
T Consensus 260 i~~~--------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNR--------QVLPCPDDCPAWVYALMIECWNEFPSRRPRF-KDIHSRLRAW 304 (308)
T ss_dssp HHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred HHcC--------CCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhc
Confidence 2222 2223455667789999999999999999999 8999988854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=431.76 Aligned_cols=242 Identities=21% Similarity=0.356 Sum_probs=194.7
Q ss_pred CcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC------CCeeEE
Q 044673 426 EPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------SRSLVF 495 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~~~LV~ 495 (780)
....+||+|+||.||+|.+. +..||||++... .......|.+|+.+|++++|||||+++++|.+ ..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999986 567999998642 33445679999999999999999999999843 247999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~ 574 (780)
|||+||+|.++|.. ..++++..+..|+.||+.||.|||+++|+||||||||+||||+. +|.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999963 45799999999999999999999999888999999999999985 899999999999865321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.....+||+.|||||++. +.|+.++|||||||+||||+||++||..............- . .. ...+
T Consensus 186 ---------~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~-~~--~~~~ 251 (290)
T 3fpq_A 186 ---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VK--PASF 251 (290)
T ss_dssp ---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CC--CGGG
T ss_pred ---------ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C-CC--CCCC
Confidence 123468999999999886 46999999999999999999999999755443332221100 0 00 1112
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+...+.++.+|+.+||..||.+||++ .+++
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~-~e~l 281 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSI-KDLL 281 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 22334578999999999999999999 6664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=437.79 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=199.5
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC------CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------~~LV~E 496 (780)
.+|...++||+|+||.||+|.++++.||||++.... .....+..|+..+.+++|||||+++|+|.+. .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 346677899999999999999999999999996532 2222344566777889999999999999542 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCccccCCCCCCceEecCCCCccccccccccc
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN------EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
||++|+|.++|.. .+++|..+++|+.|++.||.|||+. .|+||||||||+|||||.++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999953 4699999999999999999999986 23499999999999999999999999999988
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC------CCCcchhHHHHHHHHHHHHhCCCCCccchhH----------
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG------KLTPESDVYSFGIILLRLLTGRPVLRIKKDV---------- 634 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~---------- 634 (780)
....... .........||+.|||||++.+. .++.++|||||||+||||+||.+||+.....
T Consensus 158 ~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 158 HDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 7543221 11122346899999999999754 3678999999999999999998877532210
Q ss_pred ---HHHHHhccccccccCcCCC--CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 635 ---KCALEKRNFNSVLDSSAGD--WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 635 ---~~~~~~~~~~~~ld~~~~~--~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...+........+++..+. .+...+..+.+|+.+||+.||.+|||+ .+|++.|+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~~l~~ 297 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHH
Confidence 0111111111222222211 123566789999999999999999999 999999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=441.58 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|++++|||||+++++|.+. .||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999875 678999998753 334456799999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|||+||+|.++|.. .+...+++...+.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999963 24456899999999999999999999999 9999999999999999999999999998764211
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
...+..+||+.|||||++.+..|+.++||||||||||||+||++||...+........ +.......+
T Consensus 180 -------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~~~~~ 246 (350)
T 4b9d_A 180 -------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------ISGSFPPVS 246 (350)
T ss_dssp -------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHTCCCCCC
T ss_pred -------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HcCCCCCCC
Confidence 1123457999999999999999999999999999999999999999876554322111 111112233
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+|+.+||+.||.+||++ .++++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~-~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSV-NSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 3456789999999999999999999 77754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=439.35 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=204.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
..|....+||+|+||.||+|.+. +..||||++..........|.+|+.+|++++|||||+++++|.+. .|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999985 678999999765455566788999999999999999999999544 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+||+|.+++.. ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence 99999999852 46999999999999999999999999 99999999999999999999999999987753221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
..+..+||+.|||||++.+..|+.++||||||||||||+||++||...+........ ..-..+. ...+...
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~-~~~~~~~ 296 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPR-LKNLHKV 296 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSSCCC-CSCGGGS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCC-CCccccC
Confidence 234578999999999999999999999999999999999999999866554322111 0001111 1223355
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+.+|+.+||+.||.+||++ .+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta-~e~l 322 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATA-AELL 322 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH-HHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCH-HHHh
Confidence 6789999999999999999999 6653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=443.08 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=214.9
Q ss_pred HHHHHHHhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCC-CceeeEee
Q 044673 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRH-PNLVTLIG 485 (780)
Q Consensus 415 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~H-pnIv~l~g 485 (780)
..+.+-..++|...+.||+|+||.||+|.+.+ +.||||++..... .....|.+|+.+|++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34444445789999999999999999998753 4699999976543 345679999999999965 99999999
Q ss_pred eecC---CCeeEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 486 TCPE---SRSLVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 486 ~~~~---~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
+|.+ ..+||||||++|+|.++|.... ....|+|..++.|+.|||.||.|||+.+ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 9943 2589999999999999996432 1356999999999999999999999999 99999999
Q ss_pred CceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 044673 550 SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVL 628 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~ 628 (780)
+||||+.++.+||+|||+|+.+..... ....+...||+.|||||++.++.|+.++|||||||+||||+| |++||
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 999999999999999999987653321 112345678999999999999999999999999999999998 99999
Q ss_pred ccchh---HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 629 RIKKD---VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 629 ~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+. +...+..+. ....|...+.++.+|+.+||+.||.+||++ .+|++.|+.+.
T Consensus 289 ~~~~~~~~~~~~i~~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-~eil~~L~~ll 346 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLL 346 (353)
T ss_dssp TTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHH
Confidence 75432 222333221 223444566789999999999999999999 99999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=435.71 Aligned_cols=252 Identities=18% Similarity=0.220 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.+.|...++||+|+||.||+|.+. +..||||+++.... +.+|+.+|++++|||||+++++|.+. .||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 467888889999999999999985 67899999975322 24799999999999999999999654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-CcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~~~~~ 576 (780)
|+||+|.++|.. .+++++..+..|+.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999963 357999999999999999999999999 99999999999999988 599999999988754321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~ 654 (780)
. .........+||+.|||||++.+..|+.++|||||||+||||+||++||...+.. ...+..+. +.....
T Consensus 207 ~--~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~ 278 (336)
T 4g3f_A 207 G--KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------PPIREI 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------CGGGGS
T ss_pred c--cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------CCchhc
Confidence 1 1112234468999999999999999999999999999999999999999754321 11111111 111123
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
|...+..+.+|+.+||+.||.+||++ .++++.|....
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa-~el~~~l~~~l 315 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASA-MELRRKVGKAL 315 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHH
Confidence 44567789999999999999999999 88988887764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=428.22 Aligned_cols=242 Identities=23% Similarity=0.335 Sum_probs=204.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||+||+|... +..||||++... .......+.+|+.+|++++|||||++++++.+. .||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 678999998642 123356789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||++||+|.++|.. .+.+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999963 356999999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
. .......+||+.|||||++.+..|+.++|||||||+||+|+||++||...+..... +..+. ..
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------~~ 252 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---------YD 252 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------CC
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence 1 11234578999999999999999999999999999999999999999866543321 12221 23
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
+|...+.++.+|+.+||+.||.+||++ .++
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~-~e~ 282 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGC-EEM 282 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTS-GGG
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcCh-HHH
Confidence 445566789999999999999999999 655
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=438.56 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=204.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
+.|...++||+|+||.||+|.+. +..||||++..........|.+|+.+|++++|||||+++++|.+. .|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57889999999999999999985 678999999776666667789999999999999999999998544 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
+||+|.+++.. ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 99999999852 45999999999999999999999999 99999999999999999999999999987753221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
..+..+||+.|||||++.+..|+.++||||||||||||+||++||...+........ .....+.. ..+...
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~~-~~~~~~ 373 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL-KNLHKV 373 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCC-SCTTSS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCCC-cccccC
Confidence 234568999999999999999999999999999999999999999866554322111 00011111 122345
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+.+|+.+||..||.+||++ .+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta-~ell 399 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATA-AELL 399 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH-HHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCH-HHHh
Confidence 6789999999999999999999 6653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=414.79 Aligned_cols=241 Identities=25% Similarity=0.373 Sum_probs=188.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||++++++.+. .++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 378999999999999999999874 6889999986532 23356799999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+ +|+|.+++. ..+++++.....|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999 689999985 3457999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
. .....+||+.|||||++.+..| +.++|||||||+||+|+||++||...+.... .+..+.
T Consensus 166 ~--------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--------- 228 (275)
T 3hyh_A 166 N--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--------- 228 (275)
T ss_dssp -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred C--------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------
Confidence 1 1235689999999999998776 5799999999999999999999986554321 111221
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+|...+..+.+|+.+||+.||.+||++ .++++
T Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~-~eil~ 262 (275)
T 3hyh_A 229 YTLPKFLSPGAAGLIKRMLIVNPLNRISI-HEIMQ 262 (275)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCH-HHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCH-HHHHc
Confidence 22344566789999999999999999999 77654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=424.59 Aligned_cols=237 Identities=24% Similarity=0.298 Sum_probs=192.7
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||+++++|.+. .||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 4679999987532 22344688999999999999999999999554 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||||+||+|.++|.. .+++++..+..|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999963 357999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
... .....+||+.|||||++.+..|+.++|||||||+||||+||++||...+..... +..+ .
T Consensus 179 ~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------~ 242 (304)
T 3ubd_A 179 HEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------K 242 (304)
T ss_dssp --C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------C
T ss_pred CCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------C
Confidence 211 124568999999999999999999999999999999999999999876544322 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+|...+.++.+|+.+||+.||.+||+.
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 23445567789999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=418.44 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=187.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC---------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--------- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--------- 490 (780)
++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999875 6789999986533 33456799999999999999999999988421
Q ss_pred -----CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 491 -----RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 491 -----~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
.|+|||||++|+|.+++.........++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEccC
Confidence 3799999999999999975544456778889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCC-----CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh
Q 044673 566 GFFHLIPQGESTGN-----SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640 (780)
Q Consensus 566 Gla~~~~~~~~~~~-----~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~ 640 (780)
|+|+.+........ ......+..+||+.|||||++.+..|+.++|||||||+||||++ ||.........+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 99988754322111 11122345689999999999999999999999999999999997 66543322222111
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.....+..+......+.+|+.+||+.||.+||++ .+++
T Consensus 240 -----~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-~eil 278 (299)
T 4g31_A 240 -----VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-INII 278 (299)
T ss_dssp -----HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred -----HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-HHHh
Confidence 01111111122344567889999999999999999 6664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=409.14 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=197.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC--------C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--------S 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--------~ 490 (780)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|++++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999885 6789999997532 3345678899999999999999999998742 3
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.|||||||+ |+|.+++. ...++++..+..|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence 489999995 68999985 4568999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH----hccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE----KRNFNS 645 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~----~~~~~~ 645 (780)
+...... .....+..+||+.|||||++.+. .++.++||||||||||||+||++||...+....... .+....
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 6432111 12234567899999999998775 579999999999999999999999987665432211 111110
Q ss_pred c-------------ccC--cCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 646 V-------------LDS--SAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 646 ~-------------ld~--~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
. +.. .....+ ...+.++.+|+.+||..||.+||++ .++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~ 342 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-AAA 342 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 0 000 000011 1235678899999999999999999 655
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=395.20 Aligned_cols=200 Identities=24% Similarity=0.320 Sum_probs=165.6
Q ss_pred HhcCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Ce
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~ 492 (780)
..+.|...++||+|+||.||+|..+ +..||||.+.... ....+.+|+.+|..+ +|||||+++++|.+. .|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999763 4679999886543 345678999999998 699999999998544 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCcccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLI 571 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~~ 571 (780)
|||||+++|+|.+++. .+++.++..|+.||+.||.|||+.+ ||||||||+||||+.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999982 4899999999999999999999999 9999999999999877 79999999999866
Q ss_pred cCCCCCC---------------------CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCc
Q 044673 572 PQGESTG---------------------NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLR 629 (780)
Q Consensus 572 ~~~~~~~---------------------~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~ 629 (780)
....... .......+..+||+.|+|||++.+. .|+.++||||+|||||||+||++||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 4321100 0001123456899999999999875 58999999999999999999999995
Q ss_pred c
Q 044673 630 I 630 (780)
Q Consensus 630 ~ 630 (780)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=376.30 Aligned_cols=277 Identities=32% Similarity=0.619 Sum_probs=231.5
Q ss_pred CCccccCHHHHHHHhcCCCcc------cccccCCceEEEEeeecCeeEEEEEccCC----CchhHHHHHHHHHHhhcCCC
Q 044673 408 PGLLEFSFSELNEATNNFEPS------WKIGEGRYGNVYRGLLRHLHVAIKMFPSY----GPQSHLKFQNEVEVLSRVRH 477 (780)
Q Consensus 408 ~~~~~~~~~ei~~at~~f~~~------~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~----~~~~~~~f~~Ev~il~~l~H 477 (780)
..+..|++.++..++++|+.. ++||+|+||.||+|..++..||||++... .......|.+|+.++++++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999999999988 89999999999999999999999998653 23345679999999999999
Q ss_pred CceeeEeeeecC--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 478 PNLVTLIGTCPE--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 478 pnIv~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
|||+++++++.+ ..++||||+++|+|.+++.......+++|..++.|+.+++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~ 167 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD 167 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc
Confidence 999999999965 46899999999999999976556678999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-- 633 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-- 633 (780)
.++.+||+|||+++....... ........||+.|+|||.+.+ .++.++|||||||++|+|+||.+||.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred CCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 999999999999987643211 112234679999999998864 588999999999999999999999974332
Q ss_pred ----HHHHHH--hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 634 ----VKCALE--KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 634 ----~~~~~~--~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
....+. ...+...++......+...+..+.+++.+||..+|.+||++ .++++.|+.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQLLQEMTA 306 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHC-
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHhc
Confidence 111111 12233445555666788889999999999999999999999 899999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.44 Aligned_cols=260 Identities=29% Similarity=0.433 Sum_probs=207.4
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|.+.+..||||++.... ......|.+|+.+|++++||||++++++|.+. .++||||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4789999999999999999999999999999987643 33446799999999999999999999999654 5899999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++........+++..++.|+.|++.||.|||+.+++|+||||||+|||++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-- 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-- 193 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence 999999999964332334999999999999999999999998889999999999999999999999999997653221
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.......... .......|..
T Consensus 194 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~ 263 (309)
T 3p86_A 194 -----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KCKRLEIPRN 263 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----SCCCCCCCTT
T ss_pred -----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cCCCCCCCcc
Confidence 112346789999999999999999999999999999999999999986654332211110 1112233445
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
.+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~-~~ll~~L~~~~~~ 299 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSF-ATIMDLLRPLIKS 299 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 66789999999999999999999 9999999988643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=379.70 Aligned_cols=274 Identities=32% Similarity=0.566 Sum_probs=227.8
Q ss_pred cccCHHHHHHHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC
Q 044673 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489 (780)
Q Consensus 411 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~ 489 (780)
..+++.++..++++|...+.||+|+||.||+|.+. +..||||++..........|.+|+.++++++||||++++++|.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 35667777888999999999999999999999975 68899999987766677889999999999999999999999965
Q ss_pred C--CeeEEEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
. .++||||+++|+|.+++.... ....++|..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence 4 679999999999999996432 2346999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh---------HHHH
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---------VKCA 637 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---------~~~~ 637 (780)
+++........ .......||+.|+|||++.++.++.++|||||||++|+|+||++||..... ....
T Consensus 185 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 185 ISKKGTELDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp TCEECSSSSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred ccccccccccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99765422111 112345689999999999999999999999999999999999999863321 1122
Q ss_pred HHhccccccccCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 638 LEKRNFNSVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 638 ~~~~~~~~~ld~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+.+..++++. ....+...+..+.+++.+||..||.+||++ .++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~l 314 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLEYAL 314 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHh
Confidence 2344455555554 345677889999999999999999999999 89999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=414.33 Aligned_cols=247 Identities=20% Similarity=0.320 Sum_probs=205.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|.+.+.||+|+||.||+|... +..||||++..........+.+|+.+|++++|||||+|+++|.+. .+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999885 678999999876666677899999999999999999999999665 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC--CCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN--FGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~--~~~Kl~DFGla~~~~~~~ 575 (780)
|+||+|.++|. .....|++..+..|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~--~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHT--CTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999985 34457999999999999999999999999 9999999999999854 889999999998875322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~~ 653 (780)
. ....+||+.|||||++.+..|+.++|||||||+||+|++|++||...+...... ..+.+. ++. .
T Consensus 312 ~--------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~---~ 378 (573)
T 3uto_A 312 S--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDD---S 378 (573)
T ss_dssp E--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCS---G
T ss_pred c--------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CCc---c
Confidence 1 234579999999999999999999999999999999999999998766543322 222111 111 1
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+...+..+.+|+.+||+.||.+||++ .++++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~-~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTI-HQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 112345678999999999999999999 77653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=382.06 Aligned_cols=275 Identities=35% Similarity=0.622 Sum_probs=226.6
Q ss_pred CCccccCHHHHHHHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 408 PGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 408 ~~~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
.....|++.++..++++|...+.||+|+||.||+|... +..||||++..... .....|.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 44678999999999999999999999999999999874 68899999876432 22336899999999999999999999
Q ss_pred eecCC--CeeEEEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCccccCCCCCCceEecCCCC
Q 044673 486 TCPES--RSLVFEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSN---EPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 486 ~~~~~--~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~---~~~ivHrDlKp~NILLd~~~~ 559 (780)
+|.+. .++||||+++|+|.+++.... ...+++|..+..|+.+++.||.|||+. + |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCC
Confidence 99554 689999999999999996433 345699999999999999999999998 7 999999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------ 633 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------ 633 (780)
+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|+|+||++||.....
T Consensus 173 ~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp EEECCCSSCEECCSSSS------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred EEeccCccccccCcccc------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 99999999987643221 122445699999999999999999999999999999999999999962211
Q ss_pred -----HHHHHHhccccccccCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 634 -----VKCALEKRNFNSVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 634 -----~~~~~~~~~~~~~ld~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+...+....+..+.+.. .+.++...+..+.+++.+||+.+|.+||++ .+|++.|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~~ 309 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-SEVVRMLEGD 309 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHTS
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-HHHHHHhcCc
Confidence 11111222333444433 456678889999999999999999999999 8999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=414.96 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=193.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC------CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY------GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~------~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|... +..||||++... ..........++.+++.++|||||+|+++|.+. .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999885 678999998642 111122233456778888999999999999654 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
||||||++||+|.++|.. .+.+++.....|+.||+.||.|||+.+ ||||||||+|||||.+|++||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 799999999999999963 356999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld~ 649 (780)
.... ....+||+.|||||++.. ..|+.++||||||||||||+||++||...+.. ...+.... + .
T Consensus 343 ~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----~-~ 408 (689)
T 3v5w_A 343 SKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----L-T 408 (689)
T ss_dssp SSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----H-H
T ss_pred CCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----c-C
Confidence 4321 234689999999999975 47999999999999999999999999753321 01111111 1 1
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
....+|...+.++.+|+.+||+.||.+|++.
T Consensus 409 ~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 1223455567889999999999999999984
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=382.61 Aligned_cols=292 Identities=22% Similarity=0.340 Sum_probs=219.3
Q ss_pred cCCCcccccccCCceEEEEeeec--C----eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--H----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
++|...++||+|+||.||+|.+. + ..||+|.+... .......|.+|+.++++++||||++++++|.+. .++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 57899999999999999999874 2 24689988643 234567899999999999999999999999655 5699
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 95 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999999963 3467999999999999999999999999 999999999999999999999999999887533
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
... .......||+.|+|||++.++.++.++|||||||++|+|+| |++||..... ....+..+. .
T Consensus 171 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------~ 237 (327)
T 3poz_A 171 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------R 237 (327)
T ss_dssp CC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------C
T ss_pred ccc-----ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--------C
Confidence 211 12234567889999999999999999999999999999999 9999975443 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCC----CCCccCCCCCccccCCccccccccccccCcc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCV----FPVSCSGSKEHRRIPSHFVCPILQEVMKDPQ 727 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~----~~~~~~~~~~~~~~Ps~f~CPi~~evm~dP~ 727 (780)
...|...+..+..++.+||+.+|.+||++ .+++..|+.+..... ..... ........++.|.+++..+.+.|++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell~~l~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~ 315 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARDPQRYLVIQGDE-RMHLPSPTDSNFYRALMDEEDMDDV 315 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHHHHTSHHHHBCCTTGG-GCCCCCTTTCHHHHHHHC------C
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHhhhhhhhhhcCCC-ccCCCCCCchHHHHhcccccccccc
Confidence 22344456789999999999999999999 899999998853211 11000 0111123345677888888888898
Q ss_pred cccCCc
Q 044673 728 IAADGF 733 (780)
Q Consensus 728 ia~dg~ 733 (780)
+.+|++
T Consensus 316 ~~~d~~ 321 (327)
T 3poz_A 316 VDADEY 321 (327)
T ss_dssp CCHHHH
T ss_pred cCHHHc
Confidence 877764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.86 Aligned_cols=250 Identities=29% Similarity=0.426 Sum_probs=204.4
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCCCeeEEEeccCCC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGS 502 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~~LV~Ey~~~gs 502 (780)
++|...+.||+|+||.||+|.+.+..||||.+... .....|.+|+.++++++||||++++++|.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 57888899999999999999999999999999753 4567899999999999999999999999988999999999999
Q ss_pred hhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCccccCCCCCCceEecCCCC-cccccccccccccCCCCCC
Q 044673 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS---NEPCIIHGNLKPSKVLIDANFG-SKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 503 L~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~---~~~~ivHrDlKp~NILLd~~~~-~Kl~DFGla~~~~~~~~~~ 578 (780)
|.+++........+++..++.|+.|++.||.|||+ .+ |+||||||+|||++.++. +||+|||++......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 99999754444568999999999999999999999 56 999999999999998887 799999998765321
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHH--HHHhccccccccCcCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKC--ALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~--~~~~~~~~~~ld~~~~~~ 654 (780)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ... ....+ .....
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 225 (307)
T 2eva_A 160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--------TRPPL 225 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--------CCCCC
T ss_pred ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--------CCCCc
Confidence 1234689999999999999999999999999999999999999974322 111 11111 11122
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
+...+..+.+++.+||..+|.+||++ .++++.|+.+....
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~ 265 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSM-EEIVKIMTHLMRYF 265 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHGGGC
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHhc
Confidence 23445678999999999999999999 99999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=372.18 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=208.7
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|.+. +..||||++... .......|.+|+.++++++||||++++++|.+. .++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 57888899999999999999873 346999999764 344556799999999999999999999999654 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. .....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 129 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999995 34457999999999999999999999999 999999999999999999999999999877533
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ........+|+.|+|||++.+..++.++|||||||++|+|+| |..||............ .......
T Consensus 205 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------~~~~~~~ 274 (325)
T 3kul_A 205 PDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------EEGYRLP 274 (325)
T ss_dssp --C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------HTTCCCC
T ss_pred ccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HcCCCCC
Confidence 211 122334567888999999999999999999999999999999 99999755443221110 1111222
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
.|...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~-~eil~~L~~l~~~ 314 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRF-SQIVSVLDALIRS 314 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhC
Confidence 344556789999999999999999999 9999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=366.20 Aligned_cols=263 Identities=24% Similarity=0.399 Sum_probs=208.9
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec----CCCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP----ESRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~----~~~~ 492 (780)
++|...++||+|+||.||+|.+ .+..||||++..........|.+|+.++++++||||++++++|. ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 6788999999999999999984 35789999998776666778999999999999999999999983 2368
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||+++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 90 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999963 2345999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH-HHHhc---------c
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC-ALEKR---------N 642 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~-~~~~~---------~ 642 (780)
..... ........+|..|+|||++.+..++.++|||||||++|+|+||..|+........ ..... .
T Consensus 166 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 166 QDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp --------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred CCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 32211 1122345678889999999999999999999999999999999999875432111 11000 0
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...+........|...+..+.+|+.+||..+|.+||++ .++++.|+.++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHh
Confidence 00111112233455567889999999999999999999 9999999998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=374.35 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=205.3
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC------CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------~~LV~ 495 (780)
.++|...++||+|+||.||+|.+.+..||||++... ......+.+|+.++++++|||||+++++|.+. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 368999999999999999999999999999998653 23345567799999999999999999998543 37999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCccccCCCCCCceEecCCCCcccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN----------EPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
||+++|+|.+++.. .+++|..++.|+.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999953 3599999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-----CCCcchhHHHHHHHHHHHHhCCCCCccchh-----HH
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-----KLTPESDVYSFGIILLRLLTGRPVLRIKKD-----VK 635 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-----~~ 635 (780)
|+++.+...... .......||+.|+|||++.+. .++.++|||||||++|+|+||++||..... ..
T Consensus 176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999877533211 122446799999999999863 456789999999999999999999864221 00
Q ss_pred ---------HHHHhccccccccCcCCC-C-CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 636 ---------CALEKRNFNSVLDSSAGD-W-PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 636 ---------~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+..........+.... | +...+..+.+|+.+||+.||.+||++ .++++.|+.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~l~~ 318 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA-GCVGERITQMQR 318 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHH
Confidence 000000001111111111 1 22456779999999999999999999 999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=375.68 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=210.0
Q ss_pred hcCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCCc-hhHHHHHHHHHHhhcC-CCCceeeEeeeecCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~ 490 (780)
.++|...+.||+|+||.||+|.+. +..||||++..... .....|.+|+.+++++ +|||||+++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999863 24699999976533 3456799999999999 899999999999654
Q ss_pred --CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT 237 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC
Confidence 6899999999999999964321 245899999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999876432211 12234567889999999999999999999999999999999 99999754321
Q ss_pred --HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 635 --KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 635 --~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...+..+ .....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 313 ~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELFKLLKEG--------HRMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILT 364 (370)
T ss_dssp GHHHHHHTT--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 1222222 1223344566789999999999999999999 999999998853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=367.28 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=210.9
Q ss_pred cccCHHHHHHHhcC----------CCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCC
Q 044673 411 LEFSFSELNEATNN----------FEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHP 478 (780)
Q Consensus 411 ~~~~~~ei~~at~~----------f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hp 478 (780)
..|+++++..+++. |....+||+|+||.||+|... +..||||++..........|.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35788888888865 666779999999999999874 788999999876666677899999999999999
Q ss_pred ceeeEeeeecC--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 479 NLVTLIGTCPE--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 479 nIv~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
||++++++|.. ..++||||+++|+|.+++. ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC
Confidence 99999999854 4679999999999999984 346999999999999999999999999 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
++.+||+|||+++.+..... ......||+.|+|||++.++.++.++|||||||++|+|+||++||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCcEEEeeeeeeeecccCcc-------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999987643211 12346799999999999999999999999999999999999999976554332
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.... .....+. ...+...+..+.+++.+||..||.+||++ .++++
T Consensus 250 ~~~~---~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~ 294 (321)
T 2c30_A 250 MKRL---RDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATA-QELLD 294 (321)
T ss_dssp HHHH---HHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCH-HHHHT
T ss_pred HHHH---hcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 2110 0001111 11122345679999999999999999999 66643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=365.56 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=204.0
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
.++|...++||+|+||.||+|.. .+..||||++..........+.+|+.++++++||||++++++|.+ ..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999976 467899999876555556778999999999999999999999854 46799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++.. ..+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999953 35899999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...+........... .......|..
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----GTPELQNPEK 241 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH----CSCCCSCGGG
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCCCccc
Confidence 124567999999999999999999999999999999999999999766544322211100 0011122445
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+..+.+|+.+||+.||.+||++ .+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~-~ell 268 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSA-KELL 268 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCH-HHHT
T ss_pred cCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 66779999999999999999999 6664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=367.52 Aligned_cols=263 Identities=23% Similarity=0.412 Sum_probs=208.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|...+.||+|+||.||+|.+. +..||+|.+..........|.+|+.++++++||||++++++|.+. .++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 67888999999999999999985 678999998777677778899999999999999999999999544 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999963 3467999999999999999999999999 9999999999999999999999999998765332111
Q ss_pred CC-------cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcC
Q 044673 579 NS-------ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 579 ~~-------~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~ 651 (780)
.. .........||+.|+|||++.+..++.++|||||||++|+|+||.+|+.......... .......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~-- 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-GLNVRGFLDR-- 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-SBCHHHHHHH--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-hhhhhccccc--
Confidence 00 0011125679999999999999999999999999999999999999886322100000 0000000000
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
..|...+..+.+++.+||+.||.+||++ .++++.|+.++..
T Consensus 243 -~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 -YCPPNCPPSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMH 283 (310)
T ss_dssp -TCCTTCCTTHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred -cCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 1122344568999999999999999999 8999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=365.54 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhc--CCCCceeeEeeeecC------CCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSR--VRHPNLVTLIGTCPE------SRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~--l~HpnIv~l~g~~~~------~~~L 493 (780)
.++|...+.||+|+||.||+|.+++..||||++.. .....+..|.+++.. ++||||+++++++.+ ..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46899999999999999999999999999999864 344556677777766 799999999998633 2579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCccccCCCCCCceEecCCCCcccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH--------SNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
||||+++|+|.+++. ...+++..++.|+.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999993 357999999999999999999999 777 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccC------CCCcchhHHHHHHHHHHHHhC----------CCCCc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG------KLTPESDVYSFGIILLRLLTG----------RPVLR 629 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~ksDVwS~Gvil~eLltG----------~~p~~ 629 (780)
|+++........ .........||+.|+|||++.+. .++.++|||||||++|+|+|| .+||.
T Consensus 158 g~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 158 GLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp TTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999876533211 11122445799999999999876 455799999999999999999 88875
Q ss_pred cchh----HHHHHHhccccccccCcCC--CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 630 IKKD----VKCALEKRNFNSVLDSSAG--DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 630 ~~~~----~~~~~~~~~~~~~ld~~~~--~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.... ....... .......+... ..+...+..+.+|+.+||+.||.+||++ .+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKV-VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-LRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHH-HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHH
T ss_pred ccCCCCcchhhhhHH-HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-HHHHHHHhcc
Confidence 3211 1111110 00001111111 1123567889999999999999999999 8999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=375.89 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=198.0
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|.+. +..||||++... .......|.+|+.++++++|||||+++++|.+. .++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999874 467999999764 334456799999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 125 ~e~~~~~sL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999996 33457999999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
... ........+|+.|+|||++.++.++.++|||||||+||||+| |++||........ .+..+ ..
T Consensus 201 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~--------~~ 268 (373)
T 2qol_A 201 PEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--------YR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT--------EE
T ss_pred Ccc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CC
Confidence 211 111223346778999999999999999999999999999998 9999975543221 22211 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...+...+..+.+|+.+||+.+|.+||++ .+|++.|+.+...
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~-~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKF-EQIVSILDKLIRN 310 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCH-HHHHHHHHHHHhC
Confidence 12233456779999999999999999999 9999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.46 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=205.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchh-------HHHHHHHHHHhhcCCCCceeeEeeeecCCCe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQS-------HLKFQNEVEVLSRVRHPNLVTLIGTCPESRS 492 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~-------~~~f~~Ev~il~~l~HpnIv~l~g~~~~~~~ 492 (780)
.++|...+.||+|+||.||+|.+. +..||||++....... ...|.+|+.++++++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 378999999999999999999884 6789999986533221 1578999999999999999999999999899
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-----cccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-----SKLSDFGF 567 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~-----~Kl~DFGl 567 (780)
+||||+++|+|.+++. ....++++..++.|+.|++.||.|||+.+++|+||||||+|||++.++. +||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEECCTTCBHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEEEecCCCCHHHHHh--cccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999999999885 3456799999999999999999999999888999999999999988776 99999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhc--cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE--TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS 645 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~ 645 (780)
++..... .....||+.|+|||++. ...++.++|||||||++|+|+||+.||................
T Consensus 176 ~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~- 244 (287)
T 4f0f_A 176 SQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE- 244 (287)
T ss_dssp CBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-
T ss_pred ccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-
Confidence 8744321 23457899999999984 4567899999999999999999999997543211110000000
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
.......|...+..+.+++.+||..||.+||++ .++++.|+.
T Consensus 245 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~ 286 (287)
T 4f0f_A 245 --EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-SYIVKELSE 286 (287)
T ss_dssp --SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHT
T ss_pred --cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHh
Confidence 011222344556789999999999999999999 899998875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.71 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|.+ .+..||||++... .......+.+|+.+|+.++||||+++++++.+. .++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 57899999999999999999987 4788999998653 334556788999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999963 356999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLT-PESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~~~ 652 (780)
......||+.|+|||++.+..++ +++|||||||++|+|+||++||...+... ..+..+. .
T Consensus 169 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~ 231 (328)
T 3fe3_A 169 --------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------Y 231 (328)
T ss_dssp --------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred --------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------C
Confidence 12456799999999999988775 79999999999999999999998655432 1222221 1
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..|...+..+.+|+.+||..||.+||++ .+++
T Consensus 232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~-~eil 263 (328)
T 3fe3_A 232 RIPFYMSTDCENLLKRFLVLNPIKRGTL-EQIM 263 (328)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSTTTSCCH-HHHT
T ss_pred CCCCCCCHHHHHHHHHHCCCChhHCcCH-HHHh
Confidence 2344456779999999999999999999 6664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.63 Aligned_cols=251 Identities=20% Similarity=0.359 Sum_probs=207.1
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~LV~E 496 (780)
++|...+.||+|+||.||+|.+++..||||++.... ......|.+|+.++++++||||++++++|.+. .++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 678999999999999999999999999999987643 34456799999999999999999999998543 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++.. ....++++..++.|+.|++.||.|||+.+++|+||||||+|||++.++.++|+|||++....
T Consensus 90 ~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---- 164 (271)
T ss_dssp CCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----
T ss_pred ccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec----
Confidence 9999999999963 22346999999999999999999999988889999999999999999999999998865432
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCc---chhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTP---ESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~---ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.....||+.|+|||++.+..++. ++|||||||++|+|+||+.||...+........ ........
T Consensus 165 --------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~ 231 (271)
T 3kmu_A 165 --------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-----ALEGLRPT 231 (271)
T ss_dssp --------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-----HHSCCCCC
T ss_pred --------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-----HhcCCCCC
Confidence 12346789999999998765444 899999999999999999999765543322111 01111223
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.|...+..+.+++.+||..||.+||++ .++++.|+.+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 344566789999999999999999999 99999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.14 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=209.8
Q ss_pred cCCCcccccccCCceEEEEeee-cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL-RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~-~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|...+.||+|+||.||+|.+ .+..||||++.... .....|.+|+.++++++||||++++++|.+. .++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788899999999999999998 46789999997643 3456799999999999999999999999664 579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. .....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 160 (269)
T 4hcu_A 89 HGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 160 (269)
T ss_dssp TCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHH--hcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccccc----
Confidence 999999995 34457999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
........+|+.|+|||++.+..++.++||||||+++|+|+| |++||............ ........|...
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 232 (269)
T 4hcu_A 161 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STGFRLYKPRLA 232 (269)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTCCCCCCTTS
T ss_pred --cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------hcCccCCCCCcC
Confidence 112234567888999999999999999999999999999999 99999865543322111 111111223344
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
+..+.+++.+|+..+|.+||++ .++++.|+.+..
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCH-HHHHHHHHHHHH
Confidence 6779999999999999999999 899999998854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=373.09 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=213.9
Q ss_pred ccCHHHHHHHhcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceee
Q 044673 412 EFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVT 482 (780)
Q Consensus 412 ~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~ 482 (780)
.+.........++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455555566789999999999999999999853 3679999997643 33456799999999999 7999999
Q ss_pred EeeeecCC---CeeEEEeccCCChhhHHhhhCC-----------------------------------------------
Q 044673 483 LIGTCPES---RSLVFEYLRNGSLEDCLACKNK----------------------------------------------- 512 (780)
Q Consensus 483 l~g~~~~~---~~LV~Ey~~~gsL~~~L~~~~~----------------------------------------------- 512 (780)
++++|.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 99998543 6799999999999999964322
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 513 ----------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 513 ----------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999999 99999999999999999999999999986643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH---HHHHHhccccccccCcCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV---KCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~---~~~~~~~~~~~~ld~~~~ 652 (780)
........||+.|+|||++.+..++.++|||||||++|+|+| |.+||...... ...+..+ ...
T Consensus 249 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------~~~ 315 (359)
T 3vhe_A 249 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--------TRM 315 (359)
T ss_dssp -----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------CCC
T ss_pred -----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------CCC
Confidence 112345678889999999999999999999999999999999 99999754322 2222221 112
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..|...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~ 354 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLL 354 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHH
Confidence 2333456779999999999999999999 99999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.61 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=199.1
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCc----hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGP----QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~----~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|.+.+..||||++..... .....|.+|+.+++.++||||++++++|.+. .++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 36788999999999999999999999999999875322 2346789999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-ccccCCCCCCceEecC--------CCCccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP-CIIHGNLKPSKVLIDA--------NFGSKLSDFG 566 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~ivHrDlKp~NILLd~--------~~~~Kl~DFG 566 (780)
||+++|+|.+++. ..++++..++.|+.|++.||.|||+.+. +|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999983 4579999999999999999999999884 5899999999999986 7789999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ 646 (780)
+++...... .....||+.|+|||++.+..++.++||||||+++|+|+||++||...+.........
T Consensus 162 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 227 (271)
T 3dtc_A 162 LAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----
T ss_pred ccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-----
Confidence 997654321 124578999999999999999999999999999999999999998665443322111
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~ 690 (780)
........|...+..+.+++.+|+..+|.+||++ .++++.|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-TNILDQLTT 270 (271)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHC
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-HHHHHHHhc
Confidence 0111222344456789999999999999999999 899998874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=364.82 Aligned_cols=260 Identities=20% Similarity=0.364 Sum_probs=197.9
Q ss_pred hcCCCcccccccCCceEEEEeeecCe-----eEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C-
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHL-----HVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R- 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~-----~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~- 491 (780)
.++|...+.||+|+||.||+|.+... .||||++... .......|.+|+.++++++||||+++++++.+. .
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 47899999999999999999987532 6999998764 344567899999999999999999999998543 2
Q ss_pred -----eeEEEeccCCChhhHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 492 -----SLVFEYLRNGSLEDCLACKN---KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 492 -----~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEe
Confidence 79999999999999996432 2236999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhcc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~ 642 (780)
|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||..........
T Consensus 180 Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---- 250 (323)
T 3qup_A 180 DFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---- 250 (323)
T ss_dssp CCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----
T ss_pred eccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH----
Confidence 99999876432211 11234456888999999999999999999999999999999 999997544322110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
.+........+...+..+.+|+.+||..||.+||++ .++++.|+.+....
T Consensus 251 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 --YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSF-TCLRMELENILGHL 300 (323)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHC-
T ss_pred --HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHHh
Confidence 011111222334456779999999999999999999 99999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.59 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=203.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||.+... .......|.+|+.++++++||||+++++++.+. .++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 67999999999999999999874 678999988542 233456799999999999999999999999665 47999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ..++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999963 347999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
. .......||+.|+|||++.+..++.++|||||||++|+|+||++||............. ...........+
T Consensus 166 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~ 237 (294)
T 4eqm_A 166 L------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI--QDSVPNVTTDVR 237 (294)
T ss_dssp ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH--SSCCCCHHHHSC
T ss_pred c------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hccCCCcchhcc
Confidence 1 11234579999999999999999999999999999999999999998766544332211 111111111122
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+..+.+++.+|++.||.+||+..+++...|+.+
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 334577999999999999999996558888888865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=366.20 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=210.6
Q ss_pred HhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-- 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-- 490 (780)
..++|...+.||+|+||.||+|.+.+ ..||||++.... ......|.+|+.++++++||||++++++|.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 35789999999999999999998864 679999997643 33456799999999999999999999999654
Q ss_pred CeeEEEeccCCChhhHHhhhCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK---------------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
.++||||+++|+|.+++..... ..++++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp 202 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLAT 202 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCc
Confidence 6799999999999999964321 267999999999999999999999999 99999999
Q ss_pred CceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 044673 550 SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVL 628 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~ 628 (780)
+|||++.++.+||+|||+++.+..... ........||+.|+|||++.++.++.++|||||||++|+|+| |..||
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999987642211 112234567889999999999999999999999999999999 99999
Q ss_pred ccchhHH--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 629 RIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 629 ~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
....... ..+..+. ....|...+..+.+|+.+||..+|.+||++ .++++.|+.+.
T Consensus 278 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRMC 334 (343)
T ss_dssp TTSCHHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTT
T ss_pred CCCChHHHHHHHhCCC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHHHHHH
Confidence 7654322 2222221 122334456779999999999999999999 89999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.41 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=203.2
Q ss_pred cCCCcccccccCCceEEEEeeec--Ce----eEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HL----HVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
++|...+.||+|+||.||+|.+. +. .||+|.+.... ......+.+|+.++++++||||++++++|.+. .++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 57889999999999999999874 33 38888875432 23345677999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 93 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999952 3457999999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
... .......||..|+|||++.++.++.++|||||||++|+|+| |++||..... +...+..+. .
T Consensus 169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~ 235 (325)
T 3kex_A 169 DKQ-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE--------R 235 (325)
T ss_dssp TTC-----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC--------B
T ss_pred ccc-----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------C
Confidence 221 12244567889999999999999999999999999999999 9999975442 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTF-KELANEFTRMA 275 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCH-HHHHHHHHHHT
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 11222344568899999999999999999 99999999884
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.67 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=197.9
Q ss_pred hcCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
.++|...+.||+|+||.||+|.+. +..||||.+.... ......|.+|+.++++++||||+++++++.+. .++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 367888999999999999999874 3459999987643 33456799999999999999999999998654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 94 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999963 3456999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~ 651 (780)
.. .......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||...... ...+..+. .
T Consensus 170 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~--------~ 235 (281)
T 1mp8_A 170 TY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------R 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------C
T ss_pred cc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--------C
Confidence 11 11234467788999999999999999999999999999997 99999754332 22222211 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTIL 275 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 22344556789999999999999999999 89999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=380.07 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=207.8
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~LV~Ey~ 498 (780)
.++|...+.||+|+||.||+|.+.+..||||+++... ....|.+|+.+|++++|||||+++++|.+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3578888999999999999999999999999998643 45679999999999999999999999843 357999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 999999999643 3345899999999999999999999999 999999999999999999999999999854321
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.....+|..|+|||++.++.++.++|||||||+||||+| |+.||...+. +...+..+. ....|
T Consensus 343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~p 408 (450)
T 1k9a_A 343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDAP 408 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------CCCCC
T ss_pred ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 122356788999999999999999999999999999999 9999975432 222222221 12234
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..++..+.+|+.+||..+|.+||++ .+++..|+.+..
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~-~~l~~~L~~i~~ 445 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTF-LQLREQLEHIRT 445 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHH
Confidence 4566789999999999999999999 899999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=355.50 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=198.6
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~ 498 (780)
.++|...++||+|+||.||+|.+.+ .||||++.... ......|.+|+.++++++||||+++++++.+. .++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 3689999999999999999998766 59999987543 34456799999999999999999999988554 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. .....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 175 (289)
T 3og7_A 102 EGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-- 175 (289)
T ss_dssp CEEEHHHHHT--TC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred CCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccc--
Confidence 9999999995 34467999999999999999999999999 99999999999999999999999999976542211
Q ss_pred CCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH---HHHHhccccccccCcCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK---CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~---~~~~~~~~~~~ld~~~~ 652 (780)
........||+.|+|||++. +..++.++|||||||++|+|+||+.||....... ..+..+.... ...
T Consensus 176 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 248 (289)
T 3og7_A 176 ---SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----DLS 248 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----CTT
T ss_pred ---cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----chh
Confidence 11223457899999999986 6678899999999999999999999997644332 2223332222 122
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
..+...+..+.+|+.+||..+|.+||++ .++++.|+.+
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~l 286 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHT
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHH
Confidence 2333456789999999999999999999 8999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=376.09 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=207.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|++++|||||+++|+|.+. .++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 367888999999999999999985 6889999987643 23345688999999999999999999999654 689999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999963 2346899999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~ 653 (780)
. .......++..|+|||++.++.++.++|||||||+||||+| |.+||....... ..+..+. ...
T Consensus 269 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~ 335 (377)
T 3cbl_A 269 A-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--------RLP 335 (377)
T ss_dssp E-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--------CCC
T ss_pred e-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence 0 01122335678999999999999999999999999999999 999997654322 2222221 122
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.|...+..+.+|+.+||+.+|.+||++ .++++.|+.++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSF-STIYQELQSIRK 374 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHh
Confidence 334456779999999999999999999 999999998853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=371.00 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|.+. +..||||++... .......|.+|+.++++++|||||+++++|.+. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999853 357999999754 344556799999999999999999999999654 5
Q ss_pred eeEEEeccCCChhhHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---Cccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKN----KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSD 564 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~D 564 (780)
++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECC
Confidence 79999999999999997543 2346999999999999999999999999 99999999999999555 599999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhc
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKR 641 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~ 641 (780)
||+++.+...... .......||+.|+|||++.++.++.++|||||||+||+|+| |.+||......... +..+
T Consensus 228 FG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 228 FGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred Ccccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999865322111 11233467889999999999999999999999999999998 99999765543221 1111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.....|...+..+.+|+.+||+.+|.+||++ .+|++.|+.+..
T Consensus 303 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~eil~~l~~~~~ 345 (367)
T 3l9p_A 303 --------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQ 345 (367)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhh
Confidence 1122233456679999999999999999999 999999998854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.74 Aligned_cols=261 Identities=18% Similarity=0.219 Sum_probs=207.1
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|.. .+..||||++..... ...|.+|+.+++++ +||||+++++++.+. .++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999985 478899999875432 33588999999999 899999999998554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-----cccccccccccc
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-----SKLSDFGFFHLI 571 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~-----~Kl~DFGla~~~ 571 (780)
|+ +|+|.+++... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999632 457999999999999999999999999 999999999999998887 999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHH---HHhcccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCA---LEKRNFNSV 646 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~---~~~~~~~~~ 646 (780)
..................||+.|+|||++.+..++.++|||||||+||+|+||++||...+. .... +........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 54332222222223567899999999999999999999999999999999999999975321 1111 111111111
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
....... .+ .+.+++.+|+..+|.+||++ .+|.+.|+.+....
T Consensus 241 ~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~-~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 IEVLCEN----FP-EMATYLRYVRRLDFFEKPDY-DYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHTTT----CH-HHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred HHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCH-HHHHHHHHHHHHHc
Confidence 1111111 23 79999999999999999999 89999999886543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.03 Aligned_cols=254 Identities=20% Similarity=0.331 Sum_probs=200.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-------- 490 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|++++|||||+++++|.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999985 6789999987533 34567799999999999999999999987321
Q ss_pred ---------------------------------------------------CeeEEEeccCCChhhHHhhhCCCCCCCHH
Q 044673 491 ---------------------------------------------------RSLVFEYLRNGSLEDCLACKNKKSPLRWQ 519 (780)
Q Consensus 491 ---------------------------------------------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~ 519 (780)
.++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 47999999999999999765555667888
Q ss_pred HHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC-----cccccCCCCCCccc
Q 044673 520 TRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS-----ALCNESNNDSASVY 594 (780)
Q Consensus 520 ~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~Y 594 (780)
.++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........... .........||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999999 999999999999999999999999999887543211100 01223456799999
Q ss_pred CChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCC
Q 044673 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNR 674 (780)
Q Consensus 595 ~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p 674 (780)
+|||++.+..++.++|||||||++|+|+||..|+.............. ....+......+.+|+.+||+.||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--------FPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTC--------CCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccC--------CCcccccCChhHHHHHHHHccCCC
Confidence 999999999999999999999999999999888643322222222111 111123445678999999999999
Q ss_pred CCCcchHHHHHH
Q 044673 675 LNRPDLVSEIWS 686 (780)
Q Consensus 675 ~~RPs~~~ev~~ 686 (780)
.+||++ .++++
T Consensus 315 ~~Rps~-~~~l~ 325 (332)
T 3qd2_B 315 TERPEA-TDIIE 325 (332)
T ss_dssp GGSCCH-HHHHH
T ss_pred CcCCCH-HHHhh
Confidence 999999 66653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=375.75 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|..+|.++ +|||||+++++|.+. .+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999885 5789999986531 22334578999999887 899999999999665 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999963 356999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld~~~ 651 (780)
.. ......+||+.|+|||++.+..++.++|||||||++|+|+||++||........... ...+...+....
T Consensus 206 ~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 206 PG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp TT-------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred CC-------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 11 123456899999999999999999999999999999999999999964321100000 000000011112
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+|...+..+.+|+.+||+.||.+||+.
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 23455567789999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=367.15 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=211.8
Q ss_pred hcCCCcccccccCCceEEEEeeecC---------eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH---------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~ 490 (780)
.++|...++||+|+||.||+|.+.+ ..||||++.... ......|.+|+.+++++ +|||||+++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4788899999999999999998632 569999997643 33456799999999999 899999999999654
Q ss_pred --CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT 225 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc
Confidence 6799999999999999965331 246999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|+| |..||...+..
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987643221 112344567889999999999999999999999999999999 99999765432
Q ss_pred H--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 635 K--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 635 ~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
. ..+..+ .....|...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 301 ~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~ 353 (382)
T 3tt0_A 301 ELFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHHHTT--------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHHHHHHcC--------CCCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHH
Confidence 2 122221 1222334456789999999999999999999 9999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=361.34 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=200.1
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C---
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R--- 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~--- 491 (780)
.++|...+.||+|+||.||+|.. .+..||||++.... ......|.+|+.++.+++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999996 46889999997642 23345789999999999999999999988443 2
Q ss_pred -eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 492 -SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 492 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
++||||+++|+|.+++.. ..++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 899999999999999963 346999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
+...... ........||+.|+|||++.+..++.++|||||||++|+|+||++||................. ..+.
T Consensus 166 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 240 (311)
T 3ork_A 166 IADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPPS 240 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCHH
T ss_pred ccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-CCcc
Confidence 6432211 1122345789999999999999999999999999999999999999986665433221111000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+...+..+.+|+.+||+.||.+||+..+++...|..+.
T Consensus 241 --~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 241 --ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0011245679999999999999999998777777777664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=370.84 Aligned_cols=266 Identities=14% Similarity=0.181 Sum_probs=205.3
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCchhH-----------HHHHHHHHHhhcCCCCceeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGPQSH-----------LKFQNEVEVLSRVRHPNLVTL 483 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~~~~-----------~~f~~Ev~il~~l~HpnIv~l 483 (780)
.++|...+.||+|+||.||+|.+. +..||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 468999999999999999999874 35799999876542211 124456677888899999999
Q ss_pred eeeecCC------CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec--
Q 044673 484 IGTCPES------RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-- 555 (780)
Q Consensus 484 ~g~~~~~------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-- 555 (780)
+++|.+. .+|||||+ +|+|.+++.. ...++++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 9998543 57999999 9999999963 3467999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK 635 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~ 635 (780)
.++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998775332222112222345569999999999999999999999999999999999999997432111
Q ss_pred HH---HH---hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 636 CA---LE---KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 636 ~~---~~---~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
.. .. ...+..+++.... +...+..+.+++.+|+..+|.+||++ .++++.|+.+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~-~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLY-ENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCH-HHHHHHHHHHHHHc
Confidence 10 11 1122222222110 01235679999999999999999999 89999999886543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=380.39 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=209.9
Q ss_pred HhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEec
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYL 498 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~ 498 (780)
..++|...+.||+|+||.||+|.++ +..||||++.... .....|.+|+.+|++++|||||+++++|.+ ..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 3567888999999999999999986 6789999997643 456789999999999999999999999964 467999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--- 338 (454)
T 1qcf_A 265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNE--- 338 (454)
T ss_dssp TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH---
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc---
Confidence 999999999632 1235889999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p 655 (780)
........+|..|+|||++..+.++.++|||||||+||||+| |++||...+... ..+..+. ....|
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~ 407 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------RMPRP 407 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--------CCCCC
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 111233456788999999999999999999999999999999 999997554322 2222221 11223
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+..+.+|+.+||..||.+||++ .+|+..|+.+.
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~-~~i~~~L~~~~ 443 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTF-EYIQSVLDDFY 443 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHH
Confidence 4456789999999999999999999 99999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=365.14 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=200.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|..++||||++++++|.+. .++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 678999998642 123355788999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999963 356899999999999999999999999 999999999999999999999999998764322
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~ 652 (780)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.... .+..+ ..
T Consensus 159 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------~~ 222 (337)
T 1o6l_A 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------EI 222 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CC
T ss_pred CC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC---------CC
Confidence 11 12456799999999999999999999999999999999999999976543221 11111 12
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
.+|...+..+.+|+.+||..||.+|| ++ .+++
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~-~ei~ 259 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA-KEVM 259 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH-HHHH
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCH-HHHH
Confidence 24445667899999999999999999 55 5553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=351.91 Aligned_cols=253 Identities=24% Similarity=0.434 Sum_probs=208.7
Q ss_pred hcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.++|...+.||+|+||.||+|.+.+ ..||||++.... .....|.+|+.++.+++||||++++++|.+. .++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3678899999999999999998864 579999997643 3456789999999999999999999999665 47999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-- 159 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE--
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhh--
Confidence 999999999643 346999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
.......+|+.|+|||++.+..++.++||||||+++|+|+| |++||................ ....|..
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 229 (268)
T 3sxs_A 160 ----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH------RLYRPHL 229 (268)
T ss_dssp ----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------CCCCCTT
T ss_pred ----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC------CCCCCCc
Confidence 12234567788999999999899999999999999999999 999997665443322211111 1112233
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+..+.+++.+||+.+|.+||++ .++++.|+.++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~ 263 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTF-QQLLSSIEPLR 263 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHGGGC
T ss_pred ChHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 45679999999999999999999 89999998774
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=365.06 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=200.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch------hHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ------SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~------~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.+.|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|.+++|||||+++++|.+. .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999885 678999998653221 356789999999999999999999999665 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC----Ccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGF 567 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGl 567 (780)
++||||+++|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 79999999999999995 4567999999999999999999999999 99999999999998877 799999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNS 645 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~ 645 (780)
++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..... +..+.+.
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~- 236 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD- 236 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Confidence 98765321 123467999999999999999999999999999999999999999765543322 1111110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.++ .++...+..+.+|+.+||..||.+||++ .+++
T Consensus 237 -~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~l 271 (361)
T 2yab_A 237 -FDE---EFFSQTSELAKDFIRKLLVKETRKRLTI-QEAL 271 (361)
T ss_dssp -CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred -CCc---hhccCCCHHHHHHHHHHCCCChhHCcCH-HHHh
Confidence 000 0011245678999999999999999999 6654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.83 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=206.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|++++||||+++++++.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999986 6789999987532 2335678899999999999999999999854 247999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----cCCCCcccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI----DANFGSKLSDFGFFHLI 571 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL----d~~~~~Kl~DFGla~~~ 571 (780)
||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999975555556999999999999999999999999 9999999999999 88888999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhc--------cCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHH
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLE--------TGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCA 637 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~ 637 (780)
..... .....||+.|+|||++. +..++.++|||||||++|+|+||++||..... ....
T Consensus 167 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 167 EDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 53321 23457999999999986 57789999999999999999999999963221 1111
Q ss_pred HHhccccccc----------------cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 638 LEKRNFNSVL----------------DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 638 ~~~~~~~~~l----------------d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+..+.....+ -+.....+...+..+.+++.+||+.||.+||++ .++++-...-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-~ell~h~~d~ 307 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAETSDI 307 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-HHhhhccHHH
Confidence 1111111000 011123456788899999999999999999999 7887766643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.74 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=209.6
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.++++++||||++++++|.+. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 478889999999999999999762 3679999997643 34456799999999999999999999999554 6
Q ss_pred eeEEEeccCCChhhHHhhhCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCC
Q 044673 492 SLVFEYLRNGSLEDCLACKNK---------------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPS 550 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~ 550 (780)
++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~ 179 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAAR 179 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccchh
Confidence 799999999999999975332 234899999999999999999999999 999999999
Q ss_pred ceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 044673 551 KVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLR 629 (780)
Q Consensus 551 NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~ 629 (780)
|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|+| |.+||.
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987643221 112234567889999999999999999999999999999999 999997
Q ss_pred cchh--HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 630 IKKD--VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 630 ~~~~--~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.... ....+..+. ....|...+..+.+++.+||..||.+||++ .++++.|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l~~~l~~~~ 310 (314)
T 2ivs_A 255 GIPPERLFNLLKTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVF-ADISKDLEKMM 310 (314)
T ss_dssp TCCGGGHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHhhcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 5443 222222211 122344556789999999999999999999 89999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.14 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=205.9
Q ss_pred hcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.++|...+.||+|+||.||+|.+.+ ..||||++.... .....|.+|+.++.+++||||++++++|.+. .++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4688899999999999999998864 579999997643 3356799999999999999999999999664 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 174 (283)
T 3gen_A 102 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--- 174 (283)
T ss_dssp TTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH---
T ss_pred CCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccccc---
Confidence 99999999953 2456999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
........+|+.|+|||++.+..++.++||||||+++|+|+| |++||............. .......|..
T Consensus 175 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 245 (283)
T 3gen_A 175 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGLRLYRPHL 245 (283)
T ss_dssp ---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTCCCCCCTT
T ss_pred ---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh------cccCCCCCCc
Confidence 112234457888999999999999999999999999999999 999998655433221111 1111122333
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+..+.+++.+||..+|.+||++ .+++..|..+.
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~~~ 279 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTF-KILLSNILDVM 279 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHh
Confidence 45679999999999999999999 89999998874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.25 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=205.3
Q ss_pred hcCCCcccccccCCceEEEEeeecC-----eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
.++|...+.||+|+||.||+|.+.+ ..||||.+... .......|.+|+.++++++||||+++++++.+. .++|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4789999999999999999998642 35999998764 334567799999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 91 MELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999963 3356899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
.. .......+|+.|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..+. .
T Consensus 167 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~--------~ 232 (281)
T 3cc6_A 167 DY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD--------R 232 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC--------C
T ss_pred cc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC--------C
Confidence 11 11234567889999999999999999999999999999998 9999964322 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+++.+||..+|.+||++ .+++..|+.+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~ 272 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRF-TELVCSLSDVY 272 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHHHHH
Confidence 11233345679999999999999999999 89999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=349.21 Aligned_cols=261 Identities=16% Similarity=0.217 Sum_probs=207.9
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||+|.. .+..||||++.... ....+.+|+.++.++ +|||++++++++.+. .++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 6799999999999999999985 57899999986532 334578999999999 799999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-----ccccccccccccc
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-----SKLSDFGFFHLIP 572 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~-----~Kl~DFGla~~~~ 572 (780)
+ +|+|.+++.. ...++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 88 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9 9999999963 2456999999999999999999999999 999999999999987776 9999999998876
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HH---HHHHhccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VK---CALEKRNFNSVL 647 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~---~~~~~~~~~~~l 647 (780)
.................||+.|+|||++.+..++.++|||||||++|+|+||++||..... .. ..+..+......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 4432222222234567899999999999999999999999999999999999999975321 11 111111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
..... ..+..+.+++.+||..+|.+||++ .+|++.|+.+....
T Consensus 243 ~~~~~----~~~~~l~~li~~~l~~dp~~RP~~-~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 243 RELCA----GFPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLERL 285 (298)
T ss_dssp HHHTT----TSCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred HHHHh----hCcHHHHHHHHHHhcCCcccCCCH-HHHHHHHHHHHHhc
Confidence 11111 235679999999999999999999 99999999986543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.97 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=206.0
Q ss_pred HhcCCCcccccccCCceEEEEeee-------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecC--
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLL-------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE-- 489 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~-------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~-- 489 (780)
..++|...+.||+|+||.||+|.+ .+..||||++.... ......|.+|+.++.++ +||||++++++|.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999986 23579999987532 33456799999999999 89999999999954
Q ss_pred CCeeEEEeccCCChhhHHhhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 490 SRSLVFEYLRNGSLEDCLACKNK--------------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp 200 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA 200 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence 46799999999999999964322 134899999999999999999999999 99999999
Q ss_pred CceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 044673 550 SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVL 628 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~ 628 (780)
+|||++.++.+||+|||++..+..... ........||+.|+|||++.++.++.++|||||||+||+|+| |.+||
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999987643221 112234457888999999999999999999999999999998 99999
Q ss_pred ccchhH---HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 629 RIKKDV---KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 629 ~~~~~~---~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...... ...+..+ .....|...+..+.+|+.+||..||.+||++ .++++.|+.+.
T Consensus 276 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~ 333 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLGCQL 333 (344)
T ss_dssp TTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred ccCCcHHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHH
Confidence 754322 2222221 1122333456789999999999999999999 89999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.22 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=199.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc------hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
+.|...+.||+|+||.||+|... +..||||++..... .....|.+|+.+|++++||||++++++|.+. .+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56889999999999999999885 67899998865322 2356799999999999999999999999654 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC----Cccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGFF 568 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGla 568 (780)
+||||+++|+|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999995 4567999999999999999999999999 99999999999999887 7999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--Hhcccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSV 646 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ 646 (780)
+.+.... ......||+.|+|||++.+..++.++|||||||++|+|+||.+||.......... ......
T Consensus 166 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 235 (326)
T 2y0a_A 166 HKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-- 235 (326)
T ss_dssp EECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--
T ss_pred eECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--
Confidence 8764321 1234579999999999999999999999999999999999999997655432221 111110
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.. ...+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 236 ~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l~ 271 (326)
T 2y0a_A 236 FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTI-QDSLQ 271 (326)
T ss_dssp CC---HHHHTTSCHHHHHHHHHHSCSSGGGSCCH-HHHHH
T ss_pred cC---ccccccCCHHHHHHHHHHccCChhhCCCH-HHHhc
Confidence 00 00011235678999999999999999999 66643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=380.98 Aligned_cols=251 Identities=28% Similarity=0.460 Sum_probs=209.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey 497 (780)
..+|...++||+|+||.||+|.+. +..||||++.... .....|.+|+.+|++++|||||+++++|.+ ..+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467888899999999999999986 6789999997643 346789999999999999999999999965 36899999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 372 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-- 372 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCc--
Confidence 9999999999632 3456999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~~~~ 654 (780)
........+|..|+|||++..+.++.++|||||||+||||+| |.+||...+. +...+..+ .....
T Consensus 373 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------~~~~~ 440 (495)
T 1opk_A 373 ----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRMER 440 (495)
T ss_dssp ----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------CCCCC
T ss_pred ----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCCC
Confidence 112234456788999999999999999999999999999999 9999975432 22222221 12223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
|...+..+.+|+.+||+.+|.+||++ .+|++.|+.+
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~-~el~~~L~~~ 476 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 476 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHH
Confidence 44566789999999999999999999 8999999865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.04 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=211.6
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec--CC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~--~~ 492 (780)
++|...+.||+|+||.||+|.+ .+..||||++..........|.+|+.++++++||||+++++++. +. .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999984 35789999998876667778999999999999999999999874 22 56
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||+++|+|.+++... ..++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999999642 246999999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH---------hccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE---------KRNF 643 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~---------~~~~ 643 (780)
.... .........||..|+|||++.+..++.++|||||||++|+|+||..||........... ....
T Consensus 179 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKD----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCS----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cCCc----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 3221 11223456788999999999999999999999999999999999999865433211000 0000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+........|...+..+.+|+.+||+.||.+||++ .++++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF-SALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHC--
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 0111112233445567789999999999999999999 999999998854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.32 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=209.1
Q ss_pred hcCCCcccccccCCceEEEEeee-------cCeeEEEEEccCCCc-hhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL-------RHLHVAIKMFPSYGP-QSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~-------~~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||+|.+ .+..||||++..... .....|.+|+.++.++ +||||++++++|.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46889999999999999999985 246799999976433 3456799999999999 899999999999544
Q ss_pred CeeEEEeccCCChhhHHhhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 RSLVFEYLRNGSLEDCLACKNK---------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ..++++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc
Confidence 6799999999999999964332 235999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||......
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999987653321 112234557888999999999999999999999999999999 99999754321
Q ss_pred ---HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 635 ---KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 635 ---~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...+..+. ....+...+..+.+++.+||..||.+||++ .++++.|+.+...
T Consensus 255 ~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 308 (313)
T 1t46_A 255 SKFYKMIKEGF--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHHHHHTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred hHHHHHhccCC--------CCCCcccCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHHH
Confidence 22222111 111223455679999999999999999999 9999999988543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.39 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=204.6
Q ss_pred cCCCcccccccCCceEEEEeeecC-----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~L 493 (780)
..|...+.||+|+||.||+|.+.. ..||+|.+.... ......|.+|+.++++++||||++++++|.+ ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467788899999999999998642 358999987643 3445679999999999999999999998733 3579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++. .....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHH--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999995 34567899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
.... .........||+.|+|||.+.+..++.++||||||+++|+|+| |.+||...+... ..+..+.
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-------- 249 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------- 249 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC--------
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC--------
Confidence 2211 1122345567889999999999999999999999999999999 667776544322 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
....|...+..+.+++.+||..+|.+||++ .++++.|+.+...
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 292 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHh
Confidence 112233345679999999999999999999 9999999998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.96 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=208.5
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|...+.||+|+||.||+|.+. +..||+|++..... ....|.+|+.++++++||||++++++|.+. .++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888999999999999999984 67899999976433 346789999999999999999999999654 679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---- 158 (267)
T 3t9t_A 87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 158 (267)
T ss_dssp TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccccccc----
Confidence 9999999963 3456899999999999999999999999 9999999999999999999999999998764221
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 656 (780)
........||..|+|||++.+..++.++||||||+++|+|+| |++||......... +..+ .....|.
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~--------~~~~~~~ 228 (267)
T 3t9t_A 159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYKPR 228 (267)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC--------CcCCCCc
Confidence 112234567889999999999999999999999999999999 89999765443221 1111 1111233
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+..+.+++.+|+..+|.+||++ .++++.|+.+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHh
Confidence 345679999999999999999999 999999998854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=359.31 Aligned_cols=242 Identities=19% Similarity=0.297 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||+|.+... ......+.+|+.+++.++||||++++++|.+. .++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999885 678999998754 34556788999999999999999999998543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC--CCCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA--NFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~--~~~~Kl~DFGla~~~~~~~ 575 (780)
+++|+|.+++. ....++++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 83 ~~g~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999995 23457999999999999999999999999 999999999999987 7899999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||.+||......... +..+.. .
T Consensus 159 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------~ 221 (321)
T 1tki_A 159 --------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY---------T 221 (321)
T ss_dssp --------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------C
T ss_pred --------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC---------C
Confidence 113356899999999999888999999999999999999999999765543221 111111 1
Q ss_pred CCH----HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPV----AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
++. ..+..+.+|+.+||..||.+||++ .++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTA-SEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCH-HHHhc
Confidence 111 235678999999999999999999 77754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.52 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=210.6
Q ss_pred cCCCccc-ccccCCceEEEEeee----cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEE
Q 044673 423 NNFEPSW-KIGEGRYGNVYRGLL----RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVF 495 (780)
Q Consensus 423 ~~f~~~~-~IG~G~~G~Vyk~~~----~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~ 495 (780)
++|.... .||+|+||.||+|.+ .+..||||++.... ......|.+|+.++++++||||++++++|.+. .++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 4565665 899999999999986 35679999997643 34567799999999999999999999999544 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHH--hCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999995 34567999999999999999999999999 9999999999999999999999999998775332
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~ 652 (780)
.. ........||+.|+|||++.+..++.++|||||||++|+|+| |++||....... ..+..+. ..
T Consensus 165 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--------~~ 232 (287)
T 1u59_A 165 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RM 232 (287)
T ss_dssp CE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------CC
T ss_pred ce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--------cC
Confidence 11 112234567899999999998899999999999999999999 999997654322 2222221 22
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCC
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCV 696 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~ 696 (780)
..|...+..+.+++.+||..+|.+||++ .++++.|+.+..+..
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYSLA 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhcC
Confidence 3344566789999999999999999999 899999999865433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=365.84 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=196.4
Q ss_pred CCCcccccccCCceEEEEeeec-----CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~LV 494 (780)
.|...+.||+|+||.||+|.+. ...||||.+... .......|.+|+.++++++|||||+++++|.+ ..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556678999999999999873 135899998753 33456789999999999999999999998732 35799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 170 ~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999995 34556899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
... .........+|+.|+|||++.++.++.++|||||||++|+|+| |.+||...+. ....+..+. .
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--------~ 314 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------R 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--------C
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--------C
Confidence 211 1112244567889999999999999999999999999999999 7888865432 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...|...+..+.+++.+||..+|.+||++ .++++.|+.+...
T Consensus 315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~-~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 356 (373)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHh
Confidence 12233456779999999999999999999 9999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.71 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=201.2
Q ss_pred cCCCcccccccCCceEEEEeeec--Ce----eEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HL----HVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
++|...++||+|+||.||+|.+. +. .||+|.+... .......|.+|+.++++++||||++++++|.+. .++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 68999999999999999999874 33 3688877543 344567899999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
++|+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 ~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 95 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp ECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 999999999999963 3456999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~ 651 (780)
... .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||...... ...+..+. .
T Consensus 171 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------~ 237 (327)
T 3lzb_A 171 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------R 237 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------C
T ss_pred ccc-----ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 211 12234567889999999999999999999999999999999 99999754432 22222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~ 277 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKF-RELIIEFSKMA 277 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHH
Confidence 22234456679999999999999999999 99999999885
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=377.52 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=202.9
Q ss_pred HHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecC
Q 044673 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489 (780)
Q Consensus 415 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~ 489 (780)
+.++...+++|...++||+|+||.||+|.+. +..||||++..... .....|.+|+.++..++|||||+++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455556789999999999999999999985 57899999864211 112348899999999999999999999966
Q ss_pred C--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
. .+|||||+++|+|.++|.. ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhh
Confidence 5 5799999999999999963 3467999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~ 642 (780)
++.+..... .......||+.|+|||++. .+.++.++|||||||+||||+||++||...+..........
T Consensus 222 a~~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 222 CLKLMEDGT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CEECCTTSC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred hhhcccCCC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 977643221 1224468999999999997 56789999999999999999999999986654332211100
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCC--CcchHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLN--RPDLVSEIW 685 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~--RPs~~~ev~ 685 (780)
... ....+..+...+..+.+|+.+||..+|.+ ||++ .+++
T Consensus 296 ~~~--~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~-~eil 337 (437)
T 4aw2_A 296 HKE--RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGI-EDFK 337 (437)
T ss_dssp HHH--HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTT-HHHH
T ss_pred ccc--cccCCcccccCCHHHHHHHHHHhcccccccCCCCH-HHHh
Confidence 000 00111112235667899999999777776 9998 6664
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=374.62 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEecc
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLR 499 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~ 499 (780)
.++|...++||+|+||.||+|.+.+ ..||||++.... .....|.+|+.+|++++|||||+++++|.+. .++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 4678889999999999999999875 679999998643 3456899999999999999999999999654 679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 336 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 336 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCcee--
Confidence 99999999532 2345899999999999999999999999 999999999999999999999999999876432111
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 656 (780)
......+|..|+|||++.++.++.++|||||||+||||+| |++||....... ..+..+ .....|.
T Consensus 337 ----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------~~~~~~~ 404 (452)
T 1fmk_A 337 ----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMPCPP 404 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ----cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCC
Confidence 1223456788999999999999999999999999999999 999997654322 222222 1122344
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+..+.+|+.+||..+|.+||++ .+++..|+.+.
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~-~~l~~~L~~~~ 439 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYF 439 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTTT
T ss_pred CCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHh
Confidence 566789999999999999999999 89999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.78 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=206.7
Q ss_pred CCcccccccCCceEEEEeee------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----Cee
Q 044673 425 FEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSL 493 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~L 493 (780)
|...++||+|+||.||++.+ .+..||||++.... ......|.+|+.+|++++||||++++++|.+. .++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999988865 35779999997643 34456799999999999999999999999542 479
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ..+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999952 34999999999999999999999999 99999999999999999999999999987753
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--------Hhccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--------EKRNFNS 645 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--------~~~~~~~ 645 (780)
... .........||..|+|||++.+..++.++|||||||++|+|+||..||.......... ....+..
T Consensus 187 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 187 GHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 221 1122345568889999999999999999999999999999999999997543211100 0001111
Q ss_pred ccc-CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 646 VLD-SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 646 ~ld-~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
.+. ......|...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~ 311 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-ENLIPILKTVHEK 311 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHHh
Confidence 111 11223344566789999999999999999999 9999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.81 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=206.2
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~ 491 (780)
+.|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.++++++||||++++++|.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 36789999987533 33457789999999999999999999998543 4
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccccc
Confidence 799999999999999953 3356999999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh---------cc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK---------RN 642 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~---------~~ 642 (780)
..... .........||..|+|||++.+..++.++|||||||++|+|+||..|+............ ..
T Consensus 177 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 53321 112234567888999999999999999999999999999999999987533211100000 00
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+........|...+..+.+|+.+||..||.+||++ .++++.|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF-QNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHh
Confidence 00111111223344566789999999999999999999 99999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.99 Aligned_cols=243 Identities=25% Similarity=0.385 Sum_probs=199.4
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||++++++|.+. .++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999997 46789999986421 12245788999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+ +|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 7899998863 346999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
. ......||+.|+|||++.+..+ ++++|||||||++|+|+||+.||...... .+...+......
T Consensus 162 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~ 226 (336)
T 3h4j_B 162 N--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCVYV 226 (336)
T ss_dssp B--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSCCC
T ss_pred c--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCCC
Confidence 1 1234579999999999987776 78999999999999999999999743211 111112222334
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.|...+..+.+|+.+||..||.+||++ .++++
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~-~eil~ 258 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITI-QEIRR 258 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCH-HHHTT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCH-HHHHh
Confidence 455567789999999999999999999 66643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=355.94 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=200.5
Q ss_pred cCCCcccccccCCceEEEEeeecC------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
++|...+.||+|+||.||+|.+.. ..||||.+.... ......|.+|+.++++++||||++++++|.+. .++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999998753 359999987643 33456799999999999999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 9999999999999963 3457999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
.... ........+|+.|+|||++.+..++.++|||||||++|+|+| |+.||....... ..+..+ .
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~--------~ 267 (333)
T 1mqb_A 200 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG--------F 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------C
T ss_pred cccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC--------C
Confidence 2211 111233456888999999999999999999999999999999 999997554322 122211 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
....+...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~~ 309 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIR 309 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 112233456779999999999999999999 899999998854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.69 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=213.0
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEe
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLI 484 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~ 484 (780)
+..+++....++|...+.||+|+||.||+|.+. +..||||.+.... ......|.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444555556789999999999999999999865 4679999997643 33456799999999999999999999
Q ss_pred eeecCC--CeeEEEeccCCChhhHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 485 GTCPES--RSLVFEYLRNGSLEDCLACKN-------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 485 g~~~~~--~~LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
++|.+. .++||||+++|+|.+++.... ...++++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~ 172 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA 172 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc
Confidence 999654 579999999999999996422 2256899999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++....... ........||+.|+|||++.++.++.++|||||||++|+|+| |.+||......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred CCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 999999999999976542211 111233456889999999999999999999999999999999 89999765432
Q ss_pred HH--HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 635 KC--ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 635 ~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.. .+..+. ....+...+..+.+++.+||..+|.+||++ .+++..|+.+
T Consensus 248 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~e~l~~L~~~ 297 (322)
T 1p4o_A 248 QVLRFVMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEE 297 (322)
T ss_dssp HHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGG
T ss_pred HHHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHh
Confidence 21 111211 122334456779999999999999999999 8999988876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=365.03 Aligned_cols=247 Identities=17% Similarity=0.332 Sum_probs=203.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||+|++..........+.+|+.+|++++|||||+++++|.+. .++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999885 678999999876556667899999999999999999999999654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC--CCCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA--NFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~--~~~~Kl~DFGla~~~~~~~ 575 (780)
+++|+|.+++. .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 130 ~~gg~L~~~l~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999985 23457999999999999999999999999 999999999999974 4779999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~~ 653 (780)
. .....||+.|+|||++.+..++.++|||||||++|+|+||.+||...+...... ....+. .+. .
T Consensus 206 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~---~ 272 (387)
T 1kob_A 206 I--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--FDE---D 272 (387)
T ss_dssp C--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--CCS---S
T ss_pred c--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCc---c
Confidence 1 123468999999999999999999999999999999999999998765543221 111111 111 1
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+...+..+.+|+.+||..||.+||++ .++++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~-~ell~ 304 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTV-HDALE 304 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCH-HHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCH-HHHhh
Confidence 122345679999999999999999999 66643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.82 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=200.2
Q ss_pred cCCCcccccccCCceEEEEeeecC---------eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH---------LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SR 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~ 491 (780)
++|...+.||+|+||.||+|.... ..||+|++..........|.+|+.++++++||||++++++|.+ ..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999998753 4699999977656667789999999999999999999999964 46
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC--------cccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--------SKLS 563 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~--------~Kl~ 563 (780)
++||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeec
Confidence 799999999999999963 3345899999999999999999999999 999999999999998887 9999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhC-CCCCccchhHHHHHHhc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTG-RPVLRIKKDVKCALEKR 641 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~~~~~~~~ 641 (780)
|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+|| .+|+.............
T Consensus 164 Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp CCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99998654321 12346788999999987 6799999999999999999995 56665443322211111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. ....|...+..+.+|+.+||+.||.+||++ .++++.|+.+..
T Consensus 233 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 D--------RHQLPAPKAAELANLINNCMDYEPDHRPSF-RAIIRDLNSLFT 275 (289)
T ss_dssp T--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-HHHHHHHHTCC-
T ss_pred c--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhcC
Confidence 0 111122224558899999999999999999 899999997743
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=356.21 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=200.1
Q ss_pred HHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC--CCCceeeEeeeecCC------
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV--RHPNLVTLIGTCPES------ 490 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l--~HpnIv~l~g~~~~~------ 490 (780)
....++|...+.||+|+||.||+|.+++..||||++.. .....+..|.+++..+ +||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34457899999999999999999999999999999864 2334555666666655 899999999998433
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCccccCCCCCCceEecCCCCccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN--------EPCIIHGNLKPSKVLIDANFGSKL 562 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~--------~~~ivHrDlKp~NILLd~~~~~Kl 562 (780)
.++||||+++|+|.+++.. ..+++..++.|+.+++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 5799999999999999952 3699999999999999999999998 6 999999999999999999999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcc------hhHHHHHHHHHHHHhC----------CC
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPE------SDVYSFGIILLRLLTG----------RP 626 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k------sDVwS~Gvil~eLltG----------~~ 626 (780)
+|||+++.+...... .........||+.|+|||++.+..++.. +|||||||++|||+|| ..
T Consensus 184 ~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 184 ADLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp CCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EeCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999776432211 1112234579999999999987766655 9999999999999999 55
Q ss_pred CCccch----hHHHHHHhccccccccCcCC-CC-CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 627 VLRIKK----DVKCALEKRNFNSVLDSSAG-DW-PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 627 p~~~~~----~~~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
||.... ......... ....+.+... .+ +...+..+.+|+.+||+.||.+||++ .++++.|+.+...
T Consensus 261 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~ 332 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIV-CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-LRVKKTLAKMSES 332 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHH-TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred cHhhhcCCCCchhhhHHHH-hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-HHHHHHHHHHHhh
Confidence 654221 011110000 0011111111 11 12677889999999999999999999 9999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.52 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=193.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch--------------------------hHHHHHHHHHHhh
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ--------------------------SHLKFQNEVEVLS 473 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~--------------------------~~~~f~~Ev~il~ 473 (780)
.++|...+.||+|+||.||+|... +..||||++...... ....|.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999874 678999998653211 1246889999999
Q ss_pred cCCCCceeeEeeeecC----CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 474 RVRHPNLVTLIGTCPE----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 474 ~l~HpnIv~l~g~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
+++||||+++++++.+ ..++||||+++|+|.+++ ...++++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 9999999999999864 247999999999999865 3457999999999999999999999999 99999999
Q ss_pred CceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCC---CCcchhHHHHHHHHHHHHhCCC
Q 044673 550 SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK---LTPESDVYSFGIILLRLLTGRP 626 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~ksDVwS~Gvil~eLltG~~ 626 (780)
+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|+||++
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999987643211 123457999999999998765 3789999999999999999999
Q ss_pred CCccchhHHH--HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 627 VLRIKKDVKC--ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 627 p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
||........ .+...... .+. +...+..+.+|+.+||..||.+||++ .+++
T Consensus 239 pf~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~l~~li~~~l~~dp~~R~s~-~e~l 291 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALE---FPD----QPDIAEDLKDLITRMLDKNPESRIVV-PEIK 291 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCC---CCS----SSCCCHHHHHHHHHHTCSCTTTSCCH-HHHT
T ss_pred CCCCccHHHHHHHHhcccCC---CCC----ccccCHHHHHHHHHHhhcChhhCCCH-HHHh
Confidence 9976543321 11111111 011 12345679999999999999999999 6664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=365.28 Aligned_cols=260 Identities=20% Similarity=0.218 Sum_probs=200.2
Q ss_pred hcCCCcccccccC--CceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEG--RYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G--~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...++||+| +||.||+|... +..||||++... .......+.+|+.++++++|||||+++++|.+. .++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 99999999985 678999998653 233456788999999999999999999998554 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999998643 3356999999999999999999999999 99999999999999999999999999866532
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hccccccccC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLDS 649 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld~ 649 (780)
................||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+....... .+.+..+++.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 22111111222344579999999999987 5799999999999999999999999975433221111 1111111100
Q ss_pred -------------------------------------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 -------------------------------------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 -------------------------------------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....++...+..+.+|+.+||+.||.+||++ .+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~ell 332 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-STLL 332 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-HHHT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-HHHh
Confidence 0011233456779999999999999999999 6665
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=352.83 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=199.7
Q ss_pred hcCCCcccccccCCceEEEEeeecC-----eeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES---- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---- 490 (780)
.++|...+.||+|+||.||+|.+.. ..||||++.... ......|.+|+.++++++||||++++++|.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4678889999999999999997642 379999987542 33456799999999999999999999998543
Q ss_pred ---CeeEEEeccCCChhhHHhhh---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccc
Q 044673 491 ---RSLVFEYLRNGSLEDCLACK---NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSD 564 (780)
Q Consensus 491 ---~~LV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~D 564 (780)
.++||||+++|+|.+++... .....+++..++.|+.+|+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEECS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEee
Confidence 27999999999999998532 24467999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhc
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKR 641 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~ 641 (780)
||+++.+...... .......+++.|+|||.+.+..++.++|||||||++|+|+| |.+||....... ..+..+
T Consensus 191 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 191 FGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp CSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred cCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 9999876432211 11234567889999999999999999999999999999999 899997544321 111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.....|...+..+.+++.+||..+|.+||++ .+++..|+.+..
T Consensus 266 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~l~~ 308 (313)
T 3brb_A 266 --------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-SVLRLQLEKLLE 308 (313)
T ss_dssp --------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 1222334456789999999999999999999 999999998854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.75 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~LV~Ey~ 498 (780)
.++|...+.||+|+||.||+|...+..||||++... .....|.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999999999999999764 345678999999999999999999998743 368999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++... ....+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 999999999632 2234889999999999999999999999 9999999999999999999999999987553211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~p 655 (780)
....+++.|+|||++.+..++.++||||||+++|+|+| |++||...+.. ...+..+ .....+
T Consensus 172 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 236 (278)
T 1byg_A 172 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAP 236 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCCC
T ss_pred -------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCCCc
Confidence 23356788999999999999999999999999999998 99999754321 1111111 112233
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...+..+.+++.+||..||.+||++ .++++.|+.++.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~i~~ 273 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKT 273 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCH-HHHHHHHHHHHh
Confidence 4456789999999999999999999 999999998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.76 Aligned_cols=235 Identities=26% Similarity=0.372 Sum_probs=196.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||++++++|.+. .++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999874 6789999986421 12345678999999999999999999999665 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999963 356999999999999999999999999 999999999999999999999999999875421
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||...+....... ++.. ...+
T Consensus 160 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~~-~~~~ 222 (318)
T 1fot_A 160 ----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNA-ELRF 222 (318)
T ss_dssp ----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHC-CCCC
T ss_pred ----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC-CCCC
Confidence 1345799999999999999999999999999999999999999976554322211 1111 1224
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCc
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
|...+..+.+|+.+|+..||.+||
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcC
Confidence 445667899999999999999999
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=355.36 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=197.7
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHH--hhcCCCCceeeEeeeec-----C--CCe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEV--LSRVRHPNLVTLIGTCP-----E--SRS 492 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~i--l~~l~HpnIv~l~g~~~-----~--~~~ 492 (780)
.++|...+.||+|+||.||+|...+..||||++... ....+..|.++ +..++||||+++++++. + ..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 478999999999999999999999999999998642 33445555554 55689999999997542 1 236
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCccccCCCCCCceEecCCCCcccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN---------EPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~---------~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
+||||+++|+|.+++.. ..+++..++.|+.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcEEEe
Confidence 99999999999999952 3458999999999999999999998 7 9999999999999999999999
Q ss_pred cccccccccCCCCCCC-CcccccCCCCCCcccCChhhhcc-------CCCCcchhHHHHHHHHHHHHhCCCCCccchh--
Q 044673 564 DFGFFHLIPQGESTGN-SALCNESNNDSASVYIDPEYLET-------GKLTPESDVYSFGIILLRLLTGRPVLRIKKD-- 633 (780)
Q Consensus 564 DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-- 633 (780)
|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|+|+||..||.....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653321110 11122345579999999999976 3567799999999999999999766531110
Q ss_pred ------------------HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 634 ------------------VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 634 ------------------~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
.............+.... ......+..+.+|+.+||..||.+||++ .++++.|+.+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~-~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTA-QXAEERMAELMMIW 320 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcch-HHHHHHHHHHHHHH
Confidence 011111111111111111 1123467789999999999999999999 99999999997554
Q ss_pred C
Q 044673 696 V 696 (780)
Q Consensus 696 ~ 696 (780)
.
T Consensus 321 ~ 321 (336)
T 3g2f_A 321 E 321 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=361.35 Aligned_cols=245 Identities=22% Similarity=0.388 Sum_probs=200.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.++++++|||||+++++|.+. .++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999885 6789999986532 33456789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---Cccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~DFGla~~~~ 572 (780)
||+++|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999985 4457999999999999999999999999 99999999999998654 59999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
... ......||+.|+|||++.+..++.++|||||||++|+|+||.+||...+... ..+..+.+. ..
T Consensus 183 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----~~ 250 (362)
T 2bdw_A 183 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD----YP 250 (362)
T ss_dssp TCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----CC
T ss_pred CCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----CC
Confidence 321 1234679999999999999999999999999999999999999997655432 222222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...| ...+..+.+|+.+||..||.+||++ .+++
T Consensus 251 ~~~~-~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 283 (362)
T 2bdw_A 251 SPEW-DTVTPEAKSLIDSMLTVNPKKRITA-DQAL 283 (362)
T ss_dssp TTGG-GGSCHHHHHHHHHHSCSSGGGSCCH-HHHT
T ss_pred cccc-cCCCHHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 1111 2345678999999999999999999 6664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.35 Aligned_cols=243 Identities=22% Similarity=0.362 Sum_probs=198.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+|.+++|||||+++++|.+. .++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 5679999986421 22346788999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+....
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999995 4567999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchh--HHHHHHhccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VKCALEKRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~~~~~~~~~~~~ld~~ 650 (780)
......||+.|+|||++.. ..++.++|||||||++|+|+||++||..... ....... +...
T Consensus 170 --------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------~~~~ 235 (384)
T 4fr4_A 170 --------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------FETT 235 (384)
T ss_dssp --------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------HHHC
T ss_pred --------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------Hhhc
Confidence 1245679999999999974 4589999999999999999999999974332 1111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...+|...+..+.+|+.+||..||.+||+...++
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 2234445667899999999999999999853544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.02 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|... +..||+|++.... ......+.+|+.++++++|||||+++++|.+. .++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999874 7889999987543 23456789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec---CCCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID---ANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd---~~~~~Kl~DFGla~~~~ 572 (780)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999863 356999999999999999999999999 99999999999998 46789999999997764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+... ..+..+.+. ..
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----~~ 233 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD----FP 233 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----CC
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC----CC
Confidence 3211 1234679999999999999999999999999999999999999997655432 222222221 11
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...|+ ..+..+.+|+.+||..||.+||++ .++++
T Consensus 234 ~~~~~-~~s~~~~~li~~~L~~dP~~Rpta-~e~L~ 267 (444)
T 3soa_A 234 SPEWD-TVTPEAKDLINKMLTINPSKRITA-AEALK 267 (444)
T ss_dssp TTTTT-TSCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred ccccc-cCCHHHHHHHHHHcCCChhHCCCH-HHHhc
Confidence 11221 345679999999999999999999 66653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.93 Aligned_cols=234 Identities=20% Similarity=0.277 Sum_probs=198.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+|..++||||+++++++.+. .++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999885 6789999986421 22345788999999999999999999999665 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999963 246999999999999999999999999 999999999999999999999999999876421
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~~ 652 (780)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||...+.... .+..+. .
T Consensus 195 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~ 255 (350)
T 1rdq_E 195 ----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------V 255 (350)
T ss_dssp ----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred ----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------C
Confidence 1345789999999999999999999999999999999999999976554322 122221 2
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.+|...+..+.+|+.+||+.||.+||+
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccC
Confidence 234456678999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.79 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=209.4
Q ss_pred hcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEecc
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLR 499 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~ 499 (780)
.++|.....||+|+||.||+|... +..||||.+.... .....|.+|+.++++++||||+++++++.+. .++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 467888999999999999999986 4679999987643 3456799999999999999999999998654 679999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 164 (279)
T 1qpc_A 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--- 164 (279)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE---
T ss_pred CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCccc---
Confidence 99999998522 1236999999999999999999999999 99999999999999999999999999987653211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 656 (780)
.......+|..|+|||++.++.++.++||||||+++|+|+| |++||........ .+..+ .....|.
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 233 (279)
T 1qpc_A 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVRPD 233 (279)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc--------cCCCCcc
Confidence 11234567888999999999999999999999999999999 9999976543221 11111 1112233
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
..+..+.+++.+|+..+|.+||++ .++++.|+.+...
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFFTA 270 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHh
Confidence 456789999999999999999999 9999999998643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=384.29 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=201.1
Q ss_pred ccccCCceEEEEeeec----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccCCCh
Q 044673 430 KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNGSL 503 (780)
Q Consensus 430 ~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~gsL 503 (780)
.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|++++|||||+++++|.+. .++||||+++|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999874 3569999997643 34567899999999999999999999999654 6799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCccc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALC 583 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 583 (780)
.++|. .....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 423 ~~~l~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~----~~ 494 (613)
T 2ozo_A 423 HKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----YT 494 (613)
T ss_dssp HHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce----ee
Confidence 99995 34567999999999999999999999999 999999999999999999999999999876432211 11
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHHHH
Q 044673 584 NESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAEAE 660 (780)
Q Consensus 584 ~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~ 660 (780)
......+|+.|+|||++.++.++.++|||||||+||||+| |+.||...+... ..+..+. ....|..++.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~~~ 566 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RMECPPECPP 566 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------CCCCCTTCCH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCCCCCcCCH
Confidence 1223446788999999999999999999999999999998 999997654432 2222221 2233445667
Q ss_pred HHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 661 QLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 661 ~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.+.+|+.+||..+|.+||++ .+|++.|+.+..
T Consensus 567 ~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~~ 598 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDF-LTVEQRMRACYY 598 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHH
Confidence 89999999999999999999 899999998854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.36 Aligned_cols=238 Identities=22% Similarity=0.273 Sum_probs=194.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|..+|..+ +|||||+++++|.+. .+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 678999998642 122345678999999998 699999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999963 356999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
.. ......+||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... +..+ .
T Consensus 177 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------~ 240 (353)
T 3txo_A 177 NG-------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND---------E 240 (353)
T ss_dssp ----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------C
T ss_pred CC-------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------C
Confidence 21 1224567999999999999989999999999999999999999999866543321 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
..+|...+..+.+|+.+||..||.+||+.
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 22344456779999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=349.07 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=210.3
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
..++|...+.||+|+||.||+|.+. +..||||++... ......|.+|+.++++++||||++++++|.+. .++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3578999999999999999999986 678999998754 34567899999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++.. .....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999963 24466999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~ 653 (780)
.......+|+.|+|||++.+..++.++||||||+++|+|+| |.+||...+.. ...+... ....
T Consensus 167 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------~~~~ 232 (288)
T 3kfa_A 167 ------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRME 232 (288)
T ss_dssp ------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------CCCC
T ss_pred ------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc--------CCCC
Confidence 11233456788999999999999999999999999999999 99999754422 1222111 1122
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.|...+..+.+|+.+|+..||.+||++ .++++.|+.+.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~-~~~~~~l~~~~ 270 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETMF 270 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCH-HHHHHHHHHHH
Confidence 334456789999999999999999999 89999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.57 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=196.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++|||||+++++|.+. .++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999875 67899999865332 2345688999999999999999999999765 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999984 4456999999999999999999999999 99999999999999999999999999986642211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh-ccccccccCcCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK-RNFNSVLDSSAGDW 654 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~-~~~~~~ld~~~~~~ 654 (780)
........||+.|+|||++.+..+ +.++|||||||++|+|+||++||............ ........ .
T Consensus 161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~ 230 (323)
T 3tki_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-----P 230 (323)
T ss_dssp -----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST-----T
T ss_pred -----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC-----c
Confidence 112245689999999999987775 77999999999999999999999754432111110 00000011 1
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+..+.+|+.+||..||.+||++ .+++
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~-~eil 260 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITI-PDIK 260 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCH-HHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 12345678899999999999999999 6664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.59 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=212.6
Q ss_pred cCHHHHHHHhcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCCc-hhHHHHHHHHHHhhcC-CCCceeeE
Q 044673 413 FSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRV-RHPNLVTL 483 (780)
Q Consensus 413 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l-~HpnIv~l 483 (780)
+...+.....++|...+.||+|+||.||+|.+. +..||||++..... .....|.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344455555689999999999999999999752 36799999976433 3456799999999999 79999999
Q ss_pred eeeecCC---CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCC
Q 044673 484 IGTCPES---RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547 (780)
Q Consensus 484 ~g~~~~~---~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDl 547 (780)
+++|.+. .++||||+++|+|.+++..... ...+++..++.|+.|++.||.|||+.+ |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 9998542 6799999999999999964322 223899999999999999999999999 999999
Q ss_pred CCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCC
Q 044673 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRP 626 (780)
Q Consensus 548 Kp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~ 626 (780)
||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |.+
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999986643211 112234567889999999999999999999999999999998 999
Q ss_pred CCccchh---HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 627 VLRIKKD---VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 627 p~~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
||..... ....+..+. ....|...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 250 p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCc--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 9975432 222222221 112233355679999999999999999999 999999998853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=359.76 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=186.2
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
...++|...+.||+|+||.||+|... +..||||++.... ....+.+|+.+|++++||||++++++|.+. .++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999985 5679999997642 345688999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla~~~~ 572 (780)
||+++|+|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999995 4456999999999999999999999999 999999999999975 8899999999998664
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---HhccccccccC
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EKRNFNSVLDS 649 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~~~~~~~ld~ 649 (780)
... ......||+.|+|||++.+..++.++|||||||++|+|+||..||.........+ ..+...
T Consensus 203 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~----- 269 (349)
T 2w4o_A 203 HQV--------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY----- 269 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-----
T ss_pred ccc--------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-----
Confidence 221 1234578999999999999999999999999999999999999997544332221 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+....+..+.+|+.+||..||.+||++ .+++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 304 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTT-FQAL 304 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 1112223456779999999999999999999 6664
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.23 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=208.9
Q ss_pred hcCCCcccccccCCceEEEEeeec---------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~ 490 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 3569999997643 34456799999999999 899999999999654
Q ss_pred --CeeEEEeccCCChhhHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNK-------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT 191 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc
Confidence 6799999999999999964321 235899999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|+| |.+||......
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 999999999999987643211 112234567889999999999999999999999999999999 99999755432
Q ss_pred H--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 635 K--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 635 ~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. ..+..+. ....|...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 267 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HHHHHHhcCC--------CCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHh
Confidence 2 1222221 112233456779999999999999999999 999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.74 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=194.1
Q ss_pred hcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...++||+|+||.||+|... +..||||++.... ......+.+|+.++++++|||||+++++|.+. .++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 478999999999999999999984 6789999987532 22346788999999999999999999999665 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++ +|.+++. .....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9985 7888775 34456999999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH---HHHh-cccc-----cc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC---ALEK-RNFN-----SV 646 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~---~~~~-~~~~-----~~ 646 (780)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........ .... +... ..
T Consensus 175 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 175 -------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred -------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 1244578999999999876 5689999999999999999999999975443211 1110 0000 00
Q ss_pred c------c---CcCCC--C---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 L------D---SSAGD--W---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 l------d---~~~~~--~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. + ..... | ....+.++.+|+.+||..||.+||++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell 299 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-RDAM 299 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-HHHH
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-HHHh
Confidence 0 0 00000 0 11234678999999999999999999 6664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=359.09 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=197.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.++.++ +|||||+++++|.+. .++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999985 678999998653 223445688999999988 899999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999963 346999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--------HHHHHHhccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--------VKCALEKRNFNS 645 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--------~~~~~~~~~~~~ 645 (780)
.. .......||+.|+|||++.+..++.++|||||||++|+|+||++||..... ...... .
T Consensus 163 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----~ 230 (345)
T 3a8x_A 163 PG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-----V 230 (345)
T ss_dssp TT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-----H
T ss_pred CC-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-----H
Confidence 11 112456899999999999999999999999999999999999999964211 011100 0
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+. .....+|...+..+.+|+.+||..||.+||+.
T Consensus 231 i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 IL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HH-HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HH-cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11123445566789999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=357.83 Aligned_cols=240 Identities=21% Similarity=0.290 Sum_probs=189.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...++||+|+||.||+|.+. +..||||++... .......+..|+..+.++ +|||||+++++|.+. .+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67899999999999999999985 788999987653 233444566677666665 899999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+ +|+|.+++... ..+++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 77999988643 356999999999999999999999999 9999999999999999999999999987764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
......||+.|+|||++.+ .++.++|||||||++|+|+||..|+........ +..+... ..++
T Consensus 212 --------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~-------~~~~ 274 (311)
T 3p1a_A 212 --------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQGYLP-------PEFT 274 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTTTCCC-------HHHH
T ss_pred --------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HhccCCC-------cccc
Confidence 1234569999999999875 799999999999999999999766654433222 1111111 1112
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+..+.+|+.+||+.||.+||++ .+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~-~ell 303 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATA-EALL 303 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCH-HHHH
Confidence 2345779999999999999999999 6664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=359.93 Aligned_cols=240 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--C
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--R 491 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~ 491 (780)
...++|...+.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||++++++|.+. .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34689999999999999999999985 6789999986421 22345678899999887 899999999999654 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 799999999999999963 346899999999999999999999999 999999999999999999999999999754
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~ 649 (780)
.... .......||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... +..+
T Consensus 169 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 233 (345)
T 1xjd_A 169 MLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------- 233 (345)
T ss_dssp CCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--------
Confidence 3211 1124568999999999999999999999999999999999999999765543221 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+|...+..+.+|+.+||..||.+||++
T Consensus 234 -~~~~p~~~s~~~~~li~~lL~~dp~~R~~~ 263 (345)
T 1xjd_A 234 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGV 263 (345)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTT
T ss_pred -CCCCCcccCHHHHHHHHHHhcCCHhHcCCC
Confidence 122344466789999999999999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.92 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=204.7
Q ss_pred CCCcccccccCCceEEEEeeec--C---eeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC---CeeE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--H---LHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES---RSLV 494 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~---~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~---~~LV 494 (780)
.|...++||+|+||.||+|.+. + ..||+|.+..... .....|.+|+.++++++||||++++++|.+. .++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4555688999999999999863 2 3699999876433 4456799999999999999999999999543 3799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+.+|+|.+++. .....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 102 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999995 34567899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCccchhH--HHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG-RPVLRIKKDV--KCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~--~~~~~~~~~~~~ld~~~ 651 (780)
... .........+|+.|+|||.+.+..++.++|||||||++|+|+|| .+||...+.. ...+..+. .
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~ 246 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--------R 246 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------C
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------C
Confidence 111 11223456788999999999999999999999999999999994 5556543322 22222211 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...|...+..+.+++.+||..+|.+||++ .++++.|+.+...
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTF-RVLVGEVEQIVSA 288 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHH
Confidence 12233455679999999999999999999 9999999998644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=362.70 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=193.5
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEeccCCCh
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLRNGSL 503 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~~gsL 503 (780)
.+.||+|+||.||+|... +..||||++..........|.+|+.+|++++|||||+++++|.+. .+|||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999874 678999999876666777899999999999999999999999654 5799999999999
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe--cCCCCcccccccccccccCCCCCCCCc
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI--DANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL--d~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----- 244 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----- 244 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-----
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-----
Confidence 998853 3356999999999999999999999999 9999999999999 6678899999999987653221
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCCCCCHHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~~~p~~~~ 659 (780)
.....||+.|+|||++.++.++.++|||||||+||+|+||++||...+...... ....+. ..... ....+
T Consensus 245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~----~~~~~ 316 (373)
T 2x4f_A 245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDEE----FQDIS 316 (373)
T ss_dssp ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-SCSGG----GTTSC
T ss_pred ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CChhh----hccCC
Confidence 234569999999999999999999999999999999999999998665433221 111110 00000 11345
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+.+|+.+||..||.+||++ .+++.
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~-~e~l~ 342 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISA-SEALK 342 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCH-HHHhc
Confidence 679999999999999999999 77764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=357.35 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=208.5
Q ss_pred HHHhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecC
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE 489 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~ 489 (780)
.-..++|...+.||+|+||.||+|...+ ..||+|++.... ......|.+|+.+++++ +||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999998743 369999997643 33456799999999999 89999999999965
Q ss_pred C--CeeEEEeccCCChhhHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKN-----------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
. .++||||+++|+|.+++.... ...++++..++.|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECC
Confidence 4 679999999999999996432 1356899999999999999999999999 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD-- 633 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~-- 633 (780)
++.+||+|||+++....... ........||+.|+|||++.++.++.++|||||||++|+|+| |.+||.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999986643221 112234567888999999999999999999999999999999 9999975432
Q ss_pred -HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 634 -VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 634 -~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
....+..+. ....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+.
T Consensus 275 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 KFYKLVKDGY--------QMAQPAFAPKNIYSIMQACWALEPTHRPTF-QQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred HHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCcCH-HHHHHHHHHHH
Confidence 112222111 111233345679999999999999999999 89999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.83 Aligned_cols=262 Identities=18% Similarity=0.224 Sum_probs=195.7
Q ss_pred cCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCCch-----------hHHHHHHHHHHhhcCCCCceeeEeee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYGPQ-----------SHLKFQNEVEVLSRVRHPNLVTLIGT 486 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~~~-----------~~~~f~~Ev~il~~l~HpnIv~l~g~ 486 (780)
++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.++..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67999999999999999999984 467999998764322 12246788899999999999999999
Q ss_pred ecC------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC--
Q 044673 487 CPE------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-- 558 (780)
Q Consensus 487 ~~~------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-- 558 (780)
+.+ ..++||||+ +|+|.+++.. ..++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCC
Confidence 844 257999999 9999999853 237999999999999999999999999 99999999999999887
Q ss_pred CcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc--hhHHH
Q 044673 559 GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK--KDVKC 636 (780)
Q Consensus 559 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~--~~~~~ 636 (780)
.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|+||+.||... +....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999877533221111112224568999999999999999999999999999999999999999532 11111
Q ss_pred HHHhccccccccCcCCCC--CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDW--PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~--p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
..........+......+ +...+..+.+++.+||..+|.+||++ .+|++.|+.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~ 326 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-QALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHCTT
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-HHHHHHHhcc
Confidence 111111111011000000 01345679999999999999999999 8999988865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=348.11 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=204.6
Q ss_pred cCCCccc-ccccCCceEEEEeeec----CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSW-KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~-~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
++|.... .||+|+||.||+|.+. +..||||++.... ......|.+|+.++++++||||++++++|.+. .++|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence 5677777 8999999999999653 4679999987542 23356799999999999999999999999544 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 999999999999963 356999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~ 651 (780)
... ........+|+.|+|||++.+..++.++||||||+++|+|+| |++||....... ..+..+. .
T Consensus 171 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~ 238 (291)
T 1xbb_A 171 ENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------R 238 (291)
T ss_dssp CSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------C
T ss_pred CCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 211 112233457789999999998889999999999999999999 999997655432 2222221 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+++.+||..||.+||++ .++++.|+.+-
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYY 278 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 22344566789999999999999999999 89999999884
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.46 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=194.2
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.++++++||||+++++++.+. .++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999885 67899999865432 2246788999999999999999999999554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++ +|.+++. .....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 985 8998885 23467999999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc-----cc--
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF-----NS-- 645 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~-----~~-- 645 (780)
......||+.|+|||++.+. .++.++|||||||++|+|+||++||...+........ +.. ..
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 12345789999999999764 5899999999999999999999999765543322111 000 00
Q ss_pred ---cccCcCC--------CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 ---VLDSSAG--------DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 ---~ld~~~~--------~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..++... ..+...+..+.+|+.+||..||.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-KQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 0000000 0112345778999999999999999999 6664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.07 Aligned_cols=240 Identities=23% Similarity=0.292 Sum_probs=188.3
Q ss_pred hcCCCcccccccCCceEEEEeee-----cCeeEEEEEccCCC----chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG----PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~~----~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||++.. .+..||||++.... ......+.+|+.+|++++||||++++++|.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 46789999987532 23345688999999999999999999999654
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 5799999999999999963 346899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
...... ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+........ +. .
T Consensus 171 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~-~ 236 (327)
T 3a62_A 171 SIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI------LK-C 236 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH-T
T ss_pred cccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh-C
Confidence 432211 123457999999999999999999999999999999999999999765543221110 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+|...+..+.+|+.+||..||.+||++
T Consensus 237 ~~~~p~~~~~~~~~li~~~L~~dp~~R~~~ 266 (327)
T 3a62_A 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGA 266 (327)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSCGGGSTTS
T ss_pred CCCCCCCCCHHHHHHHHHHHhcCHhhccCC
Confidence 112344456789999999999999999943
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.38 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=204.1
Q ss_pred HhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee---cCCCeeEE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC---PESRSLVF 495 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~---~~~~~LV~ 495 (780)
..++|...+.||+|+||.||+|.. .+..||||++.... ....+.+|+.++..++|+|++..++.| .+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999986 47889999876532 223578999999999999888887776 23357999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~ 572 (780)
||+ +|+|.+++.. ...++++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999999853 3456999999999999999999999999 9999999999999 789999999999998876
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-----HHHHHHhccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-----VKCALEKRNFNSVL 647 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-----~~~~~~~~~~~~~l 647 (780)
.................||+.|+|||++.+..++.++|||||||++|+|+||++||...+. ....+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4432222222234567899999999999999999999999999999999999999974321 11111111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCC
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCV 696 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~ 696 (780)
..... ..+..+.+|+.+|++.+|.+||++ .++++.|+.+....+
T Consensus 240 ~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 EVLCK----GYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHTT----TSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHHT
T ss_pred hhhhc----cCCHHHHHHHHHHHhcCCCCCCCH-HHHHHHHHHHHHHhC
Confidence 11111 234679999999999999999999 999999999865433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.30 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=204.7
Q ss_pred ccccCHHHHHHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-----CCceee
Q 044673 410 LLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-----HPNLVT 482 (780)
Q Consensus 410 ~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-----HpnIv~ 482 (780)
...|++.+.....++|...++||+|+||.||+|.. .+..||||++... ......+..|+.++..+. |||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44566666666779999999999999999999998 4678999999753 344566788999999996 999999
Q ss_pred EeeeecC--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC----
Q 044673 483 LIGTCPE--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---- 556 (780)
Q Consensus 483 l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---- 556 (780)
++++|.. ..++||||+ +|+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccc
Confidence 9999854 467999999 99999999643 3346999999999999999999999999 999999999999975
Q ss_pred ---------------------CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHH
Q 044673 557 ---------------------NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFG 615 (780)
Q Consensus 557 ---------------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~G 615 (780)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 788999999999865321 1345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCccchhHHHHHHhcc-----------------ccccccC--cCCCCCHH-------------------
Q 044673 616 IILLRLLTGRPVLRIKKDVKCALEKRN-----------------FNSVLDS--SAGDWPVA------------------- 657 (780)
Q Consensus 616 vil~eLltG~~p~~~~~~~~~~~~~~~-----------------~~~~ld~--~~~~~p~~------------------- 657 (780)
|+||+|+||++||...+.......... ....++. ....||..
T Consensus 247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 999999999999976554322110000 0000000 00112110
Q ss_pred -HHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 658 -EAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 658 -~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+.+|+.+||+.||.+||++ .+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta-~elL 354 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSP-AELL 354 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCH-HHHT
T ss_pred chHHHHHHHHHHHhcCChhhCCCH-HHHh
Confidence 12568899999999999999999 6664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.31 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=210.8
Q ss_pred cCCCcccccccCCceEEEEeee------cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL------RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~ 492 (780)
++|...+.||+|+||.||+|.+ .+..||||++..........|.+|+.++++++||||++++++|.. ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688899999999999999984 367899999987666667789999999999999999999998844 357
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
+||||+++|+|.+++.. ....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999963 3356999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhc--------cc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKR--------NF 643 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~--------~~ 643 (780)
.... .........++..|+|||++.+..++.++|||||||++|+|+||..|+...... ....... .+
T Consensus 197 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 197 QDKE----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp SSCS----EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccc----ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 3221 111123456788899999999988999999999999999999999998643211 1110000 00
Q ss_pred ccccc-CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 644 NSVLD-SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 644 ~~~ld-~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...+. ......|...+..+.+|+.+||..+|.+||++ .++++.|+.++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 01111 11222344566789999999999999999999 999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.27 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=207.7
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec---CCCeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP---ESRSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~---~~~~LV~E 496 (780)
.++|...+.||+|+||.||+|.. .+..||||++..... ...+.+|+.++..++|++++..+++|. +..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999986 478999999865432 346889999999999998887777662 23579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccccC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~~ 573 (780)
|+ +|+|.+++.. ...++++..++.|+.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 9999999953 3456999999999999999999999999 9999999999999 5889999999999987764
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh-----HHHHHHhcccccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD-----VKCALEKRNFNSVLD 648 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~-----~~~~~~~~~~~~~ld 648 (780)
................||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 432221122223556899999999999999999999999999999999999999975321 111111111111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCCC
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~~ 697 (780)
.... ..+..+.+++.+||+.+|.+||++ .++++.|+.+......
T Consensus 241 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 241 VLCK----GYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHTT----TSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHTTC
T ss_pred HHHh----hCCHHHHHHHHHHHhcCcCcCCCH-HHHHHHHHHHHHhcCC
Confidence 1111 234679999999999999999999 9999999998654433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.82 Aligned_cols=263 Identities=20% Similarity=0.269 Sum_probs=191.9
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeec--------CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP--------ES 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~--------~~ 490 (780)
..+|...+.||+|+||.||+|.+ .+..||||++..........+.+|+.++.++. ||||++++++|. +.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35789999999999999999998 46789999987666666778999999999996 999999999982 11
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.++||||+. |+|.+++.......++++..++.|+.||+.||.|||+.+++|+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 468999995 79999986545566799999999999999999999999878999999999999999999999999999
Q ss_pred ccccCCCCCCCC-----cccccCCCCCCcccCChhhh---ccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh
Q 044673 569 HLIPQGESTGNS-----ALCNESNNDSASVYIDPEYL---ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640 (780)
Q Consensus 569 ~~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~---~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~ 640 (780)
+.+......... .........||+.|+|||++ .+..++.++|||||||++|+|+||+.||......... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~ 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--N 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh--c
Confidence 876533211100 00112245689999999998 5667899999999999999999999999744332111 1
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcC
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSC 695 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~ 695 (780)
+... ...+...+..+.+|+.+||+.+|.+||++ .++++.|+.+....
T Consensus 264 ~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 264 GKYS-------IPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAAR 310 (337)
T ss_dssp --CC-------CCTTCCSSGGGHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHHT
T ss_pred Cccc-------CCcccccchHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhcc
Confidence 1110 00111223458899999999999999999 89999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.18 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=184.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++|||||++++++.+. .++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 6789999987543 23346788999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 497 YLRNGSLEDCLACKN---KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|++ |+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 998 59999886432 2346999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---H-hcccccc--
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---E-KRNFNSV-- 646 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~-~~~~~~~-- 646 (780)
... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+...... . .+.....
T Consensus 161 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 161 PVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp CCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred Ccc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 211 1234578999999999976 468999999999999999999999997655432211 1 0100000
Q ss_pred --------ccCcCC-------------CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 --------LDSSAG-------------DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 --------ld~~~~-------------~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+... ..+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-~e~l 292 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-KQAL 292 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-HHHT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-HHHh
Confidence 000000 0011235679999999999999999999 6653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.25 Aligned_cols=240 Identities=18% Similarity=0.249 Sum_probs=198.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+..|..+|..+ +||||+++++++.+. .++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999986 4679999986421 23345688999999988 799999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999963 246999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.. .......||+.|+|||++.+..++.++|||||||++|||+||++||...+....... ++. ....
T Consensus 174 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~-~~~~ 239 (353)
T 2i0e_A 174 DG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IME-HNVA 239 (353)
T ss_dssp TT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CCCC
T ss_pred CC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH------HHh-CCCC
Confidence 11 112456799999999999999999999999999999999999999986554322111 111 1122
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+|...+..+.+|+.+||..||.+||+.
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 444567789999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=373.98 Aligned_cols=242 Identities=22% Similarity=0.276 Sum_probs=190.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++|.+. .+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999874 678999998642 233445688999999999999999999999544 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||+++|+|.+++.. ...+++..+..|+.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999963 3469999999999999999999998 88 99999999999999999999999999976432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
... ......||+.|+|||++.+..++.++|||||||+||+|+||++||...+..... +... .
T Consensus 302 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------~ 365 (446)
T 4ejn_A 302 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------E 365 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------C
T ss_pred CCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------C
Confidence 211 124568999999999999999999999999999999999999999765543221 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
..+|...+..+.+|+.+||..||.+|| ++ .+++
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~-~ell 403 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDA-KEIM 403 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH-HHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCH-HHHH
Confidence 223445567899999999999999999 66 5553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.96 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=204.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---------- 489 (780)
.++|...+.||+|+||.||+|... +..||||.+.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 367889999999999999999985 7889999987643 356789999999999999999998742
Q ss_pred --------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 490 --------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 490 --------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
..++||||+++|+|.+++... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 146999999999999999643 2357999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|+||..|+.........+..+
T Consensus 163 l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234 (284)
T ss_dssp ECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT
T ss_pred ECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcc
Confidence 99999998765322 1234568999999999999999999999999999999999999886433332222222
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. .+...+..+.+++.+||..||.+||++ .+++..|+.++.
T Consensus 235 ~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~-~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 I-----------ISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKK 274 (284)
T ss_dssp C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHTC
T ss_pred c-----------ccccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHhh
Confidence 1 122344568899999999999999999 999999998853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=355.26 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=199.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-----CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~L 493 (780)
+.|...+.||+|+||.||+|... +..||||++... .......|.+|+.++++++|||||+++++|.+. .++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57899999999999999999874 678999998531 122456799999999999999999999998554 579
Q ss_pred EEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---cccccccccc
Q 044673 494 VFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGFFH 569 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGla~ 569 (780)
||||+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999888543 24456899999999999999999999999 999999999999987655 9999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhcccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLD 648 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld 648 (780)
.+..... ......||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+..+.+.. .
T Consensus 182 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~--~ 252 (351)
T 3c0i_A 182 QLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM--N 252 (351)
T ss_dssp ECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCC--C
T ss_pred EecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCC--C
Confidence 7653211 123467999999999999999999999999999999999999999765431 11111221110 0
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+. .| ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 253 ~~--~~-~~~s~~~~~li~~~L~~dP~~R~s~-~e~l~ 286 (351)
T 3c0i_A 253 PR--QW-SHISESAKDLVRRMLMLDPAERITV-YEALN 286 (351)
T ss_dssp HH--HH-TTSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred cc--cc-ccCCHHHHHHHHHHCCCChhHCcCH-HHHhc
Confidence 00 00 1235678999999999999999999 66653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.92 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=193.4
Q ss_pred HhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC-----chhHHHHHHHHHHhhcCC---CCceeeEeeeecCC
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG-----PQSHLKFQNEVEVLSRVR---HPNLVTLIGTCPES 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~-----~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~~~ 490 (780)
.+++|...++||+|+||.||+|.. .+..||||++.... ......+.+|+.++++++ ||||++++++|.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999986 46789999986321 122346678888877765 99999999998542
Q ss_pred -------CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccc
Q 044673 491 -------RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLS 563 (780)
Q Consensus 491 -------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~ 563 (780)
.++||||+. |+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 468999997 5999998632 2344999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh---
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK--- 640 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~--- 640 (780)
|||+++...... ......||+.|+|||++.++.++.++|||||||++|+|+||++||...+........
T Consensus 163 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 163 DFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999998664321 123457899999999999999999999999999999999999999766543322111
Q ss_pred -cccc-----cccc------CcCCCC-----CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 -RNFN-----SVLD------SSAGDW-----PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 -~~~~-----~~ld------~~~~~~-----p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+... .... +..... ....+..+.+|+.+||+.||.+||++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 295 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-FRAL 295 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH-HHHh
Confidence 0000 0000 000000 11345678999999999999999999 6554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=384.18 Aligned_cols=246 Identities=23% Similarity=0.409 Sum_probs=200.1
Q ss_pred cccccCCceEEEEeeec----CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR----HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~g 501 (780)
++||+|+||.||+|.+. +..||||++.... ......|.+|+.+|.+++|||||+++++|.+. .+|||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999663 4679999987532 23457899999999999999999999999654 57999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 455 ~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~---- 525 (635)
T 4fl3_A 455 PLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---- 525 (635)
T ss_dssp EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc----
Confidence 9999995 3456999999999999999999999999 999999999999999999999999999877533211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
....+...||+.|+|||++.+..++.++|||||||+||||+| |+.||...+... ..+..+. ....|...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPAGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCCCC
Confidence 112234567889999999999999999999999999999998 999997655432 2222221 22334456
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+.+|+.+||..||.+||++ .+|++.|+.+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~ 630 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGF-AAVELRLRNYY 630 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 6789999999999999999999 89999998773
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.04 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=199.7
Q ss_pred HHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--
Q 044673 418 LNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-- 490 (780)
Q Consensus 418 i~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-- 490 (780)
+....++|...+.||+|+||.||+|... +..||+|++.... ......+.+|+.++..++|||||+++++|.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344688999999999999999999885 5679999986411 11223478999999999999999999999765
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+|||||++||+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 5799999999999999852 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCC----CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGK----LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ 646 (780)
+.... ........||+.|+|||++.+.. ++.++|||||||+||+|+||++||...+..............
T Consensus 218 ~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 218 MNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred eccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 64321 11234568999999999998665 789999999999999999999999866543322111100000
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCC--CcchHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLN--RPDLVSEIW 685 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~--RPs~~~ev~ 685 (780)
+. .+. +...+..+.+|+.+||..+|.+ ||++ .+|+
T Consensus 292 ~~--~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~-~ei~ 328 (410)
T 3v8s_A 292 LT--FPD-DNDISKEAKNLICAFLTDREVRLGRNGV-EEIK 328 (410)
T ss_dssp CC--CCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCH-HHHH
T ss_pred cc--CCC-cccccHHHHHHHHHHccChhhhCCCCCH-HHHh
Confidence 00 111 1134567899999999988888 9998 6664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.17 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=208.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC----CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES----RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~----~~LV~ 495 (780)
++|...++||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++|||||++++++.+. .++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888999999999999999986 6789999987532 23356788999999999999999999998543 47999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----cCCCCcccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI----DANFGSKLSDFGFFHLI 571 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL----d~~~~~Kl~DFGla~~~ 571 (780)
||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999975544555999999999999999999999999 9999999999999 88888999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCccch------hHHHH
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLET--------GKLTPESDVYSFGIILLRLLTGRPVLRIKK------DVKCA 637 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~------~~~~~ 637 (780)
.... ......||+.|+|||++.. ..++.++|||||||++|+|+||+.||.... .....
T Consensus 167 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 167 EDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CCGG--------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCC--------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 4321 1234579999999999875 567889999999999999999999996322 11111
Q ss_pred HHhccccccc----------------cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 638 LEKRNFNSVL----------------DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 638 ~~~~~~~~~l----------------d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+..+.....+ .+.....+......+.+++.+||+.||.+||++ .++++.++.+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~-~e~l~~l~~il 308 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAETSDIL 308 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH-HHHHHHHHHHh
Confidence 1112111000 011223456788899999999999999999999 89999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=346.87 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=198.2
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV 494 (780)
.++|...+.||+|+||.||+|.. .+..||||++... .......|.+|+.++++++||||++++++|.+ ..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999986 4788999998752 23445678999999999999999999999854 35799
Q ss_pred EEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||+++|+|.+++.. ......+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999854 234567999999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh----HHHHHHhccccccccC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD----VKCALEKRNFNSVLDS 649 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~----~~~~~~~~~~~~~ld~ 649 (780)
... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||..... ....+..+.+..
T Consensus 189 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 257 (310)
T 2wqm_A 189 KTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP---- 257 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC----
T ss_pred CCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC----
Confidence 211 12345689999999999999999999999999999999999999964321 111122221111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCCC
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~~ 697 (780)
..+...+..+.+|+.+||..||.+||++ .++++.|+.+......
T Consensus 258 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 ---LPSDHYSEELRQLVNMCINPDPEKRPDV-TYVYDVAKRMHACTAS 301 (310)
T ss_dssp ---CCTTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHHC-
T ss_pred ---CcccccCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHhhhh
Confidence 0112345679999999999999999999 9999999999765433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=359.18 Aligned_cols=263 Identities=19% Similarity=0.213 Sum_probs=204.7
Q ss_pred cCCCcccccccCCceEEEEeeec----------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceee----------
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR----------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT---------- 482 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~----------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~---------- 482 (780)
++|...+.||+|+||.||+|... +..||||++... ..+.+|+.++.+++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 68999999999999999999874 567999998753 35789999999999999998
Q ss_pred -----Eeeeec---CCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe
Q 044673 483 -----LIGTCP---ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI 554 (780)
Q Consensus 483 -----l~g~~~---~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL 554 (780)
+++++. ...++||||+ +|+|.+++... ...++++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE
Confidence 455553 2357999999 99999999632 2367999999999999999999999999 9999999999999
Q ss_pred cCCC--CcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch
Q 044673 555 DANF--GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK 632 (780)
Q Consensus 555 d~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~ 632 (780)
+.++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|+||+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 89999999998765332221111222345589999999999999999999999999999999999999997653
Q ss_pred -hHHHHH---H--hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhcCCC
Q 044673 633 -DVKCAL---E--KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVF 697 (780)
Q Consensus 633 -~~~~~~---~--~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~~~~ 697 (780)
...... . ......+.+.. .. ....+..+.+|+.+||..||.+||++ .++++.|+.+......
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPC-GH-WIRPSETLQKYLKVVMALTYEEKPPY-AMLRNNLEALLQDLRV 340 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTT-SC-EECCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHhccCChhhhhhhc-cc-cCCCcHHHHHHHHHHHhCChhhCCCH-HHHHHHHHHHHHhcCC
Confidence 111111 1 01111111111 00 01235679999999999999999999 9999999998655443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=368.45 Aligned_cols=247 Identities=18% Similarity=0.220 Sum_probs=190.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|...++||+|+||.||+|... +..||||++... .......+.+|+.+|+.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999874 678999998753 334456788999999999999999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.+|||||++++ |.+.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 37999999764 666663 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc--
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF-- 643 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~-- 643 (780)
...... ..+...||+.|+|||++.+..|+.++|||||||+||+|++|++||...+........ |..
T Consensus 213 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 213 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp ----CC--------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ecCCCc--------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 764321 234568999999999999999999999999999999999999999866543221110 000
Q ss_pred ----------cccccC--cCC--CC---------------CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 ----------NSVLDS--SAG--DW---------------PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ----------~~~ld~--~~~--~~---------------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+.. ... .+ ....+..+.+|+.+||..||.+||++ .+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~L 354 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DDAL 354 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 000000 000 00 01126679999999999999999999 6664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=343.43 Aligned_cols=250 Identities=24% Similarity=0.270 Sum_probs=193.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|...++||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||++++++|.+. .++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999985 6789999986533 33346788999999999999999999999554 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++ +|.+.+. .....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9986 5555553 23467999999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh-----cccc------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK-----RNFN------ 644 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~-----~~~~------ 644 (780)
......||+.|+|||++.+.. ++.++|||||||++|+|+||..||.........+.. +...
T Consensus 157 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred -------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 224567899999999998765 899999999999999999987775322222211110 0000
Q ss_pred --cccc----------CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 --SVLD----------SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 --~~ld----------~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+ ......+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 281 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-EEAL 281 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-HHHh
Confidence 0000 00111122456778999999999999999999 6664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=369.66 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=199.6
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES 490 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~ 490 (780)
.++...+++|...+.||+|+||.||++... +..||||++.... ......+.+|+.++..++|||||+++++|.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445689999999999999999999985 6789999986421 11223488999999999999999999999665
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.+|||||+++|+|.+++... ...+++..+..++.+|+.||.|||+.+ ||||||||+|||||.++++||+|||++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhh
Confidence 57999999999999999643 246999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLE-------TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
+.+..... .......||+.|+|||++. ++.++.++|||||||++|||+||++||...+.........
T Consensus 210 ~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 210 LKLRADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp EECCTTSC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred eeccCCCc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 87643221 1223468999999999997 3568999999999999999999999998665433221111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCC---cchHHHH
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNR---PDLVSEI 684 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~R---Ps~~~ev 684 (780)
.....+ ..+..+...+..+.+|+.+||. +|.+| |++ .++
T Consensus 284 ~~~~~~--~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~-~ei 325 (412)
T 2vd5_A 284 HYKEHL--SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGA-GDF 325 (412)
T ss_dssp THHHHC--CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTH-HHH
T ss_pred hcccCc--CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCH-HHH
Confidence 100001 1111123356779999999999 99988 466 555
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.99 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|.+. +..||||++... .......|.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 478999999999999999999853 356999999753 344566799999999999999999999999654 5
Q ss_pred eeEEEeccCCChhhHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNK----KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSD 564 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~D 564 (780)
++||||+++|+|.+++..... ...+++..++.|+.+++.||.|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECc
Confidence 899999999999999975332 245999999999999999999999999 999999999999984 45699999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhc
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKR 641 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~ 641 (780)
||+++........ .......||+.|+|||++.++.++.++|||||||++|+|+| |++||........ .+..+
T Consensus 187 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 187 FGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp CHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999766432211 11233467889999999999999999999999999999998 9999976543221 12221
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. ....+...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 262 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 G--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQ 304 (327)
T ss_dssp C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred C--------CCCCCCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHhc
Confidence 1 112233455679999999999999999999 899999998853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.36 Aligned_cols=240 Identities=26% Similarity=0.408 Sum_probs=199.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||+|++..........|.+|+.++++++||||++++++|.+. .++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467889999999999999999886 457999998765555677899999999999999999999999765 4799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccccCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~~~ 574 (780)
+++|+|.+++.. ...+++..++.|+.+++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+...
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999863 356899999999999999999999999 9999999999999 88899999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~ 652 (780)
. ......||+.|+|||++.+ .++.++||||||+++|+|+||++||......... +..+..
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 224 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF--------- 224 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred c--------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 2 1234578999999999865 4899999999999999999999999865543322 122211
Q ss_pred CCCH----HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPV----AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..|. ..+..+.+|+.+|++.+|.+||++ .+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~-~~~l 260 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITS-LQAL 260 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-HHHT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 1222 235679999999999999999999 6664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.35 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=198.5
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-----CchhHHHHHHHHHHhhcCCCCceeeEeeeecC
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-----GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-----~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~ 489 (780)
++....++|...+.||+|+||.||+|... +..||||++... .......|.+|+.++++++|||||+++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556688999999999999999999875 567999988542 33456789999999999999999999999966
Q ss_pred C--CeeEEEeccCCChhhHHhhhC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKN-------------------------------------KKSPLRWQTRMQIASDVCS 530 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~ 530 (780)
. .++||||+++|+|.+++.... ....+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 5 479999999999999884210 1223467888999999999
Q ss_pred HHHHHHcCCCccccCCCCCCceEecCCC--CcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc--CCCC
Q 044673 531 ALIYLHSNEPCIIHGNLKPSKVLIDANF--GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKLT 606 (780)
Q Consensus 531 aL~~LH~~~~~ivHrDlKp~NILLd~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~ 606 (780)
||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .........||+.|+|||++.+ ..++
T Consensus 180 ~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 180 ALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCCC
Confidence 999999999 99999999999998776 8999999999876432111 1122345679999999999975 6789
Q ss_pred cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 607 PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 607 ~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.++|||||||++|+|+||++||.................... .......+..+.+|+.+||..+|.+||++ .++++
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~~l~ 330 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---NPNYNVLSPLARDLLSNLLNRNVDERFDA-MRALQ 330 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT---SGGGGGSCHHHHHHHHHHSCSCTTTSCCH-HHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC---CcccccCCHHHHHHHHHHcCCChhHCCCH-HHHhc
Confidence 999999999999999999999976654432211110000000 00111245679999999999999999999 66654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=340.87 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=198.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|.....||+|+||.||+|... +..||||.+..........|.+|+.++++++||||++++++|.+. .++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 45666779999999999999874 578999999876666677899999999999999999999999554 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-CCCcccccccccccccCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-NFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++|+|.+++........+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 99999999976545556789999999999999999999999 999999999999987 89999999999987643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH-HhccccccccCcCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGK--LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL-EKRNFNSVLDSSAGDW 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~-~~~~~~~~ld~~~~~~ 654 (780)
......||+.|+|||++.++. ++.++||||||+++|+|+||++||.......... ..... ......
T Consensus 179 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~ 247 (295)
T 2clq_A 179 ------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPEI 247 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCCC
T ss_pred ------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----cccccc
Confidence 123457899999999997654 8899999999999999999999997543322211 11110 112233
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|...+..+.+|+.+||..||.+||++ .+++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll 277 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACA-NDLL 277 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCH-HHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 44556789999999999999999999 6664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.44 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=191.4
Q ss_pred cCCCcc-cccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPS-WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~-~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~E 496 (780)
+.|... +.||+|+||.||+|... +..||||++..........+.+|+.++.++ +||||+++++++.+. .++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567664 67999999999999864 678999999776555677899999999995 799999999998544 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---cccccccccccccC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGla~~~~~ 573 (780)
|+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..+..
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999643 46899999999999999999999999 999999999999998776 89999999876643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCccchh---------------
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLET-----GKLTPESDVYSFGIILLRLLTGRPVLRIKKD--------------- 633 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--------------- 633 (780)
................||+.|+|||++.. ..++.++|||||||++|+|+||++||.....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22111111112234569999999999875 5688999999999999999999999975421
Q ss_pred --HHHHHHhccccccccCcCCCCCH----HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 634 --VKCALEKRNFNSVLDSSAGDWPV----AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 634 --~~~~~~~~~~~~~ld~~~~~~p~----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+..+. ..+|. ..+..+.+|+.+||..||.+||++ .++++
T Consensus 247 ~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGK---------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-AQVLQ 295 (316)
T ss_dssp HHHHHHHHHCC---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred HHHHHHHhccC---------cccCchhcccCCHHHHHHHHHHhhCChhhCCCH-HHHhc
Confidence 111111111 12222 235679999999999999999999 66643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.16 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=200.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc------hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|... +..||||++..... .....|.+|+.++.+++||||++++++|.+. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357889999999999999999875 67899999865322 1356799999999999999999999999655 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC----Ccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGF 567 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGl 567 (780)
++||||+++|+|.+++. ...++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 79999999999999995 3467999999999999999999999999 99999999999999888 799999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||..||...............
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~---- 233 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT----
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----
Confidence 98765321 123457899999999999999999999999999999999999999765543322111110
Q ss_pred cCcCCCCC----HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWP----VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...++ ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~e~l~ 272 (321)
T 2a2a_A 234 ---SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTI-QEALR 272 (321)
T ss_dssp ---CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCH-HHHHH
T ss_pred ---ccccChhhhcccCHHHHHHHHHHcCCChhhCcCH-HHHhc
Confidence 11122 1235678999999999999999999 66643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.88 Aligned_cols=243 Identities=25% Similarity=0.407 Sum_probs=198.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||++++++|.+. .++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 578999999999999999999885 4679999985421 12245688999999999999999999999665 4799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ..++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999963 356899999999999999999999999 999999999999999999999999998654322
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
......||+.|+|||++.+..++.++||||||+++|+|+||.+||.............. ....+
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~ 226 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VEFTF 226 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------TCCCC
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------CCCCC
Confidence 12345789999999999999999999999999999999999999986554332211111 11223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
|...+..+.+|+.+||..+|.+||++ .++++
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~ 257 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPML-REVLE 257 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCH-HHHHH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCH-HHHhh
Confidence 44456778999999999999999999 77764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.47 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=203.4
Q ss_pred cCCCcccccccCCceEEEEeeec--Ce--eEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HL--HVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~--~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|... +. .||||.+... .......|.+|+.++.++ +||||++++++|.+. .++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999874 44 4599988753 233456789999999999 899999999998554 5799
Q ss_pred EEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 495 FEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
|||+++|+|.+++.... ...++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEE
Confidence 99999999999996321 2357999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHh
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEK 640 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~ 640 (780)
|+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|+| |++||...........
T Consensus 183 L~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~- 253 (327)
T 1fvr_A 183 IADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK- 253 (327)
T ss_dssp ECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred EcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-
Confidence 9999998743211 11233457888999999999899999999999999999998 9999976554322111
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
+........|...+..+.+|+.+||..+|.+||++ .+++..|+.+...
T Consensus 254 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 301 (327)
T 1fvr_A 254 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLEE 301 (327)
T ss_dssp -----GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred -----hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 11111222344556789999999999999999999 8999999988543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=340.84 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=193.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||+|+||.||++... +..||+|++.... ......+.+|+.+|++++||||++++++|.+. .++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57889999999999999999875 6789999986532 33457889999999999999999999999664 5799999
Q ss_pred ccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccccC
Q 044673 498 LRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 498 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~~ 573 (780)
+++|+|.+++... .....+++..++.|+.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999988542 23467999999999999999999999999 9999999999999 4567899999999976643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
.. ......||+.|+|||++. +.++.++|||||||++|+|+||+.||........................
T Consensus 180 ~~--------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 249 (285)
T 3is5_A 180 DE--------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR- 249 (285)
T ss_dssp ---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C-
T ss_pred cc--------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC-
Confidence 21 123457899999999986 56899999999999999999999999765543222111100000111111
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+..+.+|+.+||+.||.+||++ .+++
T Consensus 250 ---~~~~~~~~li~~~L~~dP~~Rps~-~e~l 277 (285)
T 3is5_A 250 ---PLTPQAVDLLKQMLTKDPERRPSA-AQVL 277 (285)
T ss_dssp ---CCCHHHHHHHHHHTCSCTTTSCCH-HHHH
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 134678899999999999999999 6664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=340.51 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=200.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|... +..||+|++... .......+.+|+.++++++||||++++++|.+. .++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 678999998643 334456788999999999999999999999665 47999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---ccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGla~~~~ 572 (780)
||+++|+|.+.+.. ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999998863 356999999999999999999999999 999999999999987655 9999999997664
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~ 650 (780)
... ......||+.|+|||++.+..++.++||||||+++|+|+||++||........ .+..+.... .
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~ 227 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----P 227 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----C
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC----C
Confidence 321 12345789999999999999999999999999999999999999976554322 222222111 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
... ....+..+.+|+.+||+.+|.+||++ .++++
T Consensus 228 ~~~-~~~~~~~~~~li~~~l~~dp~~Rps~-~~~l~ 261 (284)
T 3kk8_A 228 SPE-WDTVTPEAKSLIDSMLTVNPKKRITA-DQALK 261 (284)
T ss_dssp TTT-TTTSCHHHHHHHHHHSCSSTTTSCCH-HHHTT
T ss_pred chh-hcccCHHHHHHHHHHcccChhhCCCH-HHHhc
Confidence 111 12345678999999999999999999 67754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=377.89 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=208.9
Q ss_pred HhcCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEec
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYL 498 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~ 498 (780)
..++|...++||+|+||.||+|.+.+ ..||||++.... .....|.+|+.+|++++|||||+++++|.+. .+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 34678888999999999999999875 679999997643 3456899999999999999999999999654 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.++|... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--- 417 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH---
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc---
Confidence 999999999532 2245899999999999999999999999 9999999999999999999999999998764211
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p 655 (780)
........++..|+|||++..+.++.++|||||||+||||+| |+.||....... ..+..+. ....|
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~ 486 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCP 486 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 111233457788999999999999999999999999999999 999997554322 2222221 11223
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..++..+.+|+.+||..+|.+||++ .+|+..|+.+.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~L~~~~ 522 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYF 522 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTSS
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHh
Confidence 4456779999999999999999999 89999998763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=355.23 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=192.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|++++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999874 678999998543 233456789999999999999999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+ +++|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 38999999 8899999853 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc-
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF- 643 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~- 643 (780)
..... .+...||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........ +..
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 75421 234578999999999887 67999999999999999999999999866543221110 100
Q ss_pred -------------------cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 644 -------------------NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 644 -------------------~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..........++...+..+.+|+.+||..||.+||++ .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-GEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-HHHhc
Confidence 0000000111222446779999999999999999999 66643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.13 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred HhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCc--------hhHHHHHHHHHHhhcCCCCceeeEeeeecCC
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP--------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~--------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~ 490 (780)
..++|...+.||+|+||.||+|.. .+..||||++..... .....|.+|+.+|++++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999976 468899999875421 1233577899999999999999999999665
Q ss_pred --CeeEEEeccCC-ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 491 --RSLVFEYLRNG-SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 491 --~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
.++||||+.+| +|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 46899999777 9999985 4557999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ 646 (780)
++.+..... .....||+.|+|||++.+..+ +.++|||||||++|+|+||++||......
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------ 236 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------ 236 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence 987653221 133568999999999988876 88999999999999999999999743221
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
... ....|...+..+.+|+.+||..||.+||++ .++++
T Consensus 237 ~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-~ell~ 274 (335)
T 3dls_A 237 VEA-AIHPPYLVSKELMSLVSGLLQPVPERRTTL-EKLVT 274 (335)
T ss_dssp TTT-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHHHH
T ss_pred Hhh-ccCCCcccCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 111 111233356679999999999999999999 66643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=367.88 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||+++++++.+. .++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 378999999999999999999875 7889999986421 12345788999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ..+.+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999995 4567999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
. ......||+.|+|||++.+..+ +.++|||||||++|+|+||++||...+.... .+..+.
T Consensus 170 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------- 232 (476)
T 2y94_A 170 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--------- 232 (476)
T ss_dssp C--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------
T ss_pred c--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------
Confidence 1 1234579999999999988765 6899999999999999999999986543221 111121
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...|...+..+.+|+.+||..||.+||++ .+++.
T Consensus 233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~-~eil~ 266 (476)
T 2y94_A 233 FYTPQYLNPSVISLLKHMLQVDPMKRATI-KDIRE 266 (476)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred cCCCccCCHHHHHHHHHHcCCCchhCcCH-HHHHh
Confidence 12233455678999999999999999999 77764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=351.08 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=206.8
Q ss_pred HHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhc--CCCCceeeEeeeecCC-----
Q 044673 418 LNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSR--VRHPNLVTLIGTCPES----- 490 (780)
Q Consensus 418 i~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~--l~HpnIv~l~g~~~~~----- 490 (780)
-....++|.....||+|+||.||+|.+++..||||++.. .....+.+|++++.. ++||||+++++++.+.
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 344567899999999999999999999999999999864 345677889999887 7899999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCccccCCCCCCceEecCCCCcc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH--------SNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
.++||||+++|+|.+++.. .++++..++.|+.+++.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEE
Confidence 4799999999999999952 36999999999999999999999 777 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCC------CCcchhHHHHHHHHHHHHhC----------C
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK------LTPESDVYSFGIILLRLLTG----------R 625 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~ksDVwS~Gvil~eLltG----------~ 625 (780)
|+|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|+|+|| .
T Consensus 188 L~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 188 IADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp ECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999876533211 111234567999999999997652 34789999999999999999 6
Q ss_pred CCCccch----hHHHHHHhccccccccCcCC-CC-CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 626 PVLRIKK----DVKCALEKRNFNSVLDSSAG-DW-PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 626 ~p~~~~~----~~~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
.||.... ....... ......+.+... .| +...+..+.+|+.+||..||.+||++ .+|++.|+.+...
T Consensus 265 ~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred cCccccCcCcccHHHHHH-HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHH
Confidence 7775331 1111111 111111122111 11 23567789999999999999999999 9999999998643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.79 Aligned_cols=252 Identities=13% Similarity=0.127 Sum_probs=202.8
Q ss_pred HHhcCCCcccccccCCceEEEEeee-------cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC---CCceeeEeeeecC
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLL-------RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR---HPNLVTLIGTCPE 489 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~-------~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~~ 489 (780)
...++|...+.||+|+||.||+|.+ .+..||||++... ....|..|+.++..++ ||||+.++++|.+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3457899999999999999999942 3578999999764 3456778888888887 9999999999854
Q ss_pred --CCeeEEEeccCCChhhHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---------
Q 044673 490 --SRSLVFEYLRNGSLEDCLACKN--KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA--------- 556 (780)
Q Consensus 490 --~~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~--------- 556 (780)
..+|||||+++|+|.+++.... ....++|..++.|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC----
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccc
Confidence 4689999999999999996422 3567999999999999999999999999 999999999999998
Q ss_pred --CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH
Q 044673 557 --NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634 (780)
Q Consensus 557 --~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~ 634 (780)
++.+||+|||+|+.+..... ....+...||+.|+|||++.+..++.++|||||||+||+|+||++||.....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~- 290 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPK-----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG- 290 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCT-----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-
T ss_pred cccCCEEEeeCchhhhhhccCC-----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-
Confidence 89999999999976532111 1123456799999999999999999999999999999999999999864322
Q ss_pred HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 635 KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 635 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+. ..+.......+ ....+.+++..|+..+|.+||+...++.+.|+.+.
T Consensus 291 ------~~--~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 291 ------GE--CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ------TE--EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ------Cc--eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 11 11112212222 35678899999999999999766588888888764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.94 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=187.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||++... +..||||++.... .....+.+|+.++++++|||||+++++|.+. .++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999885 6789999987532 2345688999999999999999999999654 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC--cccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--SKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~--~Kl~DFGla~~~~~~~ 575 (780)
+++|+|.+++.. ..++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999999853 346999999999999999999999999 999999999999988776 9999999987443211
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcc-hhHHHHHHHHHHHHhCCCCCccchh---HHHHHHhccccccccCc-
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPE-SDVYSFGIILLRLLTGRPVLRIKKD---VKCALEKRNFNSVLDSS- 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k-sDVwS~Gvil~eLltG~~p~~~~~~---~~~~~~~~~~~~~ld~~- 650 (780)
......||+.|+|||++.+..++.+ +|||||||++|+|+||++||..... ....+.. ++...
T Consensus 173 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~ 239 (361)
T 3uc3_A 173 --------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-----ILSVKY 239 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-----HHTTCC
T ss_pred --------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-----HhcCCC
Confidence 1234579999999999988888765 8999999999999999999975432 1111111 01100
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-~ell~ 274 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISI-PEIKT 274 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCH-HHHHT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCH-HHHHh
Confidence 000111245678999999999999999999 77754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=351.13 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=192.5
Q ss_pred HHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch-----hHHHHHHHHHHhhcCCCCceeeEeeeecC--
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-----SHLKFQNEVEVLSRVRHPNLVTLIGTCPE-- 489 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-----~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-- 489 (780)
....++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.++++++||||++++++|.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999885 678999998753221 12468899999999999999999999955
Q ss_pred CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
..++||||+++ +|.+++. .....+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHH--hcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 46799999986 8888885 34457899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH---Hh-cccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL---EK-RNFN 644 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~---~~-~~~~ 644 (780)
.+.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+...... .. +...
T Consensus 161 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 161 SFGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233 (346)
T ss_dssp TTTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eccCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 764321 122456789999999999764 58999999999999999999999998665443221 11 1000
Q ss_pred c--------ccc----CcCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 S--------VLD----SSAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 ~--------~ld----~~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. ..+ ......| ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-TQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-HHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-HHHhc
Confidence 0 000 0001111 2335789999999999999999999 66643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.29 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=194.9
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
+.|...+.||+|+||.||+|.. .+..||||++..... .....|.+|+.+|++++|||||+++++|.+. .++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 478899999875432 2345789999999999999999999998543 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+. |+|.+++.. ...++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9997 688888753 2457999999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hccccccccCc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLDSS 650 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld~~ 650 (780)
.....||+.|+|||++. .+.++.++|||||||++|+|+||++||...+....... .+.. +.
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~ 272 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PA 272 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CC
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----CC
Confidence 12357899999999985 56789999999999999999999999976554332211 1111 10
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+...+..+.+|+.+||+.+|.+||++ .+++.
T Consensus 273 --~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~ll~ 305 (348)
T 1u5q_A 273 --LQSGHWSEYFRNFVDSCLQKIPQDRPTS-EVLLK 305 (348)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHTT
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCcCH-HHHhh
Confidence 1112234668899999999999999999 66654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.39 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=188.4
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCC-CCceeeEeeeecC----CC
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE----SR 491 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~----~~ 491 (780)
..++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|.++. |||||+++++|.. ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999874 678999998642 3445567889999999997 9999999999843 24
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||++ |+|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 89999997 589998852 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCC--------------CcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 572 PQGESTGN--------------SALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 572 ~~~~~~~~--------------~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
........ ......+...||+.|+|||++.+ ..++.++|||||||+||+|+||++||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 43211100 01112345689999999999976 6799999999999999999999999976654332
Q ss_pred HHHhcc-cc--c--cc----------------------cCcCCC-C------------CHHHHHHHHHHHHHchhhCCCC
Q 044673 637 ALEKRN-FN--S--VL----------------------DSSAGD-W------------PVAEAEQLAHLALRCCENNRLN 676 (780)
Q Consensus 637 ~~~~~~-~~--~--~l----------------------d~~~~~-~------------p~~~~~~l~~l~~~Cl~~~p~~ 676 (780)
...... +. . .+ ...... + +...+..+.+|+.+||..||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 211000 00 0 00 000000 0 0023467899999999999999
Q ss_pred CcchHHHHH
Q 044673 677 RPDLVSEIW 685 (780)
Q Consensus 677 RPs~~~ev~ 685 (780)
||++ .+++
T Consensus 320 R~t~-~e~l 327 (388)
T 3oz6_A 320 RISA-NDAL 327 (388)
T ss_dssp SCCH-HHHT
T ss_pred CCCH-HHHh
Confidence 9999 6653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.91 Aligned_cols=241 Identities=21% Similarity=0.306 Sum_probs=196.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.++.++ +||||++++++|.+. .++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999985 788999998753 334566788999999999 899999999998543 5799
Q ss_pred EEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC----------------
Q 044673 495 FEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN---------------- 557 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~---------------- 557 (780)
|||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999996432 2367999999999999999999999999 9999999999999844
Q ss_pred ---CCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchh
Q 044673 558 ---FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 558 ---~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
+.+||+|||++...... ....||+.|+|||++.+. .+++++|||||||++|+|++|.+|+.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred CCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47899999998876432 223589999999999866 567899999999999999999988765443
Q ss_pred HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 634 VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 634 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... +..+. ....|...+..+.+|+.+||..||.+||++ .+++
T Consensus 237 ~~~-~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll 278 (289)
T 1x8b_A 237 WHE-IRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSA-MALV 278 (289)
T ss_dssp HHH-HHTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred HHH-HHcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCH-HHHh
Confidence 322 22222 122333456779999999999999999999 6654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=340.37 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=194.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC----C--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----S--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~--~~L 493 (780)
.|.....||+|+||.||+|... +..||+|.+... .......|.+|+.++++++||||++++++|.+ . .++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677788999999999999885 567999988642 34455679999999999999999999998743 1 479
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCccccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl~DFGla~~~~ 572 (780)
||||+++|+|.+++.. ...+++..++.|+.+++.||.|||+.+++|+||||||+|||++ .++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999963 3568999999999999999999999887799999999999997 78999999999997654
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
... .....||+.|+|||++. +.++.++|||||||++|+|+||+.||................ .. ..
T Consensus 184 ~~~---------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~--~~ 249 (290)
T 1t4h_A 184 ASF---------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VK--PA 249 (290)
T ss_dssp TTS---------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CC--CG
T ss_pred ccc---------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc--CC--cc
Confidence 221 12356899999999886 569999999999999999999999997644433322211100 00 01
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+...+..+.+|+.+||..+|.+||++ .+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell 281 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSI-KDLL 281 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 1122234579999999999999999999 6664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.55 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=189.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHH-hhcCCCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEV-LSRVRHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~i-l~~l~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|..+ ++.++|||||+++++|.+. .++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999985 5679999986532 2234456778777 5778999999999999654 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...+++..+..++.+|+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999963 346889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ......||+.|+|||++.+..++.++|||||||++|||+||.+||...+....... ++.. ...
T Consensus 192 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~-~~~ 257 (373)
T 2r5t_A 192 HNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILNK-PLQ 257 (373)
T ss_dssp CCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH------HHHS-CCC
T ss_pred CCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HHhc-ccC
Confidence 211 22456799999999999999999999999999999999999999976554322111 1111 112
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLV 681 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~ 681 (780)
+|...+..+.+|+.+||..||.+||++.
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 3334567799999999999999999983
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=362.41 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=189.2
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--------chhHHHHHHHHHHhhcCCCCceeeEeeeecCC
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--------PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--------~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~ 490 (780)
..++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||+++++|...
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3578999999999999999999875 5789999986421 11223488999999999999999999998554
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---Cccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSDFG 566 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~DFG 566 (780)
.++||||+++|+|.+++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 579999999999999885 4567999999999999999999999999 99999999999997544 59999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchh---HHHHHHh
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKCALEK 640 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~~~~~ 640 (780)
+++.+.... ......||+.|+|||++. ...++.++|||||||+||+|+||++||..... ....+..
T Consensus 288 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 288 HSKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp TTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred cceecCCCc--------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 998764321 123467999999999985 36788999999999999999999999974322 2223332
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+....... .....+..+.+|+.+||+.||.+||++ .+++
T Consensus 360 ~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~l 398 (419)
T 3i6u_A 360 GKYNFIPE-----VWAEVSEKALDLVKKLLVVDPKARFTT-EEAL 398 (419)
T ss_dssp TCCCCCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred CCCCCCch-----hhcccCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 22211000 001235679999999999999999999 6654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.50 Aligned_cols=203 Identities=22% Similarity=0.340 Sum_probs=157.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------S 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------~ 490 (780)
.++|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|++++|||||+++++|.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999875 678999998653 23445679999999999999999999999832 2
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+ +|+|.+++. ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchh
Confidence 57999997 578999885 4467999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCC--------------------cccccCCCCCCcccCChhhh-ccCCCCcchhHHHHHHHHHHHHh------
Q 044673 571 IPQGESTGNS--------------------ALCNESNNDSASVYIDPEYL-ETGKLTPESDVYSFGIILLRLLT------ 623 (780)
Q Consensus 571 ~~~~~~~~~~--------------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~ksDVwS~Gvil~eLlt------ 623 (780)
+......... .....+..+||+.|+|||++ ....++.++||||||||||||+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 7532211000 00123456889999999986 45679999999999999999999
Q ss_pred -----CCCCCcc
Q 044673 624 -----GRPVLRI 630 (780)
Q Consensus 624 -----G~~p~~~ 630 (780)
|+++|..
T Consensus 286 ~~~~~~~p~f~g 297 (458)
T 3rp9_A 286 AYHADRGPLFPG 297 (458)
T ss_dssp SSGGGCCCSCC-
T ss_pred cccccccccCCC
Confidence 6677754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.45 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=195.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.++.+++||||++++++|.+. .++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 588999999999999999999874 6789999987532 22346789999999999999999999998543 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ..++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999963 356999999999999999999999999 999999999999999999999999998766432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.. .......||+.|+|||++.+..++.++||||||+++|+|+||++||...+....... +..... .....
T Consensus 188 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~-~~~~~ 257 (309)
T 2h34_A 188 KL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH---INQAIP-RPSTV 257 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH---HHSCCC-CGGGT
T ss_pred cc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH---hccCCC-Ccccc
Confidence 11 112345789999999999999999999999999999999999999986554321110 000000 01112
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCc-chHHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRP-DLVSEIWSVLEALR 692 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RP-s~~~ev~~~L~~l~ 692 (780)
+...+..+.+++.+||..||.+|| ++ .+++..|+.+.
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~-~~l~~~l~~~l 295 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTC-GDLSAAAHAAL 295 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSH-HHHHHHHHHTC
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhH-HHHHHHHHHHH
Confidence 233456799999999999999999 56 89999998763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.58 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=193.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...++||+|+||.||+|... +..||||++..... .....+.+|+.++++++||||++++++|.+. .++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368899999999999999999985 67899998865432 2346688999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++. ....+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999885 3456999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----c---------
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----R--------- 641 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~--------- 641 (780)
. ......||..|+|||++.+ ..++.++|||||||++|+|+||++||............ +
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 D-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 1234578999999999976 57899999999999999999999999765543322110 0
Q ss_pred ----c-ccccccCcCCCC-C-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 ----N-FNSVLDSSAGDW-P-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ----~-~~~~ld~~~~~~-p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. +.....+..... + ...+..+.+|+.+||..||.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell 283 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-EQLL 283 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-HHHH
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-HHHh
Confidence 0 000000000000 0 1345678999999999999999999 6664
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.41 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=198.5
Q ss_pred cCCCcccccccCCceEEEEeeec---C--eeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR---H--LHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~---~--~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~L 493 (780)
++|...+.||+|+||.||+|.+. + ..||||++... .......|.+|+.++.+++||||+++++++.+. .++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 67999999999999999999863 2 25999998753 234567799999999999999999999999654 679
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++... ...+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999999643 356899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
... .........+|+.|+|||++.+..++.++||||||+++|+|+| |++||...+........... ....
T Consensus 174 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~ 244 (291)
T 1u46_A 174 NDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----GERL 244 (291)
T ss_dssp -CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----CCCC
T ss_pred ccc----chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc-----CCCC
Confidence 221 1112234567889999999998889999999999999999999 99999765543222111000 0111
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~ 283 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEAQ 283 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCH-HHHHHHHHHhC
Confidence 1233456779999999999999999999 89999998774
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=350.80 Aligned_cols=236 Identities=22% Similarity=0.335 Sum_probs=172.7
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeEEEeccCCC
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLVFEYLRNGS 502 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV~Ey~~~gs 502 (780)
.+.||+|+||.||+|... +..||||++.. .....+.+|+.++..+. |||||+++++|.+. .++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 468999999999999985 67899999864 34567789999999997 99999999999665 579999999999
Q ss_pred hhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---CcccccccccccccCCCCCCC
Q 044673 503 LEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 503 L~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~Kl~DFGla~~~~~~~~~~~ 579 (780)
|.+++.. ..++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence 9999963 457999999999999999999999999 99999999999997665 799999999987643211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH---------HHHHHhccccccccCc
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV---------KCALEKRNFNSVLDSS 650 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~---------~~~~~~~~~~~~ld~~ 650 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.. ...+..+.+. .
T Consensus 165 ----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-----~ 235 (325)
T 3kn6_A 165 ----PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-----F 235 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-----C
T ss_pred ----cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-----C
Confidence 123457899999999999999999999999999999999999999754321 1111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
........+..+.+|+.+||..||.+||++ .++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~el 268 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKM-SGL 268 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCT-TTS
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCH-HHH
Confidence 000012346789999999999999999999 555
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=341.63 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=180.0
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|.. .+..||||++.... ......+.+|+.++++++||||+++++++.+. .++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999987 46889999986421 12246788999999999999999999999665 4799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++. ....++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHH--TCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999995 34467999999999999999999999999 999999999999999999999999999876422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.. ......||+.|+|||++.+..++.++||||||+++|+|+||++||......... ..+.. .....
T Consensus 166 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~ 231 (278)
T 3cok_A 166 HE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL-ADYEM 231 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-SCCCC
T ss_pred CC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh-cccCC
Confidence 11 112356899999999999889999999999999999999999999754321111 11111 11223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|...+..+.+++.+||..||.+||++ .+++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~-~~~l 261 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSL-SSVL 261 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCH-HHHT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCH-HHHh
Confidence 44566789999999999999999999 6664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=351.32 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=192.5
Q ss_pred hcCCCcccccccCCceEEEEeeec-CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCC--CceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRH--PNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~~--~~LV 494 (780)
.+.|...+.||+|+||.||++... +..||||++... .......|.+|+.+|.+++| |||+++++++.+. .++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 357899999999999999999875 577999998653 33345679999999999986 9999999999665 4789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|| +.+|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 568899999963 457999999999999999999999999 99999999999997 678999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLET-----------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~ 643 (780)
.. ........||+.|+|||++.+ +.++.++|||||||+||+|+||++||.........+
T Consensus 161 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----- 230 (343)
T 3dbq_A 161 TT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----- 230 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-----
T ss_pred cc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-----
Confidence 21 112235679999999999865 678999999999999999999999997533221111
Q ss_pred cccccC-cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 644 NSVLDS-SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 644 ~~~ld~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..++++ ....+|...+..+.+|+.+||+.||.+||++ .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-~e~l~ 273 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PELLA 273 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCH-HHHHh
Confidence 111221 1233444455678999999999999999999 67754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=357.54 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=188.2
Q ss_pred hcCCCcc-cccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhh-cCCCCceeeEeeeecC------CC
Q 044673 422 TNNFEPS-WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLS-RVRHPNLVTLIGTCPE------SR 491 (780)
Q Consensus 422 t~~f~~~-~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~-~l~HpnIv~l~g~~~~------~~ 491 (780)
.++|... +.||+|+||.||+|... +..||||++.. ...+.+|+.++. ..+||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567666 68999999999999885 67899999864 245678998874 4589999999998743 25
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFF 568 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla 568 (780)
+|||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 7999999999999999632 2346999999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHhcc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEKRN 642 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~~~ 642 (780)
+...... ......||+.|+|||++.++.++.++|||||||+||+|+||++||...+. ....+..+.
T Consensus 212 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 212 KETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp EECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccCCCC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 8654221 12456789999999999999999999999999999999999999975432 222222222
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+.. ....| ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 284 ~~~----~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~-~eil~ 321 (400)
T 1nxk_A 284 YEF----PNPEW-SEVSEEVKMLIRNLLKTEPTQRMTI-TEFMN 321 (400)
T ss_dssp CCC----CTTTT-TTSCHHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred ccC----CCccc-ccCCHHHHHHHHHHCCCChhHCcCH-HHHhc
Confidence 211 11111 2356679999999999999999999 77765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=342.18 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=201.9
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
+.|...+.||+|+||.||+|... +..||||++.... ......|.+|+.++++++||||++++++|.+. .++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56889999999999999999874 6789999987543 34457799999999999999999999998543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++. ..++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 99999999984 357999999999999999999999999 99999999999999999999999999977643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p 655 (780)
......||+.|+|||++.+..++.++||||||+++|+|+||++||......... +..+. ....+
T Consensus 175 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 240 (303)
T 3a7i_A 175 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--------PPTLE 240 (303)
T ss_dssp ------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCCC
T ss_pred ------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--------CCCCc
Confidence 123457899999999999999999999999999999999999999765543322 11111 11222
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~ 270 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTA-KELLK 270 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCH-HHHTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCH-HHHhh
Confidence 3345679999999999999999999 77755
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=364.21 Aligned_cols=239 Identities=12% Similarity=0.124 Sum_probs=186.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccC---CCchhHHHHHHHH---HHhhcCCCCceeeEee-------e
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPS---YGPQSHLKFQNEV---EVLSRVRHPNLVTLIG-------T 486 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~---~~~~~~~~f~~Ev---~il~~l~HpnIv~l~g-------~ 486 (780)
.++|...+.||+|+||.||+|.+. +..||||++.. ........|.+|+ .+|++++|||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478888999999999999999964 78899999863 2334567799999 5566668999999984 4
Q ss_pred ecCC-------------------CeeEEEeccCCChhhHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCccc
Q 044673 487 CPES-------------------RSLVFEYLRNGSLEDCLACKNK----KSPLRWQTRMQIASDVCSALIYLHSNEPCII 543 (780)
Q Consensus 487 ~~~~-------------------~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~iv 543 (780)
+.+. .+|||||+ +|+|.+++..... ...++|..++.|+.||+.||.|||+.+ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 3322 56999999 6899999964321 234567999999999999999999999 99
Q ss_pred cCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-----------CCCcchhHH
Q 044673 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-----------KLTPESDVY 612 (780)
Q Consensus 544 HrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~ksDVw 612 (780)
||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 999999999999999999999999985432 1234467 899999999887 899999999
Q ss_pred HHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 613 SFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 613 S~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
||||+||+|+||++||...... .....+.. ... ..+..+.+|+.+||..||.+||++ .++++
T Consensus 298 SlG~il~elltg~~Pf~~~~~~------~~~~~~~~-~~~----~~~~~~~~li~~~L~~dp~~Rpt~-~e~l~ 359 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAAL------GGSEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLP-LQAME 359 (377)
T ss_dssp HHHHHHHHHHHSSCCC------------CCSGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGCCCH-HHHHT
T ss_pred HHHHHHHHHHHCCCCCcccccc------cchhhhhh-hcc----CCCHHHHHHHHHHcCCCchhCCCH-HHHhh
Confidence 9999999999999999643321 11111111 112 234678999999999999999999 77763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.24 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=189.0
Q ss_pred CHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch--hHHHHHHHHHHhhcCCCCceeeEeeeecC
Q 044673 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ--SHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~--~~~~f~~Ev~il~~l~HpnIv~l~g~~~~ 489 (780)
+...-....++|...++||+|+||.||+|... +..||||++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 25 SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp -------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred ccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 33334455689999999999999999999764 688999999754322 24567899999999999999999999955
Q ss_pred C--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-----CCCCccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-----ANFGSKL 562 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-----~~~~~Kl 562 (780)
. .++||||++ |+|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred CCEEEEEEecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEE
Confidence 4 579999998 59999985 3456999999999999999999999999 99999999999994 4556999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||++|+|+||++||.............
T Consensus 179 ~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 179 GDFGLARAFGIPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp CCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcCCCccccCCccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 99999987643211 12345789999999999874 48999999999999999999999998665543322111
Q ss_pred cccccccC-c------CCCC----------------CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 NFNSVLDS-S------AGDW----------------PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ~~~~~ld~-~------~~~~----------------p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
......+. . ...| +...+..+.+|+.+||+.||.+||++ .+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 317 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-KNAL 317 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 00000000 0 0000 01135678999999999999999999 6664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=353.24 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC------CCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------SRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~~~L 493 (780)
.++|...+.||+|+||.||++.. .+..||||++..........|.+|+.++++++||||++++++|.. ..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36899999999999999999986 468899999876666667789999999999999999999999841 3569
Q ss_pred EEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
||||+++|+|.+++... ....++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999998642 34567999999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCCC--CcccccCCCCCCcccCChhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCccch----hHHHHHHhccc
Q 044673 573 QGESTGN--SALCNESNNDSASVYIDPEYLETGK---LTPESDVYSFGIILLRLLTGRPVLRIKK----DVKCALEKRNF 643 (780)
Q Consensus 573 ~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~ksDVwS~Gvil~eLltG~~p~~~~~----~~~~~~~~~~~ 643 (780)
....... ..........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence 2110000 0000112335788999999987554 6889999999999999999999996321 11111111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
......+...+..+.+++.+||..||.+||++ .++++.|+.+.
T Consensus 263 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQ 305 (317)
T ss_dssp -----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTC
T ss_pred -----cCCCCccccCCHHHHHHHHHHhhcChhhCCCH-HHHHHHhhhcC
Confidence 01111122345679999999999999999999 99999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.74 Aligned_cols=248 Identities=19% Similarity=0.231 Sum_probs=189.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+++.++||||++++++|...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999874 678999998653 233456788999999999999999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+++ +|.+.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 3799999975 7888774 34899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc-cc----
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN-FN---- 644 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~-~~---- 644 (780)
...... ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.......... +.
T Consensus 176 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 176 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred cccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 654221 12345789999999999999999999999999999999999999986654332111000 00
Q ss_pred ------------------------------ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 ------------------------------SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 ------------------------------~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...-+.....+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-DEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-HHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-HHHhC
Confidence 000000000112346789999999999999999999 67754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.01 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=200.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeec----CCCee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP----ESRSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~----~~~~L 493 (780)
.++|.....||+|+||.||+|... +..||+|.+... .......|.+|+.++++++||||++++++|. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999884 678999998753 2344567999999999999999999999873 23579
Q ss_pred EEEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC---CccccCCCCCCceEecCCCCcccccccccc
Q 044673 494 VFEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNE---PCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
||||+++|+|.+++... .....+++..++.|+.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999643 23456999999999999999999999976 259999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~l 647 (780)
....... ......||+.|+|||++.+..++.++||||||+++|+|+||++||...+... ..+..+..
T Consensus 165 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---- 233 (279)
T 2w5a_A 165 ILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---- 233 (279)
T ss_dssp HC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred eeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence 7643211 0122457889999999999999999999999999999999999998655322 22222222
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSV 687 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~ 687 (780)
...|...+..+.+++.+||..+|.+||++ .++++.
T Consensus 234 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~ 268 (279)
T 2w5a_A 234 ----RRIPYRYSDELNEIITRMLNLKDYHRPSV-EEILEN 268 (279)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHTS
T ss_pred ----ccCCcccCHHHHHHHHHHcCCCcccCCCH-HHHHhC
Confidence 12333456779999999999999999999 777553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.14 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=196.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC--------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------- 489 (780)
.++|...++||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||++++++|.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999984 6789999886533 2334578899999999999999999999854
Q ss_pred --CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 --SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
..++||||+++ +|.+.+. .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 24799999985 7777774 33456999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~ 642 (780)
++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||............ +.
T Consensus 171 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9876532211 1223355678999999999876 45899999999999999999999999866543222111 11
Q ss_pred ccccc-------------cCcCCCC-CH-------HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNSVL-------------DSSAGDW-PV-------AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~~l-------------d~~~~~~-p~-------~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..... ....... .. ..+..+.+|+.+||..||.+||++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 310 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-DDAL 310 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-HHHh
Confidence 00000 0000000 00 013568899999999999999999 6654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=351.69 Aligned_cols=257 Identities=19% Similarity=0.249 Sum_probs=193.7
Q ss_pred HHHHHHHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc-----------hhHHHHHHHHHHhhcCCCCceee
Q 044673 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP-----------QSHLKFQNEVEVLSRVRHPNLVT 482 (780)
Q Consensus 415 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~-----------~~~~~f~~Ev~il~~l~HpnIv~ 482 (780)
+.++....++|...+.||+|+||.||+|... +..||||++..... .....|.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5667778899999999999999999999764 68899998854221 12367899999999999999999
Q ss_pred Eeeeec-----C--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 483 LIGTCP-----E--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 483 l~g~~~-----~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
++++|. . ..++||||+. |+|.+++. .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc
Confidence 999882 2 2479999998 68888885 34557999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~ 634 (780)
.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp TTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCCCEEEEecCccccccccc--------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999997543221 1234578999999999877 67999999999999999999999999765433
Q ss_pred HHHHHh----cc-------------ccccccCcC-----CCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 635 KCALEK----RN-------------FNSVLDSSA-----GDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 635 ~~~~~~----~~-------------~~~~ld~~~-----~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...... +. ....+.... ..| +...+..+.+|+.+||..||.+||++ .+++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell 315 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-EQAL 315 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-HHHH
Confidence 211100 00 000000000 001 12235678999999999999999999 6664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=356.12 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=191.7
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCC--CchhHHHHHHHHHHhhcCC--CCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVR--HPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~--HpnIv~l~g~~~~~--~~LV~ 495 (780)
.+|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|.+++ |||||++++++... .++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45899999999999999999875 677999998653 3344577999999999996 59999999988554 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
| +.+|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 578899999963 347899999999999999999999999 99999999999995 5889999999998764322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccc
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLET-----------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN 644 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~ 644 (780)
. ........||+.|+|||++.+ +.++.++||||||||||+|+||++||.........+ .
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-----~ 278 (390)
T 2zmd_A 209 T-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-----H 278 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----H
T ss_pred c-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH-----H
Confidence 1 112245679999999999875 468999999999999999999999997543221111 1
Q ss_pred ccccCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 SVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 ~~ld~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.++++. ...+|...+..+.+|+.+||..||.+||++ .+++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~ell~ 320 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PELLA 320 (390)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCH-HHHhh
Confidence 112211 122333335678999999999999999999 77754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=339.82 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=199.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc------hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
++|...+.||+|+||.||+|... +..||+|++..... .....|.+|+.++++++||||++++++|.+. .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999885 67899998864321 2367799999999999999999999999654 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC----Cccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGFF 568 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGla 568 (780)
+||||+++++|.+++.. ..++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999963 356999999999999999999999999 99999999999998877 7999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
....... ......||+.|+|||++.++.++.++||||||+++|+|+||.+||...................+
T Consensus 160 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 160 HKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred eeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 8764321 12345689999999999999999999999999999999999999976554322211111000000
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH--HHHHH
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS--VLEAL 691 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~--~L~~l 691 (780)
. ..+...+..+.+++.+||..||.+||++ .+++. .++.+
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~~l~h~~~~~~ 272 (283)
T 3bhy_A 232 E---EYFSNTSELAKDFIRRLLVKDPKRRMTI-AQSLEHSWIKAI 272 (283)
T ss_dssp H---HHHTTCCHHHHHHHHTTSCSSGGGSCCH-HHHHHCHHHHHH
T ss_pred c---hhcccCCHHHHHHHHHHccCCHhHCcCH-HHHHhCHHHHHH
Confidence 0 0011235678999999999999999999 67764 44544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=342.37 Aligned_cols=247 Identities=20% Similarity=0.300 Sum_probs=196.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|.....||+|+||.||+|... +..||+|++..........|.+|+.++++++||||++++++|.+. .++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999986 678999999876666678899999999999999999999998543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++... ...+++..++.|+.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999988632 356999999999999999999999999 9999999999999999999999999975432110
Q ss_pred CCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
.......||+.|+|||++. ...++.++|||||||++|+|+||.+||...+........... +....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~ 242 (302)
T 2j7t_A 172 -----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----DPPTL 242 (302)
T ss_dssp -----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCC
T ss_pred -----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----CCccc
Confidence 1123457899999999984 567899999999999999999999999866544332211110 01111
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
..+...+..+.+++.+||..||.+||++ .++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l 273 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSA-AQL 273 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCH-HHH
Confidence 1233445679999999999999999999 555
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.74 Aligned_cols=243 Identities=21% Similarity=0.361 Sum_probs=195.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|... +..||||++..... .+.+|++++.++ +|||||+++++|.+. .++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999885 67899999976432 234788888888 799999999999765 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-C---Cccccccccccccc
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-F---GSKLSDFGFFHLIP 572 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~---~~Kl~DFGla~~~~ 572 (780)
|+++|+|.+++. ....+++..+..|+.+|+.||.|||+.+ |+||||||+|||+..+ + .+||+|||+++.+.
T Consensus 97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999995 3457999999999999999999999999 9999999999998433 3 49999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccch-----hHHHHHHhccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKK-----DVKCALEKRNFNSVL 647 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~-----~~~~~~~~~~~~~~l 647 (780)
.... ......||+.|+|||++.+..++.++|||||||++|+|+||.+||.... .+...+..+.+.
T Consensus 172 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--- 241 (342)
T 2qr7_A 172 AENG-------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS--- 241 (342)
T ss_dssp CTTC-------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC---
T ss_pred CCCC-------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc---
Confidence 3221 1234578999999999988889999999999999999999999997422 122222333221
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. ....+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 242 -~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~~il~ 277 (342)
T 2qr7_A 242 -L-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTA-ALVLR 277 (342)
T ss_dssp -C-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCH-HHHTT
T ss_pred -c-CccccccCCHHHHHHHHHHCCCChhHCcCH-HHHhc
Confidence 1 111223456779999999999999999999 66643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=374.92 Aligned_cols=238 Identities=20% Similarity=0.320 Sum_probs=197.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|.+++|||||+++++|.+. .+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 477999999999999999999885 678999998642 122345688999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||++||+|.+++... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.+...
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999998632 2345999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------HHHHHHhcccccccc
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------VKCALEKRNFNSVLD 648 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~~~~~~~~~~~~~ld 648 (780)
. ......||+.|+|||++.+..++.++|||||||++|+|+||++||..... +...+.
T Consensus 340 ~--------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--------- 402 (576)
T 2acx_A 340 Q--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--------- 402 (576)
T ss_dssp C--------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH---------
T ss_pred c--------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh---------
Confidence 1 11345899999999999998999999999999999999999999975431 111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.....+|...+..+.+|+.+||..||.+||+
T Consensus 403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred cccccCCccCCHHHHHHHHHhccCCHHHcCC
Confidence 1122344556778999999999999999993
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=376.58 Aligned_cols=240 Identities=18% Similarity=0.251 Sum_probs=199.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--Cee
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSL 493 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~L 493 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+..|..+|..+ +||||+.+++++.+. .+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999985 467999998642 123345678999999988 799999999999664 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.++|... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999643 46999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~ 653 (780)
... ......||+.|+|||++.+..|+.++|||||||+||||+||++||...+....... ++. ....
T Consensus 495 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~-~~~~ 560 (674)
T 3pfq_A 495 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IME-HNVA 560 (674)
T ss_dssp TTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHS-SCCC
T ss_pred CCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH------HHh-CCCC
Confidence 211 13456899999999999999999999999999999999999999987654332211 111 1223
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
+|...+..+.+|+.+||..||.+||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 455667889999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.33 Aligned_cols=243 Identities=20% Similarity=0.344 Sum_probs=200.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+. .++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999885 5779999985421 12345788999999999999999999999654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999643 46899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
......||+.|+|||++.+..++.++||||||+++|+|+||.+||............. . ....+
T Consensus 168 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~-~~~~~ 231 (284)
T 2vgo_A 168 ---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV------N-VDLKF 231 (284)
T ss_dssp ---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------T-TCCCC
T ss_pred ---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh------c-cccCC
Confidence 1134578999999999999999999999999999999999999997655433221110 0 11223
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
|...+..+.+++.+|+..+|.+||++ .++++
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~ 262 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPL-KGVME 262 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCH-HHHHT
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCH-HHHhh
Confidence 44456789999999999999999999 77754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.29 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=188.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||+|+||.||+|... +..||||++...... ....+.+|+.+|++++||||++++++|.+. .++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999885 678999998753322 122456899999999999999999999554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
++ |+|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 589888853 3456999999999999999999999999 99999999999999999999999999976542211
Q ss_pred CCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC-
Q 044673 578 GNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP- 655 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p- 655 (780)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........... +-.+....||
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 227 (324)
T 3mtl_A 156 ------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI--LGTPTEETWPG 227 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCTTTSTT
T ss_pred ------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hCCCChHhchh
Confidence 1234578999999999876 56899999999999999999999999765543221110000 0000000111
Q ss_pred ------------------------HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 656 ------------------------VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 656 ------------------------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+..+.+|+.+||+.||.+||++ .+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 280 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-EDAM 280 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-HHHT
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-HHHh
Confidence 1235678999999999999999999 6664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.44 Aligned_cols=245 Identities=21% Similarity=0.302 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||++... +..||+|++... .......|.+|+.++++++||||++++++|.+. .++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888999999999999999985 567999988643 234456789999999999999999999999665 4799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++++|.+++.. ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999998853 346999999999999999999999999 999999999999999999999999999876422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
.. ......||+.|+|||++.+..++.++||||||+++|+|+||+.||.............. .....
T Consensus 169 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~ 234 (294)
T 2rku_A 169 GE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-------NEYSI 234 (294)
T ss_dssp TC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCCC
T ss_pred cc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-------ccCCC
Confidence 11 12345789999999999988899999999999999999999999986554332211110 01122
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
|...+..+.+++.+||..||.+||++ .+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~ 265 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTI-NELLN 265 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCG-GGGGG
T ss_pred ccccCHHHHHHHHHHcccChhhCcCH-HHHhh
Confidence 33455678999999999999999999 66654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=341.84 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=183.4
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
.++|...+.||+|+||.||+|.. .+..||||.+.... ......|.+|+.++.+++||||++++++|.+ ..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 47899999999999999999987 46789999986533 3345678899999999999999999999854 4679999
Q ss_pred eccCCChhhHHhhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 497 YLRNGSLEDCLACK-----NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 497 y~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
|+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999998531 13456999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hcccccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLD 648 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld 648 (780)
...... ..........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||........... .+.......
T Consensus 172 ~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 172 ATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp C-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred ccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 432111 11111234578999999999876 5689999999999999999999999976543322211 111111110
Q ss_pred C-cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 649 S-SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 649 ~-~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. .....+...+..+.+|+.+||..||.+||++ .+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll 286 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-AELL 286 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-HHHH
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 0 0111122345678999999999999999999 6664
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=342.56 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|.....||+|+||.||++... +..||||++..........+.+|+.++++++||||++++++|.+. .++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367888999999999999999874 688999999865544556789999999999999999999999655 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccccCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~~~ 574 (780)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999853 346899999999999999999999999 9999999999999 78899999999998754321
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~~~ 652 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||.+||....... ..+..+... ...
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~~~ 228 (304)
T 2jam_A 163 ---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-----FES 228 (304)
T ss_dssp ---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----CCT
T ss_pred ---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----CCc
Confidence 1123458899999999999999999999999999999999999997554322 122222211 011
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+...+..+.+++.+||..||.+||++ .+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~~l~ 261 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTC-EKALS 261 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCH-HHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCH-HHHhc
Confidence 1222455779999999999999999999 66653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=348.25 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=198.3
Q ss_pred cccCHHHHHHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeee
Q 044673 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTC 487 (780)
Q Consensus 411 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~ 487 (780)
..+++.++....++|...+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3455566666789999999999999999999998 47889999987543 3456788999999999 799999999998
Q ss_pred cC--------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC
Q 044673 488 PE--------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559 (780)
Q Consensus 488 ~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~ 559 (780)
.. ..++||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCC
Confidence 43 357999999999999999642 2357999999999999999999999999 999999999999999999
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhH
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~ 634 (780)
+||+|||++..+.... .......||+.|+|||++. +..++.++|||||||++|+|+||.+||...+..
T Consensus 168 ~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp EEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EEEeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 9999999987654221 1123457899999999987 567899999999999999999999999765544
Q ss_pred HHHHH--hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 635 KCALE--KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 635 ~~~~~--~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..... ...... ..+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 241 ~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~ 286 (326)
T 2x7f_A 241 RALFLIPRNPAPR-------LKSKKWSKKFQSFIESCLVKNHSQRPAT-EQLMK 286 (326)
T ss_dssp HHHHHHHHSCCCC-------CSCSCSCHHHHHHHHHHCCSSGGGSCCH-HHHHT
T ss_pred HHHHHhhcCcccc-------CCccccCHHHHHHHHHHhccChhhCCCH-HHHhh
Confidence 33221 111111 1112234678999999999999999999 66654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=351.89 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=197.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...+.||+|+||.||+|... +..||+|++... .......|.+|+.++++++||||++++++|.+. .++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 67899999999999999999986 678999998764 334456799999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
+++|+|.+++.. ...+++..+..|+.+++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999963 34689999999999999999999985 8 999999999999999999999999998765321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcc--------------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRN-------------- 642 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~-------------- 642 (780)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........+.
T Consensus 186 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp -------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred -------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 12345789999999999999999999999999999999999999975443211100000
Q ss_pred ----------------------ccccccCcCCCCC-HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 ----------------------FNSVLDSSAGDWP-VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ----------------------~~~~ld~~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+..+........+ ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~ 324 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-KQLMV 324 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-HHHHT
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-HHHhh
Confidence 0000000111111 1245679999999999999999999 66653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=366.87 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=199.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|.+++|||||+++++|.+. .++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368899999999999999999984 6789999986421 12345688999999999999999999998654 5799
Q ss_pred EEeccCCChhhHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 495 FEYLRNGSLEDCLACKN-KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
|||++||+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999986432 2457999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh---HHHHHHhccccccccCc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKCALEKRNFNSVLDSS 650 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~~~~~~~~~~~ld~~ 650 (780)
... ......||+.|+|||++.+..++.++|||||||+||||+||++||..... ...... . ++. .
T Consensus 342 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~-~----i~~-~ 408 (543)
T 3c4z_A 342 GQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-R----VLE-Q 408 (543)
T ss_dssp TCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-H----HHH-C
T ss_pred CCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-H----Hhh-c
Confidence 221 12345899999999999999999999999999999999999999975421 111111 0 011 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
...+|...+..+.+|+.+||..||.+||++
T Consensus 409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 223455567789999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.16 Aligned_cols=247 Identities=20% Similarity=0.344 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||||.+.... ....+.+|+.++.+++||||+++++++.+. .++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 468999999999999999999885 6789999987643 346788999999999999999999998543 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.+++.. ....+++..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999853 3457999999999999999999999999 99999999999999999999999999977643211
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHH
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
......||+.|+|||++.+..++.++||||||+++|+|+||++||...+........... .+.....+..
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 250 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN----PPPTFRKPEL 250 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSSGGG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----CCcccCCccc
Confidence 123457899999999999999999999999999999999999999866544332211000 0011112333
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+.+|+.+||..||.+||++ .+++.
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~-~~ll~ 278 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATA-TQLLQ 278 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCH-HHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCH-HHHHh
Confidence 45679999999999999999999 66643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.78 Aligned_cols=256 Identities=19% Similarity=0.292 Sum_probs=200.6
Q ss_pred HHHHHHHhcCCCcc-cccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCC-CCceeeEeeeec
Q 044673 415 FSELNEATNNFEPS-WKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP 488 (780)
Q Consensus 415 ~~ei~~at~~f~~~-~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~ 488 (780)
+.......+.|... +.||+|+||.||+|... +..||||++... .......+.+|+.++.++. ||||++++++|.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33344445667776 78999999999999875 688999998753 2334678899999999995 699999999996
Q ss_pred CC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCcccc
Q 044673 489 ES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLS 563 (780)
Q Consensus 489 ~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~ 563 (780)
+. .++||||+++|+|.+++.. .....+++..++.|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEe
Confidence 55 5799999999999999842 23467999999999999999999999999 999999999999988 7899999
Q ss_pred cccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccc
Q 044673 564 DFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNF 643 (780)
Q Consensus 564 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~ 643 (780)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||++||...............
T Consensus 177 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp CGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eCccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 999998764321 123457999999999999999999999999999999999999999766544332211111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. . ......+...+..+.+|+.+||..||.+||++ .+++
T Consensus 249 ~--~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~~ll 286 (327)
T 3lm5_A 249 N--V-DYSEETFSSVSQLATDFIQSLLVKNPEKRPTA-EICL 286 (327)
T ss_dssp C--C-CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH-HHHT
T ss_pred c--c-ccCchhhcccCHHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 1 1 11112223456679999999999999999999 6663
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.72 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=200.9
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--------hhHHHHHHHHHHhhcC-CCCceeeEe
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--------QSHLKFQNEVEVLSRV-RHPNLVTLI 484 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--------~~~~~f~~Ev~il~~l-~HpnIv~l~ 484 (780)
.......++|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999985 78899999865331 1134688999999999 799999999
Q ss_pred eeecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccc
Q 044673 485 GTCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKL 562 (780)
Q Consensus 485 g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl 562 (780)
++|... .+|||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence 998544 5799999999999999963 356999999999999999999999999 999999999999999999999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........
T Consensus 242 ~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999998765322 1234679999999999864 3588899999999999999999999976544322
Q ss_pred --HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 637 --ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 637 --~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+..+...... + .| ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 314 ~~~i~~~~~~~~~-~---~~-~~~~~~~~~li~~~L~~dP~~Rps~-~ell~ 359 (365)
T 2y7j_A 314 LRMIMEGQYQFSS-P---EW-DDRSSTVKDLISRLLQVDPEARLTA-EQALQ 359 (365)
T ss_dssp HHHHHHTCCCCCH-H---HH-SSSCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred HHHHHhCCCCCCC-c---cc-ccCCHHHHHHHHHHcCCChhHCcCH-HHHhc
Confidence 11222111000 0 00 1234568999999999999999999 66653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.25 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.+.|...++||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999985 6789999987532 33456789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC---CCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN---FGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~---~~~Kl~DFGla~~~~ 572 (780)
||+++|+|.+++.. ..++++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999998863 356999999999999999999999999 9999999999999764 559999999998765
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~ 650 (780)
... ......||+.|+|||++. +.++.++|||||||++|+|+||.+||........ .+..+.+.. .
T Consensus 191 ~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~ 257 (494)
T 3lij_A 191 NQK--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF----D 257 (494)
T ss_dssp TTB--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----C
T ss_pred CCc--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----C
Confidence 322 123467999999999986 5699999999999999999999999986654322 222222211 1
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...| ...+..+.+|+.+||+.+|.+||++ .+++
T Consensus 258 ~~~~-~~~s~~~~~li~~~L~~dp~~R~s~-~e~l 290 (494)
T 3lij_A 258 SPEW-KNVSEGAKDLIKQMLQFDSQRRISA-QQAL 290 (494)
T ss_dssp SGGG-TTSCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred chhc-ccCCHHHHHHHHHHCCCChhhCccH-HHHh
Confidence 1111 1345678999999999999999999 7776
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=375.08 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=205.7
Q ss_pred hcCCCcccccccCCceEEEEeeec-----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
.++|...+.||+|+||.||+|.+. +..||||.+.... ......|.+|+.++++++|||||+++|+|.+. .++|
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv 468 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 468 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEE
Confidence 467888999999999999999874 3469999987643 33456799999999999999999999999654 6799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 469 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 469 MELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999963 3456999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHH--HHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
.. .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||........ .+..+ ..
T Consensus 545 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------~~ 610 (656)
T 2j0j_A 545 TY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ER 610 (656)
T ss_dssp ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT--------CC
T ss_pred cc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--------CC
Confidence 11 12234567789999999999999999999999999999997 9999976544322 12221 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+|+.+||..||.+||++ .++++.|+.+.
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~-~el~~~L~~il 650 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTIL 650 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHH
Confidence 22344556789999999999999999999 89999998874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.20 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=201.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||++... +..||+|++... .......|.+|+.++++++||||++++++|.+. .++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468899999999999999999885 567999998642 234556789999999999999999999999665 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999998853 356999999999999999999999999 999999999999999999999999999876422
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--HhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ld~~~~ 652 (780)
.. ......||..|+|||++.+..++.++|||||||++|+|+||+.||.......... ..+. .
T Consensus 195 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------~ 258 (335)
T 2owb_A 195 GE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------Y 258 (335)
T ss_dssp TC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------C
T ss_pred cc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------C
Confidence 11 1234578999999999999999999999999999999999999998654432221 1111 1
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..|...+..+.+|+.+||..||.+||++ .+++.
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~ 291 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTI-NELLN 291 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCG-GGGGG
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 1233445678999999999999999999 66654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.51 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCceEEEEeee-----cCeeEEEEEccCCC----chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC-
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG----PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~~----~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~- 490 (780)
.++|...+.||+|+||.||+|.. .+..||||++.... ......+.+|+.+|.++ +||||++++++|.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 46789999986422 22345677899999999 699999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.+|||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 57999999999999999643 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCccchh---HHHHHHhcccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKCALEKRNFN 644 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~~~~~~~~~ 644 (780)
.+..... .......||+.|+|||++.++ .++.++|||||||+||+|+||+.||..... ...... ...
T Consensus 208 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~- 279 (355)
T 1vzo_A 208 EFVADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RIL- 279 (355)
T ss_dssp ECCGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-HHH-
T ss_pred ecccCCC------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH-HHh-
Confidence 6642211 112345689999999999863 478999999999999999999999964321 111111 000
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 645 SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 645 ~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
.....+|...+..+.+|+.+||..||.+|| ++ .+++
T Consensus 280 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~-~ell 320 (355)
T 1vzo_A 280 ----KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA-DEIK 320 (355)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH-HHHH
T ss_pred ----ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCH-HHHH
Confidence 112234445667799999999999999999 66 5554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.35 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=191.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|.....||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999875 7889999986421 22345788999999999999999999998654 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999632 46899999999999999999999999 999999999999999999999999998776432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~~ 651 (780)
. ......||+.|+|||++.+..+ +.++||||||+++|+|+||+.||........ .+..+ .
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~ 227 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG---------V 227 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------C
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------c
Confidence 1 1134568999999999987765 6899999999999999999999976543221 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...|...+..+.+++.+||..||.+||++ .++++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~l~ 261 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATI-KDIRE 261 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCH-HHHHh
Confidence 12233455679999999999999999999 77754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=340.48 Aligned_cols=243 Identities=21% Similarity=0.337 Sum_probs=192.7
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecC--C--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE--S--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~--~--~~LV~ 495 (780)
++|...++||+|+||.||+|.. .+..||||++... ....+.+|+.++.+++ ||||+++++++.+ . .++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999976 4678999998753 3567889999999997 9999999999865 2 47999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-CcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~~~ 574 (780)
||+++|+|.+++. .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999883 3889999999999999999999999 99999999999999777 8999999999876532
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH----------------
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---------------- 637 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---------------- 637 (780)
.. .....||..|+|||++.+ ..++.++|||||||++|+|+||+.||.........
T Consensus 185 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 185 QE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp CC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred Cc--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 21 234578999999999987 67899999999999999999999998432211100
Q ss_pred HHhcccc------ccccC---------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 638 LEKRNFN------SVLDS---------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 638 ~~~~~~~------~~ld~---------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+...... ..+.. .....+...+..+.+|+.+||..||.+||++ .+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~e~l 318 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-REAM 318 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-HHHh
Confidence 0000000 00000 0011122246789999999999999999999 6664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=363.14 Aligned_cols=260 Identities=19% Similarity=0.259 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCcee-eEeeee--cCCCeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV-TLIGTC--PESRSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv-~l~g~~--~~~~~LV~E 496 (780)
.++|...++||+|+||.||+|.+. +..||||++..... ...+.+|+.++..++|++.+ .+..++ .+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999874 78899998765432 23578999999999875544 443333 344679999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccccC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~~~ 573 (780)
|+ +|+|.+++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999963 2456999999999999999999999999 9999999999999 6889999999999988764
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh--HH---HHHHhcccccccc
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD--VK---CALEKRNFNSVLD 648 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~--~~---~~~~~~~~~~~ld 648 (780)
................||..|+|||++.+..++.++||||||||||+|+||+.||..... .. ..+....+...+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 332222222233467899999999999999999999999999999999999999975332 11 1111111111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.... ..+..+.+|+.+||..+|.+||++ .+|++.|+.+..
T Consensus 239 ~l~~----~~p~~l~~li~~cl~~dP~~RPs~-~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCR----GYPTEFASYFHYCRSLRFDDKPDY-SYLKRLFRDLFI 278 (483)
T ss_dssp HHHT----TSCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHH
T ss_pred HHhc----CCcHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHH
Confidence 1111 234679999999999999999999 899999998843
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.81 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=194.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|.....||+|+||.||+|... +..||||++..... .....+.+|+.++++++||||++++++|.+. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999985 67899998865332 2345688999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++++|.+++. ....+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998874 3456999999999999999999999999 9999999999999999999999999997664321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc--------
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN-------- 642 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~-------- 642 (780)
. ......||+.|+|||++.+. .++.++|||||||++|+|+||++||............ +.
T Consensus 179 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 179 E-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 12345789999999999875 7899999999999999999999999766543322110 00
Q ss_pred ------ccccccCc-CCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 ------FNSVLDSS-AGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ------~~~~ld~~-~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.....+. ....+ ...+..+.+|+.+||..||.+||++ .+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-~ell 305 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-AELL 305 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG-GGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH-HHHh
Confidence 00000000 00111 1346779999999999999999999 5554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=344.43 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=198.9
Q ss_pred HhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
..++|.....||+|+||.||+|.+.+ .||+|++.... ......|.+|+.++++++||||++++++|.+. .++|||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 35789999999999999999998866 59999987532 23345678999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++. .....+++..++.|+.+|+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTT--SSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999995 33457999999999999999999999999 99999999999998 67999999999876532211
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc---------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccc
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET---------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNS 645 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~ 645 (780)
. ..........||+.|+|||++.. ..++.++|||||||++|+|+||+.||......... +..+....
T Consensus 185 ~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 185 G--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred c--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 1 11122334568999999999874 45789999999999999999999999865543322 12221111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 646 ~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.. +...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 263 ~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~l~~ 302 (319)
T 2y4i_B 263 LS-------QIGMGKEISDILLFCWAFEQEERPTF-TKLMDMLEKLPK 302 (319)
T ss_dssp CC-------CSSCCTTHHHHHHHHHCSSTTTSCCH-HHHHHHHTTC--
T ss_pred CC-------cCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHH
Confidence 11 11234568999999999999999999 899999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=334.51 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=183.1
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCc-hhH-HHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP-QSH-LKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~-~~~-~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|.. .+..||||++..... ... ..+.++...++.++||||++++++|.+. .++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999998 478899999876422 222 3344555668889999999999999554 57999
Q ss_pred EeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 496 EYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 496 Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||++ |+|.+++.. .....++++..++.|+.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588887753 23456799999999999999999999997 8 99999999999999999999999999977643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhh----ccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYL----ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
... .....||+.|+|||++ .+..++.++|||||||++|+|+||+.||.........+...... .
T Consensus 163 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~ 230 (290)
T 3fme_A 163 DVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----P 230 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS----C
T ss_pred ccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc----C
Confidence 211 1334689999999996 56678999999999999999999999997533222111111000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....+...+..+.+++.+||..+|.+||++ .++++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~e~l~ 266 (290)
T 3fme_A 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTY-PELMQ 266 (290)
T ss_dssp CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-HHHTT
T ss_pred CCCcccccCCHHHHHHHHHHhhcChhhCcCH-HHHHh
Confidence 0111112345679999999999999999999 77754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.89 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=187.7
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--C-
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--S- 490 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~- 490 (780)
.......++|...+.||+|+||.||+|... +..||||++.... .....+.+++..+..++||||++++++|.. .
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667799999999999999999999985 6789999886532 233456788999999999999999999832 1
Q ss_pred ------CeeEEEeccCCChhhHH-hhhCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCccccCCCCCCceEecC-CCCc
Q 044673 491 ------RSLVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSALIYLH--SNEPCIIHGNLKPSKVLIDA-NFGS 560 (780)
Q Consensus 491 ------~~LV~Ey~~~gsL~~~L-~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--~~~~~ivHrDlKp~NILLd~-~~~~ 560 (780)
.++||||++++ |.+.+ ........+++..+..|+.+++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcE
Confidence 46899999874 44443 22345677999999999999999999999 888 999999999999997 8999
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE 639 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~ 639 (780)
||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|+|+||++||...+.......
T Consensus 172 kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEeeCCCceecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 9999999987653221 23457899999999987654 89999999999999999999999986554322111
Q ss_pred hc----c--------------ccccccCc-------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 KR----N--------------FNSVLDSS-------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 ~~----~--------------~~~~ld~~-------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.. . .....+.. ....+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 313 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-YEAL 313 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-HHHT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-HHHh
Confidence 00 0 00000000 111222356789999999999999999999 6664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.31 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=198.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|.....||+|+||.||+|... +..||||++... .......+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999875 678999998643 233456789999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999984 4457999999999999999999999999 99999999999999999999999999976642211
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHH---HHHHhccccccccCcCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVK---CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~---~~~~~~~~~~~ld~~~~ 652 (780)
........||+.|+|||++.+..+ +.++||||||+++|+|+||+.||....... ..+.... ...
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~----- 228 (276)
T 2yex_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYL----- 228 (276)
T ss_dssp -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TTS-----
T ss_pred -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--ccc-----
Confidence 111245678999999999987765 779999999999999999999997544311 1111110 000
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+...+..+.+|+.+||..||.+||++ .+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il 260 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITI-PDIK 260 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCH-HHHT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCH-HHHh
Confidence 1112345678999999999999999999 6663
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=362.20 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=197.3
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-------------hhHHHHHHHHHHhhcCCCCceeeEee
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-------------QSHLKFQNEVEVLSRVRHPNLVTLIG 485 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-------------~~~~~f~~Ev~il~~l~HpnIv~l~g 485 (780)
..++|...++||+|+||.||+|... +..||||++..... .....+.+|+.+|++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999985 57899999865321 23567899999999999999999999
Q ss_pred eecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC---Cc
Q 044673 486 TCPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF---GS 560 (780)
Q Consensus 486 ~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~---~~ 560 (780)
+|.+. .++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence 99765 4799999999999999863 356999999999999999999999999 99999999999998776 69
Q ss_pred ccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHH
Q 044673 561 KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CAL 638 (780)
Q Consensus 561 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~ 638 (780)
||+|||+++.+.... ......||+.|+|||++. +.++.++|||||||++|+|+||.+||...+... ..+
T Consensus 189 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp EECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEECCCCEEcCCCC--------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999998765321 124467999999999987 569999999999999999999999998665432 222
Q ss_pred HhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 639 EKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 639 ~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+.+..... .| ...+..+.+|+.+||..||.+||++ .+++.
T Consensus 260 ~~~~~~~~~~----~~-~~~s~~~~~li~~~L~~dp~~R~t~-~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFDFN----DW-KNISDEAKELIKLMLTYDYNKRCTA-EEALN 301 (504)
T ss_dssp HHCCCCCCHH----HH-TTSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred HcCCCCCCcc----cc-CCCCHHHHHHHHHHcCCChhHCCCH-HHHhc
Confidence 2222111000 00 1235679999999999999999999 67653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=363.56 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++|||||+++++|.+. .++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357899999999999999999885 6789999986532 34567799999999999999999999999765 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe---cCCCCcccccccccccc
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLI 571 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---d~~~~~Kl~DFGla~~~ 571 (780)
|||+.+|+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999985 3457999999999999999999999999 9999999999999 56788999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~ 649 (780)
.... ......||+.|+|||++.+ .++.++|||||||++|+|+||.+||...+.... .+..+.+...
T Consensus 180 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 247 (484)
T 3nyv_A 180 EASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--- 247 (484)
T ss_dssp CCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred cccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 5321 1133469999999999865 699999999999999999999999986654332 2222222111
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...| ...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 248 -~~~~-~~~s~~~~~li~~~L~~dp~~R~s~-~e~l~ 281 (484)
T 3nyv_A 248 -LPQW-KKVSESAKDLIRKMLTYVPSMRISA-RDALD 281 (484)
T ss_dssp -SGGG-GGSCHHHHHHHHHHTCSSGGGSCCH-HHHHT
T ss_pred -Cccc-ccCCHHHHHHHHHHCCCChhHCcCH-HHHhh
Confidence 1111 2356779999999999999999999 67653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.27 Aligned_cols=246 Identities=20% Similarity=0.277 Sum_probs=179.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------- 489 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++|..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 688999998653 23345678899999999999999999999843
Q ss_pred CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
..++|+||+ +++|.+++. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 257999998 789999884 257999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc-
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF- 643 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~- 643 (780)
..... .+...||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........ +..
T Consensus 181 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 181 HTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred ccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 65421 234578999999999887 67899999999999999999999999766543221110 000
Q ss_pred ------------cccccC--cCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 ------------NSVLDS--SAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ------------~~~ld~--~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+.. .....+ ...+..+.+|+.+||..||.+||++ .+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~-~e~L 310 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-AQAL 310 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH-HHHh
Confidence 000000 001111 1234678999999999999999999 6654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=361.27 Aligned_cols=245 Identities=23% Similarity=0.379 Sum_probs=198.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...++||+|+||.||+|... +..||||++... .......+.+|+.+|++++|||||+++++|.+. .++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999885 678999998532 123456789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec---CCCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID---ANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd---~~~~~Kl~DFGla~~~~ 572 (780)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+.
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988633 46999999999999999999999999 99999999999995 45679999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld~~ 650 (780)
... ......||+.|+|||++.+ .++.++|||||||++|+|+||.+||...+.... .+..+.+...
T Consensus 176 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 242 (486)
T 3mwu_A 176 QNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---- 242 (486)
T ss_dssp CC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC----
T ss_pred CCC--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence 321 1234579999999999875 599999999999999999999999976654332 2222222111
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...| ...+..+.+|+.+||..+|.+||++ .++++
T Consensus 243 ~~~~-~~~s~~~~~li~~~L~~dp~~R~t~-~~~l~ 276 (486)
T 3mwu_A 243 LPQW-RTISDDAKDLIRKMLTFHPSLRITA-TQCLE 276 (486)
T ss_dssp SGGG-GGSCHHHHHHHHHHTCSSTTTSCCH-HHHHH
T ss_pred Cccc-CCCCHHHHHHHHHHcCCChhhCcCH-HHHhc
Confidence 1111 2346779999999999999999999 67764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.39 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=196.3
Q ss_pred HHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC-------
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------- 489 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------- 489 (780)
....++|...+.||+|+||.||+|... +..||||++..... .+.+|+.+++.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345688999999999999999999874 67899998865422 22379999999999999999998821
Q ss_pred -------------------------------C--CeeEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHH
Q 044673 490 -------------------------------S--RSLVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYL 535 (780)
Q Consensus 490 -------------------------------~--~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~L 535 (780)
. .++||||++ |+|.+.+.. ......+++..+..|+.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 458999998 588877753 23456799999999999999999999
Q ss_pred HcCCCccccCCCCCCceEec-CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHH
Q 044673 536 HSNEPCIIHGNLKPSKVLID-ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYS 613 (780)
Q Consensus 536 H~~~~~ivHrDlKp~NILLd-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS 613 (780)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||
T Consensus 158 H~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 158 HSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999 99999999999998 688999999999987643221 2345789999999998765 4899999999
Q ss_pred HHHHHHHHHhCCCCCccchhHHHHHHhc----------------cccccccCc--CCC----CCHHHHHHHHHHHHHchh
Q 044673 614 FGIILLRLLTGRPVLRIKKDVKCALEKR----------------NFNSVLDSS--AGD----WPVAEAEQLAHLALRCCE 671 (780)
Q Consensus 614 ~Gvil~eLltG~~p~~~~~~~~~~~~~~----------------~~~~~ld~~--~~~----~p~~~~~~l~~l~~~Cl~ 671 (780)
|||++|+|++|++||...+......... .+....-+. ... .|...+..+.+|+.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999998665443221110 000000000 111 123356679999999999
Q ss_pred hCCCCCcchHHHHH--HHHHHHH
Q 044673 672 NNRLNRPDLVSEIW--SVLEALR 692 (780)
Q Consensus 672 ~~p~~RPs~~~ev~--~~L~~l~ 692 (780)
.||.+||++ .+++ +.++.++
T Consensus 308 ~dP~~R~t~-~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 308 YEPDLRINP-YEAMAHPFFDHLR 329 (383)
T ss_dssp SSGGGSCCH-HHHHTSGGGHHHH
T ss_pred CChhhCCCH-HHHhcCHHHHHHH
Confidence 999999999 6775 3444443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.89 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC--------CCceeeEeeeec---
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR--------HPNLVTLIGTCP--- 488 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~--------HpnIv~l~g~~~--- 488 (780)
.++|...++||+|+||.||+|... +..||||++... ......+.+|+.+|++++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 378999999999999999999764 678999999753 344567889999999996 888999999885
Q ss_pred -C--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCC------
Q 044673 489 -E--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANF------ 558 (780)
Q Consensus 489 -~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~------ 558 (780)
+ ..+|||||+ +|+|.+.+.. .....+++..++.|+.||+.||.|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhh
Confidence 2 357999999 5667666643 2345799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------CcccccccccccccCCCCCCCCcccccCCCCCCcccC
Q 044673 559 -------------------------------------------GSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595 (780)
Q Consensus 559 -------------------------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 595 (780)
.+||+|||+++..... .+...||+.|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 7999999999876421 23457899999
Q ss_pred ChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh------H---HHHHH-----------hcccc-----------
Q 044673 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD------V---KCALE-----------KRNFN----------- 644 (780)
Q Consensus 596 aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~------~---~~~~~-----------~~~~~----------- 644 (780)
|||++.+..++.++|||||||+||+|+||++||...+. . ..... .+...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999999999999999999999999999999964321 1 11100 00000
Q ss_pred ccccC----------cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 SVLDS----------SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ~~ld~----------~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+.+. ....++...+..+.+|+.+||+.||.+||++ .+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 390 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-AECL 390 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-HHHH
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-HHHh
Confidence 00000 0124567888899999999999999999999 6664
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.19 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=191.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---------- 489 (780)
.++|...+.||+|+||.||+|... +..||||++..........+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368999999999999999999986 68899999987666667789999999999999999999998732
Q ss_pred ------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCccc
Q 044673 490 ------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKL 562 (780)
Q Consensus 490 ------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl 562 (780)
..++||||++ |+|.+++. ..++++..++.|+.|++.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEE
Confidence 2469999998 69999884 357999999999999999999999999 99999999999997 5678999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
+|||+++........ ........||..|+|||.+.+ ..++.++|||||||++|+|+||++||...+.........
T Consensus 163 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 163 GDFGLARIMDPHYSH----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCccccccCCCccc----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999876432111 111233467889999998875 678999999999999999999999998665432211100
Q ss_pred c-c--------ccc-------ccC--cCCCC-----CHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 N-F--------NSV-------LDS--SAGDW-----PVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 ~-~--------~~~-------ld~--~~~~~-----p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. . ..+ +.. ..... +...+..+.+|+.+||..||.+||++ .++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-EEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-HHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-HHHhC
Confidence 0 0 000 000 00000 11345779999999999999999999 67753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.11 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=196.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC-------CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------~~ 491 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999985 7889999987543 3345678899999999999999999998753 24
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+. |+|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 79999997 689998853 46999999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCCCCCC---cccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc
Q 044673 572 PQGESTGNS---ALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF 643 (780)
Q Consensus 572 ~~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~ 643 (780)
......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+........ +..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 532211110 1112334678999999998765 67899999999999999999999999866543221110 000
Q ss_pred c--------------ccccC--cCCC-----CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 644 N--------------SVLDS--SAGD-----WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 644 ~--------------~~ld~--~~~~-----~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. ..+.. .... .+...+..+.+|+.+||..||.+||++ .++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-KEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-HHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-HHHhc
Confidence 0 00000 0000 012345678999999999999999999 66643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.76 Aligned_cols=246 Identities=21% Similarity=0.279 Sum_probs=197.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC----chhHHHHHHHHHHhhcCCCCceeeEeeee--cC--CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG----PQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PE--SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~----~~~~~~f~~Ev~il~~l~HpnIv~l~g~~--~~--~~ 491 (780)
.++|.....||+|+||.||+|... +..||||++.... ......|.+|+.++++++||||+++++++ .+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999884 5789999986421 23456799999999999999999999998 33 35
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++| |.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 7999999887 77776532 3467999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccc
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGK--LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVL 647 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~l 647 (780)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...+..... +..+.
T Consensus 160 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~----- 229 (305)
T 2wtk_C 160 HPFAAD-----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS----- 229 (305)
T ss_dssp CTTCSS-----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----
T ss_pred Cccccc-----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-----
Confidence 432111 1123457899999999997644 378999999999999999999999865543221 12221
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...|...+..+.+|+.+||..||.+||++ .++++
T Consensus 230 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~ 263 (305)
T 2wtk_C 230 ----YAIPGDCGPPLSDLLKGMLEYEPAKRFSI-RQIRQ 263 (305)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSTTTSCCH-HHHHH
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCCCH-HHHhc
Confidence 12333456778999999999999999999 77764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=354.11 Aligned_cols=200 Identities=23% Similarity=0.307 Sum_probs=162.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|++++|||||++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999875 578999998753 334456799999999999999999999998443
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.|+||||+. |+|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 579999986 59999985 4467999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCC---------------cccccCCCCCCcccCChhhh-ccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 571 IPQGESTGNS---------------ALCNESNNDSASVYIDPEYL-ETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 571 ~~~~~~~~~~---------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
.......... .....+...||+.|+|||++ ....++.++|||||||+||||+||..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 7533211000 00123567899999999986 556799999999999999999984333
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.00 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=198.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---------hhHHHHHHHHHHhhcCC-CCceeeEeeeecC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---------QSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---------~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~ 489 (780)
.++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999984 67899999865431 22456889999999996 9999999999966
Q ss_pred C--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 S--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 ~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
. .++||||+++|+|.+++.. ...+++..++.|+.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccc
Confidence 5 5799999999999999963 356999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhc------cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHH
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE------TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALE 639 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~ 639 (780)
+..+.... ......||+.|+|||++. ...++.++||||||+++|+|+||.+||...+.... .+.
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 98764321 123457899999999985 45688999999999999999999999976554322 122
Q ss_pred hccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 KRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 ~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+.... ... .....+..+.+|+.+||..||.+||++ .+++
T Consensus 243 ~~~~~~----~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll 282 (298)
T 1phk_A 243 SGNYQF----GSP-EWDDYSDTVKDLVSRFLVVQPQKRYTA-EEAL 282 (298)
T ss_dssp HTCCCC----CTT-TGGGSCHHHHHHHHHHCCSSGGGSCCH-HHHT
T ss_pred cCCccc----Ccc-cccccCHHHHHHHHHHccCCcccCCCH-HHHH
Confidence 222111 011 112456779999999999999999999 6653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.71 Aligned_cols=248 Identities=13% Similarity=0.077 Sum_probs=177.2
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcC--CCCceeeEeeeec------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRV--RHPNLVTLIGTCP------ 488 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l--~HpnIv~l~g~~~------ 488 (780)
..+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456889999999999999999874 67899999987442 3345677885444444 6999888653221
Q ss_pred --------------------CCCeeEEEeccCCChhhHHhhhCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCcc
Q 044673 489 --------------------ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTR------MQIASDVCSALIYLHSNEPCI 542 (780)
Q Consensus 489 --------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~i 542 (780)
...+|||||++ |+|.+++.... ..+.+..+ +.|+.||+.||.|||+.+ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--C
Confidence 22589999999 89999996432 23456666 888999999999999999 9
Q ss_pred ccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHH
Q 044673 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLR 620 (780)
Q Consensus 543 vHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~e 620 (780)
+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999998664211 13456689999999987 679999999999999999
Q ss_pred HHhCCCCCccchhHHHH-HHhcccccccc-CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 621 LLTGRPVLRIKKDVKCA-LEKRNFNSVLD-SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 621 LltG~~p~~~~~~~~~~-~~~~~~~~~ld-~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
|+||++||......... +.......... ......+...+..+.+|+.+||..||.+||++ .+++
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 351 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-LEAM 351 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH-HHHT
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 99999999754321000 00000000000 00111112456789999999999999999999 6664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=346.38 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=196.4
Q ss_pred HhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
..++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|.+++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3578999999999999999999874 6789999987543 33446789999999999999999999998432
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+. |+|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 479999997 589998842 46999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-cc---
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-RN--- 642 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~~--- 642 (780)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+..... ... +.
T Consensus 178 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 178 ADPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp CCGGGCB----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred cCCCCCc----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 6432111 111245689999999998764 45899999999999999999999999754432111 100 00
Q ss_pred --------------ccccccCcCCCC---CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 --------------FNSVLDSSAGDW---PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 --------------~~~~ld~~~~~~---p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...........| +...+..+.+|+.+||..||.+||++ .+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 312 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-EQAL 312 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 000000001111 11235678999999999999999999 6664
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.60 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=193.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc--------hhHHHHHHHHHHhhcCCCCceeeEeeeecC-C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP--------QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-S 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~--------~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~ 490 (780)
.++|...+.||+|+||.||+|... +..||||++..... .....|.+|+.+|++++||||+++++++.. .
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 57899999865321 123358899999999999999999999854 4
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---cccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGF 567 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGl 567 (780)
.++||||+++|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 679999999999999885 4567999999999999999999999999 999999999999987665 99999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCccchh---HHHHHHhc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKCALEKR 641 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~~~~~~ 641 (780)
++...... ......||+.|+|||++. +..++.++|||||||++|+|+||.+||..... ....+..+
T Consensus 164 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 164 SKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp CEECCCCH--------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred ceeccccc--------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 98764221 112345889999999974 46789999999999999999999999964332 22223322
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....- ..+...+..+.+|+.+||..||.+||++ .+++
T Consensus 236 ~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~-~~~l 273 (322)
T 2ycf_A 236 KYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTT-EEAL 273 (322)
T ss_dssp CCCCCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred ccccCc-----hhhhhcCHHHHHHHHHHcccCHhhCCCH-HHHh
Confidence 221100 0001235678999999999999999999 6665
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.87 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=190.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC------C--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------S--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~--~~ 492 (780)
.+|...+.||+|+||.||+|.+. +..||||++..... .+.+|+.+|++++|||||+++++|.. . .+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999984 67899999865321 23479999999999999999998822 1 35
Q ss_pred eEEEeccCCChhhHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLAC-KNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHL 570 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla~~ 570 (780)
+||||+++ +|.+.+.. ......+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 89999986 56665532 234567999999999999999999999999 9999999999999965 5689999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc--------
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR-------- 641 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~-------- 641 (780)
+..... .....||+.|+|||++.+. .++.++||||||||||||+||++||...+.........
T Consensus 207 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 207 LVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 643211 2345789999999999765 79999999999999999999999998665433221110
Q ss_pred --------cccccccCcC--CCC----CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 --------NFNSVLDSSA--GDW----PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 --------~~~~~ld~~~--~~~----p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+....-+.. ..| +...+..+.+|+.+||..||.+||++ .+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-~e~l 335 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-LEAC 335 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-HHHh
Confidence 0011100110 111 22345789999999999999999999 6665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.88 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=199.6
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCch-----------------hHHHHHHHHHHhhcCCCCceeeEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQ-----------------SHLKFQNEVEVLSRVRHPNLVTLI 484 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~-----------------~~~~f~~Ev~il~~l~HpnIv~l~ 484 (780)
.++|...+.||+|+||.||+|...+..||||++...... ....|.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 478999999999999999999998899999998642111 117899999999999999999999
Q ss_pred eeecCC--CeeEEEeccCCChhhH------HhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEec
Q 044673 485 GTCPES--RSLVFEYLRNGSLEDC------LACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 485 g~~~~~--~~LV~Ey~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd 555 (780)
++|.+. .++||||+++|+|.++ +. .....++++..++.|+.|++.||.|||+ .+ |+||||||+|||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSC-SSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhh-hccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEc
Confidence 998654 5799999999999998 53 1225789999999999999999999999 88 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCc-chhHHHHHHHHHHHHhCCCCCccchh
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTP-ESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~-ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|+|+||.+||.....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999876432 12446789999999999877 6666 99999999999999999999976543
Q ss_pred ---HHHHHHhccccccccCc--C--------CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 634 ---VKCALEKRNFNSVLDSS--A--------GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 634 ---~~~~~~~~~~~~~ld~~--~--------~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+..+......+.. . ...+...+..+.+|+.+||..||.+||++ .+++
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-~e~l 321 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-EDAL 321 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-HHHH
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 22222222211110000 0 00013356789999999999999999999 6664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.07 Aligned_cols=245 Identities=19% Similarity=0.275 Sum_probs=191.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--C----
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--R---- 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~---- 491 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||++++++|.+. .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999874 6889999987532 33356788999999999999999999998543 2
Q ss_pred --eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 492 --SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 492 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
++||||+. |+|.+++. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 89999997 68888772 34999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc-
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF- 643 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~- 643 (780)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........ +..
T Consensus 193 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 193 HADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 65421 234578999999999987 67999999999999999999999999865543222110 000
Q ss_pred ----------------cccccCcCCC---CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 ----------------NSVLDSSAGD---WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ----------------~~~ld~~~~~---~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+....... .+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell 322 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-AQAL 322 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-HHHH
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-HHHh
Confidence 0000000011 112346789999999999999999999 6664
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.23 Aligned_cols=245 Identities=19% Similarity=0.261 Sum_probs=193.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|.....||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999874 7889999986532 23356789999999999999999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+. |+|.+++. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 279999997 68888773 34999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc-
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF- 643 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~- 643 (780)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........ +..
T Consensus 175 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 175 HADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred CCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 65321 134578999999999887 67899999999999999999999999865543211100 000
Q ss_pred ----------------ccc---ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 644 ----------------NSV---LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 644 ----------------~~~---ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..+ ........+...+..+.+|+.+||..||.+||++ .+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~e~l 304 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-AQAL 304 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-HHHH
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 000 0011112233456789999999999999999999 6664
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=352.01 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=191.3
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC------C--Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------S--RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~--~~L 493 (780)
.+|...+.||+|+||.||+|.+. +..||+|++..... ...+|+.+++.++|||||+++++|.. . .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56899999999999999999984 45699998764322 12379999999999999999999822 1 458
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCccccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl~DFGla~~~~ 572 (780)
||||++++.+............+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+.
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999988655554443445677999999999999999999999999 99999999999999 79999999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc----------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR---------- 641 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~---------- 641 (780)
.... .....||+.|+|||++.+. .++.++|||||||+||+|+||++||...+.........
T Consensus 194 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 194 AGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 3221 2345789999999998765 58999999999999999999999998665433221110
Q ss_pred ------cccccccCcCCC------CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 ------NFNSVLDSSAGD------WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ------~~~~~ld~~~~~------~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+....-+.... ++...+..+.+|+.+||..||.+||++ .+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~l 320 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-IEAL 320 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-HHHH
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-HHHh
Confidence 000000001111 122345689999999999999999999 6664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=333.43 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=189.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---------- 489 (780)
.++|...+.||+|+||.||+|... +..||||++... ......+.+|+.++++++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999874 678999998642 3445678999999999999999999998732
Q ss_pred -----CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccc
Q 044673 490 -----SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSD 564 (780)
Q Consensus 490 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~D 564 (780)
..++||||+++|+|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 24699999999999999963 3456888999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCC-------CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHH
Q 044673 565 FGFFHLIPQGESTG-------NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636 (780)
Q Consensus 565 FGla~~~~~~~~~~-------~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~ 636 (780)
||+++......... ...........||+.|+|||++.+. .++.++|||||||++|+|+| ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99997664221000 0001122456789999999999754 78999999999999999999 4432221111
Q ss_pred HHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 637 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.... +..........++...+..+.+++.+||..||.+||++ .+++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll 282 (303)
T 1zy4_A 237 ILKK--LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-RTLL 282 (303)
T ss_dssp HHHH--HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred HHHh--ccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-HHHh
Confidence 1111 00111111223444556778999999999999999999 6664
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=335.80 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=196.5
Q ss_pred hcCCCcccccccCCceEEEEeee---cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc------eeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL---RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN------LVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~---~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn------Iv~l~g~~~~~-- 490 (780)
.++|...+.||+|+||.||+|.. .+..||||++... ......+.+|+.++..++|+| +++++++|.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999976 4678999999753 344567889999999997765 99999998543
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC--------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-------------- 556 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-------------- 556 (780)
.++||||+ +|+|.+++... ...++++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccc
Confidence 57999999 88999998632 3357999999999999999999999999 999999999999987
Q ss_pred -----CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 557 -----NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 557 -----~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999765321 13457899999999999999999999999999999999999999765
Q ss_pred hhHHHHH--Hh--ccc----------cccccCc-----------------------CCCCCHHHHHHHHHHHHHchhhCC
Q 044673 632 KDVKCAL--EK--RNF----------NSVLDSS-----------------------AGDWPVAEAEQLAHLALRCCENNR 674 (780)
Q Consensus 632 ~~~~~~~--~~--~~~----------~~~ld~~-----------------------~~~~p~~~~~~l~~l~~~Cl~~~p 674 (780)
+...... .. +.+ ....... ....+...+..+.+|+.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 4432111 00 000 0000000 011233557789999999999999
Q ss_pred CCCcchHHHHH
Q 044673 675 LNRPDLVSEIW 685 (780)
Q Consensus 675 ~~RPs~~~ev~ 685 (780)
.+||++ .+++
T Consensus 318 ~~Rpt~-~ell 327 (339)
T 1z57_A 318 AKRITL-REAL 327 (339)
T ss_dssp TTSCCH-HHHT
T ss_pred ccccCH-HHHh
Confidence 999999 6664
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.82 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=195.8
Q ss_pred HhcCCCcccccccCCceEEEEeeec---CeeEEEEEccCCC--chhHHHHHHHHHHhhcC---CCCceeeEeeeec----
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRV---RHPNLVTLIGTCP---- 488 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~---- 488 (780)
+.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999873 5789999886422 12233566788777766 8999999999985
Q ss_pred -C--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 489 -E--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 489 -~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
. ..++||||+. |+|.+++... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecC
Confidence 2 2579999998 6999998632 3345999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH---HHh-c
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---LEK-R 641 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---~~~-~ 641 (780)
|+++...... ......||..|+|||++.++.++.++|||||||++|+|+||++||......... +.. +
T Consensus 165 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 165 GLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9987654211 224567899999999999999999999999999999999999999865543221 110 0
Q ss_pred c-----ccc-------ccc----CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 642 N-----FNS-------VLD----SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 642 ~-----~~~-------~ld----~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. +.. .+. ......+...+..+.+|+.+||..||.+||++ .+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l 295 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSAL 295 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 0 000 000 00011123356778999999999999999999 6664
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=348.87 Aligned_cols=197 Identities=26% Similarity=0.365 Sum_probs=168.6
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC------CCCceeeEeeeecC--CC
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV------RHPNLVTLIGTCPE--SR 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l------~HpnIv~l~g~~~~--~~ 491 (780)
..+|...+.||+|+||.||+|... +..||||++... ......+.+|+.++..+ .||||++++++|.. ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999875 578999999753 33456678888888877 57799999999854 46
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC--cccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG--SKLSDFGFFH 569 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~--~Kl~DFGla~ 569 (780)
++||||+. |+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 79999996 6999988643 3356999999999999999999999999 999999999999999987 9999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
..... .....||+.|+|||++.+..++.++|||||||+||+|+||++||...+.
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 65321 1345789999999999999999999999999999999999999976554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.44 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=195.1
Q ss_pred hcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-----------CCceeeEeeeec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-----------HPNLVTLIGTCP 488 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-----------HpnIv~l~g~~~ 488 (780)
.++|...+.||+|+||.||+|.. .+..||||++... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999986 4788999999753 334567889999999886 899999999985
Q ss_pred C------CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEec------
Q 044673 489 E------SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLID------ 555 (780)
Q Consensus 489 ~------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd------ 555 (780)
. ..++||||+ +|+|.+++... ....+++..++.|+.||+.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCc
Confidence 3 356899999 89999998642 345699999999999999999999998 9 99999999999994
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV- 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~- 634 (780)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||+|+||++||......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4457999999999876421 23457899999999999999999999999999999999999999744311
Q ss_pred --------HHHHH-hcccc-----------------cccc--------------CcCCCCCHHHHHHHHHHHHHchhhCC
Q 044673 635 --------KCALE-KRNFN-----------------SVLD--------------SSAGDWPVAEAEQLAHLALRCCENNR 674 (780)
Q Consensus 635 --------~~~~~-~~~~~-----------------~~ld--------------~~~~~~p~~~~~~l~~l~~~Cl~~~p 674 (780)
..... .+.+. ..+. .....++...+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 11100 00000 0000 01123556778899999999999999
Q ss_pred CCCcchHHHHHH
Q 044673 675 LNRPDLVSEIWS 686 (780)
Q Consensus 675 ~~RPs~~~ev~~ 686 (780)
.+||++ .+++.
T Consensus 323 ~~Rpt~-~ell~ 333 (373)
T 1q8y_A 323 RKRADA-GGLVN 333 (373)
T ss_dssp TTCBCH-HHHHT
T ss_pred cccCCH-HHHhh
Confidence 999999 66643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.71 Aligned_cols=198 Identities=26% Similarity=0.441 Sum_probs=149.6
Q ss_pred CCc-ccccccCCceEEEEeeec----CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeec--C--CCeeEE
Q 044673 425 FEP-SWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--E--SRSLVF 495 (780)
Q Consensus 425 f~~-~~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~--~~~LV~ 495 (780)
|.. .++||+|+||.||+|.+. +..||||++.... ....+.+|+.+|++++|||||+++++|. + ..+|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999864 5679999997543 2346889999999999999999999982 2 357999
Q ss_pred EeccCCChhhHHhhh------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----cCCCCcccccc
Q 044673 496 EYLRNGSLEDCLACK------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI----DANFGSKLSDF 565 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL----d~~~~~Kl~DF 565 (780)
||+.+ +|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+||
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99974 788777422 12335999999999999999999999999 9999999999999 77899999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
|+++.+..... .........||+.|+|||++.+. .++.++|||||||+||+|+||++||...
T Consensus 177 g~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 177 GFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99987643211 11223456899999999999874 5899999999999999999999999643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.20 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=175.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHH-HhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVE-VLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~-il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|.....||+|+||.||+|... +..||||++.... ......+..|+. +++.++||||++++++|.+. .++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 378999999999999999999985 7889999987643 334455666666 77888999999999998554 57999
Q ss_pred EeccCCChhhHHhh--hCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 496 EYLRNGSLEDCLAC--KNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
||+++ +|.+++.. ......+++..+..|+.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 88887743 22356799999999999999999999998 8 9999999999999999999999999997664
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhh----ccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYL----ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
... ......||+.|+|||++ .+..++.++|||||||++|+|+||+.||.........+. .+..
T Consensus 178 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~ 244 (327)
T 3aln_A 178 DSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-----QVVK 244 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-----CCCC
T ss_pred ccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-----HHhc
Confidence 321 11334689999999998 456789999999999999999999999976443222211 1111
Q ss_pred CcC----CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 649 SSA----GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 649 ~~~----~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
... ...+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY-KELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH-HHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH-HHHHh
Confidence 111 11112356679999999999999999999 66643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.74 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=191.3
Q ss_pred HHHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCch------hHHHHHHHHHHhhcC----CCCceeeEeee
Q 044673 419 NEATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQ------SHLKFQNEVEVLSRV----RHPNLVTLIGT 486 (780)
Q Consensus 419 ~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~------~~~~f~~Ev~il~~l----~HpnIv~l~g~ 486 (780)
....++|...+.||+|+||.||+|.. .+..||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999987 4678999999754321 223466799999998 89999999999
Q ss_pred ecC--CCeeEEEe-ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCccc
Q 044673 487 CPE--SRSLVFEY-LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKL 562 (780)
Q Consensus 487 ~~~--~~~LV~Ey-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl 562 (780)
|.+ ..++|||| +.+|+|.+++.. ..++++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 854 46799999 789999999964 346999999999999999999999999 99999999999999 8899999
Q ss_pred ccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhc
Q 044673 563 SDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLT-PESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641 (780)
Q Consensus 563 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~ 641 (780)
+|||+++...... .....||..|+|||++.+..+. .++|||||||++|+|+||+.||........ .
T Consensus 182 ~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~ 248 (312)
T 2iwi_A 182 IDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE----A 248 (312)
T ss_dssp CCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----T
T ss_pred EEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----h
Confidence 9999998764321 2345689999999999877764 589999999999999999999975433211 1
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 642 ~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...++...+..+.+++.+||..+|.+||++ .+++.
T Consensus 249 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~ 283 (312)
T 2iwi_A 249 ---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSL-EEILL 283 (312)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCH-HHHHH
T ss_pred ---------ccCCcccCCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 112333456678999999999999999999 66753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=326.59 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=196.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|...+.||+|+||.||+|... +..||||++... .......|.+|+.++++++||||+++++++.+. .++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999884 678999998642 233467799999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC---CCccccccccccccc
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN---FGSKLSDFGFFHLIP 572 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~---~~~Kl~DFGla~~~~ 572 (780)
||+++++|.+++... ..+++..++.|+.+|+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999988633 46899999999999999999999999 9999999999999764 469999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHH--HHHHhccccccccCc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK--CALEKRNFNSVLDSS 650 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~--~~~~~~~~~~~ld~~ 650 (780)
.... .....||+.|+|||++.+ .++.++||||||+++|+|+||.+||...+... ..+..+.......
T Consensus 176 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 244 (287)
T 2wei_A 176 QNTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-- 244 (287)
T ss_dssp CCSS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--
T ss_pred CCCc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch--
Confidence 3211 123357889999999865 58999999999999999999999997655432 2222222211110
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
. ....+..+.+++.+||..+|.+||++ .++++
T Consensus 245 --~-~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~ 276 (287)
T 2wei_A 245 --Q-WRTISDDAKDLIRKMLTFHPSLRITA-TQCLE 276 (287)
T ss_dssp --G-GTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHH
T ss_pred --h-hhhcCHHHHHHHHHHcccChhhCcCH-HHHhc
Confidence 0 01345679999999999999999999 77765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.42 Aligned_cols=208 Identities=27% Similarity=0.343 Sum_probs=170.5
Q ss_pred CHHHHHHHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CC-----ceeeEee
Q 044673 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HP-----NLVTLIG 485 (780)
Q Consensus 414 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-Hp-----nIv~l~g 485 (780)
.+.......++|...+.||+|+||.||+|... +..||||++... ......+..|+.++..++ |+ +|+.+++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 33334445689999999999999999999875 678999999753 334566788999988885 44 4999999
Q ss_pred eecC--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec--CCCCcc
Q 044673 486 TCPE--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID--ANFGSK 561 (780)
Q Consensus 486 ~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd--~~~~~K 561 (780)
+|.. ..+|||||+. |+|.+++... ....+++..+..|+.|++.||.|||....+||||||||+||||+ .++.+|
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 8843 4679999996 5999998643 33569999999999999999999995322399999999999994 578899
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV 634 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~ 634 (780)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||+||+|+||++||...+..
T Consensus 202 L~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp ECCCTTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeccCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999876421 13457899999999999999999999999999999999999999865543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.94 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=193.9
Q ss_pred ccCHHHHHHHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCC--CchhHHHHHHHHHHhhcCC--CCceeeEeee
Q 044673 412 EFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVR--HPNLVTLIGT 486 (780)
Q Consensus 412 ~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~--HpnIv~l~g~ 486 (780)
.+.+..+....++|...+.||+|+||.||++... +..||||++... .......|.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3444444445678999999999999999999875 677999998653 3344567999999999997 5999999999
Q ss_pred ecCC--CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccc
Q 044673 487 CPES--RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSD 564 (780)
Q Consensus 487 ~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~D 564 (780)
+.+. .++||| +.+|+|.+++.. ...+++..++.|+.|++.||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEee
Confidence 8655 468999 668899999963 357899999999999999999999999 999999999999964 8899999
Q ss_pred ccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCccchh
Q 044673 565 FGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-----------GKLTPESDVYSFGIILLRLLTGRPVLRIKKD 633 (780)
Q Consensus 565 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~ 633 (780)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.....
T Consensus 170 fg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 170 FGIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp CSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 999987643211 111234578999999999875 4788999999999999999999999975432
Q ss_pred HHHHHHhccccccccCc-CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 634 VKCALEKRNFNSVLDSS-AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 634 ~~~~~~~~~~~~~ld~~-~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
....+. .++++. ...+|...+..+.+++.+||..||.+||++ .+++.
T Consensus 245 ~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~ 292 (313)
T 3cek_A 245 QISKLH-----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PELLA 292 (313)
T ss_dssp HHHHHH-----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred HHHHHH-----HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCH-HHHhc
Confidence 211111 111111 122333345679999999999999999999 66654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=330.40 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=193.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--C-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc------eeeEeeeecC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--H-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN------LVTLIGTCPE--S 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn------Iv~l~g~~~~--~ 490 (780)
.++|...+.||+|+||.||+|... + ..||||++... ......+.+|+.++++++|+| ++.+++++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 378999999999999999999874 3 67999999753 344567889999999998776 8899888754 4
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe----------------
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI---------------- 554 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL---------------- 554 (780)
.++||||+ +|+|.+++.. ....++++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccccc
Confidence 67999999 6677777653 23357999999999999999999999999 9999999999999
Q ss_pred ---cCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 044673 555 ---DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631 (780)
Q Consensus 555 ---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~ 631 (780)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999765321 13457899999999999999999999999999999999999999765
Q ss_pred hhHHHHH--Hh--ccc----------cccccCc-----------------------CCCCCHHHHHHHHHHHHHchhhCC
Q 044673 632 KDVKCAL--EK--RNF----------NSVLDSS-----------------------AGDWPVAEAEQLAHLALRCCENNR 674 (780)
Q Consensus 632 ~~~~~~~--~~--~~~----------~~~ld~~-----------------------~~~~p~~~~~~l~~l~~~Cl~~~p 674 (780)
....... .. +.+ ....... ........+..+.+|+.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 4432111 00 000 0000000 001122446689999999999999
Q ss_pred CCCcchHHHHH
Q 044673 675 LNRPDLVSEIW 685 (780)
Q Consensus 675 ~~RPs~~~ev~ 685 (780)
.+||++ .+++
T Consensus 323 ~~Rpt~-~e~l 332 (355)
T 2eu9_A 323 AQRITL-AEAL 332 (355)
T ss_dssp TTSCCH-HHHT
T ss_pred hhCcCH-HHHh
Confidence 999999 6664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.12 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=183.3
Q ss_pred hcCC-CcccccccCCceEEE-EeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNF-EPSWKIGEGRYGNVY-RGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f-~~~~~IG~G~~G~Vy-k~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.+++ ...+.||+|+||+|| .+...+..||||++.. .....+.+|+.+|.++ +|||||++++++.+. .++|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3444 445789999999996 4555689999999864 2345678999999886 899999999999665 478999
Q ss_pred eccCCChhhHHhhhCCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-------------CC
Q 044673 497 YLRNGSLEDCLACKNKKS----PLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-------------FG 559 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~----~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-------------~~ 559 (780)
|+. |+|.+++....... ..++..++.|+.||+.||.|||+.+ |+||||||+|||++.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 69999996432211 1233456789999999999999999 9999999999999754 47
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhcc-------CCCCcchhHHHHHHHHHHHHh-CCCCCccc
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET-------GKLTPESDVYSFGIILLRLLT-GRPVLRIK 631 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~ 631 (780)
+||+|||+++.+....... ........||+.|+|||++.+ +.++.++|||||||++|+|+| |++||...
T Consensus 167 ~kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 9999999998775432110 111234679999999999975 678999999999999999999 99999755
Q ss_pred hhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 632 ~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
......+..+... ++......+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 244 ~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~eil 294 (434)
T 2rio_A 244 YSRESNIIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-MKVL 294 (434)
T ss_dssp TTHHHHHHHTCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred hhhHHHHhcCCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCH-HHHH
Confidence 4333222222211 1111122245677889999999999999999999 6665
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=333.71 Aligned_cols=247 Identities=20% Similarity=0.294 Sum_probs=169.2
Q ss_pred hcCCCccc-ccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC----C--Ce
Q 044673 422 TNNFEPSW-KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----S--RS 492 (780)
Q Consensus 422 t~~f~~~~-~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~--~~ 492 (780)
.++|.... .||+|+||.||+|... +..||||++... ..........+..+.||||+++++++.. . .+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 56898865 5999999999999886 688999998652 1112223334567799999999998843 2 57
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCcccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFFH 569 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla~ 569 (780)
+||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999632 2357999999999999999999999999 999999999999976 4559999999997
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccc
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVL 647 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~l 647 (780)
...... .....||+.|+|||++.+..++.++|||||||++|+|+||++||......... ..........
T Consensus 180 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 180 ETTQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp EC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eccccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 654221 23457899999999998888999999999999999999999999654332110 0000000000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...... ....+..+.+|+.+||..||.+||++ .+++.
T Consensus 251 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~ 287 (336)
T 3fhr_A 251 GFPNPE-WSEVSEDAKQLIRLLLKTDPTERLTI-TQFMN 287 (336)
T ss_dssp CCCTTT-STTCCHHHHHHHHHHSCSSGGGSCCH-HHHHH
T ss_pred ccCchh-hccCCHHHHHHHHHHCCCChhHCcCH-HHHhc
Confidence 000111 12456779999999999999999999 77765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=353.98 Aligned_cols=260 Identities=24% Similarity=0.314 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--------S 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--------~ 490 (780)
.++|....+||+|+||.||+|.+. +..||||++... .......|.+|+.++.+++|||||++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999874 678999998764 34456679999999999999999999998743 2
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC---cccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG---SKLSDFGF 567 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~---~Kl~DFGl 567 (780)
.++||||+++|+|.+++.......++++..++.|+.+++.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 4799999999999999975555567999999999999999999999999 999999999999997765 89999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--------H
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--------E 639 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--------~ 639 (780)
+....... ......||+.|+|||++.++.++.++|||||||++|+|+||..||.......... .
T Consensus 171 a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 98764322 1234678999999999999999999999999999999999999996432211100 0
Q ss_pred hcccccccc---------CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHH-----HHHHHHHHH
Q 044673 640 KRNFNSVLD---------SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSE-----IWSVLEALR 692 (780)
Q Consensus 640 ~~~~~~~ld---------~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~e-----v~~~L~~l~ 692 (780)
......... +.....+...+..+.+|+.+||..||.+||++ .+ +...++.+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa-~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-PQNPNVGCFQALDSIL 308 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC-TTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH-HHHhcCHHHHHHHHHH
Confidence 000000000 01122344578899999999999999999998 55 456666653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.86 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=194.4
Q ss_pred HHhcCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCch------hHHHHHHHHHHhhcCC--CCceeeEeeeecC
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQ------SHLKFQNEVEVLSRVR--HPNLVTLIGTCPE 489 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~------~~~~f~~Ev~il~~l~--HpnIv~l~g~~~~ 489 (780)
...++|.....||+|+||.||+|.. .+..||||++...... ....|.+|+.++.+++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999987 4688999998653211 2245678999999996 5999999999965
Q ss_pred C--CeeEEEeccC-CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCcccccc
Q 044673 490 S--RSLVFEYLRN-GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKLSDF 565 (780)
Q Consensus 490 ~--~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl~DF 565 (780)
. .++||||+.+ ++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 4 5789999976 899999863 356899999999999999999999999 99999999999999 7899999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN 644 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~ 644 (780)
|+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....... .+..
T Consensus 195 g~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~- 260 (320)
T 3a99_A 195 GSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV- 260 (320)
T ss_dssp TTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCCC-
T ss_pred cccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----cccc-
Confidence 9998764321 234578999999999987766 678999999999999999999997544321 1110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 ~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.++...+..+.+|+.+||..||.+||++ .++++
T Consensus 261 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~ 293 (320)
T 3a99_A 261 --------FFRQRVSSECQHLIRWCLALRPSDRPTF-EEIQN 293 (320)
T ss_dssp --------CCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHHHT
T ss_pred --------cccccCCHHHHHHHHHHccCChhhCcCH-HHHhc
Confidence 1222345678999999999999999999 66643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=340.18 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=184.2
Q ss_pred cCCCcccccccCCceE-EEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGN-VYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~-Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
.+|.....||+|+||+ ||++...+..||||++..... ..+.+|+.+|+++ +|||||++++++.+. .+|||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4688889999999998 667777889999999865332 2356899999999 799999999999654 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-----CCCcccccccccccccC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-----NFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-----~~~~Kl~DFGla~~~~~ 573 (780)
. |+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 101 ~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 699999963 3334555667899999999999999999 999999999999943 23577999999987653
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhc---cCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLE---TGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
.... ........||+.|+|||++. ...++.++|||||||++|+|+| |.+||+...........+... .
T Consensus 176 ~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--~-- 247 (432)
T 3p23_A 176 GRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS--L-- 247 (432)
T ss_dssp --------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC--C--
T ss_pred CCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC--c--
Confidence 2211 11234567999999999997 4567889999999999999999 999997554333222111110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.....+......+.+|+.+||+.||.+||++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~evl 282 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSA-KHVL 282 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCH-HHHH
Confidence 1111223456678899999999999999999 6776
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.37 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=174.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCch-hH-HHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-SH-LKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-~~-~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
.++|.....||+|+||.||+|.+. +..||||++...... .. ..+..+..+++.++||||++++++|.+. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 478999999999999999999985 678999998764322 22 3344555678888999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
||+ ++.+..++.. ...++++..++.|+.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 5555555432 245799999999999999999999995 8 999999999999999999999999998766432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~ 649 (780)
. ......||+.|+|||++. ...++.++|||||||++|+|+||+.||.........+.... .. ..+
T Consensus 179 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~ 248 (318)
T 2dyl_A 179 K--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QE-EPP 248 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HS-CCC
T ss_pred c--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-cc-CCC
Confidence 1 123456899999999994 56788999999999999999999999975332221111100 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
... .....+..+.+|+.+||..||.+||++ .++++
T Consensus 249 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~ 283 (318)
T 2dyl_A 249 LLP-GHMGFSGDFQSFVKDCLTKDHRKRPKY-NKLLE 283 (318)
T ss_dssp CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCH-HHHTT
T ss_pred CCC-ccCCCCHHHHHHHHHHccCChhHCcCH-HHHhh
Confidence 010 011245678999999999999999999 66653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=356.53 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=193.2
Q ss_pred hcCCCcccccccCCceEEEEeeec---CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--C-----
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--S----- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~----- 490 (780)
.++|.....||+|+||.||+|.+. +..||||++.... ......|.+|+.++.+++|||||+++++|.+ .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999874 6789999986533 3445678999999999999999999999843 2
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+|||||+++|+|.+++. .+++|..++.|+.||+.||.|||+.+ ||||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchh
Confidence 489999999999998773 27999999999999999999999999 9999999999999986 899999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
.... ....||+.|+|||++.++. +.++|||||||+||+|++|.+||.... .+..
T Consensus 231 ~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~--------------~~~~ 284 (681)
T 2pzi_A 231 INSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY--------------VDGL 284 (681)
T ss_dssp TTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE--------------CSSC
T ss_pred cccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc--------------cccc
Confidence 6421 3457999999999998764 899999999999999999999886321 0111
Q ss_pred CCCC-CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 651 AGDW-PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 651 ~~~~-p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.... .......+.+|+.+||+.||.+||+..+++...|..+
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 1111 1233467999999999999999998767777777665
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.60 Aligned_cols=226 Identities=16% Similarity=0.141 Sum_probs=179.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++..... .....|.+|+.++.+++||||+++++++.+. .++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999986 68899999976432 3346799999999999999999999998544 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. . .+ ......+|+.|++.||.|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~---~-~~-~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVAD---T-SP-SPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHT---T-CC-CHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHh---c-CC-ChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 9999999999984 1 23 45578899999999999999999 9999999999999999999998554
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCC---
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAG--- 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~--- 652 (780)
|++ .++.++|||||||+||+|+||+.||...+..... ......+.....
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQPIEPA 226 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSCBCCHH
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccCCCChh
Confidence 333 2788999999999999999999999754321100 000000000000
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
..+...+..+.+|+.+||+.||.+| ++ .++++.|+.+...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~-~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SA-STLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CH-HHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CH-HHHHHHHHHHhcc
Confidence 1112345679999999999999999 88 9999999988643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.45 Aligned_cols=238 Identities=15% Similarity=0.149 Sum_probs=181.9
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCCC--------chhHHHHHHHHHHhhcCC---------CCceeeEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYG--------PQSHLKFQNEVEVLSRVR---------HPNLVTLI 484 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~--------~~~~~~f~~Ev~il~~l~---------HpnIv~l~ 484 (780)
.++|...++||+|+||.||+|..++..||||++.... ......+.+|+.+|+.++ |||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3678889999999999999999999999999987532 223467889999998886 66666665
Q ss_pred ee-----------------e---------------cCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHH
Q 044673 485 GT-----------------C---------------PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532 (780)
Q Consensus 485 g~-----------------~---------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL 532 (780)
+. | .+..+|||||+++|++.+.+. ...+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHH
Confidence 54 3 234689999999998777663 25689999999999999999
Q ss_pred HHHH-cCCCccccCCCCCCceEecCCC--------------------CcccccccccccccCCCCCCCCcccccCCCCCC
Q 044673 533 IYLH-SNEPCIIHGNLKPSKVLIDANF--------------------GSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591 (780)
Q Consensus 533 ~~LH-~~~~~ivHrDlKp~NILLd~~~--------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt 591 (780)
.||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ...||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt 240 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFC 240 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECC
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEe
Confidence 9999 899 99999999999999887 8999999999876521 23689
Q ss_pred cccCChhhhccCCCCcchhHHHHHHH-HHHHHhCCCCCccchhHHHHHHhccccc-ccc-CcCCCCCHHHHHHHHHHHHH
Q 044673 592 SVYIDPEYLETGKLTPESDVYSFGII-LLRLLTGRPVLRIKKDVKCALEKRNFNS-VLD-SSAGDWPVAEAEQLAHLALR 668 (780)
Q Consensus 592 ~~Y~aPE~~~~~~~~~ksDVwS~Gvi-l~eLltG~~p~~~~~~~~~~~~~~~~~~-~ld-~~~~~~p~~~~~~l~~l~~~ 668 (780)
+.|+|||++.+.. +.++||||||++ .+++++|..||....+........ +.. ... ......+...+..+.+|+.+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-LKQMTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH-HHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh-hhhhccCcccchhhhhhcCHHHHHHHHH
Confidence 9999999998665 899999998777 778899999996533222211110 000 001 11111234678899999999
Q ss_pred chhhCCCCCcchHHHHH
Q 044673 669 CCENNRLNRPDLVSEIW 685 (780)
Q Consensus 669 Cl~~~p~~RPs~~~ev~ 685 (780)
||+.+ ++ .+++
T Consensus 319 ~L~~d-----sa-~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SA-TDLL 329 (336)
T ss_dssp GGGSS-----SH-HHHH
T ss_pred HhccC-----CH-HHHH
Confidence 99965 56 5554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=329.65 Aligned_cols=239 Identities=14% Similarity=0.111 Sum_probs=179.3
Q ss_pred HHhcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCC-CceeeE----------
Q 044673 420 EATNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRH-PNLVTL---------- 483 (780)
Q Consensus 420 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~H-pnIv~l---------- 483 (780)
..+.+|...+.||+|+||.||+|.+. +..||||++..... .....|.+|+.++..++| +|....
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34556778889999999999999975 78999999874332 235679999999999987 322111
Q ss_pred -----------eeeecC-------CCeeEEEeccCCChhhHHhh----hCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCc
Q 044673 484 -----------IGTCPE-------SRSLVFEYLRNGSLEDCLAC----KNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541 (780)
Q Consensus 484 -----------~g~~~~-------~~~LV~Ey~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ 541 (780)
+.++.. ..+++|++ .+|+|.+++.. .....++++..++.|+.||+.||.|||+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 111111 12345554 57899998842 223456899999999999999999999999
Q ss_pred cccCCCCCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhh----------ccCCCCcchhH
Q 044673 542 IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL----------ETGKLTPESDV 611 (780)
Q Consensus 542 ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~~~ksDV 611 (780)
||||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 999999999999999999999999998765321 234567 899999999 55568889999
Q ss_pred HHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 612 YSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 612 wS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
|||||+||+|+||+.||...... .....++.. .. ..+..+.+|+.+||..||.+||++ .++
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~------~~~~~~~~~-~~----~~~~~~~~li~~~l~~dP~~Rpt~-~~~ 361 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAAL------GGSEWIFRS-CK----NIPQPVRALLEGFLRYPKEDRLLP-LQA 361 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGG------SCSGGGGSS-CC----CCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchh------hhHHHHHhh-cc----cCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 99999999999999999754421 111122221 11 234679999999999999999997 444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.21 Aligned_cols=224 Identities=22% Similarity=0.357 Sum_probs=175.7
Q ss_pred hcCCCcc-cccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHh-hcCCCCceeeEeeeecC----C--C
Q 044673 422 TNNFEPS-WKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVL-SRVRHPNLVTLIGTCPE----S--R 491 (780)
Q Consensus 422 t~~f~~~-~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il-~~l~HpnIv~l~g~~~~----~--~ 491 (780)
.++|... +.||+|+||.||+|... +..||||++.. ...+.+|+.++ +.++||||++++++|.+ . .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4677777 67999999999999874 67899999864 24567899988 56689999999998853 2 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFF 568 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla 568 (780)
++||||+++|+|.+++... ...++++..++.|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 7999999999999999642 3357999999999999999999999999 999999999999998 788999999997
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
.... +..++.++|||||||++|+|+||++||......... ......+.
T Consensus 168 ~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~ 215 (299)
T 3m2w_A 168 KETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIR 215 (299)
T ss_dssp EECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------CCSCCSSC
T ss_pred cccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---HHHHHHHh
Confidence 6542 134678999999999999999999999754432211 01111111
Q ss_pred CcCCCCCH----HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 649 SSAGDWPV----AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 649 ~~~~~~p~----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....+|. ..+..+.+|+.+||..||.+||++ .+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-~e~l~ 256 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-TEFMN 256 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCH-HHHhc
Confidence 11222332 346789999999999999999999 77754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=292.39 Aligned_cols=182 Identities=19% Similarity=0.132 Sum_probs=125.6
Q ss_pred cccCCceEEEEeee--cCeeEEEEEccCCC----------chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeEE
Q 044673 431 IGEGRYGNVYRGLL--RHLHVAIKMFPSYG----------PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 431 IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~----------~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++.|++|.++.+.. -+..||||++.... .....+|.+|+++|+++ .||||++|++++.+. .||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566665554433 36779999986532 12345699999999999 699999999999765 68999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||++||+|.++|. ..++++.. +|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 322 Eyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999995 44567654 48999999999999999 9999999999999999999999999998765322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL 628 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~ 628 (780)
. ..+..+||+.|||||++.+ .+..++|+||+|+++++|.+|..++
T Consensus 394 ~-------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 S-------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred c-------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 1 1234579999999999864 5677899999999988887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-27 Score=274.06 Aligned_cols=191 Identities=18% Similarity=0.215 Sum_probs=145.7
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCc--h------hHHHHHHHHHHhhcCCCCcee--eEeeeecCCCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGP--Q------SHLKFQNEVEVLSRVRHPNLV--TLIGTCPESRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~--~------~~~~f~~Ev~il~~l~HpnIv--~l~g~~~~~~~ 492 (780)
..+...+.||+|+||.||+|...+..+++|....... . ....|.+|+.+|++++||||+ .++++..+..+
T Consensus 336 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 336 KRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred ccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 3334566899999999999988889999998654221 1 134589999999999999999 66777777889
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
|||||+++|+|.+++.. ++.|+.|++.||.|||+.+ |+||||||+|||++. .+||+|||+++...
T Consensus 416 lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999999952 5689999999999999999 999999999999998 99999999998875
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLET--GKLTPESDVYSFGIILLRLLTGRPVL 628 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ksDVwS~Gvil~eLltG~~p~ 628 (780)
.................||+.|||||++.. ..|+..+|+||.++-.++-+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 321100000001134578999999999986 56888899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-23 Score=218.50 Aligned_cols=149 Identities=16% Similarity=0.156 Sum_probs=118.2
Q ss_pred HHHHHhcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc------------------hhHHHHHHHHHHhhcCCC
Q 044673 417 ELNEATNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP------------------QSHLKFQNEVEVLSRVRH 477 (780)
Q Consensus 417 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~------------------~~~~~f~~Ev~il~~l~H 477 (780)
.+......|...+.||+|+||.||+|.+. +..||||+++.... .....|.+|+.+|++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 33344456667799999999999999984 68899999864321 134568999999999994
Q ss_pred CceeeEeeeec-CCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 478 PNLVTLIGTCP-ESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 478 pnIv~l~g~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
+++++++. +..++||||+++|+|.+ +. . .....|+.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 ---~~v~~~~~~~~~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 ---LAVPKVYAWEGNAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS- 227 (282)
T ss_dssp ---SSSCCEEEEETTEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-
T ss_pred ---CCcCeEEeccceEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-
Confidence 55555442 34689999999999998 52 1 224469999999999999999 99999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhc
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 601 (780)
++.+||+|||+|+... .|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~~~--------------------~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVEVG--------------------EEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEETT--------------------STTHHHHHH
T ss_pred CCcEEEEECCCCeECC--------------------CCCHHHHHH
Confidence 9999999999986432 378999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.9e-20 Score=191.05 Aligned_cols=135 Identities=16% Similarity=0.156 Sum_probs=105.6
Q ss_pred CCcccccccCCceEEEEeee--cCee--EEEEEccCCCch------------------------hHHHHHHHHHHhhcCC
Q 044673 425 FEPSWKIGEGRYGNVYRGLL--RHLH--VAIKMFPSYGPQ------------------------SHLKFQNEVEVLSRVR 476 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~--~~~~--VAiK~l~~~~~~------------------------~~~~f~~Ev~il~~l~ 476 (780)
|.....||+|+||.||+|.+ .+.. ||||++...... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999998 6888 999987542111 1135789999999998
Q ss_pred CCce--eeEeeeecCCCeeEEEeccC-C----ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCccccCCCC
Q 044673 477 HPNL--VTLIGTCPESRSLVFEYLRN-G----SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH-SNEPCIIHGNLK 548 (780)
Q Consensus 477 HpnI--v~l~g~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~ivHrDlK 548 (780)
|+|+ ..+++ ....+|||||+.+ | +|.+++.. .++.....++.|++.||.||| +.+ |||||||
T Consensus 129 ~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred hCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence 8864 33443 2467899999942 4 66665421 234567889999999999999 899 9999999
Q ss_pred CCceEecCCCCcccccccccccc
Q 044673 549 PSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 549 p~NILLd~~~~~Kl~DFGla~~~ 571 (780)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 8999999998754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=169.12 Aligned_cols=138 Identities=13% Similarity=0.128 Sum_probs=112.9
Q ss_pred cCCCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHH-H-HHHHHHHHHHHh
Q 044673 14 SDVEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHAD-K-IQVFDQYLLLLS 89 (780)
Q Consensus 14 ~~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~-~-~~ll~~~~~~c~ 89 (780)
+.|+++|+||||+| +.|..|++||+..+ .+++|+++||.++...........+ ....+... . ++.|+.+...+.
T Consensus 2 ~~~~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~ 79 (146)
T 3s3t_A 2 NARYTNILVPVDSS-DAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVL-SELLDAEAAHAKDAMRQRQQFVA 79 (146)
T ss_dssp CCCCCEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHH-HHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCccceEEEEcCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccc-HHHHHHHHHHHHHHHHHHHHHHH
Confidence 45789999999999 99999999998866 5899999999887543221110011 11111111 1 789999999999
Q ss_pred hcCc-eeeEEEeecCchhhHHHH-HHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 90 QAGV-QGDSVWIEKDNVEDGIVE-VITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 90 ~~~V-~~e~~vie~~~v~~~I~~-~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
..|+ +++..+..| ++++.|++ +|++.++|+||||++|++++.+.++|| ++.+|+++++ |+|+||
T Consensus 80 ~~g~~~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs---~~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 80 TTSAPNLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGS---TTSYVVDHAP--CNVIVI 145 (146)
T ss_dssp TSSCCCCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCH---HHHHHHHHCS--SEEEEE
T ss_pred hcCCcceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcc---hHHHHhccCC--CCEEEe
Confidence 9999 999888876 78899999 999999999999999999999999999 9999999999 999998
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=167.97 Aligned_cols=137 Identities=17% Similarity=0.122 Sum_probs=111.2
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCccccc---ccCCH-HHHH-HHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAV---NGLKQ-HADK-IQVFDQYLLLL 88 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~---~~~~~-~~~~-~~ll~~~~~~c 88 (780)
|+++|+||||+| +.|..|++||++.+ .+++|+++||.++...........+. ....+ .... ++.++.+...+
T Consensus 1 M~~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 79 (147)
T 3hgm_A 1 MFNRIMVPVDGS-KGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRA 79 (147)
T ss_dssp CCSEEEEECCSB-HHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHH
T ss_pred CCceEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHH
Confidence 678999999999 99999999998866 58999999999875411111111111 11122 2222 88999999999
Q ss_pred hhcCcee---eEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 89 SQAGVQG---DSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 89 ~~~~V~~---e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
...|+++ +..+..| +++++|++++.++++|+||||++|++++.+.++|| ++.+|+++++ |+|+||
T Consensus 80 ~~~g~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs---~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 80 TELGVPADKVRAFVKGG-RPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGS---VAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp HHTTCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCH---HHHHHHHHCS--SCEEEC
T ss_pred HhcCCCccceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCccccceeecc---HHHHHHhhCC--CCEEEC
Confidence 9999998 8766665 88999999999999999999999999999999999 9999999999 999986
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=168.84 Aligned_cols=140 Identities=13% Similarity=0.152 Sum_probs=110.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCC-----CccccCCcc--c-ccc-----cCCHHHH--HH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPS-----HVFAFKESK--C-AVN-----GLKQHAD--KI 78 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~-----~~~~~~~~~--~-~~~-----~~~~~~~--~~ 78 (780)
|.++|+||||+| +.|..|++||++.+ .+++|+++||.++. ......... + +.. ...+... .+
T Consensus 4 ~~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (162)
T 1mjh_A 4 MYKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAK 82 (162)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCC-HHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHH
Confidence 678999999999 99999999998877 58899999998764 111110000 1 110 0111111 17
Q ss_pred HHHHHHHHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEE
Q 044673 79 QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWF 158 (780)
Q Consensus 79 ~ll~~~~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~v 158 (780)
+.|+.+...+...|++++..+..| +++++|+++|+++++|+||||++|++++.+.++|| ++.+|+++++ |+|+|
T Consensus 83 ~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GS---v~~~vl~~~~--~pVlv 156 (162)
T 1mjh_A 83 NKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGS---VTENVIKKSN--KPVLV 156 (162)
T ss_dssp HHHHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCH---HHHHHHHHCC--SCEEE
T ss_pred HHHHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecc---hHHHHHHhCC--CCEEE
Confidence 789999999999999999887775 78999999999999999999999999999999999 9999999998 99999
Q ss_pred EeeC
Q 044673 159 CCKG 162 (780)
Q Consensus 159 v~kg 162 (780)
|..+
T Consensus 157 v~~~ 160 (162)
T 1mjh_A 157 VKRK 160 (162)
T ss_dssp ECCC
T ss_pred EeCC
Confidence 9654
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-18 Score=162.11 Aligned_cols=136 Identities=21% Similarity=0.247 Sum_probs=109.5
Q ss_pred CCCCeEEEEec--CCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHH-HHHHHHHHHHHHh
Q 044673 15 DVEETIFVAVG--KNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHAD-KIQVFDQYLLLLS 89 (780)
Q Consensus 15 ~~~~~I~VAVD--~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~-~~~ll~~~~~~c~ 89 (780)
.++++|+|||| +| +.|..|++||++.+ .+++|+++||.++...... +. .+......... .++.|+.+...+.
T Consensus 13 ~~~~~ILv~vD~~~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~~~~~~~ 89 (156)
T 3fg9_A 13 LVYRRILLTVDEDDN-TSSERAFRYATTLAHDYDVPLGICSVLESEDINIF-DS-LTPSKIQAKRKHVEDVVAEYVQLAE 89 (156)
T ss_dssp CCCC-EEEECCSCCC-HHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCC-CS-SHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCceEEEEECCCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCcccc-cc-CCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 46899999999 99 99999999998866 5899999999987643211 11 11111111111 1789999999999
Q ss_pred hcCc-eeeEEEeecCchhhHHHHH-HHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 90 QAGV-QGDSVWIEKDNVEDGIVEV-ITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 90 ~~~V-~~e~~vie~~~v~~~I~~~-~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
..|+ .++..+..+++++++|+++ |+++++|+||||++|++++.+ ++|| ++.+|+++++ |+|+||
T Consensus 90 ~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~-~~Gs---~~~~vl~~a~--~PVlvV 155 (156)
T 3fg9_A 90 QRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSK-IAGA---IGPRLARKAP--ISVIVV 155 (156)
T ss_dssp HHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSS-SCSC---HHHHHHHHCS--SEEEEE
T ss_pred HcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccce-eecc---hHHHHHHhCC--CCEEEe
Confidence 9999 4888888856889999999 999999999999999999975 8999 9999999999 999998
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=163.00 Aligned_cols=139 Identities=12% Similarity=0.070 Sum_probs=109.0
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccc---------cccCCHHHHH--HHHHH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCA---------VNGLKQHADK--IQVFD 82 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~---------~~~~~~~~~~--~~ll~ 82 (780)
|.++|+||||+| +.|..|++||+..+ .+++|++|||.++...... +..++ .....+.... ++.|+
T Consensus 4 m~~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 81 (170)
T 2dum_A 4 MFRKVLFPTDFS-EGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEEL-MDGYSFFYDNAEIELKDIKEKLKEEASRKLQ 81 (170)
T ss_dssp CCSEEEEECCSS-HHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCC-C------------CCTTSHHHHHHHHHHHHH
T ss_pred ccceEEEEecCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccc-ccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 678999999999 99999999998877 5899999999876432111 10111 1111111111 78899
Q ss_pred HHHHHHhhcCceeeE--EEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 83 QYLLLLSQAGVQGDS--VWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 83 ~~~~~c~~~~V~~e~--~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
.+...+...|++++. .+..| +++++|+++|+++++|+||||++|++++.+.++|| ++.+|+++++ |+|+||.
T Consensus 82 ~~~~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gs---v~~~vl~~~~--~PVlvv~ 155 (170)
T 2dum_A 82 EKAEEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGS---TVMRVLRKTK--KPVLIIK 155 (170)
T ss_dssp HHHHHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCH---HHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCccccceech---HHHHHHHhCC--CCEEEEc
Confidence 999998888999987 66665 78999999999999999999999999999999999 9999999999 9999996
Q ss_pred eC
Q 044673 161 KG 162 (780)
Q Consensus 161 kg 162 (780)
.+
T Consensus 156 ~~ 157 (170)
T 2dum_A 156 EV 157 (170)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=162.20 Aligned_cols=140 Identities=15% Similarity=0.104 Sum_probs=107.5
Q ss_pred ccCCCCeEEEEecCCccccHHHHHHHhhhc-CCCeEEEE--eecCCCCccccCCcccccccCCHHH--HHHHHHHHHHHH
Q 044673 13 VSDVEETIFVAVGKNVEKNKTTVFWALQNF-AGKKISLL--HVHKPSHVFAFKESKCAVNGLKQHA--DKIQVFDQYLLL 87 (780)
Q Consensus 13 ~~~~~~~I~VAVD~s~~~S~~Al~wAl~~~-~~~~i~lv--HV~~~~~~~~~~~~~~~~~~~~~~~--~~~~ll~~~~~~ 87 (780)
...+.++|+||||+| +.|..|++||++.+ .+++|+|| ||.++..... +...+...+.+.. ..++.|+.+...
T Consensus 13 ~~~~~~~ILv~vD~s-~~s~~al~~A~~lA~~~a~l~ll~a~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~ 89 (163)
T 1tq8_A 13 SLSAYKTVVVGTDGS-DSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARA--ADILKDESYKVTGTAPIYEILHDAKER 89 (163)
T ss_dssp CCCCCCEEEEECCSS-HHHHHHHHHHHHHHTTTSEEEEEEECCC----------------------CCTHHHHHHHHHHH
T ss_pred ccccCCEEEEEcCCC-HHHHHHHHHHHHHhCCCCEEEEEEeeeccCccccc--ccccccHHHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999 99999999997755 68899999 8876543201 1001111111111 117889999999
Q ss_pred HhhcCce-eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 88 LSQAGVQ-GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 88 c~~~~V~-~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
+...|++ ++..+..| +++++|+++|++.++|+||||++|++++.+.++|| ++.+|+++++ |+|+||..
T Consensus 90 ~~~~gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGS---va~~vl~~a~--~PVlvV~~ 158 (163)
T 1tq8_A 90 AHNAGAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGS---VPANVSRRAK--VDVLIVHT 158 (163)
T ss_dssp HHTTTCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBB---HHHHHHHHTT--CEEEEECC
T ss_pred HHHcCCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceeecc---HHHHHHHhCC--CCEEEEeC
Confidence 9999998 98877775 78999999999999999999999999999999999 9999999999 99999953
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=156.66 Aligned_cols=132 Identities=18% Similarity=0.286 Sum_probs=100.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHH-HHHHHHHHHHHhhcC
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADK-IQVFDQYLLLLSQAG 92 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~-~~ll~~~~~~c~~~~ 92 (780)
|+++|+||||+| +.|..|++||++.+ .+++|+++||.++... .. +...+.....+.... ++.|+.+... .|
T Consensus 1 m~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-~~-~~~~~~~~~~~~~~~~~~~l~~~~~~---~g 74 (137)
T 2z08_A 1 MFKTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPD-YL-GEPFFEEALRRRLERAEGVLEEARAL---TG 74 (137)
T ss_dssp CCSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHH---HC
T ss_pred CcceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-cc-cccchHHHHHHHHHHHHHHHHHHHHH---cC
Confidence 568999999999 99999999998866 5889999999986431 11 111111111111111 5566655443 68
Q ss_pred c-eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 93 V-QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 93 V-~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
+ +++..+..| +++++|+++++++++|+||||++|++++.+.++|| ++.+|+++++ |+|+||
T Consensus 75 ~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs---~~~~vl~~~~--~pVlvv 136 (137)
T 2z08_A 75 VPKEDALLLEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGS---QSQRVVAEAP--CPVLLV 136 (137)
T ss_dssp CCGGGEEEEES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCH---HHHHHHHHCS--SCEEEE
T ss_pred CCccEEEEEec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhcc---HHHHHHhcCC--CCEEEe
Confidence 9 888877765 78999999999999999999999999999999999 9999999998 999998
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-17 Score=156.10 Aligned_cols=138 Identities=17% Similarity=0.142 Sum_probs=93.8
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccc-cCCcccccc-cCCHHHHHHHHHHHHHHHHhhc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFA-FKESKCAVN-GLKQHADKIQVFDQYLLLLSQA 91 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~-~~~~~~~~~-~~~~~~~~~~ll~~~~~~c~~~ 91 (780)
++++|+||||+| +.|..|++||+..+ .+++|+++||.++..... ..+...+.. ....+...++....+..++.+.
T Consensus 5 ~~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 83 (150)
T 3tnj_A 5 VYHHILLAVDFS-SEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTL 83 (150)
T ss_dssp CCSEEEEECCCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHc
Confidence 478999999999 99999999998866 589999999998754210 112222221 1111222233344444455666
Q ss_pred Ccee-eEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 92 GVQG-DSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 92 ~V~~-e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
|+.. +..+.. ++++++|++++.++++|+||||++|++++. .++|| ++.+|+++++ |+|+||..
T Consensus 84 ~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~~~Gs---~~~~vl~~~~--~pVlvv~~ 147 (150)
T 3tnj_A 84 GIDPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLA-LLLGS---TANSVLHYAK--CDVLAVRL 147 (150)
T ss_dssp TCCGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC---------CCC---HHHHHHHHCS--SEEEEEEC
T ss_pred CCCcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcC-eEecc---hHHHHHHhCC--CCEEEEeC
Confidence 8874 665555 588999999999999999999999999999 99999 9999999999 99999953
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.3e-17 Score=155.77 Aligned_cols=134 Identities=12% Similarity=0.099 Sum_probs=102.0
Q ss_pred CeEEEEecCCccc--cHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 18 ETIFVAVGKNVEK--NKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 18 ~~I~VAVD~s~~~--S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
++|+||||+| +. |..|++||+..+ .+++|+++||.++....+..+...+.......+..++.+..+..++.+.|+
T Consensus 2 k~ILv~vD~s-~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 80 (143)
T 3fdx_A 2 NAILVPIDIS-DKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSI 80 (143)
T ss_dssp CEEEEECCTT-CSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCC
T ss_pred CEEEEEecCC-hHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCC
Confidence 6899999999 99 999999997765 689999999998764332222111111111122226788888888888775
Q ss_pred ---eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 94 ---QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 94 ---~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
+++..+..| +++++|+++++++++|+||||+++ +++.+.++|| ++.+|+++++ |+|+||
T Consensus 81 ~~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs---~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 81 PEDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHR-PDITTYLLGS---NAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp CGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCH---HHHHHHHHCS--SEEEEE
T ss_pred CCCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeecc---HHHHHHHhCC--CCEEEe
Confidence 457766665 889999999999999999999996 8899999999 9999999999 999998
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=159.77 Aligned_cols=131 Identities=15% Similarity=0.160 Sum_probs=109.5
Q ss_pred cCCCCeEEEEecC-CccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhh
Q 044673 14 SDVEETIFVAVGK-NVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQ 90 (780)
Q Consensus 14 ~~~~~~I~VAVD~-s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~ 90 (780)
..|+++|+||||+ | +.|..|++||++.+ .+++|++|||.++... .. ....+..++.|+.+...+.+
T Consensus 21 ~mm~~~ILv~vD~~s-~~s~~al~~A~~la~~~~a~l~llhV~~~~~~---------~~-~~~~~~~~~~l~~~~~~~~~ 89 (155)
T 3dlo_A 21 GMIYMPIVVAVDKKS-DRAERVLRFAAEEARLRGVPVYVVHSLPGGGR---------TK-DEDIIEAKETLSWAVSIIRK 89 (155)
T ss_dssp -CCCCCEEEECCSSS-HHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT---------SC-HHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCeEEEEECCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc---------cc-HHHHHHHHHHHHHHHHHHHh
Confidence 3468899999999 9 99999999998866 5889999999986421 00 01111127899999999999
Q ss_pred cCceeeEE-EeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 91 AGVQGDSV-WIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 91 ~~V~~e~~-vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
.|+.++.. .+..++++++|+++|.++++|+||||++|++++.+.++|| ++.+|+++++ |+|+||.
T Consensus 90 ~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGS---v~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 90 EGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGS---VARDVILKAN--KPVICIK 155 (155)
T ss_dssp TTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCH---HHHHHHHHCS--SCEEEEC
T ss_pred cCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEecc---HHHHHHHhCC--CCEEEeC
Confidence 99988764 3556789999999999999999999999999999999999 9999999999 9999983
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-17 Score=161.31 Aligned_cols=140 Identities=19% Similarity=0.303 Sum_probs=99.7
Q ss_pred CCCeEEEEecCCcc---------ccHHHHHHHhhhc-----CCCeEEEEeecCCCCc-cccCCc-ccccc---cCCH--H
Q 044673 16 VEETIFVAVGKNVE---------KNKTTVFWALQNF-----AGKKISLLHVHKPSHV-FAFKES-KCAVN---GLKQ--H 74 (780)
Q Consensus 16 ~~~~I~VAVD~s~~---------~S~~Al~wAl~~~-----~~~~i~lvHV~~~~~~-~~~~~~-~~~~~---~~~~--~ 74 (780)
..++||||||+| + .|..|++||++.+ .+++|++|||.++... +...+. ..... .+.+ .
T Consensus 4 ~~~~ILv~vD~s-~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (175)
T 2gm3_A 4 EPTKVMVAVNAS-TIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNK 82 (175)
T ss_dssp -CEEEEEECCBC-SSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHH
T ss_pred CccEEEEEECCC-cccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHH
Confidence 467999999999 8 9999999999865 2679999999865421 110001 11010 0111 1
Q ss_pred HHHHHHHHHHHHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCc
Q 044673 75 ADKIQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISC 154 (780)
Q Consensus 75 ~~~~~ll~~~~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C 154 (780)
...++.|+.+...+...|++++..+..| +++++|+++|.++++|+||||++|++++.+.++|| ++.+|+++++ |
T Consensus 83 ~~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gs---va~~vl~~a~--~ 156 (175)
T 2gm3_A 83 AKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGT---VSAFCVKHAE--C 156 (175)
T ss_dssp HHHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------C---HHHHHHHHCS--S
T ss_pred HHHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCc---hHHHHHhCCC--C
Confidence 1126789999999988999998877775 78999999999999999999999999999999999 9999999999 9
Q ss_pred EEEEEeeC
Q 044673 155 HIWFCCKG 162 (780)
Q Consensus 155 ~V~vv~kg 162 (780)
+|+||..+
T Consensus 157 pVlvv~~~ 164 (175)
T 2gm3_A 157 PVMTIKRN 164 (175)
T ss_dssp CEEEEECC
T ss_pred CEEEEcCC
Confidence 99999643
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=9e-18 Score=157.76 Aligned_cols=131 Identities=15% Similarity=0.237 Sum_probs=107.1
Q ss_pred CeEEEEecCCccccHHHHHHHhhhc---CCCeEEEEeecCCCCccccCCcccccccCCHH--HHHHHHHHHHHHHHhhcC
Q 044673 18 ETIFVAVGKNVEKNKTTVFWALQNF---AGKKISLLHVHKPSHVFAFKESKCAVNGLKQH--ADKIQVFDQYLLLLSQAG 92 (780)
Q Consensus 18 ~~I~VAVD~s~~~S~~Al~wAl~~~---~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~~~~c~~~~ 92 (780)
++|+||||+| +.|..|++||++.+ .+++|+++||.++.......+ ..+.....+. +..++.|+.+...+...|
T Consensus 2 ~~ILv~~D~s-~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 79 (138)
T 3idf_A 2 KKLLFAIDDT-EACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAV-LAAYDEIEMKEEEKAKLLTQKFSTFFTEKG 79 (138)
T ss_dssp EEEEEECCSS-HHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccc-cCcHHHHHHHHHHHHHHHHHHHHHHHHHCC
Confidence 6899999999 99999999998766 688999999998764322111 1111111111 112789999999999999
Q ss_pred ceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 93 VQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 93 V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
++++..+..| +++++|++++. ++|+||||++|++++.+.+ || ++.+|+++++ |+|+||
T Consensus 80 ~~~~~~v~~g-~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~-Gs---~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 80 INPFVVIKEG-EPVEMVLEEAK--DYNLLIIGSSENSFLNKIF-AS---HQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp CCCEEEEEES-CHHHHHHHHHT--TCSEEEEECCTTSTTSSCC-CC---TTCHHHHHCS--SCEEEE
T ss_pred CCeEEEEecC-ChHHHHHHHHh--cCCEEEEeCCCcchHHHHh-Cc---HHHHHHhcCC--CCEEEe
Confidence 9999888776 78999999999 9999999999999999999 99 9999999999 999998
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=147.17 Aligned_cols=134 Identities=16% Similarity=0.152 Sum_probs=96.1
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCC-CCccccCCcccccccCCH--HHHHHHHHHHHHHHHhh
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKP-SHVFAFKESKCAVNGLKQ--HADKIQVFDQYLLLLSQ 90 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~-~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~~~~c~~ 90 (780)
|+++|+||||+| +.|..|++||+..+ .+++|+++||.++ +...+...... .....+ .+..++.|+. ++.+
T Consensus 1 m~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~---~~~~ 75 (141)
T 1jmv_A 1 MYKHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVN-MSSMQDRISTETQKALLD---LAES 75 (141)
T ss_dssp CCSEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHH-HHHHTTCCCCHHHHHHHH---HHHH
T ss_pred CCceEEEEecCc-hhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccc-hHHHHHHHHHHHHHHHHH---HHHH
Confidence 578999999999 99999999998866 5889999999844 22111110000 000000 0001344444 4455
Q ss_pred cCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 91 AGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 91 ~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
.|+.+....+..++++++|+++|+++++|+||||++ ++++.+ +|| ++.+|+++++ |+|+||..+
T Consensus 76 ~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~--lgs---~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 76 VDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK--LMS---STRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp SSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH--HHH---HHHHHHTTCC--SEEEEEECC
T ss_pred cCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh--hcc---hHHHHHhcCC--CCEEEeeCC
Confidence 688873334444688999999999999999999999 998888 388 9999999999 999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=8.3e-16 Score=168.53 Aligned_cols=135 Identities=11% Similarity=0.149 Sum_probs=95.2
Q ss_pred CCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc--------------hhHHHHHHHHHHhhcCCCCceeeEeee--
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP--------------QSHLKFQNEVEVLSRVRHPNLVTLIGT-- 486 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~--------------~~~~~f~~Ev~il~~l~HpnIv~l~g~-- 486 (780)
-|.+..+||.|+||.||+|... |..||||+++.... .....+..++.+.....|+|+++|+..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999874 78999998753110 111222333333333334444444321
Q ss_pred ------ecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCC-
Q 044673 487 ------CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG- 559 (780)
Q Consensus 487 ------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~- 559 (780)
.....+|||||++|++|..+.. . .....++.|++.+|.|||+.+ ||||||||.||||+.++.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCc
Confidence 1223579999999998876542 1 123568899999999999999 999999999999988773
Q ss_pred ---------cccccccccc
Q 044673 560 ---------SKLSDFGFFH 569 (780)
Q Consensus 560 ---------~Kl~DFGla~ 569 (780)
+.|+||+-+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 7899998654
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.3e-15 Score=158.07 Aligned_cols=138 Identities=11% Similarity=0.117 Sum_probs=109.4
Q ss_pred CCCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHH-H-HHHHHHHHHHHHhh
Q 044673 15 DVEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHA-D-KIQVFDQYLLLLSQ 90 (780)
Q Consensus 15 ~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~-~-~~~ll~~~~~~c~~ 90 (780)
.|+++|+||||+| +.|..|++||+..+ .++.|+++||.++........+..+ ....+.. . .++.|+.+...+..
T Consensus 20 ~m~~~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~ 97 (294)
T 3loq_A 20 FQSNAMLLPTDLS-ENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDI-DHYIDEMSEKAEEVLPEVAQKIEA 97 (294)
T ss_dssp STTCEEEEECCSC-TGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCT-THHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhccEEEecCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccH-HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999 99999999998765 6899999999877542211111111 1111111 1 17899999999999
Q ss_pred cCceeeE-EEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 91 AGVQGDS-VWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 91 ~~V~~e~-~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
.|++++. .+.+.++++++| ++.+.++|+||||++|++++.+.++|| ++.+|+++++ |+|+||..
T Consensus 98 ~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs---~~~~vl~~~~--~PVlvv~~ 162 (294)
T 3loq_A 98 AGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGS---VSEGVLHDSK--VPVYIFKH 162 (294)
T ss_dssp TTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCC---HHHHHHHHCS--SCEEEECC
T ss_pred cCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeecc---HHHHHHhcCC--CCEEEecC
Confidence 9999998 666356888999 999999999999999999999999999 9999999999 99999953
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=152.64 Aligned_cols=133 Identities=13% Similarity=0.053 Sum_probs=98.6
Q ss_pred CCCeEEEEecCCccc-------cHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEK-------NKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLL 86 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~-------S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 86 (780)
.+++|+||+|+| +. |..|++||+..+ .+++|+|+||.++...... .+..... +...++.......
T Consensus 133 ~~~~Ilva~D~s-~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~----~~~~~~~-~~~~~~~~~~l~~ 206 (290)
T 3mt0_A 133 TGGKILAAVDVG-NNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA----DPTFQLS-ETIEARYREACRT 206 (290)
T ss_dssp TTCEEEEEECTT-CCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC-------------CHHHH-HHHHHHHHHHHHH
T ss_pred CCCeEEEEECCC-CcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc----CchhHHH-HHHHHHHHHHHHH
Confidence 468999999999 77 899999998766 6899999999987542111 1110001 1111233333344
Q ss_pred HHhhcCce-eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 87 LLSQAGVQ-GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 87 ~c~~~~V~-~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
++.+.|++ ++..+..| +++++|+++++++++|+||||++|++++.+.|+|| ++.+|+++++ |+|+||.
T Consensus 207 ~~~~~g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gs---v~~~vl~~~~--~pVLvv~ 275 (290)
T 3mt0_A 207 FQAEYGFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGN---TAEVVLDTLE--SDVLVLK 275 (290)
T ss_dssp HHHHHTCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCH---HHHHHHTTCS--SEEEEEC
T ss_pred HHHHcCCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecch---HHHHHHhcCC--CCEEEEC
Confidence 55566885 45555554 89999999999999999999999999999999999 9999999999 9999995
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=136.69 Aligned_cols=125 Identities=6% Similarity=0.024 Sum_probs=93.3
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeec-CC-CCccccCCc-ccccc-cCCHHHH--HHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVH-KP-SHVFAFKES-KCAVN-GLKQHAD--KIQVFDQYLLL 87 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~-~~-~~~~~~~~~-~~~~~-~~~~~~~--~~~ll~~~~~~ 87 (780)
+.++|+||||+| +.|..|++||++.+ .+++|+++||. ++ +. .+..+. ..+.. ...+... .++.|+.+ ..
T Consensus 3 ~~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~ 79 (138)
T 1q77_A 3 AMKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNL-ERANVTFGLPFPPEIKEESKKRIERRLREV-WE 79 (138)
T ss_dssp CCEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHH-HHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HH
T ss_pred cccEEEEEccCC-HhHHHHHHHHHHHHHHcCCeEEEEEEecccccc-cccccccCCCCChHHHHHHHHHHHHHHHHH-HH
Confidence 678999999999 99999999998866 58899999998 63 10 110000 11111 1111111 16778888 76
Q ss_pred H--hhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 88 L--SQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 88 c--~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
| ...| +++..+.. ++++++|+++|+++++|+||||++|+ | ++.+|+++++ |+|+||
T Consensus 80 ~~~~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~---------s---v~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 80 KLTGSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS---------A---YLCKVIDGLN--LASLIV 137 (138)
T ss_dssp HHHSCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG---------G---GTHHHHHHSS--SEEEEC
T ss_pred HhhccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC---------c---hHHHHHHhCC--CceEee
Confidence 4 5667 78877665 57899999999999999999999986 5 9999999999 999997
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.3e-14 Score=154.04 Aligned_cols=139 Identities=14% Similarity=0.144 Sum_probs=109.1
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCccccc---ccCCHHHH--HHHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAV---NGLKQHAD--KIQVFDQYLLLL 88 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~---~~~~~~~~--~~~ll~~~~~~c 88 (780)
+.++||||+|+| +.|..|+.||+..+ .++.|+++||.++..... ...... ....+... .++.|+.+...+
T Consensus 6 ~~k~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 82 (319)
T 3olq_A 6 KYQNLLVVIDPN-QDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDM--TTLLSPDERNAMRKGVINQKTAWIKQQARYY 82 (319)
T ss_dssp CSCEEEEECCTT-CSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGC--TTTSCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEECCC-cccHHHHHHHHHHHHHcCCeEEEEEEecccchhh--ccccChhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 457999999999 99999999998765 588999999987533211 111110 01111111 167888888888
Q ss_pred hhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 89 SQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 89 ~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
...|++++..+...+++..+|++++.+.++|+||||++|.+++.+.++|| ++..|+++++ |+|+||..+
T Consensus 83 ~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs---~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 83 LEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTP---LDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCH---HHHHHHHHCS--SCEEEEESS
T ss_pred hhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccc---cHHHHHhcCC--CCEEEecCc
Confidence 88999999888845688999999999999999999999999999999999 9999999999 999999754
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=152.91 Aligned_cols=138 Identities=16% Similarity=0.219 Sum_probs=107.3
Q ss_pred CCCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHH-HHHHHHHHHHHHHHhhc
Q 044673 15 DVEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQH-ADKIQVFDQYLLLLSQA 91 (780)
Q Consensus 15 ~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~-~~~~~ll~~~~~~c~~~ 91 (780)
.+.++|+||||+| +.|..|++||+..+ .++.|+++||.++.. .+..+...+....... +..++.|+.+...+...
T Consensus 17 ~~~~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 94 (309)
T 3cis_A 17 NSSLGIIVGIDDS-PAAQVAVRWAARDAELRKIPLTLVHAVSPEV-ATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQA 94 (309)
T ss_dssp -CTTEEEEECCSS-HHHHHHHHHHHHHHHHHTCCEEEEEECCCCC-CCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCeEEEEECCC-HHHHHHHHHHHHHHHhcCCcEEEEEEecCcc-cccccCCCCchhhHHHHHHHHHHHHHHHHHHHHh
Confidence 3568999999999 99999999998766 588999999987532 1111111111100011 11177888888888776
Q ss_pred -----CceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 92 -----GVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 92 -----~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
|++++..+..| +++++|++++. ++|+||||++|++++.+.++|| ++.+|+++++ |+|+||..+
T Consensus 95 ~~~~~~~~~~~~~~~g-~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs---~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 95 SLRAGPPTVHSEIVPA-AAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGS---VSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp CSSSCCSCEEEEEESS-CHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCH---HHHHHHHHCS--SCEEEECTT
T ss_pred cccCCCceEEEEEecC-CHHHHHHHHhc--CCCEEEECCCCCccccccccCc---HHHHHHHhCC--CCEEEEcCC
Confidence 99999877765 78999999986 8999999999999999999999 9999999998 999999643
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=150.08 Aligned_cols=135 Identities=14% Similarity=0.057 Sum_probs=105.3
Q ss_pred CeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCcc-cc-CCcccccccC-------CHH--HHHHHHHHHH
Q 044673 18 ETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVF-AF-KESKCAVNGL-------KQH--ADKIQVFDQY 84 (780)
Q Consensus 18 ~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~-~~-~~~~~~~~~~-------~~~--~~~~~ll~~~ 84 (780)
++|+||||+| +.|..|++||+..+ .++.++++||.++.... .. .+........ .+. +..++.|+.+
T Consensus 1 k~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 79 (268)
T 3ab8_A 1 MRILLATDGS-PQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERV 79 (268)
T ss_dssp CCEEEECCSC-GGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCC-HHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999 99999999998866 58899999998754211 00 0100000011 001 1117899999
Q ss_pred HHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCc-hhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 85 LLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADK-HYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 85 ~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~-~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
...+...|++++..+..| ++++.|+++ +.++|+||||++|++ ++.+.++|| ++.+|+++++ |+|+||..
T Consensus 80 ~~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs---~~~~v~~~a~--~PVlvv~~ 149 (268)
T 3ab8_A 80 RQSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGS---TADRVLRASP--VPVLLAPG 149 (268)
T ss_dssp HHHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCH---HHHHHHHHCS--SCEEEECS
T ss_pred HHHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCccccccccch---hHHHHHHhCC--CCEEEECC
Confidence 999999999999887765 788999999 999999999999999 999999999 9999999999 99999953
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.9e-14 Score=150.45 Aligned_cols=121 Identities=14% Similarity=0.147 Sum_probs=106.7
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
|.++|+||+|+| +.|..|++||+..+ .++.|+++||.+| . . .++.|+.+...+...|+
T Consensus 6 ~~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~--------------~-~----~~~~l~~~~~~~~~~~~ 65 (290)
T 3mt0_A 6 AIRSILVVIEPD-QLEGLALKRAQLIAGVTQSHLHLLVCEKR--------------R-D----HSAALNDLAQELREEGY 65 (290)
T ss_dssp TCCEEEEECCSS-CSCCHHHHHHHHHHHHHCCEEEEEEECSS--------------S-C----CHHHHHHHHHHHHHTTC
T ss_pred hhceEEEEeCCC-ccchHHHHHHHHHHHhcCCeEEEEEeeCc--------------H-H----HHHHHHHHHHHHhhCCC
Confidence 468999999999 99999999998765 6889999999873 0 0 14567777777788899
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
+++..+..+++++++|++++++.++|+||||++|++++.+.++|| ++..|+++++ |+|+||..
T Consensus 66 ~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs---~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 66 SVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTP---DDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp CEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCH---HHHHHHHHCS--SCEEEECC
T ss_pred eEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCH---HHHHHHhcCC--CCEEEecC
Confidence 999988877889999999999999999999999999999999999 9999999999 99999963
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.5e-14 Score=147.66 Aligned_cols=122 Identities=14% Similarity=0.211 Sum_probs=107.1
Q ss_pred CCCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcC
Q 044673 15 DVEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAG 92 (780)
Q Consensus 15 ~~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~ 92 (780)
...++|+||+|+| +.|..|++||+..+ .+++|+++||.++.. .++.++.+...+.+.|
T Consensus 168 ~~~~~Ilv~~d~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~-------------------~~~~l~~~~~~l~~~~ 227 (294)
T 3loq_A 168 SLFDRVLVAYDFS-KWADRALEYAKFVVKKTGGELHIIHVSEDGD-------------------KTADLRVMEEVIGAEG 227 (294)
T ss_dssp CTTSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEECSSSC-------------------CHHHHHHHHHHHHHTT
T ss_pred ccCCEEEEEECCC-HHHHHHHHHHHHHhhhcCCEEEEEEEccCch-------------------HHHHHHHHHHHHHHcC
Confidence 4568999999999 99999999998866 588999999987642 1456777778888889
Q ss_pred ceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEeeC
Q 044673 93 VQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCKG 162 (780)
Q Consensus 93 V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~kg 162 (780)
++++..+..| +++++|++++.+.++|+||||++|++++.+.++|| ++..|+++++ |+|+||..+
T Consensus 228 ~~~~~~~~~g-~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs---~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 228 IEVHVHIESG-TPHKAILAKREEINATTIFMGSRGAGSVMTMILGS---TSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp CCEEEEEECS-CHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHC---HHHHHHHHCS--SCEEEECSC
T ss_pred CcEEEEEecC-CHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCc---HHHHHHhcCC--CCEEEECCC
Confidence 9988877665 88999999999999999999999999999999999 9999999999 999999643
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.8e-14 Score=149.48 Aligned_cols=137 Identities=15% Similarity=0.023 Sum_probs=101.8
Q ss_pred CCCeEEEEecCCcc-------ccHHHHHHHhhhc--C--CCeEEEEeecCCCCccccCCcccccccCCH--HHHHHHHHH
Q 044673 16 VEETIFVAVGKNVE-------KNKTTVFWALQNF--A--GKKISLLHVHKPSHVFAFKESKCAVNGLKQ--HADKIQVFD 82 (780)
Q Consensus 16 ~~~~I~VAVD~s~~-------~S~~Al~wAl~~~--~--~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~ 82 (780)
..++|+||+|+| . .|..|+.||+..+ . +++|+|+||.++..... +...+.....+ ++..++...
T Consensus 155 ~~~~Ilva~D~s-~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (319)
T 3olq_A 155 EYGTIVVAANLS-NEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AIELPDFDPNLYNNALRGQHLI 231 (319)
T ss_dssp TTCEEEEECCCS-CCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CTTCTTCCHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCC-CcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hccCCcccHHHHHHHHHHHHHH
Confidence 468999999999 7 4699999997755 3 89999999998754221 11111110001 111134444
Q ss_pred HHHHHHhhcCce-eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEee
Q 044673 83 QYLLLLSQAGVQ-GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCCK 161 (780)
Q Consensus 83 ~~~~~c~~~~V~-~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~k 161 (780)
.+..++.+.|+. ++..+.. ++++++|+++++++++|+||||++|++++.+.|+|| ++.+|+++++ |+|+||..
T Consensus 232 ~l~~~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gs---v~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 232 AMKELRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGN---TAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHH---HHHHHHTTCC--SEEEEECC
T ss_pred HHHHHHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCccccccH---HHHHHHhhCC--CCEEEECC
Confidence 445566677874 4455555 578999999999999999999999999999999999 9999999999 99999953
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.5e-14 Score=121.96 Aligned_cols=73 Identities=23% Similarity=0.355 Sum_probs=68.4
Q ss_pred ccccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
....|..|.|||..++|.||+++..|+||++.+|+.|+.. +.+||+|+++|.+.+|+||++||.+|++|+++|
T Consensus 8 ~~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~l~pn~~L~~~i~~~~~~~ 80 (85)
T 2kr4_A 8 YSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLN-SPTDPFNRQMLTESMLEPVPELKEQIQAWMREK 80 (85)
T ss_dssp CTTCCTTTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCGGGCEECHHHHHHHHHHHHHH
T ss_pred hhcCchheECcccCchhcCCeECCCCCEECHHHHHHHHhc-CCCCCCCcCCCChHhcchHHHHHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999985 789999999999999999999999999998764
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B | Back alignment and structure |
|---|
Probab=99.46 E-value=5.2e-14 Score=124.58 Aligned_cols=73 Identities=23% Similarity=0.359 Sum_probs=68.9
Q ss_pred ccccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
....|..|.|||..++|.||+++..|+||++.+|+.|+.. +.+||+|+++|.+.+|+||++||.+|++|+.+|
T Consensus 23 ~~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~ 95 (100)
T 2kre_A 23 YSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLN-SPTDPFNRQTLTESMLEPVPELKEQIQAWMREK 95 (100)
T ss_dssp CSSCSTTTBCTTTCSBCSSEEEETTTEEEEHHHHHHHTTS-CSBCSSSCCBCCTTSSEECHHHHHHHHHHHHTT
T ss_pred hccCcHhhCCcCccCcccCCeECCCCCEEchHHHHHHHHc-CCCCCCCCCCCChhhceECHHHHHHHHHHHHHh
Confidence 4568999999999999999999999999999999999984 789999999999999999999999999999875
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=122.30 Aligned_cols=73 Identities=25% Similarity=0.376 Sum_probs=68.7
Q ss_pred ccccCCccccccccccccCcccccCC-cccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADG-FTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg-~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
....|..|.|||..++|.||+++..| ++|++.+|+.|+.. +.+||+|+++|.+.+|+||++||.+|++|+.++
T Consensus 16 ~~~~p~~~~CpI~~~~m~dPV~~~cG~htf~r~cI~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~ 89 (98)
T 1wgm_A 16 YADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CCSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred hhcCcHhcCCcCccccccCCeECCCCCeEECHHHHHHHHHh-CCCCCCCCCCCChhhceEcHHHHHHHHHHHHHc
Confidence 35689999999999999999999999 99999999999986 789999999999999999999999999999864
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=144.97 Aligned_cols=130 Identities=15% Similarity=0.108 Sum_probs=100.9
Q ss_pred CCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHH-HHHHHHHHHHHHHhh--c
Q 044673 17 EETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHA-DKIQVFDQYLLLLSQ--A 91 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~-~~~~ll~~~~~~c~~--~ 91 (780)
.++|+||+|+| +.|..|++||+..+ .+++|++|||.++..... .+.....+.. ..++.+..+...+.. .
T Consensus 171 ~~~Ilv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 244 (309)
T 3cis_A 171 QAPVLVGVDGS-SASELATAIAFDEASRRNVDLVALHAWSDVDVSE-----WPGIDWPATQSMAEQVLAERLAGWQERYP 244 (309)
T ss_dssp CCCEEEECCSS-HHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTT-----CSSCCHHHHHHHHHHHHHHHHTTHHHHCT
T ss_pred CCeEEEEeCCC-hHHHHHHHHHHHHHHhcCCEEEEEEEeecccccC-----CCcccHHHHHHHHHHHHHHHHHHHHhhCC
Confidence 47999999999 99999999998766 688999999987643211 1110001111 114556655554433 5
Q ss_pred CceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 92 GVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 92 ~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
|+.++..+..| +++++|++++. ++|+||||++|++++.+.|+|| ++..|+++++ |+|+||.
T Consensus 245 ~~~~~~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gs---v~~~vl~~~~--~pVlvv~ 305 (309)
T 3cis_A 245 NVAITRVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGS---VGETVAQLAR--TPVIVAR 305 (309)
T ss_dssp TSCEEEEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCH---HHHHHHHHCS--SCEEEEC
T ss_pred CCcEEEEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCc---HHHHHHhcCC--CCEEEeC
Confidence 89888876665 88999999997 9999999999999999999999 9999999999 9999995
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-13 Score=134.61 Aligned_cols=73 Identities=30% Similarity=0.466 Sum_probs=68.4
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
..+|..|.|||..++|.||+++.+|+||++.+|..|+..++.+||+|+.+|.+.+|+||++||.+|++|+.+|
T Consensus 101 ~~ip~~f~CPI~~elm~DPV~~~~Ghtfer~~I~~~l~~~~~tcP~t~~~l~~~~L~pN~~Lk~~Ie~~~~~~ 173 (179)
T 2f42_A 101 REIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQEN 173 (179)
T ss_dssp CCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECHHHHHHHHHHHHHC
T ss_pred cCCcHhhcccCccccCCCCeECCCCCEECHHHHHHHHHhCCCCCCCCcCCCChhhCcchHHHHHHHHHHHHHC
Confidence 4579999999999999999999999999999999999875558999999999999999999999999999875
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A | Back alignment and structure |
|---|
Probab=99.37 E-value=2.2e-13 Score=160.72 Aligned_cols=73 Identities=26% Similarity=0.492 Sum_probs=68.7
Q ss_pred ccccCCccccccccccccCcccccCC-cccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADG-FTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg-~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
...+|++|.|||+.++|.||++.++| +||||.+|+.|+.+ +.|||+|+++|.+.+|+||++||++|++|+.++
T Consensus 885 ~~~iP~~F~cPIs~~lM~DPVilpsG~~TydR~~I~~wl~~-~~tdP~Tr~~L~~~~liPN~~Lk~~I~~w~~~~ 958 (968)
T 3m62_A 885 YGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFKKQK 958 (968)
T ss_dssp HCCSCGGGBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHHHH
T ss_pred ccCCcHHhCCcchhhHHhCCeEcCCCCEEECHHHHHHHHhc-CCCCCCCCCCCCcccccccHHHHHHHHHHHHHH
Confidence 35789999999999999999999997 89999999999987 789999999999999999999999999999763
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=129.24 Aligned_cols=113 Identities=13% Similarity=0.111 Sum_probs=96.0
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
..++|+||+|+| +.|..|+.||.+.. .+++++++||.++. + ..++.++.+...+.+.|+
T Consensus 153 ~~~~ilv~~d~s-~~~~~al~~a~~la~~~~a~l~ll~v~~~~----------------~--~~~~~l~~~~~~l~~~~~ 213 (268)
T 3ab8_A 153 ELEGALLGYDAS-ESAVRALHALAPLARALGLGVRVVSVHEDP----------------A--RAEAWALEAEAYLRDHGV 213 (268)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHHHHHHTCCEEEEEECSSH----------------H--HHHHHHHHHHHHHHHTTC
T ss_pred CCCEEEEEECCC-HHHHHHHHHHHHhhhcCCCEEEEEEEcCcH----------------H--HHHHHHHHHHHHHHHcCC
Confidence 357999999999 99999999997654 57889999998652 0 124567777788888899
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
+++..+.. ++++++|+++++++ |+||||+ ++.+.++|| ++..|+++++ |+|+||
T Consensus 214 ~~~~~~~~-g~~~~~i~~~a~~~--dliV~G~----~~~~~~~Gs---~~~~vl~~~~--~pvlvv 267 (268)
T 3ab8_A 214 EASALVLG-GDAADHLLRLQGPG--DLLALGA----PVRRLVFGS---TAERVIRNAQ--GPVLTA 267 (268)
T ss_dssp CEEEEEEC-SCHHHHHHHHCCTT--EEEEEEC----CCSCCSSCC---HHHHHHHHCS--SCEEEE
T ss_pred ceEEEEeC-CChHHHHHHHHHhC--CEEEECC----cccccEecc---HHHHHHhcCC--CCEEEe
Confidence 99887665 58899999999999 9999999 678889999 9999999999 999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=8.2e-12 Score=130.06 Aligned_cols=144 Identities=14% Similarity=0.106 Sum_probs=110.4
Q ss_pred HHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCC--CeeE
Q 044673 418 LNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 418 i~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~--~~LV 494 (780)
+.....+|.....+|.|+++.||+....+..+++|+...........+.+|+.++..+. |.++.++++++.+. .++|
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34455778888888888999999998778899999986421122345889999999885 67778888887544 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN------------------------------------ 538 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------ 538 (780)
|||++|.+|.+.+. +......++.+++.+|..||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999987641 1122347889999999999981
Q ss_pred --------------------C-CccccCCCCCCceEecCCCCcccccccccc
Q 044673 539 --------------------E-PCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 539 --------------------~-~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
. +.++|||++|.|||++.+..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1 248999999999999876667799999653
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.1e-12 Score=109.76 Aligned_cols=71 Identities=31% Similarity=0.461 Sum_probs=64.3
Q ss_pred cCCccccccccccccCccccc-CCcccchHHHHhhhccC-----CCCCCCCcCC---CCCCCCcccHHHHHHHHHHHhhC
Q 044673 710 IPSHFVCPILQEVMKDPQIAA-DGFTYEGEAIRGWLKSG-----HNTSPMTNLK---LEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 710 ~Ps~f~CPi~~evm~dP~ia~-dg~tye~~~i~~~l~~~-----~~t~p~t~~~---l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
.+..|.|||..++|.||++.. .|++|++.+|+.|+..+ ..+||+|+.+ |...+|+||++|+.+|++|++++
T Consensus 4 ~~~~~~CPI~~~~~~dPV~~~~cGh~f~r~cI~~~l~~~~~~~~~~~CP~tgc~~~~l~~~~L~pn~~L~~~I~~~~~~~ 83 (94)
T 2yu4_A 4 GSSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLIQDEALRRAIENHNKKR 83 (94)
T ss_dssp CSSCCBCTTTCSBCSSEEEESSSCCEEEHHHHHHHHHHHHTTTCCBCCCSTTCCCCCBCGGGEEECHHHHHHHHHHHTTC
T ss_pred CCcEeECcCcCchhcCCEEcCCCCCeecHHHHHHHHHHccCcCCCCCCCcCcCcccccCHhhCcCCHHHHHHHHHHHHHh
Confidence 467899999999999999996 99999999999999763 3599998877 99999999999999999998764
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.2e-12 Score=101.42 Aligned_cols=56 Identities=21% Similarity=0.406 Sum_probs=51.4
Q ss_pred CccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHH
Q 044673 712 SHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYA 768 (780)
Q Consensus 712 s~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~ 768 (780)
..|.|||+.++|.||+++ .+|++|++++|+.|+.. +.+||+|+++|.+.+|+||++
T Consensus 2 ~~~~CpIs~~~m~dPV~~~~sG~~yer~~I~~~l~~-~~~cP~t~~~L~~~~Lip~~~ 58 (61)
T 2bay_A 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIVP 58 (61)
T ss_dssp --CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEECCC
T ss_pred CeEEecCCCCCCCCCEEeCCCCcEEcHHHHHHHHHh-CCCCcCCcCCCChhhcEECcc
Confidence 368999999999999999 99999999999999986 578999999999999999975
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 | Back alignment and structure |
|---|
Probab=99.09 E-value=5.1e-11 Score=125.68 Aligned_cols=74 Identities=28% Similarity=0.451 Sum_probs=69.5
Q ss_pred ccccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
....|..|.|||..++|.||++...|+||++.+|+.|+..++.+||+|+.++.+.+|+||++||.+|++|+.+|
T Consensus 202 ~~~~~~~~~c~i~~~~~~dPv~~~~gh~f~~~~i~~~~~~~~~~cP~~~~~~~~~~l~~n~~l~~~i~~~~~~~ 275 (281)
T 2c2l_A 202 KRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 275 (281)
T ss_dssp CCCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCCCcccCCcCcCCHhcCCeECCCCCEECHHHHHHHHHHCCCCCcCCCCCCchhcCcccHHHHHHHHHHHHHC
Confidence 34678999999999999999999999999999999999987778999999999999999999999999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.9e-10 Score=124.15 Aligned_cols=139 Identities=12% Similarity=0.196 Sum_probs=107.6
Q ss_pred cccccccCCceEEEEeeecCeeEEEEEcc--CCC-chhHHHHHHHHHHhhcCC--CCceeeEeeeecCC-----CeeEEE
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKMFP--SYG-PQSHLKFQNEVEVLSRVR--HPNLVTLIGTCPES-----RSLVFE 496 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~--~~~-~~~~~~f~~Ev~il~~l~--HpnIv~l~g~~~~~-----~~LV~E 496 (780)
....|+.|.++.||+....+..+++|+.. ... ......+.+|+.+++.+. +.++.+++++|.+. .++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 45679999999999998888889999876 322 122346778999999987 45678889988665 679999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN-------------------------------------- 538 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-------------------------------------- 538 (780)
|++|..+.+.. ...++...+..++.+++..|..||+.
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998885522 23478889999999999999999973
Q ss_pred ------------------CCccccCCCCCCceEecCCCC--ccccccccccc
Q 044673 539 ------------------EPCIIHGNLKPSKVLIDANFG--SKLSDFGFFHL 570 (780)
Q Consensus 539 ------------------~~~ivHrDlKp~NILLd~~~~--~Kl~DFGla~~ 570 (780)
.+.++|||++|.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997754 68999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=3.6e-10 Score=116.76 Aligned_cols=134 Identities=16% Similarity=0.126 Sum_probs=95.0
Q ss_pred hcCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc--eeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN--LVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--Iv~l~g~~~~~--~~LV~E 496 (780)
..+|......+.|..+.||+.... +..+++|+.... ....+.+|+.++..+.+.+ +.++++++.+. .++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 345544333335556999998764 567999997653 2245778999999886544 44577777543 589999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE------------------------------------- 539 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------- 539 (780)
|++|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 21 1 11 2356777888888888643
Q ss_pred ------------------C-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 540 ------------------P-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 540 ------------------~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
+ .++|||++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1 39999999999999887667799999754
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=98.96 E-value=5.3e-10 Score=94.11 Aligned_cols=72 Identities=43% Similarity=0.779 Sum_probs=68.5
Q ss_pred ccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 709 RIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
..|..|.|||-.++|.||++..-|++|.+..|..|+..++.+||+++.++...+++||++|+.+|++|+.+|
T Consensus 4 ~~~~~~~C~IC~~~~~~Pv~~~CgH~fc~~Ci~~~~~~~~~~CP~C~~~~~~~~l~~n~~l~~~i~~~~~~~ 75 (78)
T 1t1h_A 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCcccCCCCCccccccCCEEcCCCCeecHHHHHHHHHHCcCCCCCCcCCCChhhCccCHHHHHHHHHHHHHc
Confidence 468899999999999999999999999999999999987899999999999999999999999999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-09 Score=116.02 Aligned_cols=183 Identities=22% Similarity=0.221 Sum_probs=121.9
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCc--eeeEeeeecCC-----CeeEEEecc
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPN--LVTLIGTCPES-----RSLVFEYLR 499 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-Hpn--Iv~l~g~~~~~-----~~LV~Ey~~ 499 (780)
...++.|.+..||+.. ..+++|+... ......+.+|+.+|..+. +.. +..+++.+.+. .++||+|++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4468999999999864 5689998653 234567889999998873 332 34445554322 368999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE---------------------------------------- 539 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------------- 539 (780)
|.+|.+... ..++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 998876442 24677788888888888888888611
Q ss_pred ----------------CccccCCCCCCceEecC--CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhc
Q 044673 540 ----------------PCIIHGNLKPSKVLIDA--NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLE 601 (780)
Q Consensus 540 ----------------~~ivHrDlKp~NILLd~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 601 (780)
+.++|||++|.|||++. +..+.|+||+.+..-...... ....... .-..|+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~---~~~~~~~~~ 246 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDD---EEYGMEFVS 246 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTT---TSCCHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhc---cccCHHHHH
Confidence 24799999999999998 556789999988654321000 0000000 002232211
Q ss_pred ----c-CCC---------CcchhHHHHHHHHHHHHhCCCCC
Q 044673 602 ----T-GKL---------TPESDVYSFGIILLRLLTGRPVL 628 (780)
Q Consensus 602 ----~-~~~---------~~ksDVwS~Gvil~eLltG~~p~ 628 (780)
. +.. ....+.|++|.+++.+.+|.++|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 111 12368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.8e-06 Score=90.51 Aligned_cols=133 Identities=17% Similarity=0.164 Sum_probs=91.3
Q ss_pred ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCC---ceeeEeeeec---CCCeeEEEeccCC
Q 044673 428 SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHP---NLVTLIGTCP---ESRSLVFEYLRNG 501 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hp---nIv~l~g~~~---~~~~LV~Ey~~~g 501 (780)
...++.|....||+. +..+++|+... ......+.+|+.+|..+.+. .+...+.++. +..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 446788888899986 56788998532 33456788999999999752 2445555553 2357999999998
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN------------------------------------------- 538 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------------- 538 (780)
.|.+... ..++...+..++.+++..|..||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876321 1234455555555555555555542
Q ss_pred --------------C-CccccCCCCCCceEecC---CCC-ccccccccccc
Q 044673 539 --------------E-PCIIHGNLKPSKVLIDA---NFG-SKLSDFGFFHL 570 (780)
Q Consensus 539 --------------~-~~ivHrDlKp~NILLd~---~~~-~Kl~DFGla~~ 570 (780)
. +.++|||++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1 24699999999999987 455 48999997653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=6e-06 Score=91.12 Aligned_cols=74 Identities=20% Similarity=0.180 Sum_probs=51.6
Q ss_pred ccccccCCceEEEEeee--cCeeEEEEEccCCCc-------hhHHHHHHHHHHhhcCCC--Cc-eeeEeeeecCCCeeEE
Q 044673 428 SWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGP-------QSHLKFQNEVEVLSRVRH--PN-LVTLIGTCPESRSLVF 495 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~-------~~~~~f~~Ev~il~~l~H--pn-Iv~l~g~~~~~~~LV~ 495 (780)
...||.|.++.||++.. .+..|+||....... .....+..|..+|..+.. |. +.+++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 55799999999999965 357899997654211 123456789988887742 44 4466776677788999
Q ss_pred EeccCC
Q 044673 496 EYLRNG 501 (780)
Q Consensus 496 Ey~~~g 501 (780)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2e-06 Score=93.35 Aligned_cols=77 Identities=10% Similarity=0.093 Sum_probs=53.4
Q ss_pred ccc-ccCCceEEEEeeec--------CeeEEEEEccCCC---chhHHHHHHHHHHhhcCC-C--CceeeEeeeecCC---
Q 044673 429 WKI-GEGRYGNVYRGLLR--------HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVR-H--PNLVTLIGTCPES--- 490 (780)
Q Consensus 429 ~~I-G~G~~G~Vyk~~~~--------~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~-H--pnIv~l~g~~~~~--- 490 (780)
..| +.|....+|+.... +..+++|+..... ......+.+|+.++..+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999987765 6678999865422 001235678888888874 2 3466778877554
Q ss_pred --CeeEEEeccCCChhh
Q 044673 491 --RSLVFEYLRNGSLED 505 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~ 505 (780)
.++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 479999999876653
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.17 E-value=3.3e-06 Score=85.89 Aligned_cols=72 Identities=11% Similarity=0.208 Sum_probs=64.2
Q ss_pred cccCCccccccccccccCcccc-cCCcccchHHHHhhhccC-CCCCCC--CcCCCCCCCCcccHHHHHHHHHHHhh
Q 044673 708 RRIPSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSG-HNTSPM--TNLKLEHCNLLPNYALHQAIIEWQQR 779 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~-~~t~p~--t~~~l~~~~l~pn~~l~~~i~~~~~~ 779 (780)
......|.|||..++|.||++. .-|++|++.+|..|+..+ ..+||+ ++..+...+|+||..|+..|+.|+.+
T Consensus 176 ~~~~~el~CPIcl~~f~DPVts~~CGHsFcR~cI~~~~~~~~~~~CPvtGCr~~l~~~dL~pN~~L~~lve~~k~r 251 (267)
T 3htk_C 176 EGGKIELTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIMELRCKIAKMK 251 (267)
T ss_dssp CSSBCCSBCTTTSSBCSSEEEESSSCCEEEHHHHHHHSTTCSCEECSGGGCSCEECGGGEEECHHHHHHHHHHHHH
T ss_pred cCCceeeECcCccCcccCCeeeCCCCCcccHHHHHHHHHhCCCCCCCcccccCcCchhhCCcCHHHHHHHHHHHHH
Confidence 4567889999999999999986 789999999999999763 458999 55999999999999999999999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.3e-05 Score=81.20 Aligned_cols=130 Identities=16% Similarity=0.115 Sum_probs=86.6
Q ss_pred ccccCCce-EEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeec--CCCeeEEEeccCCCh
Q 044673 430 KIGEGRYG-NVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP--ESRSLVFEYLRNGSL 503 (780)
Q Consensus 430 ~IG~G~~G-~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~--~~~~LV~Ey~~~gsL 503 (780)
.+..|..| .||+-... +..+++|+-.. .....+.+|..+|+.+. +--+.++++++. +..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555555 68976543 46789998654 23456788999998874 223556677664 346899999999887
Q ss_pred hhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 044673 504 EDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE-------------------------------------------- 539 (780)
Q Consensus 504 ~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-------------------------------------------- 539 (780)
.+.... .......++.+++..|.-||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765421 01223345555555555555321
Q ss_pred -----------C-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 540 -----------P-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 540 -----------~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
+ .++|||+.|.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27899999999999988777899999754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.8e-05 Score=81.42 Aligned_cols=137 Identities=13% Similarity=0.094 Sum_probs=78.5
Q ss_pred cccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-----CCceeeEe-e----eecCCCeeEEEec
Q 044673 429 WKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-----HPNLVTLI-G----TCPESRSLVFEYL 498 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-----HpnIv~l~-g----~~~~~~~LV~Ey~ 498 (780)
..|+.|..+.||+....+..+++|+.... ...+..|+.++..|. .|.++... | ...+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 45666778999998877767999998752 223334555555443 34444311 1 1233457999999
Q ss_pred cCCChh--------------hHHhhhCC-C----------CCCCHHHHH-------------------------------
Q 044673 499 RNGSLE--------------DCLACKNK-K----------SPLRWQTRM------------------------------- 522 (780)
Q Consensus 499 ~~gsL~--------------~~L~~~~~-~----------~~l~~~~~~------------------------------- 522 (780)
+|..+. ..|+.... . ..-.|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986543 11221111 1 012343211
Q ss_pred HHHHHHHHHHHHHHc-----------CCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 523 QIASDVCSALIYLHS-----------NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 523 ~i~~~i~~aL~~LH~-----------~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.+...+..++.+|+. ..+.++|||++|.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123446667763 12369999999999999888889999999754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=5.9e-05 Score=83.85 Aligned_cols=74 Identities=14% Similarity=0.113 Sum_probs=48.4
Q ss_pred cccccccCCceEEEEeeecCeeEEEEEccCC----Cc-----hhHHHHHHHHHHhhc-CCCCceeeEeeeecCCCeeEEE
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKMFPSY----GP-----QSHLKFQNEVEVLSR-VRHPNLVTLIGTCPESRSLVFE 496 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~----~~-----~~~~~f~~Ev~il~~-l~HpnIv~l~g~~~~~~~LV~E 496 (780)
....||.|..+.||+....+..++||..... .. .....+..|+..+.. .....+.+++.+..+..++|||
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e 117 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMR 117 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEEC
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEe
Confidence 3457899999999998776778999943211 11 133344445443322 2334567778777777889999
Q ss_pred ec-cC
Q 044673 497 YL-RN 500 (780)
Q Consensus 497 y~-~~ 500 (780)
|+ ++
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0001 Score=77.85 Aligned_cols=74 Identities=11% Similarity=0.159 Sum_probs=49.1
Q ss_pred CCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEec-cCCC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEYL-RNGS 502 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey~-~~gs 502 (780)
+.....|+.|....+|+. ..+++|+....... .....+|+.++..+..-++ .++++++.+...+|+||+ ++.+
T Consensus 20 ~~~i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CCSCEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEE
T ss_pred ccceeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCcc
Confidence 333678988999999987 56888987653211 1122467777776642222 577788887789999999 6544
Q ss_pred h
Q 044673 503 L 503 (780)
Q Consensus 503 L 503 (780)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3ztg_A E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mRNA processing, mRNA splicing; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.58 E-value=9.3e-05 Score=63.74 Aligned_cols=73 Identities=26% Similarity=0.404 Sum_probs=64.3
Q ss_pred ccccCCccccccccccccCccccc-CCcccchHHHHhhhcc-CCCCCCCCcCCC-CCCCCcccHHHHHHHHHHHhh
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIAA-DGFTYEGEAIRGWLKS-GHNTSPMTNLKL-EHCNLLPNYALHQAIIEWQQR 779 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia~-dg~tye~~~i~~~l~~-~~~t~p~t~~~l-~~~~l~pn~~l~~~i~~~~~~ 779 (780)
....+..+.|||=.+++.+|++.. =|++|-...|..|+.. +..+||+.+.++ ....+.||.+|+.+|+.|+..
T Consensus 7 ~~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~~~ 82 (92)
T 3ztg_A 7 DDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKNE 82 (92)
T ss_dssp CCCCCTTTEETTTTEECSSCEECTTTCCEECHHHHHHHHHHCTTCCCTTTCCSSCCTTSCEECHHHHHHHHHHHHH
T ss_pred cccCCcCCCCCCCChhhcCceECCCCCCHHHHHHHHHHHHhcCCCcCcCCCCcCCCccccCcCHHHHHHHHHHHHH
Confidence 345678899999999999999988 4999999999999964 447999999998 677999999999999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00011 Score=77.24 Aligned_cols=77 Identities=18% Similarity=0.226 Sum_probs=55.7
Q ss_pred CCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCC--C-ceeeEeeeecCCCeeEEEeccC
Q 044673 425 FEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH--P-NLVTLIGTCPESRSLVFEYLRN 500 (780)
Q Consensus 425 f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H--p-nIv~l~g~~~~~~~LV~Ey~~~ 500 (780)
......+|.|..+.||+..+. |+.|.+|+...........|..|...|+.|.- + -+.+.+++ +..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 444667999999999999874 78999998765544444567899999888742 2 23444544 346899999987
Q ss_pred CCh
Q 044673 501 GSL 503 (780)
Q Consensus 501 gsL 503 (780)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00048 Score=73.37 Aligned_cols=136 Identities=16% Similarity=0.140 Sum_probs=89.4
Q ss_pred cccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC---CCceeeEeeeec--CCCeeEEEeccCC
Q 044673 427 PSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR---HPNLVTLIGTCP--ESRSLVFEYLRNG 501 (780)
Q Consensus 427 ~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~--~~~~LV~Ey~~~g 501 (780)
....|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+.++++. +..++||||+++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3457899999999998877788999987642 3556889999888874 355777777764 3468999999997
Q ss_pred Chhh-----------HHhhhCCCC-------------------CCCHHHHH---HHHH----------------HHHHHH
Q 044673 502 SLED-----------CLACKNKKS-------------------PLRWQTRM---QIAS----------------DVCSAL 532 (780)
Q Consensus 502 sL~~-----------~L~~~~~~~-------------------~l~~~~~~---~i~~----------------~i~~aL 532 (780)
.+.. .|+.....+ .-+|..-+ ++.. .++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 222211100 12565432 1111 122122
Q ss_pred -HHHH--cCCCccccCCCCCCceEecCCCCccccccc
Q 044673 533 -IYLH--SNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 533 -~~LH--~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
..|. ...|.+||+|+.+.|+|++.++ +.|.||+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2342 2345799999999999999887 8888874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.001 Score=70.62 Aligned_cols=158 Identities=13% Similarity=0.144 Sum_probs=89.0
Q ss_pred ccccCHHHHHHHhcCCCc-----ccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc--eee
Q 044673 410 LLEFSFSELNEATNNFEP-----SWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN--LVT 482 (780)
Q Consensus 410 ~~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--Iv~ 482 (780)
+..++.+++......|.. ...|+.|....+|+....+..+++|+..... ....+..|+.++..+...+ +.+
T Consensus 4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 345667777777776754 2346677788999987766689999887521 1223456777776664212 223
Q ss_pred Eeee--------ecCCCeeEEEeccCCChhh--------------HHhhhCCC--CC-------CCHHHHHHH-------
Q 044673 483 LIGT--------CPESRSLVFEYLRNGSLED--------------CLACKNKK--SP-------LRWQTRMQI------- 524 (780)
Q Consensus 483 l~g~--------~~~~~~LV~Ey~~~gsL~~--------------~L~~~~~~--~~-------l~~~~~~~i------- 524 (780)
++.. ..+..+++|+|++|..+.. .++..... .+ ..|...+.-
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 1233468999999865421 12211100 01 124331111
Q ss_pred -----HHHHHHHHHHHHcC----CC-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 525 -----ASDVCSALIYLHSN----EP-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 525 -----~~~i~~aL~~LH~~----~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
...+...+.+|+.. .| .++|+|+.|.|||++.+..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11244455666532 23 59999999999999987666899998653
|
| >3fl2_A E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA damage, DNA repair, ring finger domain, metal binding, DNA replication; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00095 Score=60.83 Aligned_cols=68 Identities=13% Similarity=0.160 Sum_probs=62.0
Q ss_pred CCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCC-CCCcccHHHHHHHHHHHh
Q 044673 711 PSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEH-CNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 711 Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~-~~l~pn~~l~~~i~~~~~ 778 (780)
+..+.|||=.+++.+|++..=|++|-...|..|+..+..+||+.+.++.. ..+.||..|+.+|+.|..
T Consensus 50 ~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~p 118 (124)
T 3fl2_A 50 EETFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQTVLNQLFP 118 (124)
T ss_dssp HHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCCCHHHHHHHHHHST
T ss_pred ccCCCCCcCChHHcCcEEeeCCCcccHHHHHHHHhHCcCCCCCCCccCCCCCCCCCCHHHHHHHHHHcc
Confidence 44578999999999999999999999999999998766799999999988 889999999999999864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.001 Score=71.03 Aligned_cols=140 Identities=10% Similarity=0.004 Sum_probs=72.9
Q ss_pred cccccCCceE-EEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCC--CceeeEeeeecCCCeeEEEeccCCChh
Q 044673 429 WKIGEGRYGN-VYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH--PNLVTLIGTCPESRSLVFEYLRNGSLE 504 (780)
Q Consensus 429 ~~IG~G~~G~-Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~~~~LV~Ey~~~gsL~ 504 (780)
..|+.|+... +|+.... +..+++|....... ..+..|+.++..+.. -.+.+++.++.+..++|||++.+..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 3465554444 6676653 66777776554321 223356666665532 235567777666678999999776665
Q ss_pred hHHhhh---------------------CC--CCCCCHHHHH-------HH-------------HHHHHHHHHHHH---cC
Q 044673 505 DCLACK---------------------NK--KSPLRWQTRM-------QI-------------ASDVCSALIYLH---SN 538 (780)
Q Consensus 505 ~~L~~~---------------------~~--~~~l~~~~~~-------~i-------------~~~i~~aL~~LH---~~ 538 (780)
+.+... .. .+.++..... .+ ...+...+..|- ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 433210 00 1112211100 00 001112222221 12
Q ss_pred CC-ccccCCCCCCceEecCC----CCcccccccccccc
Q 044673 539 EP-CIIHGNLKPSKVLIDAN----FGSKLSDFGFFHLI 571 (780)
Q Consensus 539 ~~-~ivHrDlKp~NILLd~~----~~~Kl~DFGla~~~ 571 (780)
.| .++|||+.|.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23 69999999999999874 67899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00049 Score=76.72 Aligned_cols=72 Identities=15% Similarity=0.193 Sum_probs=49.8
Q ss_pred ccccccCCceEEEEeeec---------CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEe
Q 044673 428 SWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEY 497 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey 497 (780)
...|+.|....||+.... +..+++|+..... ....+..|..++..+...++ .++++.+.+. +||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g--~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSGG--RLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETTE--EEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC--EEEEE
Confidence 456788888999998764 3578999874321 11455579988888853333 6778877653 89999
Q ss_pred ccCCCh
Q 044673 498 LRNGSL 503 (780)
Q Consensus 498 ~~~gsL 503 (780)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0013 Score=73.90 Aligned_cols=73 Identities=10% Similarity=0.055 Sum_probs=48.4
Q ss_pred ccccccCCceEEEEeeecC--eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEeccCCCh
Q 044673 428 SWKIGEGRYGNVYRGLLRH--LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEYLRNGSL 503 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~--~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey~~~gsL 503 (780)
...|+.|-...+|+....+ ..+++|+........ ..-.+|..++..|...++ .++++.+.+ .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC--eEEEEeeCCccC
Confidence 4568878889999988776 789999875422111 112478888888864444 577888753 369999988554
|
| >1z6u_A NP95-like ring finger protein isoform B; structural genomics consortium, ligase, ubiquitin-protein ligase, cell cycle regulation, SGC; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0011 Score=62.51 Aligned_cols=70 Identities=16% Similarity=0.224 Sum_probs=63.7
Q ss_pred ccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCC-CCcccHHHHHHHHHHHh
Q 044673 709 RIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHC-NLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~-~l~pn~~l~~~i~~~~~ 778 (780)
..+..+.|||=.+++.+|++..=|.+|-...|..|+..+..+||+.+.++... .+.||..|+.+|+.|..
T Consensus 74 ~l~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~n~~l~~lv~~~~p 144 (150)
T 1z6u_A 74 KLEQSFMCVCCQELVYQPVTTECFHNVCKDCLQRSFKAQVFSCPACRHDLGQNYIMIPNEILQTLLDLFFP 144 (150)
T ss_dssp HHHHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCBCHHHHHHHHHHST
T ss_pred hCccCCEeecCChhhcCCEEcCCCCchhHHHHHHHHHhCCCcCCCCCccCCCCCCCCCCHHHHHHHHHHhh
Confidence 34567889999999999999999999999999999997666999999999988 99999999999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0023 Score=69.92 Aligned_cols=138 Identities=17% Similarity=0.239 Sum_probs=82.8
Q ss_pred cccccCCceEEEEeeec---------CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCCCeeEEEec
Q 044673 429 WKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPESRSLVFEYL 498 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~~~LV~Ey~ 498 (780)
..|..|-...+|+.... +..+++|+.... ......+.+|..+++.+. +.-..+++++|.++ +||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEEEEe
Confidence 45766777889987763 357899986332 223445668999888774 33336778888764 999999
Q ss_pred cCCChhhH-----------------HhhhC---CCCCC-CHHHHHHHHHHHHH-------------------HHHHHH--
Q 044673 499 RNGSLEDC-----------------LACKN---KKSPL-RWQTRMQIASDVCS-------------------ALIYLH-- 536 (780)
Q Consensus 499 ~~gsL~~~-----------------L~~~~---~~~~l-~~~~~~~i~~~i~~-------------------aL~~LH-- 536 (780)
+|..|..- |+... ...+. -|....++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98655321 11111 11122 34555555544322 233332
Q ss_pred --cC-CC-ccccCCCCCCceEecCC----CCcccccccccc
Q 044673 537 --SN-EP-CIIHGNLKPSKVLIDAN----FGSKLSDFGFFH 569 (780)
Q Consensus 537 --~~-~~-~ivHrDlKp~NILLd~~----~~~Kl~DFGla~ 569 (780)
.. .| .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 23 69999999999999876 688999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0025 Score=69.22 Aligned_cols=73 Identities=16% Similarity=0.168 Sum_probs=44.4
Q ss_pred ccccccCCceEEEEeeecC----------eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc-eeeEeeeecCCCeeEEE
Q 044673 428 SWKIGEGRYGNVYRGLLRH----------LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN-LVTLIGTCPESRSLVFE 496 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~----------~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-Iv~l~g~~~~~~~LV~E 496 (780)
...|+.|..-.+|+....+ ..+++|+...... .......|..++..+...+ ..++++.+ ...+|||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 3467777788999887653 5788888754321 1112357888888775333 34666655 3578999
Q ss_pred eccCCCh
Q 044673 497 YLRNGSL 503 (780)
Q Consensus 497 y~~~gsL 503 (780)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.013 Score=62.05 Aligned_cols=157 Identities=8% Similarity=0.070 Sum_probs=87.1
Q ss_pred ccccCHHHHHHHhcCCCc-----ccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCc--ee
Q 044673 410 LLEFSFSELNEATNNFEP-----SWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPN--LV 481 (780)
Q Consensus 410 ~~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--Iv 481 (780)
+..++.+.+..+...|.. ...|+ |....||+.... +..+++|...... .....+..|..++..+.... +.
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 445666666666554432 33566 778899987764 5579999986431 13445667888877764222 33
Q ss_pred eEeee-------ecCCCeeEEEeccCCChhh-----------H---HhhhCC------CCCCCHHHH----HHHH-----
Q 044673 482 TLIGT-------CPESRSLVFEYLRNGSLED-----------C---LACKNK------KSPLRWQTR----MQIA----- 525 (780)
Q Consensus 482 ~l~g~-------~~~~~~LV~Ey~~~gsL~~-----------~---L~~~~~------~~~l~~~~~----~~i~----- 525 (780)
+++.. ..+..++||+|++|..+.. . ++.... ...+++... ..++
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44433 1122357999998854421 1 111100 112333211 0010
Q ss_pred ----------HHHHHHHHHHHc----CCC-ccccCCCCCCceEecCCCCccccccccccc
Q 044673 526 ----------SDVCSALIYLHS----NEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 526 ----------~~i~~aL~~LH~----~~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
..+-..+..+.. ..| .++|||++|.|||++ + .+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111122333322 123 589999999999999 4 889999987643
|
| >2y43_A E3 ubiquitin-protein ligase RAD18; DNA repair, metal-binding, translesion synthesis, UB conjugation pathway; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0023 Score=55.66 Aligned_cols=70 Identities=19% Similarity=0.206 Sum_probs=62.7
Q ss_pred ccCCccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhh
Q 044673 709 RIPSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQR 779 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~ 779 (780)
..+..+.|||=.+.+.+|++. .=|++|-...|..|+.. ..+||+.+..+...++.||..|+..|+.|++.
T Consensus 18 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~l~~n~~l~~~i~~~~~~ 88 (99)
T 2y43_A 18 TIDDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSY-KTQCPTCCVTVTEPDLKNNRILDELVKSLNFA 88 (99)
T ss_dssp HHHHHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHHH
T ss_pred hCCCCCCcccCChhhCCcCEECCCCCHhhHHHHHHHHHC-CCCCCCCCCcCChhhCCcCHHHHHHHHHHHHH
Confidence 345568899999999999887 79999999999999985 57999999999999999999999999999763
|
| >1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0082 Score=53.95 Aligned_cols=65 Identities=11% Similarity=0.141 Sum_probs=59.7
Q ss_pred CCccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHh
Q 044673 711 PSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 711 Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~ 778 (780)
...+.|||=.+++.+|++. .=|++|=...|..|+. .+||+.+.++...++.||+.|+..|..|++
T Consensus 20 ~~~~~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~---~~CP~Cr~~~~~~~~~~n~~l~~l~~~~~~ 85 (117)
T 1jm7_B 20 EKLLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG---TGCPVCYTPAWIQDLKINRQLDSMIQLCSK 85 (117)
T ss_dssp HHTTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT---TBCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred hhCCCCCCCChHhhCccEeCCCCCHHHHHHHHHHhc---CCCcCCCCcCccccccccHHHHHHHHHHHH
Confidence 3467899999999999998 8999999999999996 789999999999999999999999998875
|
| >3hct_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 3hcu_A 2eci_A 2jmd_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0044 Score=55.86 Aligned_cols=70 Identities=17% Similarity=0.315 Sum_probs=63.6
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~ 777 (780)
...+..+.|||=.+++.+|++..=|.+|-...|..|+..+..+||+.+.++...+++||..++..|.++.
T Consensus 13 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~i~~l~ 82 (118)
T 3hct_A 13 PPLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSLM 82 (118)
T ss_dssp SCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTSE
T ss_pred cCCCCCCCCCcCChhhcCeEECCcCChhhHHHHHHHHhhCCCCCCCCCCCcCHHhcccCHHHHHHHccce
Confidence 4567789999999999999999999999999999999876669999999999999999999999998653
|
| >2ckl_A Polycomb group ring finger protein 4; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_B 2h0d_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0093 Score=52.72 Aligned_cols=69 Identities=12% Similarity=0.285 Sum_probs=62.0
Q ss_pred ccCCccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCC----CCcccHHHHHHHHHHHh
Q 044673 709 RIPSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHC----NLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~----~l~pn~~l~~~i~~~~~ 778 (780)
..+..+.|||=.+++.+|++. .=|++|-...|..|+.. ..+||+.+..+... .+.||..|+..|+.|..
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~l~~n~~l~~~i~~~~~ 84 (108)
T 2ckl_A 11 ELNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLET-SKYCPICDVQVHKTRPLLNIRSDKTLQDIVYKLVP 84 (108)
T ss_dssp HHGGGTBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHTS-CSBCTTTCCBSCSSCGGGGEEECHHHHHHHHHHST
T ss_pred ccCCcCCCccCChHHhCcCEeCCCCChhhHHHHHHHHHh-CCcCcCCCccccccCcccccCcCHHHHHHHHHHhh
Confidence 456678999999999999997 89999999999999986 48999999999887 88999999999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.027 Score=56.03 Aligned_cols=97 Identities=15% Similarity=0.180 Sum_probs=63.5
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL-HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
||.++|.. ...||++.+.|.+++|.+.+|.-+ +...+ ..+=+-|..|+|..+|.+-+.+ +.+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 78999964 457899999999999999988776 21221 1222457899999999877764 2110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT 623 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt 623 (780)
.....+.+||.+. ...+.+.=|||||++||.-+-
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0111366888764 235677889999999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.051 Score=58.16 Aligned_cols=31 Identities=16% Similarity=0.245 Sum_probs=27.3
Q ss_pred ccccCCCCCCceEecCCCCcccccccccccc
Q 044673 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 541 ~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
.++|+|+.|.|||++.++.+.|+||+.+..-
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5999999999999998888999999876543
|
| >2ckl_B Ubiquitin ligase protein RING2; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_C 2h0d_B | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0078 Score=57.60 Aligned_cols=69 Identities=22% Similarity=0.350 Sum_probs=61.1
Q ss_pred cCCccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCC-CCCCCcccHHHHHHHHHHHh
Q 044673 710 IPSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKL-EHCNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 710 ~Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l-~~~~l~pn~~l~~~i~~~~~ 778 (780)
....+.|||=.+.+.+|++. .=|++|-...|..|+..++.+||+.+.++ ....+.||..|+..|..|..
T Consensus 51 ~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~~~~l~~~i~~~~~ 121 (165)
T 2ckl_B 51 LHSELMCPICLDMLKNTMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYP 121 (165)
T ss_dssp CHHHHBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHHTTCCBCTTTCCBCCSGGGEEECHHHHHHHHHHC-
T ss_pred CCCCCCCcccChHhhCcCEeCCCCChhHHHHHHHHHHhCcCCCCCCCCcCCCcccCCcCHHHHHHHHHHHc
Confidence 45678999999999999987 78999999999999998788999999998 45679999999999998854
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=95.62 E-value=1.3 Score=45.23 Aligned_cols=65 Identities=9% Similarity=0.094 Sum_probs=44.7
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHH
Q 044673 326 NQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECGNAQRR 390 (780)
Q Consensus 326 ~~~~~~~~e~~~~~~~~~~l~~~~~~~~~~~~e~e~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 390 (780)
.+++.+..|++.+..+...++.++.+....+.+++..+......+..++.+....+.+.+....+
T Consensus 90 kE~~aL~kEie~~~~~i~~lE~eile~~e~ie~~~~~l~~~~~~l~~~~~~l~~~~~~~~~~~~e 154 (256)
T 3na7_A 90 RELRSLNIEEDIAKERSNQANREIENLQNEIKRKSEKQEDLKKEMLELEKLALELESLVENEVKN 154 (256)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45666777788888888888888887777777777777777666666666655555555444433
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=95.34 E-value=0.48 Score=64.11 Aligned_cols=15 Identities=7% Similarity=0.169 Sum_probs=8.9
Q ss_pred CCeEEEEecCCcccc
Q 044673 17 EETIFVAVGKNVEKN 31 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S 31 (780)
+.-+||.|+||++.|
T Consensus 1647 GhaLLVGvgGSGkqS 1661 (3245)
T 3vkg_A 1647 GHALLIGVSGGGKSV 1661 (3245)
T ss_dssp CCEEEEESTTSSHHH
T ss_pred CCeEEecCCCCcHHH
Confidence 456677777764443
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A | Back alignment and structure |
|---|
Probab=95.23 E-value=1.7 Score=39.41 Aligned_cols=90 Identities=23% Similarity=0.315 Sum_probs=34.7
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 044673 302 KEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLR 381 (780)
Q Consensus 302 eE~~~r~~~e~~l~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~l~~~~~~~~~~~~e~e~~~~~~~~~~~~~~~~~~~l~ 381 (780)
.+...|++++.....-.+++..+..+++.-...+..+.++...|..+-.++...+.+++..+...-+....+.....++.
T Consensus 31 k~e~~r~ele~~~~~l~~Ek~~L~~qL~~E~~~l~e~EE~~~~L~~~k~eLe~~l~el~~rleeeee~~~~L~~~kkkle 110 (129)
T 2fxo_A 31 KSEARRKELEEKMVSLLQEKNDLQLQVQAEQDNLADAEERCDQLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLE 110 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 33344555555444444444444333333222233333333333333333333333333333333333333334444444
Q ss_pred HHHhhHHHHH
Q 044673 382 IECGNAQRRV 391 (780)
Q Consensus 382 ~~~~~~~~~~ 391 (780)
.++......+
T Consensus 111 ~e~~~Lk~~l 120 (129)
T 2fxo_A 111 DECSELKRDI 120 (129)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 3433333333
|
| >2egp_A Tripartite motif-containing protein 34; ZF-C3HC4 domain, tripartite motif protein 34, interferon- responsive finger protein 1; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.0034 Score=51.92 Aligned_cols=66 Identities=18% Similarity=0.302 Sum_probs=57.7
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccC------CCCCCCCcCCCCCCCCcccHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSG------HNTSPMTNLKLEHCNLLPNYALHQAI 773 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~------~~t~p~t~~~l~~~~l~pn~~l~~~i 773 (780)
......+.|||=.+.+.+|++..=|++|=...|..|+... ..++|+.+..+...++.||+.|+..|
T Consensus 7 ~~~~~~~~C~IC~~~~~~p~~l~CgH~fC~~Ci~~~~~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~lv 78 (79)
T 2egp_A 7 GNVQEEVTCPICLELLTEPLSLDCGHSLCRACITVSNKEAVTSMGGKSSCPVCGISYSFEHLQANQHLANIV 78 (79)
T ss_dssp CCCCCCCEETTTTEECSSCCCCSSSCCCCHHHHSCCCCCCSSSCCCCCCCSSSCCCCCSSGGGTCSSSCCCC
T ss_pred hhcccCCCCcCCCcccCCeeECCCCCHHHHHHHHHHHHhcccCCCCCCcCCCCCCcCCHhhCCcCHHHHHhh
Confidence 3456788999999999999999999999999999999863 67899999999999999999876543
|
| >3hcs_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.01 Score=57.06 Aligned_cols=69 Identities=17% Similarity=0.324 Sum_probs=63.2
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEW 776 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~ 776 (780)
...+..+.|||=.+++.+|+...=|.+|=...|..|+..+..++|+.+.++...+++||.+++..|.++
T Consensus 13 ~~~~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~i~~l 81 (170)
T 3hcs_A 13 PPLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSL 81 (170)
T ss_dssp SCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTS
T ss_pred cCCCCCCCCCCCChhhcCcEECCCCCHHHHHHHHHHHHhCCCCCCCCccCcchhhhhhhHHHHHHHhhc
Confidence 467788999999999999999999999999999999987667999999999999999999999998764
|
| >2b9c_A Striated-muscle alpha tropomyosin; alpha-helix, coiled coil, alanine, axial stagger, radius, SIDE-chain packing, crystal packing; 2.30A {Rattus norvegicus} SCOP: h.1.5.1 | Back alignment and structure |
|---|
Probab=95.05 E-value=0.35 Score=44.98 Aligned_cols=111 Identities=18% Similarity=0.188 Sum_probs=74.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHH
Q 044673 264 EAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNS 343 (780)
Q Consensus 264 E~~~~r~e~~~~~~~~~~ae~e~~~a~~ka~~le~~~~eE~~~r~~~e~~l~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 343 (780)
|+++.---+...+.+...|++.+-++.+..+.|++.-...-.+-..++.+|...+...+..-..+++....+..+...+.
T Consensus 11 eLer~eerl~~a~~kLeeaek~adE~eR~~k~lE~r~~~deEr~~~lE~qLkeak~~aeeadrKyeE~~RKl~~~E~dLe 90 (147)
T 2b9c_A 11 ELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLE 90 (147)
T ss_dssp CCGGGGTTTTHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHH
Confidence 33333333444455666777777787777788877666666666777788877777777777777777777777777777
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHHHHHH
Q 044673 344 ALEGQLAESHSVVKELEEKIISAVELLISFK 374 (780)
Q Consensus 344 ~l~~~~~~~~~~~~e~e~~~~~~~~~~~~~~ 374 (780)
..+.++......+.+|++.|..+-..+.++.
T Consensus 91 raeeRae~aE~k~~eLEeeL~~~~~nlKsLE 121 (147)
T 2b9c_A 91 RAEERAELSEGKCAELEEELKTVTNNLKSLE 121 (147)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhH
Confidence 7776766666677777777666555444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.063 Score=59.38 Aligned_cols=138 Identities=12% Similarity=0.194 Sum_probs=83.0
Q ss_pred ccccccCCceEEEEeeec---------CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecCCCeeEEEe
Q 044673 428 SWKIGEGRYGNVYRGLLR---------HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPESRSLVFEY 497 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~---------~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~~~LV~Ey 497 (780)
...|..|-...+|+.... +..+++++....... ...-.+|..+++.+. +.-..++++.+. ..+||||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--EGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--CCEEEEE
Confidence 345666777889988775 577999986543211 112247888887774 322455666554 4789999
Q ss_pred ccCCChhh--------------H---Hhhh-------C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 044673 498 LRNGSLED--------------C---LACK-------N---KKSPLRWQTRMQIASDV-------------------CSA 531 (780)
Q Consensus 498 ~~~gsL~~--------------~---L~~~-------~---~~~~l~~~~~~~i~~~i-------------------~~a 531 (780)
++|..|.. . ||.. . ...+.-|....++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99866421 0 1110 0 12223355544444332 222
Q ss_pred HHHHHc---------------------CCC-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 532 LIYLHS---------------------NEP-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 532 L~~LH~---------------------~~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
+.+|.. ..| .++|+|+.+.||| +.++.+.|+||..+.
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 333321 123 5899999999999 788889999998764
|
| >2csy_A Zinc finger protein 183-like 1; ring finger protein 161, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.029 Score=46.61 Aligned_cols=67 Identities=9% Similarity=0.098 Sum_probs=57.7
Q ss_pred ccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHH
Q 044673 709 RIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~ 777 (780)
.....+.|||=.+.+.+|++..=|++|-...|..|+.. ..+||+.+.++. ..+.||..|...++.++
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~-~~~~~~~~l~~~~~~~~ 77 (81)
T 2csy_A 11 EEEIPFRCFICRQAFQNPVVTKCRHYFCESCALEHFRA-TPRCYICDQPTG-GIFNPAKELMAKLQKSG 77 (81)
T ss_dssp CCCCCSBCSSSCSBCCSEEECTTSCEEEHHHHHHHHHH-CSBCSSSCCBCC-SCCEECHHHHHHHSSSC
T ss_pred cCCCCCCCcCCCchhcCeeEccCCCHhHHHHHHHHHHC-CCcCCCcCcccc-ccCCcHHHHHHHHHhhC
Confidence 45567899999999999999999999999999999975 679999999997 78889988877665543
|
| >2ecw_A Tripartite motif-containing protein 30; metal binding protein, structural genomics, NPPSFA; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.01 Score=49.55 Aligned_cols=66 Identities=23% Similarity=0.368 Sum_probs=57.7
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccC-----CCCCCCCcCCCCCCCCcccHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSG-----HNTSPMTNLKLEHCNLLPNYALHQAI 773 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~-----~~t~p~t~~~l~~~~l~pn~~l~~~i 773 (780)
......+.|||=.+.+.+|++..=|++|=...|..|+... ..+||+.+..+...++.||++|+..|
T Consensus 14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v 84 (85)
T 2ecw_A 14 EMIKEEVTCPICLELLKEPVSADCNHSFCRACITLNYESNRNTDGKGNCPVCRVPYPFGNLKPNLHVANIV 84 (85)
T ss_dssp CCCCTTTSCTTTCSCCSSCEECTTSCCBCHHHHHHHHHHSBCTTSCBCCTTTCCCCCTTCCEECSCCCSSC
T ss_pred HhCccCCCCcCCChhhCcceeCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCcCCHHhCCcCHHHHHhh
Confidence 4566789999999999999998899999999999999863 67899999999999999998876543
|
| >2ecv_A Tripartite motif-containing protein 5; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.012 Score=49.16 Aligned_cols=66 Identities=18% Similarity=0.390 Sum_probs=57.8
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhcc-----CCCCCCCCcCCCCCCCCcccHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKS-----GHNTSPMTNLKLEHCNLLPNYALHQAI 773 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~-----~~~t~p~t~~~l~~~~l~pn~~l~~~i 773 (780)
......+.|||=.+.+.+|.+..=|++|=...|..|+.. +..+||+.+..+...++.||+.|+..|
T Consensus 14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v 84 (85)
T 2ecv_A 14 VNVKEEVTCPICLELLTQPLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPENIRPNRHVANIV 84 (85)
T ss_dssp CCCCCCCCCTTTCSCCSSCBCCSSSCCBCTTHHHHHHHHHHHTTSCCCCTTTCCSSCSSSCCCSCCCCCCC
T ss_pred HHccCCCCCCCCCcccCCceeCCCCCHHHHHHHHHHHHHhhcCCCCCcCCCCCCccCHHhcCccHHHHHhh
Confidence 456678999999999999999999999999999999975 367899999999999999998876543
|
| >1jm7_A BRCA1, breast cancer type 1 susceptibility protein; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=94.56 E-value=0.025 Score=50.01 Aligned_cols=67 Identities=16% Similarity=0.247 Sum_probs=59.1
Q ss_pred CccccccccccccCcccccCCcccchHHHHhhhccC--CCCCCCCcCCCCCCCCcccHHHHHHHHHHHh
Q 044673 712 SHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSG--HNTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 712 s~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~--~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~ 778 (780)
..+.|||=.+.+.+|++..=|++|-...|..|+..+ ..+||+.+.++...++.||..|...++.+++
T Consensus 20 ~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~~~~~~~ 88 (112)
T 1jm7_A 20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (112)
T ss_dssp HHTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CCCCCcccChhhcCeEECCCCCHHHHHHHHHHHHhCCCCCCCcCCCCcCCHhhcCccHHHHHHHHHHHH
Confidence 346799999999999999999999999999999853 3589999999999999999999988888764
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=94.31 E-value=2.7 Score=57.03 Aligned_cols=17 Identities=18% Similarity=0.239 Sum_probs=8.5
Q ss_pred HHhcCcceEEeeccCCc
Q 044673 113 ITQQNIRWLVMGAAADK 129 (780)
Q Consensus 113 ~~~~~id~lVmGs~g~~ 129 (780)
...-+-..|.+|-.|.|
T Consensus 1642 L~qp~GhaLLVGvgGSG 1658 (3245)
T 3vkg_A 1642 FRQPQGHALLIGVSGGG 1658 (3245)
T ss_dssp HTSTTCCEEEEESTTSS
T ss_pred HccCCCCeEEecCCCCc
Confidence 33334455666655544
|
| >3l11_A E3 ubiquitin-protein ligase RNF168; E3 ligase, ring domain, DNA damage, chromatin regulator, CHR protein, DNA repair, metal-binding, nucleus; 2.12A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.30 E-value=0.029 Score=49.99 Aligned_cols=69 Identities=17% Similarity=0.174 Sum_probs=62.1
Q ss_pred ccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCC-------CCCcccHHHHHHHHHHH
Q 044673 709 RIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEH-------CNLLPNYALHQAIIEWQ 777 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~-------~~l~pn~~l~~~i~~~~ 777 (780)
.....+.|||=.+.+.+|++..=|++|=...|..|+..+..+||+.+..+.. .++.+|..|...|+.|.
T Consensus 11 ~~~~~~~C~iC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~n~~l~~~i~~~~ 86 (115)
T 3l11_A 11 PSLSECQCGICMEILVEPVTLPCNHTLCKPCFQSTVEKASLCCPFCRRRVSSWTRYHTRRNSLVNVELWTIIQKHY 86 (115)
T ss_dssp CCHHHHBCTTTCSBCSSCEECTTSCEECHHHHCCCCCTTTSBCTTTCCBCHHHHHHHHHTTCCBCHHHHHHHHHHS
T ss_pred CCCCCCCCccCCcccCceeEcCCCCHHhHHHHHHHHhHCcCCCCCCCcccCccccccccccchhhHHHHHHHHHHC
Confidence 3445789999999999999999999999999999998878899999999874 78889999999999986
|
| >2ecy_A TNF receptor-associated factor 3; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.094 Score=41.50 Aligned_cols=57 Identities=11% Similarity=0.233 Sum_probs=50.4
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCc
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLL 764 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~ 764 (780)
...+..+.|||=.+.+.+|++..=|++|-...|..|+..+..++|+.+.++...+++
T Consensus 10 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~if 66 (66)
T 2ecy_A 10 KTVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKVF 66 (66)
T ss_dssp CSCCCCEECTTTCCEESSCCCCSSSCCCCHHHHHHHHTTSSCCCTTTCCCCCTTTCC
T ss_pred hcCCcCCCCCCCChHhcCeeECCCCCHHHHHHHHHHHHhCcCCCCCCCcCCChhhcC
Confidence 456778999999999999999999999999999999976678999999998877664
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=93.99 E-value=0.15 Score=63.87 Aligned_cols=13 Identities=8% Similarity=0.036 Sum_probs=8.4
Q ss_pred HHHHhhcCceeeE
Q 044673 85 LLLLSQAGVQGDS 97 (780)
Q Consensus 85 ~~~c~~~~V~~e~ 97 (780)
...+.+.||....
T Consensus 501 q~ey~~Egi~~~~ 513 (1184)
T 1i84_S 501 QEEYQREGIEWNF 513 (1184)
T ss_dssp HHHHHHHTCSCCC
T ss_pred HHHHHhcCCCccc
Confidence 3555677887654
|
| >3lrq_A E3 ubiquitin-protein ligase TRIM37; structural genomics, PSI-2, protein structure initiative, northeast structural genomics consortium, NESG; HET: MSE; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.95 E-value=0.042 Score=47.77 Aligned_cols=68 Identities=19% Similarity=0.237 Sum_probs=59.6
Q ss_pred cCCccccccccccccCccc-ccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHH
Q 044673 710 IPSHFVCPILQEVMKDPQI-AADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777 (780)
Q Consensus 710 ~Ps~f~CPi~~evm~dP~i-a~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~ 777 (780)
....+.|||=.+.+.+|+. ..=|++|=...|..|+..+..+||+.+.++...++++|..+...++...
T Consensus 19 l~~~~~C~IC~~~~~~p~~~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~l~~~~~~~~i~~~~~ 87 (100)
T 3lrq_A 19 IAEVFRCFICMEKLRDARLCPHCSKLCCFSCIRRWLTEQRAQCPHCRAPLQLRELVNCRWAEEVTQQLD 87 (100)
T ss_dssp HHHHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECTTHHHHHHHHH
T ss_pred CCCCCCCccCCccccCccccCCCCChhhHHHHHHHHHHCcCCCCCCCCcCCHHHhHhhHHHHHHHHHHH
Confidence 3456789999999999999 7789999999999999886679999999999999999999888776543
|
| >1rmd_A RAG1; V(D)J recombination, antibody, MAD, ring finger, zinc binuclear cluster, zinc finger, DNA-binding protein; 2.10A {Mus musculus} SCOP: g.37.1.1 g.44.1.1 | Back alignment and structure |
|---|
Probab=93.62 E-value=0.053 Score=48.40 Aligned_cols=68 Identities=13% Similarity=0.114 Sum_probs=58.5
Q ss_pred ccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcc-cHHHHHHHHHH
Q 044673 709 RIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLP-NYALHQAIIEW 776 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~p-n~~l~~~i~~~ 776 (780)
..+..+.|||=.+++.+|++..=|.+|-...|..|+..+..++|+.+.++...++++ +..+...|.++
T Consensus 19 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~l~~~i~~l 87 (116)
T 1rmd_A 19 HFVKSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILNSL 87 (116)
T ss_dssp HHHHHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHHHC
T ss_pred hccCCCCCCCCCcHhcCcEEcCCCCcccHHHHHHHHhHCcCcCCCCCCCCCHhhccccHHHHHHHHHHh
Confidence 455678999999999999999999999999999999876789999999999888764 67777777653
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=92.89 E-value=0.14 Score=64.02 Aligned_cols=36 Identities=11% Similarity=0.004 Sum_probs=13.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 044673 262 KIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQ 297 (780)
Q Consensus 262 ~~E~~~~r~e~~~~~~~~~~ae~e~~~a~~ka~~le 297 (780)
..|++.++.++......+..++.+.-....+..+++
T Consensus 863 ~~eL~el~~~L~~le~~l~ele~~l~~Le~e~~~l~ 898 (1184)
T 1i84_S 863 DEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQ 898 (1184)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 334444433333332233333333333333333333
|
| >2yur_A Retinoblastoma-binding protein 6; P53-associated cellular protein of testis, proliferation potential-related protein, protein P2P-R; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.57 E-value=0.17 Score=41.09 Aligned_cols=61 Identities=26% Similarity=0.373 Sum_probs=49.8
Q ss_pred CccccCCccccccccccccCccccc-CCcccchHHHHhhhccC-CCCCCCCcCCC-CCCCCccc
Q 044673 706 EHRRIPSHFVCPILQEVMKDPQIAA-DGFTYEGEAIRGWLKSG-HNTSPMTNLKL-EHCNLLPN 766 (780)
Q Consensus 706 ~~~~~Ps~f~CPi~~evm~dP~ia~-dg~tye~~~i~~~l~~~-~~t~p~t~~~l-~~~~l~pn 766 (780)
.....+..+.|||=.+++.+|++.. =|++|-...|..|+... ..++|+.+.++ ....++||
T Consensus 8 ~~~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n 71 (74)
T 2yur_A 8 EDDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALSGP 71 (74)
T ss_dssp CCCCSCGGGSCSSSCCCCTTCEECSSSCCEECTTHHHHHHHHSSSSCCSSSCCSSCCTTTTTCT
T ss_pred ccccCCCCCCCcCCChHHhCCeEcCCCCCHHHHHHHHHHHHhcCCCcCCCCCCcCCCccccccC
Confidence 3456778899999999999999987 59999999999999853 36899999874 44555666
|
| >4ayc_A E3 ubiquitin-protein ligase RNF8; DNA damage, K63 chains; HET: CPQ; 1.90A {Homo sapiens} PDB: 4epo_C | Back alignment and structure |
|---|
Probab=92.46 E-value=0.13 Score=47.50 Aligned_cols=62 Identities=15% Similarity=0.256 Sum_probs=50.7
Q ss_pred ccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHH
Q 044673 713 HFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQ 777 (780)
Q Consensus 713 ~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~ 777 (780)
.+.|||=.+.+.+|++..=|++|-...|..|+.. +.+||+.+.++.... +|..+...|..+.
T Consensus 53 ~~~C~iC~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~--~~~~~~~~i~~~~ 114 (138)
T 4ayc_A 53 ELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKR-KIECPICRKDIKSKT--YSLVLDNCINKMV 114 (138)
T ss_dssp HSBCTTTCSBCSSEEEETTSCEEEHHHHHHHTTT-CSBCTTTCCBCCCEE--ECHHHHHHHHHHH
T ss_pred cCCCcccCcccCCceECCCCCCccHHHHHHHHHc-CCcCCCCCCcCCCCC--CccchhHHHHHHH
Confidence 4679999999999999999999999999999986 689999999987642 4555555555543
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=92.43 E-value=10 Score=38.42 Aligned_cols=7 Identities=43% Similarity=0.643 Sum_probs=3.4
Q ss_pred eeecCCC
Q 044673 485 GTCPESR 491 (780)
Q Consensus 485 g~~~~~~ 491 (780)
-+|+...
T Consensus 223 v~Cp~Cg 229 (256)
T 3na7_A 223 ITCPYCG 229 (256)
T ss_dssp EECTTTC
T ss_pred EECCCCC
Confidence 3555543
|
| >2ocy_A RAB guanine nucleotide exchange factor SEC2; RAB, GEF, guanine exchange factor, coiled-coil, endocytosis/exocytosis complex; 3.30A {Saccharomyces cerevisiae} SCOP: h.1.33.1 | Back alignment and structure |
|---|
Probab=92.32 E-value=7 Score=36.25 Aligned_cols=75 Identities=16% Similarity=0.095 Sum_probs=36.2
Q ss_pred hHHhhHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhHHHHHHHHHHHHHHHHHHHHhh
Q 044673 253 KSQSRLEQAKIEAKNSKKMVYE---EVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLAKEKQEVQRTKNQ 327 (780)
Q Consensus 253 ~~~~~~~~~~~E~~~~r~e~~~---~~~~~~~ae~e~~~a~~ka~~le~~~~eE~~~r~~~e~~l~~~~~~~~~~~~~ 327 (780)
.+.+.|.....+++.++..... ....+..+..+..+...+.+.|.....+|..+|.+.|..+.+..++++.+-..
T Consensus 17 ~LeD~L~~~R~el~~~~~ri~~lE~~r~~~~~l~~~~~~~~~e~~~L~~~l~~E~~~R~~aE~~~~~ie~ElEeLTas 94 (154)
T 2ocy_A 17 HLEEQLNKSLKTIASQKAAIENYNQLKEDYNTLKRELSDRDDEVKRLREDIAKENELRTKAEEEADKLNKEVEDLTAS 94 (154)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3455555555555433321111 11123333344444444455555556666666666666666555555555433
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=92.11 E-value=3.5 Score=50.71 Aligned_cols=7 Identities=0% Similarity=-0.092 Sum_probs=2.8
Q ss_pred hhcCcee
Q 044673 89 SQAGVQG 95 (780)
Q Consensus 89 ~~~~V~~ 95 (780)
.+.||..
T Consensus 478 ~~EgI~w 484 (1080)
T 2dfs_A 478 MKEQIPW 484 (1080)
T ss_dssp HHHTCCT
T ss_pred hhcCCcc
Confidence 3334443
|
| >2djb_A Polycomb group ring finger protein 6; PCGF6, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.07 E-value=0.25 Score=39.80 Aligned_cols=60 Identities=15% Similarity=0.181 Sum_probs=53.1
Q ss_pred ccccCCccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccH
Q 044673 707 HRRIPSHFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNY 767 (780)
Q Consensus 707 ~~~~Ps~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~ 767 (780)
.......+.|||=.+.+.+|++. .=|++|=...|..|+.. ..++|+.+..+...++++|.
T Consensus 9 ~~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 69 (72)
T 2djb_A 9 LSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYY-SNRCPKCNIVVHQTQPLSGP 69 (72)
T ss_dssp CCCCCGGGSCTTTSSCCSSCEECSSSCCEECHHHHHHHHHH-CSSCTTTCCCCCSSCSCCCC
T ss_pred HhhcCCCCCCCCCChHHHCcCEECCCCCHHHHHHHHHHHHc-CCcCCCcCcccCcccccccC
Confidence 34566789999999999999886 78999999999999976 67999999999999999884
|
| >3knv_A TNF receptor-associated factor 2; cross-brace, alternative splicing, apoptosis, cytoplasm, metal-binding, UBL conjugation, zinc, zinc-finger; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.92 E-value=0.045 Score=50.87 Aligned_cols=68 Identities=18% Similarity=0.332 Sum_probs=58.3
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCC---------CCCCCcccHHHHHHHHH
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKL---------EHCNLLPNYALHQAIIE 775 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l---------~~~~l~pn~~l~~~i~~ 775 (780)
......+.|||=.+++.+|+...=|.+|=...|..|+..+..+||+.+.++ ....++||.+++..|.+
T Consensus 26 ~~l~~~~~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~l~~~~~~~d~~~~~~i~~ 102 (141)
T 3knv_A 26 TKLEAKYLCSACRNVLRRPFQAQCGHRYCSFCLASILSSGPQNCAACVHEGIYEEGISILESSSAFPDNAARREVES 102 (141)
T ss_dssp GGCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHGGGSCEECHHHHHTTCCCTTTTEECGGGCEECHHHHHHHHT
T ss_pred ccCCcCcCCCCCChhhcCcEECCCCCccCHHHHHHHHhcCCCCCCCCCCcccccccccccchhhhcccHHHHHHHcc
Confidence 356788999999999999999999999999999999987767899988753 34578899999998864
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=91.62 E-value=5.4 Score=49.13 Aligned_cols=15 Identities=13% Similarity=0.222 Sum_probs=10.1
Q ss_pred CCCeEEEEeecCCCC
Q 044673 43 AGKKISLLHVHKPSH 57 (780)
Q Consensus 43 ~~~~i~lvHV~~~~~ 57 (780)
.....+.|+.+.|..
T Consensus 652 ~~t~phfVRCIkPN~ 666 (1080)
T 2dfs_A 652 NATTPHYVRCIKPND 666 (1080)
T ss_dssp HSSEEEEEEEECCCS
T ss_pred HhcCCeeEEEecCCC
Confidence 456677787776653
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.60 E-value=3.5 Score=42.33 Aligned_cols=55 Identities=18% Similarity=0.158 Sum_probs=45.5
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhHHH
Q 044673 254 SQSRLEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRK 308 (780)
Q Consensus 254 ~~~~~~~~~~E~~~~r~e~~~~~~~~~~ae~e~~~a~~ka~~le~~~~eE~~~r~ 308 (780)
.++.|.....|+++.|++.+++..+..+...|+..+-+||+..=....+|-.+.+
T Consensus 99 ~~~~L~~~~~e~ek~RK~~Ke~w~r~eKk~~dae~~l~KAK~~Y~~r~ee~ekak 153 (279)
T 3qwe_A 99 YYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARS 153 (279)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3456667888999999999999999999999999999999887777777765443
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=89.47 E-value=1.4 Score=49.05 Aligned_cols=97 Identities=9% Similarity=0.078 Sum_probs=65.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
.+++|+||+.|. ..|..++.++.+.. .|-.++++||..... | .. ..+-......+|.+.||
T Consensus 17 ~~~~vlVa~SGG-~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr-----g---------~~--s~~~~~~v~~~~~~lgi 79 (464)
T 3a2k_A 17 EGAAVIVGVSGG-PDSLALLHVFLSLRDEWKLQVIAAHVDHMFR-----G---------RE--SEEEMEFVKRFCVERRI 79 (464)
T ss_dssp CSSBEEEECCSS-HHHHHHHHHHHHHHHTTTCBCEEEEEECTTC-----T---------HH--HHHHHHHHHHHHHHTTC
T ss_pred CCCEEEEEEcCc-HHHHHHHHHHHHHHHHcCCeEEEEEEECCCC-----c---------cc--cHHHHHHHHHHHHHcCC
Confidence 346999999999 77876665554322 467899999985421 0 00 02234567888999999
Q ss_pred eeeEEEeecC--------ch--------hhHHHHHHHhcCcceEEeeccCCc
Q 044673 94 QGDSVWIEKD--------NV--------EDGIVEVITQQNIRWLVMGAAADK 129 (780)
Q Consensus 94 ~~e~~vie~~--------~v--------~~~I~~~~~~~~id~lVmGs~g~~ 129 (780)
++..+-+... ++ -..+.+++.++|++.|++|.+.+-
T Consensus 80 ~~~v~~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~dD 131 (464)
T 3a2k_A 80 LCETAQIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGDD 131 (464)
T ss_dssp EEEEEECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHHH
T ss_pred cEEEEEechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChHH
Confidence 8876655321 11 135667888999999999998654
|
| >3ng2_A RNF4, snurf, ring finger protein 4; ring domain, E3 ligase, ubiquitylation, sumoylation, zinc-FI metal binding protein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=88.84 E-value=0.22 Score=39.77 Aligned_cols=57 Identities=25% Similarity=0.388 Sum_probs=49.6
Q ss_pred cCCccccccccccccCc-------ccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccH
Q 044673 710 IPSHFVCPILQEVMKDP-------QIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNY 767 (780)
Q Consensus 710 ~Ps~f~CPi~~evm~dP-------~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~ 767 (780)
....+.|||=.+.+.+| .+..=|++|-...|..|+.. +.++|+.+..+...++.|++
T Consensus 7 ~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 70 (71)
T 3ng2_A 7 PSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY 70 (71)
T ss_dssp CTTCCBCTTTCCBHHHHHTTTCCEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCCCSCCCCC
T ss_pred CCCCCCCcccChhhhccccccCCeEeCCCCChHhHHHHHHHHHc-CCCCCCCCCccChhheeecc
Confidence 44568899999999888 66678999999999999986 57999999999999999875
|
| >3bas_A Myosin heavy chain, striated muscle/general control protein GCN4 chimera; alpha-helical coiled coil, disorder, salt links; 2.30A {Argopecten irradians} SCOP: h.1.26.1 PDB: 1nkn_A 3bat_A | Back alignment and structure |
|---|
Probab=87.89 E-value=6.2 Score=33.18 Aligned_cols=26 Identities=23% Similarity=0.111 Sum_probs=12.9
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHhh
Q 044673 302 KEMSQRKELEELLAKEKQEVQRTKNQ 327 (780)
Q Consensus 302 eE~~~r~~~e~~l~~~~~~~~~~~~~ 327 (780)
.+...|++++.....-.++...+..+
T Consensus 32 k~e~~rkele~~~~~l~~ek~~L~~q 57 (89)
T 3bas_A 32 KTERIKKELEEQNVTLLEQKNDLFGS 57 (89)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34455666666544444444444433
|
| >2ocy_A RAB guanine nucleotide exchange factor SEC2; RAB, GEF, guanine exchange factor, coiled-coil, endocytosis/exocytosis complex; 3.30A {Saccharomyces cerevisiae} SCOP: h.1.33.1 | Back alignment and structure |
|---|
Probab=87.88 E-value=12 Score=34.83 Aligned_cols=49 Identities=20% Similarity=0.184 Sum_probs=38.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhH
Q 044673 258 LEQAKIEAKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQ 306 (780)
Q Consensus 258 ~~~~~~E~~~~r~e~~~~~~~~~~ae~e~~~a~~ka~~le~~~~eE~~~ 306 (780)
+..+..|+.+|+.++..+..+|..||.+.-...+-+.+|-...++|.-.
T Consensus 53 ~~~~~~e~~~L~~~l~~E~~~R~~aE~~~~~ie~ElEeLTasLFeEAN~ 101 (154)
T 2ocy_A 53 LSDRDDEVKRLREDIAKENELRTKAEEEADKLNKEVEDLTASLFDEANN 101 (154)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3467788888888998998888888888888777777777777777643
|
| >2ysl_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.75 E-value=1.2 Score=35.50 Aligned_cols=56 Identities=14% Similarity=0.379 Sum_probs=48.2
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhcc--CCCCCCCCcCCCCCCCC
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKS--GHNTSPMTNLKLEHCNL 763 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~--~~~t~p~t~~~l~~~~l 763 (780)
......+.|||=.+.+.+|++..=|++|-...|..|+.. +..++|+.+.++...++
T Consensus 15 ~~~~~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~ 72 (73)
T 2ysl_A 15 NKLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLCKTSVRKNAI 72 (73)
T ss_dssp CCCCCCCBCTTTCSBCSSEEECTTCCEEEHHHHHHHCSSSCSCCCCSSSCCCCCCCCC
T ss_pred HhCccCCEeccCCcccCCeEEcCCCChhhHHHHHHHHHcCCCCCCCCCCCCcCCcccC
Confidence 456778999999999999999999999999999999973 45689999998876554
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=86.84 E-value=2.8 Score=44.13 Aligned_cols=96 Identities=8% Similarity=-0.013 Sum_probs=63.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCe-EEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcC
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKK-ISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAG 92 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~-i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~ 92 (780)
.+++|+||+.|. ..|..++.++.+.. .|-. |+++||..... + +. .+-......+|.+.|
T Consensus 23 ~~~~vlva~SGG-~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r---------~-----~s---~~~~~~v~~~a~~lg 84 (317)
T 1wy5_A 23 GERRVLIAFSGG-VDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR---------E-----SA---ERDEEFCKEFAKERN 84 (317)
T ss_dssp SCCEEEEECCSS-HHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS---------T-----HH---HHHHHHHHHHHHHHT
T ss_pred CCCEEEEEecch-HHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC---------c-----cc---HHHHHHHHHHHHHcC
Confidence 357999999999 77876665554432 3556 99999975321 0 00 122455677888889
Q ss_pred ceeeEEEeec--------Cchh--------hHHHHHHHhcCcceEEeeccCCc
Q 044673 93 VQGDSVWIEK--------DNVE--------DGIVEVITQQNIRWLVMGAAADK 129 (780)
Q Consensus 93 V~~e~~vie~--------~~v~--------~~I~~~~~~~~id~lVmGs~g~~ 129 (780)
|++..+-+.. .++. ..+.+++.++|++.|+.|.+.+.
T Consensus 85 i~~~v~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~dD 137 (317)
T 1wy5_A 85 MKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (317)
T ss_dssp CCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred CcEEEEEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchhH
Confidence 9877655431 1111 25667888999999999998653
|
| >3u1c_A Tropomyosin alpha-1 chain; anti-parallel coiled coil, contractIle protein; 1.80A {Gallus gallus} PDB: 3u1a_A | Back alignment and structure |
|---|
Probab=86.28 E-value=15 Score=31.52 Aligned_cols=27 Identities=19% Similarity=0.203 Sum_probs=10.0
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHH
Q 044673 345 LEGQLAESHSVVKELEEKIISAVELLI 371 (780)
Q Consensus 345 l~~~~~~~~~~~~e~e~~~~~~~~~~~ 371 (780)
++..++.++..+.-++..+..+.+.+.
T Consensus 42 ~E~Ei~sL~kk~~~lE~eld~~ee~L~ 68 (101)
T 3u1c_A 42 LEDDIVQLEKQLRVTEDSRDQVLEELH 68 (101)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 333333333333333333333333333
|
| >3u1c_A Tropomyosin alpha-1 chain; anti-parallel coiled coil, contractIle protein; 1.80A {Gallus gallus} PDB: 3u1a_A | Back alignment and structure |
|---|
Probab=86.22 E-value=15 Score=31.51 Aligned_cols=19 Identities=5% Similarity=-0.163 Sum_probs=7.8
Q ss_pred HHHHHHHHHHHHHHHHHHH
Q 044673 264 EAKNSKKMVYEEVVKRWKE 282 (780)
Q Consensus 264 E~~~~r~e~~~~~~~~~~a 282 (780)
=|..+|.|+-.-..++..+
T Consensus 10 Km~~lk~e~e~a~drae~~ 28 (101)
T 3u1c_A 10 KMQMLKLDKENALDRAEQA 28 (101)
T ss_dssp HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH
Confidence 3444444444433333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.11 E-value=0.27 Score=53.84 Aligned_cols=30 Identities=17% Similarity=0.317 Sum_probs=24.3
Q ss_pred ccccCCCCCCceEe------cCCCCccccccccccc
Q 044673 541 CIIHGNLKPSKVLI------DANFGSKLSDFGFFHL 570 (780)
Q Consensus 541 ~ivHrDlKp~NILL------d~~~~~Kl~DFGla~~ 570 (780)
.++|+|+.+.|||+ +.+..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4466789999987643
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=85.95 E-value=2.9 Score=46.18 Aligned_cols=36 Identities=14% Similarity=0.178 Sum_probs=30.8
Q ss_pred CCeEEEEecCCccccHHHHHHHhhhcCCCeEEEEeecCC
Q 044673 17 EETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKP 55 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S~~Al~wAl~~~~~~~i~lvHV~~~ 55 (780)
.++|+||+.|. ..|..++.|+.+. |..|+.+|+...
T Consensus 10 ~~KVvVA~SGG-lDSSvll~~L~e~--G~eViavtvd~G 45 (455)
T 1k92_A 10 GQRIGIAFSGG-LDTSAALLWMRQK--GAVPYAYTANLG 45 (455)
T ss_dssp TSEEEEECCSS-HHHHHHHHHHHHT--TCEEEEEEEECC
T ss_pred CCeEEEEEcCh-HHHHHHHHHHHHc--CCEEEEEEEEcC
Confidence 46999999999 7888899999775 788999999754
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A | Back alignment and structure |
|---|
Probab=85.74 E-value=20 Score=32.28 Aligned_cols=49 Identities=12% Similarity=0.147 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 044673 337 TVQDQNSALEGQLAESHSVVKELEEKIISAVELLISFKQKRDQLRIECG 385 (780)
Q Consensus 337 ~~~~~~~~l~~~~~~~~~~~~e~e~~~~~~~~~~~~~~~~~~~l~~~~~ 385 (780)
.+..++..|+.++.+......+.++...........+..+...|+....
T Consensus 73 ~L~~~k~eLe~~l~el~~rleeeee~~~~L~~~kkkle~e~~~Lk~~le 121 (129)
T 2fxo_A 73 QLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLEDECSELKRDID 121 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444555566666666555656555555555555555555555544433
|
| >3mq7_A Bone marrow stromal antigen 2; HIV, antiviral protein; 2.28A {Homo sapiens} PDB: 3mqc_A 3mqb_A 3mkx_A 3nwh_A 2xg7_A* 2x7a_A | Back alignment and structure |
|---|
Probab=84.57 E-value=19 Score=31.35 Aligned_cols=34 Identities=21% Similarity=0.040 Sum_probs=19.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHH
Q 044673 270 KMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKE 303 (780)
Q Consensus 270 ~e~~~~~~~~~~ae~e~~~a~~ka~~le~~~~eE 303 (780)
.+|-+..+-...+|-++.++++-+..|.....+|
T Consensus 32 ~qLTqAQe~l~~~eaQAaTCNqTV~tL~~SL~~e 65 (121)
T 3mq7_A 32 QELTEAQKGFQDVEAQAATANHTVMALMASLDAE 65 (121)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444444444556677777777777665444444
|
| >2ect_A Ring finger protein 126; metal binding protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=84.05 E-value=1.5 Score=35.61 Aligned_cols=58 Identities=21% Similarity=0.352 Sum_probs=48.0
Q ss_pred ccCCccccccccccccCcccc---cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccH
Q 044673 709 RIPSHFVCPILQEVMKDPQIA---ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNY 767 (780)
Q Consensus 709 ~~Ps~f~CPi~~evm~dP~ia---~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~ 767 (780)
.....+.|||=.+.+.+|... .=|+.|-...|..|+.. +.++|+.+..+...++.||.
T Consensus 11 ~~~~~~~C~IC~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 71 (78)
T 2ect_A 11 HVGSGLECPVCKEDYALGESVRQLPCNHLFHDSCIVPWLEQ-HDSCPVCRKSLTGQNTATNP 71 (78)
T ss_dssp TSSSSCCCTTTTSCCCTTSCEEECTTSCEEETTTTHHHHTT-TCSCTTTCCCCCCSCSCCCC
T ss_pred cCCCCCCCeeCCccccCCCCEEEeCCCCeecHHHHHHHHHc-CCcCcCcCCccCCcccCCCC
Confidence 445678899999988877543 57888999999999976 58999999999999998874
|
| >2xeu_A Ring finger protein 4; transcription, zinc-finger, metal-binding; HET: SUC; 1.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.02 E-value=0.36 Score=37.43 Aligned_cols=54 Identities=26% Similarity=0.414 Sum_probs=46.2
Q ss_pred ccccccccccccCc-------ccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccH
Q 044673 713 HFVCPILQEVMKDP-------QIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNY 767 (780)
Q Consensus 713 ~f~CPi~~evm~dP-------~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~ 767 (780)
.+.|||=.+.+.+| .+..=|++|-...|..|+.. +.++|+.+.++...++.|++
T Consensus 3 ~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 63 (64)
T 2xeu_A 3 MVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY 63 (64)
T ss_dssp CCBCTTTCCBHHHHHHTTCCEEEETTSCEEEHHHHHHHHHH-CSBCTTTCCBCTTTCEEECC
T ss_pred CCCCCccChhhhCccccCCCEEeCCCCCchhHHHHHHHHHc-CCCCCCCCccCCccceeeee
Confidence 46788888888877 56678999999999999987 77999999999999988864
|
| >1sur_A PAPS reductase; assimilatory sulfate reduction, 3-phospho-adenylyl-sulfate reductase, oxidoreductase; 2.00A {Escherichia coli} SCOP: c.26.2.2 | Back alignment and structure |
|---|
Probab=84.00 E-value=4.7 Score=39.61 Aligned_cols=94 Identities=9% Similarity=0.027 Sum_probs=59.2
Q ss_pred CeEEEEecCCccccHHHHHHHhhhcCCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCceeeE
Q 044673 18 ETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQGDS 97 (780)
Q Consensus 18 ~~I~VAVD~s~~~S~~Al~wAl~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~~e~ 97 (780)
++|+||+.|. +.|...|..+.+.. ..|.++||..... . .+..+....+|.+.||++..
T Consensus 45 ~~v~Va~SGG-kDS~vLL~ll~~~~--~~v~~v~vd~g~~--------~-----------~e~~~~v~~~~~~~gi~~~v 102 (215)
T 1sur_A 45 GEYVLSSSFG-IQAAVSLHLVNQIR--PDIPVILTDTGYL--------F-----------PETYRFIDELTDKLKLNLKV 102 (215)
T ss_dssp SEEEEECCCC-TTHHHHHHHHHHHS--TTCEEEEEECSCB--------C-----------HHHHHHHHHHHHHTTCEEEE
T ss_pred CCEEEEecCC-HHHHHHHHHHHHhC--CCCeEEEeeCCCC--------C-----------HHHHHHHHHHHHHhCCcEEE
Confidence 5999999999 88886665554432 4588999976421 1 11234556788888998775
Q ss_pred EEeecC---------c-----hh-----------hHHHHHHHhcCcceEEeeccCCchhhH
Q 044673 98 VWIEKD---------N-----VE-----------DGIVEVITQQNIRWLVMGAAADKHYSK 133 (780)
Q Consensus 98 ~vie~~---------~-----v~-----------~~I~~~~~~~~id~lVmGs~g~~~~~r 133 (780)
+-.... . +. ..+-+++.+++++.+++|.+..-...|
T Consensus 103 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~K~~~l~~~~~~~~~~~i~~G~r~dd~~~r 163 (215)
T 1sur_A 103 YRATESAAWQEARYGKLWEQGVEGIEKYNDINKVEPMNRALKELNAQTWFAGLRREQSGSR 163 (215)
T ss_dssp EECSSCHHHHHHHHCCGGGSHHHHHHHHHHHHTHHHHHHHHHHTTEEEEECCCCTTSSSTT
T ss_pred EeCCCCHHHHHHhcCCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCceEEEEeehhhhhhh
Confidence 543321 0 00 023456778888889999876554444
|
| >3s4r_A Vimentin; alpha-helix, cytoskeleton, intermediate filament, structural; 2.45A {Homo sapiens} PDB: 3ssu_A | Back alignment and structure |
|---|
Probab=83.99 E-value=8.2 Score=32.72 Aligned_cols=79 Identities=14% Similarity=0.239 Sum_probs=40.3
Q ss_pred HHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHhhHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHH
Q 044673 318 KQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSV-----VKELEEKIISAVELLISFKQKRDQLRIECGNAQRRVR 392 (780)
Q Consensus 318 ~~~~~~~~~~~~~~~~e~~~~~~~~~~l~~~~~~~~~~-----~~e~e~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 392 (780)
|++++.+-...+....+.+.+..++..|+.++...... ..-.+..|..+...+..+..++.++..+.++....+.
T Consensus 8 Ke~mq~LNdRlAsyIdKVR~LEqqN~~Le~~i~~l~~~~~~~~~~~ye~~i~~Lr~~i~~~~~ek~~l~~e~dnl~~~~~ 87 (93)
T 3s4r_A 8 KVELQELNDRFANLIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIM 87 (93)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44445555555555555555555566665555443221 1112444444455555555555556666666555555
Q ss_pred HHHH
Q 044673 393 DIKK 396 (780)
Q Consensus 393 ~~~~ 396 (780)
+++.
T Consensus 88 ~~k~ 91 (93)
T 3s4r_A 88 RLRE 91 (93)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 5543
|
| >1wt6_A Myotonin-protein kinase; coiled-coil, kinase activation, DMPK, molecular replacement, transferase; 1.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.67 E-value=12 Score=30.41 Aligned_cols=48 Identities=25% Similarity=0.386 Sum_probs=25.7
Q ss_pred HHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHH
Q 044673 308 KELEELLAKEKQEVQRTKNQHDKTVKELQTVQDQNSALEGQLAESHSVVKELEEK 362 (780)
Q Consensus 308 ~~~e~~l~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~l~~~~~~~~~~~~e~e~~ 362 (780)
.+++..|+.|.+.++-+.+++.+ ++..+..++.++.++.....+|..+
T Consensus 13 leLQSALeaEIqAKQ~i~EELs~-------vr~~ni~~eskL~eae~rn~eL~~e 60 (81)
T 1wt6_A 13 RELQEALEEEVLTRQSLSREMEA-------IRTDNQNFASQLREAEARNRDLEAH 60 (81)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 36777777777777666544433 3334444444555544444444333
|
| >3swk_A Vimentin; cytoskeleton, intermediate filament, alpha-helix, structural; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.64 E-value=12 Score=31.24 Aligned_cols=51 Identities=18% Similarity=0.154 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhHHHHHHHHHH
Q 044673 265 AKNSKKMVYEEVVKRWKEEDNAVEAKCKVKAMQSLCVKEMSQRKELEELLA 315 (780)
Q Consensus 265 ~~~~r~e~~~~~~~~~~ae~e~~~a~~ka~~le~~~~eE~~~r~~~e~~l~ 315 (780)
++.||..+.....-....+-+.-.+.--+.++...|.+|+..|..+|..+.
T Consensus 2 i~eLr~qi~~l~~e~~~l~~e~dn~~~~~edfk~KyE~E~~~R~~~E~d~~ 52 (86)
T 3swk_A 2 MRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQ 52 (86)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 445555544444444455555555666667777778888888887776443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.42 E-value=2.4 Score=41.95 Aligned_cols=123 Identities=7% Similarity=0.034 Sum_probs=79.2
Q ss_pred HHHHhhcCCCCceeeEeeeecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCC
Q 044673 468 EVEVLSRVRHPNLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNL 547 (780)
Q Consensus 468 Ev~il~~l~HpnIv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDl 547 (780)
|+.+| ...||+++..- .-.+..-+++.|-..++..++-. -..++...+++++..|+....+++. -+|--|
T Consensus 36 el~LL-~~~~~~Fl~~~-I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L 105 (215)
T 4ann_A 36 LMYLL-EQHSPYFIDAE-LTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVL 105 (215)
T ss_dssp GGGGG-GSCCTTBCCEE-EEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS----SEECCC
T ss_pred HHHHH-hccCCcccceE-EEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEE
Confidence 44444 23688888662 32333355555544443333321 2347789999999999977755553 357788
Q ss_pred CCCceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 044673 548 KPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPV 627 (780)
Q Consensus 548 Kp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p 627 (780)
.|+||++|.++.++|.-.|+-..+++ . .++...=+-.+=|++..+++|+..
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~l~P------------------------~-----~~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNVVDP------------------------L-----PVSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTTBSC------------------------C-----CCCHHHHHHHHHHHHHHHHCTTCC
T ss_pred ecceEEEcCCCCEEEEEccCccCCCC------------------------C-----CCCHHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999887433221 1 112222244678899999999888
Q ss_pred Cc
Q 044673 628 LR 629 (780)
Q Consensus 628 ~~ 629 (780)
|.
T Consensus 157 Fe 158 (215)
T 4ann_A 157 FD 158 (215)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3hnw_A Uncharacterized protein; coiled-coil, structural genomics, PSI-2, protein structure initiative, midwest center for structural genomics, MCSG; 2.20A {Eubacterium eligens} | Back alignment and structure |
|---|
Probab=82.86 E-value=11 Score=34.46 Aligned_cols=28 Identities=11% Similarity=0.096 Sum_probs=11.4
Q ss_pred HHHHHHHHhhhHHHHHHHHHHHHHHHHH
Q 044673 318 KQEVQRTKNQHDKTVKELQTVQDQNSAL 345 (780)
Q Consensus 318 ~~~~~~~~~~~~~~~~e~~~~~~~~~~l 345 (780)
..++..+|.++.....++..+.+.+..+
T Consensus 88 ~kE~~~lK~el~~~~~k~e~~~~e~~~l 115 (138)
T 3hnw_A 88 DKEIYDLKHELIAAQIKAESSAKEIKEL 115 (138)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4444444444444433333333333333
|
| >2ct2_A Tripartite motif protein 32; zinc-finger protein HT2A, TAT- interacting protein, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.76 E-value=1.2 Score=36.83 Aligned_cols=63 Identities=19% Similarity=0.281 Sum_probs=51.4
Q ss_pred cccCCccccccccccccC----cccccCCcccchHHHHhhhccC--CCCCCCCcCCCCC---CCCcccHHHH
Q 044673 708 RRIPSHFVCPILQEVMKD----PQIAADGFTYEGEAIRGWLKSG--HNTSPMTNLKLEH---CNLLPNYALH 770 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~d----P~ia~dg~tye~~~i~~~l~~~--~~t~p~t~~~l~~---~~l~pn~~l~ 770 (780)
......+.|||=.+.+.+ |.+..=|++|-...|..|+..+ ..+||+.+..+.. ..|.+|+++.
T Consensus 10 ~~~~~~~~C~IC~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~i~~l~~n~~~~ 81 (88)
T 2ct2_A 10 DALREVLECPICMESFTEEQLRPKLLHCGHTICRQCLEKLLASSINGVRCPFCSKITRITSLTQLTDNLTVL 81 (88)
T ss_dssp CCCCSCCBCTTTCCBCCTTSSCEEECSSSCEEEHHHHHHHHHHCSSCBCCTTTCCCBCCSSTTTSEECTTTT
T ss_pred hhccCCCCCccCCccccccCCCeEECCCCChhhHHHHHHHHHcCCCCcCCCCCCCcccchhHHHHHHHHHHH
Confidence 456677899999999999 9888899999999999999864 4689999988765 3566676553
|
| >3q8t_A Beclin-1; autophagy, ATG14L uvrag, apoptosis; 1.90A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=81.05 E-value=25 Score=29.91 Aligned_cols=13 Identities=31% Similarity=0.481 Sum_probs=4.6
Q ss_pred HHHHHHHHHHHHH
Q 044673 333 KELQTVQDQNSAL 345 (780)
Q Consensus 333 ~e~~~~~~~~~~l 345 (780)
.++..+......|
T Consensus 39 ~el~~le~E~~~L 51 (96)
T 3q8t_A 39 ENLEKVQAEAERL 51 (96)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 3333333333333
|
| >1g25_A CDK-activating kinase assembly factor MAT1; ring finger (C3HC4), metal binding protein; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=80.94 E-value=1.3 Score=34.59 Aligned_cols=54 Identities=17% Similarity=0.269 Sum_probs=46.6
Q ss_pred ccccccccc-cccCcc----cccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCccc
Q 044673 713 HFVCPILQE-VMKDPQ----IAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPN 766 (780)
Q Consensus 713 ~f~CPi~~e-vm~dP~----ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn 766 (780)
.+.|||=.+ .+.+|. +..=|++|=...|..|+..+..++|+.+.++...++.||
T Consensus 3 ~~~C~IC~~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~ 61 (65)
T 1g25_A 3 DQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNFRVQ 61 (65)
T ss_dssp TTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTSSSCTTTCCCCSSCCCEEE
T ss_pred CCcCCcCCCCccCCCccCeecCCCCCHhHHHHHHHHHHcCCCcCCCCCCccccccceee
Confidence 467999988 888995 457899999999999987777889999999999888886
|
| >3u59_A Tropomyosin beta chain; muscle contraction, actin, contractIle protein; 2.50A {Gallus gallus} | Back alignment and structure |
|---|
Probab=80.79 E-value=26 Score=30.00 Aligned_cols=10 Identities=20% Similarity=0.434 Sum_probs=3.9
Q ss_pred hHHHHHHHHH
Q 044673 386 NAQRRVRDIK 395 (780)
Q Consensus 386 ~~~~~~~~~~ 395 (780)
.+...+..+.
T Consensus 83 ~AE~evasLn 92 (101)
T 3u59_A 83 DAEAEVASLN 92 (101)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 3333444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.43 E-value=0.23 Score=55.58 Aligned_cols=57 Identities=11% Similarity=0.067 Sum_probs=16.3
Q ss_pred ccccccCCceEEEEeeecC--eeEEE------EEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeee
Q 044673 428 SWKIGEGRYGNVYRGLLRH--LHVAI------KMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~--~~VAi------K~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~ 487 (780)
.++|| ||.||+|.+.+ .+||| |...... ......|.+|..++..+.|||+++.+++.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 44566 99999999974 57898 7665422 22334688899999999999999997764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 780 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-20 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 3e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-16 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 2e-12 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 5e-09 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 6e-05 | |
| d1fbva4 | 79 | g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [Ta | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 9e-52
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 18/276 (6%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNL 480
+IG G +G VY+G VA+KM + PQ F+NEV VL + RH N+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 481 VTLIGTCPES-RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
+ +G ++V ++ SL L ++ + IA + YLH+
Sbjct: 67 LLFMGYSTAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
IIH +LK + + + + K+ DFG + + + + S ++ PE
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL-----WMAPEV 177
Query: 600 LET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
+ + +SDVY+FGI+L L+TG+ + + L
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-RGYLSPDLSKVRS 236
Query: 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
+ + L C + R RP +I + +E L
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPL-FPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-51
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 24/273 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+ IG+G +G+V G R VA+K + + F E V++++RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 64
Query: 483 LIGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L+G E + +V EY+ GSL D L +S L ++ + DVC A+ YL N
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+H +L VL+ + +K+SDFG + TG + + PE
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----------WTAPEA 171
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659
L K + +SDV+SFGI+L + + V + +K + + V D P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCP 226
Query: 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
+ + C + RP ++ LE ++
Sbjct: 227 PAVYEVMKNCWHLDAAMRPS-FLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-48
Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 18/274 (6%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+ ++G G++G V+ G H VA+K G S F E ++ +++H LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 482 TLIGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L E ++ EY+ NGSL D L L + +A+ + + ++
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
IH +L+ + +L+ K++DFG LI E T + PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK------FPIKWTAPEAI 182
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660
G T +SDV+SFGI+L ++T + ++ + P E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----LERGYRMVRPDNCPE 237
Query: 661 QLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694
+L L C + +RP + SVLE +
Sbjct: 238 ELYQLMRLCWKERPEDRPT-FDYLRSVLEDFFTA 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 5e-48
Identities = 64/297 (21%), Positives = 117/297 (39%), Gaps = 31/297 (10%)
Query: 413 FSFSELNEATNNFEPSW---------KIGEGRYGNVYRGLLRHLH-----VAIKMF-PSY 457
F+F + NEA F IG G +G V G L+ VAIK Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 458 GPQSHLKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSP 515
+ F +E ++ + HPN++ L G ++ E++ NGSL+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF--LRQNDGQ 124
Query: 516 LRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575
+ + + + + YL + +H +L +L+++N K+SDFG +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634
S + + PE ++ K T SDV+S+GI++ +++ G +
Sbjct: 183 SDPTY--TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 635 KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
N++ P+ L L L C + +R +RP +I + L+ +
Sbjct: 241 DV------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 64/273 (23%), Positives = 112/273 (41%), Gaps = 20/273 (7%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+ +IG G++G V+ G + VAIK G S F E EV+ ++ HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 482 TLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L G C LVFE++ +G L D + ++ +T + + DVC + YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLE--E 119
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
C+IH +L L+ N K+SDFG + + T ++ + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEV 173
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659
+ + +SDV+SFG+++ + + + + +E + P +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-----ISTGFRLYKPRLAS 228
Query: 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
+ + C + +RP S + L +
Sbjct: 229 THVYQIMNHCWKERPEDRPA-FSRLLRQLAEIA 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF-PSYGPQSHLKFQNEVEVLSRVRH 477
++FE ++G G G V++ + +A K+ P + E++VL
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 478 PNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
P +V G S+ E++ GSL+ L K + Q +++ V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
+ I+H ++KPS +L+++ KL DFG + + + Y+
Sbjct: 121 RE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---------YM 170
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE L+ + +SD++S G+ L+ + GR
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-46
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 22/268 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+ ++G G++G V G R VAIKM G S +F E +V+ + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 482 TLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
L G C + R ++ EY+ NG L + L + Q +++ DVC A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEY 599
+H +L L++ K+SDFG + E T + + PE
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK------FPVRWSPPEV 172
Query: 600 LETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659
L K + +SD+++FG+++ + + + + E + P +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-----IAQGLRLYRPHLAS 227
Query: 660 EQLAHLALRCCENNRLNRP---DLVSEI 684
E++ + C RP L+S I
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 72/274 (26%), Positives = 108/274 (39%), Gaps = 18/274 (6%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL-HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLV 481
+ K+G+G +G V+ G VAIK G S F E +V+ ++RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 482 TLIGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L E +V EY+ GSL D LR + +A+ + S + Y+
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 132
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
+H +L+ + +L+ N K++DFG LI E T + PE
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK------FPIKWTAPEAA 186
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660
G+ T +SDV+SFGI+L L T V + L++ V P E
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----VERGYRMPCPPECPE 241
Query: 661 QLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694
L L +C RP + + LE S
Sbjct: 242 SLHDLMCQCWRKEPEERPTF-EYLQAFLEDYFTS 274
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 4e-45
Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 20/273 (7%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
+ K+G G+YG VY G+ + VA+K +F E V+ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 481 VTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V L+G C ++ E++ G+L D L N++ + + +A+ + SA+ YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK 134
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
IH +L L+ N K++DFG L+ T ++ + PE
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPE 186
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658
L K + +SDV++FG++L + T D+ E + + P
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGC 241
Query: 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
E++ L C + N +RP +EI E +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-45
Identities = 63/296 (21%), Positives = 108/296 (36%), Gaps = 42/296 (14%)
Query: 430 KIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE 489
IG+GR+G V+RG R VA+K+F S +S + E+ +RH N++ I +
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 490 SRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN----- 538
LV +Y +GSL D L + + + +++A S L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 539 -EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
+P I H +LK +L+ N ++D G T + A ++ Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP---NHRVGTKRYMAP 181
Query: 598 EYLET------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS- 650
E L+ + +D+Y+ G++ + + I +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 651 -------------AGDWPVAEA-EQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
W EA +A + C N R I L L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-ALRIKKTLSQLS 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 57/268 (21%), Positives = 106/268 (39%), Gaps = 24/268 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK--FQNEVEVLSRVRHPNLVTL 483
++G G +G V +G + VA+K+ + LK E V+ ++ +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 484 IGTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCI 542
IG C ES LV E G L L + ++ + +++ V + YL +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--NF 128
Query: 543 IHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLET 602
+H +L VL+ +K+SDFG + E+ + ++ + PE +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECINY 184
Query: 603 GKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQ 661
K + +SDV+SFG+++ + G+ R K + P +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGERMGCPAGCPRE 238
Query: 662 LAHLALRCCENNRLNRPDLVSEIWSVLE 689
+ L C + NRP + + L
Sbjct: 239 MYDLMNLCWTYDVENRPGF-AAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 26/287 (9%)
Query: 430 KIGEGRYGNVYRGLLRHLH----VAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTLI 484
++G G +G+V +G+ R VAIK+ ++ + E +++ ++ +P +V LI
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 485 GTC-PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCII 543
G C E+ LV E G L L K+ + ++ V + YL +
Sbjct: 76 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK--NFV 131
Query: 544 HGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
H +L VL+ +K+SDFG + +S + + + PE +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFR 187
Query: 604 KLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQL 662
K + SDV+S+G+ + L+ G+ + K + + + P +L
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMECPPECPPEL 241
Query: 663 AHLALRCCENNRLNRPDLVSEIWSVLEALRVSCVFPVSCSGSKEHRR 709
L C +RPD +V + +R +C + ++ H
Sbjct: 242 YALMSDCWIYKWEDRPD----FLTVEQRMR-ACYYSLASKVEGHHHH 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 9e-44
Identities = 53/261 (20%), Positives = 93/261 (35%), Gaps = 28/261 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPNLVTLIG 485
+IG G + VY+GL VA +F+ E E+L ++HPN+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 486 TCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
+ + LV E + +G+L+ L + ++ + + L +LH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 540 PCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
P IIH +LK + I GS K+ D G L + ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE---------FMAPE 183
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658
E K DVY+FG+ +L + T ++ + +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SFDKVA 238
Query: 659 AEQLAHLALRCCENNRLNRPD 679
++ + C N+ R
Sbjct: 239 IPEVKEIIEGCIRQNKDERYS 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-43
Identities = 52/268 (19%), Positives = 98/268 (36%), Gaps = 25/268 (9%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPN 479
++E + IG G YG + + + K S +EV +L ++HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 480 LVTLIGTCPESRS----LVFEYLRNGSLEDCL-ACKNKKSPLRWQTRMQIASDVCSALIY 534
+V + + +V EY G L + ++ L + +++ + + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 535 LHSNEPC---IIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
H ++H +LKP+ V +D KL DFG ++ S + +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY----- 179
Query: 592 SVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651
Y+ PE + +SD++S G +L L P +K + +
Sbjct: 180 --YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIREGKF 231
Query: 652 GDWPVAEAEQLAHLALRCCENNRLNRPD 679
P +++L + R +RP
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPS 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 51/258 (19%), Positives = 98/258 (37%), Gaps = 24/258 (9%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G+G +G VY+ + A K+ + + + E+++L+ HPN+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ ++ E+ G+++ + + PL + AL YLH N IIH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHDN--KIIHR 134
Query: 546 NLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL----- 600
+LK +L + KL+DFG + +S + ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT-------PYWMAPEVVMCETS 187
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660
+ ++DV+S GI L+ + P ++ L+ + W
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS----S 243
Query: 661 QLAHLALRCCENNRLNRP 678
+C E N R
Sbjct: 244 NFKDFLKKCLEKNVDARW 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 2e-42
Identities = 68/312 (21%), Positives = 113/312 (36%), Gaps = 44/312 (14%)
Query: 411 LEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSH 462
L L NN E IGEG +G V++ L VA+KM
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 463 LKFQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCL------------- 507
FQ E +++ +PN+V L+G C + L+FEY+ G L + L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 508 --------ACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG 559
PL ++ IA V + + YL +H +L L+ N
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMV 178
Query: 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILL 619
K++DFG I + N+ ++ PE + + T ESDV+++G++L
Sbjct: 179 VKIADFGLSRNIYSADYYKAD-----GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 620 RLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPD 679
+ + + + V D + P +L +L C +RP
Sbjct: 234 EIFSYGLQPYYGMAHEEVIYY-----VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 680 LVSEIWSVLEAL 691
I +L+ +
Sbjct: 289 F-CSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 3e-42
Identities = 68/281 (24%), Positives = 104/281 (37%), Gaps = 33/281 (11%)
Query: 408 PGLLEFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK- 464
P + E F + + F +IG G +G VY VAIK G QS+ K
Sbjct: 2 PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 465 --FQNEVEVLSRVRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQT 520
EV L ++RHPN + G + LV EY + + K PL+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVE 116
Query: 521 RMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580
+ L YLHS+ +IH ++K +L+ KL DFG ++ S +
Sbjct: 117 IAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
Query: 581 ALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA 637
++ PE + G+ + DV+S GI + L +P L + A
Sbjct: 175 PY-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A 222
Query: 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRP 678
L N +G W E + C + +RP
Sbjct: 223 LYHIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRP 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-42
Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 28/284 (9%)
Query: 422 TNNFEPSW-----KIGEGRYGNVYRGLLR------HLHVAIKMF-PSYGPQSHLKFQNEV 469
T PS IG G +G VY+G+L+ + VAIK Y + + F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 470 EVLSRVRHPNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASD 527
++ + H N++ L G + + + + EY+ NG+L+ + K + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRG 118
Query: 528 VCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESN 587
+ + + YL + +H +L +L+++N K+SDFG ++ + S
Sbjct: 119 IAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT----SG 172
Query: 588 NDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647
+ PE + K T SDV+SFGI++ ++T + ++ +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----IN 227
Query: 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
D P+ + L ++C + R RP ++I S+L+ L
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKL 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 430 KIGEGRYGNVYRGLLRH-----LHVAIKMFPSYGPQSHLK-FQNEVEVLSRVRHPNLVTL 483
IG G +G VY G L +H A+K + F E ++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 484 IGTCPESRS---LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
+G C S +V Y+++G L + +N+ + + V + +L S
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 149
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
+H +L ++D F K++DFG + E ++ N++ ++ E L
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKWMALESL 206
Query: 601 ETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAE 660
+T K T +SDV+SFG++L L+T + +L P +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LLQGRRLLQPEYCPD 261
Query: 661 QLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
L + L+C RP SE+ S + A+
Sbjct: 262 PLYEVMLKCWHPKAEMRPSF-SELVSRISAIF 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLR----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-R 476
N+ + IGEG +G V + ++ + AIK Y H F E+EVL ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 477 HPNLVTLIGTC--PESRSLVFEYLRNGSLEDCL-------------ACKNKKSPLRWQTR 521
HPN++ L+G C L EY +G+L D L + S L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 522 MQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581
+ A+DV + YL IH +L +L+ N+ +K++DFG
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKR 641
L ++ E L T SDV+S+G++L +++ EK
Sbjct: 188 LPVR--------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK- 238
Query: 642 NFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
+ + P+ +++ L +C RP ++I L +
Sbjct: 239 ----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS-FAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-41
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 22/279 (7%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSYG---PQSHLKFQNEVEVLSR 474
+ K+G+G +G V RG + + VA+K P++ F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 475 VRHPNLVTLIGTCPESR-SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALI 533
+ H NL+ L G +V E GSL D + + T + A V +
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 534 YLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASV 593
YL S IH +L +L+ K+ DFG +PQ + + +
Sbjct: 126 YLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFA 179
Query: 594 YIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653
+ PE L+T + SD + FG+ L + T I + L K + D
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
P + + ++ ++C + +RP + L +
Sbjct: 240 CP----QDIYNVMVQCWAHKPEDRPT-FVALRDFLLEAQ 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (376), Expect = 7e-41
Identities = 65/282 (23%), Positives = 119/282 (42%), Gaps = 23/282 (8%)
Query: 422 TNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP---SYGPQSHLKFQNEVEVLSRVR 476
++ +E +G G V+ LH VA+K+ + P +L+F+ E + + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 477 HPNLVTLIGTCPESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
HP +V + T +V EY+ +L D + + P+ + +++ +D C
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS 590
AL + H N IIH ++KP+ ++I A K+ DFG I ++ +
Sbjct: 123 ALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----AAVIG 176
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650
+ Y+ PE + SDVYS G +L +LTG P V A + + + S+
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692
+ + L + L+ N NR +E+ + L +
Sbjct: 237 RHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 63/299 (21%), Positives = 107/299 (35%), Gaps = 43/299 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-------VAIKMFPSYGPQSHLK-FQNEVEVLSR 474
N E +G G +G V + VA+KM S + +E++++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 475 V-RHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKK------------------ 513
+ H N+V L+G C S L+FEY G L + L K +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 514 --SPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571
+ L ++ + A V + +L +H +L VL+ K+ DFG I
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 572 PQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK 631
+ ++ PE L G T +SDV+S+GI+L + +
Sbjct: 215 MSDSNYVVRGNARLPVK-----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 632 KDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEA 690
V K + + D P E++ + C + RP + S L
Sbjct: 270 IPVDANFYKL----IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-FPNLTSFLGC 323
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 55/269 (20%), Positives = 105/269 (39%), Gaps = 21/269 (7%)
Query: 414 SFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEV 471
S + + + KIG+G G VY + VAI+ NE+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 472 LSRVRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
+ ++PN+V + + + +V EYL GSL D + ++ + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
AL +LHSN +IH ++K +L+ + KL+DFGF I +S ++ +
Sbjct: 127 QALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY--- 181
Query: 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649
++ PE + P+ D++S GI+ + ++ G P + ++ +
Sbjct: 182 ----WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 650 SAGDWPVAEAEQLAHLALRCCENNRLNRP 678
+ RC + + R
Sbjct: 238 NPEKLS----AIFRDFLNRCLDMDVEKRG 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL-------HVAIKMF-PSYGPQSHLKFQNEVEVLSR 474
S ++G+G +G VY G+ + + VAIK + + ++F NE V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 475 VRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKK-------SPLRWQTRMQIA 525
++V L+G + ++ E + G L+ L +P +Q+A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
++ + YL++N +H +L ++ +F K+ DFG I + +
Sbjct: 140 GEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG----- 192
Query: 586 SNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS 645
++ PE L+ G T SDV+SFG++L + T + L
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----- 247
Query: 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689
V++ D P + L L C + N RP EI S ++
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-FLEIISSIK 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 51/262 (19%), Positives = 86/262 (32%), Gaps = 20/262 (7%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP-SYGPQSHLKFQNEVEVLSRVRHPN 479
+++ +GEG YG V + R VA+K+ + E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 480 LVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V G + L EY G L D + + + + + ++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
I H ++KP +L+D K+SDFG + + Y+ P
Sbjct: 122 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-----YVAP 174
Query: 598 EYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
E L+ + DV+S GI+L +L G D +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID- 233
Query: 657 AEAEQLAHLALRCCENNRLNRP 678
L + N R
Sbjct: 234 ---SAPLALLHKILVENPSARI 252
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 146 bits (369), Expect = 4e-39
Identities = 50/262 (19%), Positives = 105/262 (40%), Gaps = 21/262 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
++++ ++G G +G V+R R A K + + E++ +S +RHP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 481 VTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
V L + +++E++ G L + + ++ + + ++ VC L ++H N
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 539 EPCIIHGNLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
+H +LKP ++ + KL DFG + +S + E +
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE--------FAA 193
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
PE E + +D++S G++ LL+G + D + ++ + +D SA
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI- 252
Query: 657 AEAEQLAHLALRCCENNRLNRP 678
+E + + R
Sbjct: 253 --SEDGKDFIRKLLLADPNTRM 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 7e-39
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 28/263 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP---SYGPQSHLKFQNEVEVLSRVRH 477
+FE +G+G++GNVY + +A+K+ + + EVE+ S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 478 PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
PN++ L G ++ + + EY G++ L K S Q +++ +AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
HS +IH ++KP +L+ + K++DFG+ P T Y+
Sbjct: 123 HSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---------TLCGTLDYL 171
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655
PE +E + D++S G++ L G+P + +P
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------FTFP 224
Query: 656 VAEAEQLAHLALRCCENNRLNRP 678
E L R ++N RP
Sbjct: 225 DFVTEGARDLISRLLKHNPSQRP 247
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-39
Identities = 62/293 (21%), Positives = 103/293 (35%), Gaps = 38/293 (12%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSR 474
N +G G +G V L VA+KM PS +E++VLS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 475 V-RHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACK---------------NKKSPL 516
+ H N+V L+G C ++ EY G L + L K + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
+ + + V + +L S IH +L +L+ +K+ DFG I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636
++ PE + T ESDV+S+GI L L + V
Sbjct: 201 YVVKGNAR-----LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689
K + + P ++ + C + + L RP +I ++E
Sbjct: 256 KFYKM----IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-FKQIVQLIE 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 25/281 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-----VAIKMFPSYGPQSHLK-FQNEVEVLSRVR 476
E IGEG++G+V++G+ VAIK + S + F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 477 HPNLVTLIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
HP++V LIG E+ ++ E G L + +K L + + A + +AL YL
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
S +H ++ VL+ +N KL DFG + S ++
Sbjct: 125 ESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK------LPIKWM 176
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655
PE + + T SDV+ FG+ + +L + + + + P
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERLPMP 231
Query: 656 VAEAEQLAHLALRCCENNRLNRP---DLVSEIWSVLEALRV 693
L L +C + RP +L +++ ++LE +
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 53/275 (19%), Positives = 106/275 (38%), Gaps = 23/275 (8%)
Query: 425 FEPSWKIGEGRYGNVYRGLLRH------LHVAIK-MFPSYGPQSHLKFQNEVEVLSRVRH 477
F+ +G G +G VY+GL + VAIK + + P+++ + +E V++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 478 PNLVTLIGTCPESRS-LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
P++ L+G C S L+ + + G L D + K + Q + + + YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
++H +L VL+ K++DFG L+ E ++ ++
Sbjct: 129 DR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-----WMA 181
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
E + T +SDV+S+G+ + L+T + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEKGERLPQPP 236
Query: 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+ + ++C + +RP E+ +
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPK-FRELIIEFSKM 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (356), Expect = 2e-37
Identities = 43/255 (16%), Positives = 95/255 (37%), Gaps = 21/255 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
++G G +G V+R + + K + P +NE+ +++++ HP L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 488 PESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
+ L+ E+L G L D + + + + C L ++H + I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHL 151
Query: 546 NLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
++KP ++ + S K+ DFG + E + E + PE ++
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE--------FAAPEIVDRE 203
Query: 604 KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663
+ +D+++ G++ LL+G + D++ + + + E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRCDWEFDEDAFSSVSPE-AK 260
Query: 664 HLALRCCENNRLNRP 678
+ R
Sbjct: 261 DFIKNLLQKEPRKRL 275
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 39/295 (13%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH---------VAIKMFPSYGPQSHLK-FQNEVEVL 472
+ +GEG +G V L VA+KM S + L +E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 473 SRV-RHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACK-------------NKKSPL 516
+ +H N++ L+G C + ++ EY G+L + L + N + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
+ + A V + YL S IH +L VL+ + K++DFG I +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC 636
+ ++ PE L T +SDV+SFG++L + T V+
Sbjct: 191 YKKTTNGRLPVK-----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 637 ALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+ + + D P +L + C RP ++ L+ +
Sbjct: 246 LFKL-----LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-FKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 55/262 (20%), Positives = 95/262 (36%), Gaps = 24/262 (9%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFP---SYGPQSHLKFQNEVEVLSRVRHP 478
+F+ +GEG + V AIK+ E +V+SR+ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 479 NLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
V L T E Y +NG L + K +++ SAL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
IIH +LKP +L++ + +++DFG ++ + ++ + Y+
Sbjct: 126 G--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPV 656
PE L SD+++ G I+ +L+ G P R + + D+P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------YDFPE 231
Query: 657 AEAEQLAHLALRCCENNRLNRP 678
+ L + + R
Sbjct: 232 KFFPKARDLVEKLLVLDATKRL 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (337), Expect = 1e-35
Identities = 62/269 (23%), Positives = 107/269 (39%), Gaps = 24/269 (8%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLK---------FQNEVEVL 472
N+EP +G G V R + + A+K+ G S EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 473 SRVR-HPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
+V HPN++ L T + LVF+ ++ G L D L +K L + +I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNND 589
+ LH I+H +LKP +L+D + KL+DFGF + GE +C +
Sbjct: 121 EVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176
Query: 590 SASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDS 649
+ + E D++S G+I+ LL G P +K + + + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSGNYQF 234
Query: 650 SAGDWPVAEAEQLAHLALRCCENNRLNRP 678
+ +W ++ + L R R
Sbjct: 235 GSPEWDDY-SDTVKDLVSRFLVVQPQKRY 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 46/255 (18%), Positives = 97/255 (38%), Gaps = 22/255 (8%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
+G G +G V+R + K + + E+ +L+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 488 --PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHG 545
E ++FE++ + + + L + + VC AL +LHS+ I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHF 126
Query: 546 NLKPSKVLIDANFGS--KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG 603
+++P ++ S K+ +FG + G++ +A Y PE +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--------RLLFTAPEYYAPEVHQHD 178
Query: 604 KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLA 663
++ +D++S G ++ LL+G + + + + + N+ + E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMNAEYTFDEEAFKEISIE-AM 235
Query: 664 HLALRCCENNRLNRP 678
R R +R
Sbjct: 236 DFVDRLLVKERKSRM 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 56/272 (20%), Positives = 99/272 (36%), Gaps = 24/272 (8%)
Query: 415 FSELNEATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF-PSYGPQSHLKFQNEVEV 471
+ + + + ++ +G G + V + VAIK +NE+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 472 LSRVRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVC 529
L +++HPN+V L L+ + + G L D + +K + ++ V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 530 SALIYLHSNEPCIIHGNLKPSKVLI---DANFGSKLSDFGFFHLIPQGESTGNSALCNES 586
A+ YLH + I+H +LKP +L D + +SDFG + G +
Sbjct: 118 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG- 174
Query: 587 NNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSV 646
Y+ PE L + D +S G+I LL G P + D K L ++ +
Sbjct: 175 -------YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAE 225
Query: 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRP 678
+ + W E + R
Sbjct: 226 YEFDSPYWDDISDS-AKDFIRHLMEKDPEKRF 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 54/227 (23%), Positives = 82/227 (36%), Gaps = 36/227 (15%)
Query: 412 EFSFSELNEATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEV 469
E S+++ IG G +G VY+ L VAIK Q E+
Sbjct: 19 EVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNREL 64
Query: 470 EVLSRVRHPNLVTLIGTCPESRS--------LVFEYLRNGSLEDCLACKNKKSPLRWQTR 521
+++ ++ H N+V L S LV +Y+ K L
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 522 MQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFG-SKLSDFGFFHLIPQGESTGNS 580
+ +L Y+HS I H ++KP +L+D + KL DFG + +GE +
Sbjct: 125 KLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 581 ALCNESNNDSASVYIDP-EYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y P T DV+S G +L LL G+P
Sbjct: 183 ICSRY--------YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (325), Expect = 1e-33
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFP---SYGPQSHLKFQNEVEVLSRVRH 477
+F+ +G G +G V+ RH + A+K+ + +E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 478 PNLVTLIGTCPESRSL--VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
P ++ + GT +++ + + +Y+ G L L + A++VC AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYL 120
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
H II+ +LKP +L+D N K++DFGF +P T YI
Sbjct: 121 H--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD----------YI 168
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE + T D +SFGI++ +L G
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-33
Identities = 65/338 (19%), Positives = 112/338 (33%), Gaps = 44/338 (13%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP---SYGPQSHLKFQNEVEVLSRV-R 476
+F +G+G +G V+ + + AIK E VLS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 477 HPNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
HP L + T +L F EYL G L + A+++ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
LHS I++ +LK +L+D + K++DFG G++ N+ Y
Sbjct: 119 LHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-------Y 169
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654
I PE L K D +SFG++L +L G+ + + + R N +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-------FY 222
Query: 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEI----------WSVLEALRVSCVFPVSCSGS 704
P ++ L ++ R + +I W LE + F
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP 282
Query: 705 KEHRRIPSHFVCPILQEVMKDPQIAA-------DGFTY 735
+ F+ + D + F++
Sbjct: 283 FDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 6e-33
Identities = 51/278 (18%), Positives = 91/278 (32%), Gaps = 17/278 (6%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
N + KIG G +G++Y G VAIK+ H + E ++ ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 481 VTLIGTC---PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+ I C + +V E L + C +T + +A + S + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKL---SDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
IH ++KP L+ L DFG + + N + Y
Sbjct: 122 K--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDSSAGD 653
+ + D+ S G +L+ G + K K +R + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+ A C ++PD S + + L
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 128 bits (323), Expect = 7e-33
Identities = 51/267 (19%), Positives = 101/267 (37%), Gaps = 29/267 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP------SYGPQSHLKFQNEVEVLSR 474
N+F IG G +G VY A+K G L + + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 475 VRHPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
P +V + P+ S + + + G L L ++ A+++ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
++H+ +++ +LKP+ +L+D + ++SD G + + +
Sbjct: 121 EHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---------ASVGTH 169
Query: 593 VYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSA 651
Y+ PE L+ G +D +S G +L +LL G R K +K + + + A
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLTMA 225
Query: 652 GDWPVAEAEQLAHLALRCCENNRLNRP 678
+ P + + +L L + + R
Sbjct: 226 VELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 57/271 (21%), Positives = 95/271 (35%), Gaps = 14/271 (5%)
Query: 420 EATNNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLK-FQNEVEVLSRVR 476
+ + IGEG YG V VAIK + Q++ + E+++L R R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 477 HPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIY 534
H N++ + P + YL + L K L + L Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 535 LHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
+HS ++H +LKPS +L++ K+ DFG + + + Y
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF----LTEYVATRWY 178
Query: 595 IDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGD 653
PE + K T D++S G IL +L+ RP+ K + + S D
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 236
Query: 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684
+ + L N++ L
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 6e-31
Identities = 56/296 (18%), Positives = 105/296 (35%), Gaps = 39/296 (13%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-------VAIKMF-PSYGPQSHLKFQNEVEVLSR 474
+ + +G G +G V + VA+KM H +E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 475 -VRHPNLVTLIGTCPESRS---LVFEYLRNGSLEDCLACKNK-------------KSPLR 517
H N+V L+G C + ++ E+ + G+L L K K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 518 WQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577
+ + + V + +L S IH +L +L+ K+ DFG I +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA 637
++ PE + T +SDV+SFG++L + + +
Sbjct: 191 VRKGDARLPLK-----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 638 LEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRP---DLVSEIWSVLEA 690
+R + + + P ++ L C RP +LV + ++L+A
Sbjct: 246 FCRR----LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-30
Identities = 56/262 (21%), Positives = 94/262 (35%), Gaps = 31/262 (11%)
Query: 431 IGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTC 487
+G G G V + + A+KM Q K + EVE+ R + P++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 488 PESRS------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPC 541
+ +V E L G L + + +I + A+ YLHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI--N 131
Query: 542 IIHGNLKPSKVLIDANFGS---KLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE 598
I H ++KP +L + + KL+DFGF S Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY--------YVAPE 183
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRPVLRIK--KDVKCALEKRNFNSVLDSSAGDWPV 656
L K D++S G+I+ LL G P + ++ R + +W
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 657 AEAEQLAHLALRCCENNRLNRP 678
+E++ L + R
Sbjct: 244 V-SEEVKMLIRNLLKTEPTQRM 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 29/286 (10%)
Query: 421 ATNNFEPSWKIGEGRYGNVYRGLLRHL---HVAIKMFP--SYGPQSHLKFQNEVEV---L 472
A +E +IGEG YG V++ VA+K + L EV V L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 473 SRVRHPNLVTLIGTCPESRS-------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIA 525
HPN+V L C SR+ LVFE++ K + + +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 526 SDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNE 585
+ L +LHS+ ++H +LKP +L+ ++ KL+DFG + + + +
Sbjct: 123 FQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 586 SNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNS 645
Y PE L D++S G I + +P+ R DV + +
Sbjct: 181 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDV 230
Query: 646 VLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691
+ DWP A + + D+ +L
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 118 bits (297), Expect = 3e-30
Identities = 43/290 (14%), Positives = 90/290 (31%), Gaps = 29/290 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL 480
+++ +IGEG +G ++ G + VAIK P + ++E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 481 VTLI---GTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+ + G LV + L + +T A + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 538 NEPCIIHGNLKPSKVLIDANFGS-----KLSDFGFFHLIPQGESTGNSALCNESNNDSAS 592
+++ ++KP LI + DFG + + + N +
Sbjct: 120 K--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 593 VYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA-----LEKRNFNSVL 647
Y+ + + D+ + G + + L G + K + ++ ++ L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPD---LVSEIWSVLEALRVS 694
+P E+ PD L VLE L +
Sbjct: 238 RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-30
Identities = 55/270 (20%), Positives = 98/270 (36%), Gaps = 30/270 (11%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP------SYGPQSHLKFQNEVEVLSR 474
+ ++ ++G G++ V + + A K S S + EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 475 VRHPNLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
++HPN++TL L+ E + G L D +K L + + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQILNGV 126
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDANFGS----KLSDFGFFHLIPQGESTGNSALCNESNN 588
YLHS I H +LKP +++ K+ DFG H I G N E
Sbjct: 127 YYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--- 181
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648
++ PE + L E+D++S G+I LL+G + N ++V
Sbjct: 182 -----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVNY 233
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRP 678
++ + R + R
Sbjct: 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (294), Expect = 9e-30
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 18/210 (8%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPN 479
+ KIGEG YG VY+ + A+K E+ +L ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 480 LVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS 537
+V L + LVFE+L + C+ L T + + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 538 NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDP 597
++H +LKP +LI+ K++DFG + Y P
Sbjct: 119 R--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT-------LWYRAP 169
Query: 598 EYLE-TGKLTPESDVYSFGIILLRLLTGRP 626
+ L + K + D++S G I ++ G P
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 47/208 (22%), Positives = 76/208 (36%), Gaps = 14/208 (6%)
Query: 424 NFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP--SYGPQSHLKFQNEVEVLSRVRHPN 479
NF+ KIGEG YG VY+ + VA+K + E+ +L + HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 480 LVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE 539
+V L+ L + + + + + L + HS+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 540 PCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPE- 598
++H +LKP +LI+ KL+DFG T + Y PE
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-------LWYRAPEI 173
Query: 599 YLETGKLTPESDVYSFGIILLRLLTGRP 626
L + D++S G I ++T R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 55/236 (23%), Positives = 92/236 (38%), Gaps = 24/236 (10%)
Query: 430 KIGEGRYGNVYRGLLRHLH--VAIKMFP-----SYGPQSHLKFQNEVEVLSRVRHPNLVT 482
+GEG++ VY+ ++ + VAIK + E+++L + HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 483 LIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEP 540
L+ + SLVF+++ K+ L L YLH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 541 CIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYL 600
I+H +LKP+ +L+D N KL+DFG + Y PE L
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------TRWYRAPELL 172
Query: 601 ETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655
++ D+++ G IL LL P L D+ R F ++ + WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWP 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-27
Identities = 54/270 (20%), Positives = 100/270 (37%), Gaps = 40/270 (14%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP------SYGPQSHLKFQNEVEVLSR 474
+ ++ +G G +G+VY G+ + VAIK + + EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 475 VR--HPNLVTLIGTC--PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
V ++ L+ P+S L+ E ++ L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLE 121
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNND 589
A+ + H+ ++H ++K +LID N G KL DFG L+ T + D
Sbjct: 122 AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------DFD 170
Query: 590 SASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648
VY PE++ + + V+S GI+L ++ G +++ + F +
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--QVFFRQRVS 228
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRP 678
+ HL C +RP
Sbjct: 229 -----------SECQHLIRWCLALRPSDRP 247
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 45/211 (21%), Positives = 79/211 (37%), Gaps = 19/211 (9%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP---SYGPQSHLKFQNEVEVLSRVRH 477
N+F+ +G+G +G V + A+K+ E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 478 PNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
P L L L F EY G L L +++ + +++ SAL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYI 595
H +++ ++K +++D + K++DFG +T Y+
Sbjct: 122 H--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEYL 172
Query: 596 DPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
PE LE D + G+++ ++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-27
Identities = 41/230 (17%), Positives = 75/230 (32%), Gaps = 32/230 (13%)
Query: 413 FSFSELNEAT----NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF--PSYGPQSHLK 464
F E+ + + +G G YG V + VAIK P +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 465 FQNEVEVLSRVRHPNLVTLIGTCPESRS--------LVFEYLRNGSLEDCLACKNKKSPL 516
E+ +L +RH N++ L+ + LV ++ + K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKL 118
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
+ + L Y+H+ H +LKP + ++ + K+ DFG +
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
L + T D++S G I+ ++TG+
Sbjct: 177 GYVVTRWY---------RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-27
Identities = 46/218 (21%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHL--HVAIKMFP--SYGPQSHLKFQNEVEVLSRVRHP 478
+ +E KIG+G +G V++ R VA+K + + E+++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 479 NLVTLIGTCPESRS----------LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDV 528
N+V LI C S LVF++ + N ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126
Query: 529 CSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNN 588
+ L Y+H N I+H ++K + VLI + KL+DFG +++ + +
Sbjct: 127 LNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN--RYTNRV 182
Query: 589 DSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ L P D++ G I+ + T P
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 48/224 (21%), Positives = 80/224 (35%), Gaps = 17/224 (7%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFP--SYGPQSHLKFQNEVEVLSRVRHP 478
+E KIGEG YG V++ R H VA+K E+ +L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 479 NLVTLIGTCPESRS--LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLH 536
N+V L + LVFE+ + +C + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118
Query: 537 SNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYID 596
S ++H +LKP +LI+ N KL++FG ++ + +
Sbjct: 119 SR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------TLWYRPP 170
Query: 597 PEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640
+ D++S G I L L DV L++
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 8e-26
Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 30/250 (12%)
Query: 385 GNAQRRVRDIKKSIKREALSFFQPGLLEFSFSELNEAT-NNFEPSWKIGEGRYGNVYRGL 443
G+ Q V++ K + L ++ N A + F+ +G G +G V
Sbjct: 9 GSEQESVKEFLAKAKEDFLK-------KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 444 LRHL--HVAIKMFP---SYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPESRSL--VFE 496
+ H A+K+ + NE +L V P LV L + ++ +L V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556
Y+ G + L + A+ + YLHS +I+ +LKP +LID
Sbjct: 122 YVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQ 176
Query: 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGI 616
+++DFGF + T + PE + + D ++ G+
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWTLCGTPE----------ALAPEIILSKGYNKAVDWWALGV 226
Query: 617 ILLRLLTGRP 626
++ + G P
Sbjct: 227 LIYEMAAGYP 236
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 9e-26
Identities = 51/230 (22%), Positives = 81/230 (35%), Gaps = 30/230 (13%)
Query: 412 EFSFSELN----EATNNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF--PSYGPQSHL 463
F ELN E ++ +G G YG+V VA+K P
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 464 KFQNEVEVLSRVRHPNLVTLIGTCPESRSL-------VFEYLRNGSLEDCLACKNKKSPL 516
+ E+ +L ++H N++ L+ +RSL + +L L + K L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKL 118
Query: 517 RWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576
+ + L Y+HS IIH +LKPS + ++ + K+ DFG
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173
Query: 577 TGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ L D++S G I+ LLTGR
Sbjct: 174 ------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (255), Expect = 3e-24
Identities = 46/226 (20%), Positives = 86/226 (38%), Gaps = 26/226 (11%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPN 479
++++ K+G G+Y V+ + + V +K+ P K + E+++L +R PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPN 91
Query: 480 LVTLIGTCPESRS----LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYL 535
++TL + S LVFE++ N + L ++ AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 536 HSNEPCIIHGNLKPSKVLIDANFGS-KLSDFGFFHLIPQGESTGNSALCNESNNDSASVY 594
HS I+H ++KP V+ID +L D+G G+ S
Sbjct: 146 HSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-------ASRYFK 196
Query: 595 IDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK 640
++ D++S G +L ++ + D L +
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 6e-24
Identities = 55/270 (20%), Positives = 95/270 (35%), Gaps = 28/270 (10%)
Query: 423 NNFEPSWKIGEGRYGNVYRGLLRHLH-----VAIKMFP----SYGPQSHLKFQNEVEVLS 473
NFE +G G YG V+ H A+K+ ++ + E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 474 RVRH-PNLVTLIGTCPESRSLVF--EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCS 530
+R P LVTL L +Y+ G L L +++ ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVL 140
Query: 531 ALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDS 590
AL +LH II+ ++K +L+D+N L+DFG E+ C +
Sbjct: 141 ALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 591 ASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIK--KDVKCALEKRNFNSVLD 648
+ + D +S G+++ LLTG + K+ + + +R S
Sbjct: 199 PDIVRGGDS----GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP- 253
Query: 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRP 678
+P + L R + R
Sbjct: 254 ----PYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.6 bits (226), Expect = 2e-20
Identities = 41/215 (19%), Positives = 72/215 (33%), Gaps = 25/215 (11%)
Query: 430 KIGEGRYGNVYRGLLRHL--HVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC 487
K+G G + V+ HVA+K+ ++E+++L RV +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 488 ---------------PESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSAL 532
P +V + G L K + + QI+ + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 533 IYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSA 591
Y+H IIH ++KP VL++ L L + +N+
Sbjct: 139 DYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADL-----GNACWYDEHYTNSIQT 192
Query: 592 SVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
Y PE L +D++S ++ L+TG
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (223), Expect = 4e-20
Identities = 43/231 (18%), Positives = 82/231 (35%), Gaps = 32/231 (13%)
Query: 412 EFSFSELNEAT----NNFEPSWKIGEGRYGNVYRGLLRHLH--VAIKMF--PSYGPQSHL 463
+F E+ ++T ++ IG G G V L VAIK P
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 464 KFQNEVEVLSRVRHPNLVTLIGTCPESRS--------LVFEYLRNGSLEDCLACKNKKSP 515
+ E+ ++ V H N+++L+ ++ LV E + + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---- 117
Query: 516 LRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575
+ + + + +LHS IIH +LKPS +++ ++ K+ DFG
Sbjct: 118 --HERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRP 626
+ Y PE + D++S G I+ ++ +
Sbjct: 174 MMTPYVVTRY--------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 74.7 bits (183), Expect = 3e-17
Identities = 34/77 (44%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 703 GSKEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCN 762
GS E P +F CPI E+MKDP I + G TYE +I+ WL +GH T P + L H
Sbjct: 1 GSPE---FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAG 57
Query: 763 LLPNYALHQAIIEWQQR 779
L PNY L I W +
Sbjct: 58 LTPNYVLKSLIALWCES 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.0 bits (181), Expect = 9e-16
Identities = 23/148 (15%), Positives = 42/148 (28%), Gaps = 18/148 (12%)
Query: 430 KIGEGRYGNVYRGLL-RHLHVAIKMF----------PSYGPQSHLKFQNEVEVLSRVRHP 478
+GEG+ V+ + +K L F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 479 NLVTLIGTCPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN 538
L L G + + N L + + K ++ + + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYHR 122
Query: 539 EPCIIHGNLKPSKVLIDANFGSKLSDFG 566
I+HG+L VL+ G + DF
Sbjct: 123 --GIVHGDLSQYNVLVS-EEGIWIIDFP 147
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 61.0 bits (147), Expect = 2e-12
Identities = 21/72 (29%), Positives = 35/72 (48%)
Query: 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNY 767
R IP + I E+M++P I G TY+ + I L+ + +P+T L L+PN
Sbjct: 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNL 61
Query: 768 ALHQAIIEWQQR 779
A+ + I +
Sbjct: 62 AMKEVIDAFISE 73
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (124), Expect = 5e-09
Identities = 14/75 (18%), Positives = 23/75 (30%)
Query: 705 KEHRRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLL 764
+ + F+ PI+ +M DP + + T P L +
Sbjct: 14 ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIR 73
Query: 765 PNYALHQAIIEWQQR 779
PN L + I W
Sbjct: 74 PNTELKEKIQRWLAE 88
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (94), Expect = 6e-05
Identities = 12/73 (16%), Positives = 25/73 (34%), Gaps = 2/73 (2%)
Query: 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKS--GHNTSPMTNLKLEHCNLLP 765
+ CPI E++K+P + + L G + P+ + +L
Sbjct: 16 NAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQE 75
Query: 766 NYALHQAIIEWQQ 778
+ Q + E +
Sbjct: 76 STRFSQLVEELLK 88
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} Length = 79 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.4 bits (81), Expect = 0.002
Identities = 10/54 (18%), Positives = 19/54 (35%)
Query: 712 SHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLP 765
+ +C I E KD +I G + W +S P +++ +
Sbjct: 22 TFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPIV 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.83 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.83 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.78 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.76 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.74 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.66 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.49 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.45 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 97.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.11 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 96.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.83 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 95.71 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.34 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 94.59 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 92.86 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 86.97 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 84.94 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=431.40 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCceEEEEeeecCeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEec
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYL 498 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~ 498 (780)
.++|...++||+|+||.||+|.+++ .||||+++.. .......|.+|+.+|++++|||||+++|+|.+. .+|||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 3689999999999999999998765 5999998653 345567899999999999999999999999654 68999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.++|. ....+++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 86 ~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~-- 159 (276)
T d1uwha_ 86 EGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-- 159 (276)
T ss_dssp CEEEHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCC--
Confidence 9999999996 34457999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCcccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchhHH---HHHHhccccccccCcCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVK---CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~---~~~~~~~~~~~ld~~~~ 652 (780)
....+...||+.|||||++.+ +.|+.++|||||||+||||+||+.||...+... ..+..+... +...
T Consensus 160 ---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~~~ 232 (276)
T d1uwha_ 160 ---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CCGG
T ss_pred ---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----Ccch
Confidence 112345689999999999864 458999999999999999999999997654332 222333221 2222
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
..+...+..+.+|+.+||..||.+||++ .+|+..|+.+..+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~-~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHc
Confidence 2334456789999999999999999999 9999999988643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-51 Score=434.89 Aligned_cols=266 Identities=25% Similarity=0.456 Sum_probs=204.1
Q ss_pred ccCHHHHHHHhcCC---------CcccccccCCceEEEEeeecC-----eeEEEEEccCC-CchhHHHHHHHHHHhhcCC
Q 044673 412 EFSFSELNEATNNF---------EPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVR 476 (780)
Q Consensus 412 ~~~~~ei~~at~~f---------~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~ 476 (780)
.||++++.+++.+| ...+.||+|+||.||+|.+.. ..||||.+... .......|.+|+.+|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 35566666666544 445789999999999998742 35899998764 3445567999999999999
Q ss_pred CCceeeEeeeecC--CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEe
Q 044673 477 HPNLVTLIGTCPE--SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLI 554 (780)
Q Consensus 477 HpnIv~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILL 554 (780)
|||||+++|+|.+ ..++||||+++|+|.+++. ...+.++|.+++.|+.||+.||.|||+.+ ||||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEE
Confidence 9999999999954 4689999999999999885 34567999999999999999999999999 9999999999999
Q ss_pred cCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh
Q 044673 555 DANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD 633 (780)
Q Consensus 555 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~ 633 (780)
+.++.+||+|||+++.+...... ..........||+.|||||++.++.++.++|||||||+||||+| |++||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSD--PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp CTTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCCcEEECCcccceEccCCCCc--ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999887543221 11222334568999999999999999999999999999999998 8999976554
Q ss_pred HH--HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 634 VK--CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 634 ~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.. ..+..+ .....|...+..+.+|+.+||+.||.+||++ .+|++.|+++.
T Consensus 240 ~~~~~~i~~~--------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 QDVINAIEQD--------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHH
T ss_pred HHHHHHHHcC--------CCCCCCccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHh
Confidence 32 122221 1222344567789999999999999999999 89999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=421.01 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=200.3
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~Ey~~ 499 (780)
++|...+.||+|+||.||+|.+. +..||||++... ......|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57888999999999999999985 567999999764 3445789999999999999999999999954 4689999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. .....++|..++.|+.||+.||.|||+.+ |+||||||+|||||.++.+||+|||+++.+......
T Consensus 84 ~g~L~~~l~--~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-- 157 (263)
T d1sm2a_ 84 HGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-- 157 (263)
T ss_dssp TCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce--
Confidence 999999985 34567999999999999999999999999 999999999999999999999999999876532211
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 656 (780)
......||+.|+|||++.++.++.++|||||||+||||+| |.+||...+... ..+..+ .....|.
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~--------~~~~~p~ 225 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT--------CCCCCCT
T ss_pred ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc--------CCCCCcc
Confidence 1234578999999999999999999999999999999999 566666544322 112221 1222344
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+..+.+|+.+||+.||.+||++ ++|++.|+.+..
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~-~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAF-SRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHHh
Confidence 556789999999999999999999 999999998853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=422.60 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=208.1
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~ 500 (780)
++|...++||+|+||.||+|.++ +..||||++.... .....|.+|+.+|++++|||||+++|+|.+. .++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 57888899999999999999986 5789999997643 4456799999999999999999999999654 6799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|.+++... ...+++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~----- 163 (272)
T d1qpca_ 92 GSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----- 163 (272)
T ss_dssp CBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-----
T ss_pred CcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCc-----
Confidence 9999987532 2345999999999999999999999999 9999999999999999999999999998875322
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCccchhHH--HHHHhccccccccCcCCCCCHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG-RPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVA 657 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 657 (780)
....+...||+.|+|||++.++.++.++|||||||+||||+|| .+|+...+... ..+..+ .....|..
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--------~~~~~p~~ 234 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVRPDN 234 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCTT
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------CCCCCccc
Confidence 1223456789999999999999999999999999999999995 55555443322 112211 12223445
Q ss_pred HHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 658 EAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 658 ~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
.+..+.+|+.+||+.||.+||++ ++|++.|+.+-
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~-~ei~~~L~~~f 268 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFF 268 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhhhh
Confidence 56789999999999999999999 99999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=420.86 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=209.3
Q ss_pred cCCCccc-ccccCCceEEEEeeec----CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEE
Q 044673 423 NNFEPSW-KIGEGRYGNVYRGLLR----HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~-~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~ 495 (780)
++|.... +||+|+||.||+|.++ +..||||+++... ......|.+|+.+|++++|||||+++|+|.+ ..+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 3455555 4999999999999774 3469999997643 3445789999999999999999999999964 467999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. .....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 88 E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999884 34467999999999999999999999999 9999999999999999999999999998875432
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~ 652 (780)
. .........||+.|+|||++.++.++.++|||||||+||||+| |++||...+... ..+..+. ..
T Consensus 164 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------~~ 231 (285)
T d1u59a_ 164 S----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RM 231 (285)
T ss_dssp C----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------CC
T ss_pred c----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 1 1222345678999999999999999999999999999999998 999997655432 2223222 23
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..|...+..+.+|+.+||..+|.+||++ .+|.+.|+.+.
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~-~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACY 270 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 3455567789999999999999999999 88999888763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-49 Score=420.05 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=208.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...++||+|+||.||+|.+. +..||||+++... ....+|.+|+.+|++++|||||+++|+|.+. .++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 367888999999999999999985 6789999997643 4467899999999999999999999999654 6799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+++|+|.++|.. .....++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred ccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 999999999863 34567999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCC-ccchhHH--HHHHhccccccccCcCCCC
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVL-RIKKDVK--CALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~-~~~~~~~--~~~~~~~~~~~ld~~~~~~ 654 (780)
...+...||+.|+|||++.++.|+.++|||||||++|||+||..|+ ...+... ..+..+ .....
T Consensus 171 -----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------~~~~~ 237 (287)
T d1opja_ 171 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRMER 237 (287)
T ss_dssp -----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------CCCCC
T ss_pred -----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------CCCCC
Confidence 1223446888999999999999999999999999999999966554 4333211 122221 12233
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
|...+..+.+|+.+||+.||.+||++ .+|++.|+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~-~ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTT
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 44566789999999999999999999 89999898763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=416.07 Aligned_cols=245 Identities=24% Similarity=0.414 Sum_probs=200.9
Q ss_pred cccccCCceEEEEeeec----CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC-CCeeEEEeccCC
Q 044673 429 WKIGEGRYGNVYRGLLR----HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-SRSLVFEYLRNG 501 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~----~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-~~~LV~Ey~~~g 501 (780)
++||+|+||.||+|.++ +..||||+++.. .......|.+|+.+|++++|||||+++|+|.+ ..+|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999874 256999998653 23345679999999999999999999999965 467999999999
Q ss_pred ChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCCc
Q 044673 502 SLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNSA 581 (780)
Q Consensus 502 sL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~ 581 (780)
+|.+++. ...+++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..... .
T Consensus 93 ~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~----~ 163 (277)
T d1xbba_ 93 PLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN----Y 163 (277)
T ss_dssp EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----E
T ss_pred cHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccc----c
Confidence 9999985 3457999999999999999999999999 99999999999999999999999999987753321 1
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH--HHHHhccccccccCcCCCCCHHH
Q 044673 582 LCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK--CALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 582 ~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
........||+.|+|||++.++.++.++|||||||++|||+| |++||...+... ..+..+ .....|...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--------~~~~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCccc
Confidence 122345678999999999999999999999999999999998 899997654432 222222 123344556
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
+..+.+|+.+||+.||.+||++ .+|...|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~-~~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhCH
Confidence 6789999999999999999999 8898888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=414.75 Aligned_cols=256 Identities=23% Similarity=0.436 Sum_probs=200.6
Q ss_pred cCCCcccccccCCceEEEEeeecC------eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~L 493 (780)
+.|+..+.||+|+||.||+|.+++ ..||||++.... ......|.+|+.+|++++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 467888999999999999998753 369999987543 3345679999999999999999999999965 3578
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+.+|+|.+++. .....++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHH--HTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhh--cccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999875 34467999999999999999999999999 99999999999999999999999999987753
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCC-CCCccchhHHHHHHhccccccccCcCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~-~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
.... ........||+.|+|||++.++.++.++|||||||+||||+||. +|+...+... .+. .+.+....
T Consensus 163 ~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~-----~i~~~~~~ 232 (283)
T d1mqba_ 163 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMK-----AINDGFRL 232 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH-----HHHTTCCC
T ss_pred CCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHH-----HHhccCCC
Confidence 3211 11233457899999999999999999999999999999999964 5554333221 111 11122233
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..|...+..+.+|+.+||+.||.+||++ .+|++.|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~-~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIR 272 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCH-HHHHHHHHHHhh
Confidence 3455566789999999999999999999 899999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=416.27 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=204.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
++|...++||+|+||.||+|... +..||||++..........|.+|+.+|++++|||||+++++|.+. .+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999875 788999998765555567899999999999999999999998544 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.. .++++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence 99999998742 36999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCCHHH
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAE 658 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 658 (780)
......||+.|+|||++.++.|+.++|||||||+||+|+||++||...+............ ......|...
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~ 242 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNPEKL 242 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC----SCCCSSGGGS
T ss_pred -----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----CCCCCCcccC
Confidence 2345689999999999999999999999999999999999999997665443222111000 0111234456
Q ss_pred HHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 659 AEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 659 ~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+..+.+|+.+||+.||.+||++ .+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~-~eil 268 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSA-KELL 268 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCH-HHHT
T ss_pred CHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 7789999999999999999999 6663
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=416.06 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=195.3
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC----CCeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE----SRSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~----~~~LV 494 (780)
++|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||+++++|.+ ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999875 6789999987543 3345679999999999999999999998843 24799
Q ss_pred EEeccCCChhhHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---ccccCCCCCCceEecCCCCccccccccccc
Q 044673 495 FEYLRNGSLEDCLACK-NKKSPLRWQTRMQIASDVCSALIYLHSNEP---CIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~---~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
|||+++|+|.+++... .....+++..++.|+.||+.||.|||+.++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 245679999999999999999999998652 499999999999999999999999999988
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHH--HHHhcccccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKC--ALEKRNFNSVLD 648 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~--~~~~~~~~~~ld 648 (780)
+..... ......||+.|+|||++.+..|+.++|||||||+||||+||++||...+.... .+..+.+
T Consensus 164 ~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~----- 231 (269)
T d2java1 164 LNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----- 231 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred cccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 753221 12456899999999999999999999999999999999999999986554322 2222222
Q ss_pred CcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 649 SSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 649 ~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...|...+.++.+|+.+||+.||.+||++ .+++
T Consensus 232 ---~~~~~~~s~~l~~li~~~L~~dp~~Rps~-~ell 264 (269)
T d2java1 232 ---RRIPYRYSDELNEIITRMLNLKDYHRPSV-EEIL 264 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred ---CCCCcccCHHHHHHHHHHcCCChhHCcCH-HHHH
Confidence 22344566789999999999999999999 7664
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=411.03 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=202.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|++++|||||++++++.+. .++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 678999998642 123356789999999999999999999999665 56999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. ..++++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999963 356999999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.....||+.|+|||++.+..++.++|||||||+||+|+||++||...+......... .....+|
T Consensus 161 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~~p 224 (263)
T d2j4za1 161 ---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------RVEFTFP 224 (263)
T ss_dssp ---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTCCCCC
T ss_pred ---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCCC
Confidence 234579999999999999999999999999999999999999998655433221111 1112334
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+|+.+||+.||.+||++ .++++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~-~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPML-REVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCH-HHHHc
Confidence 4566789999999999999999999 77753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=405.05 Aligned_cols=247 Identities=24% Similarity=0.420 Sum_probs=208.5
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~~ 499 (780)
++|...++||+|+||+||+|.++ +..||||+++... .....|.+|+.++++++|||||+++|+|.+. .++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999996 5689999998643 3456899999999999999999999999654 578999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.+++. .....+++..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~g~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--- 155 (258)
T d1k2pa_ 83 NGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--- 155 (258)
T ss_dssp TEEHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC---
T ss_pred CCcHHHhhh--ccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCc---
Confidence 999999975 34457899999999999999999999999 99999999999999999999999999987653221
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHH--HHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCA--LEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 656 (780)
.......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+..... +..+ .....|.
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 224 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRLYRPH 224 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT--------CCCCCCT
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC--------CCCCCcc
Confidence 12344679999999999999999999999999999999998 89999866543322 2221 1222344
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
..+..+.+|+.+||+.||.+||++ ++++..|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~-~eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTF-KILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCH-HHHHHHhh
Confidence 556789999999999999999999 88988775
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=412.47 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=197.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|++++|||||++++++.+. .+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999985 6789999986543 23345689999999999999999999999654 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+++|+|.++|. ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999984 4567999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
....+..+||+.|||||++.+..+ +.++|||||||+||+|+||++||................ ......+
T Consensus 159 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 229 (271)
T d1nvra_ 159 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPW 229 (271)
T ss_dssp -----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT----CTTSTTG
T ss_pred -----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCcc
Confidence 112345789999999999988776 578999999999999999999997544321111110000 0011111
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...+..+.+|+.+||+.||.+||++ .++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~-~ei 257 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITI-PDI 257 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 2345678899999999999999999 666
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=414.92 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=202.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
+.|+..+.||+|+||.||+|.+. +..||||++..........|.+|+.+|++++|||||+++++|.+. .+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999985 578999999876667777899999999999999999999998544 57999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++.. ...++++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 99999998853 2356999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCcccccCCCCCCcccCChhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcC
Q 044673 579 NSALCNESNNDSASVYIDPEYLE-----TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
........||+.|+|||++. ...|+.++|||||||+||+|+||++||...+..... +..+.. ..
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~------~~ 234 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------PT 234 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC------CC
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------CC
Confidence 11234568999999999984 456899999999999999999999999765543322 112211 11
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
...|...+..+.+|+.+||+.||.+||++ .++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~-~el 266 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTT-SQL 266 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 22344566789999999999999999999 665
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=408.18 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=202.2
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCeeEEEecc
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSLVFEYLR 499 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~LV~Ey~~ 499 (780)
++|...+.||+|+||.||+|.++++.||||+++.. .....|.+|+.+|++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 56788899999999999999999999999999764 345679999999999999999999999843 3579999999
Q ss_pred CCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCC
Q 044673 500 NGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGN 579 (780)
Q Consensus 500 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~ 579 (780)
+|+|.++|... ...+++|..+++|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 99999999643 2345899999999999999999999999 999999999999999999999999999865422
Q ss_pred CcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcCCCCCH
Q 044673 580 SALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSAGDWPV 656 (780)
Q Consensus 580 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~~~~p~ 656 (780)
.....+|..|+|||++.++.+++++|||||||++|||+| |++||...+.. ...+..+ .....|.
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------~~~~~~~ 223 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCCCT
T ss_pred -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------CCCCCCc
Confidence 123467889999999999999999999999999999998 78888754432 2222222 2233444
Q ss_pred HHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 657 AEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 657 ~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
..+..+.+|+.+||..||.+||++ .++++.|+.++.
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~-~~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKT 259 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHh
Confidence 556789999999999999999999 899999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=419.88 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=203.4
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--R 491 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~ 491 (780)
++|...+.||+|+||.||+|.+.+ ..||||.+... .......|.+|+.+|.++ +|||||+++|+|.+. .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 678889999999999999998753 35999998653 334456799999999998 899999999999554 6
Q ss_pred eeEEEeccCCChhhHHhhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCc
Q 044673 492 SLVFEYLRNGSLEDCLACKNK--------------------KSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSK 551 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~N 551 (780)
+|||||+++|+|.++|..... ..+++|..++.|+.||+.||.|||+.+ ||||||||+|
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~N 194 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARN 194 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhc
Confidence 799999999999999964321 246999999999999999999999999 9999999999
Q ss_pred eEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCcc
Q 044673 552 VLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRI 630 (780)
Q Consensus 552 ILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~ 630 (780)
||++.++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||+||||+| |++||..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999987653221 112234568999999999999999999999999999999998 8999975
Q ss_pred chhH---HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHH
Q 044673 631 KKDV---KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLE 689 (780)
Q Consensus 631 ~~~~---~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~ 689 (780)
.+.. ...+..+ ...+.|...+..+.+|+.+||+.||.+||++ ++|++.|.
T Consensus 270 ~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLG 322 (325)
T ss_dssp CCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHH
T ss_pred CCHHHHHHHHHhcC--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHh
Confidence 4432 2222221 1223445567789999999999999999999 89988885
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=410.37 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=201.7
Q ss_pred cCCCcccccccCCceEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEEEeccC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVFEYLRN 500 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~Ey~~~ 500 (780)
++|.....||+|+||.||+|.+++ ..||||++... ......|.+|+.++++++|||||+++|+|.+. .++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 678999999999999999999865 57999999754 34567899999999999999999999999654 6799999999
Q ss_pred CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCCCC
Q 044673 501 GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTGNS 580 (780)
Q Consensus 501 gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~ 580 (780)
|+|..++... ....++|..++.|+.||+.||.|||+.+ |+||||||+|||||.++.+||+|||+++.+.....
T Consensus 96 g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~---- 168 (285)
T d1fmka3 96 GSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---- 168 (285)
T ss_dssp CBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred Cchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCc----
Confidence 9999988643 2346999999999999999999999999 99999999999999999999999999987653221
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCC-CCCccchhHHHHHHhccccccccCcCCCCCHHHH
Q 044673 581 ALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVLRIKKDVKCALEKRNFNSVLDSSAGDWPVAEA 659 (780)
Q Consensus 581 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~-~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 659 (780)
...+...||+.|+|||++..+.++.++|||||||+||||+||. +|+..... ...+..- ........|...+
T Consensus 169 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i-----~~~~~~~~~~~~~ 240 (285)
T d1fmka3 169 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV-----ERGYRMPCPPECP 240 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH-----HTTCCCCCCTTSC
T ss_pred --eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH-----HhcCCCCCCcccC
Confidence 1234467899999999999999999999999999999999965 44443332 2221110 0111122344566
Q ss_pred HHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 660 EQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 660 ~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+.+|+.+||+.||.+||++ ++|+..|+...
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~~~ 272 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTTT
T ss_pred HHHHHHHHHHcccCHhHCcCH-HHHHHHHhhhh
Confidence 789999999999999999999 89999888653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=406.83 Aligned_cols=242 Identities=21% Similarity=0.360 Sum_probs=193.8
Q ss_pred CcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC------CCeeEE
Q 044673 426 EPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------SRSLVF 495 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~~~LV~ 495 (780)
....+||+|+||+||+|.+. +..||+|.+... .......|.+|+++|++++|||||+++++|.+ ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999985 567999988643 33445679999999999999999999999843 247999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec-CCCCcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID-ANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd-~~~~~Kl~DFGla~~~~~~ 574 (780)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999963 3579999999999999999999999988899999999999996 5789999999999865322
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDW 654 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~ 654 (780)
. .....||+.|+|||++.+ .++.++|||||||+||||+||++||............-. .. .. ...+
T Consensus 169 ~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~-~~-~~--~~~~ 234 (270)
T d1t4ha_ 169 F---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SG-VK--PASF 234 (270)
T ss_dssp S---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-TT-CC--CGGG
T ss_pred c---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH-cC-CC--Cccc
Confidence 1 134579999999999865 699999999999999999999999975544333222110 00 00 1112
Q ss_pred CHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 655 PVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 655 p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+...+.++.+|+.+||+.||.+||++ .+++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~-~ell 264 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSI-KDLL 264 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCH-HHHh
Confidence 22345568999999999999999999 7764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-48 Score=412.94 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=210.3
Q ss_pred HhcCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCCch-hHHHHHHHHHHhhcCCCCceeeEeeeecC--C
Q 044673 421 ATNNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYGPQ-SHLKFQNEVEVLSRVRHPNLVTLIGTCPE--S 490 (780)
Q Consensus 421 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~~~-~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~ 490 (780)
..++|...+.||+|+||+||+|.+.+ ..||||++...... ....|.+|+.+|++++||||++++++|.+ .
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 35789999999999999999998753 57999999764433 45679999999999999999999999965 4
Q ss_pred CeeEEEeccCCChhhHHhhhC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCC
Q 044673 491 RSLVFEYLRNGSLEDCLACKN---------------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKP 549 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp 549 (780)
.++||||+++|+|.++|.... ....++|..++.|+.|++.||.|||+.+ ||||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp 168 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLAT 168 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcc
Confidence 679999999999999996422 2345899999999999999999999999 99999999
Q ss_pred CceEecCCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCC-CCC
Q 044673 550 SKVLIDANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVL 628 (780)
Q Consensus 550 ~NILLd~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~-~p~ 628 (780)
+|||||.++.+||+|||+|+.+..... ....+...||+.|+|||++.+..|++++|||||||+||||+||. +||
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999987643221 11234567889999999999999999999999999999999985 678
Q ss_pred ccchhHHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 629 RIKKDVKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
...+....... +.+......|...+.++.+|+.+||+.+|.+||++ .+|++.|+++
T Consensus 244 ~~~~~~e~~~~------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~-~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVIYY------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRM 299 (301)
T ss_dssp TTSCHHHHHHH------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHT
T ss_pred CCCCHHHHHHH------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHh
Confidence 76554432211 11222233455566789999999999999999999 8999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=412.76 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=206.8
Q ss_pred cCCCcccccccCCceEEEEeeecC------eeEEEEEccC-CCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH------LHVAIKMFPS-YGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~VAiK~l~~-~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV 494 (780)
.+|+..+.||+|+||.||+|.+.. ..||||.+.. ........|.+|+.+|++++|||||+++|+|.+. .+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 469999999999999999998742 2599998865 3345567899999999999999999999999665 5789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
+||+.+|+|.+++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 89 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 999999999998853 4567999999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchh--HHHHHHhccccccccCcC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKD--VKCALEKRNFNSVLDSSA 651 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~--~~~~~~~~~~~~~ld~~~ 651 (780)
... .......||+.|+|||++.++.++.++|||||||+||||+| |.+||...+. +...+..+. .
T Consensus 165 ~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~--------~ 231 (317)
T d1xkka_ 165 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------R 231 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------C
T ss_pred ccc-----ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 221 12234568999999999999999999999999999999999 7899975432 233333221 2
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...|...+..+.+|+.+||..||.+||++ .+|+..|+.+.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMA 271 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCH-HHHHHHHHHHH
Confidence 23344566789999999999999999999 89999888874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=404.31 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=198.8
Q ss_pred cCCCcccccccCCceEEEEeeecC-----eeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC-CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~LV~ 495 (780)
++|...+.||+|+||.||+|.+.. ..||||.+.... ......|.+|+.+|++++|||||+++|+|.+. .++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 578889999999999999998742 458999987543 33456799999999999999999999999654 67999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++. ....++++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 E~~~~g~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 87 ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp ECCTTEEHHHHHH--HTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EeccCCcHHhhhh--ccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999875 34567999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH--HHHHHhccccccccCcCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV--KCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~--~~~~~~~~~~~~ld~~~~ 652 (780)
. ...+...||+.|+|||++.++.++.++|||||||+||||+| |.+||...+.. ...+..+. ..
T Consensus 163 ~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------~~ 228 (273)
T d1mp8a_ 163 Y------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------RL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------CC
T ss_pred c------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 1 12345678999999999999999999999999999999998 89999755432 22222221 22
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..|...+..+.+|+.+||..||.+||++ .+|++.|+.+.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~-~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTIL 267 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 3344566789999999999999999999 89999998774
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=416.03 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=199.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.++|...++||+|+||.||+|... +..||||+++.. .......+.+|+.+|++++|||||+++++|.+. .+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999975 678999998754 334456799999999999999999999999655 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+ ++ |+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999963 3469999999999999999999997 58 999999999999999999999999999876421
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH-----hcccc------
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE-----KRNFN------ 644 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~-----~~~~~------ 644 (780)
..+..+||+.|+|||++.+..|++++|||||||++|||+||+.||...+....... .+...
T Consensus 159 --------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 159 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp --------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred --------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 12346899999999999999999999999999999999999999965432111100 00000
Q ss_pred -------------------------ccccCcCCCCC-HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 645 -------------------------SVLDSSAGDWP-VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 645 -------------------------~~ld~~~~~~p-~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+........| ...+.++.+|+.+||..||.+|||+ .++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-~e~L~ 297 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-KQLMV 297 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-HHHhh
Confidence 00000000011 1234678999999999999999999 77764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=410.03 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=186.7
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc-hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP-QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
.+.|...+.||+|+||+||+|... +..||||++..... .....|.+|+.+|++++|||||++++++.+. .+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999885 67899999875432 2345688999999999999999999999665 579999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec---CCCCcccccccccccccC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID---ANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd---~~~~~Kl~DFGla~~~~~ 573 (780)
|++||+|.++|. ...++++..+..|+.||+.||.|||+.+ ||||||||+|||+. .++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999995 4567999999999999999999999999 99999999999994 578999999999987643
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSA 651 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~ 651 (780)
.. ......||+.|+|||++.++.|+.++|||||||+||+|+||++||......... +..+... . .
T Consensus 163 ~~--------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~---~ 229 (307)
T d1a06a_ 163 GS--------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--F---D 229 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--C---C
T ss_pred CC--------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--C---C
Confidence 22 123467999999999999999999999999999999999999999765543322 2222111 1 1
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~eil 262 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTC-EQAL 262 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCH-HHHh
Confidence 11223456779999999999999999999 6664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=407.97 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=201.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|++++|||||+++++|.+. .++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 678999998642 123346789999999999999999999999654 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+++|+|.+++.. .+++++..+..|+.|++.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999998863 356999999999999999999999999 9999999999999999999999999998875322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.. .......||+.|+|||++.+..|+.++|||||||+||+|+||++||...+........ + .....+|
T Consensus 163 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~-~~~~~~p 230 (288)
T d1uu3a_ 163 KQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------I-KLEYDFP 230 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-TTCCCCC
T ss_pred cc-----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------H-cCCCCCC
Confidence 11 1234567999999999999999999999999999999999999999866543322111 0 0112344
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
...+..+.+|+.+||+.||.+||++ ++++.
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~-~e~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGC-EEMEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTS-GGGTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCH-HHHcC
Confidence 5567789999999999999999998 66644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=408.88 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=196.6
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc---hhHHHHHHHHHHhhcCCCCceeeEeeeecC--CCeeEEE
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP---QSHLKFQNEVEVLSRVRHPNLVTLIGTCPE--SRSLVFE 496 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~---~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~--~~~LV~E 496 (780)
.|+..+.||+|+||.||+|... +..||||++..... .....|.+|+.+|++++|||||+++++|.+ ..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999874 67899999876432 234568999999999999999999999954 3679999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
||++|+|..++. ...++++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 999999987664 3457999999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCcccccCCCCCCcccCChhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH--hccccccccCcC
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLET---GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE--KRNFNSVLDSSA 651 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~--~~~~~~~ld~~~ 651 (780)
.....||+.|||||++.+ +.|+.++|||||||++|||+||++||...+....... .+....
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~------ 233 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------ 233 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 134579999999999864 4689999999999999999999999976554432221 111111
Q ss_pred CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 652 GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 652 ~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
..+...+..+.+|+.+||+.||.+||++ .++++
T Consensus 234 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~ell~ 266 (309)
T d1u5ra_ 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTS-EVLLK 266 (309)
T ss_dssp -CSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHTT
T ss_pred -CCCCCCCHHHHHHHHHHCcCChhHCcCH-HHHHh
Confidence 1122345679999999999999999999 77743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-47 Score=412.37 Aligned_cols=247 Identities=20% Similarity=0.323 Sum_probs=205.1
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||||++..........|.+|+.+|++++|||||+++++|.+. .+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999875 788999999876666677899999999999999999999998554 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec--CCCCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID--ANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd--~~~~~Kl~DFGla~~~~~~~ 575 (780)
|+||+|.+++. ....++++..+..|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHT--CTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999985 34457999999999999999999999999 99999999999995 46889999999998775322
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
. .....||+.|||||++.+..++.++|||||||++|+|+||++||...+..... +..+... .+ ..
T Consensus 181 ~--------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~---~~ 247 (350)
T d1koaa2 181 S--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MD---DS 247 (350)
T ss_dssp C--------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SC---CG
T ss_pred c--------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC---cc
Confidence 1 23457899999999999999999999999999999999999999865543322 1222111 11 11
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.+...+..+.+|+.+||..||.+||++ .+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~-~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTI-HQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCH-HHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 112345678999999999999999999 66643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=402.10 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=199.5
Q ss_pred cCCCcccccccCCceEEEEeeecC-----eeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-Cee
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES-RSL 493 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~-~~L 493 (780)
++|+..+.||+|+||.||+|.+++ ..||||++... .......|.+|+.+|++++|||||+++|+|.+. .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 578889999999999999998742 36999998753 234456799999999999999999999999665 579
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccC
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQ 573 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~ 573 (780)
||||+++|+|.+++.. ...++++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999998864 3456999999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHHHHHHhccccccccCcCC
Q 044673 574 GESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVKCALEKRNFNSVLDSSAG 652 (780)
Q Consensus 574 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~~~~~~~~~~~~ld~~~~ 652 (780)
... .........||..|+|||++.+..++.++|||||||++|||+| |++||...+..........- ....
T Consensus 164 ~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-----~~~~ 234 (273)
T d1u46a_ 164 NDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----GERL 234 (273)
T ss_dssp -CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----CCCC
T ss_pred CCC----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----CCCC
Confidence 321 1122345568889999999999999999999999999999998 89999766554332111110 1112
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
..|...+..+.+|+.+||..||.+||++ .+|.+.|+..
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~-~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEA 272 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhc
Confidence 2333455779999999999999999999 8999888764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-46 Score=409.42 Aligned_cols=246 Identities=17% Similarity=0.327 Sum_probs=205.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||||++..........+.+|+.+|++++|||||+++++|.+. .+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999874 678999999876666677889999999999999999999999655 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec--CCCCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID--ANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd--~~~~~Kl~DFGla~~~~~~~ 575 (780)
+++|+|.+++. ....++++..++.|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999998874 34457999999999999999999999999 99999999999998 57899999999998875332
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
......||+.|+|||++.+..++.++|||||||+||+|+||++||...+..... +..+.+. . ...
T Consensus 184 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~---~~~ 250 (352)
T d1koba_ 184 --------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--F---DED 250 (352)
T ss_dssp --------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--C---CSS
T ss_pred --------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--C---Ccc
Confidence 123457899999999999999999999999999999999999999866554322 2222211 1 111
Q ss_pred CCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 654 WPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 654 ~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~-~eil 281 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTV-HDAL 281 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 223456778999999999999999999 6664
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=400.89 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=203.7
Q ss_pred ccccccCCceEEEEeeecC-----eeEEEEEccCC-CchhHHHHHHHHHHhhcCCCCceeeEeeeecC---CCeeEEEec
Q 044673 428 SWKIGEGRYGNVYRGLLRH-----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE---SRSLVFEYL 498 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~~-----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~---~~~LV~Ey~ 498 (780)
.++||+|+||+||+|.+.+ ..||||+++.. .......|.+|+++|++++|||||+++|+|.+ ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3579999999999998742 35999999753 44456789999999999999999999999843 257999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
++|+|.+++. .....+++..+++|+.|++.||.|||+.+ |+||||||+|||||+++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 9999999986 45567889999999999999999999999 999999999999999999999999999887543221
Q ss_pred CCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH---HHHHHhccccccccCcCCCCC
Q 044673 579 NSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV---KCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~---~~~~~~~~~~~~ld~~~~~~p 655 (780)
.........||+.|+|||++.++.++.++|||||||+||||+||..||...... ...+..+. ....|
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--------~~~~p 256 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 256 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--------CCCCC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCCCc
Confidence 122234567899999999999999999999999999999999977666533221 11222221 22234
Q ss_pred HHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHhc
Q 044673 656 VAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRVS 694 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~~ 694 (780)
...+..+.+|+.+||..||.+||++ .+|++.|+.+...
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHh
Confidence 4456779999999999999999999 9999999999654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=401.17 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=198.2
Q ss_pred cCCCcccccccCCceEEEEeeecC-------eeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecC---C
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH-------LHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE---S 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~---~ 490 (780)
++|...++||+|+||.||+|.+.+ +.||||++.... ......|.+|+.++.++ +|||||.+++++.+ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 678999999999999999998642 469999997543 33456788899888887 68999999999843 3
Q ss_pred CeeEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC
Q 044673 491 RSLVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN 557 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~ 557 (780)
.++||||+++|+|.++|.... ....++|..++.|+.||+.||.|||+.+ ||||||||+||||+.+
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK 170 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCC
Confidence 579999999999999996432 1346999999999999999999999999 9999999999999999
Q ss_pred CCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCccchh---
Q 044673 558 FGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG-RPVLRIKKD--- 633 (780)
Q Consensus 558 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~--- 633 (780)
+.+||+|||+|+....... ....+...||+.|+|||++.++.++.++|||||||++|||+|| .+||...+.
T Consensus 171 ~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp GCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999987643221 1223456899999999999999999999999999999999997 567865432
Q ss_pred HHHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 634 VKCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 634 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
+...+..+. ....|...+..+.+|+.+||+.||.+||++ .++++.|+.+.
T Consensus 246 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-~eil~~L~~il 295 (299)
T d1ywna1 246 FCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred HHHHHhcCC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHH
Confidence 222223222 122334456779999999999999999999 89999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-46 Score=393.65 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhhcCCCCceeeEeeeecCC------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------ 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------ 490 (780)
.++|...+.||+|+||.||+|... +..||||+++... ......|.+|+.+|++++|||||++++++.+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999874 7889999997533 23455799999999999999999999988432
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+|||||++||+|.+++.. .+++++.+++.|+.||+.||.|||+.+ ||||||||+||||+.++..+|+|||++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhh
Confidence 4799999999999998853 357999999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSS 650 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~ 650 (780)
...... .........||+.|+|||++.+..+++++|||||||+||+|+||++||...+..........-.... +.
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-~~ 235 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PS 235 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-GG
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-Cc
Confidence 543221 1123355689999999999999999999999999999999999999998766544332211111110 10
Q ss_pred CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 651 AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 651 ~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
..+...+..+.+|+.+||+.||.+||+.+++++..|.+++
T Consensus 236 --~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 --ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0112345679999999999999999954489998888775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=400.41 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=205.3
Q ss_pred cCCCcccccccCCceEEEEeeecC----eeEEEEEccCC-CchhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH----LHVAIKMFPSY-GPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~----~~VAiK~l~~~-~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||.||+|.+.+ ..||||.+... .......|.+|+.+|+++ +|||||+++|+|.+. .++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999853 25889988653 334556799999999999 799999999999654 5799
Q ss_pred EEeccCCChhhHHhhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcc
Q 044673 495 FEYLRNGSLEDCLACK-------------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSK 561 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~K 561 (780)
|||+++|+|.++|... .....|+|..++.++.||+.||.|||+.+ ||||||||+|||++.++.+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceE
Confidence 9999999999999643 23467999999999999999999999999 99999999999999999999
Q ss_pred cccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCC-CCCccchhHHHHHHh
Q 044673 562 LSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGR-PVLRIKKDVKCALEK 640 (780)
Q Consensus 562 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~-~p~~~~~~~~~~~~~ 640 (780)
|+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||+||. +||...+..... .
T Consensus 168 l~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-~- 237 (309)
T d1fvra_ 168 IADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-E- 237 (309)
T ss_dssp ECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-H-
T ss_pred Eccccccccccccc--------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH-H-
Confidence 99999997654211 113446899999999999999999999999999999999975 677655433221 1
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
.+........|...+..+.+|+.+||+.||.+||++ .+|++.|+.+..
T Consensus 238 ----~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 ----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLE 285 (309)
T ss_dssp ----HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred ----HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 111222334455667889999999999999999999 999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=398.45 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=200.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC------chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--Ce
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG------PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~------~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~ 492 (780)
+.|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|++++|||||+++++|.+. .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999985 6789999985421 12356799999999999999999999999665 47
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC----Cccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF----GSKLSDFGFF 568 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~----~~Kl~DFGla 568 (780)
|||||+++|+|.++|.. ..++++..+..|+.|++.||.|||+.+ ||||||||+|||++.++ .+||+|||+|
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999963 346999999999999999999999999 99999999999998876 4899999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH--Hhcccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL--EKRNFNSV 646 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~--~~~~~~~~ 646 (780)
+.+.... ......||+.|+|||++.+..++.++|||||||+||+|+||++||...+...... ..+....
T Consensus 165 ~~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1jksa_ 165 HKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF- 235 (293)
T ss_dssp EECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-
T ss_pred hhcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-
Confidence 8765322 1245678999999999999999999999999999999999999998665443221 1111110
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
....+...+..+.+|+.+||..||.+||++ .+++
T Consensus 236 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~eil 269 (293)
T d1jksa_ 236 ----EDEYFSNTSALAKDFIRRLLVKDPKKRMTI-QDSL 269 (293)
T ss_dssp ----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred ----CchhcCCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 000112345678999999999999999999 6664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=403.37 Aligned_cols=237 Identities=20% Similarity=0.272 Sum_probs=200.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeE
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV 494 (780)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|++++|||||+++++|.+. .++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999974 678999998642 123456788999999999999999999999765 5789
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999863 356899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~ 652 (780)
.. .....+||+.|+|||++.+..|+.++|||||||+||||+||++||...+..... +..+ ..
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~---------~~ 222 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------EI 222 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CC
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC---------CC
Confidence 21 124568999999999999999999999999999999999999999866543221 1111 12
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcc
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPD 679 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs 679 (780)
.+|...+.++.+|+.+||+.||.+||+
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcc
Confidence 345556778999999999999999996
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=394.09 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=206.1
Q ss_pred cCCCcccccccCCceEEEEeeecC---------eeEEEEEccCCCc-hhHHHHHHHHHHhhcC-CCCceeeEeeeecCC-
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRH---------LHVAIKMFPSYGP-QSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~~-~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~- 490 (780)
++|...+.||+|+||.||+|...+ +.||||+++.... ....+|.+|+..+.++ +|||||+++|+|.+.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999998632 4699999976543 3457899999999998 799999999999654
Q ss_pred -CeeEEEeccCCChhhHHhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC
Q 044673 491 -RSLVFEYLRNGSLEDCLACKN-------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA 556 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~ 556 (780)
.++||||+++|+|.++|.... ....+++.+++.|+.||+.||.|||+.+ ||||||||+|||++.
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTE 170 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecC
Confidence 578999999999999996432 1246999999999999999999999999 999999999999999
Q ss_pred CCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhHH
Q 044673 557 NFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDVK 635 (780)
Q Consensus 557 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~~ 635 (780)
++.+||+|||+++........ .......||+.|+|||++.++.|+.++|||||||+||||+| |.+||...+...
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999877533211 12345678999999999999999999999999999999998 788987554322
Q ss_pred HHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 636 CALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 636 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
. .. .+.+......|...+..+.+|+.+||+.||.+||++ .+|++.|+++.+
T Consensus 246 ~-~~-----~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-~eil~~L~~i~a 296 (299)
T d1fgka_ 246 L-FK-----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVA 296 (299)
T ss_dssp H-HH-----HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred H-HH-----HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHhh
Confidence 1 11 111122233444566789999999999999999999 999999998854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=396.81 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=208.5
Q ss_pred cCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeec--CCCe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCP--ESRS 492 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~--~~~~ 492 (780)
++|...++||+|+||.||+|.+. ++.||||+++... ......|.+|+.++++++|||||+++|+|. +..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67888899999999999999875 3679999997543 344567999999999999999999999995 4468
Q ss_pred eEEEeccCCChhhHHhhh-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccc
Q 044673 493 LVFEYLRNGSLEDCLACK-------NKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDF 565 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DF 565 (780)
+||||+++|+|.+++... .....++|..++.|+.+++.||.|||+.+ |+||||||+|||||.++++||+||
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEeec
Confidence 999999999999998642 23356899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCccchhHHHHHHhcccc
Q 044673 566 GFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTG-RPVLRIKKDVKCALEKRNFN 644 (780)
Q Consensus 566 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG-~~p~~~~~~~~~~~~~~~~~ 644 (780)
|+++.+.... .........||+.|+|||.+.++.++.++|||||||+||||+|| .+||...+..... .
T Consensus 178 Gla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~ 246 (308)
T d1p4oa_ 178 GMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------R 246 (308)
T ss_dssp TCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------H
T ss_pred ccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------H
Confidence 9998764322 12223445789999999999999999999999999999999998 4778655443221 1
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHH
Q 044673 645 SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEAL 691 (780)
Q Consensus 645 ~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l 691 (780)
.+.+......|...+..+.+|+.+||+.+|.+||++ .+|++.|+..
T Consensus 247 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEE 292 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGG
T ss_pred HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHh
Confidence 111222233344556789999999999999999999 8998888754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=398.81 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=198.1
Q ss_pred cCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC------CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------~~LV~E 496 (780)
.+|...++||+|+||.||+|.+++..||||++.... .....+..|+..+.+++|||||+++|+|.+. .++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 356677889999999999999999999999986432 1222233455566788999999999999532 479999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCccccCCCCCCceEecCCCCccccccccccc
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSN------EPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
|+++|+|.++|.. .+++|..+++++.+++.||.|||+. .++||||||||+|||||.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999953 3599999999999999999999974 12499999999999999999999999999988
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC------CCCcchhHHHHHHHHHHHHhCCCCCccchhH----------
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG------KLTPESDVYSFGIILLRLLTGRPVLRIKKDV---------- 634 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~---------- 634 (780)
...... ..........||+.|+|||++... .++.++|||||||+||||+||.+||......
T Consensus 158 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 158 HDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 754322 122233457899999999998754 2677999999999999999999887532210
Q ss_pred ---HHHHHhccccccccCcCCC-C-CHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 635 ---KCALEKRNFNSVLDSSAGD-W-PVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 635 ---~~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...+........+++..+. + +......+.+|+.+||..||.+||++ .+|++.|+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~ei~~~L~~i~~ 297 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHH
Confidence 0011111111122222211 1 22455679999999999999999999 999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-46 Score=397.88 Aligned_cols=240 Identities=26% Similarity=0.374 Sum_probs=200.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|...+.||+|+||.||+|... +..||||++... .......|.+|+.+|++++|||||++++++.+. .++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999975 678999998642 123356789999999999999999999999665 57999
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||++||+|..++. ....+++.....++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999885 4456889999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+........ +. ....+|
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~~~~p 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LN-AELRFP 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-CCCCCC
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------Hc-CCCCCC
Confidence 23468999999999999999999999999999999999999999866543322111 00 112234
Q ss_pred HHHHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
...+..+.+++.+||..||.+|| ++ ++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~-~~il 255 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGT-EDVK 255 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTT-HHHH
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhH-HHHH
Confidence 45567799999999999999996 55 5553
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=392.64 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCceEEEEeeec-------CeeEEEEEccCCC-chhHHHHHHHHHHhhcC-CCCceeeEeeeecCC--
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR-------HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPES-- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~~-- 490 (780)
.++|...++||+|+||.||+|.+. ++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999863 3579999997643 34556799999999999 699999999999654
Q ss_pred CeeEEEeccCCChhhHHhhhC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec
Q 044673 491 RSLVFEYLRNGSLEDCLACKN---------------KKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID 555 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd 555 (780)
.++||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+ ||||||||+|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc
Confidence 689999999999999996432 2346999999999999999999999999 99999999999999
Q ss_pred CCCCcccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCccchhH
Q 044673 556 ANFGSKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLT-GRPVLRIKKDV 634 (780)
Q Consensus 556 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLlt-G~~p~~~~~~~ 634 (780)
.++.+||+|||+++....... ....+...||+.|+|||++.++.++.++|||||||+||||+| |.+||...+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987653221 122345688999999999999999999999999999999999 67777544332
Q ss_pred ---HHHHHhccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 635 ---KCALEKRNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 635 ---~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
...+..+. ....|...+..+.+|+.+||+.||.+||++ .+|++.|+++.
T Consensus 255 ~~~~~~i~~~~--------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKMIKEGF--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred HHHHHHHhcCC--------CCCCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhh
Confidence 22222221 112233455779999999999999999999 99999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-45 Score=399.21 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCC---CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY---GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~---~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~ 495 (780)
++|..++.||+|+||.||+|.+. +..||||++... .......+.+|+.+|+.++|||||++++++.+. .++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999875 678999998642 123345788999999999999999999999665 46899
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~ 575 (780)
||+.+|+|.+++.. .+.+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999963 346999999999999999999999999 999999999999999999999999999876422
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccccCcCCCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLDSSAGDWP 655 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld~~~~~~p 655 (780)
.....||+.|||||++.+..++.++|||||||+||+|+||++||...+.......... .....|
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~~~~p 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GKVRFP 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCCCC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc-------CCCCCC
Confidence 1345799999999999999999999999999999999999999987654432211110 111234
Q ss_pred HHHHHHHHHHHHHchhhCCCCCc-----chHHHHH
Q 044673 656 VAEAEQLAHLALRCCENNRLNRP-----DLVSEIW 685 (780)
Q Consensus 656 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~ev~ 685 (780)
...+..+.+|+.+||+.||.+|+ ++ ++++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~-~ell 292 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGV-NDIK 292 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTT-HHHH
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccH-HHHH
Confidence 45567899999999999999995 66 5554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-45 Score=400.37 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=192.8
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHH---HHHHHhhcCCCCceeeEeeeecCC--C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQ---NEVEVLSRVRHPNLVTLIGTCPES--R 491 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~---~Ev~il~~l~HpnIv~l~g~~~~~--~ 491 (780)
.++|...+.||+|+||.||+|... +..||||++.... ......+. .++.+++.++|||||+++++|.+. .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999885 6789999985321 11122333 457788888999999999999654 5
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLI 571 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~ 571 (780)
++||||+++|+|.++|.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 799999999999999963 356889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhH-HHHHHhccccccccC
Q 044673 572 PQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDV-KCALEKRNFNSVLDS 649 (780)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~-~~~~~~~~~~~~ld~ 649 (780)
.... .....||+.|+|||++..+ .|++++|||||||+||+|+||++||...+.. ...+.... ..
T Consensus 158 ~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~~ 223 (364)
T d1omwa3 158 SKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LT 223 (364)
T ss_dssp SSSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-----SS
T ss_pred CCCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----cc
Confidence 5321 2346799999999999754 6899999999999999999999999754321 11111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
....+|...+..+.+|+.+||+.||.+||+.
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 1223344566789999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.7e-45 Score=382.61 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=200.2
Q ss_pred cCCCcccccccCCceEEEEeee--cCeeEEEEEccCCCch---------hHHHHHHHHHHhhcCC-CCceeeEeeeecCC
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL--RHLHVAIKMFPSYGPQ---------SHLKFQNEVEVLSRVR-HPNLVTLIGTCPES 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~VAiK~l~~~~~~---------~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~~ 490 (780)
++|...+.||+|+||+||+|.. .+..||||++...... ....+.+|+.+|++++ |||||+++++|.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999987 4688999998653211 1235889999999997 99999999999765
Q ss_pred --CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccc
Q 044673 491 --RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFF 568 (780)
Q Consensus 491 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla 568 (780)
.+|||||+++|+|.++|.. .+++++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhe
Confidence 4799999999999999963 357999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHh
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLET------GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEK 640 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~ 640 (780)
+.+.... ..+...||+.|+|||++.+ ..++.++|||||||+||+|+||++||...+..... +..
T Consensus 158 ~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 158 CQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp EECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 8775322 1245679999999999863 34788999999999999999999999876643321 222
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 641 RNFNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 641 ~~~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+.... ....+...+.++.+|+.+||+.+|.+||++ .+++
T Consensus 230 ~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~-~eil 268 (277)
T d1phka_ 230 GNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-EEAL 268 (277)
T ss_dssp TCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-HHHT
T ss_pred CCCCC-----CCcccccCCHHHHHHHHHHccCChhHCcCH-HHHH
Confidence 22210 111123456789999999999999999999 6663
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=393.04 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=194.6
Q ss_pred hcCCCccc-ccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcC-CCCceeeEeeeecC------CC
Q 044673 422 TNNFEPSW-KIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRV-RHPNLVTLIGTCPE------SR 491 (780)
Q Consensus 422 t~~f~~~~-~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l-~HpnIv~l~g~~~~------~~ 491 (780)
.++|.+.. .||+|+||.||+|... +..||||++.. ...+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898775 5999999999999874 67899999864 24577899987655 89999999998843 25
Q ss_pred eeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC---CCCccccccccc
Q 044673 492 SLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA---NFGSKLSDFGFF 568 (780)
Q Consensus 492 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~---~~~~Kl~DFGla 568 (780)
|||||||+||+|.++|... ...++++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccccee
Confidence 7999999999999999632 2357999999999999999999999999 999999999999985 567999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVLD 648 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~ld 648 (780)
+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+....... +...+.
T Consensus 162 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~ 230 (335)
T d2ozaa1 162 KETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIR 230 (335)
T ss_dssp EECCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred eeccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHh
Confidence 87653321 2456799999999999999999999999999999999999999975443221100 000011
Q ss_pred CcCCCCC----HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 649 SSAGDWP----VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 649 ~~~~~~p----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
.....+| ...+..+.+|+.+||+.||.+||++ .+++.
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~eil~ 271 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-TEFMN 271 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-HHHHc
Confidence 1111122 2456789999999999999999999 77754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.00 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=199.5
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC---chhHHHHHHHHHHhh-cCCCCceeeEeeeecCC--CeeE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG---PQSHLKFQNEVEVLS-RVRHPNLVTLIGTCPES--RSLV 494 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~---~~~~~~f~~Ev~il~-~l~HpnIv~l~g~~~~~--~~LV 494 (780)
++|...+.||+|+||+||+|... +..||||+++... ......+..|+.++. .++|||||++++++.+. .++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999984 6889999986421 233456777777765 68999999999999665 5799
Q ss_pred EEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCC
Q 044673 495 FEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 495 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~ 574 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999963 356899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAG 652 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~ 652 (780)
. ...+...||+.|+|||++.++.++.++|||||||++|+|+||++||...+..... +..+ ..
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------~~ 220 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------NP 220 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CC
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CC
Confidence 1 1234568999999999999999999999999999999999999999866543322 2211 12
Q ss_pred CCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 653 DWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 653 ~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.+|...+..+.+|+.+||..||.+||++..++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 34445677899999999999999999983244
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=383.16 Aligned_cols=245 Identities=24% Similarity=0.255 Sum_probs=189.8
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccCCCch-----hHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEec
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQ-----SHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEYL 498 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~-----~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey~ 498 (780)
+++||+|+||+||+|... +..||||++...... ....+.+|+.+|++++|||||+++++|.+. .+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999874 678999998653221 124688999999999999999999999654 67999999
Q ss_pred cCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCCC
Q 044673 499 RNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGESTG 578 (780)
Q Consensus 499 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~~ 578 (780)
.+|++..++ .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 998777665 34567999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccccc--ccc---
Q 044673 579 NSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFNS--VLD--- 648 (780)
Q Consensus 579 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~~--~ld--- 648 (780)
......||+.|+|||++..+ .|+.++|||||||++|||+||.+||...+........ +.... ..+
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 12345799999999998754 5799999999999999999999999876654432110 00000 000
Q ss_pred -------CcCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 649 -------SSAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 649 -------~~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
......+ ...+..+.+|+.+||+.||.+|||+ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-TQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-HHHH
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH-HHHh
Confidence 0011111 1235679999999999999999999 6664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=389.02 Aligned_cols=242 Identities=19% Similarity=0.308 Sum_probs=200.4
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
.++|...+.||+|+||.||+|... +..||||+++... .....+.+|+.+|++++|||||++++++.+. .+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 6789999997653 3455688999999999999999999998544 5799999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC--CCcccccccccccccCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN--FGSKLSDFGFFHLIPQGE 575 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~--~~~Kl~DFGla~~~~~~~ 575 (780)
|+||+|.++|. ....++++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~--~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999995 23457999999999999999999999999 9999999999999854 578999999998764321
Q ss_pred CCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH--HHhccccccccCcCCC
Q 044673 576 STGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA--LEKRNFNSVLDSSAGD 653 (780)
Q Consensus 576 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~--~~~~~~~~~ld~~~~~ 653 (780)
......||+.|+|||.+.+..|+.++|||||||+||+|+||++||...+..... +..+.+ .
T Consensus 159 --------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~---------~ 221 (321)
T d1tkia_ 159 --------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY---------T 221 (321)
T ss_dssp --------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------C
T ss_pred --------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 113356889999999999999999999999999999999999999866543322 111111 1
Q ss_pred CCH----HHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 654 WPV----AEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 654 ~p~----~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+|. ..+.++.+|+.+||..||.+||++ .++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~-~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTA-SEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 121 245678999999999999999999 77764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=378.79 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=194.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|...+.||+|+||+||+|... ++.||||+++... ......|.+|+.+|++++|||||+++++|.+. .++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999875 6789999986532 22356799999999999999999999999654 578999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+.++ +.+++. ......+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~-~~~~~~-~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQD-LKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEE-HHHHHH-HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCc-hhhhhh-hhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99765 444443 234567999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccccccc----
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFNSVL---- 647 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~~~l---- 647 (780)
......||+.|+|||.+.... ++.++|||||||++|+|+||++||...+........ +......
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 224457999999999877665 578999999999999999999999866544322111 1111000
Q ss_pred ---cCcCCCCC-----------HHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 648 ---DSSAGDWP-----------VAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 648 ---d~~~~~~p-----------~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
......++ ...+..+.+|+.+||..||.+||++ .++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-KAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-HHHhC
Confidence 00000000 1234678999999999999999999 77643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=380.01 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=194.8
Q ss_pred hcCCCcccccccCCceEEEEeeec---CeeEEEEEccCC--CchhHHHHHHHHHHhhcC---CCCceeeEeeeecC----
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR---HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRV---RHPNLVTLIGTCPE---- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~---~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l---~HpnIv~l~g~~~~---- 489 (780)
.++|...++||+|+||+||+|.+. +..||||++... .......+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999873 456999998642 122233466788877665 89999999999832
Q ss_pred ---CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 490 ---SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 490 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
..+++|||+.+|++..... .....+++..+..|+.|++.||.|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchh
Confidence 2468999999887765543 45567999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN 642 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~ 642 (780)
+++..... .......||+.|+|||++.+..|+.++|||||||+||||+||++||...+........ +.
T Consensus 162 ~~~~~~~~--------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhccc--------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 98765322 1235678999999999999999999999999999999999999999866544322110 00
Q ss_pred -----c-----------cccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 -----F-----------NSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 -----~-----------~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
+ ..........++...+..+.+|+.+||+.||.+|||+ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-~e~L 291 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSAL 291 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-HHHh
Confidence 0 0000000111233446678999999999999999999 6664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-43 Score=372.65 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=194.6
Q ss_pred cCCCcccccccCCceEEEEeeec-CeeEEEEEccCCCc--hhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR-HLHVAIKMFPSYGP--QSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~VAiK~l~~~~~--~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|...++||+|+||+||+|.+. +..||||++..... .....|.+|+.+|++++|||||+++++|.+. .++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68899999999999999999875 67899999866432 2356799999999999999999999999554 5789999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGEST 577 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~~ 577 (780)
+.++.+..+.. ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 98877777663 4577999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccc--------c
Q 044673 578 GNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNF--------N 644 (780)
Q Consensus 578 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~--------~ 644 (780)
......|++.|+|||.+... .++.++|||||||++|||+||++||...+........ +.. .
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 12344688999999998754 5789999999999999999999999765543321110 000 0
Q ss_pred cc------ccCc-C---CCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 SV------LDSS-A---GDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ~~------ld~~-~---~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.. .... . ...+...+..+.+|+.+||+.||.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-KQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 00 0000 0 01122345678999999999999999999 7775
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=378.55 Aligned_cols=235 Identities=23% Similarity=0.330 Sum_probs=191.7
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCc------hhHHHHHHHHHHhhcCC--CCceeeEeeeecCC--
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGP------QSHLKFQNEVEVLSRVR--HPNLVTLIGTCPES-- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~------~~~~~f~~Ev~il~~l~--HpnIv~l~g~~~~~-- 490 (780)
++|...+.||+|+||.||+|... +..||||++..... ....++.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999985 67899999864211 12234678999999997 89999999999654
Q ss_pred CeeEEEeccC-CChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCC-CCccccccccc
Q 044673 491 RSLVFEYLRN-GSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDAN-FGSKLSDFGFF 568 (780)
Q Consensus 491 ~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~-~~~Kl~DFGla 568 (780)
.++||||+.+ +++.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence 5799999976 677777753 356999999999999999999999999 9999999999999854 78999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCcccCChhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhccccccc
Q 044673 569 HLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKL-TPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFNSVL 647 (780)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~~~l 647 (780)
+..... ..+...||+.|+|||++.+..+ +.++|||||||+||+|+||++||...+.+. .+.
T Consensus 159 ~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----~~~----- 220 (273)
T d1xwsa_ 159 ALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQ----- 220 (273)
T ss_dssp EECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCC-----
T ss_pred eecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----hcc-----
Confidence 875422 1245679999999999987765 567999999999999999999998654321 111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..++...+.++.+|+.+||..||.+||++ .+++
T Consensus 221 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~-~eil 253 (273)
T d1xwsa_ 221 ----VFFRQRVSSECQHLIRWCLALRPSDRPTF-EEIQ 253 (273)
T ss_dssp ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred ----cCCCCCCCHHHHHHHHHHccCCHhHCcCH-HHHh
Confidence 12233456779999999999999999999 6663
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-43 Score=372.32 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=197.4
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeee-c--CCCeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTC-P--ESRSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~-~--~~~~LV~Ey 497 (780)
++|...+.||+|+||.||+|.+. +..||||++.... ....+..|+++++.++|+|+|.+++.| . +..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56999999999999999999875 6789999887543 234578999999999988877666555 2 335689999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEec---CCCCcccccccccccccCC
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLID---ANFGSKLSDFGFFHLIPQG 574 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd---~~~~~Kl~DFGla~~~~~~ 574 (780)
+ +|+|.+.+. .....+++..++.++.|++.||.|||+.+ ||||||||+|||++ .+..+||+|||+|+.+...
T Consensus 85 ~-~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 8 556766664 24457999999999999999999999999 99999999999975 4567999999999987644
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHH-----HhccccccccC
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCAL-----EKRNFNSVLDS 649 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~-----~~~~~~~~ld~ 649 (780)
...............||+.|+|||.+.+..++.++|||||||++|||+||++||.......... ...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 3332222333456789999999999999999999999999999999999999997543321111 01101100011
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHH
Q 044673 650 SAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALR 692 (780)
Q Consensus 650 ~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~ 692 (780)
... ..+.++.+++.+|+..+|.+||++ +++.+.|+.+.
T Consensus 240 ~~~----~~p~~~~~li~~cl~~~p~~RP~~-~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 LCK----GYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLF 277 (299)
T ss_dssp HTT----TSCHHHHHHHHHHHHSCTTCCCCH-HHHHHHHHHHH
T ss_pred hcc----CCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHH
Confidence 111 234678999999999999999999 88888888763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=367.82 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------- 489 (780)
.++|+..++||+|+||+||+|.+. +..||||++... .......+.+|+.+|++++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 678999998653 23345678899999999999999999998733
Q ss_pred --CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccc
Q 044673 490 --SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGF 567 (780)
Q Consensus 490 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGl 567 (780)
..++||||+.++.+.... .....++...+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence 247999999888776554 34567899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH----hcc
Q 044673 568 FHLIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE----KRN 642 (780)
Q Consensus 568 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~----~~~ 642 (780)
++.+...... .........||+.|+|||++.+. .+++++|||||||++|+|+||++||...+....... .+.
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9877533221 11223446799999999998765 689999999999999999999999976554432211 111
Q ss_pred ccccccC-------------c-CCCCCH-------HHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 FNSVLDS-------------S-AGDWPV-------AEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 ~~~~ld~-------------~-~~~~p~-------~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
...-... . ....+. .....+.+|+.+||+.||.+||++ .+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-~elL 303 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-DDAL 303 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-HHHH
Confidence 1100000 0 000111 113467789999999999999999 6664
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=374.46 Aligned_cols=247 Identities=19% Similarity=0.262 Sum_probs=189.9
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecCC-------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------- 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------- 490 (780)
.++|...++||+|+||+||+|... +..||||++... .......+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999875 788999999753 233456789999999999999999999998543
Q ss_pred -CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 491 -RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 491 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.++||||+ +++|..++. ..++++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence 37999999 567777663 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc--
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN-- 642 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~-- 642 (780)
..... .+...||+.|+|||++.+. .++.++|||||||++|+|+||++||...+........ +.
T Consensus 170 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 170 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 76422 2456799999999998764 5689999999999999999999999765543221110 00
Q ss_pred ------------------ccccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHH
Q 044673 643 ------------------FNSVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWS 686 (780)
Q Consensus 643 ------------------~~~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~ 686 (780)
+...........+...+..+.+|+.+||..||.+|||+ .+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~eiL~ 300 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-GEALA 300 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-HHHHH
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-HHHhc
Confidence 00000000001112345678899999999999999999 77754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=375.25 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=194.3
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC-chhHHHHHHHHHHhhcCCCCceeeEeeeecCC------Ce
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG-PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES------RS 492 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~-~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~------~~ 492 (780)
+.+|..+++||+|+||+||+|... +..||||++.... ......+.+|+.+|++++|||||+++++|... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999875 7889999997643 33456789999999999999999999998543 24
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccccc
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIP 572 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~ 572 (780)
++++|+.+|+|.+++.. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 67788889999999952 36999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhc-cCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHhcccc-------
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLE-TGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEKRNFN------- 644 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~~~~~------- 644 (780)
..... ........||+.|+|||++. ...++.++||||+||++|+|+||++||...+............
T Consensus 161 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 32211 12234578999999999985 4567899999999999999999999997554322211100000
Q ss_pred ----------c-c-ccCcCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 645 ----------S-V-LDSSAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 645 ----------~-~-ld~~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
. . ..+.....+ ...+.++.+|+.+||+.||.+||++ .+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-~e~L 293 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-EQAL 293 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 0 0 000001111 1224578999999999999999999 7775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=375.88 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=191.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCceeeEeeeecC------C--Cee
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE------S--RSL 493 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~------~--~~L 493 (780)
+|...++||+|+||+||+|.+. +..||||++..... .+.+|+.+|++++|||||+++++|.. . .+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999985 67899999876432 23479999999999999999998832 1 368
Q ss_pred EEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-Cccccccccccccc
Q 044673 494 VFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIP 572 (780)
Q Consensus 494 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~ 572 (780)
||||+++|.+..+........++++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999987765555544456678999999999999999999999999 99999999999999775 89999999998764
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----cc-----
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLET-GKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RN----- 642 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~----- 642 (780)
... ......||..|+|||.+.+ ..++.++|||||||++|||+||++||...+........ |.
T Consensus 175 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 175 RGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp TTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 322 1234578999999998765 56899999999999999999999999765543221110 00
Q ss_pred -------ccc-cccCc-----CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 643 -------FNS-VLDSS-----AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 643 -------~~~-~ld~~-----~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... .+... ........+..+.+|+.+||..||.+|||+ .+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~L 301 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-LEAC 301 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 000 00000 001122345678999999999999999999 7765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-42 Score=365.50 Aligned_cols=259 Identities=16% Similarity=0.212 Sum_probs=202.2
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCCC-CceeeEeeeecCC--CeeEEEe
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH-PNLVTLIGTCPES--RSLVFEY 497 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H-pnIv~l~g~~~~~--~~LV~Ey 497 (780)
++|.+.++||+|+||.||+|.+. +..||||++.... ....+.+|++++..+.| ||++.+++++.+. .++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 67999999999999999999874 6889999986543 23356789999999975 8999999888554 5789999
Q ss_pred ccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecC-----CCCccccccccccccc
Q 044673 498 LRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDA-----NFGSKLSDFGFFHLIP 572 (780)
Q Consensus 498 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~-----~~~~Kl~DFGla~~~~ 572 (780)
+ +|+|.+++.. ....+++.+++.|+.|++.||.|||+.+ ||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 8 7899998853 3456999999999999999999999999 999999999999974 5679999999999876
Q ss_pred CCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchh---HHH--HHHhccccccc
Q 044673 573 QGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKD---VKC--ALEKRNFNSVL 647 (780)
Q Consensus 573 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~---~~~--~~~~~~~~~~l 647 (780)
.................||+.|||||++.+..++.++|||||||++|||+||+.||..... ... .+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 4433222223334567899999999999999999999999999999999999999964321 111 11111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHHHHHHHHHh
Q 044673 648 DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIWSVLEALRV 693 (780)
Q Consensus 648 d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~~~L~~l~~ 693 (780)
...... .+.++.+++..|+..+|.+||+. +.+.+.|+.+..
T Consensus 238 ~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y-~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 RELCAG----FPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLE 278 (293)
T ss_dssp HHHTTT----SCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHH
T ss_pred HHhcCC----CCHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHHH
Confidence 111122 34568999999999999999998 788888887643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=353.07 Aligned_cols=249 Identities=23% Similarity=0.242 Sum_probs=195.8
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecCC--CeeEEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPES--RSLVFE 496 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~~--~~LV~E 496 (780)
++|+..++||+|+||+||+|.+. +..||||+++... ......+.+|+.+|++++|||||+++++|.+. .++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 5779999986432 33467899999999999999999999999655 568999
Q ss_pred eccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccccccCCCC
Q 044673 497 YLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHLIPQGES 576 (780)
Q Consensus 497 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~~~~~~~ 576 (780)
|+.+++|..++. ....+++..+..++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988775 4567899999999999999999999999 99999999999999999999999999987653321
Q ss_pred CCCCcccccCCCCCCcccCChhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh-----ccc-------
Q 044673 577 TGNSALCNESNNDSASVYIDPEYLETGK-LTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK-----RNF------- 643 (780)
Q Consensus 577 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~-----~~~------- 643 (780)
......+++.|+|||.+.... ++.++|||||||++|||+||+.||.........+.. +..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred -------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 123446778899999987665 689999999999999999999886433222211110 000
Q ss_pred -cccc----------cCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHH
Q 044673 644 -NSVL----------DSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEI 684 (780)
Q Consensus 644 -~~~l----------d~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev 684 (780)
.... .......+...+..+.+|+.+||+.||.+|||+ +++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-~e~ 280 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-EEA 280 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 0000 001112233445678899999999999999999 666
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-41 Score=364.57 Aligned_cols=247 Identities=18% Similarity=0.212 Sum_probs=185.5
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCC--CchhHHHHHHHHHHhhcCCCCceeeEeeeecC--------
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSY--GPQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------- 489 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~--~~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------- 489 (780)
.++|...++||+|+||+||+|.+. +..||||++... .......+.+|+.+|++++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 788999998753 23445678999999999999999999999842
Q ss_pred CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCcccccccccc
Q 044673 490 SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 490 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
..|+||||+.+|.+. .+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhh
Confidence 247999999765554 442 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHH----------
Q 044673 570 LIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALE---------- 639 (780)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~---------- 639 (780)
...... ..+...||+.|+|||++.+..+++++||||+||++++|++|++||...+.......
T Consensus 168 ~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 168 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccccc--------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 664321 22456789999999999999999999999999999999999999975543321110
Q ss_pred --------------hccc-------c----ccccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 640 --------------KRNF-------N----SVLDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 640 --------------~~~~-------~----~~ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
.+.. . ....+.....+...+..+.+|+.+||..||.+|||+ ++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-~elL 309 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DDAL 309 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-HHHh
Confidence 0000 0 000000111123456789999999999999999999 7764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=358.35 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=191.6
Q ss_pred cCCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeecC----CCeeEE
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCPE----SRSLVF 495 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~~----~~~LV~ 495 (780)
++|...++||+|+||+||+|... +..||||+++.. ....+.+|+.+|++++ ||||++++++|.. ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999974 788999998753 3567889999999996 9999999999842 257899
Q ss_pred EeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCC-CcccccccccccccCC
Q 044673 496 EYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANF-GSKLSDFGFFHLIPQG 574 (780)
Q Consensus 496 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~-~~Kl~DFGla~~~~~~ 574 (780)
||+.+|+|..+. ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997754 35999999999999999999999999 99999999999998765 5899999999876533
Q ss_pred CCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHH----------------
Q 044673 575 ESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCA---------------- 637 (780)
Q Consensus 575 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~---------------- 637 (780)
. ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.........
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 2 12456789999999998765 4799999999999999999999999644322111
Q ss_pred HHhcc------ccccccCc---------CCCCCHHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 638 LEKRN------FNSVLDSS---------AGDWPVAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 638 ~~~~~------~~~~ld~~---------~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
..... +...+... ........+.++.+|+.+||..||.+|||+ ++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~e~L 317 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-REAM 317 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 00000 00111000 001112345678999999999999999999 7764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=368.27 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=192.3
Q ss_pred cCCCcccccccCCceEEEEeee-----cCeeEEEEEccCC----CchhHHHHHHHHHHhhcCCC-CceeeEeeeecCC--
Q 044673 423 NNFEPSWKIGEGRYGNVYRGLL-----RHLHVAIKMFPSY----GPQSHLKFQNEVEVLSRVRH-PNLVTLIGTCPES-- 490 (780)
Q Consensus 423 ~~f~~~~~IG~G~~G~Vyk~~~-----~~~~VAiK~l~~~----~~~~~~~f~~Ev~il~~l~H-pnIv~l~g~~~~~-- 490 (780)
++|...++||+|+||.||+|.. .+..||||++... .......+.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999975 2578999998642 12334568899999999976 8999999998544
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.++||||+.+|+|.+++... ..++......++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 57899999999999999633 45678899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCccchhH--HHHHHhcccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG--KLTPESDVYSFGIILLRLLTGRPVLRIKKDV--KCALEKRNFNSV 646 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~--~~~~~~~~~~~~ 646 (780)
+..... .......|++.|++||.+.+. .++.++|||||||+||+|+||++||...+.. ...+..+...
T Consensus 179 ~~~~~~------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-- 250 (322)
T d1vzoa_ 179 FVADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-- 250 (322)
T ss_dssp CCGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred hccccc------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--
Confidence 643221 122345789999999999754 4788999999999999999999999654321 1111111111
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHchhhCCCCCcch
Q 044673 647 LDSSAGDWPVAEAEQLAHLALRCCENNRLNRPDL 680 (780)
Q Consensus 647 ld~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RPs~ 680 (780)
.....|...+..+.+|+.+||+.||.+||++
T Consensus 251 ---~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 251 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ---CCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 1123344667889999999999999999963
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=361.05 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCceEEEEeeec--CeeEEEEEccCCC--chhHHHHHHHHHHhhcCCCCceeeEeeeecC-------C
Q 044673 422 TNNFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYG--PQSHLKFQNEVEVLSRVRHPNLVTLIGTCPE-------S 490 (780)
Q Consensus 422 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~--~~~~~~f~~Ev~il~~l~HpnIv~l~g~~~~-------~ 490 (780)
.++|...++||+|+||+||+|... +..||||++.... ......+.+|+.+|++++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999874 7889999997543 3344578899999999999999999998842 2
Q ss_pred CeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccccccc
Q 044673 491 RSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFGFFHL 570 (780)
Q Consensus 491 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFGla~~ 570 (780)
.+++++|+.+|+|.+++. ..++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcc
Confidence 367889999999999984 346999999999999999999999999 99999999999999999999999999865
Q ss_pred ccCCCCCCCCcccccCCCCCCcccCChhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCccchhHHHHHHh----ccccc
Q 044673 571 IPQGESTGNSALCNESNNDSASVYIDPEYLETG-KLTPESDVYSFGIILLRLLTGRPVLRIKKDVKCALEK----RNFNS 645 (780)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~~~~~~~----~~~~~ 645 (780)
... ......||+.|+|||.+.+. .++.++|||||||++|+|+||++||...+........ +....
T Consensus 171 ~~~----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 171 TDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CTG----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCc----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 432 12446789999999987765 4688999999999999999999999765543221110 00000
Q ss_pred -------------ccc--CcCCCCC-----HHHHHHHHHHHHHchhhCCCCCcchHHHHH
Q 044673 646 -------------VLD--SSAGDWP-----VAEAEQLAHLALRCCENNRLNRPDLVSEIW 685 (780)
Q Consensus 646 -------------~ld--~~~~~~p-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~ev~ 685 (780)
... ......+ ...+..+.+|+.+||..||.+|||+ .+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~elL 299 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-AQAL 299 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-HHHh
Confidence 000 0001111 1235678899999999999999999 6664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-36 Score=329.49 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=189.2
Q ss_pred CCCcccccccCCceEEEEeeec--CeeEEEEEccCCCchhHHHHHHHHHHhhcCC-----------CCceeeEeeeecC-
Q 044673 424 NFEPSWKIGEGRYGNVYRGLLR--HLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-----------HPNLVTLIGTCPE- 489 (780)
Q Consensus 424 ~f~~~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-----------HpnIv~l~g~~~~- 489 (780)
+|...++||+|+||+||+|... +..||||+++... .....+.+|+.+++.++ |||||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4899999999999999999874 7889999997642 33457789999998875 5789999988743
Q ss_pred ---CCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCccccCCCCCCceEecCCCC------
Q 044673 490 ---SRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHS-NEPCIIHGNLKPSKVLIDANFG------ 559 (780)
Q Consensus 490 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~ivHrDlKp~NILLd~~~~------ 559 (780)
..+++|+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccce
Confidence 245778887766655555445667789999999999999999999997 78 999999999999987654
Q ss_pred cccccccccccccCCCCCCCCcccccCCCCCCcccCChhhhccCCCCcchhHHHHHHHHHHHHhCCCCCccchhH-----
Q 044673 560 SKLSDFGFFHLIPQGESTGNSALCNESNNDSASVYIDPEYLETGKLTPESDVYSFGIILLRLLTGRPVLRIKKDV----- 634 (780)
Q Consensus 560 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ksDVwS~Gvil~eLltG~~p~~~~~~~----- 634 (780)
+||+|||.+...... .....||+.|+|||++....+++++|||||||++++|+||++||...+..
T Consensus 171 ~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred eeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 899999998765321 23467999999999999999999999999999999999999998633211
Q ss_pred -HH--------------HHHhccc-cccc-------c-------------CcCCCCCHHHHHHHHHHHHHchhhCCCCCc
Q 044673 635 -KC--------------ALEKRNF-NSVL-------D-------------SSAGDWPVAEAEQLAHLALRCCENNRLNRP 678 (780)
Q Consensus 635 -~~--------------~~~~~~~-~~~l-------d-------------~~~~~~p~~~~~~l~~l~~~Cl~~~p~~RP 678 (780)
.. .+..+.. .... . ......+...+..+.+|+.+||..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 00 0000000 0000 0 011233456788899999999999999999
Q ss_pred chHHHHH
Q 044673 679 DLVSEIW 685 (780)
Q Consensus 679 s~~~ev~ 685 (780)
|+ ++++
T Consensus 321 ta-~e~L 326 (362)
T d1q8ya_ 321 DA-GGLV 326 (362)
T ss_dssp CH-HHHH
T ss_pred CH-HHHh
Confidence 99 7764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.1e-23 Score=203.99 Aligned_cols=163 Identities=15% Similarity=0.164 Sum_probs=120.3
Q ss_pred CcccccccCCceEEEEeee-cCeeEEEEEccCCCc------------------hhHHHHHHHHHHhhcCCCCceeeEeee
Q 044673 426 EPSWKIGEGRYGNVYRGLL-RHLHVAIKMFPSYGP------------------QSHLKFQNEVEVLSRVRHPNLVTLIGT 486 (780)
Q Consensus 426 ~~~~~IG~G~~G~Vyk~~~-~~~~VAiK~l~~~~~------------------~~~~~f~~Ev~il~~l~HpnIv~l~g~ 486 (780)
...++||+|+||.||+|.. ++..||||+++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3467899999999999986 578999998753110 012335678899999999999998876
Q ss_pred ecCCCeeEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCccccCCCCCCceEecCCCCccccccc
Q 044673 487 CPESRSLVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNEPCIIHGNLKPSKVLIDANFGSKLSDFG 566 (780)
Q Consensus 487 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ivHrDlKp~NILLd~~~~~Kl~DFG 566 (780)
. ..+|+|||++++.+.+ +++.....++.|++.+|.|||+.+ |+||||||+|||+++++ ++|+|||
T Consensus 83 ~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 E--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp E--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETTE-EEECCCT
T ss_pred c--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCCC-EEEEECC
Confidence 4 3589999998866543 233445679999999999999999 99999999999999655 8999999
Q ss_pred ccccccCCCCCCCCcccccCCCCCCcccCCh------hhhccCCCCcchhHHHHHHHHH
Q 044673 567 FFHLIPQGESTGNSALCNESNNDSASVYIDP------EYLETGKLTPESDVYSFGIILL 619 (780)
Q Consensus 567 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~~~ksDVwS~Gvil~ 619 (780)
+|.....+.. ..|... +++ ...|+.++|+||..--++
T Consensus 148 ~a~~~~~~~~---------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 148 QSVEVGEEGW---------------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TCEETTSTTH---------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CcccCCCCCc---------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 9876532210 112211 222 355788999999765443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.83 E-value=1.1e-20 Score=182.91 Aligned_cols=139 Identities=18% Similarity=0.264 Sum_probs=99.5
Q ss_pred CeEEEEecCCcc---------ccHHHHHHHhhhc--CCC---eEEEEeecCCCCcccc-CCcc-ccc----ccCCHHHHH
Q 044673 18 ETIFVAVGKNVE---------KNKTTVFWALQNF--AGK---KISLLHVHKPSHVFAF-KESK-CAV----NGLKQHADK 77 (780)
Q Consensus 18 ~~I~VAVD~s~~---------~S~~Al~wAl~~~--~~~---~i~lvHV~~~~~~~~~-~~~~-~~~----~~~~~~~~~ 77 (780)
.||+|||||| . .|++||+||++++ .++ .|+++||.++...... .+.. ... ....+....
T Consensus 2 ~ki~vavd~s-~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (171)
T d2gm3a1 2 TKVMVAVNAS-TIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAK 80 (171)
T ss_dssp EEEEEECCBC-SSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHH
T ss_pred CEEEEEEcCC-cccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHH
Confidence 4899999998 6 7999999999988 344 5999999876532211 1111 110 001111111
Q ss_pred -HHHHHHHHHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEE
Q 044673 78 -IQVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHI 156 (780)
Q Consensus 78 -~~ll~~~~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V 156 (780)
.++|+.+...|...|+++++++.+| ++.++|+++|+++++|+||||++|++++.|.++|| ++.+|+++++ |+|
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGS---v~~~vi~~~~--cpV 154 (171)
T d2gm3a1 81 GLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGT---VSAFCVKHAE--CPV 154 (171)
T ss_dssp HHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------C---HHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhhcCCcEEEeccCCccccccCccCc---HHHHHHhCCC--CCE
Confidence 7899999999999999999877765 78999999999999999999999999999999999 9999999999 999
Q ss_pred EEEeeCc
Q 044673 157 WFCCKGC 163 (780)
Q Consensus 157 ~vv~kg~ 163 (780)
+||.++.
T Consensus 155 lvV~~~~ 161 (171)
T d2gm3a1 155 MTIKRNA 161 (171)
T ss_dssp EEEECCG
T ss_pred EEEeCCC
Confidence 9997553
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.83 E-value=1.8e-20 Score=179.01 Aligned_cols=140 Identities=11% Similarity=0.117 Sum_probs=112.5
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccC--Cccc---ccccCCHHH--------HH--H
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFK--ESKC---AVNGLKQHA--------DK--I 78 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~--~~~~---~~~~~~~~~--------~~--~ 78 (780)
|+++||||||+| +.|++|++||++.+ .+++|+|+||.++....... .... ......+.. .. +
T Consensus 2 m~~~ILvavD~s-~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (160)
T d1mjha_ 2 MYKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAK 80 (160)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHH
T ss_pred CcCeEEEEECCC-HHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHH
Confidence 789999999999 99999999998876 68899999998765432210 0000 001111110 00 6
Q ss_pred HHHHHHHHHHhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEE
Q 044673 79 QVFDQYLLLLSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWF 158 (780)
Q Consensus 79 ~ll~~~~~~c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~v 158 (780)
+.|+.+...|...||++++++..| +++++|+++|++.++|+||||++|++++.+.|+|| ++.+|++++| |+|+|
T Consensus 81 ~~l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS---~a~~vl~~s~--~pVlv 154 (160)
T d1mjha_ 81 NKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGS---VTENVIKKSN--KPVLV 154 (160)
T ss_dssp HHHHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCH---HHHHHHHHCC--SCEEE
T ss_pred HHHHHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCc---HHHHHHhcCC--CCEEE
Confidence 788999999999999999988876 88999999999999999999999999999999999 9999999999 99999
Q ss_pred EeeC
Q 044673 159 CCKG 162 (780)
Q Consensus 159 v~kg 162 (780)
|.+.
T Consensus 155 V~~~ 158 (160)
T d1mjha_ 155 VKRK 158 (160)
T ss_dssp ECCC
T ss_pred EcCC
Confidence 9754
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.78 E-value=2.5e-19 Score=165.98 Aligned_cols=133 Identities=15% Similarity=0.195 Sum_probs=102.6
Q ss_pred CCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCce
Q 044673 17 EETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGVQ 94 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V~ 94 (780)
|++|+||||+| +.|.+|++||++.+ .+++|+|+||.++..... +.........+ . .+++...+..++...|+.
T Consensus 1 yk~Ilv~~D~s-~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~--~~~~~~~~~~~-~-~~~~~~~l~~~~~~~~~~ 75 (135)
T d2z3va1 1 FKTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL--GEPFFEEALRR-R-LERAEGVLEEARALTGVP 75 (135)
T ss_dssp CCEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTC--CTTHHHHHHHH-H-HHHHHHHHHHHHHHHCCC
T ss_pred CCEEEEEECCC-HHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccc--ccchhHHHHHH-H-HHHHHHHHHHHHHhcCCC
Confidence 57999999999 99999999998876 689999999998754221 11111111111 1 133333334444555776
Q ss_pred eeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEE
Q 044673 95 GDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFC 159 (780)
Q Consensus 95 ~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv 159 (780)
..+.++..+++.++|+++|.++++|+||||++|++++.|+++|| ++.+|++++| |+|+||
T Consensus 76 ~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs---~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 76 KEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGS---QSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp GGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBH---HHHHHHHHCS--SCEEEE
T ss_pred eEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCc---HHHHHHHhCC--CCEEeC
Confidence 66666777789999999999999999999999999999999999 9999999999 999997
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.76 E-value=2.5e-18 Score=161.32 Aligned_cols=139 Identities=17% Similarity=0.107 Sum_probs=102.4
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc-CCCeEEEEeecCCCCccccCCcccccccCCH--HHHHHHHHHHHHHHHhhcC
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF-AGKKISLLHVHKPSHVFAFKESKCAVNGLKQ--HADKIQVFDQYLLLLSQAG 92 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~-~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~~~~c~~~~ 92 (780)
.+++|+||||+| +.|++|++||+..+ .++..+++|++.+.................+ ....++.++.+...|.+.|
T Consensus 4 ~yk~ILv~vD~s-~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (147)
T d1tq8a_ 4 AYKTVVVGTDGS-DSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAG 82 (147)
T ss_dssp CCCEEEEECCSS-HHHHHHHHHHHHHHTTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTT
T ss_pred CCCEEEEEECCC-HHHHHHHHHHHHHHhcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 368999999999 99999999998866 4445555555544322211111111111111 1111789999999999999
Q ss_pred ceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 93 VQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 93 V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
+......+..+++.+.|+++++++++|+||||+++++++.+.++|| ++.+|++++| |+|+||.
T Consensus 83 ~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs---~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 83 AKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGS---VPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp CCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBB---HHHHHHHHTT--CEEEEEC
T ss_pred CCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccccccc---HHHHHHHhCC--CCEEEEe
Confidence 9754555666788999999999999999999999999999999999 9999999999 9999995
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.74 E-value=2.4e-18 Score=160.05 Aligned_cols=135 Identities=15% Similarity=0.088 Sum_probs=104.1
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
|+++|+||||+| +.|+.|+.||+..+ .+++|+++||.++.................+.. .+++...+...+.+.++
T Consensus 1 myk~ILv~vD~s-~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 78 (140)
T d1jmva_ 1 MYKHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRI-STETQKALLDLAESVDY 78 (140)
T ss_dssp CCSEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCC-CCHHHHHHHHHHHHSSS
T ss_pred CCCeEEEEECCC-HHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHH-HHHHHHHHHHHHHhcCC
Confidence 789999999999 99999999998877 689999999987764322211111000000000 04556666677777788
Q ss_pred eeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhhcchhHHHHHhhCCCCcEEEEEe
Q 044673 94 QGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLELKSKKAIFVCQQAPISCHIWFCC 160 (780)
Q Consensus 94 ~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs~s~va~~V~~~ap~~C~V~vv~ 160 (780)
...+.++..++++++|+++++++++|+||||++|+++. .+|| ++.+|+++++ |+|+||-
T Consensus 79 ~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~---~lgs---~~~~li~~~~--~pVliVp 137 (140)
T d1jmva_ 79 PISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWS---KLMS---STRQVMNTIK--IDMLVVP 137 (140)
T ss_dssp CCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHH---HHHH---HHHHHHTTCC--SEEEEEE
T ss_pred ceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCC---Cccc---HHHHHHhccC--CCEEEEe
Confidence 77777787889999999999999999999999998865 3788 9999999999 9999994
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.66 E-value=8e-17 Score=148.98 Aligned_cols=120 Identities=8% Similarity=0.055 Sum_probs=91.9
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc--CCCeEEEEeecCCCCcccc----CCcccccccCCHHHH--HHHHHHHHHHH
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF--AGKKISLLHVHKPSHVFAF----KESKCAVNGLKQHAD--KIQVFDQYLLL 87 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~--~~~~i~lvHV~~~~~~~~~----~~~~~~~~~~~~~~~--~~~ll~~~~~~ 87 (780)
+-++||||+|+| +.|+.||+||++.+ .+++|+|+||.++...... .+..... ...++.. .++.++.+...
T Consensus 3 ~mk~ILv~~D~S-~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~-~~~e~~~~~~~~~l~~~~~~ 80 (138)
T d1q77a_ 3 AMKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPP-EIKEESKKRIERRLREVWEK 80 (138)
T ss_dssp CCEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCT-HHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEeCC-HHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhh-hhhhhhhhhccccchhhccc
Confidence 558999999999 99999999998876 5899999999875432211 1111111 1111111 16667777777
Q ss_pred HhhcCceeeEEEeecCchhhHHHHHHHhcCcceEEeeccCCchhhHhhhhh
Q 044673 88 LSQAGVQGDSVWIEKDNVEDGIVEVITQQNIRWLVMGAAADKHYSKKLLEL 138 (780)
Q Consensus 88 c~~~~V~~e~~vie~~~v~~~I~~~~~~~~id~lVmGs~g~~~~~r~~~gs 138 (780)
+...++.++..+..| ++++.|+++|+++++|+||||++|.++++|.++||
T Consensus 81 ~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~ 130 (138)
T d1q77a_ 81 LTGSTEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGL 130 (138)
T ss_dssp HHSCCCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHS
T ss_pred ccccceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCC
Confidence 777888888877665 78999999999999999999999999999999998
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2e-14 Score=124.49 Aligned_cols=74 Identities=24% Similarity=0.371 Sum_probs=68.1
Q ss_pred CccccCCccccccccccccCcccccCC-cccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 706 EHRRIPSHFVCPILQEVMKDPQIAADG-FTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 706 ~~~~~Ps~f~CPi~~evm~dP~ia~dg-~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
....+|..|.|||..++|.||++...| .||++.+|+.||.. +.+||.|+++|...+|+||++||.+|++|+.++
T Consensus 15 ~~~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~~ 89 (98)
T d1wgma_ 15 TYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CCCSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred hhcCCcHHhCCcCchhHHHHHHhcccccchhhHHHHHHHHHh-cCCcccccccccchhhcchHHHHHHHHHHHHHH
Confidence 346799999999999999999999876 59999999999976 679999999999999999999999999999764
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.45 E-value=2.5e-14 Score=118.84 Aligned_cols=73 Identities=42% Similarity=0.764 Sum_probs=69.7
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
+.+|+.|.|||..++|.||++...|++|.+..|+.|+..+..++|.++.++...+++||++||++|++|+++|
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCCccCCCcCcCchhhCceEccCCCcchHHHHHHHHHHCCCCCCcccccCCcccccchHHHHHHHHHHHHHh
Confidence 3588999999999999999999999999999999999988889999999999999999999999999999876
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.42 E-value=5.2e-14 Score=117.45 Aligned_cols=73 Identities=29% Similarity=0.454 Sum_probs=69.5
Q ss_pred cccCCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHhhC
Q 044673 708 RRIPSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQRW 780 (780)
Q Consensus 708 ~~~Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~~~ 780 (780)
+..|+.|.|||..++|.||++...|+||++..|+.|+..++.+||.+++++...+|+||++||++|++|+.+|
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~~ 74 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 74 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCCccccCcCcCchhhhhcccCCcCeecHHHHHHHHhcCCccCCCccccccccccccHHHHHHHHHHHHHHC
Confidence 4679999999999999999999999999999999999988889999999999999999999999999999875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=3.6e-07 Score=92.10 Aligned_cols=146 Identities=13% Similarity=0.105 Sum_probs=94.3
Q ss_pred HHHHHHhcCCCcccccccCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCC-CCceeeEeeeec--CCCe
Q 044673 416 SELNEATNNFEPSWKIGEGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVR-HPNLVTLIGTCP--ESRS 492 (780)
Q Consensus 416 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~-HpnIv~l~g~~~--~~~~ 492 (780)
+|+......|...+..+-|+.+.||+...++..+.+|+...........+.+|+..+..+. +--+.+++.++. +..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4566666777766554444457899988788889999876543333445678888877664 322455666553 3357
Q ss_pred eEEEeccCCChhhHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 044673 493 LVFEYLRNGSLEDCLACKNKKSPLRWQTRMQIASDVCSALIYLHSNE--------------------------------- 539 (780)
Q Consensus 493 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--------------------------------- 539 (780)
+||++++|.++.+... . .. ....++.+++..|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~---~--~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE---D--EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTT---T--CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccc---c--cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999988765431 0 01 11223444444444444311
Q ss_pred -----------------------C-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 540 -----------------------P-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 540 -----------------------~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
+ .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 37899999999999987767799998754
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.32 E-value=6.9e-08 Score=73.63 Aligned_cols=52 Identities=19% Similarity=0.390 Sum_probs=48.1
Q ss_pred cccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCccc
Q 044673 714 FVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPN 766 (780)
Q Consensus 714 f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn 766 (780)
.+|||..++|.||++. ..|++|++++|..|+.. +++||+|+++|...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEEC
T ss_pred CCCccCCchHHhcCccCCCCCcccHHHHHHHHhh-ccCCCccCCcCCHHhceeC
Confidence 4799999999999988 48999999999999997 6799999999999999985
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00012 Score=77.97 Aligned_cols=76 Identities=20% Similarity=0.153 Sum_probs=50.5
Q ss_pred ccccccCCceEEEEeeec--CeeEEEEEccC----CC---chhHHHHHHHHHHhhcCC---CCceeeEeeeecCCCeeEE
Q 044673 428 SWKIGEGRYGNVYRGLLR--HLHVAIKMFPS----YG---PQSHLKFQNEVEVLSRVR---HPNLVTLIGTCPESRSLVF 495 (780)
Q Consensus 428 ~~~IG~G~~G~Vyk~~~~--~~~VAiK~l~~----~~---~~~~~~f~~Ev~il~~l~---HpnIv~l~g~~~~~~~LV~ 495 (780)
.+.||.|....||+.... +..|+||.-.. .+ +....+...|...|..+. ...+.++++++++...+||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence 346899999999998764 45789996432 11 112233446777776652 2456778888888889999
Q ss_pred EeccCCCh
Q 044673 496 EYLRNGSL 503 (780)
Q Consensus 496 Ey~~~gsL 503 (780)
||+++..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99987543
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.32 E-value=0.00019 Score=60.47 Aligned_cols=63 Identities=11% Similarity=0.148 Sum_probs=56.3
Q ss_pred ccccccccccccCcccc-cCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCcccHHHHHHHHHHHh
Q 044673 713 HFVCPILQEVMKDPQIA-ADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 713 ~f~CPi~~evm~dP~ia-~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~ 778 (780)
.+.|||-.++|.+|+.. .=|++|-...|..|+. ..||..+.++...++.||.+|...|+.+..
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~---~~CP~Cr~~~~~~~l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG---TGCPVCYTPAWIQDLKINRQLDSMIQLCSK 85 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT---TBCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred cCCCccCCchhhcCceeCCCCCchhHHHHHHHHh---ccccccCCcCchhhCcccHHHHHHHHHHHH
Confidence 46799999999999876 4699999999999995 369999999999999999999999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.11 E-value=0.0004 Score=68.54 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=77.2
Q ss_pred ccccCCc-eEEEEeeecC-eeEEEEEccCCCchhHHHHHHHHHHhhcCCC--CceeeEeeeecC--CCeeEEEeccCCCh
Q 044673 430 KIGEGRY-GNVYRGLLRH-LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRH--PNLVTLIGTCPE--SRSLVFEYLRNGSL 503 (780)
Q Consensus 430 ~IG~G~~-G~Vyk~~~~~-~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~H--pnIv~l~g~~~~--~~~LV~Ey~~~gsL 503 (780)
.+..|.. +.||+...++ ..+++|....... ..+..|+..|+.+.. -.+.++++++.+ ..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 6899887764 4578887665432 235577777776642 234556666544 35799999988665
Q ss_pred hhH--------------HhhhC----CCCCCC--HHHHHHHHH--------------------HHHHHHHHHHcCC----
Q 044673 504 EDC--------------LACKN----KKSPLR--WQTRMQIAS--------------------DVCSALIYLHSNE---- 539 (780)
Q Consensus 504 ~~~--------------L~~~~----~~~~l~--~~~~~~i~~--------------------~i~~aL~~LH~~~---- 539 (780)
.+. |..-. ...++. +.....-.. .....+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 331 11100 000111 111110000 1222333443322
Q ss_pred C-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 540 P-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 540 ~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
+ .++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2 37999999999999987777899998654
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.35 E-value=0.0011 Score=56.12 Aligned_cols=66 Identities=17% Similarity=0.259 Sum_probs=58.8
Q ss_pred ccccccccccccCcccccCCcccchHHHHhhhccCC--CCCCCCcCCCCCCCCcccHHHHHHHHHHHh
Q 044673 713 HFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGH--NTSPMTNLKLEHCNLLPNYALHQAIIEWQQ 778 (780)
Q Consensus 713 ~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~--~t~p~t~~~l~~~~l~pn~~l~~~i~~~~~ 778 (780)
.+.|||=.+++.+|++..=|++|-+..|..|+.... ..||+.+.++...+|.||..|+..|+.+++
T Consensus 21 ~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~~ 88 (103)
T d1jm7a_ 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (103)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CcCCCccCchhCCeEEcCCCCchhhHHHHHHHHHCCCCCcCcCCCCcCChhhCCcCHHHHHHHHHHHH
Confidence 356999999999999999999999999999997543 479999999999999999999999988864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.08 E-value=0.0091 Score=60.52 Aligned_cols=156 Identities=12% Similarity=0.062 Sum_probs=80.7
Q ss_pred ccCHHHHHHHhcCCCcccccc-----cCCceEEEEeeecCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce--eeEe
Q 044673 412 EFSFSELNEATNNFEPSWKIG-----EGRYGNVYRGLLRHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLI 484 (780)
Q Consensus 412 ~~~~~ei~~at~~f~~~~~IG-----~G~~G~Vyk~~~~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI--v~l~ 484 (780)
.+|.+||.....+|....... .|---+.|+...++..+++|++..... ......|+.++..|...++ ...+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 457788888888887654433 343456798887777899999865322 2233345666666532221 1111
Q ss_pred e--------eecCCCeeEEEeccCCChhh--------------HHhhhCC-------CCCCCHH----------------
Q 044673 485 G--------TCPESRSLVFEYLRNGSLED--------------CLACKNK-------KSPLRWQ---------------- 519 (780)
Q Consensus 485 g--------~~~~~~~LV~Ey~~~gsL~~--------------~L~~~~~-------~~~l~~~---------------- 519 (780)
- ........++.++.+..... .++.... .....+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11222335666665532211 0110000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHcC-CC-ccccCCCCCCceEecCCCCcccccccccc
Q 044673 520 -TRMQIASDVCSALIYLHSN-EP-CIIHGNLKPSKVLIDANFGSKLSDFGFFH 569 (780)
Q Consensus 520 -~~~~i~~~i~~aL~~LH~~-~~-~ivHrDlKp~NILLd~~~~~Kl~DFGla~ 569 (780)
.....+..+...+.-.+.. -| .+||+|+.++|||++.+...-|.|||.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111122222223333322 23 59999999999999998877899999753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.83 E-value=0.0061 Score=64.27 Aligned_cols=71 Identities=15% Similarity=0.230 Sum_probs=46.3
Q ss_pred cccccCCceEEEEeeecC---------eeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce-eeEeeeecCCCeeEEEec
Q 044673 429 WKIGEGRYGNVYRGLLRH---------LHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL-VTLIGTCPESRSLVFEYL 498 (780)
Q Consensus 429 ~~IG~G~~G~Vyk~~~~~---------~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI-v~l~g~~~~~~~LV~Ey~ 498 (780)
..|+.|--=.+|+..... ..|.+++.-. . .......+|..+++.+.-.++ .+++++|++ .+|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEEe
Confidence 457767677899877532 3466666542 2 222344578888888853344 578888864 6899999
Q ss_pred cCCCh
Q 044673 499 RNGSL 503 (780)
Q Consensus 499 ~~gsL 503 (780)
+|..|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87544
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.71 E-value=0.0049 Score=50.16 Aligned_cols=63 Identities=16% Similarity=0.170 Sum_probs=55.7
Q ss_pred CCccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCc-ccHHHHHHH
Q 044673 711 PSHFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLL-PNYALHQAI 773 (780)
Q Consensus 711 Ps~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~-pn~~l~~~i 773 (780)
...+.|||=.+++.+|++..=|++|=+..|+.|++.+..+||+.+.++.-.+|. |..++++.+
T Consensus 21 ~~~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l 84 (86)
T d1rmda2 21 VKSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNIL 84 (86)
T ss_dssp HHHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHH
T ss_pred ccCcCCccCCcchhcceecCCCChhhHHHHHHHHhhCCCcCcccCCCCChhhccCHHHHHHHHh
Confidence 345789999999999999999999999999999988778999999999988887 688877654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.34 E-value=0.023 Score=57.87 Aligned_cols=65 Identities=9% Similarity=0.044 Sum_probs=39.4
Q ss_pred eEEEEeee-cCeeEEEEEccCCCchhHHHHHHHHHHhhcCCCCce--eeEeee-------ecCCCeeEEEeccCCC
Q 044673 437 GNVYRGLL-RHLHVAIKMFPSYGPQSHLKFQNEVEVLSRVRHPNL--VTLIGT-------CPESRSLVFEYLRNGS 502 (780)
Q Consensus 437 G~Vyk~~~-~~~~VAiK~l~~~~~~~~~~f~~Ev~il~~l~HpnI--v~l~g~-------~~~~~~LV~Ey~~~gs 502 (780)
=.||+... +|..|++|+.+.. .....++..|...+..|...++ +..+.. ..+..+.+++|++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 37999887 4778999998753 2245567788888877642221 111111 1222456889887643
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.59 E-value=0.022 Score=45.27 Aligned_cols=52 Identities=19% Similarity=0.320 Sum_probs=46.7
Q ss_pred ccccccccccccCcccccCCcccchHHHHhhhccCCCCCCCCcCCCCCCCCc
Q 044673 713 HFVCPILQEVMKDPQIAADGFTYEGEAIRGWLKSGHNTSPMTNLKLEHCNLL 764 (780)
Q Consensus 713 ~f~CPi~~evm~dP~ia~dg~tye~~~i~~~l~~~~~t~p~t~~~l~~~~l~ 764 (780)
...|||=.+.+.+|.+..=|++|-.+.|..|+.++..+||+.+..+...+.+
T Consensus 23 ~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~i 74 (79)
T d1fbva4 23 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPI 74 (79)
T ss_dssp TTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCCS
T ss_pred CCCCccCCCcCCCeEEeCCCCeeeHHHHHHHHHHCcCcCCCCCcCccCCcee
Confidence 4579999999999999999999999999999988788999999999876644
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=92.86 E-value=0.17 Score=48.02 Aligned_cols=104 Identities=6% Similarity=-0.062 Sum_probs=65.9
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhc----CCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhc
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNF----AGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQA 91 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~----~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~ 91 (780)
.+++|+|||.|. ..|...|..+ ..+ ....|+++||..-.. .+. .+-......+|...
T Consensus 23 ~~~kv~Va~SGG-~DS~~Ll~lL-~~~~~~~~~~~i~~~~vdh~~r--------------~~s---~~~~~~~~~~~~~l 83 (216)
T d1wy5a1 23 GERRVLIAFSGG-VDSVVLTDVL-LKLKNYFSLKEVALAHFNHMLR--------------ESA---ERDEEFCKEFAKER 83 (216)
T ss_dssp SCCEEEEECCSS-HHHHHHHHHH-HHSTTTTTCSEEEEEEEECCSS--------------THH---HHHHHHHHHHHHHH
T ss_pred CCCeEEEEeCCc-HHHHHHHHHH-HHHHHhcCCCcEEEEEeecccc--------------cch---hhhhhHHHHHHHhh
Confidence 357999999999 8887555444 333 345799999965311 000 11124457888888
Q ss_pred CceeeEEEeec--------Cch--------hhHHHHHHHhcCcceEEeeccCCc----hhhHhhhhh
Q 044673 92 GVQGDSVWIEK--------DNV--------EDGIVEVITQQNIRWLVMGAAADK----HYSKKLLEL 138 (780)
Q Consensus 92 ~V~~e~~vie~--------~~v--------~~~I~~~~~~~~id~lVmGs~g~~----~~~r~~~gs 138 (780)
||++...-+.. .+. -..+.+++.++|+|.|++|.+.+- .+.+.+.|+
T Consensus 84 ~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD~~Et~l~~l~rg~ 150 (216)
T d1wy5a1 84 NMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLNDLLETSLLFFTRGT 150 (216)
T ss_dssp TCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHHHHHHHHHHHHHCC
T ss_pred hhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeeccchHHHHHHHhhcCC
Confidence 99876443321 111 135678999999999999999763 344555554
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=86.97 E-value=0.43 Score=45.34 Aligned_cols=104 Identities=14% Similarity=-0.040 Sum_probs=63.0
Q ss_pred CCeEEEEecCCccccHHHHHHHhh---hcCCCeEEEEeecCCCCccccCCcccccccCCHHHHHHHHHHHHHHHHhhcCc
Q 044673 17 EETIFVAVGKNVEKNKTTVFWALQ---NFAGKKISLLHVHKPSHVFAFKESKCAVNGLKQHADKIQVFDQYLLLLSQAGV 93 (780)
Q Consensus 17 ~~~I~VAVD~s~~~S~~Al~wAl~---~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~V 93 (780)
.++|+|||.|. ..|...+..+.+ ...+..|+++||..-.. + .. .+-......+|.+.||
T Consensus 13 ~kkvlva~SGG-~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r---------~----~s----~~~~~~~~~~~~~~~i 74 (227)
T d1ni5a1 13 SRQILVAFSGG-LDSTVLLHQLVQWRTENPGVALRAIHVHHGLS---------A----NA----DAWVTHCENVCQQWQV 74 (227)
T ss_dssp CSEEEEECCSB-HHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC---------S----SH----HHHHHHHHHHHHHTTC
T ss_pred CCcEEEEecCc-HHHHHHHHHHHHHHHhCCCceEEEEEeCCCCC---------c----ch----hhhHHHHHHHHhhccC
Confidence 46999999999 778765554433 22577899999975321 0 11 2234557888999999
Q ss_pred eeeEEEeecCchhh----------HHHHHHHhcCcceEEeeccCCc----hhhHhhhhh
Q 044673 94 QGDSVWIEKDNVED----------GIVEVITQQNIRWLVMGAAADK----HYSKKLLEL 138 (780)
Q Consensus 94 ~~e~~vie~~~v~~----------~I~~~~~~~~id~lVmGs~g~~----~~~r~~~gs 138 (780)
+.....+....... .........+++.|++|-+.+- .+.+.+.|+
T Consensus 75 ~~~i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~dD~~Et~l~~l~~g~ 133 (227)
T d1ni5a1 75 PLVVERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHLDDQCETFLLALKRGS 133 (227)
T ss_dssp CEEEECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCHHHHHHHHHHHHTTTC
T ss_pred cceeeeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhhhhhHhhhccc
Confidence 87654333211111 1222345678888888877643 344555544
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=84.94 E-value=2.7 Score=38.63 Aligned_cols=37 Identities=16% Similarity=0.420 Sum_probs=28.1
Q ss_pred CCCeEEEEecCCccccHHHHHHHhhhcCCCeEEEEeecCC
Q 044673 16 VEETIFVAVGKNVEKNKTTVFWALQNFAGKKISLLHVHKP 55 (780)
Q Consensus 16 ~~~~I~VAVD~s~~~S~~Al~wAl~~~~~~~i~lvHV~~~ 55 (780)
..+||+||+.|. ..|.-++.++.+ .|..|+.||+...
T Consensus 3 ~~gKvvv~~SGG-~DS~vla~ll~k--~g~~v~av~~~~~ 39 (218)
T d2c5sa1 3 VGGKVMVLLSGG-IDSPVAAYLTMK--RGVSVEAVHFHSP 39 (218)
T ss_dssp TTEEEEEECCSS-SHHHHHHHHHHH--BTEEEEEEEEECT
T ss_pred CCCEEEEEecCc-HHHHHHHHHHHH--cCCeEEEEEEeCC
Confidence 346999999999 777666666654 3678999999753
|